Clustering O 0 1.3548194033319305e-07
of O 0 5.492749033386701e-10
missense O 0 2.1159705283935182e-05
mutations O 0 0.00011934088979614899
in O 0 7.694953119141701e-09
the O 0 6.133375336503377e-07
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999639987945557
telangiectasia I-Disease 1 0.9999990463256836
gene O 0 3.897721035173163e-05
in O 0 1.3055234671099925e-10
a O 0 1.1069869465529791e-09
sporadic B-Disease 0 3.765170049518929e-06
T I-Disease 1 0.9381572604179382
- I-Disease 0 0.15224005281925201
cell I-Disease 0 0.22740498185157776
leukaemia I-Disease 1 0.931911826133728
. O 0 1.3236781448711099e-08

Ataxia B-Disease 1 0.999993085861206
- I-Disease 1 0.9999788999557495
telangiectasia I-Disease 1 0.9999983310699463
( O 0 0.0033578132279217243
A B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999977350234985
T I-Disease 1 0.9999998807907104
) O 0 4.068200498696939e-10
is O 0 4.669782355942731e-12
a O 0 5.601722211090454e-11
recessive B-Disease 0 0.0001317562273470685
multi I-Disease 1 0.6733967661857605
- I-Disease 1 0.9999935626983643
system I-Disease 1 0.9869400858879089
disorder I-Disease 1 0.9829331636428833
caused O 0 9.39371602726169e-09
by O 0 1.2148025640978943e-12
mutations O 0 1.119435655283496e-09
in O 0 4.789099889226933e-13
the O 0 1.053126336136856e-12
ATM O 0 1.347281886410201e-05
gene O 0 2.3834319407001203e-08
at O 0 1.5187598734200947e-08
11q22 O 0 1.1116575393543826e-07
- O 0 3.3951712339330697e-06
q23 O 0 4.6030226030779886e-07
( O 0 4.763459418577476e-11
ref O 0 1.912733978315373e-06
. O 0 2.923256471956681e-12
3 O 0 5.450843595933286e-11
) O 0 5.886315740388781e-12
. O 0 3.476371274180323e-11

The O 0 6.351391856895816e-09
risk O 0 1.3930060731581762e-06
of O 0 2.265145432334137e-10
cancer B-Disease 0 6.52060725769843e-06
, O 0 1.5265619324189572e-10
especially O 0 2.9240457277701637e-10
lymphoid B-Disease 0 9.712818638263343e-08
neoplasias I-Disease 0 1.7778708070181892e-06
, O 0 1.4362176378734937e-11
is O 0 1.2693155554410751e-11
substantially O 0 1.546958117160102e-08
elevated O 0 1.873823202913627e-05
in O 0 1.2293146944841737e-08
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 7.518630445702001e-05
and O 0 1.1647195430342094e-09
has O 0 1.0587106746839936e-09
long O 0 2.542011934281163e-09
been O 0 3.76197029083869e-09
associated O 0 1.9382541405210674e-10
with O 0 3.5148868704482084e-08
chromosomal O 1 0.9999997615814209
instability O 1 0.9999978542327881
. O 0 3.3636410989856813e-07

By O 0 1.3119243469361663e-09
analysing O 0 7.243903610287816e-07
tumour B-Disease 1 0.9999297857284546
DNA O 0 1.4346216630656272e-05
from O 0 8.17047762780021e-10
patients O 0 4.419241916853167e-10
with O 0 6.895109917054443e-12
sporadic B-Disease 0 3.2536794947191083e-07
T I-Disease 1 0.6049872636795044
- I-Disease 0 0.010082335211336613
cell I-Disease 0 0.06355613470077515
prolymphocytic I-Disease 0 0.4971897602081299
leukaemia I-Disease 0 0.18207667768001556
( O 0 3.5312945900756176e-09
T B-Disease 0 0.00041677901754155755
- I-Disease 0 7.072644166328246e-06
PLL I-Disease 0 1.601978874532506e-05
) O 0 2.3057838624551685e-11
, O 0 1.6607192238147356e-13
a O 0 2.753551076387084e-12
rare O 0 2.1218482526563776e-10
clonal B-Disease 0 4.693598611993366e-07
malignancy I-Disease 0 2.3986789528862573e-05
with O 0 2.0890555951780243e-10
similarities O 0 5.389160784297076e-10
to O 0 4.4029406856549436e-12
a O 0 3.5936409403802827e-10
mature B-Disease 0 1.637131816778492e-07
T I-Disease 0 3.381465285201557e-05
- I-Disease 0 1.1418087524361908e-06
cell I-Disease 0 1.2008972589683253e-05
leukaemia I-Disease 0 0.0003883510653395206
seen O 0 8.279971552838106e-07
in O 0 6.5091793066685e-10
A B-Disease 1 0.9999828338623047
- I-Disease 1 0.9999945163726807
T I-Disease 1 1.0
, O 0 1.8224263764743398e-10
we O 0 1.082968350413216e-12
demonstrate O 0 2.9123803520735014e-13
a O 0 1.6363013645871033e-13
high O 0 8.155418007582682e-11
frequency O 0 1.6405311137335232e-11
of O 0 2.7555895933117913e-12
ATM O 0 0.00013822599430568516
mutations O 0 6.940114758435811e-07
in O 0 2.6468864877671194e-09
T B-Disease 0 0.00743924779817462
- I-Disease 0 0.0003333531494718045
PLL I-Disease 0 0.0005207994254305959
. O 0 7.146743641328612e-09

In O 0 6.067060742687147e-10
marked O 0 7.047450956143564e-10
contrast O 0 7.816033931185018e-11
to O 0 1.7964031954684212e-12
the O 0 2.313633225975442e-12
ATM O 0 3.6916153476340696e-05
mutation O 0 1.1960150914092083e-07
pattern O 0 4.295778239793435e-07
in O 0 3.070385190540037e-08
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
, O 0 1.819286804538578e-10
the O 0 2.0816185689227773e-13
most O 0 1.4971388657882695e-13
frequent O 0 2.8200326188804192e-12
nucleotide O 0 4.75154804391309e-10
changes O 0 3.457472155798946e-11
in O 0 3.0098900802300044e-12
this O 0 2.955460529086018e-11
leukaemia B-Disease 0 2.5547771656420082e-05
were O 0 1.86995219308983e-09
missense O 0 2.294225168952835e-06
mutations O 0 2.3245272586791543e-06
. O 0 3.5754701421808477e-09

These O 0 2.661561526728917e-10
clustered O 0 2.4232200246387947e-08
in O 0 2.06608723185564e-11
the O 0 3.659514531684227e-12
region O 0 9.182873211832643e-12
corresponding O 0 1.1399444756199362e-11
to O 0 3.9472904111992335e-12
the O 0 3.907961194232756e-12
kinase O 0 3.295575723427646e-08
domain O 0 3.170876672342615e-09
, O 0 3.68461823552213e-11
which O 0 1.7929868744229194e-12
is O 0 1.042219804382738e-12
highly O 0 2.2111396914825665e-12
conserved O 0 2.255534647943591e-11
in O 0 6.297029304241919e-12
ATM O 0 1.2444088497431949e-05
- O 0 6.913215884196688e-07
related O 0 5.0592530165261e-09
proteins O 0 1.2670570148642923e-10
in O 0 4.089824832964606e-12
mouse O 0 1.0176972864428535e-06
, O 0 1.3764323014697766e-10
yeast O 0 2.1353539381152586e-08
and O 0 5.813947240307371e-11
Drosophila O 0 4.934564978853473e-10
. O 0 1.7505724647648435e-10

The O 0 8.729404421536913e-10
resulting O 0 4.223835503580631e-09
amino O 0 3.962987271677321e-09
- O 0 7.485455171263311e-07
acid O 0 1.984953978961812e-09
substitutions O 0 4.75903982888326e-10
are O 0 1.7127280496631592e-12
predicted O 0 4.5532844161755293e-10
to O 0 8.67952237859626e-12
interfere O 0 2.081737893178115e-09
with O 0 1.7011395070376523e-10
ATP O 0 2.4928190214268398e-06
binding O 0 3.876728627005832e-08
or O 0 9.918690313526213e-10
substrate O 0 5.9133800078825516e-08
recognition O 0 1.4645682444580643e-09
. O 0 1.0292385832499917e-09

Two O 0 4.6536580144973527e-10
of O 0 7.2128622519151975e-12
seventeen O 0 1.0225509328165572e-08
mutated O 0 2.6135726329812314e-06
T B-Disease 0 0.0010001584887504578
- I-Disease 0 1.0714289828683832e-06
PLL I-Disease 0 1.4503217471428798e-06
samples O 0 8.206685997436125e-09
had O 0 6.531640228679692e-10
a O 0 5.575635873139584e-12
previously O 0 1.0413376827500542e-08
reported O 0 1.0566413948254194e-06
A B-Disease 1 0.9999350309371948
- I-Disease 1 0.9999861717224121
T I-Disease 1 0.9999988079071045
allele O 0 1.1642661775113083e-05
. O 0 4.993543800679845e-09

In O 0 1.2250798153701226e-09
contrast O 0 1.4198440201340645e-09
, O 0 5.957996682820488e-12
no O 0 5.824555681516186e-12
mutations O 0 1.7593903001156264e-09
were O 0 2.978483015780853e-10
detected O 0 7.833955351088662e-08
in O 0 6.527669572410633e-13
the O 0 7.06565069039794e-13
p53 O 0 7.101525097141792e-12
gene O 0 1.233077945306249e-10
, O 0 5.119485022540837e-13
suggesting O 0 1.3772095963648923e-10
that O 0 1.1729939068672035e-11
this O 0 1.2667379645225907e-10
tumour B-Disease 1 0.9999992847442627
suppressor O 0 7.140429715946084e-06
is O 0 6.228476223668622e-08
not O 0 1.9792065208967813e-10
frequently O 0 3.261162451195787e-10
altered O 0 2.5313870999355004e-09
in O 0 1.1538615549144815e-11
this O 0 2.4341406668071386e-10
leukaemia B-Disease 0 0.0001402540656272322
. O 0 1.6371692890260192e-09

Occasional O 0 1.00377292255871e-06
missense O 0 7.650522456970066e-05
mutations O 0 3.338618989801034e-05
in O 0 7.830272541475836e-10
ATM O 0 0.00048311095451936126
were O 0 1.1295546187284344e-07
also O 0 5.747662346067273e-10
found O 0 1.1471303906773755e-09
in O 0 1.3506956664244285e-10
tumour B-Disease 1 0.9999904632568359
DNA O 0 1.8963255570270121e-06
from O 0 4.4952266908815375e-10
patients O 0 5.167366534664097e-10
with O 0 2.434668786022165e-11
B B-Disease 0 2.631219331306056e-07
- I-Disease 0 8.738107680983376e-06
cell I-Disease 0 0.0007801871979609132
non I-Disease 0 0.009847786277532578
- I-Disease 1 0.8324646949768066
Hodgkins I-Disease 1 0.9999562501907349
lymphomas I-Disease 0 0.013489801436662674
( O 0 4.816607113156124e-10
B B-Disease 0 2.403175471954455e-07
- I-Disease 0 9.09333493837039e-07
NHL I-Disease 0 1.7587724414624972e-06
) O 0 4.285266152342926e-12
and O 0 7.418351414927027e-13
a O 0 2.1431644653402415e-11
B B-Disease 0 7.582972472164329e-08
- I-Disease 0 5.019061291022808e-07
NHL I-Disease 0 3.931174603621912e-07
cell O 0 1.0276858120050747e-07
line O 0 2.9214395453891484e-06
. O 0 7.941939328404146e-10

The O 0 8.473761275995528e-11
evidence O 0 5.849218331910322e-11
of O 0 3.449143097869478e-13
a O 0 6.691247382561993e-12
significant O 0 1.0159066296533403e-11
proportion O 0 3.3897662454762667e-10
of O 0 3.803408282765375e-11
loss O 0 2.8301911925154855e-07
- O 0 5.246739647191134e-07
of O 0 3.244914115185793e-09
- O 0 5.721721026930027e-05
function O 0 8.682437169227342e-08
mutations O 0 2.9688109748349234e-07
and O 0 1.1014772427486719e-09
a O 0 1.5912292317121768e-10
complete O 0 2.3373487589850583e-09
absence O 0 1.8317878325291304e-09
of O 0 4.5325161267435743e-13
the O 0 5.837011429754568e-12
normal O 0 5.547334293309891e-12
copy O 0 3.752408106461047e-10
of O 0 2.8115899365632746e-12
ATM O 0 3.8171824598975945e-06
in O 0 8.733659628834545e-12
the O 0 3.578364167478032e-12
majority O 0 7.975783228308941e-12
of O 0 1.709582649056518e-11
mutated O 0 6.527319783344865e-05
tumours B-Disease 1 0.9999985694885254
establishes O 0 3.432290043292596e-07
somatic O 0 4.2331410554652393e-07
inactivation O 0 3.0024361876712646e-06
of O 0 7.782094738582879e-13
this O 0 9.782268988985446e-14
gene O 0 3.5289882127642613e-11
in O 0 1.4490051682396893e-13
the O 0 4.849472602999616e-13
pathogenesis O 0 1.9916540638931224e-10
of O 0 7.2369510557834804e-12
sporadic B-Disease 0 1.1741213938876172e-06
T I-Disease 0 0.23140589892864227
- I-Disease 0 3.471642776275985e-05
PLL I-Disease 0 1.1834027645818423e-05
and O 0 6.412931297106184e-11
suggests O 0 3.340172236021566e-11
that O 0 1.6844581285369031e-12
ATM O 0 2.3884983875177568e-06
acts O 0 3.198205078547289e-08
as O 0 1.8718888938895617e-10
a O 0 5.755871335111351e-09
tumour B-Disease 1 0.999993085861206
suppressor O 0 0.00010008193930843845
. O 0 1.295750706731269e-08

As O 0 1.2877794386412234e-09
constitutional O 0 3.940221413034628e-11
DNA O 0 6.469355895433182e-08
was O 0 2.341982074938187e-08
not O 0 1.0088024166021725e-12
available O 0 2.034217412572037e-12
, O 0 7.978396047124414e-13
a O 0 1.2083564704390426e-10
putative O 0 7.261587143148063e-06
hereditary O 0 0.4305063486099243
predisposition O 0 0.01551205012947321
to O 0 1.243658175553719e-06
T B-Disease 1 0.5983551144599915
- I-Disease 0 2.9374781661317684e-05
PLL I-Disease 0 6.873299753351603e-06
will O 0 5.3261086513378686e-11
require O 0 7.272786431249123e-13
further O 0 1.297735925881796e-13
investigation O 0 8.928370542893305e-11
. O 0 4.115075467880924e-12
. O 0 5.196600441625954e-11

Myotonic B-Disease 1 0.999972939491272
dystrophy I-Disease 1 0.999995231628418
protein O 0 0.001017671194858849
kinase O 0 0.0002757500624284148
is O 0 1.1199353666668799e-09
involved O 0 5.224168667106177e-11
in O 0 1.097281242105376e-13
the O 0 7.776230017981361e-14
modulation O 0 4.843207432325691e-12
of O 0 7.687793544125521e-13
the O 0 4.982275009224324e-11
Ca2 O 0 1.5180783918822272e-07
+ O 0 2.889658219373814e-07
homeostasis O 0 9.028478234540671e-05
in O 0 1.407408856124448e-09
skeletal O 0 0.003396320389583707
muscle O 0 3.3634041756158695e-05
cells O 0 4.718875956655211e-08
. O 0 8.574010945672228e-10

Myotonic B-Disease 1 0.9999828338623047
dystrophy I-Disease 1 0.9999979734420776
( O 0 0.0005484505672939122
DM B-Disease 1 0.9999984502792358
) O 0 6.110241645984615e-09
, O 0 1.2930321960716307e-12
the O 0 8.785263640696817e-13
most O 0 3.537838910716573e-10
prevalent O 0 6.718597433064133e-05
muscular B-Disease 1 0.9763630628585815
disorder I-Disease 1 0.5015044808387756
in O 0 8.385288574608296e-10
adults O 0 3.8162329474289436e-07
, O 0 2.3955709638201483e-10
is O 0 5.270308633953391e-10
caused O 0 2.0464518968310585e-09
by O 0 5.042793266296641e-11
( O 0 8.275524709944193e-11
CTG O 0 1.606228039463531e-07
) O 0 1.744358021742165e-12
n O 0 9.031311254403818e-10
- O 0 1.1077562867001234e-08
repeat O 0 6.848551503679801e-09
expansion O 0 7.95615726079113e-11
in O 0 5.128258318757954e-14
a O 0 2.473497210005171e-13
gene O 0 9.185902906383436e-12
encoding O 0 1.323060151020572e-11
a O 0 5.117949952726519e-10
protein O 0 1.0373613434921936e-07
kinase O 0 6.060919986339286e-05
( O 0 3.026134720585105e-08
DM B-Disease 1 0.9999990463256836
protein O 0 2.085890173475491e-06
kinase O 0 3.224806732760044e-06
; O 0 1.6332012131581308e-10
DMPK O 0 2.8138383640907705e-06
) O 0 1.7640045240491231e-12
and O 0 1.011647837441225e-13
involves O 0 3.70516681572064e-12
changes O 0 7.823248125704563e-12
in O 0 2.0246332822076996e-12
cytoarchitecture O 0 1.935496953819893e-07
and O 0 3.609894883016551e-10
ion O 0 1.5373976225419028e-07
homeostasis O 0 4.6971734263934195e-05
. O 0 2.5973996287120826e-09

To O 0 1.0873408423650588e-10
obtain O 0 3.759226263611026e-11
clues O 0 1.3843368673605028e-09
to O 0 3.9401897543311915e-12
the O 0 1.0298025453214787e-12
normal O 0 1.7233658944348917e-11
biological O 0 2.677182087129637e-10
role O 0 4.270125225636079e-11
of O 0 3.4343071463917296e-13
DMPK O 0 3.233683969483536e-07
in O 0 4.826865903501121e-12
cellular O 0 2.419747318072041e-07
ion O 0 4.577898238267153e-08
homeostasis O 0 9.612148460291792e-06
, O 0 1.5413890649962347e-11
we O 0 1.6633331864635004e-11
have O 0 1.829669011785273e-12
compared O 0 4.648492701875284e-11
the O 0 1.4645612847474787e-11
resting O 0 2.4029944256653835e-07
[ O 0 1.7533191565277662e-10
Ca2 O 0 5.596833552168334e-10
+ O 0 1.1670077126879619e-09
] O 0 3.2384636639015696e-10
i O 0 6.191869239557946e-10
, O 0 1.9786625273356465e-14
the O 0 4.040367063677273e-15
amplitude O 0 6.409110438546084e-13
and O 0 5.434873905085791e-12
shape O 0 3.014786684185644e-11
of O 0 4.975100192927684e-13
depolarization O 0 2.2993554282813022e-10
- O 0 4.302861270844005e-06
induced O 0 3.170535592289525e-06
Ca2 O 0 8.309602783640457e-09
+ O 0 1.1475264072302593e-09
transients O 0 6.66942057137021e-08
, O 0 3.6307033768334662e-12
and O 0 2.802090970279586e-13
the O 0 2.0009559262876113e-14
content O 0 1.8212363041281154e-12
of O 0 7.28281841842586e-14
ATP O 0 6.228378257588929e-09
- O 0 9.768943876053982e-09
driven O 0 8.930559403097504e-09
ion O 0 8.160950137892087e-09
pumps O 0 1.9079284641065897e-07
in O 0 1.4174829712776393e-11
cultured O 0 3.7920563045190647e-07
skeletal O 0 3.018254938069731e-05
muscle O 0 7.118612899148502e-08
cells O 0 1.0175206510698587e-10
of O 0 9.267679939445328e-13
wild O 0 4.221461580300456e-08
- O 0 6.383145228028297e-05
type O 0 1.38186715048505e-05
and O 0 1.1277534461839878e-08
DMPK O 0 8.653355507703964e-06
[ O 0 7.836787330184336e-10
- O 0 6.914376058375638e-07
/ O 0 6.735750730513246e-07
- O 0 5.1899692152801435e-06
] O 0 7.657354750278955e-09
knockout O 0 1.1742748711185413e-06
mice O 0 6.801476047257893e-06
. O 0 8.444497323623068e-10

In O 0 5.933216140618924e-09
vitro O 0 3.3128490031231195e-06
- O 0 2.5240697141271085e-05
differentiated O 0 5.584843165706843e-06
DMPK O 0 0.0001334630069322884
[ O 0 8.254439798349722e-09
- O 0 7.304304858735122e-07
/ O 0 8.036964231905586e-07
- O 0 8.771536386120715e-07
] O 0 2.9452146277364477e-10
myotubes O 0 3.707887108461705e-09
exhibit O 0 4.282449048154113e-11
a O 0 1.4981144796921697e-11
higher O 0 7.058535422821421e-10
resting O 0 4.147002741206052e-08
[ O 0 1.2172578223168529e-10
Ca2 O 0 6.894024795478515e-10
+ O 0 5.138628411671675e-10
] O 0 8.890034541852998e-11
i O 0 1.419410006198163e-10
than O 0 1.9285930545707292e-13
do O 0 1.9485791018930554e-12
wild O 0 1.0536938682692565e-10
- O 0 4.673699436352763e-07
type O 0 3.5448712765173696e-07
myotubes O 0 1.102715941669885e-06
because O 0 1.3788760411248546e-10
of O 0 2.220076471834767e-13
an O 0 5.673775251707758e-12
altered O 0 1.1700768132172357e-09
open O 0 4.477836157423809e-11
probability O 0 5.626644983269813e-13
of O 0 3.814813048785837e-12
voltage O 0 7.517176072724396e-07
- O 0 1.2667784176301211e-05
dependent O 0 9.596144536772044e-07
l O 0 2.436383056192426e-06
- O 0 3.0609655254920654e-07
type O 0 1.3458782177622197e-07
Ca2 O 0 4.832565903001296e-09
+ O 0 1.3586493041728431e-09
and O 0 1.374763636263765e-10
Na O 0 1.9193106481907307e-07
+ O 0 2.8751196978760163e-09
channels O 0 1.8149977520920402e-08
. O 0 1.6545732561823456e-09

The O 0 4.2321718352056337e-10
mutant O 0 1.4145309989999078e-07
myotubes O 0 2.355938875098218e-07
exhibit O 0 2.075814187207925e-09
smaller O 0 3.924472691263503e-10
and O 0 9.52255895664278e-12
slower O 0 8.885483460119303e-09
Ca2 O 0 3.6049701002127676e-09
+ O 0 2.7592214624228006e-10
responses O 0 7.089737217441661e-12
upon O 0 4.754804406106872e-13
triggering O 0 1.9873848400298044e-10
by O 0 9.674764244946288e-13
acetylcholine O 0 4.629114158660741e-08
or O 0 6.1841065601697665e-09
high O 0 2.59217046050253e-07
external O 0 3.804560577691518e-08
K O 0 1.934236877332296e-07
+ O 0 2.8494282489077705e-09
. O 0 2.3004215199406985e-10

In O 0 1.064314969489999e-09
addition O 0 1.7101771387917353e-10
, O 0 2.7209105194631045e-12
we O 0 9.036363237541201e-13
observed O 0 1.0306651365699082e-12
that O 0 6.70304333956831e-14
these O 0 1.9403077235191635e-13
Ca2 O 0 1.9813981566585426e-09
+ O 0 3.262856651531365e-09
transients O 0 2.773939229427924e-07
partially O 0 3.7981944700504755e-08
result O 0 1.968363146087615e-11
from O 0 4.327300507939863e-13
an O 0 4.498959798454605e-13
influx O 0 3.817185716820104e-12
of O 0 9.943067013186771e-14
extracellular O 0 3.0555838415047276e-10
Ca2 O 0 9.64533453107208e-10
+ O 0 3.072161275374796e-11
through O 0 2.453191946458211e-12
the O 0 1.9230303113793035e-11
l O 0 1.417172086348728e-07
- O 0 1.2936571636146255e-07
type O 0 2.5980401829883704e-08
Ca2 O 0 1.0831689323254068e-08
+ O 0 2.585448077851993e-09
channel O 0 3.37887975376816e-08
. O 0 1.3659430253554206e-09

Neither O 0 4.152670030066474e-08
the O 0 3.1400285149807416e-11
content O 0 1.3442243151917666e-10
nor O 0 2.8898291745682592e-11
the O 0 3.5347915458387724e-13
activity O 0 1.809875339875422e-11
of O 0 4.074849724138019e-13
Na O 0 3.490069673262042e-07
+ O 0 2.1694099849867143e-09
/ O 0 4.944412435037293e-09
K O 0 8.451961797106833e-09
+ O 0 5.805506075873268e-10
ATPase O 0 2.1378479431177766e-08
and O 0 1.4848870744099685e-10
sarcoplasmic O 0 6.278020947547702e-08
reticulum O 0 4.6581916990362515e-08
Ca2 O 0 2.7775467259516518e-08
+ O 0 1.8039880700371214e-08
- O 0 1.4877199419061071e-06
ATPase O 0 2.143854089808883e-06
are O 0 1.3780662722062686e-10
affected O 0 2.295236639637821e-10
by O 0 9.54357860100119e-12
DMPK O 0 4.278356209397316e-05
absence O 0 2.2550949552169186e-08
. O 0 4.587403235056797e-10

In O 0 6.149698528190584e-10
conclusion O 0 6.414864472947812e-11
, O 0 1.4006475016273279e-12
our O 0 1.3318648484431095e-13
data O 0 9.73626474581879e-12
suggest O 0 2.3200155338520823e-11
that O 0 6.150032306334596e-12
DMPK O 0 3.298752346836409e-07
is O 0 1.693107633260471e-11
involved O 0 1.8341845403613277e-11
in O 0 1.7411792222876005e-13
modulating O 0 1.9916274185405314e-10
the O 0 8.268668952662872e-13
initial O 0 1.7196808213548742e-12
events O 0 2.2138911797559002e-12
of O 0 1.911998771114698e-12
excitation O 0 2.2298980439927618e-08
- O 0 0.010684363543987274
contraction O 0 0.017066948115825653
coupling O 0 2.9346531391638564e-06
in O 0 2.592736914053262e-09
skeletal O 0 0.001498862518928945
muscle O 0 3.0520361633534776e-06
. O 0 2.7191533746862007e-11
. O 0 1.694559076392821e-10

Constitutional O 0 2.111516550939996e-06
RB1 O 0 0.002480869647115469
- O 0 4.915351019008085e-05
gene O 0 3.5142047636327334e-06
mutations O 0 7.158067546697566e-06
in O 0 3.0819113927549324e-10
patients O 0 4.141460063777913e-09
with O 0 1.0852937298855281e-10
isolated O 0 2.169218305425602e-06
unilateral B-Disease 0 5.6553461035946384e-05
retinoblastoma I-Disease 0 0.0017579264240339398
. O 0 1.0588506071940174e-08

In O 0 6.434817678702132e-10
most O 0 3.6115117840740396e-11
patients O 0 2.334086812716407e-10
with O 0 1.484620065772546e-11
isolated O 0 3.407857036563655e-07
unilateral B-Disease 0 4.896513928542845e-06
retinoblastoma I-Disease 0 5.092769788461737e-05
, O 0 1.5887583471041467e-09
tumor B-Disease 0 8.227383432313218e-07
development O 0 4.3791657799996386e-11
is O 0 1.7558685408425312e-11
initiated O 0 1.0049140339307705e-11
by O 0 1.2608310662881594e-12
somatic O 0 2.341261851057652e-09
inactivation O 0 7.207532917163917e-07
of O 0 5.813719731323497e-13
both O 0 6.1171818478700235e-12
alleles O 0 1.5601180070046183e-11
of O 0 2.2705546210560756e-12
the O 0 2.2232791996312784e-10
RB1 O 0 5.8016201364807785e-05
gene O 0 8.147453911533376e-08
. O 0 1.490435108664201e-09

However O 0 7.038749583188064e-09
, O 0 2.2404281121296554e-12
some O 0 3.5384188119694585e-14
of O 0 5.428113741910018e-14
these O 0 5.034102908835214e-12
patients O 0 1.902680096810272e-10
can O 0 8.00865346262114e-11
transmit O 0 7.558577635791153e-06
retinoblastoma B-Disease 0 0.00011879226804012433
predisposition O 0 6.730479981342796e-06
to O 0 5.856533036308065e-10
their O 0 9.265077038911329e-10
offspring O 0 4.8301821209406626e-08
. O 0 5.331010077824772e-10

To O 0 5.684273884920543e-11
determine O 0 2.3953870137427558e-11
the O 0 3.286435793642406e-12
frequency O 0 2.4250357277821877e-09
and O 0 3.661003444843658e-11
nature O 0 9.720751981134867e-12
of O 0 1.045636667529326e-12
constitutional O 0 5.737676112005374e-09
RB1 O 0 2.848005351552274e-05
- O 0 3.1915087106426654e-07
gene O 0 4.824500976496893e-08
mutations O 0 1.3009143629005848e-07
in O 0 5.154232596282782e-11
patients O 0 6.664150897783827e-10
with O 0 5.636920097362719e-11
isolated O 0 7.598969773425779e-07
unilateral B-Disease 0 1.989561951631913e-06
retinoblastoma I-Disease 0 4.516865374171175e-06
, O 0 1.6150723120000876e-11
we O 0 6.346547094283894e-13
analyzed O 0 1.3392331514594513e-11
DNA O 0 6.751539416427477e-08
from O 0 5.479062759050635e-10
peripheral O 0 1.1973990694968961e-05
blood O 0 1.8641931092133746e-06
and O 0 1.1335496985509508e-09
from O 0 8.276081486791043e-10
tumor B-Disease 0 1.059002443071222e-05
tissue O 0 3.42414000442659e-06
. O 0 2.5622668431424245e-09

The O 0 1.32811248110265e-10
analysis O 0 1.9848545029788056e-10
of O 0 2.6689492838016804e-09
tumors B-Disease 1 0.9999997615814209
from O 0 2.855566805237686e-08
54 O 0 5.901526378693234e-07
( O 0 1.2524362102972475e-10
71 O 0 7.591564710196508e-09
% O 0 2.854526294157611e-12
) O 0 1.2603832636858686e-13
of O 0 3.653487018126511e-13
76 O 0 2.125617548642822e-08
informative O 0 2.9351514996278638e-08
patients O 0 7.387024680838294e-08
showed O 0 2.1858595289359073e-07
loss O 0 2.9416414193406126e-08
of O 0 4.712977230703075e-11
constitutional O 0 4.865077016802388e-07
heterozygosity O 0 0.0001870409760158509
( O 0 9.492926977827665e-08
LOH O 1 0.9999405145645142
) O 0 3.552722283028942e-10
at O 0 2.4642066165370125e-09
intragenic O 0 1.667209744482534e-06
loci O 0 6.235572413970658e-08
. O 0 2.10688333446285e-09

Three O 0 9.786020882529556e-10
of O 0 6.873959040865074e-11
13 O 0 8.061396883363159e-09
uninformative O 0 4.25489924964495e-05
patients O 0 4.247622769071313e-07
had O 0 1.0865292665585002e-08
constitutional O 0 2.3833397477801554e-09
deletions O 0 3.4419113035255577e-06
. O 0 9.516817556232127e-09

For O 0 3.8521652534484474e-10
39 O 0 1.3539308563181862e-09
randomly O 0 1.2012563166408086e-09
selected O 0 2.3111510927265044e-07
tumors B-Disease 1 0.9999992847442627
, O 0 8.385128147381238e-10
SSCP O 0 2.1936872144578956e-05
, O 0 4.904956996121257e-11
hetero O 0 1.0531026362059492e-07
- O 0 1.402136540207266e-08
duplex O 0 3.637753707153024e-07
analysis O 0 4.682056825577874e-11
, O 0 1.5342219682190628e-13
sequencing O 0 5.990750256978927e-11
, O 0 6.525880964086683e-12
and O 0 2.853361210503058e-12
Southern O 0 8.485769053580283e-13
blot O 0 1.0751357848448606e-07
analysis O 0 4.6133034892203995e-11
were O 0 1.7377569869192477e-11
used O 0 5.121695168669449e-12
to O 0 7.962677284027719e-13
identify O 0 7.435035365155329e-10
mutations O 0 1.5937548170086302e-08
. O 0 6.54341136829828e-10

Mutations O 0 1.8773667761706747e-05
were O 0 4.534842723558086e-09
detected O 0 9.83135805654456e-07
in O 0 1.6766835142512093e-10
21 O 0 9.285497704070167e-09
( O 0 1.9323471642240797e-11
91 O 0 8.157864939128956e-10
% O 0 1.0363562221935019e-12
) O 0 3.188025744001871e-13
of O 0 8.06499918931669e-12
23 O 0 1.677028922131285e-05
tumors B-Disease 1 0.9999997615814209
with O 0 6.21163326286478e-06
LOH O 1 0.9999886751174927
. O 0 3.748649817225669e-07

In O 0 9.262290490141822e-09
6 O 0 1.596133714087955e-08
( O 0 1.4055349766006753e-11
38 O 0 2.2189411419404337e-10
% O 0 5.377078448297323e-13
) O 0 1.290009088049035e-13
of O 0 4.9845535685100195e-12
16 O 0 1.2059343134751543e-05
tumors B-Disease 1 1.0
without O 0 1.0460016710567288e-06
LOH O 1 0.9999887943267822
, O 0 9.146064461340586e-11
one O 0 7.0400811916226935e-12
mutation O 0 3.4044049801451592e-09
was O 0 8.488121494565348e-08
detected O 0 4.916841476187983e-07
, O 0 6.074676872636076e-11
and O 0 1.4936243908358904e-10
in O 0 2.3504184709643994e-11
9 O 0 1.9272851758955767e-08
( O 0 4.200955121963501e-12
56 O 0 2.0291122948545848e-10
% O 0 2.643899097050373e-13
) O 0 5.247509038083277e-14
of O 0 1.3071916596038569e-12
the O 0 5.109966991767578e-07
tumors B-Disease 1 1.0
without O 0 5.952436367806513e-06
LOH O 1 0.9999940395355225
, O 0 2.1124556270901707e-10
both O 0 1.3975313961633873e-11
mutations O 0 9.204666362450098e-09
were O 0 9.144098256363975e-10
found O 0 6.455030732155365e-09
. O 0 1.1607409478031627e-09

Thus O 0 6.8134511366224615e-09
, O 0 5.334035730469866e-12
a O 0 3.4756203991237467e-12
total O 0 1.1292950082009146e-11
of O 0 1.2829429359151323e-12
45 O 0 5.658078450210269e-10
mutations O 0 2.7166018767843525e-08
were O 0 3.097382128558479e-09
identified O 0 7.409390434531815e-08
in O 0 1.1165546265345938e-09
tumors B-Disease 1 0.9999997615814209
of O 0 4.601494740796852e-10
36 O 0 1.551333184579562e-06
patients O 0 2.6182071621860814e-08
. O 0 2.5960561478299837e-10

Thirty O 0 1.0619029211511588e-07
- O 0 7.964729888954025e-07
nine O 0 2.9939657419930654e-09
of O 0 1.8805543060274044e-12
the O 0 6.488645992036579e-12
mutations O 0 6.612746794587565e-09
- O 0 1.5324425817198062e-07
including O 0 2.131324450260763e-09
34 O 0 2.928350228970089e-09
small O 0 6.30924756883644e-11
mutations O 0 2.634427254122329e-08
, O 0 3.4478312566088576e-11
2 O 0 6.678321784470143e-11
large O 0 6.361597360005078e-10
structural O 0 8.816052286420017e-06
alterations O 0 5.335247124094167e-07
, O 0 2.9520480504530155e-10
and O 0 2.983031321956986e-10
hypermethylation O 0 3.92632910006796e-06
in O 0 2.981479951813526e-09
3 O 0 9.862744263955392e-06
tumors O 1 0.9999998807907104
- O 0 0.00020397664047777653
were O 0 2.0090119789983873e-08
not O 0 2.1662860741344936e-11
detected O 0 3.00462899005538e-09
in O 0 7.726892720496051e-14
the O 0 4.3997737311091134e-13
corresponding O 0 4.145084830931012e-10
peripheral O 0 1.0175914439969347e-06
blood O 0 2.89766006744685e-08
DNA O 0 7.244774451464764e-07
. O 0 2.6702935418398965e-09

In O 0 9.245558096893092e-09
6 O 0 3.8871238672300024e-08
( O 0 3.129899464604513e-11
17 O 0 3.013604088497601e-10
% O 0 8.271913698714578e-14
) O 0 4.975427486458503e-15
of O 0 9.527376615772482e-15
the O 0 3.0730286371127846e-11
36 O 0 3.998995623533119e-08
patients O 0 4.097418238035999e-10
, O 0 1.1352935057979893e-13
a O 0 4.670504000908737e-12
mutation O 0 7.660188927616218e-09
was O 0 1.2683716477113194e-07
detected O 0 2.0127693289850868e-07
in O 0 2.3896269078088617e-12
constitutional O 0 2.4543349991246188e-11
DNA O 0 2.9149785518711724e-07
, O 0 1.498095397733934e-10
and O 0 2.1480794573647266e-11
1 O 0 8.549327044915511e-12
of O 0 3.093414196672639e-13
these O 0 8.14333669940659e-12
mutations O 0 1.977763197658078e-08
is O 0 2.2822637113506516e-09
known O 0 1.685299455544964e-09
to O 0 2.409437094286204e-10
be O 0 5.837220484750105e-09
associated O 0 2.4182172930764523e-10
with O 0 5.257508317590975e-10
reduced O 0 2.5979221618399606e-07
expressivity O 0 7.178376108640805e-05
. O 0 5.083357290658341e-09

The O 0 4.368089778772344e-10
presence O 0 4.572657530399482e-10
of O 0 8.076817751938303e-13
a O 0 6.468679758508955e-11
constitutional O 0 1.7240218141978403e-09
mutation O 0 2.945920982710959e-07
was O 0 1.3043870694673387e-06
not O 0 1.8474924368128143e-10
associated O 0 7.986012892646777e-12
with O 0 3.2118183980467396e-12
an O 0 4.230854208642221e-11
early O 0 4.678452625306306e-10
age O 0 1.0953372431288244e-08
at O 0 3.93545072085999e-08
treatment O 0 9.063239936324408e-09
. O 0 2.1514920400811377e-10

In O 0 2.6944007025520023e-09
1 O 0 3.773000134543736e-09
patient O 0 3.743561904911985e-08
, O 0 5.82551108047058e-12
somatic O 0 6.01454956949965e-08
mosaicism O 0 0.00011398339847801253
was O 0 2.6544773845671443e-07
demonstrated O 0 2.637998153254273e-11
by O 0 2.3647953712423175e-14
molecular O 0 2.9964060746512367e-12
analysis O 0 1.2532354711283777e-12
of O 0 3.5156556485449464e-13
DNA O 0 1.9753548485823558e-07
and O 0 7.32135740921791e-10
RNA O 0 1.1341730221658963e-08
from O 0 5.923307955235657e-10
peripheral O 0 2.3628184862900525e-05
blood O 0 1.497896050750569e-06
. O 0 1.899185919640445e-09

In O 0 3.2616558343079305e-09
2 O 0 5.195871732865953e-09
patients O 0 1.1982973502355776e-09
without O 0 6.3748546372255355e-12
a O 0 1.3325758552173994e-10
detectable O 0 5.969627636659425e-06
mutation O 0 1.3022230405113078e-06
in O 0 1.1656796639059053e-09
peripheral O 0 0.0006985332001931965
blood O 0 4.1347695514559746e-05
, O 0 5.476659681313834e-10
mosaicism O 0 3.284692866145633e-06
was O 0 1.2404771609908494e-07
suggested O 0 1.3076274507639596e-09
because O 0 3.098844444937576e-11
1 O 0 2.5891701976865633e-12
of O 0 3.130111187604756e-13
the O 0 5.181697293465959e-10
patients O 0 3.536047898933248e-08
showed O 0 2.5078602448047604e-06
multifocal O 1 0.9212685227394104
tumors B-Disease 1 1.0
and O 0 9.440812576144708e-09
the O 0 2.9754494007550036e-11
other O 0 4.9982556288297175e-11
later O 0 2.9462894346465873e-09
developed O 0 5.884284348667279e-08
bilateral B-Disease 0 1.8647798469828558e-06
retinoblastoma I-Disease 0 7.761629967717454e-05
. O 0 8.237862836324439e-09

In O 0 6.301000277098012e-10
conclusion O 0 3.9879603092041194e-11
, O 0 4.5664474805640065e-12
our O 0 2.8912501733036056e-12
results O 0 1.5865483839888617e-12
emphasize O 0 3.1473199046949674e-11
that O 0 5.462882750328912e-12
the O 0 1.5337925157385413e-12
manifestation O 0 1.0295644337077192e-09
and O 0 2.2682270992002707e-11
transmissibility O 0 2.6167679134658783e-09
of O 0 1.108650280953749e-12
retinoblastoma B-Disease 0 3.3100015173204156e-08
depend O 0 5.5999916509508196e-11
on O 0 1.6923561163562084e-10
the O 0 4.264831977157657e-12
nature O 0 1.3678944262018877e-11
of O 0 2.0905510395713423e-13
the O 0 3.3508523646780253e-12
first O 0 3.38612804462457e-10
mutation O 0 2.7547936154448394e-10
, O 0 8.344941491295055e-13
its O 0 5.791031716662065e-13
time O 0 3.3095550605599655e-11
in O 0 1.6252816150211236e-12
development O 0 4.081562561888963e-13
, O 0 1.8010346903088448e-12
and O 0 2.3635353656875635e-12
the O 0 6.006819390849683e-13
number O 0 1.1695987234272565e-10
and O 0 9.14090261816547e-11
types O 0 1.8673458612727956e-10
of O 0 3.0693717966573386e-12
cells O 0 4.636080963571487e-10
that O 0 4.208126902494058e-11
are O 0 3.923415411999365e-11
affected O 0 1.6461174090487418e-10
. O 0 1.7609454476194553e-12
. O 0 1.4480459886723196e-10

Hereditary B-Disease 1 0.9999496936798096
deficiency I-Disease 1 0.999941349029541
of I-Disease 0 1.3309737756372897e-09
the I-Disease 0 1.6384024692506216e-10
fifth I-Disease 0 4.7343192477455887e-07
component I-Disease 0 1.617547340515557e-08
of I-Disease 0 9.019286185962816e-12
complement I-Disease 0 1.4257681701934644e-09
in O 0 3.222497269028679e-11
man O 0 1.2926694807902095e-06
. O 0 8.851225863359957e-10

I O 0 0.0002563869929872453
. O 0 1.0616173540256568e-07

Clinical O 0 2.197213143517729e-05
, O 0 2.9346014507325435e-09
immunochemical O 0 7.01528870195034e-06
, O 0 2.7634033950008074e-10
and O 0 4.426883512542723e-11
family O 0 2.543456001369293e-10
studies O 0 8.25632201495452e-11
. O 0 3.7723005275047683e-10

The O 0 1.5360726024482574e-09
first O 0 4.198446035275083e-09
recognized O 0 4.5655310643155644e-09
human O 0 4.8120021745035046e-08
kindred O 0 1.248424086952582e-05
with O 0 2.993461521327845e-06
hereditary B-Disease 1 0.9999651908874512
deficiency I-Disease 1 0.9951497912406921
of I-Disease 0 2.400225677934298e-11
the I-Disease 0 1.1115987991194842e-10
fifth I-Disease 0 9.727797305458807e-07
component I-Disease 0 9.476699602828376e-08
of I-Disease 0 3.8571645877283345e-10
complement I-Disease 0 9.847462933976203e-08
( O 0 2.2750305805896431e-10
C5 O 0 2.123098965967074e-06
) O 0 9.066892202314047e-12
is O 0 1.2405932184322843e-11
described O 0 2.4869657444526183e-09
. O 0 4.215583715438953e-10

The O 0 1.913117664287256e-09
proband O 0 1.2080394071745104e-06
, O 0 1.1747111963722467e-11
a O 0 4.1963585384330315e-12
20 O 0 2.6593425378473867e-11
- O 0 2.8427200149394594e-08
year O 0 2.4079638283325266e-09
- O 0 8.788752552391088e-07
old O 0 7.154941613407573e-06
black O 0 4.3882030809072603e-07
female O 0 5.389103989728028e-07
with O 0 6.206075227055408e-07
systemic B-Disease 1 0.9999996423721313
lupus I-Disease 1 0.9999511241912842
erythematosus I-Disease 1 0.9999963045120239
since O 0 9.112297050251073e-08
age O 0 5.931815749704583e-08
11 O 0 7.315847039279788e-09
, O 0 5.6105009527129823e-11
lacked O 0 4.121627128483851e-08
serum O 0 9.76822957454715e-06
hemolytic O 0 0.00022496050223708153
complement O 0 2.7402788926877975e-09
activity O 0 7.551763658852906e-09
, O 0 4.271051394499903e-12
even O 0 7.860136153059472e-11
during O 0 3.970505868533536e-10
remission O 0 2.0156949176453054e-07
. O 0 8.726607769737882e-10

C5 O 0 0.0027957377023994923
was O 0 9.743276677909307e-06
undetectable O 0 0.0001734773104544729
in O 0 1.1402409572092154e-10
her O 0 7.804463186822375e-10
serum O 0 1.2063495979930394e-08
by O 0 2.340843014217442e-12
both O 0 5.7158680566438136e-11
immunodiffusion O 0 4.850307504966622e-06
and O 0 8.06693378763157e-09
hemolytic O 0 0.00037255973438732326
assays O 0 2.662316319401725e-06
. O 0 2.7450917094995475e-09

Other O 0 1.4921380797616735e-10
complement O 0 1.840373964334674e-10
components O 0 4.60407800773055e-09
were O 0 2.366143739274129e-11
normal O 0 6.222087949037114e-12
during O 0 1.1404099019285407e-11
remission O 0 1.0726215471379419e-09
of O 0 6.61253829470354e-11
lupus O 0 0.0012820812407881021
, O 0 8.253896871535105e-11
but O 0 2.1663573712693562e-10
C1 O 0 1.6717405742383562e-05
, O 0 2.7793881085536043e-10
C4 O 0 0.00010219104296993464
, O 0 2.3674144866703273e-09
C2 O 0 3.026171907549724e-05
, O 0 3.792051950224362e-10
and O 0 1.675469540884933e-09
C3 O 0 0.08771024644374847
levels O 0 1.2845804064909316e-07
fell O 0 2.1766949430457316e-05
during O 0 5.774157596505347e-09
exacerbations O 0 1.498053825343959e-05
. O 0 6.644224614937855e-10

A O 0 8.817499974611565e-08
younger O 0 8.667875306400674e-08
half O 0 1.0902160951786755e-08
- O 0 2.2119886125437915e-05
sister O 0 8.397825877182186e-05
, O 0 7.051376704758638e-10
who O 0 1.6877097053225043e-08
had O 0 9.904538700311605e-08
no O 0 2.7435747895765417e-08
underlying O 0 4.3230640585534275e-05
disease O 0 0.014467434026300907
, O 0 5.779146050599593e-10
was O 0 1.163563680961488e-07
also O 0 4.5335779574884327e-10
found O 0 5.501808453267643e-10
to O 0 2.9243299448644677e-10
lack O 0 6.7502750056291916e-09
immunochemically O 0 1.5507474017795175e-05
detectable O 0 9.835560376814101e-06
C5 O 0 4.0117134631145746e-05
. O 0 3.139025928078354e-09

By O 0 4.3411422012695766e-08
hemolytic O 0 0.010412784293293953
assay O 0 6.7506898631108925e-06
, O 0 3.866727826817851e-09
she O 0 1.6186831430786697e-08
exhibited O 0 2.4488677752287913e-08
1 O 0 9.236053033490066e-10
- O 0 7.810618853909546e-07
2 O 0 3.0351681168383493e-09
% O 0 2.054970641351614e-13
of O 0 5.966815854342028e-14
the O 0 2.0901627650893317e-11
normal O 0 2.5090063360266868e-09
serum O 0 3.5887339322471234e-07
C5 O 0 1.1583416608118569e-06
level O 0 3.7092025007012808e-09
and O 0 2.297564482417469e-12
normal O 0 7.152252423127392e-13
concentrations O 0 7.988389463808865e-12
of O 0 4.1229826762976055e-14
other O 0 3.2280425619861386e-13
complement O 0 5.592306132062852e-11
components O 0 1.5003072562080888e-08
. O 0 5.185039064770081e-10

C5 O 0 0.0004259018460288644
levels O 0 3.7986259826539026e-07
of O 0 2.1088072260644353e-11
other O 0 3.6874867742620054e-11
family O 0 5.501157862575212e-10
members O 0 1.0737375615368916e-12
were O 0 5.231365254182441e-12
either O 0 2.3153857303670478e-12
normal O 0 7.556247294537854e-12
or O 0 3.79633997849016e-12
approximately O 0 4.6823048910349385e-12
half O 0 9.016337121359186e-10
- O 0 5.429256361821899e-06
normal O 0 1.8122236156159488e-08
, O 0 2.08855259475893e-11
consistent O 0 2.1756908774595018e-10
with O 0 4.142332657441905e-11
autosomal O 0 2.3699469693383435e-06
codominant O 0 1.636193587728485e-06
inheritance O 0 5.052984253239856e-09
of O 0 2.2193717350016406e-11
the O 0 7.624050835097762e-10
gene O 0 5.24482129549142e-06
determining O 0 0.008844929747283459
C5 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999980926513672
. O 0 2.176199487280428e-08

Normal O 0 0.00022518134210258722
hemolytic O 1 0.8733444809913635
titers O 0 0.0008628486539237201
were O 0 1.0251462789767629e-08
restored O 0 5.112488654646086e-09
to O 0 3.034117748712539e-11
both O 0 5.10459630120863e-09
homozygous O 0 0.4800342619419098
C5 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999994039535522
deficient I-Disease 1 0.9999998807907104
( O 0 8.610941222286783e-07
C5D B-Disease 1 0.9999991655349731
) O 0 1.3338065374401964e-10
sera O 0 4.445655399365478e-09
by O 0 1.7116103185384896e-13
addition O 0 9.13716259771935e-13
of O 0 3.236661698206855e-13
highly O 0 5.676736303250607e-10
purified O 0 7.295586357258799e-09
human O 0 3.528870529123651e-09
C5 O 0 1.1827169146272354e-05
. O 0 1.7373280591925777e-09

In O 0 1.8206137708531855e-09
specific O 0 5.788368673265154e-10
C5 O 0 1.3662684068549424e-05
titrations O 0 7.879818440414965e-06
, O 0 1.9384464866600837e-10
however O 0 1.0300898155291005e-11
, O 0 5.359579425233407e-13
it O 0 6.964301964978992e-12
was O 0 1.0059070021384287e-08
noted O 0 1.3467597870242543e-10
that O 0 1.2309147841629842e-12
when O 0 2.488946722334351e-11
limited O 0 9.962605827112947e-13
amounts O 0 1.777883829739979e-12
of O 0 1.8476702372954845e-12
C5 O 0 7.751211228423927e-07
were O 0 6.635634403062696e-11
assayed O 0 3.3629330431494964e-09
in O 0 4.56580032028725e-13
the O 0 6.824856977304117e-13
presence O 0 4.0857102423519365e-11
of O 0 7.634210646458028e-13
low O 0 1.0718164134004837e-08
dilutions O 0 1.7402872032334926e-08
of O 0 3.0696542530073145e-11
either O 0 1.6734462349177193e-07
C5D B-Disease 1 0.9999992847442627
serum O 0 8.211375643440988e-06
, O 0 1.1029261271638946e-12
curving O 0 4.633620917515735e-11
rather O 0 7.276810447612303e-13
than O 0 1.1951109047704522e-13
linear O 0 2.5329092122328145e-12
dose O 0 7.005769853130062e-10
- O 0 5.8559326276963475e-09
response O 0 1.3786964625506215e-11
plots O 0 1.87195328682499e-10
were O 0 1.5607971859399328e-10
consistently O 0 1.706889851682547e-09
obtained O 0 5.139887213762018e-12
, O 0 1.482309690574099e-13
suggesting O 0 1.6629619556396413e-11
some O 0 1.464001175063151e-13
inhibitory O 0 1.419056094853488e-09
effect O 0 2.8660089856913373e-09
. O 0 2.9297567150088355e-10

Further O 0 6.917470485312549e-10
studies O 0 9.313691484713615e-11
suggested O 0 1.6363256583051822e-10
that O 0 4.919504907607841e-12
low O 0 3.797701708663226e-08
dilutions O 0 4.8784759201225825e-06
of O 0 6.142374608941736e-09
C5D B-Disease 1 0.9999994039535522
serum O 0 2.1753712644567713e-05
contain O 0 9.230188280362484e-10
a O 0 7.723324063624304e-11
factor O 0 1.5137846531843024e-09
( O 0 6.063722440829977e-12
or O 0 4.720228027887963e-11
factors O 0 6.200399915723409e-11
) O 0 3.2259500517932416e-13
interfering O 0 9.609082279871117e-11
at O 0 1.5644215090038216e-10
some O 0 2.7575652265104944e-13
step O 0 3.511485824336802e-10
in O 0 2.142860758627685e-12
the O 0 4.475957451899326e-11
hemolytic O 0 2.110368996000034e-06
assay O 0 1.417020190075391e-08
of O 0 2.4387073957465866e-11
C5 O 0 1.4151305549603421e-05
, O 0 4.381870734315729e-12
rather O 0 6.327027118370465e-13
than O 0 2.768581154263816e-12
a O 0 3.2946905620390154e-11
true O 0 5.388300472475294e-09
C5 O 0 3.376706445124e-05
inhibitor O 0 8.449240453956008e-07
or O 0 5.54466650370955e-09
inactivator O 0 1.0849350474018138e-05
. O 0 1.5236160111342656e-09

Of O 0 3.0113300741874127e-09
clinical O 0 1.2496168437792221e-06
interest O 0 5.950274726274074e-07
are O 0 3.8032357818629237e-10
( O 0 3.1788226564910538e-12
a O 0 1.5122651395027553e-11
) O 0 1.7634687926506437e-13
the O 0 3.317362931663098e-13
documentation O 0 4.0110403887183566e-09
of O 0 1.4424102801058325e-08
membranous O 1 0.8096874952316284
glomerulonephritis B-Disease 1 0.9999995231628418
, O 0 4.906588219455443e-05
vasculitis B-Disease 1 0.9999985694885254
, O 0 7.033142424006655e-08
and O 0 2.764423925327719e-06
arthritis B-Disease 1 0.9999998807907104
in O 0 6.699973215118504e-11
an O 0 1.9447309040909744e-10
individual O 0 1.6053229856538564e-09
lacking O 0 1.3006533627901717e-08
C5 O 0 5.797213361802278e-06
( O 0 1.03199150613964e-11
and O 0 8.280616318502576e-13
its O 0 4.759032794579565e-13
biologic O 0 2.7103224109481516e-09
functions O 0 7.783212442602494e-12
) O 0 1.886258944178154e-12
, O 0 9.74603319055245e-13
and O 0 3.160252962097765e-11
( O 0 5.981156108586516e-12
b O 0 6.60822951914497e-10
) O 0 1.9149574504231937e-13
a O 0 3.5177167168748413e-12
remarkable O 0 1.2161583962111422e-09
propensity O 0 1.5436679632330197e-06
to O 0 3.5165035683348833e-07
bacterial B-Disease 1 0.9999997615814209
infections I-Disease 1 0.9999998807907104
in O 0 2.082856942475786e-10
the O 0 3.346702429074533e-11
proband O 0 3.471271838861867e-07
, O 0 2.7018328980360495e-12
even O 0 7.466504844955146e-12
during O 0 3.21317863809234e-12
periods O 0 7.174088580141902e-12
of O 0 2.6261991713238952e-12
low O 0 1.4931637792869878e-07
- O 0 9.021451319313201e-07
dose O 0 8.419251962266117e-09
or O 0 2.5687381041694657e-11
alternate O 0 2.99338019649209e-11
- O 0 1.4565632966423436e-07
day O 0 2.1526599169874316e-08
corticosteroid O 0 1.1078808483944158e-06
therapy O 0 1.279004546717033e-08
. O 0 8.110757204748964e-11

Other O 0 1.7234290383694173e-10
observations O 0 4.5508444235231593e-10
indicate O 0 5.424161120259896e-10
that O 0 2.7798426754932493e-11
the O 0 4.279356868863715e-10
C5D B-Disease 1 0.9999991655349731
state O 0 2.2545637579085565e-10
is O 0 4.418554931662211e-12
compatible O 0 1.2865193632638494e-10
with O 0 1.7343364591693167e-11
normal O 0 5.867532154590904e-11
coagulation O 0 5.798094893094685e-09
function O 0 4.061393721332962e-10
and O 0 3.715600049858381e-11
the O 0 8.544599923443474e-12
capacity O 0 8.403637785647788e-10
to O 0 3.041457060162789e-12
mount O 0 1.8297781423370907e-07
a O 0 9.555198232646944e-08
neutrophilic O 0 0.09744153171777725
leukocytosis O 0 0.05284186080098152
during O 0 8.749314019951271e-07
pyogenic B-Disease 0 0.06902443617582321
infection I-Disease 0 0.01998896710574627
. O 0 2.528239839705293e-10
. O 0 5.448070883318223e-10

Susceptibility O 0 0.008377790451049805
to O 0 1.2235260328452569e-05
ankylosing B-Disease 1 0.9999994039535522
spondylitis I-Disease 1 1.0
in O 0 7.206672762549715e-06
twins O 0 3.837195981759578e-05
: O 0 4.576448161403013e-12
the O 0 6.658689983944643e-13
role O 0 1.591277665191626e-10
of O 0 3.292168512629423e-13
genes O 0 2.3745358457283317e-10
, O 0 5.622828591622664e-12
HLA O 0 7.6188362285734e-09
, O 0 8.19822595227171e-12
and O 0 1.2577571796568154e-11
the O 0 2.245348872109698e-11
environment O 0 2.8486022429774494e-09
. O 0 1.3014857247473088e-10

OBJECTIVE O 0 1.1264034149860436e-08
To O 0 1.9608314971719665e-11
determine O 0 6.346081993235941e-11
the O 0 7.198733796565104e-12
relative O 0 4.800227437762317e-10
effects O 0 1.1701168922684246e-09
of O 0 7.230986642792203e-13
genetic O 0 1.3397819742522188e-08
and O 0 1.3239999374636824e-10
environmental O 0 7.800068924090908e-11
factors O 0 7.432518142613809e-12
in O 0 3.878340357199583e-12
susceptibility O 0 9.038028565555578e-07
to O 0 2.1479452243511332e-06
ankylosing B-Disease 1 0.9999998807907104
spondylitis I-Disease 1 1.0
( O 0 3.9897000533528626e-05
AS B-Disease 1 0.999930739402771
) O 0 2.903587925651152e-10
. O 0 1.947109973254868e-10

METHODS O 0 1.9675194380397443e-06
Twins O 0 9.156670421361923e-05
with O 0 5.523663304529691e-08
AS B-Disease 1 0.9991196990013123
were O 0 1.4707988993389876e-10
identified O 0 4.3613795908115094e-10
from O 0 6.569891766033953e-12
the O 0 4.0143524615565696e-10
Royal O 0 5.206316586736648e-07
National O 0 5.984025847283192e-06
Hospital O 0 8.44485782636184e-07
for O 0 3.0928969607657564e-08
Rheumatic B-Disease 0 0.008282036520540714
Diseases I-Disease 0 4.6712625589862e-06
database O 0 2.326511321371072e-07
. O 0 6.303840560661911e-09

Clinical O 0 7.366744739556452e-06
and O 0 1.4331105191445204e-09
radiographic O 0 2.059788812402985e-06
examinations O 0 2.523362923056993e-07
were O 0 3.314801766407527e-09
performed O 0 4.454310809087758e-10
to O 0 2.1191687727545316e-12
establish O 0 8.5766110879959e-10
diagnoses O 0 1.3267565009300597e-05
, O 0 1.347387312833348e-09
and O 0 1.1052911474962457e-08
disease O 0 6.913558991072932e-06
severity O 0 1.7495969473202422e-07
was O 0 1.978038532968185e-08
assessed O 0 2.6515960538375793e-09
using O 0 2.696954881642455e-10
a O 0 3.6382907797616326e-10
combination O 0 4.814733611802069e-10
of O 0 3.182389681638531e-12
validated O 0 2.2807157051829563e-08
scoring O 0 3.262577763507579e-08
systems O 0 2.323788237390545e-07
. O 0 1.307128738581298e-09

HLA O 0 7.291412657650653e-06
typing O 0 6.614969265683612e-07
for O 0 2.5561103234039706e-10
HLA O 0 1.745250841622692e-07
- O 0 1.4414125359962782e-07
B27 O 0 1.493500612070875e-08
, O 0 5.2069958587919185e-12
HLA O 0 1.371814994932663e-09
- O 0 8.020891506532735e-09
B60 O 0 1.7343284586246455e-09
, O 0 4.1501258809736874e-13
and O 0 1.026515786435589e-12
HLA O 0 1.2679188365893879e-08
- O 0 8.923086170398165e-06
DR1 O 0 0.02312745526432991
was O 0 2.6718639745126893e-08
performed O 0 1.6135636229930306e-11
by O 0 4.180942769185965e-14
polymerase O 0 1.2655552161788819e-09
chain O 0 3.3528539944427393e-08
reaction O 0 8.488688051089266e-12
with O 0 1.1857878502892494e-13
sequence O 0 2.7289873919672525e-12
- O 0 8.607782264746788e-10
specific O 0 3.768549708405011e-12
primers O 0 8.746045665475322e-08
, O 0 5.631178249393409e-12
and O 0 9.826556885902948e-13
zygosity O 0 5.348122833481739e-09
was O 0 5.8202827973863336e-11
assessed O 0 1.447435643564532e-10
using O 0 8.61656579420611e-11
microsatellite O 0 1.2846327081206255e-05
markers O 0 4.062133302795701e-05
. O 0 1.0674443551295099e-08

Genetic O 0 8.367612281290349e-06
and O 0 2.915775398903975e-10
environmental O 0 1.904756213866321e-11
variance O 0 6.4698246760031e-12
components O 0 1.3229714213025545e-08
were O 0 1.3264417342284673e-10
assessed O 0 2.0464518968310585e-09
with O 0 1.310160053363818e-11
the O 0 1.5773975875488233e-11
program O 0 1.276967837027243e-10
Mx O 0 1.2417502581740791e-08
, O 0 2.3524330947837305e-14
using O 0 8.861055606716045e-14
data O 0 2.0929641353362172e-10
from O 0 3.5395900620238674e-12
this O 0 8.37119707320505e-13
and O 0 5.3247246022125605e-12
previous O 0 1.531075093097467e-11
studies O 0 8.05497107816272e-13
of O 0 3.01914721521912e-12
twins O 0 1.2998705187783344e-06
with O 0 3.851711394275981e-09
AS B-Disease 1 0.9999765157699585
. O 0 1.3066558501861891e-08

RESULTS O 0 2.255415978424935e-07
Six O 0 5.949931658477681e-09
of O 0 1.2088498257956104e-10
8 O 0 4.4665490861461876e-08
monozygotic O 0 6.188301995280199e-06
( O 0 1.2501290003186227e-09
MZ O 1 0.9929717183113098
) O 0 1.3831807921249606e-09
twin O 0 4.415524472278776e-06
pairs O 0 4.127111026264174e-07
were O 0 1.0667709915423984e-07
disease O 0 8.482924158670357e-07
concordant O 0 3.0876275758373595e-08
, O 0 4.917434168194568e-11
compared O 0 2.511294727725044e-09
with O 0 4.9541967750421634e-11
4 O 0 4.5477382970560143e-10
of O 0 4.7983917186855685e-12
15 O 0 2.6576467693217865e-09
B27 O 0 1.1891972739874745e-08
- O 0 8.88469685378368e-07
positive O 0 9.780578125173633e-09
dizygotic O 0 1.7803857588205574e-07
( O 0 8.807905793606352e-11
DZ O 0 0.00043072536936961114
) O 0 6.100848992662833e-11
twin O 0 2.2066011240440275e-07
pairs O 0 1.594238341340315e-08
( O 0 2.2499585528024113e-10
27 O 0 8.350021118985751e-09
% O 0 1.7352058375233459e-12
) O 0 4.15384794703183e-13
and O 0 2.250887844168492e-12
4 O 0 2.6879613118646617e-11
of O 0 8.390224279231084e-12
32 O 0 5.039128154749051e-07
DZ O 1 0.9548812508583069
twin O 0 4.454717782209627e-05
pairs O 0 1.217296556887959e-07
overall O 0 3.4314691674808273e-06
( O 0 5.485692455842184e-10
12 O 0 1.080345812809469e-09
. O 0 1.057724003869498e-12
5 O 0 7.628017661964748e-11
% O 0 9.084889958377307e-13
) O 0 4.9314454429738586e-12
. O 0 6.293670445911559e-11

Nonsignificant O 0 7.072453445289284e-05
increases O 0 1.827265009524126e-06
in O 0 2.4401125217621278e-11
similarity O 0 8.029991255265045e-11
with O 0 6.818354908455504e-12
regard O 0 3.9726930078920475e-11
to O 0 6.362248922142655e-11
age O 0 8.48491694682707e-08
at O 0 8.55919665809779e-07
disease O 0 4.840925976168364e-05
onset O 0 6.832271992607275e-08
and O 0 1.4414380800076287e-10
all O 0 1.5757457188028678e-12
of O 0 1.2744723896021548e-12
the O 0 5.633934430093746e-10
disease O 0 1.9262288333266042e-06
severity O 0 7.505411403485596e-09
scores O 0 4.545171183867325e-10
assessed O 0 8.275126361922958e-08
were O 0 6.453598766498203e-10
noted O 0 1.292082552062368e-09
in O 0 3.9741726576281167e-10
disease O 0 3.4464937925804406e-05
- O 0 0.00017266353825107217
concordant O 0 0.0006611956632696092
MZ O 1 0.9990559220314026
twins O 0 7.073526649037376e-05
compared O 0 1.987436348827032e-08
with O 0 3.708846840755342e-10
concordant O 0 6.608869443880394e-05
DZ O 1 0.996837854385376
twins O 0 0.00035762341576628387
. O 0 2.00107175274411e-09

HLA O 0 0.00018114324484486133
- O 0 8.520166738890111e-05
B27 O 0 1.0739403251136537e-06
and O 0 3.67041591564643e-10
B60 O 0 2.7202298191753016e-09
were O 0 1.8332085849337432e-11
associated O 0 3.046578180704307e-12
with O 0 5.4069266425260665e-12
the O 0 8.981254628892543e-10
disease O 0 1.4025669770489912e-05
in O 0 9.404139966751046e-11
probands O 0 2.211875425928156e-06
, O 0 1.853873478341317e-11
and O 0 6.274812700685084e-12
the O 0 1.2098179229258488e-11
rate O 0 2.4239934646175243e-06
of O 0 7.661967726946273e-10
disease O 0 4.443040324986214e-06
concordance O 0 1.3936949372350682e-08
was O 0 3.3927321396731713e-08
significantly O 0 8.485366187471755e-09
increased O 0 3.4678580007607707e-09
among O 0 1.0875238487528804e-09
DZ O 1 0.745121955871582
twin O 0 1.433431953046238e-05
pairs O 0 9.883003748711872e-09
in O 0 1.617905809325748e-11
which O 0 2.172654417487152e-11
the O 0 1.4623846578132316e-10
co O 0 3.53680552507285e-05
- O 0 0.00012513785623013973
twin O 0 0.0004599388048518449
was O 0 1.5487034943362232e-07
positive O 0 2.3550406416661396e-11
for O 0 6.50085671058398e-13
both O 0 3.7726492936596134e-12
B27 O 0 5.444728667924892e-09
and O 0 4.176527734767177e-10
DR1 O 0 0.00020347120880614966
. O 0 1.6326540119848687e-09

Additive O 0 8.340665402783998e-08
genetic O 0 2.9463694772857707e-06
effects O 0 5.990301588099101e-07
were O 0 1.0745949963197887e-10
estimated O 0 6.715236700038929e-11
to O 0 5.3708695477161505e-12
contribute O 0 3.0679278562040224e-11
97 O 0 5.552770465655499e-10
% O 0 1.8017415359151967e-13
of O 0 1.3866879717519716e-14
the O 0 8.277994717649506e-13
population O 0 1.6008654905169672e-12
variance O 0 1.484632139447939e-10
. O 0 5.220704424324651e-10

CONCLUSION O 0 2.2130514309992577e-08
Susceptibility O 0 4.560173692880198e-06
to O 0 1.4531383207838644e-08
AS B-Disease 1 0.9934684038162231
is O 0 1.9765043768327217e-11
largely O 0 1.0226151522796378e-12
genetically O 0 4.1662800986941306e-10
determined O 0 6.031626309521698e-10
, O 0 5.5345992545918765e-12
and O 0 7.206688371064196e-12
the O 0 2.380210611940825e-12
environmental O 0 3.063929387980835e-10
trigger O 0 5.2063708011473864e-08
for O 0 1.2656899139873445e-10
the O 0 7.970165083470704e-10
disease O 0 1.2471714398998301e-06
is O 0 7.303514737433403e-11
probably O 0 1.36349354029619e-09
ubiquitous O 0 2.7627797294371703e-07
. O 0 2.182033886910517e-09

HLA O 0 7.315284892683849e-05
- O 0 6.843997198302532e-06
B27 O 0 5.057480478853904e-08
accounts O 0 1.9309591425820116e-10
for O 0 5.352206525199854e-12
a O 0 4.710440371091806e-12
minority O 0 3.4106521860227668e-12
of O 0 1.1712131915350699e-13
the O 0 1.699918200995243e-12
overall O 0 9.872829664914207e-09
genetic O 0 5.3936499710971475e-08
susceptibility O 0 1.4864914987811062e-07
to O 0 6.7465166786462305e-09
AS B-Disease 1 0.9999266862869263
. O 0 3.234835288523641e-09

Cell O 0 2.3657521524000913e-05
cycle O 0 2.3003787646302953e-05
- O 0 9.660611249273643e-05
dependent O 0 7.392365546365909e-07
colocalization O 0 1.9650522062875098e-06
of O 0 9.037751103058156e-11
BARD1 O 0 6.908427167218179e-05
and O 0 4.951148380172299e-10
BRCA1 O 0 2.998276329435612e-07
proteins O 0 3.734499168239758e-11
in O 0 2.0331147518575649e-13
discrete O 0 4.4580164559882007e-10
nuclear O 0 5.9634952776832506e-05
domains O 0 1.1941657476199907e-06
. O 0 2.8852609190721523e-09

Germ O 0 0.001505589229054749
- O 0 8.961889398051426e-05
line O 0 9.691849527371232e-07
mutations O 0 2.5077540044549096e-08
of O 0 3.1547106506962797e-12
the O 0 5.503359226666227e-11
BRCA1 O 0 1.1582639672269579e-05
gene O 0 9.251062138559973e-09
predispose O 0 4.611814219401822e-08
women O 0 6.210711944731884e-10
to O 0 9.32328433206342e-12
early O 0 2.150922773225261e-09
- O 0 0.4312533736228943
onset O 1 0.9190390706062317
breast B-Disease 1 0.9999767541885376
and I-Disease 1 0.9744835495948792
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999951124191284
by O 0 3.609399168436056e-10
compromising O 0 1.6017138477764092e-06
the O 0 5.1261342393083e-11
genes O 0 5.982511819269121e-09
presumptive O 0 7.96527001512004e-06
function O 0 3.291296124530163e-09
as O 0 2.653324782109223e-10
a O 0 1.316883269097957e-09
tumor B-Disease 0 5.214418251853203e-06
suppressor O 0 9.993877029046416e-06
. O 0 1.6369764210821813e-08

Although O 0 2.1998778354515025e-09
the O 0 9.207303322544824e-12
biochemical O 0 6.476946534661465e-09
properties O 0 1.5760306393275414e-09
of O 0 5.670997352269502e-11
BRCA1 O 0 8.5097984992899e-05
polypeptides O 0 1.2421605788404122e-07
are O 0 3.180712082606618e-10
not O 0 8.834422082770743e-11
understood O 0 2.8869770463124667e-10
, O 0 3.8770882663206885e-13
their O 0 9.484488932079427e-13
expression O 0 6.829551507658849e-11
pattern O 0 5.834805083537731e-09
and O 0 3.6210784370993565e-11
subcellular O 0 2.087495287739216e-09
localization O 0 5.464850794112408e-09
suggest O 0 6.547106190524232e-10
a O 0 2.1312664133521508e-10
role O 0 6.326799528721949e-09
in O 0 5.4090924447858235e-12
cell O 0 5.378815259859948e-08
- O 0 1.4712679330841638e-05
cycle O 0 6.160050361359026e-06
regulation O 0 4.1770820757847105e-07
. O 0 9.425370484095197e-10

When O 0 2.3899605139376945e-07
resting O 0 2.142454150089179e-06
cells O 0 8.626329872640781e-08
are O 0 3.546220955774615e-11
induced O 0 3.452601049502846e-08
to O 0 2.002390614430638e-11
proliferate O 0 2.4165464651559887e-07
, O 0 1.786023911230783e-12
the O 0 5.384816941303439e-13
steady O 0 7.903953047616596e-09
- O 0 2.170536816947788e-08
state O 0 2.67607273146675e-11
levels O 0 3.018929550790972e-11
of O 0 2.277371542215578e-13
BRCA1 O 0 4.399180397740565e-08
increase O 0 1.2964587736696842e-10
in O 0 3.027420165686162e-13
late O 0 3.0839250424186115e-12
G1 O 0 4.718119939184362e-08
and O 0 7.973441351616373e-12
reach O 0 1.7412332426608446e-12
a O 0 7.420336047003762e-12
maximum O 0 4.155486788004481e-10
during O 0 4.4583395308883667e-10
S O 0 8.473836032862891e-07
phase O 0 1.5529171282224752e-09
. O 0 3.532491799074222e-10

Moreover O 0 1.2988539310754277e-07
, O 0 1.0462081895257214e-10
in O 0 5.240013284391054e-12
S O 0 8.819701520224044e-07
phase O 0 1.918434522352186e-09
cells O 0 4.833782707436285e-09
, O 0 2.7917713280034562e-11
BRCA1 O 0 7.954360512485437e-07
polypeptides O 0 1.1101866981277908e-08
are O 0 5.0556211994567946e-11
hyperphosphorylated O 0 5.234849353996651e-08
and O 0 4.733650103838638e-12
accumulate O 0 2.6121291241132383e-10
into O 0 3.1102355933787518e-12
discrete O 0 8.466999545930776e-09
subnuclear O 0 4.207392339594662e-05
foci O 0 1.1454253581177909e-06
termed O 0 4.2893964291579323e-07
" O 0 5.550104376084164e-09
BRCA1 O 0 4.025753696623724e-06
nuclear O 0 2.0267759737180313e-06
dots O 0 5.053617314842995e-06
. O 0 1.097903634672548e-08

" O 0 4.1748478452063864e-07
BRCA1 O 0 0.00011579760757740587
associates O 0 2.86920771941368e-06
in O 0 2.8030577858828565e-10
vivo O 0 5.678468824044103e-07
with O 0 2.8151328490544358e-11
a O 0 4.962834587729503e-10
structurally O 0 5.396510118771403e-07
related O 0 1.060145926601308e-08
protein O 0 1.9373493387320195e-07
termed O 0 4.642660655918007e-07
BARD1 O 0 0.0002842438407242298
. O 0 2.3381783176290583e-09

Here O 0 2.590423653359153e-09
we O 0 1.686561480751525e-11
show O 0 2.6175341408252173e-11
that O 0 6.358502862690435e-14
the O 0 7.228224773283068e-14
steady O 0 2.233821794206392e-09
- O 0 2.878633154068666e-08
state O 0 3.842066248482823e-11
levels O 0 4.934675237877606e-11
of O 0 2.4381470692218243e-13
BARD1 O 0 6.355951143177663e-08
, O 0 1.022205120570531e-13
unlike O 0 5.024814657243748e-13
those O 0 5.648710123783152e-13
of O 0 4.486801988973221e-12
BRCA1 O 0 8.096940291579813e-06
, O 0 7.083320041623153e-11
remain O 0 1.3688450373194883e-10
relatively O 0 6.271091718829114e-12
constant O 0 3.880060717165179e-10
during O 0 2.823787037531389e-10
cell O 0 1.579726500722245e-07
cycle O 0 2.689273742362275e-06
progression O 0 9.412736403646704e-07
. O 0 1.65366453863669e-09

However O 0 3.124297265344467e-08
, O 0 5.749830819801183e-11
immunostaining O 0 1.9038859022657562e-07
revealed O 0 4.2307636505256596e-08
that O 0 1.062201299140142e-10
BARD1 O 0 5.949383194092661e-06
resides O 0 8.189141809111788e-09
within O 0 1.1894222586017467e-11
BRCA1 O 0 5.478249931911705e-06
nuclear O 0 1.8056218777928734e-06
dots O 0 1.883060321006269e-07
during O 0 1.4414771598580955e-09
S O 0 3.382868953849538e-07
phase O 0 3.9619401509538577e-11
of O 0 1.4313271705021502e-12
the O 0 1.488674981897642e-11
cell O 0 4.2532565913688813e-08
cycle O 0 2.5907024792104494e-07
, O 0 4.556913527076212e-11
but O 0 7.704894664992135e-13
not O 0 2.2113579955899965e-13
during O 0 2.145833288618934e-13
the O 0 1.6288567716848945e-12
G1 O 0 6.841816571068193e-07
phase O 0 9.122518740412033e-09
. O 0 9.334575334918327e-10

Nevertheless O 0 1.598875314812176e-06
, O 0 9.300151204705287e-10
BARD1 O 0 9.999616850109305e-07
polypeptides O 0 4.7502632938289935e-09
are O 0 1.0961862494107688e-11
found O 0 1.543254239677605e-11
exclusively O 0 5.217931989265345e-12
in O 0 2.580826448817658e-13
the O 0 2.2342774874152538e-13
nuclear O 0 2.182783065407534e-09
fractions O 0 8.258219412124457e-13
of O 0 1.644141230496346e-13
both O 0 4.150349768722306e-12
G1 O 0 2.661684277427412e-07
- O 0 4.881556833424838e-06
and O 0 2.1138601979941996e-08
S O 0 5.3780431699124165e-06
- O 0 1.397210240838831e-07
phase O 0 6.917579842280475e-09
cells O 0 9.006715373516272e-09
. O 0 1.9059491485062807e-10

Therefore O 0 1.5801944641680166e-08
, O 0 1.1286059760362566e-11
progression O 0 8.200328749374819e-10
to O 0 3.988865487913884e-11
S O 0 2.048567694146186e-06
phase O 0 1.0295291286155361e-09
is O 0 1.1686308865055395e-10
accompanied O 0 7.600319679168521e-12
by O 0 1.4302374931086936e-13
the O 0 2.8725651956933163e-13
aggregation O 0 2.727938985813694e-10
of O 0 1.1908638138102834e-11
nuclear O 0 1.6190710994123947e-06
BARD1 O 0 8.584934363398133e-08
polypeptides O 0 4.517695106898145e-10
into O 0 3.6338366343757755e-11
BRCA1 O 0 3.835208644886734e-06
nuclear O 0 6.772988285774773e-07
dots O 0 6.494762487818662e-07
. O 0 1.8137892299208147e-09

This O 0 3.0988694943445694e-10
cell O 0 2.4768607431724377e-07
cycle O 0 2.449691010042443e-06
- O 0 2.4464214220643044e-05
dependent O 0 1.338076600632121e-07
colocalization O 0 1.5678858744649915e-07
of O 0 1.5463304248175547e-11
BARD1 O 0 1.7094089344027452e-05
and O 0 1.4981667295632661e-10
BRCA1 O 0 1.6537732960841822e-07
indicates O 0 7.77105255145294e-11
a O 0 1.9240133791731395e-11
role O 0 1.7925314566014094e-09
for O 0 1.712872552128708e-11
BARD1 O 0 2.4738701540627517e-06
in O 0 8.746049023899971e-11
BRCA1 O 0 6.49280336801894e-05
- O 0 0.0006171829882077873
mediated O 0 0.0006726792780682445
tumor B-Disease 0 0.00021511054364964366
suppression O 0 1.0115176252156743e-07
. O 0 1.7335214375080454e-09

Ethnic O 0 1.6960321147507784e-08
differences O 0 1.337408122026318e-07
in O 0 3.6116977464306643e-11
the O 0 4.6027209821275505e-11
HFE O 0 0.00011362116492819041
codon O 0 8.66202299221186e-07
282 O 0 2.1123946680745576e-06
( O 0 2.216066219418167e-09
Cys O 0 0.00020552438218146563
/ O 0 4.1850112211250234e-06
Tyr O 0 9.152932761935517e-06
) O 0 1.0500424835191424e-10
polymorphism O 0 2.1965082908081968e-07
. O 0 3.371526613449305e-09

Recent O 0 1.3035045043352511e-08
studies O 0 8.000687889975211e-10
have O 0 9.693619240636053e-10
shown O 0 3.362800171657909e-08
that O 0 3.2952225410554092e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 0.0013757756678387523
HH B-Disease 1 0.9962604641914368
) O 0 1.185342490828134e-09
is O 0 2.3414215011285933e-10
likely O 0 3.037738116606903e-10
to O 0 2.7496897120338204e-11
be O 0 8.823480834863062e-10
caused O 0 1.9307970500204163e-10
by O 0 1.2670701076897273e-12
homozygosity O 0 3.9658928585595277e-08
for O 0 7.402129256761647e-12
a O 0 8.096490838882531e-11
Cys282Tyr O 0 2.991915266647993e-07
mutation O 0 7.024117731901924e-09
in O 0 2.47865573552164e-12
the O 0 5.714788711697061e-11
HFE O 0 1.3961147487862036e-05
gene O 0 2.494273232400701e-08
located O 0 4.330744207692305e-09
4 O 0 2.2465087567979936e-08
. O 0 1.398212656766873e-09

5 O 0 3.847961522751575e-07
Mb O 0 1.3997222595207859e-05
telomeric O 0 2.4860952180461027e-05
to O 0 6.85945389378162e-09
HLA O 0 5.418181899585761e-06
- O 0 9.273831892642193e-06
A O 0 9.895946817550794e-08
. O 0 2.2146506850617698e-09

Population O 0 1.11857967333151e-09
studies O 0 1.7371638849628113e-11
of O 0 2.857924400606615e-13
this O 0 2.2396320908946166e-13
polymorphism O 0 5.5897558581818885e-08
are O 0 1.108703753804896e-11
facilitated O 0 1.7176009226016475e-10
by O 0 8.272158999456103e-12
the O 0 3.275391026111296e-12
fact O 0 4.199819311767605e-11
that O 0 1.1131513245887792e-11
the O 0 1.2531309323549067e-11
Cys282Tyr O 0 7.385473850263224e-07
mutation O 0 1.048686559812495e-08
creates O 0 2.256957065682741e-09
a O 0 1.7962825671347105e-09
Rsal O 0 2.1692555947083747e-06
restriction O 0 4.4099990326174066e-09
site O 0 5.876295894324812e-09
. O 0 5.032294025930639e-10

We O 0 2.90207928799191e-08
have O 0 6.876030994584781e-11
studied O 0 1.1540646910335184e-10
the O 0 8.624174291371745e-12
codon O 0 4.743656134564844e-08
282 O 0 2.0508416298525844e-07
( O 0 6.781294414892614e-10
Cys O 0 4.810796235688031e-05
/ O 0 3.3325779895676533e-06
Tyr O 0 1.3876335742679657e-06
) O 0 3.523753771411675e-12
polymorphism O 0 8.751877556001375e-10
in O 0 3.7190489945472527e-13
different O 0 1.173243360103049e-13
ethnic O 0 1.4261474813592745e-11
groups O 0 8.54538731442922e-11
. O 0 3.437327089628184e-10

In O 0 2.117119590749894e-09
agreement O 0 1.3563856982035105e-10
with O 0 1.147308051514806e-12
previous O 0 8.191129198531488e-12
observations O 0 6.159133619787482e-11
the O 0 2.410410586406453e-11
Tyr O 0 3.9290756603804766e-07
allele O 0 1.4342241172471404e-08
appeared O 0 1.0766230573722169e-08
to O 0 1.7098175306151653e-11
be O 0 1.4872396369991492e-10
rare O 0 2.043829550046894e-10
or O 0 2.598222081928725e-09
absent O 0 1.3995533265642734e-07
in O 0 7.086212172602302e-11
Asiatic O 0 3.111897584062717e-08
( O 0 9.618540339206838e-12
Indian O 0 9.048393284638578e-11
, O 0 3.7964610296627177e-13
Chinese O 0 2.969074367874941e-13
) O 0 9.958521637529194e-13
populations O 0 7.033239962650484e-11
. O 0 4.1379736442914705e-11

The O 0 8.100558002155367e-10
highest O 0 1.831320695089289e-08
allele O 0 8.828148878592401e-09
frequency O 0 2.6350504001015906e-08
( O 0 1.7954047970558662e-10
7 O 0 7.059181572621753e-10
. O 0 8.015552739777665e-13
5 O 0 2.4992508063093055e-11
% O 0 2.9477334744128225e-13
) O 0 1.7533699915150275e-13
was O 0 1.1537410610218402e-10
found O 0 1.6721994622326264e-10
in O 0 5.1212676460687945e-11
Swedes O 0 3.332581036374904e-05
. O 0 3.365563827628648e-09

Saamis O 0 0.0002167884522350505
( O 0 3.2880271838564568e-09
2 O 0 2.6280320142291203e-09
% O 0 2.4295147491026903e-11
) O 0 3.960064914876327e-12
and O 0 3.7105433309259084e-11
Mordvinians O 0 1.1937007116102905e-07
( O 0 7.663260651047388e-12
1 O 0 2.4863085548720854e-11
. O 0 3.5162457255773216e-13
8 O 0 2.1458813892483164e-10
% O 0 1.3833151204373229e-13
) O 0 9.3089171625e-14
had O 0 8.262119460811235e-11
significantly O 0 5.4255450826490303e-11
lower O 0 1.740029925700881e-10
frequencies O 0 6.008808034474455e-11
of O 0 3.844380976752992e-12
the O 0 2.770591256417987e-10
Tyr O 0 3.2592558909527725e-06
allele O 0 7.640624488658432e-08
. O 0 2.3661550496711925e-09

Comparisons O 0 3.440083551353723e-09
with O 0 3.437961026975245e-11
allele O 0 1.0403822248150618e-09
frequencies O 0 8.219872005277296e-10
based O 0 3.4262894604841776e-11
on O 0 4.781312568091778e-10
prevalence O 0 1.4827367067482555e-07
estimates O 0 4.160848332546152e-10
of O 0 2.9125889200454225e-11
HH B-Disease 0 0.406892865896225
showed O 0 1.456763220630819e-05
some O 0 1.1940957771183758e-11
disagreements O 0 1.8818354874383658e-08
with O 0 6.836821039857277e-12
the O 0 1.9096952751790353e-12
RFLP O 0 3.698682178310264e-07
data O 0 7.296173976101272e-08
, O 0 1.719963754753806e-11
particularly O 0 2.355431474865277e-11
in O 0 5.500848040962403e-12
Finns O 0 2.486925495759351e-06
. O 0 1.313531838853521e-09

The O 0 5.6574336326775665e-09
newly O 0 3.8735802831979527e-07
described O 0 4.949510312712846e-08
HFE O 0 1.5584180800942704e-05
marker O 0 2.6760622517940647e-07
provides O 0 3.4625604466986815e-11
a O 0 6.869499327016859e-12
new O 0 4.873369503083369e-12
approach O 0 2.2939039990427235e-12
to O 0 6.922419451896311e-14
the O 0 6.212677670491135e-14
screening O 0 3.687901720117459e-11
of O 0 4.025243246358334e-12
HH B-Disease 0 3.945285425288603e-05
as O 0 1.4002863313322678e-09
well O 0 1.423595529653765e-11
as O 0 2.3452316477712287e-12
studies O 0 4.976189138484674e-14
of O 0 7.275821248655182e-14
the O 0 1.1695133576850036e-11
relationship O 0 4.851017365581356e-09
between O 0 7.038956223448523e-11
the O 0 2.4185448088687167e-10
HFE O 0 9.001442231237888e-05
Tyr O 0 1.6796544741737307e-06
allele O 0 9.462177530394911e-08
and O 0 3.2225988544354323e-09
different O 0 1.3682193156228095e-09
disorders O 0 0.0025286541786044836
including O 0 1.3733398418480647e-07
cancer B-Disease 0 0.00034138679620809853

Autosomal B-Disease 1 0.999686598777771
dominant I-Disease 1 0.9996802806854248
neurohypophyseal I-Disease 1 0.9998998641967773
diabetes I-Disease 1 0.9999903440475464
insipidus I-Disease 1 0.9994895458221436
associated O 0 1.1064038289987366e-06
with O 0 7.269853469216159e-11
a O 0 5.162901356436933e-11
missense O 0 2.253444506550295e-07
mutation O 0 2.7344951192276312e-08
encoding O 0 1.825545581368715e-08
Gly23 O 0 0.00014608653145842254
- O 0 0.00032186153111979365
- O 0 0.0001926785334944725
> O 0 4.409193934407085e-07
Val O 0 0.00016687331662978977
in O 0 4.771045225560044e-10
neurophysin O 0 3.9924675547808874e-06
II O 0 8.162593076121993e-06
. O 0 9.899884245712087e-10

Autosomal B-Disease 1 0.9994799494743347
dominant I-Disease 1 0.999235987663269
neurohypophyseal I-Disease 1 0.9997417330741882
diabetes I-Disease 1 0.9999687671661377
insipidus I-Disease 1 0.999189555644989
( O 0 6.681643753836397e-07
ADNDI B-Disease 0 0.001141457469202578
) O 0 9.239735643262748e-10
is O 0 3.5073108861638502e-09
an O 0 1.5844096878936398e-06
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.01040906086564064
by O 0 3.7892053939003745e-09
progressive O 0 8.268010986967056e-08
degeneration O 0 1.5941728634061292e-05
of O 0 4.408094028685028e-11
the O 0 4.0739290413371876e-11
magnocellular O 0 1.139680492201478e-07
neurons O 0 7.788392153429413e-09
of O 0 4.771978385359477e-12
the O 0 4.571826597854489e-11
hypothalamus O 0 1.681546812903889e-08
leading O 0 1.619674350195055e-08
to O 0 8.65776755842873e-11
decreased O 0 4.201235981327045e-07
ability O 0 4.859850299965274e-10
to O 0 2.3548417989877057e-12
produce O 0 1.557677459240736e-10
the O 0 5.177963058322632e-10
hormone O 0 6.198534379109333e-07
arginine O 0 1.7021505982484086e-08
vasopressin O 0 1.710628971807182e-08
( O 0 6.204102509510534e-11
AVP O 0 9.732214039104292e-07
) O 0 6.36215247151739e-11
. O 0 1.0167543196271112e-10

Affected O 0 2.1129267224750947e-06
individuals O 0 1.4569785378171218e-09
are O 0 2.3293355091991153e-11
not O 0 1.3158273949598343e-11
symptomatic O 0 1.719461195648364e-08
at O 0 1.9163691078460943e-08
birth O 0 1.4177885532262735e-07
, O 0 9.415249135891202e-11
but O 0 3.5802591447087195e-10
usually O 0 1.3310302193758616e-08
develop O 0 4.01308079744922e-06
diabetes B-Disease 0 0.003743305802345276
insipidus I-Disease 0 6.995604053372517e-05
at O 0 5.293667300065863e-07
1 O 0 2.63311676462763e-07
- O 0 0.007690900005400181
6 O 0 2.7710123049473623e-06
yr O 0 0.00016003867494873703
of O 0 1.320172027252653e-10
age O 0 7.149377978521443e-08
. O 0 5.156487459245795e-10

The O 0 2.2615839756490175e-10
genetic O 0 2.8275895402885e-08
locus O 0 1.498217443440808e-07
of O 0 1.8487966713109927e-10
the O 0 2.7251945144968204e-09
disease O 0 1.868211620603688e-05
is O 0 1.1979334191281055e-10
the O 0 4.6407145487536994e-11
AVP O 0 0.0002516223175916821
- O 0 9.02308092918247e-05
neurophysin O 0 0.00028668620507232845
II O 0 0.00010977602505590767
( O 0 3.8897437354412645e-11
NPII O 0 5.305797756705033e-08
) O 0 1.7321132592465482e-13
gene O 0 8.267001666562024e-12
, O 0 7.701266382421912e-13
and O 0 4.654647760976571e-12
mutations O 0 4.897856786811872e-09
that O 0 9.563924097122367e-10
cause O 0 2.2274411648481873e-08
ADNDI B-Disease 0 0.002699055941775441
have O 0 2.8272388874484022e-08
been O 0 5.406047609568532e-09
found O 0 9.249503940544912e-10
in O 0 1.8347502336868438e-12
both O 0 3.3740751078509268e-12
the O 0 4.92580498959172e-12
signal O 0 7.033511550957883e-10
peptide O 0 3.446766136394608e-11
of O 0 4.572022556555144e-13
the O 0 3.282428495676726e-11
prepro O 0 1.8715892338150297e-06
- O 0 2.0444376787054352e-06
AVP O 0 7.793744589434937e-05
- O 0 2.447365204716334e-06
NPII O 0 5.899989901081426e-06
precursor O 0 9.884016938244145e-10
and O 0 1.56806824469502e-11
within O 0 6.9981238685901115e-12
NPII O 0 1.8784771782520693e-06
itself O 0 3.4063405429662907e-09
. O 0 6.781398220745416e-10

An O 0 5.465350838562699e-09
affected O 0 3.8437505622823664e-08
girl O 0 2.3116845113690943e-05
who O 0 1.3724646308332922e-08
presented O 0 9.303535025706466e-11
at O 0 6.770179972193091e-10
9 O 0 6.060467683255411e-10
months O 0 8.238860288445338e-11
of O 0 1.1052636670477733e-12
age O 0 7.047239236612768e-09
and O 0 8.417188473996973e-11
her O 0 8.156402220294012e-10
similarly O 0 1.0247841464305907e-09
affected O 0 3.8153041836963553e-10
younger O 0 1.1997129956142771e-09
brother O 0 7.687533809530578e-08
and O 0 1.5144201448435979e-09
father O 0 4.404957465453663e-08
were O 0 3.5475627990777525e-10
all O 0 3.882833291002363e-12
found O 0 6.519069728483373e-10
to O 0 3.853794366959207e-11
have O 0 1.1338366356916652e-10
a O 0 3.1043561818377974e-12
novel O 0 2.9083269126317646e-10
missense O 0 3.305390521290974e-07
mutation O 0 1.2113302716443286e-07
( O 0 5.366694241781822e-11
G1758 O 0 9.037192327809862e-09
- O 0 2.1928028672846267e-06
- O 0 4.6646673581562936e-05
> O 0 7.446211469641639e-08
T O 0 4.886978331342107e-06
) O 0 1.6146086475200133e-13
encoding O 0 6.261813441897635e-13
the O 0 2.0453121618232983e-13
amino O 0 9.401839549949553e-12
acid O 0 9.039281476108663e-12
substitution O 0 8.224128843214995e-12
Gly23 O 0 6.812596353711342e-08
- O 0 1.0435375088491128e-06
- O 0 5.6909384511527605e-06
> O 0 2.0920641219390745e-08
Val O 0 1.1278908459644299e-05
within O 0 3.170157025778053e-09
NPII O 0 4.510124563239515e-05
. O 0 1.3003227383734384e-09

The O 0 2.324974657241796e-09
mutation O 0 6.256146320993139e-07
was O 0 5.956417936658909e-08
confirmed O 0 1.9899605574469348e-10
by O 0 2.5516409731668466e-12
restriction O 0 1.1416771694694461e-10
endonuclease O 0 2.0436159786640928e-07
analysis O 0 3.998063213828118e-09
. O 0 8.922859118243309e-10

A O 0 5.3245120312794825e-08
T1 O 0 4.884823283646256e-05
- O 0 8.334685475119841e-08
weighted O 0 7.368671006702243e-09
magnetic O 0 1.0248387694034022e-09
resonance O 0 2.260567510958822e-09
imaging O 0 1.2558459729916649e-06
of O 0 1.173852237634776e-09
the O 0 7.358070774898806e-08
fathers O 0 0.00031423239852301776
pituitary O 0 0.0035507455468177795
gland O 0 7.467568593710894e-06
demonstrates O 0 1.1677563804823876e-08
an O 0 7.069503316081693e-10
attenuated O 0 0.00022038772294763476
posterior O 0 0.0005660417955368757
pituitary O 0 0.010654269717633724
bright O 0 5.957906523690326e-07
spot O 0 2.0721977307402994e-06
. O 0 8.182646560328521e-09

This O 0 2.984728908472789e-09
mutation O 0 1.5533896657871082e-06
may O 0 6.89576484802501e-09
be O 0 1.084175392691844e-12
valuable O 0 6.645104605462748e-12
for O 0 9.944266547365355e-13
developing O 0 1.5049371471231865e-10
models O 0 1.7014462727615864e-08
of O 0 9.336635631296275e-11
dominantly B-Disease 0 0.0007346445345319808
inherited I-Disease 1 0.9780365824699402
neurodegeneration I-Disease 1 0.9999997615814209
, O 0 1.4895633171363443e-08
as O 0 4.26356554228402e-11
the O 0 1.6577200766601519e-12
early O 0 6.0269657320422e-11
age O 0 2.46153386562753e-09
of O 0 3.89928159205688e-11
onset O 0 1.316677639806585e-06
of O 0 4.276748288845056e-09
symptoms O 0 2.572974437953235e-07
suggests O 0 1.697728589655778e-11
that O 0 2.0069627383600963e-12
this O 0 2.6473571598795154e-12
mutation O 0 1.1048469161778485e-07
may O 0 4.809121278981365e-08
be O 0 3.921135638407236e-10
particularly O 0 5.194915678186085e-11
deleterious O 0 1.2021961204311538e-09
to O 0 3.475480970724365e-12
the O 0 1.522498967176933e-11
magnocellular O 0 1.0409745954120808e-07
neuron O 0 1.962206113148568e-07
. O 0 4.556478805373132e-11
. O 0 3.0181654397942737e-10

Frequent O 0 2.1506220946321264e-06
inactivation O 0 1.2263869393791538e-05
of O 0 2.0617825224888975e-09
PTEN O 0 0.003109766636043787
/ O 0 6.1673010350205e-05
MMAC1 O 0 0.010233619250357151
in O 0 2.201469584406368e-08
primary O 0 0.0005192385870032012
prostate B-Disease 1 0.9999988079071045
cancer I-Disease 1 0.9999923706054688
. O 0 3.1595649829796457e-07

Sporadic B-Disease 0 0.3080403208732605
prostate I-Disease 1 0.9999600648880005
carcinoma I-Disease 1 0.9999998807907104
is O 0 9.688051250122953e-07
the O 0 3.5403027731639725e-10
most O 0 1.029808016639322e-09
common O 0 1.4532853143123248e-08
male B-Disease 0 1.3569878376529232e-07
cancer I-Disease 0 5.759037335906214e-08
in O 0 7.51800791759516e-12
the O 0 2.206149984917971e-10
Western O 0 1.1010004019595954e-09
world O 0 1.0089491553344487e-07
, O 0 3.593891026790197e-12
yet O 0 9.683551703554283e-13
many O 0 6.778432405895847e-15
of O 0 6.058491246662898e-14
the O 0 3.78058001571091e-12
major O 0 2.7451005357725933e-10
genetic O 0 6.133263896757057e-10
events O 0 2.996299042212769e-11
involved O 0 7.623425224423386e-10
in O 0 1.5815933632201684e-12
the O 0 1.7452000131493173e-12
progression O 0 3.262126679892674e-10
of O 0 8.361355878505616e-12
this O 0 1.5114268170357548e-10
often O 0 9.74988552115974e-08
fatal O 0 0.033004097640514374
cancer B-Disease 0 0.0001110982775571756
remain O 0 9.900795738815305e-09
to O 0 3.7445133799218766e-11
be O 0 1.1343109784789362e-09
elucidated O 0 7.134801194297324e-07
. O 0 9.682199486604759e-10

Numerous O 0 2.0551564006154877e-08
cytogenetic O 0 8.634010009700432e-05
and O 0 3.179744823000874e-08
allelotype O 0 5.418155978986761e-06
studies O 0 1.991271370016534e-09
have O 0 4.947608434058282e-10
reported O 0 8.724415856420364e-09
frequent O 0 1.197541066311203e-09
loss O 0 2.7603716645785425e-08
of O 0 2.5086590790812657e-11
heterozygosity O 0 3.955546617362415e-06
on O 0 4.784163252224971e-07
chromosomal O 1 0.9787091612815857
arm O 0 0.3829258382320404
10q O 0 3.0434300697379513e-06
in O 0 2.01928740395374e-09
sporadic B-Disease 0 0.0019187899306416512
prostate I-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999939203262329
. O 0 1.151555224510048e-07

Deletion O 0 2.831540314218728e-06
mapping O 0 1.0751579111456522e-06
studies O 0 1.7975926525082286e-08
have O 0 5.177034356762533e-10
unambiguously O 0 2.01031767232962e-07
identified O 0 3.3394893961258276e-08
a O 0 3.523058234033982e-10
region O 0 2.2220073003786922e-10
of O 0 1.4030065303982653e-11
chromosome O 0 0.00031205418054014444
10q23 O 0 1.1808754862840942e-07
to O 0 6.317773387776171e-11
be O 0 4.419577204206604e-11
the O 0 8.358513534090228e-13
minimal O 0 2.229559870059461e-10
area O 0 1.908746771750458e-10
of O 0 7.592542566881022e-11
loss O 0 8.701906608621357e-07
. O 0 1.874226329690032e-09

A O 0 1.3163213630207338e-08
new O 0 8.359323233619875e-10
tumor B-Disease 0 9.896702124478907e-08
suppressor O 0 1.3647787966419855e-07
gene O 0 1.7436603627629665e-07
, O 0 6.970448662713125e-10
PTEN O 0 0.00012273927859496325
/ O 0 1.1160504072904587e-05
MMAC1 O 0 0.0016611359314993024
, O 0 7.349073016804653e-10
was O 0 8.001912910060582e-09
isolated O 0 1.1093293394992543e-08
recently O 0 6.007854125300582e-08
at O 0 9.103846010383165e-10
this O 0 2.7105613760458613e-12
region O 0 2.917420471870713e-11
of O 0 3.1914956788448023e-12
chromosome O 0 2.0877188944723457e-05
10q23 O 0 2.4644053908673413e-08
and O 0 9.06743291562151e-11
found O 0 1.9575850662700844e-10
to O 0 2.8168181762794342e-12
be O 0 3.36292972635821e-11
inactivated O 0 5.31249544355461e-10
by O 0 4.2439914972082493e-13
mutation O 0 1.6946375414050863e-09
in O 0 2.7891167153626384e-10
three O 0 1.0586863936623558e-05
prostate B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999957084655762
cell O 0 5.2936778956791386e-05
lines O 0 3.725279384525493e-05
. O 0 8.562526687683203e-09

We O 0 7.369855126171387e-08
screened O 0 6.299855613178806e-06
80 O 0 2.161231122954632e-06
prostate B-Disease 1 0.9704325199127197
tumors I-Disease 1 0.9999994039535522
by O 0 1.4160812800145806e-10
microsatellite O 0 2.495949502190342e-06
analysis O 0 1.1551207101945238e-08
and O 0 1.788863279728048e-09
found O 0 7.463356155312795e-09
chromosome O 0 3.776789890252985e-05
10q23 O 0 5.326035434904952e-08
to O 0 5.04999271566664e-11
be O 0 2.0960032320882505e-11
deleted O 0 1.3515286667598048e-09
in O 0 6.014503131646087e-12
23 O 0 2.669762466656067e-10
cases O 0 2.632390139201135e-10
. O 0 3.8755859632644274e-10

We O 0 3.2218750334322976e-08
then O 0 1.5815405929320292e-10
proceeded O 0 1.2950148765844549e-11
with O 0 5.577118695793311e-14
sequence O 0 1.1749676481331156e-13
analysis O 0 2.534222560534455e-13
of O 0 9.396074819893394e-14
the O 0 2.6976671764489257e-12
entire O 0 4.554676191759199e-09
PTEN O 0 4.1417471948079765e-05
/ O 0 6.694591547784512e-08
MMAC1 O 0 3.2134939829120412e-06
coding O 0 3.3309655123048287e-07
region O 0 5.918384116121445e-10
and O 0 1.0202408362580684e-11
tested O 0 1.9032910802962988e-09
for O 0 2.460622851307992e-13
homozygous O 0 1.5603812686393326e-09
deletion O 0 1.8543634405787657e-09
with O 0 4.3985530495671554e-11
new O 0 1.2148948513868163e-09
intragenic O 0 3.7003192687734554e-07
markers O 0 1.6898991361813387e-07
in O 0 4.5159678947748194e-12
these O 0 1.661125664104146e-12
23 O 0 2.533776799484855e-10
cases O 0 5.0888432356899216e-11
with O 0 9.497060776686439e-11
10q23 O 0 2.8997609646808087e-08
loss O 0 7.124437040317844e-09
of O 0 2.9088302946900235e-11
heterozygosity O 0 6.452475190599216e-06
. O 0 4.704530542909424e-09

The O 0 3.497440531630147e-11
identification O 0 7.723780642843181e-11
of O 0 5.516598029081665e-12
the O 0 9.843820203414566e-12
second O 0 6.292908860672242e-09
mutational O 0 5.528368660634442e-07
event O 0 7.3075909767794656e-09
in O 0 6.721464357317686e-11
10 O 0 7.985198613447153e-10
( O 0 1.0664231650525657e-11
43 O 0 4.100187744882078e-09
% O 0 1.3199957793474937e-10
) O 0 5.288991467011783e-09
tumors B-Disease 1 0.9999990463256836
establishes O 0 7.026919320196612e-06
PTEN O 0 0.0018798206001520157
/ O 0 1.85784631412389e-06
MMAC1 O 0 4.626859299605712e-05
as O 0 6.467878316263054e-11
a O 0 1.2857532746823885e-11
main O 0 1.1329870375220708e-10
inactivation O 0 1.1151296774869479e-07
target O 0 4.1248002236038417e-10
of O 0 1.3174314070218962e-12
10q O 0 1.156580164973775e-08
loss O 0 2.1452045473324688e-08
in O 0 3.6288516636062695e-10
sporadic B-Disease 0 0.0185580775141716
prostate I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999958276748657
. O 0 2.4329349646023957e-09
. O 0 2.6724438217939905e-09

Risk O 0 2.3624963432666846e-05
reversals O 0 2.6055442958750064e-07
in O 0 3.89163597180886e-11
predictive O 0 3.192871744772674e-08
testing O 0 3.726130728409771e-07
for O 0 6.871084679005435e-08
Huntington B-Disease 1 0.9999951124191284
disease I-Disease 1 0.9999971389770508
. O 0 4.903131056721577e-08

The O 0 2.974604243477508e-11
first O 0 6.92177955577411e-12
predictive O 0 1.3562957423829403e-09
testing O 0 5.0286431019230804e-08
for O 0 2.3361019785284043e-08
Huntington B-Disease 1 0.9999990463256836
disease I-Disease 1 0.9999997615814209
( O 0 1.7608473568131444e-09
HD B-Disease 0 0.00017954201030079275
) O 0 9.749556717508767e-11
was O 0 6.084431847241945e-10
based O 0 1.9723721354086843e-12
on O 0 4.1386522681152726e-11
analysis O 0 2.8454807954325645e-12
of O 0 5.310562645015338e-13
linked O 0 7.799288326282294e-09
polymorphic O 0 4.818279664142722e-10
DNA O 0 8.82742838825834e-08
markers O 0 1.0750434853434854e-07
to O 0 2.9577826732990475e-12
estimate O 0 2.9122499550782166e-11
the O 0 2.224201725575803e-12
likelihood O 0 3.3870839466487723e-10
of O 0 1.5031226046832713e-12
inheriting O 0 2.433757728681485e-08
the O 0 6.748569064685128e-11
mutation O 0 3.0940163764370254e-09
for O 0 1.2990751530050915e-10
HD B-Disease 0 0.00023628849885426462
. O 0 4.009457210685241e-09

Limits O 0 1.9239504212009706e-08
to O 0 1.2466798426924441e-11
accuracy O 0 4.071880332912059e-10
included O 0 5.755346720037746e-12
recombination O 0 8.611932694746471e-11
between O 0 6.655839074332093e-11
the O 0 3.222667575505933e-12
DNA O 0 3.08199730625347e-07
markers O 0 8.801755029708147e-06
and O 0 1.5735016622997477e-09
the O 0 1.6938804525690188e-10
mutation O 0 2.270771943813088e-07
, O 0 4.6392389929650335e-10
pedigree O 0 1.4688108649352216e-06
structure O 0 3.072218746069666e-08
, O 0 2.4590676717117788e-11
and O 0 4.742115445981188e-13
whether O 0 3.9458128604785703e-13
DNA O 0 7.639757160227134e-10
samples O 0 9.965961389468703e-11
were O 0 4.047932562062373e-12
available O 0 1.0219425132518278e-12
from O 0 3.980754094412564e-12
family O 0 5.430848548648726e-10
members O 0 4.83658148253685e-11
. O 0 4.0712433424516803e-10

With O 0 2.0140628054221565e-10
direct O 0 7.214324970750141e-11
tests O 0 2.1785739878765753e-09
for O 0 5.281370501521165e-13
the O 0 3.0507530095896795e-12
HD B-Disease 0 4.654865188058466e-05
mutation O 0 3.6015560311852823e-08
, O 0 2.4529824352303997e-11
we O 0 2.269667960519417e-11
have O 0 7.172743844187368e-13
assessed O 0 4.076245244122312e-11
the O 0 4.688325465698751e-13
accuracy O 0 5.847907047495937e-09
of O 0 2.4613564224978957e-12
results O 0 1.0824546987919792e-11
obtained O 0 2.277846097506475e-12
by O 0 4.0796009691083934e-13
linkage O 0 2.5402866477008956e-09
approaches O 0 2.2446991487790058e-10
when O 0 6.229539661894989e-10
requested O 0 5.825713522700227e-11
to O 0 8.279341622008385e-12
do O 0 1.7616012815135917e-11
so O 0 1.463174741957174e-13
by O 0 4.4180279687488014e-14
the O 0 9.040121082271035e-13
test O 0 3.485091548682817e-09
individuals O 0 7.011621838692861e-11
. O 0 8.075731056100821e-11

For O 0 2.3170756979773444e-10
six O 0 6.241600014611492e-10
such O 0 1.873834941379382e-11
individuals O 0 7.756540548742308e-11
, O 0 1.0983208266479583e-11
there O 0 6.3669200120464176e-12
was O 0 4.516990781411323e-09
significant O 0 7.105702137799597e-11
disparity O 0 1.2339425481400212e-08
between O 0 7.690397624271483e-11
the O 0 3.037958495877291e-10
tests O 0 1.6921585199725087e-07
. O 0 3.1681124390559035e-10

Three O 0 7.388289535725789e-09
went O 0 5.404470648784354e-09
from O 0 1.6378891298796106e-11
a O 0 1.0008305989517297e-10
decreased O 0 3.48603151678617e-07
risk O 0 9.91037385489335e-09
to O 0 6.62111728291781e-12
an O 0 1.2838768936873635e-10
increased O 0 7.080196695596896e-08
risk O 0 2.115373263222864e-07
, O 0 5.5406616794595465e-12
while O 0 1.685063200085324e-11
in O 0 1.1701302090900284e-13
another O 0 1.0885397618010106e-11
three O 0 4.188651855918657e-11
the O 0 1.2625174239389025e-09
risk O 0 1.4880490653013112e-06
was O 0 4.088153104930825e-07
decreased O 0 7.55345126890461e-07
. O 0 4.6550430177205726e-10

Knowledge O 0 1.0625401669628332e-09
of O 0 4.785412951319179e-12
the O 0 1.4991255849541862e-12
potential O 0 1.782207714740025e-10
reasons O 0 8.339308518907906e-13
for O 0 3.6703177660763614e-14
these O 0 8.201063119621724e-14
changes O 0 3.745675644650781e-12
in O 0 9.899358893381005e-13
results O 0 6.355493908927201e-11
and O 0 4.3885142048116776e-11
impact O 0 1.1701811741815504e-10
of O 0 4.0282593883819717e-13
these O 0 7.436531425375481e-12
risk O 0 3.5663569875055146e-09
reversals O 0 1.2784964198431226e-09
on O 0 1.1237890618076563e-09
both O 0 2.472378413109766e-10
patients O 0 8.0071255181835e-11
and O 0 2.729133325579669e-12
the O 0 3.976352667273142e-12
counseling O 0 7.482223174370972e-10
team O 0 7.595207102140122e-11
can O 0 2.455045498492292e-12
assist O 0 8.994890769720154e-12
in O 0 2.6984274190122726e-13
the O 0 3.9343598908295196e-13
development O 0 7.048807609648378e-14
of O 0 5.954900472466412e-14
strategies O 0 1.641501344573637e-11
for O 0 1.0703351182791976e-12
the O 0 5.34751279715473e-12
prevention O 0 6.459390355928463e-09
and O 0 3.507108492506461e-10
, O 0 2.8441350836960755e-12
where O 0 6.827763614908333e-12
necessary O 0 3.3789375377540898e-12
, O 0 7.277643114880772e-13
management O 0 7.003995907556293e-13
of O 0 3.5365228134203244e-14
a O 0 2.101019497269263e-10
risk O 0 3.128949188635488e-08
reversal O 0 3.9385478212139446e-10
in O 0 6.942914938714434e-14
any O 0 1.4706844683048947e-13
predictive O 0 3.2951386064183907e-10
testing O 0 3.790417701932114e-10
program O 0 2.488206342354804e-11
. O 0 1.1135203002721195e-12
. O 0 3.6001156916709576e-11

A O 0 2.3158099438091995e-08
novel O 0 5.456955332050484e-09
common O 0 2.855826908287895e-09
missense O 0 5.336610797712638e-07
mutation O 0 5.733718353440054e-07
G301C O 0 2.6716092449419193e-08
in O 0 6.135796298128993e-12
the O 0 5.287884279753241e-12
N O 0 4.626069767255103e-06
- O 0 9.326206054538488e-06
acetylgalactosamine O 0 0.00016986769333016127
- O 0 7.631806511199102e-06
6 O 0 2.9084583275107434e-07
- O 0 3.913454747817013e-06
sulfate O 0 2.898473496770748e-07
sulfatase O 0 2.1112336412443256e-07
gene O 0 2.029020285121419e-09
in O 0 3.4378236368759474e-11
mucopolysaccharidosis B-Disease 0 1.3871546116206446e-06
IVA I-Disease 0 0.0015861570136621594
. O 0 1.268659133302208e-08

Mucopolysaccharidosis B-Disease 0 0.26921844482421875
IVA I-Disease 1 0.9991068243980408
( O 0 0.0006090251263231039
MPS B-Disease 1 0.9999771118164062
IVA I-Disease 1 0.9999966621398926
) O 0 9.962857205891851e-08
is O 0 6.864742108092514e-09
an O 0 4.2262712440788164e-08
autosomal B-Disease 1 0.9999809265136719
recessive I-Disease 1 0.9999955892562866
lysosomal I-Disease 1 0.9999948740005493
storage I-Disease 1 0.9999974966049194
disorder I-Disease 1 0.9999959468841553
caused O 0 3.8489929465868045e-06
by O 0 2.2058345428010995e-10
a O 0 1.3123684539095848e-07
genetic B-Disease 1 0.999998927116394
defect I-Disease 1 0.9999994039535522
in O 0 3.815036730969723e-09
N O 0 7.500699575757608e-05
- O 0 0.0002231797989225015
acetylgalactosamine O 0 0.004312078934162855
- O 0 0.0002379880752414465
6 O 0 6.708301953040063e-06
- O 0 0.0018589087994769216
sulfate O 0 3.985449075116776e-05
sulfatase O 0 3.371146158315241e-05
( O 0 2.838534685078997e-10
GALNS O 0 6.249800890145707e-07
) O 0 6.992256773585837e-11
. O 0 1.1269738614538838e-10

In O 0 1.978467834007347e-09
previous O 0 1.430797147428109e-09
studies O 0 6.29718915901023e-11
, O 0 7.718843793302899e-12
we O 0 9.551700576315714e-12
have O 0 7.720872010306967e-13
found O 0 7.238469372505829e-12
two O 0 1.0418307709592067e-11
common O 0 2.5078375487375126e-10
mutations O 0 2.910642393771923e-09
in O 0 5.718263969972659e-12
Caucasians O 0 1.2220744416424623e-08
and O 0 6.428585996864911e-10
Japanese O 0 4.4150258560193834e-08
, O 0 2.2419980802435013e-11
respectively O 0 9.224398467289063e-10
. O 0 4.754031612819176e-10

To O 0 3.3704830593173085e-10
characterize O 0 6.582470124527617e-09
the O 0 3.5601892961478754e-11
mutational O 0 7.464269913270982e-08
spectrum O 0 2.8675073426853714e-09
in O 0 1.348146204047107e-12
various O 0 1.3380649940917394e-13
ethnic O 0 6.660989034651399e-13
groups O 0 8.618710671363938e-13
, O 0 4.751703587893563e-13
mutations O 0 6.045813849553383e-11
in O 0 1.8240720349102513e-13
the O 0 3.83533569486838e-12
GALNS O 0 9.648763352743117e-07
gene O 0 1.8925609968079016e-09
in O 0 1.2983468467009374e-10
Colombian O 0 1.3662344827025663e-05
MPS B-Disease 1 0.9999872446060181
IVA I-Disease 1 0.9999995231628418
patients O 0 1.7530403511045733e-06
were O 0 1.427021695254993e-10
investigated O 0 2.2706457158960802e-08
, O 0 2.5644595821883165e-11
and O 0 1.1123447649086238e-11
genetic O 0 6.292089071990858e-10
backgrounds O 0 8.553181773951479e-11
were O 0 2.4671860041070026e-11
extensively O 0 7.549941227757984e-11
analyzed O 0 2.9554170222212406e-10
to O 0 2.3321884787957936e-12
identify O 0 4.768868633320267e-11
racial O 0 1.0381773912770953e-10
origin O 0 7.014992753351379e-11
, O 0 1.0920870327849053e-12
based O 0 1.2530108244382387e-12
on O 0 8.703050086156239e-11
mitochondrial O 0 1.884154610110045e-09
DNA O 0 2.0279387058508291e-07
( O 0 1.174525234015622e-11
mtDNA O 0 7.440624782972804e-10
) O 0 8.55066451671549e-12
lineages O 0 1.0662493110658033e-09
. O 0 7.297558668462045e-10

Three O 0 9.724656635512474e-10
novel O 0 2.4447970314867007e-09
missense O 0 3.945668140659109e-06
mutations O 0 1.189733939099824e-05
never O 0 4.7504471467618714e-07
identified O 0 2.1580659037567784e-08
previously O 0 1.4558516170382063e-08
in O 0 3.748069563047629e-12
other O 0 1.28248600975156e-11
populations O 0 5.530784719098847e-10
and O 0 2.060500103873153e-10
found O 0 4.4622550099404634e-09
in O 0 2.857523939692186e-11
16 O 0 9.319470750668302e-10
out O 0 1.1474367012098696e-09
of O 0 6.990710094134656e-11
19 O 0 4.02869687832208e-07
Colombian O 0 2.798899231493124e-06
MPS B-Disease 1 0.9989945292472839
IVA I-Disease 1 0.9999279975891113
unrelated O 0 1.2169576280030014e-07
alleles O 0 2.73061595557067e-09
account O 0 7.664014423092169e-10
for O 0 1.3445523860955433e-10
84 O 0 4.08877234292504e-08
. O 0 7.767055332230655e-10

2 O 0 5.218201337697792e-08
% O 0 4.933442543375577e-11
of O 0 3.885327660730492e-13
the O 0 2.7517868626120157e-12
alleles O 0 1.4214582289007183e-10
in O 0 1.821385707187484e-12
this O 0 1.6751666243389196e-12
study O 0 1.5845177947504396e-10
. O 0 4.3923514825294774e-10

The O 0 2.924420705596731e-09
G301C O 0 2.3001524596111267e-07
and O 0 8.073898494220799e-11
S162F O 0 2.0034431891247095e-09
mutations O 0 2.0824209023828644e-09
account O 0 1.1264603139160556e-10
for O 0 2.4056853731302397e-10
68 O 0 1.9090222735940188e-07
. O 0 2.045363212133111e-09

4 O 0 6.035257911207736e-07
% O 0 1.3979912782957626e-09
and O 0 1.681160211042254e-10
10 O 0 3.191109321232233e-10
. O 0 1.0093731406257689e-10

5 O 0 4.126740194010381e-08
% O 0 1.0216180679201159e-10
of O 0 2.5154041176367326e-12
mutations O 0 6.337067759432102e-08
, O 0 1.0782619241922475e-10
respectively O 0 7.679304969698819e-10
, O 0 1.8327008747404117e-12
whereas O 0 3.3236093998495475e-12
the O 0 6.338892518525929e-12
remaining O 0 1.0985775622529559e-09
F69V O 0 4.079957216163166e-05
is O 0 4.708127776531512e-10
limited O 0 1.6380110809399717e-11
to O 0 1.584099171281217e-12
a O 0 3.969383155499884e-11
single O 0 2.6232507721601905e-08
allele O 0 4.59856863699315e-08
. O 0 1.3723383540664713e-09

The O 0 2.5933938330169326e-10
skewed O 0 6.191544343892019e-08
prevalence O 0 7.2083016675605904e-06
of O 0 5.84122403224363e-11
G301C O 0 1.908606783729283e-08
in O 0 3.4351085344275223e-12
only O 0 1.6918251738787249e-12
Colombian O 0 5.0418171859689664e-09
patients O 0 1.112218095400408e-10
and O 0 6.094841428425091e-13
haplotype O 0 1.8309731508736604e-10
analysis O 0 1.3540791751753822e-11
by O 0 2.4657639211694837e-12
restriction O 0 1.0070923955884936e-10
fragment O 0 4.365601657951856e-09
length O 0 2.0314532278575825e-08
polymorphisms O 0 3.2155278972823e-07
in O 0 1.4368203675452218e-11
the O 0 2.7906586763659647e-11
GALNS O 0 5.341964879335137e-06
gene O 0 1.8055913431069825e-09
suggest O 0 2.070443400059574e-10
that O 0 8.969261965086073e-12
G301C O 0 5.912381140227296e-10
originated O 0 8.785557698010038e-11
from O 0 2.8901859204510938e-12
a O 0 5.620387141802574e-11
common O 0 4.415560139747754e-10
ancestor O 0 3.756042588065611e-08
. O 0 3.6254079738284872e-09

Investigation O 0 2.9082022123816387e-08
of O 0 4.30453554745025e-11
the O 0 1.5019426674589553e-11
genetic O 0 1.999668519658826e-08
background O 0 2.969305079592033e-10
by O 0 4.7399744719511805e-12
means O 0 1.4174181793558116e-11
of O 0 1.703003515117485e-13
mtDNA O 0 1.5459890312374824e-10
lineages O 0 4.0356717967426903e-10
indicate O 0 1.2358379875010428e-09
that O 0 1.7775118182905558e-11
all O 0 3.0871576128799205e-11
our O 0 2.249504804652247e-09
patients O 0 4.0233417292201423e-11
are O 0 8.458407992030167e-14
probably O 0 7.581945488110975e-12
of O 0 4.403602320030703e-13
native O 0 1.822371697990377e-09
American O 0 2.3428493989285926e-07
descent O 0 6.120693433331326e-05

Low O 0 8.513641205354361e-07
frequency O 0 2.724946490673119e-08
of O 0 2.426774614594507e-10
BRCA1 O 0 9.061866876436397e-05
germline O 0 5.858320491824998e-06
mutations O 0 8.301055459014606e-06
in O 0 9.48884526508209e-10
45 O 0 3.045142875635065e-06
German O 1 0.9999673366546631
breast B-Disease 1 0.9999967813491821
/ I-Disease 1 0.9999988079071045
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999982118606567
families O 0 6.043592293281108e-07
. O 0 4.14244727409141e-09

In O 0 2.848209723627093e-10
this O 0 4.1416644961690674e-13
study O 0 6.716048615677817e-13
we O 0 5.201060068737995e-12
investigated O 0 1.2827130468906489e-08
45 O 0 6.818589071144743e-08
German O 1 0.9972978234291077
breast B-Disease 1 0.9999862909317017
/ I-Disease 1 0.9999980926513672
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 1.3456973313452636e-09
for O 0 2.0203292164233666e-11
germline O 0 8.49401686764395e-08
mutations O 0 6.925240114696862e-08
in O 0 5.254926268433158e-12
the O 0 1.9577306442641884e-10
BRCA1 O 0 5.1900071412092075e-05
gene O 0 3.210735144421051e-07
. O 0 2.9631059828005846e-09

We O 0 3.243181723178168e-09
identified O 0 7.279458702491581e-10
four O 0 2.017087365191461e-11
germline O 0 1.7929072271272162e-07
mutations O 0 1.8606602907311753e-06
in O 0 2.587434988488013e-10
three O 0 1.0365920388721861e-07
breast B-Disease 0 0.1051894873380661
cancer I-Disease 0 3.429863500059582e-05
families O 0 1.3205050386488892e-09
and O 0 2.7523894274850136e-09
in O 0 1.4468596321037808e-09
one O 0 0.0019285070011392236
breast B-Disease 1 0.9999994039535522
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 6.665071055067529e-07
. O 0 4.1436264142102885e-12
among O 0 7.804842709624449e-12
these O 0 1.1327849465739281e-12
were O 0 2.84583134835259e-10
one O 0 1.7645582217618028e-10
frameshift O 0 7.216343647087342e-07
mutation O 0 3.55066390511638e-07
, O 0 9.06675845513405e-11
one O 0 9.117226418275948e-10
nonsense O 0 5.025573955208529e-06
mutation O 0 3.68880108680969e-07
, O 0 2.422643162469651e-11
one O 0 6.357442350335418e-12
novel O 0 2.545125499242573e-10
splice O 0 1.0714048585214186e-05
site O 0 6.257816949073458e-07
mutation O 0 1.7843374280346325e-06
, O 0 2.5750576670979797e-10
and O 0 1.9066061229811027e-11
one O 0 1.3377736418629382e-10
missense O 0 1.080799938790733e-05
mutation O 0 9.887030500976834e-06
. O 0 9.559077973619878e-09

The O 0 1.6761086962802096e-09
missense O 0 8.933320714277215e-06
mutation O 0 9.019416029332206e-05
was O 0 5.898780273128068e-06
also O 0 8.076952995317299e-10
found O 0 2.608464833020463e-10
in O 0 6.285929242400012e-12
2 O 0 2.625446970938583e-09
. O 0 5.574503081362536e-10

8 O 0 2.1027238972237683e-07
% O 0 5.611346109990478e-11
of O 0 7.82428971873167e-13
the O 0 3.595241509016245e-12
general O 0 1.1986366760252665e-11
population O 0 1.7543745319328896e-12
, O 0 4.32373646434836e-13
suggesting O 0 1.3871377657626027e-10
that O 0 8.478946711409918e-12
it O 0 9.957695085160978e-11
is O 0 1.471680777243023e-09
not O 0 5.1731476879979255e-09
disease O 0 5.785890380138881e-07
associated O 0 3.6036071349165866e-10
. O 0 4.863355274054015e-10

The O 0 5.891353516140896e-10
average O 0 6.028596430951438e-07
age O 0 6.334034452493142e-08
of O 0 1.065789789755911e-09
disease O 0 0.0007533761090599
onset O 0 1.1641513992799446e-06
in O 0 4.799382766207394e-11
those O 0 7.96590571283673e-11
families O 0 5.6113679675062755e-11
harbouring O 0 3.598858711484354e-06
causative O 0 7.501387244701618e-06
mutations O 0 1.0058284942715545e-06
was O 0 8.4324177862527e-08
between O 0 1.6576561234771248e-09
32 O 0 6.402112830983242e-07
. O 0 4.347577853280882e-09

3 O 0 7.439056304292535e-08
and O 0 1.0009800766042076e-09
37 O 0 2.729768766585039e-08
. O 0 4.645206996833906e-10

4 O 0 1.7149945108485554e-07
years O 0 4.048649415722139e-09
, O 0 2.033170073273416e-12
whereas O 0 3.9585093015992445e-12
the O 0 3.87799254514265e-12
family O 0 3.7602462810149007e-10
harbouring O 0 6.902990890012006e-07
the O 0 1.3794145513335021e-11
missense O 0 9.918699106492568e-08
mutation O 0 2.5682186333142454e-07
had O 0 4.820987342668559e-08
an O 0 4.258900176967728e-11
average O 0 1.0490465456314269e-06
age O 0 1.6058658403039772e-08
of O 0 1.7192716000868913e-11
onset O 0 4.0573400639232204e-08
of O 0 4.425785779527125e-11
51 O 0 6.249920261325315e-07
. O 0 1.8155752457005292e-09

2 O 0 3.623854922807368e-07
years O 0 5.646052869678897e-08
. O 0 4.181001322933753e-09

These O 0 1.6062777496994585e-10
findings O 0 5.484897536156552e-10
show O 0 1.258656734393071e-08
that O 0 1.5164165756420545e-10
BRCA1 O 0 2.7173275157110766e-05
is O 0 1.6934808000357293e-09
implicated O 0 2.592432508663478e-07
in O 0 1.3043972369244927e-12
a O 0 3.3953083400373174e-12
small O 0 3.683142679733464e-11
fraction O 0 2.589674430453215e-08
of O 0 5.25899031345034e-06
breast B-Disease 1 0.9999983310699463
/ I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 2.431340284658745e-08
suggesting O 0 5.435265570952197e-09
the O 0 4.848568161547329e-12
involvement O 0 1.3728095327181222e-09
of O 0 1.0855576420415458e-12
another O 0 3.340836496334987e-10
susceptibility O 0 5.849594941764735e-08
gene O 0 8.488542135864918e-08
( O 0 1.541449634601122e-09
s O 0 1.6669437172822654e-05
) O 0 9.232939746084412e-09

Paternal O 0 0.029412945732474327
transmission O 1 0.9874640703201294
of O 0 0.0009290857124142349
congenital B-Disease 1 0.9999973773956299
myotonic I-Disease 1 0.9999986886978149
dystrophy I-Disease 1 0.999998927116394
. O 0 2.1455789465107955e-05

We O 0 1.3485141003855006e-08
report O 0 1.2776572855255353e-10
a O 0 2.1480618932895323e-12
rare O 0 1.2472982716116299e-11
case O 0 6.649320538620884e-10
of O 0 3.3189646586606614e-09
paternally O 1 0.9969069361686707
transmitted O 1 0.9999949932098389
congenital B-Disease 1 0.9999994039535522
myotonic I-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999996423721313
( O 0 0.0002669001987669617
DM B-Disease 1 0.9999958276748657
) O 0 6.407670838370905e-08
. O 0 3.5730569614145224e-09

The O 0 1.2090116685570251e-09
proband O 0 1.2634945960598998e-06
is O 0 2.7922678058622807e-10
a O 0 8.53887030527467e-11
23 O 0 4.440195988664186e-10
year O 0 9.588266292048786e-11
old O 0 8.158981472661253e-06
, O 0 2.340776461551286e-08
mentally B-Disease 1 0.9999995231628418
retarded I-Disease 1 0.9999992847442627
male O 0 9.590465924702585e-05
who O 0 7.675162487430498e-05
suffers O 1 0.9886227250099182
severe O 1 0.956125795841217
muscular B-Disease 1 0.9985154271125793
weakness I-Disease 1 0.9428685307502747
. O 0 4.058091107594919e-08

He O 0 1.05532205907366e-06
presented O 0 2.471207061205405e-08
with O 0 7.922973566110159e-08
respiratory O 0 0.003717245301231742
and O 0 1.5012117771107114e-08
feeding O 0 1.9938886907766573e-05
difficulties O 0 7.791379630361916e-07
at O 0 1.089927081920905e-08
birth O 0 3.703330833104701e-07
. O 0 1.0537065664451006e-09

His O 0 2.683703712591523e-07
two O 0 8.216901647983832e-08
sibs O 1 0.6384059190750122
suffer O 0 0.00022375062690116465
from O 0 8.746341428889082e-09
childhood O 0 3.427626870688982e-05
onset O 0 0.026427963748574257
DM B-Disease 1 0.9999916553497314
. O 0 1.6551523174257454e-07

Their O 0 4.9385500133780624e-09
late O 0 3.4554845651513233e-09
father O 0 3.773988410671336e-08
had O 0 4.378917506375757e-10
the O 0 2.931211046455773e-13
adult O 0 2.1582902132166737e-10
type O 0 9.824552726911406e-09
of O 0 1.024065054977541e-09
DM B-Disease 1 1.0
, O 0 1.3720949931794735e-09
with O 0 2.2252253858989768e-11
onset O 0 2.692295808515155e-08
around O 0 1.493790424689223e-09
30 O 0 2.0390131250103138e-10
years O 0 1.4948499382771985e-10
. O 0 8.889711883286466e-11

Only O 0 6.575740507663852e-10
six O 0 4.9063697549200924e-11
other O 0 7.434045241373755e-13
cases O 0 1.4220541411091858e-11
of O 0 1.9225718239646028e-11
paternal O 0 0.00010915536404354498
transmission O 1 0.9416897296905518
of O 0 1.3146375749784056e-05
congenital B-Disease 1 0.9999986886978149
DM I-Disease 1 1.0
have O 0 7.760716016491642e-07
been O 0 1.1646800857079143e-08
reported O 0 1.4964433248110254e-08
recently O 0 1.4390322178314818e-07
. O 0 3.6144146009498e-10

We O 0 1.497547530426857e-09
review O 0 2.885588122614191e-11
the O 0 7.083881007827197e-13
sex O 0 6.342913971835173e-10
related O 0 1.841743424435549e-10
effects O 0 7.055682149648135e-10
on O 0 7.227329845704844e-10
transmission O 0 3.4902790503110737e-05
of O 0 2.817238282659673e-07
congenital B-Disease 1 0.9999758005142212
DM I-Disease 1 0.9999972581863403
. O 0 2.7767899268837937e-07

Decreased O 0 7.511364674428478e-05
fertility O 0 1.7772113096725661e-06
of O 0 3.7063699331874034e-11
males O 0 2.1166268737715654e-09
with O 0 4.553944166207913e-10
adult O 0 5.915257133892737e-06
onset O 0 0.014522074721753597
DM B-Disease 1 1.0
and O 0 2.0181242632588692e-07
contraction O 0 8.471614023619622e-07
of O 0 1.0203629391067337e-12
the O 0 2.317449183941722e-12
repeat O 0 2.4184165781093725e-09
upon O 0 1.4289493199814984e-11
male O 0 4.5706693985181346e-10
transmission O 0 2.1813274742044086e-08
contribute O 0 1.8661593104152274e-11
to O 0 1.924746603418348e-12
the O 0 1.4763569056511217e-12
almost O 0 7.966999976405376e-11
absent O 0 8.922280136935967e-10
occurrence O 0 5.792499258028272e-10
of O 0 1.130991481024246e-11
paternal O 0 4.564071787171997e-06
transmission O 0 0.0369817353785038
of O 0 8.74039233167423e-06
congenital B-Disease 1 0.9999889135360718
DM I-Disease 1 0.9999969005584717
. O 0 5.001554086447868e-07

Also O 0 4.7926022261890466e-08
the O 0 7.875680142765962e-12
fathers O 0 2.5624269373025754e-10
of O 0 2.874455773231588e-13
the O 0 2.1151235277128144e-11
reported O 0 8.798566852874501e-08
congenitally O 0 7.515565812354907e-06
affected O 0 4.767202810285198e-08
children O 0 4.756952054485453e-10
showed O 0 3.895107791862529e-09
, O 0 2.609097833616847e-13
on O 0 1.5707353820393344e-11
average O 0 7.792166023534719e-09
, O 0 1.4984910014226305e-12
shorter O 0 7.621942521573999e-10
CTG O 0 3.508878521074621e-08
repeat O 0 3.382734314882896e-09
lengths O 0 2.7480421493919494e-08
and O 0 4.5047365837547204e-10
hence O 0 3.0558341967967806e-10
less O 0 2.214916916543075e-09
severe O 0 3.5199564081267454e-06
clinical O 0 2.6802868546838e-07
symptoms O 0 1.1033854008246635e-07
than O 0 1.7878815832331196e-12
the O 0 5.124452945315383e-11
mothers O 0 1.7557841403004204e-08
of O 0 1.8626636691387866e-11
children O 0 4.596586578031747e-08
with O 0 1.1754859770007897e-06
congenital B-Disease 1 0.9999526739120483
DM I-Disease 1 0.9999986886978149
. O 0 2.3036824359223829e-07

We O 0 3.591607677932984e-09
conclude O 0 1.1903131813539858e-09
that O 0 4.1948243489908776e-11
paternal O 0 1.2246246114955284e-06
transmission O 0 0.08918758481740952
of O 0 2.8028414362779586e-06
congenital B-Disease 1 0.9999991655349731
DM I-Disease 1 1.0
is O 0 8.602700063420343e-07
rare O 0 8.51227444087499e-09
and O 0 3.920139213242635e-11
preferentially O 0 7.669673229848684e-10
occurs O 0 5.209898831792792e-11
with O 0 1.4135088065303503e-11
onset O 0 4.3216861200789936e-08
of O 0 1.0400011962730105e-09
DM B-Disease 1 0.9999997615814209
past O 0 6.076817840039439e-07
30 O 0 1.805054217207669e-09
years O 0 4.324021002366507e-11
in O 0 2.1769661540018553e-13
the O 0 4.495513770269577e-12
father O 0 1.3581707314358482e-08
. O 0 4.5955431300648275e-12
. O 0 7.570316595817417e-11

The O 0 4.926357544121629e-09
RB1 O 0 3.823042425210588e-05
gene O 0 2.969637762362254e-07
mutation O 0 5.750869718212925e-07
in O 0 1.5666909436440335e-10
a O 0 6.220957970981544e-09
child O 0 0.00041628823964856565
with O 0 2.0133099951635813e-06
ectopic B-Disease 1 0.9999538660049438
intracranial I-Disease 1 0.9999663829803467
retinoblastoma I-Disease 1 0.996160626411438
. O 0 4.866882363785408e-07

The O 0 7.842234417410054e-09
RB1 O 0 3.051372004847508e-05
gene O 0 1.214886680145355e-07
mutation O 0 2.0139789569384448e-07
was O 0 2.3054971265423774e-08
investigated O 0 1.9772016912611434e-07
in O 0 1.1293064400286212e-10
a O 0 2.3976120644420007e-08
child O 0 0.036278191953897476
with O 0 1.2267297506696195e-06
ectopic B-Disease 1 0.9999459981918335
intracranial I-Disease 1 0.9980146884918213
retinoblastoma I-Disease 0 3.887801995006157e-06
using O 0 3.06215913736807e-10
DNA O 0 4.1463195543656184e-07
obtained O 0 1.4590809671588545e-09
from O 0 4.1639264952708643e-11
both O 0 4.2141266171080716e-11
the O 0 4.129649400219648e-10
pineal B-Disease 0 8.177645213436335e-06
and I-Disease 0 6.45091020601285e-08
retinal I-Disease 0 6.3646771195635665e-06
tumours I-Disease 1 0.999998927116394
of O 0 2.6907338579462703e-09
the O 0 1.7950023689650152e-08
patient O 0 3.458477976892027e-06
. O 0 1.8755637043454954e-09

A O 0 4.9997794349110336e-08
nonsense O 0 3.029802542187099e-07
mutation O 0 6.58165646427733e-08
in O 0 1.85010097519811e-11
exon O 0 5.563864533542073e-07
17 O 0 1.1461701632242693e-07
( O 0 2.1359116732233563e-12
codon O 0 3.9852629529768535e-10
556 O 0 4.449886570334627e-10
) O 0 1.514951494330577e-13
of O 0 4.986069947220985e-14
the O 0 5.500585664036661e-12
RB1 O 0 2.9967520731588593e-06
gene O 0 2.557615097487087e-08
was O 0 1.4012436544419415e-08
found O 0 2.819185995761586e-10
to O 0 6.8273602917001686e-12
be O 0 7.211628516579083e-11
present O 0 1.430307261518493e-11
homozygously O 0 7.98181076788751e-08
in O 0 4.067312025374248e-12
both O 0 2.6461367819141657e-11
the O 0 2.1037904751608494e-10
retinal B-Disease 0 1.1741220617977888e-07
and I-Disease 0 3.5189383851275124e-08
the I-Disease 0 8.08904658811116e-08
pineal I-Disease 0 0.013683395460247993
tumours I-Disease 1 0.9999943971633911
. O 0 4.568425637785367e-08

The O 0 3.075598664636914e-10
same O 0 1.1598838556281521e-10
mutation O 0 9.014659951844806e-08
was O 0 3.4950986105286574e-08
present O 0 4.193847699673903e-11
heterozygously O 0 1.0621399582078084e-07
in O 0 2.7359020539526047e-13
the O 0 1.0638804968281582e-13
DNA O 0 1.4055317798522537e-08
from O 0 1.6369490832279787e-11
the O 0 4.234404493708155e-12
constitutional O 0 2.7828464532753117e-10
cells O 0 8.829402486920657e-11
of O 0 2.639929724476686e-12
the O 0 3.5500263839693957e-10
patient O 0 2.4197468917463993e-08
, O 0 9.874353938676972e-13
proving O 0 4.909489481619289e-10
it O 0 1.21259937854723e-11
to O 0 4.4897896164797224e-12
be O 0 3.822185276614043e-11
of O 0 3.2412228283262845e-12
germline O 0 4.6571788203664255e-08
origin O 0 2.5091930755394287e-09
. O 0 1.7002970142954155e-09

The O 0 1.9616329394178678e-10
initial O 0 2.831386236579192e-10
mutation O 0 1.365476691717049e-07
was O 0 1.600851220473487e-07
shown O 0 9.496848862866614e-10
to O 0 1.7649746247849762e-11
have O 0 5.378817183321338e-11
occurred O 0 3.363410938650446e-11
in O 0 2.0892608389860845e-12
the O 0 1.0102282899104864e-10
paternally O 0 1.482574361943989e-06
derived O 0 3.86296816756726e-09
RB1 O 0 2.967220643768087e-05
allele O 0 3.7273642305990506e-07
. O 0 5.010832193619308e-09

The O 0 7.067776919278401e-10
mutation O 0 2.896671844609955e-07
is O 0 2.628272710580859e-09
in O 0 3.1461298410223604e-12
an O 0 1.4637123110783357e-11
area O 0 2.2068570582067792e-10
of O 0 2.2729723919007183e-12
the O 0 7.214871061700379e-12
gene O 0 6.864420837304763e-11
that O 0 8.268069930962574e-13
encodes O 0 2.4340094176289462e-11
the O 0 6.883546250363581e-12
protein O 0 2.9079900709660933e-09
- O 0 3.016511413989065e-07
binding O 0 4.0065618378548606e-08
region O 0 1.0507918146718254e-10
known O 0 2.1114968107305288e-10
as O 0 4.307837073169729e-11
the O 0 8.911896394458996e-12
pocket O 0 3.228764398954809e-05
region O 0 1.0178788478754086e-08
and O 0 2.05260874963642e-09
has O 0 9.170140202741095e-10
been O 0 9.90012447021904e-11
detected O 0 1.5171636169597491e-09
in O 0 1.3465728640645047e-13
other O 0 1.6785687152309076e-13
cases O 0 1.0804065107838934e-11
of O 0 7.463629540793715e-12
retinoblastoma B-Disease 0 1.1509287105582189e-06
. O 0 6.307646766012809e-11
. O 0 2.179836311455574e-10

Low O 0 5.30556462763343e-05
levels O 0 5.444794126674424e-08
of O 0 5.576390477851634e-12
beta O 0 2.1012599993319725e-10
hexosaminidase O 0 2.915523396040953e-07
A O 0 4.183091206755307e-09
in O 0 2.9572309878656e-11
healthy O 0 6.937095342607336e-09
individuals O 0 7.658267076049441e-11
with O 0 4.714096668578804e-09
apparent O 0 2.767505793599412e-05
deficiency O 0 0.0010099841747432947
of O 0 2.5003697029513106e-12
this O 0 3.1078650070126557e-11
enzyme O 0 2.4164913270396937e-07
. O 0 9.47578682186645e-10

Appreciable O 0 3.35842341883108e-05
beta O 0 1.345180180578609e-07
hexosaminidase O 0 1.753706055751536e-05
A O 0 8.136102280786872e-08
( O 0 3.633781123224544e-11
hex O 0 2.59301373262133e-07
A O 0 1.0779828141238568e-09
) O 0 5.475439979890639e-13
activity O 0 3.035651591209998e-11
has O 0 2.2313753275660098e-11
been O 0 1.5738153835709312e-11
detected O 0 9.297886016668144e-09
in O 0 1.7249705136501703e-11
cultured O 0 3.4643144317669794e-06
skin O 0 3.447177368798293e-05
fibroblasts O 0 9.305692287853162e-07
and O 0 2.1611765532725258e-07
melanoma B-Disease 1 0.783620297908783
tissue O 0 0.000531847937963903
from O 0 8.736387613339502e-09
healthy O 0 1.4991692864896322e-07
individuals O 0 2.0978961623452363e-10
previously O 0 3.757511635171795e-08
reported O 0 5.014085786569922e-07
as O 0 2.499245681519824e-07
having O 0 4.372043986222707e-05
deficiency B-Disease 0 2.2029449610272422e-05
of I-Disease 0 1.2984397628271194e-12
hex I-Disease 0 3.815599484369159e-06
A I-Disease 0 9.495834119022106e-10
activity O 0 1.8617055119740655e-10
indistinguishable O 0 1.1999504168080932e-10
from O 0 1.3780752797579177e-12
that O 0 1.723249798066262e-12
of O 0 9.385517536764088e-12
patients O 0 6.095086213520062e-09
with O 0 6.210373726389662e-07
Tay B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
Sachs I-Disease 1 0.9999998807907104
disease I-Disease 1 0.992037296295166
( O 0 1.0986906939791652e-09
TSD B-Disease 0 1.6566475096624345e-05
) O 0 2.0939863731861408e-10
. O 0 1.1953747713899787e-10

Identification O 0 2.0139765410931432e-08
and O 0 8.12981237885424e-10
quantitation O 0 7.330571634156513e-07
of O 0 1.9659103511759923e-10
hex O 0 1.5659596101613715e-05
A O 0 8.791165129196088e-09
, O 0 2.239090857170112e-12
amounting O 0 2.1968744878808621e-10
to O 0 3.472969307971585e-12
3 O 0 5.325319074600543e-10
. O 0 1.4181326946083317e-10

5 O 0 1.9327229949794855e-07
% O 0 1.7440811017621627e-09
- O 0 3.6903882119077025e-06
6 O 0 8.292948905364028e-08
. O 0 3.6278552384416685e-10

9 O 0 3.338114424877858e-07
% O 0 5.833319244308299e-11
of O 0 1.3439357049102596e-12
total O 0 7.121930128972664e-11
beta O 0 5.212045725566661e-11
hexosaminidase O 0 1.333345522880336e-07
activity O 0 3.767599565662749e-09
, O 0 2.460835354933799e-12
has O 0 6.9839893417078525e-12
been O 0 5.59887813195159e-12
obtained O 0 2.1399568315288997e-12
by O 0 1.834737223260774e-11
cellulose O 0 1.2971501746505965e-05
acetate O 0 2.0881589080090635e-06
gel O 0 1.1502229426696431e-05
electrophoresis O 0 1.1865650151321461e-07
, O 0 2.4106772134047105e-11
DEAE O 0 2.3441056384854164e-07
- O 0 5.754414900138727e-08
cellulose O 0 2.341487515877816e-06
ion O 0 1.0231947733529978e-08
- O 0 3.281676299593528e-07
exchange O 0 5.455758511629938e-09
chromatography O 0 1.0723644194854387e-08
, O 0 3.710400042766793e-12
radial O 0 5.884012832524377e-09
immunodiffusion O 0 1.7384550687893352e-07
, O 0 2.0413936166474578e-11
and O 0 4.776916015525323e-11
radioimmunoassay O 0 6.910085517120024e-07
. O 0 6.314583300692789e-10

Previous O 0 5.890533429919742e-07
family O 0 3.7172501521354206e-08
studies O 0 4.599684869099896e-11
suggested O 0 6.201301139263649e-10
that O 0 8.249297078766205e-12
these O 0 2.0602109428169424e-12
individuals O 0 1.3442139068509107e-10
may O 0 1.2216403444398338e-09
be O 0 2.742449930343005e-12
compound O 0 2.0683415917488457e-12
heterozygotes O 0 2.990117597967412e-10
for O 0 2.4569005684094147e-12
the O 0 9.801179833013318e-12
common O 0 1.0121150584296856e-09
mutant O 0 3.2496049584551656e-07
TSD B-Disease 0 3.519667870932608e-06
gene O 0 1.644192337835193e-08
and O 0 7.940299806552531e-11
a O 0 3.2171190711416386e-10
rare O 0 6.86747902989282e-09
( O 0 6.610154784647548e-11
allelic O 0 1.2352518119485012e-08
) O 0 4.732786038075254e-11
mutant O 0 5.5978212287755014e-08
gene O 0 7.192022621893557e-08
. O 0 3.2710505415423086e-09

Thus O 0 5.871680031077631e-09
, O 0 3.550625505416294e-12
the O 0 3.4654836509120934e-13
postulated O 0 1.473587918354724e-09
rate O 0 1.304303225424519e-07
mutant O 0 8.10181646215824e-08
gene O 0 1.5607035663833813e-08
appears O 0 1.4235101986059817e-09
to O 0 9.349902579600111e-13
code O 0 4.17703371891065e-12
for O 0 1.0603419184351814e-12
the O 0 1.916672332999414e-12
expression O 0 2.018480521615018e-11
of O 0 3.397340460169207e-13
low O 0 4.166138989347701e-09
amounts O 0 1.0118746118781274e-11
of O 0 3.938115892415661e-12
hex O 0 2.6057577997562476e-05
A O 0 2.482758176824973e-08
. O 0 7.126798595713524e-10

Heterozygotes O 0 9.163885579255293e-07
for O 0 4.0148423474661854e-10
the O 0 4.121746693952488e-11
rare O 0 8.527790140711033e-10
mutant O 0 5.2786472224397585e-06
may O 0 2.188937919811451e-08
be O 0 5.6893469969898636e-12
indistinguishable O 0 1.7064039070646686e-10
from O 0 9.97396176066756e-12
heterozygotes O 0 1.224598422666645e-09
for O 0 1.590317396001073e-12
the O 0 1.3078581620473706e-11
common O 0 2.5382231871873273e-09
TSD B-Disease 0 1.1934658687096089e-05
mutant O 0 1.200036081172584e-06
. O 0 1.3168807155850004e-09

However O 0 8.037185139642133e-09
, O 0 9.11994785246506e-12
direct O 0 7.968545094605428e-12
visualization O 0 7.618316288926508e-08
and O 0 1.1655061360471564e-09
quantitation O 0 8.654756697978883e-07
of O 0 8.339173795945953e-11
hex O 0 4.027220256830333e-06
A O 0 4.603662728808189e-10
by O 0 7.068710308928694e-13
the O 0 5.136826836289743e-13
methods O 0 5.305589301229929e-10
described O 0 3.369612144865641e-08
may O 0 4.763853200806523e-10
prevent O 0 1.7883233782711727e-10
false O 0 1.1773211294752173e-09
- O 0 1.4004601780470693e-06
positive O 0 1.5180552370708256e-09
prenatal O 0 1.0182734655472814e-07
diagnosis O 0 1.8620838204697066e-08
of O 0 1.9140357701563637e-11
TSD B-Disease 0 2.376841803197749e-05
in O 0 4.664090225148243e-10
fetuses O 0 2.4893504360079532e-06
having O 0 1.6009900072333494e-09
the O 0 1.0664068586518916e-11
incomplete O 0 4.840022072016836e-08
hex B-Disease 0 0.0398569293320179
A I-Disease 0 5.305301601765677e-05
deficiency I-Disease 0 0.0005626163328997791
of O 0 2.0699201901119846e-12
the O 0 1.560916396137202e-10
type O 0 7.530129551014397e-06
described O 0 7.845543592566173e-08
in O 0 7.201452975613698e-12
the O 0 2.8107871932747663e-11
four O 0 1.5846222112259056e-08
healthy O 0 3.1321172855314217e-07
individuals O 0 1.1379694520030625e-08

The O 0 7.735420304300078e-09
tumor B-Disease 0 3.3784338029363425e-06
suppressor O 0 2.4716323423490394e-06
gene O 0 4.621739662979962e-06
Smad4 O 0 5.593333116848953e-05
/ O 0 7.2918924161058385e-06
Dpc4 O 0 1.1340754099364858e-05
is O 0 1.784990488751248e-10
required O 0 4.700272289437368e-12
for O 0 1.2023869313398938e-12
gastrulation O 0 2.774548368833507e-09
and O 0 4.0600148243363776e-10
later O 0 1.4516741975167946e-10
for O 0 4.5050952551806134e-11
anterior O 0 5.7887934445943756e-08
development O 0 1.5156863394580333e-12
of O 0 4.3140323128035285e-13
the O 0 2.4289820155232178e-11
mouse O 0 8.196704584406689e-06
embryo O 0 3.5818382002617e-06
. O 0 9.50896072993146e-09

Mutations O 0 2.496949309716001e-05
in O 0 4.3861397847066996e-10
the O 0 1.5847716194894446e-10
SMAD4 O 0 0.00016375236737076193
/ O 0 2.7205326205148594e-06
DPC4 O 0 2.7818899980047718e-05
tumor B-Disease 0 1.6400713320763316e-07
suppressor O 0 1.286545181500287e-08
gene O 0 4.5261150383169024e-09
, O 0 2.097870054756923e-12
a O 0 8.81133013774793e-12
key O 0 2.4265407461143695e-08
signal O 0 5.940123060099722e-09
transducer O 0 8.323596745185569e-08
in O 0 8.264763005916276e-12
most O 0 3.036392665078935e-11
TGFbeta O 0 9.620866876502987e-07
- O 0 1.3024726968069444e-06
related O 0 1.1079933415203413e-07
pathways O 0 6.803247032394211e-08
, O 0 5.393073574527785e-12
are O 0 1.4919962238336276e-13
involved O 0 5.9973545227243186e-12
in O 0 4.1449680601886307e-13
50 O 0 2.490262163146184e-11
% O 0 3.7853570104828815e-12
of O 0 3.324438724305878e-09
pancreatic B-Disease 1 0.9707587361335754
cancers I-Disease 0 0.4049134850502014
. O 0 3.313690655204482e-08

Homozygous O 0 0.007561297621577978
Smad4 O 0 0.005524039268493652
mutant O 0 0.004716761410236359
mice O 0 0.02923654019832611
die O 0 7.922381337266415e-05
before O 0 4.982811940834608e-09
day O 0 1.0754177548477628e-09
7 O 0 1.3193973691372207e-09
. O 0 2.387196551545401e-10

5 O 0 1.812569294656896e-08
of O 0 2.260592130154393e-10
embryogenesis O 0 7.055270430100791e-07
. O 0 1.5767652072895544e-08

Mutant O 0 1.0470465667822282e-06
embryos O 0 1.0497190032765502e-06
have O 0 4.851452573007009e-09
reduced O 0 1.3666863196704071e-08
size O 0 4.082468763044744e-07
, O 0 1.1252733189692776e-09
fail O 0 2.0989947557836786e-08
to O 0 6.212046849141117e-11
gastrulate O 0 4.5162710193835665e-06
or O 0 6.337702029846071e-10
express O 0 2.9666883533119304e-11
a O 0 2.3600980111199155e-12
mesodermal O 0 3.742589349542413e-09
marker O 0 1.0865115882552345e-06
, O 0 8.539928486595016e-11
and O 0 1.2853421105241125e-10
show O 0 3.740286445008678e-07
abnormal O 0 4.4476976768237364e-07
visceral O 0 1.41923877094996e-07
endoderm O 0 2.2232870833249763e-06
development O 0 6.1919438465452e-09
. O 0 2.793489217722822e-09

Growth B-Disease 1 0.9999964237213135
retardation I-Disease 1 0.9999991655349731
of O 0 2.408253152452744e-09
the O 0 1.9571266829387923e-09
Smad4 O 0 0.00012710629380308092
- O 0 5.9793706896016374e-05
deficient O 0 7.093346539477352e-06
embryos O 0 1.316536657469669e-09
results O 0 1.8532231305101732e-11
from O 0 4.420704687729815e-12
reduced O 0 5.368837041608288e-10
cell O 0 4.536142483857475e-08
proliferation O 0 6.621419288421748e-07
rather O 0 1.0647321566081835e-11
than O 0 1.018574460887045e-11
increased O 0 6.375907024569472e-10
apoptosis O 0 1.6986639650440338e-08
. O 0 5.934039370991684e-10

Aggregation O 0 7.269211437233025e-07
of O 0 1.7478509750645799e-09
mutant O 0 6.973705239943229e-06
Smad4 O 0 1.7581589418114163e-05
ES O 0 2.7051598294747237e-07
cells O 0 5.319322315955333e-09
with O 0 2.7884559244961693e-11
wild O 0 7.259804135628656e-08
- O 0 0.00012773006164934486
type O 0 3.958369234169368e-06
tetraploid O 0 3.1079464406502666e-06
morulae O 0 6.695499905617908e-06
rescues O 0 7.758206947983126e-07
the O 0 1.8599521922624263e-10
gastrulation B-Disease 0 4.216225988784572e-06
defect I-Disease 0 8.72789096320048e-05
. O 0 1.9987140831290162e-09

These O 0 2.362275652867396e-10
results O 0 7.214713826364516e-10
indicate O 0 1.946746985836967e-09
that O 0 1.3386210195864834e-10
Smad4 O 0 9.844436590356054e-07
is O 0 3.614483434777327e-10
initially O 0 1.190571530251816e-10
required O 0 5.691906364638233e-13
for O 0 9.02395766075835e-14
the O 0 5.628949997088517e-14
differentiation O 0 1.1709552598382356e-11
of O 0 1.4370498064089632e-12
the O 0 1.907537322543007e-11
visceral O 0 6.7281149540576735e-09
endoderm O 0 4.910459239226839e-08
and O 0 1.1676372368985e-10
that O 0 1.5630270515376576e-12
the O 0 4.568346569089332e-12
gastrulation B-Disease 0 8.21497465608445e-08
defect I-Disease 0 1.1561785413505277e-06
in O 0 4.6779659139406515e-12
the O 0 2.51965497077844e-11
epiblast O 0 1.8842833924281877e-06
is O 0 3.0948779095041345e-09
secondary O 0 2.761433970377425e-09
and O 0 8.645610338753329e-10
non O 0 7.644356259106644e-08
- O 0 5.227333986113081e-06
cell O 0 3.5523237329471158e-06
autonomous O 0 8.81221673409982e-09
. O 0 2.2469706095762376e-09

Rescued O 0 2.9646011171280406e-05
embryos O 0 0.0002200364542659372
show O 0 0.012999195605516434
severe O 0 0.0375053808093071
anterior O 0 0.0002982730802614242
truncations O 0 4.042559885419905e-05
, O 0 1.903581292594936e-09
indicating O 0 8.82003625690686e-09
a O 0 1.3058770731433356e-10
second O 0 9.295208158732748e-09
important O 0 5.689005933007252e-10
role O 0 3.2603679755993653e-09
for O 0 3.386604191524256e-11
Smad4 O 0 6.660546887360397e-07
in O 0 5.224248117441377e-11
anterior O 0 3.2171949442272307e-06
patterning O 0 9.811276413529413e-07
during O 0 4.336257575232594e-09
embryogenesis O 0 2.393875035977544e-07
. O 0 3.6608391873471646e-09

Prevalence O 0 0.0014555166708305478
of O 0 1.458641318841103e-09
p16 O 0 2.9982649607518397e-07
and O 0 7.375473010107214e-10
CDK4 O 0 1.3407376172835939e-05
germline O 0 1.781643959475332e-06
mutations O 0 1.5014001064628246e-06
in O 0 2.2896572138275673e-10
48 O 0 6.413882829292561e-07
melanoma B-Disease 1 0.9986000657081604
- O 1 0.9080968499183655
prone O 1 0.9514294862747192
families O 0 4.175337053879957e-08
in O 0 7.686499770009902e-10
France O 0 4.523012194113107e-06
. O 0 1.8155855707746582e-09

The O 0 4.600832710366376e-07
French O 0 0.0011471501784399152
Familial B-Disease 0 0.16890385746955872
Melanoma I-Disease 1 0.9988740086555481
Study O 0 1.675258545219549e-07
Group O 0 6.001898356089441e-08
. O 0 2.4921984476122816e-09

Germline O 0 0.0003560365003068
mutations O 0 0.00016430010145995766
in O 0 2.0170960735033105e-10
the O 0 1.1057914132972524e-11
p16 O 0 9.11399666847501e-09
and O 0 1.4585183061299745e-10
CDK4 O 0 7.072678158692725e-07
genes O 0 3.2614067002612046e-09
have O 0 7.402697899117072e-11
been O 0 2.4474364201942933e-10
reported O 0 2.862058090524755e-10
in O 0 1.0024415379814716e-13
a O 0 1.1007824426284563e-12
subset O 0 5.971310945707131e-11
of O 0 4.444381529467023e-10
melanoma B-Disease 0 0.015071183443069458
pedigrees O 0 1.216678469972976e-06
, O 0 2.1363090463299983e-10
but O 0 1.2876527968885831e-11
their O 0 2.308794128103031e-11
prevalence O 0 2.774163931462681e-06
is O 0 4.727032099083317e-10
not O 0 3.4919480501605094e-11
well O 0 1.0455319249258466e-10
known O 0 6.32706464998023e-09
. O 0 5.246478806952837e-10

We O 0 4.596862890338116e-10
searched O 0 2.8918320515991525e-10
for O 0 3.928653192694642e-13
such O 0 3.234217906510073e-13
germline O 0 1.95742639874652e-08
mutations O 0 2.2101919228134648e-07
in O 0 1.210220118563754e-10
48 O 0 1.1552967862371588e-06
French O 0 0.0006006187759339809
melanoma B-Disease 1 0.9998393058776855
- O 1 0.9236493110656738
prone O 0 0.4246640205383301
families O 0 2.2281878564456292e-09
selected O 0 3.272645002216912e-11
according O 0 1.1115122765335134e-13
to O 0 9.900379127625314e-13
two O 0 1.2806648970464796e-11
major O 0 9.151548407970722e-10
criteria O 0 6.437346766752228e-10
families O 0 1.944087252292448e-12
with O 0 2.4658766781954222e-12
at O 0 3.827395900213304e-10
least O 0 5.9058162006631054e-12
three O 0 2.986800251569832e-10
affected O 0 4.39156622178416e-09
members O 0 4.841507837000103e-12
( O 0 3.742098211162448e-12
n O 0 1.7736459767547785e-07
= O 0 7.577897065402794e-08
20 O 0 1.1114339448781152e-09
) O 0 1.2867904441646316e-12
or O 0 1.1565651214517914e-11
families O 0 2.956147045901636e-12
with O 0 5.440381218441148e-12
two O 0 2.9508545607015435e-10
affected O 0 1.5625891691684046e-08
members O 0 3.4046398512954656e-12
, O 0 2.322350753543312e-13
one O 0 2.871365254938918e-13
of O 0 1.2817755212259085e-13
them O 0 4.776950102841626e-12
affected O 0 5.539671152354764e-11
before O 0 3.781503322280999e-12
the O 0 1.2658478865806844e-12
age O 0 2.7811697389523715e-10
of O 0 1.7481016634235402e-12
50 O 0 3.2389144144495674e-10
( O 0 4.867748999021204e-12
n O 0 1.7294476606366516e-07
= O 0 3.5953419796896924e-07
28 O 0 9.25536713936026e-09
) O 0 9.027336170253086e-13
, O 0 1.685697886616086e-13
and O 0 8.579756371508707e-13
one O 0 1.7170129250690391e-12
additional O 0 2.9669884604732744e-11
minor O 0 2.685278888137077e-09
criterion O 0 9.406107892573345e-08
. O 0 1.0226088864584426e-09

Sixteen O 0 7.78055309069714e-09
different O 0 3.689949387708502e-11
p16 O 0 4.016631294234685e-08
germline O 0 3.1520650622951507e-07
mutations O 0 3.139846967314952e-06
were O 0 6.220044479476883e-09
found O 0 1.2446004227228968e-08
in O 0 8.693625680455952e-11
21 O 0 4.478113879713419e-09
families O 0 2.1242931025344802e-11
, O 0 1.2898300049551947e-12
while O 0 7.739394194961058e-12
one O 0 3.1808743139460915e-11
germline O 0 6.811114872107282e-08
mutation O 0 1.0451883980522325e-07
, O 0 1.369388213934286e-10
Arg24His O 0 2.048316218861146e-07
, O 0 8.546001580012064e-12
was O 0 1.401082583285529e-09
detected O 0 1.3212288152431029e-08
in O 0 1.912998188677295e-12
the O 0 4.4754110140043935e-11
CDK4 O 0 2.7391643016017042e-05
gene O 0 1.676787597659768e-08
. O 0 7.742532170951222e-10

The O 0 5.097411034937771e-11
frequency O 0 1.7677988239928055e-10
of O 0 9.23556261848979e-13
p16 O 0 1.0768074210076861e-09
gene O 0 1.1844699665530811e-09
mutation O 0 4.392965102795188e-09
in O 0 4.355589673654681e-12
our O 0 2.5053119301343685e-11
sample O 0 1.0549085216471354e-10
( O 0 3.684040052187587e-12
44 O 0 1.7517147454793047e-10
% O 0 3.019030338224926e-13
) O 0 8.061114980823653e-14
is O 0 2.511802343809627e-13
among O 0 2.1054773864052218e-13
the O 0 4.506416507316091e-12
highest O 0 4.823056656277913e-07
rates O 0 5.6039389164652675e-06
yet O 0 2.6114030937662847e-09
reported O 0 1.546226435777953e-08
and O 0 1.914707455086262e-11
the O 0 1.4585119570420524e-11
CDK4 O 0 7.000458936090581e-06
mutation O 0 5.8238529554444085e-09
is O 0 1.0628741636820038e-10
the O 0 3.9126896167474e-12
second O 0 5.1374251519575864e-09
mutation O 0 1.6972164118556066e-08
detected O 0 2.569796322404727e-07
in O 0 5.179525428347653e-13
this O 0 3.683180876176001e-13
gene O 0 1.1813520162107238e-09
worldwide O 0 3.404874249213208e-08
. O 0 8.25708168505912e-10

In O 0 1.8659795930631162e-09
summary O 0 3.2752709433481186e-09
, O 0 1.0871536310075314e-11
our O 0 3.641689380606827e-12
results O 0 3.6208831072359615e-12
show O 0 1.0497747116033906e-09
frequent O 0 4.34013380790077e-11
involvement O 0 2.0779444831475757e-10
of O 0 2.5789762578103115e-13
the O 0 2.290799711382463e-12
p16 O 0 8.488939551298813e-10
gene O 0 9.527637567785519e-10
in O 0 8.913188763448598e-12
familial B-Disease 0 2.641275841597235e-06
melanoma I-Disease 0 0.3984416425228119
and O 0 2.8371989202469194e-09
confirm O 0 7.55905227300957e-10
the O 0 3.862713621183289e-11
role O 0 2.4690194333487625e-09
of O 0 5.339764004227976e-13
the O 0 1.6369303482144382e-11
CDK4 O 0 1.2863509937233175e-06
gene O 0 7.636056786886058e-10
as O 0 4.501127248701664e-11
a O 0 8.86088813434327e-10
melanoma B-Disease 0 0.007872505113482475
- O 0 3.2437081245006993e-05
predisposing O 0 1.578690216774703e-06
gene O 0 1.4222353961201861e-08
. O 0 5.211886824896261e-11
. O 0 1.831112761419007e-10

Progression O 0 1.2926990393680171e-06
of O 0 2.2713192437961993e-10
somatic O 0 2.1176754216867266e-06
CTG O 0 4.289406570023857e-05
repeat O 0 4.893125264970877e-07
length O 0 3.686268357228073e-08
heterogeneity O 0 1.739424426716596e-08
in O 0 1.7971785518100525e-11
the O 0 3.5434287448676827e-11
blood O 0 1.2730570233543403e-06
cells O 0 2.442621962472913e-07
of O 0 1.2533297422123724e-06
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999996423721313
patients O 0 0.0006159304175525904
. O 0 8.374328785976104e-09

The O 0 2.6472993241988263e-10
genetic O 0 1.741503297125746e-07
basis O 0 1.1518364573248618e-07
of O 0 1.339588561677374e-05
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 0 7.625116995768622e-05
DM B-Disease 1 0.9999998807907104
) O 0 1.7554148135090486e-09
is O 0 4.836449817025024e-12
the O 0 2.550325944351839e-13
expansion O 0 1.3425714706638558e-10
of O 0 8.316534960695066e-12
an O 0 1.8416670410914548e-09
unstable O 0 4.643768534151604e-06
CTG O 0 1.145855776485405e-06
repeat O 0 4.834025091327021e-08
in O 0 7.177373279043664e-12
the O 0 6.4200268365399715e-12
34 O 0 6.472756219899622e-10
UTR O 0 1.8302407367443152e-09
of O 0 3.655852096745571e-12
the O 0 3.609800236503702e-09
DM B-Disease 1 0.9999994039535522
protein O 0 8.210854218759778e-08
kinase O 0 1.4315189389435545e-07
gene O 0 2.789203312758559e-09
on O 0 5.591213270150774e-09
chromosome O 0 4.0589926356915385e-05
19 O 0 5.1187949878794825e-08
. O 0 7.565110204943437e-10

One O 0 1.887103806552659e-09
of O 0 9.012236269756446e-12
the O 0 6.3378286993542865e-12
principal O 0 2.453316161332708e-10
features O 0 3.287415478725464e-11
of O 0 6.431523282696139e-12
the O 0 9.449819593498887e-09
DM B-Disease 1 0.9999998807907104
mutation O 0 1.2763661061399034e-06
is O 0 2.741814553175459e-10
an O 0 2.2300520804985347e-11
extraordinarily O 0 3.0517520599460113e-07
high O 0 6.25809775556263e-07
level O 0 5.707812444910587e-09
of O 0 6.7185640731382e-12
somatic O 0 3.999660123099602e-07
mosaicism O 0 1.1060988981625997e-05
, O 0 1.6531338797864947e-10
due O 0 2.8484256620053827e-11
to O 0 9.672550304110072e-13
an O 0 1.5517195167680242e-11
extremely O 0 1.4278337401307795e-09
high O 0 8.428908238045096e-09
degree O 0 8.776073617822178e-12
of O 0 6.105781678866773e-12
somatic O 0 2.75717570730194e-06
instability O 0 3.959834884881275e-06
both O 0 7.626814735317566e-10
within O 0 5.479875234137843e-11
and O 0 5.102296918302329e-10
between O 0 1.2474177246701856e-10
different O 0 9.911007431417929e-11
tissues O 0 3.61598040399258e-07
. O 0 2.7319482787113714e-10

This O 0 6.7571406248134736e-09
instability O 0 8.863970606398652e-07
appears O 0 2.869816162487382e-09
to O 0 1.3339350240712533e-12
be O 0 1.983333880158436e-13
biased O 0 5.302873157947419e-12
towards O 0 2.209924273742156e-13
further O 0 4.856951429585421e-13
expansion O 0 3.4848287450151005e-11
and O 0 2.2443243010566993e-12
continuous O 0 1.0829359110842152e-11
throughout O 0 2.27636507733886e-12
the O 0 1.8155967181077148e-12
life O 0 2.068508385411061e-11
of O 0 3.250098215730468e-13
an O 0 2.5705319817159733e-11
individual O 0 1.706136273926795e-11
, O 0 5.473834493313623e-12
features O 0 1.0379680448480144e-09
that O 0 9.671788925302849e-10
could O 0 6.868057766951097e-08
be O 0 4.326665692389042e-09
associated O 0 1.1442451847143431e-10
with O 0 4.18638353150147e-11
the O 0 6.654544970619014e-11
progressive O 0 1.453891673719454e-09
nature O 0 2.6120607898860726e-09
of O 0 9.936939465715611e-11
the O 0 9.355240848663016e-08
disease O 0 0.0007294129463844001
. O 0 7.426832926427096e-09

Although O 0 6.19758799835779e-10
increasing O 0 2.5366442280017054e-10
measured O 0 3.305974605183337e-09
allele O 0 3.977997042881043e-09
size O 0 5.2891863333570655e-08
between O 0 1.9710175713782974e-09
patients O 0 2.4098889550572267e-09
clearly O 0 2.567004248055227e-11
correlates O 0 4.5548367161307723e-11
with O 0 1.1814454796421625e-11
an O 0 7.755445591284271e-11
increased O 0 4.14059293518676e-08
severity O 0 5.465436743179453e-07
of O 0 8.45205860855458e-09
symptoms O 0 2.5491078758932417e-06
and O 0 2.520938492678315e-11
an O 0 1.2143352295934662e-11
earlier O 0 5.2916862003371534e-09
age O 0 2.4628265649084824e-08
of O 0 9.175944032380201e-11
onset O 0 1.857102773783481e-07
, O 0 3.5823863406975187e-12
this O 0 3.5969115191750514e-14
correlation O 0 2.780268237856376e-10
is O 0 4.89383637780616e-11
not O 0 6.1669202730541e-13
precise O 0 1.8631335363394896e-10
and O 0 4.615805238028514e-10
measured O 0 9.394346989211044e-08
allele O 0 3.775138424089164e-09
length O 0 2.955674744953285e-07
cannot O 0 6.769630545022665e-08
be O 0 1.0515657095089281e-10
used O 0 1.810059324647284e-10
as O 0 1.5202094791333387e-11
an O 0 5.444032269256993e-13
accurate O 0 1.1460636883953157e-08
predictor O 0 2.4411556296399795e-06
of O 0 1.3750678373725123e-10
age O 0 4.907846573587449e-08
of O 0 5.174507489158486e-10
onset O 0 1.3897199096390978e-05
. O 0 5.103613087698022e-09

In O 0 5.660604207591291e-10
order O 0 9.064021234961306e-12
to O 0 2.399930297894426e-13
further O 0 2.959852144195779e-13
characterize O 0 5.830760874125929e-11
the O 0 2.4038071880227996e-12
dynamics O 0 5.915565814973434e-09
of O 0 6.77404188298425e-10
DM B-Disease 1 0.999997615814209
CTG O 0 2.0119079636060633e-05
repeat O 0 4.5015937644166115e-07
somatic O 0 1.834673867051606e-06
instability O 0 2.173361735913204e-06
, O 0 2.538322503575774e-11
we O 0 3.551209673546829e-11
have O 0 4.073740476895349e-12
studied O 0 4.850806822193077e-12
repeat O 0 5.195661678669694e-10
length O 0 9.75285296966888e-10
changes O 0 6.0004210801489766e-12
over O 0 5.369807029587115e-11
time O 0 4.0214948038297393e-10
in O 0 3.33166050303646e-10
111 O 0 0.0001243518345290795
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999998807907104
patients O 0 1.00802174074488e-06
with O 0 4.159970978800942e-12
varying O 0 1.6242288763956836e-11
clinical O 0 2.3443018193347598e-08
severity O 0 1.8939458357181138e-07
and O 0 1.2133588578322474e-10
CTG O 0 2.996166870161687e-07
repeat O 0 5.808923830841195e-08
size O 0 1.6691801718593524e-08
over O 0 2.51708298648623e-09
time O 0 4.2913558817581077e-10
intervals O 0 1.9487382818539345e-09
of O 0 7.14753733629947e-12
1 O 0 8.253712158179383e-10
- O 0 3.606176051107468e-07
7 O 0 7.704587190460188e-09
years O 0 5.184920270906446e-10
. O 0 1.8351022090801195e-10

We O 0 3.525562419781636e-08
have O 0 3.365008618971821e-11
found O 0 2.9077304800062542e-12
a O 0 1.7965118867362129e-13
direct O 0 1.7354111854148146e-12
progression O 0 7.573310312203319e-10
of O 0 1.1287066116819067e-12
the O 0 4.330200694541153e-12
size O 0 1.162132057253018e-09
heterogeneity O 0 8.782512495031369e-10
over O 0 5.120830981475422e-10
time O 0 4.6156620192583375e-11
related O 0 3.166419210165472e-11
to O 0 8.619235967316508e-13
initial O 0 4.556407334765922e-12
CTG O 0 1.2514513869632538e-08
repeat O 0 6.033321398035696e-09
size O 0 7.498900167490774e-09
and O 0 7.413861191629678e-11
the O 0 1.9852160280248166e-12
time O 0 1.668172822100189e-10
interval O 0 3.5716940516294926e-09
and O 0 2.4864698841553512e-11
always O 0 8.462304641743135e-12
biased O 0 5.423196267062558e-11
towards O 0 8.9532585989191e-13
further O 0 7.370206007994984e-12
expansion O 0 6.028119114986907e-10
. O 0 2.6669835784254303e-10

Attempts O 0 9.229277786459988e-09
to O 0 7.9758439436306e-12
mathematically O 0 4.5374012880294856e-10
model O 0 5.218078857893715e-09
the O 0 2.190534212354045e-11
dynamics O 0 2.60974701404848e-07
have O 0 9.930848143824278e-09
proved O 0 1.530084858814007e-08
only O 0 1.9744508111818604e-11
partially O 0 5.0643148341578126e-08
successful O 0 4.485831150979891e-10
suggesting O 0 2.6087645377259605e-09
that O 0 2.6823979235729434e-12
individual O 0 5.001445763617995e-13
specific O 0 8.596399416957445e-13
genetic O 0 1.437628593947693e-08
and O 0 3.8816025949017785e-09
/ O 0 5.539595093750904e-08
or O 0 4.6540331588573736e-09
environmental O 0 1.450329967234154e-09
factors O 0 2.650102914891761e-10
also O 0 5.678966741307079e-10
play O 0 7.810225799431691e-10
a O 0 1.126187407218815e-10
role O 0 3.3232976370811684e-09
in O 0 2.1924768858067045e-12
somatic O 0 2.7844102135077264e-08
mosaicism O 0 3.7553588754235534e-06
. O 0 4.907539652432291e-11
. O 0 2.962505518677716e-10

Aspartylglucosaminuria B-Disease 1 0.9994206428527832
among O 0 2.2542569411143631e-07
Palestinian O 0 3.430938306792086e-07
Arabs O 0 1.5811718867553282e-07
. O 0 5.0881885371723e-09

Aspartylglucosaminuria B-Disease 1 0.9999796152114868
( O 0 0.00018582063785288483
AGU B-Disease 1 0.9999761581420898
) O 0 1.4290270078376466e-09
is O 0 1.203269012206576e-10
a O 0 9.608355222567866e-10
rare O 0 1.1393851764296414e-06
disorder B-Disease 0 0.27496615052223206
of I-Disease 0 3.1885556417421412e-09
glycoprotein I-Disease 0 0.0011845784028992057
metabolism I-Disease 0 0.004570991266518831
caused O 0 1.0542175914451946e-06
by O 0 4.155502608682582e-10
the O 0 1.6545605774354044e-07
deficiency B-Disease 0 0.008397677913308144
of I-Disease 0 1.5299834316140348e-11
the I-Disease 0 2.7365703036963396e-09
lysosomal I-Disease 0 0.006016864906996489
enzyme I-Disease 0 5.827058703289367e-05
aspartylglucosaminidase I-Disease 0 2.4353366825380363e-05
( O 0 1.707276542362024e-10
AGA O 0 1.9075185875294665e-08
) O 0 4.019391763865343e-11
. O 0 7.033763155250838e-11

AGU B-Disease 1 0.9998745918273926
is O 0 6.062114152882714e-06
inherited O 0 0.01249468233436346
as O 0 3.6020029625660754e-08
an O 0 8.499198678180164e-09
autosomal O 1 0.9535189867019653
recessive O 1 0.9997290968894958
trait O 0 0.3062893748283386
and O 0 6.264456686722042e-08
occurs O 0 4.5759987465920915e-10
with O 0 4.071037344038908e-12
a O 0 2.457643533126941e-10
high O 0 3.475405776498519e-07
frequency O 0 8.508025928222196e-08
in O 0 6.431136734263987e-10
Finland O 0 2.019829480559565e-06
because O 0 2.1138339689752428e-10
of O 0 6.527682582836702e-13
a O 0 3.294396977437941e-10
founder O 0 1.6173227379567834e-07
effect O 0 3.2538281402594293e-08
. O 0 4.1304529241337207e-10

While O 0 2.0798140099032025e-08
very O 0 7.196266499365223e-11
few O 0 4.8868221969033954e-11
patients O 0 4.908216610921556e-10
with O 0 4.909620487936195e-10
AGU B-Disease 1 0.9999986886978149
have O 0 9.064172523665093e-09
been O 0 4.811355203138135e-10
reported O 0 3.943350923574229e-10
from O 0 2.254794788381087e-11
non O 0 9.803217437820422e-08
- O 0 5.252699793345528e-06
Finnish O 0 2.2582387373404345e-06
origin O 0 3.603703446763973e-10
, O 0 7.911515886860343e-11
we O 0 1.255058368343498e-08
diagnosed O 0 1.5320041711675003e-05
the O 0 3.6863232466544105e-09
disorder O 0 0.000411596498452127
in O 0 1.0113811871326206e-10
8 O 0 8.599548628751563e-09
patients O 0 3.330947323521016e-11
originating O 0 6.93365850845673e-12
from O 0 8.15356376165921e-12
3 O 0 1.082127096263541e-10
unrelated O 0 1.1964542689923974e-09
families O 0 5.777522557592896e-11
, O 0 1.0048310924645754e-12
all O 0 2.203523604901725e-12
Palestinian O 0 2.6947696851742364e-10
Arabs O 0 1.2612749733520445e-10
from O 0 4.672321557430692e-12
the O 0 8.130796383398753e-12
region O 0 4.1171187986632773e-11
of O 0 5.2710275380563054e-12
Jerusalem O 0 3.5343865079084935e-07
. O 0 5.8112590295422706e-09

The O 0 9.937304312757078e-10
clinical O 0 2.4514622509741457e-07
diagnosis O 0 3.490564995445311e-05
of O 0 1.3872615056698123e-07
AGU B-Disease 1 0.9999996423721313
is O 0 8.779804829828208e-07
often O 0 1.3602698967218885e-09
difficult O 0 6.158889509499943e-10
, O 0 4.229689948981319e-12
in O 0 2.0330140565807953e-13
particular O 0 1.5455952490084357e-12
early O 0 1.5590469887305503e-11
in O 0 2.5544213012179684e-12
the O 0 6.82249179026484e-12
course O 0 3.7995526169787297e-10
of O 0 1.6362498161948125e-11
the O 0 3.1676063994012793e-09
disease O 0 3.4713582863332704e-05
, O 0 2.7698288107558255e-11
and O 0 5.0881412798353676e-12
most O 0 4.951121977680994e-13
of O 0 1.3424369038270156e-12
the O 0 1.1793798160297797e-09
patients O 0 3.5147644794619737e-09
are O 0 2.0014752355468346e-10
diagnosed O 0 4.175811341156077e-07
after O 0 1.7277571040530404e-10
the O 0 1.0885858880982369e-10
age O 0 9.840306347541627e-09
of O 0 1.0327259880593687e-11
5 O 0 1.1624202711502107e-09
years O 0 5.277128733993663e-10
. O 0 2.242841745658808e-10

However O 0 8.50957970754962e-09
, O 0 1.5591481231091997e-11
since O 0 8.769747948667028e-12
these O 0 3.6745221665759886e-13
patients O 0 1.1786949020986537e-11
excrete O 0 2.1886548129401717e-11
early O 0 5.7808678633961e-13
large O 0 1.6017207091906238e-12
amounts O 0 1.1007452761779835e-11
of O 0 4.6574003334520775e-12
aspartylglucosamine O 0 1.0785570339066908e-06
in O 0 3.758609742887664e-11
urine O 0 1.6745532960271703e-08
, O 0 7.987501719070034e-13
biochemical O 0 3.5040442769584956e-11
screening O 0 7.315086036907559e-11
is O 0 5.1327943631496176e-12
easy O 0 1.1515881130630401e-11
by O 0 8.912950238970652e-12
urine O 0 1.3303779411444339e-08
chromatography O 0 3.425641281751268e-08
. O 0 5.428378233029996e-12
. O 0 8.0471011798533e-11

Detection O 0 6.158671794764814e-08
of O 0 1.186859915902616e-10
heterozygous O 0 1.076036326708163e-07
carriers O 0 4.292047961484968e-08
of O 0 2.2959283085821625e-10
the O 0 2.9262996577017475e-06
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.999998927116394
telangiectasia I-Disease 1 0.9999998807907104
( O 0 5.419538524620293e-07
ATM O 0 5.600859003607184e-05
) O 0 4.627507144833176e-12
gene O 0 1.974123295389596e-11
by O 0 2.641279773021865e-12
G2 O 0 7.354885411814394e-08
phase O 0 6.4433938185004536e-09
chromosomal O 0 0.0009173969156108797
radiosensitivity O 0 6.845458847237751e-05
of O 0 2.4163786527253706e-09
peripheral O 0 0.0029543903656303883
blood O 0 0.00034381847945041955
lymphocytes O 0 0.0001108821525122039
. O 0 5.447076123488159e-09

In O 0 3.680658483062871e-05
ataxia B-Disease 1 0.9999972581863403
- I-Disease 1 0.9999892711639404
telangiectasia I-Disease 1 0.9999997615814209
( O 0 0.00033448863541707397
A B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
) O 0 2.183479530515342e-08
patients O 0 9.341414308750018e-10
, O 0 4.137527451729406e-13
mutations O 0 1.9660302552626518e-10
in O 0 1.0628811199231425e-12
a O 0 1.467592367077053e-11
single O 0 4.226277106056386e-09
gene O 0 5.1738289208458355e-09
, O 0 1.5814191969831803e-11
ATM O 0 2.5357721824548207e-06
, O 0 1.0738451100555935e-10
result O 0 6.971246357956318e-10
in O 0 9.758105434798381e-09
an O 0 0.131128191947937
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 4.0578200355412264e-08
embraces O 0 4.9652419953361004e-09
a O 0 3.884377541840678e-10
variety O 0 1.4164081019174546e-10
of O 0 1.1708391201015189e-11
clinical O 0 1.0294825436574229e-08
features O 0 2.6315746026739362e-08
and O 0 3.750049160089475e-09
manifests O 0 2.6443750300586544e-08
extreme O 0 4.087881144698713e-09
radiosensitivity O 0 6.844675226602703e-07
and O 0 8.345077406879398e-11
a O 0 9.352195406986397e-11
strong O 0 4.758694549522602e-10
pre O 0 3.5523606811693753e-07
- O 0 8.37090101413196e-06
disposition O 0 4.174549133040273e-07
to O 0 7.282736080860275e-10
malignancy B-Disease 0 3.368707257322967e-05
. O 0 9.100478148837965e-10

Heterozygotes O 0 1.0940134416159708e-06
for O 0 1.3046770608315938e-10
the O 0 7.626995389420355e-12
ATM O 0 1.0386366739112418e-05
gene O 0 2.161250591825592e-07
have O 0 2.372735341538146e-09
no O 0 3.8620801001698624e-11
clinical O 0 3.6586247920133985e-10
expression O 0 1.2827337803056338e-10
of O 0 5.121328916501966e-10
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
but O 0 7.066070793371182e-06
may O 0 1.2105333269119e-07
be O 0 5.753676202147062e-09
cancer B-Disease 0 4.7533113445297204e-08
prone O 0 7.422134018497673e-08
with O 0 1.1393967366823965e-11
a O 0 2.9087318664799966e-10
moderate O 0 6.178930700428964e-09
increase O 0 7.791318701322325e-09
in O 0 2.292907703982383e-11
in O 0 1.3978519730617478e-10
vitro O 0 4.9197587941307575e-06
radiosensitivity O 0 2.6099658498424105e-05
. O 0 1.5155238175523777e-09

We O 0 6.359297799463093e-08
performed O 0 5.688075788157221e-09
a O 0 1.1598041971261353e-10
blind O 0 1.3304819468373807e-08
chromosomal O 0 4.7273530867641966e-07
analysis O 0 1.940777122344528e-10
on O 0 1.2632666024359196e-09
G2 O 0 1.5357929328274622e-07
- O 0 4.229303556257946e-07
phase O 0 1.302050822715728e-08
lymphocytes O 0 1.038844388290272e-07
from O 0 4.718344204929226e-12
7 O 0 5.044332312964528e-11
unrelated O 0 1.1259931653739841e-08
A B-Disease 1 0.9999618530273438
- I-Disease 1 0.9999984502792358
T I-Disease 1 1.0
patients O 0 4.208055088383844e-06
, O 0 2.7464649478281533e-12
13 O 0 1.6636724983754014e-11
obligate O 0 2.6586170065456827e-07
A B-Disease 1 0.9999828338623047
- I-Disease 1 0.999996542930603
T I-Disease 1 0.9999997615814209
heterozygotes O 0 7.0257669904094655e-06
( O 0 8.387999496373144e-12
parents O 0 4.681143927348641e-12
of O 0 1.791833825412481e-13
the O 0 5.10095160555224e-11
patients O 0 1.6599459307098385e-10
) O 0 6.592458241631849e-13
, O 0 5.687370062748554e-13
and O 0 5.62604693735147e-12
14 O 0 8.437135018413144e-11
normal O 0 7.0388859671477455e-12
controls O 0 2.46416909099878e-09
following O 0 3.1052934529318676e-11
X O 0 3.0676801543449983e-06
- O 0 3.7230972083079905e-08
irradiation O 0 6.811186614719134e-10
with O 0 5.508820136168602e-11
1 O 0 6.231057336769652e-11
Gy O 0 1.8678179003472906e-08
in O 0 3.626867144286561e-13
order O 0 2.507872110934367e-13
to O 0 2.970353116574752e-14
evaluate O 0 7.855455869121286e-12
this O 0 1.5317738735949084e-14
cytogenetic O 0 2.0612467288572134e-10
method O 0 1.6714428452413443e-11
as O 0 5.989169663683791e-12
a O 0 4.854080462232679e-13
tool O 0 5.592479812577267e-10
for O 0 2.932346206130365e-13
detection O 0 5.271070385726162e-11
of O 0 9.320510509225333e-12
ATM O 0 0.004504984710365534
carriers O 0 1.7255513284908375e-06
. O 0 9.321977634257905e-10

Both O 0 4.2503862118792313e-07
A B-Disease 1 0.9998025298118591
- I-Disease 1 0.9999706745147705
T I-Disease 1 0.9999995231628418
homozygotes O 0 9.73772766883485e-05
and O 0 6.552425269035211e-11
heterozygotes O 0 2.4661250819235647e-09
showed O 0 8.244555038672274e-10
significantly O 0 1.5349942150688634e-10
increased O 0 3.767049866487682e-11
levels O 0 3.364970108110654e-11
of O 0 3.784497888681404e-12
radiation O 0 1.761145654199936e-06
- O 0 0.0009129407117143273
induced O 0 0.0015641141217201948
chromatid O 0 0.02061665989458561
damage O 0 2.8175143143016612e-06
relative O 0 4.2827208446283294e-10
to O 0 1.0343221504977018e-12
that O 0 5.675287171637289e-13
of O 0 1.4194654566340725e-12
normal O 0 8.854433852789612e-10
controls O 0 2.7126753820994054e-07
. O 0 1.0095796421083492e-09

These O 0 5.787062842821378e-11
results O 0 8.780799698460129e-11
show O 0 1.0964172902916403e-09
that O 0 2.6083926685238623e-12
the O 0 1.2574303577539414e-12
G2 O 0 1.002153879881007e-07
- O 0 1.8058132411624683e-07
phase O 0 7.286644621018468e-09
chromosomal O 0 0.0005731767159886658
radiosensitivity O 0 6.464590569521533e-06
assay O 0 5.8995457408173024e-08
can O 0 1.4776090073720383e-10
be O 0 3.5242982577426973e-12
used O 0 2.504737302982951e-12
for O 0 6.44850451790753e-14
the O 0 8.58268127791953e-14
detection O 0 9.428030578462199e-10
of O 0 1.114998982032489e-09
A B-Disease 1 0.9999977350234985
- I-Disease 1 0.9999973773956299
T I-Disease 1 0.9999992847442627
heterozygotes O 0 0.0002488929603714496
. O 0 2.0874117989677643e-09

In O 0 1.304824581715991e-09
combination O 0 2.306692392650689e-09
with O 0 8.728762504461862e-12
molecular O 0 2.130003728950669e-09
genetic O 0 8.328614597985506e-08
analyses O 0 2.7684281533879584e-08
, O 0 5.512898124115928e-11
this O 0 7.052176984739811e-12
test O 0 4.182363397831068e-07
may O 0 7.244775335202291e-10
be O 0 9.051439610850698e-13
of O 0 7.814560630536871e-14
value O 0 2.9274049850869233e-10
in O 0 1.7799229971859898e-12
studies O 0 1.693859245574525e-12
of O 0 4.762794325596786e-12
familial B-Disease 0 1.4980274727349752e-06
and I-Disease 0 1.2845885244416877e-08
sporadic I-Disease 0 6.013356710354856e-07
cancers I-Disease 0 0.0006537881563417614
aimed O 0 2.3294619211355894e-07
at O 0 2.672404342263235e-08
determination O 0 2.1793042370710225e-10
of O 0 5.218533735023602e-14
the O 0 7.7321010922074e-13
potential O 0 8.036993293103478e-11
involvement O 0 1.5873914682718038e-10
of O 0 2.684189242402324e-12
ATM O 0 0.005166534334421158
mutations O 0 1.6789652363513596e-05
in O 0 3.897218547876946e-09
tumor B-Disease 0 0.00029110073228366673
risk O 0 9.00927773272997e-07
or O 0 3.210939847342331e-10
development O 0 1.9104320556073695e-11
. O 0 1.3061678474923788e-11
. O 0 2.0528739819170028e-10

Ataxia B-Disease 1 0.9999967813491821
- I-Disease 1 0.9999409914016724
telangiectasia I-Disease 1 0.9999940395355225
: O 0 6.052777834497647e-09
identification O 0 1.2657357106871103e-10
and O 0 6.072264219225687e-12
detection O 0 4.997600666634128e-10
of O 0 2.983336841455575e-11
founder O 0 2.864055090867623e-07
- O 0 1.8238131815451197e-05
effect O 0 1.348169487158657e-08
mutations O 0 1.8304536775204383e-09
in O 0 2.8356893114027393e-13
the O 0 4.1414121481134214e-13
ATM O 0 1.0039826747743064e-06
gene O 0 6.80716039092033e-10
in O 0 1.0063405187291097e-12
ethnic O 0 1.6080088649506052e-11
populations O 0 6.0753775343869165e-09
. O 0 3.1228467034516427e-10

To O 0 6.087969711687791e-11
facilitate O 0 8.266134304824035e-12
the O 0 4.097443413210444e-13
evaluation O 0 4.153604109963238e-12
of O 0 1.3875803717838808e-13
ATM O 0 1.3215940271038562e-06
heterozygotes O 0 1.7605795932240653e-08
for O 0 9.026893815766712e-12
susceptibility O 0 3.5345022464383646e-09
to O 0 2.9637532011905776e-11
other O 0 3.269464698973934e-10
diseases O 0 5.619162379844056e-07
, O 0 2.8344739749774917e-12
such O 0 1.0634940844633789e-11
as O 0 6.299119093000627e-08
breast B-Disease 0 0.0009582850034348667
cancer I-Disease 0 2.9527884635172086e-06
, O 0 7.868896506613154e-11
we O 0 3.134644765978578e-10
have O 0 1.7355278672526175e-11
attempted O 0 1.6119903190059404e-09
to O 0 1.0565028019104972e-11
define O 0 3.9939759832741117e-10
the O 0 6.129994515463588e-12
most O 0 1.1364883860387476e-11
common O 0 2.205454742443269e-11
mutations O 0 2.625105133269301e-10
and O 0 6.474305466741548e-12
their O 0 7.030017193376814e-12
frequencies O 0 2.887211003610446e-08
in O 0 8.321104871811258e-08
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999974966049194
telangiectasia I-Disease 1 1.0
( O 0 0.0015967199578881264
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999992847442627
T I-Disease 1 0.9999998807907104
) O 0 4.580915369256644e-10
homozygotes O 0 7.3224506458302585e-09
from O 0 2.838379921724088e-12
10 O 0 2.4958431588811836e-12
ethnic O 0 7.148409468527017e-12
populations O 0 2.2657904441558685e-09
. O 0 1.2888329292692902e-10

Both O 0 1.1344948314118142e-09
genomic O 0 1.1848371883615982e-07
mutations O 0 1.5534473277512006e-05
and O 0 1.9473227474975374e-09
their O 0 1.8181864000488268e-11
effects O 0 4.4495554463175324e-10
on O 0 9.312123988580723e-12
cDNA O 0 9.94395399356307e-11
were O 0 2.3740243104697356e-10
characterized O 0 2.445543101359249e-09
. O 0 1.0497046565305368e-09

Protein O 0 3.5644890772346116e-07
- O 0 1.9442883569809055e-07
truncation O 0 1.7879455072034034e-07
testing O 0 2.283083411214193e-08
of O 0 5.524977177151502e-13
the O 0 2.38577278592611e-13
entire O 0 1.7194324089531143e-11
ATM O 0 1.2996035536616546e-07
cDNA O 0 5.017045667798925e-10
detected O 0 1.7215802472492214e-07
92 O 0 8.47252490387973e-09
( O 0 1.2922045378171987e-11
66 O 0 6.827445830914769e-10
% O 0 3.0103133527581427e-13
) O 0 4.675811604223923e-14
truncating O 0 4.741570469590783e-10
mutations O 0 2.9107201093836466e-09
in O 0 2.1956154342556156e-12
140 O 0 6.87387993747457e-11
mutant O 0 4.0933294087608374e-08
alleles O 0 8.71510152933297e-09
screened O 0 3.021030806849012e-06
. O 0 2.917779351463423e-09

The O 0 1.8257744205385507e-09
haplotyping O 0 2.6653419809008483e-06
of O 0 1.0707323222503007e-10
patients O 0 2.914175345480885e-09
with O 0 5.832559695634343e-12
identical O 0 2.887574623855471e-08
mutations O 0 2.0951345049979864e-06
indicates O 0 3.989640262602734e-08
that O 0 2.9597324591179586e-10
almost O 0 2.236933277499631e-10
all O 0 1.1648871971192687e-11
of O 0 8.550710053206734e-13
these O 0 2.54738591332071e-12
represent O 0 4.849680379503951e-11
common O 0 1.556303308447582e-09
ancestry O 0 5.3534016331013845e-08
and O 0 1.2307992403037815e-09
that O 0 1.0160506463963159e-10
very O 0 1.1530591759179032e-10
few O 0 1.1727530058180946e-10
spontaneously O 0 9.972911385602856e-09
recurring O 0 2.4334710815310245e-06
ATM O 0 0.0016524585662409663
mutations O 0 1.8566506696515717e-05
exist O 0 3.284418426119373e-08
. O 0 3.3387488329594817e-09

Assays O 0 8.231385777435207e-07
requiring O 0 4.91610752106908e-09
minimal O 0 4.83210305102233e-10
amounts O 0 2.6253941728948682e-11
of O 0 1.4796543439284104e-13
genomic O 0 3.601318965262834e-10
DNA O 0 1.4335726064018672e-06
were O 0 1.3889176475601062e-09
designed O 0 1.7609212976665845e-09
to O 0 6.35673534209874e-13
allow O 0 1.645148969310617e-12
rapid O 0 9.038970960606463e-12
screening O 0 4.627438709992049e-11
for O 0 1.034910221756058e-12
common O 0 1.3994145252327339e-11
ethnic O 0 1.6179337383737113e-11
mutations O 0 8.93882869945628e-08
. O 0 8.537277551567968e-10

These O 0 1.8680368363277466e-10
rapid O 0 3.293864736519936e-09
assays O 0 1.1867494009720758e-07
detected O 0 2.39060341300501e-07
mutations O 0 1.2495543444401847e-07
in O 0 2.4756613425935825e-11
76 O 0 3.909415013936268e-08
% O 0 5.3132806314415415e-12
of O 0 2.8406778665446275e-11
Costa O 0 1.8963580714626005e-06
Rican O 0 2.2897346241279593e-07
patients O 0 7.829799031355833e-09
( O 0 2.9336062658952278e-12
3 O 0 5.0991807998279626e-11
) O 0 2.951187471483818e-13
, O 0 1.078387799522372e-13
50 O 0 4.647869762675061e-12
% O 0 3.6842141208463797e-13
of O 0 6.540313429725941e-11
Norwegian O 0 0.013400922529399395
patients O 0 1.5256124186180386e-07
( O 0 1.960816578550073e-11
1 O 0 2.1858358179027704e-10
) O 0 1.8231581608990632e-12
, O 0 9.69205184858657e-13
25 O 0 2.407681172489351e-11
% O 0 4.2161562327329427e-13
of O 0 5.1039682896769634e-11
Polish O 0 0.00028505935915745795
patients O 0 8.177060806247027e-09
( O 0 2.8519684443922833e-12
4 O 0 3.1594588056904627e-10
) O 0 2.4238714334268163e-12
, O 0 1.6901158207335842e-12
and O 0 1.8643234525606012e-11
14 O 0 2.157179018746902e-10
% O 0 1.7402703627114602e-12
of O 0 6.458225620953328e-11
Italian O 0 3.810964335571043e-05
patients O 0 1.352878342686381e-08
( O 0 2.6133028033226147e-12
1 O 0 7.515001121394249e-11
) O 0 4.387925786608626e-12
, O 0 3.197326301287995e-12
as O 0 4.744544687684815e-11
well O 0 3.35855163124954e-11
as O 0 6.840985417033707e-11
in O 0 3.735594299170142e-12
patients O 0 1.668410548605337e-11
of O 0 3.814019412795577e-12
Amish O 0 6.41591614112258e-05
/ O 0 4.412686848809244e-06
Mennonite O 0 1.8688640466280049e-06
and O 0 1.234580935260965e-07
Irish O 0 1.9635049284261186e-06
English O 0 8.537396567476208e-09
backgrounds O 0 1.0664715333064123e-08
. O 0 2.281980826523977e-09

Additional O 0 4.708031298150672e-09
mutations O 0 6.563541319337673e-07
were O 0 9.71794422710559e-10
observed O 0 9.69946345463768e-10
in O 0 7.449122915725859e-12
Japanese O 0 1.8477329666310993e-09
, O 0 5.643013725568913e-13
Utah O 0 6.155207420144304e-12
Mormon O 0 3.5218991351754214e-12
, O 0 1.5548767785464324e-12
and O 0 1.0959144182420832e-11
African O 0 1.0054878457621541e-10
American O 0 3.0065321343641926e-09
patients O 0 6.024693521844426e-10
. O 0 9.003649215078013e-11

These O 0 1.4358593480867654e-10
assays O 0 1.5834226374522586e-08
should O 0 1.3288872606487256e-11
facilitate O 0 2.772290643576758e-12
screening O 0 2.7253230228119207e-10
for O 0 1.442827107789313e-10
A B-Disease 1 0.9994413256645203
- I-Disease 1 0.9999653100967407
T I-Disease 1 0.9999996423721313
heterozygotes O 0 8.246353786489635e-07
in O 0 7.00106075543494e-12
the O 0 2.471018181737783e-12
populations O 0 6.172717198493771e-11
studied O 0 1.5805273756441807e-10
. O 0 5.993123532166411e-12
. O 0 1.3370490825614922e-10

The O 0 1.2138328031596757e-07
von B-Disease 1 0.7640224099159241
Hippel I-Disease 1 0.923836886882782
- I-Disease 1 0.9818986058235168
Lindau I-Disease 1 0.9740798473358154
tumor I-Disease 0 0.0008667057263664901
suppressor O 0 1.8014355873674504e-06
gene O 0 8.252899874605646e-07
is O 0 8.979370025308242e-10
required O 0 1.3630136949660532e-11
for O 0 2.8231004773476842e-12
cell O 0 1.541967797891175e-08
cycle O 0 2.3779041669058643e-07
exit O 0 3.106400114916141e-08
upon O 0 1.2550721573134638e-09
serum O 0 2.5961289793485776e-06
withdrawal O 0 2.3655065461980485e-08
. O 0 3.362623790525987e-10

The O 0 5.275478387467558e-10
inactivation O 0 5.400602844929381e-07
of O 0 2.9182663230375994e-11
the O 0 1.3898399098266623e-09
von B-Disease 1 0.9899780750274658
Hippel I-Disease 1 0.9987285733222961
- I-Disease 1 0.9998936653137207
Lindau I-Disease 1 0.9994396567344666
( I-Disease 0 1.0129733851726996e-07
VHL I-Disease 0 7.833907147869468e-05
) I-Disease 0 4.3220590301151773e-11
tumor I-Disease 0 4.2751111095640226e-08
suppressor O 0 4.433582887486409e-07
gene O 0 5.129976443640771e-07
predisposes O 0 1.0521251169848256e-05
affected O 0 3.0846376830595545e-07
individuals O 0 4.255378549533617e-10
to O 0 4.580476276050405e-11
the O 0 1.0610744283212625e-08
human O 0 0.0035773965064436197
VHL B-Disease 1 0.9999774694442749
cancer I-Disease 1 0.9999551773071289
syndrome I-Disease 1 0.9999879598617554
and O 0 2.0628998509408802e-09
is O 0 6.629110038680608e-10
associated O 0 2.731135595457346e-10
with O 0 1.0978994602339753e-08
sporadic B-Disease 0 0.08578953146934509
renal I-Disease 1 0.9999493360519409
cell I-Disease 1 0.9999735355377197
carcinomas I-Disease 1 1.0
( O 0 6.148163083707914e-05
RCC B-Disease 1 0.5406572818756104
) O 0 1.1391550813755202e-08
and O 0 3.284368332856502e-08
brain B-Disease 0 0.00045641596079804003
hemangioblastomas I-Disease 0 0.001216952339746058
. O 0 1.3695019340786985e-08

VHL O 0 0.00574636273086071
- O 0 5.901834447286092e-05
negative O 0 6.615120469177782e-07
786 O 0 5.518310445040697e-06
- O 0 9.145587682723999e-05
0 O 0 2.4212148730384797e-08
RCC B-Disease 0 3.0078758754825685e-06
cells O 0 1.9323351807543077e-08
are O 0 7.399690582499119e-11
tumorigenic O 0 1.4954496236896375e-06
in O 0 1.9541827878111206e-10
nude O 0 0.06524597108364105
mice O 0 0.000947903492487967
which O 0 5.14150999553209e-10
is O 0 7.082776205813435e-12
suppressed O 0 8.628090429618762e-12
by O 0 6.200697914111528e-14
the O 0 5.003563752561946e-13
reintroduction O 0 3.6050320506575417e-09
of O 0 4.953188414980048e-10
VHL B-Disease 0 9.302885155193508e-05
. O 0 2.2580162184482333e-09

Remarkably O 0 3.696714657053235e-06
, O 0 1.4427088690371903e-10
this O 0 1.9545376059824926e-13
occurs O 0 2.806403547050973e-12
without O 0 6.76340710867307e-13
affecting O 0 5.4891126366474197e-11
the O 0 6.727193888750316e-12
growth O 0 2.263621752263134e-07
rate O 0 7.814448395038198e-07
and O 0 3.901022213592675e-11
cell O 0 1.5661905550246047e-08
cycle O 0 2.1919235848599783e-07
profile O 0 7.953224923085145e-08
of O 0 5.919958533801006e-12
these O 0 3.6253476349418223e-12
cells O 0 7.141027352774998e-11
in O 0 1.7145585081909664e-12
culture O 0 5.091321253480885e-10
. O 0 4.366607075922957e-10

The O 0 1.3698722156618715e-09
786 O 0 2.3725154107978597e-07
- O 0 3.836869382212171e-06
0 O 0 3.3872409321844543e-09
cell O 0 3.5008235954592237e-07
line O 0 8.837786822368798e-07
, O 0 6.914416521980327e-12
like O 0 6.735028507121044e-11
many O 0 2.0711524943012316e-12
cancer B-Disease 0 6.796124107921742e-09
cells O 0 7.775856347702614e-11
, O 0 1.0279602689899914e-11
fails O 0 3.9435166243606545e-10
to O 0 6.558270094526863e-13
exit O 0 4.683166632268865e-10
the O 0 3.064331080548932e-11
cell O 0 3.164600670402251e-08
cycle O 0 1.992009401874384e-08
upon O 0 8.164070808280854e-11
serum O 0 1.483438296645545e-07
withdrawal O 0 3.1605094097386655e-09
. O 0 2.248345676303387e-10

Here O 0 1.2583303288238312e-08
, O 0 1.5211028617234668e-11
it O 0 1.2443297260633646e-12
is O 0 1.1724408336549752e-12
shown O 0 1.1546095026251924e-12
that O 0 1.4616121016947613e-14
reintroduction O 0 1.4757719352109788e-11
of O 0 5.343808620432433e-13
the O 0 1.3271547055770938e-11
wild O 0 1.9976486953510175e-07
- O 0 9.821855928748846e-05
type O 0 2.806008296829532e-06
VHL B-Disease 0 1.2285503316888935e-06
gene O 0 7.29043547753605e-10
restores O 0 5.5933573328559305e-09
the O 0 1.548136445428394e-11
ability O 0 2.4436594969756698e-09
of O 0 5.992692453382631e-11
VHL O 0 0.0003381966380402446
- O 0 0.0002359487843932584
negative O 0 1.0685487723094411e-05
RCC B-Disease 0 0.016828566789627075
cancer I-Disease 0 3.0118139875412453e-06
cells O 0 4.952489529586046e-10
to O 0 2.6373226519327275e-12
exit O 0 1.084640377513324e-09
the O 0 3.5205442727725966e-11
cell O 0 1.941827463269874e-07
cycle O 0 5.63460559988016e-07
and O 0 1.6789876433609408e-10
enter O 0 1.1790148024548586e-10
G0 O 0 1.499514041825023e-07
/ O 0 7.76603759078398e-09
quiescence O 0 1.1928369758607005e-07
in O 0 2.639056473352497e-10
low O 0 7.785155275996658e-07
serum O 0 6.226858658919809e-06
. O 0 1.7218364511961681e-09

Both O 0 1.6120394263907656e-07
VHL O 0 0.0005840912344865501
- O 0 6.156940071377903e-05
positive O 0 1.4800708925122308e-07
and O 0 3.3060061355172365e-09
VHL O 0 0.00011001998791471124
- O 0 2.2940803319215775e-05
negative O 0 5.149053095010458e-07
RCC B-Disease 0 2.4586772269685753e-05
cells O 0 7.100385168712364e-09
exit O 0 1.8090041686846803e-09
the O 0 1.981464124722887e-11
cell O 0 4.6250015373061615e-08
cycle O 0 8.814776464305396e-08
by O 0 1.031749893853906e-10
contact O 0 1.7299772991918871e-07
inhibition O 0 7.327091680053854e-07
. O 0 2.1412545070376154e-09

The O 0 8.711478649559012e-09
cyclin O 0 3.0036651878617704e-05
- O 0 3.494892007438466e-05
dependent O 0 1.1521389069457655e-06
kinase O 0 3.6234030176274246e-06
inhibitor O 0 3.109121280431282e-07
, O 0 5.250468029099897e-12
p27 O 0 4.973731981827711e-10
, O 0 1.72306152635901e-13
accumulates O 0 3.157601957681777e-11
upon O 0 1.5101401032446837e-12
serum O 0 1.6704573724268812e-08
withdrawal O 0 2.0710280712599172e-10
, O 0 2.0050752507980163e-13
only O 0 6.653493945033007e-14
in O 0 2.048544981651107e-13
the O 0 1.209967889770347e-11
presence O 0 1.4180415730535856e-09
of O 0 2.7126832030655024e-11
VHL B-Disease 0 8.51700588100357e-06
, O 0 2.4500974166175027e-11
as O 0 6.428456725271481e-12
a O 0 6.021126305877367e-12
result O 0 8.653767806510171e-12
of O 0 6.248045700610327e-13
the O 0 2.0751473456259717e-11
stabilization O 0 2.343205185439956e-09
of O 0 8.81727633614271e-13
the O 0 8.605545442907925e-11
protein O 0 9.230686437433633e-09
. O 0 3.00829167132477e-10

We O 0 4.002397080427045e-09
propose O 0 1.0823959506467418e-09
that O 0 1.346224867693202e-11
the O 0 2.5511689115409464e-12
loss O 0 1.4264835979105328e-09
of O 0 1.8570435987574907e-12
wild O 0 2.096730611356179e-07
- O 0 0.004393306095153093
type O 0 2.274190410389565e-05
VHL B-Disease 0 3.0405753932427615e-06
gene O 0 1.516773040499686e-09
results O 0 3.1095254843238607e-11
in O 0 1.9753038722931937e-13
a O 0 1.7071412642885586e-12
specific O 0 5.472814215701227e-11
cellular O 0 0.0001525172556284815
defect O 0 4.6579552872572094e-05
in O 0 2.922055097887011e-10
serum O 0 3.6976455248804996e-06
- O 0 6.85939130562474e-06
dependent O 0 4.828173700843763e-07
growth O 0 1.074215347784957e-07
control O 0 3.6319973695242425e-09
, O 0 2.4776973875373365e-11
which O 0 5.005439812633128e-11
may O 0 1.046204678445406e-09
initiate O 0 2.8287965303519513e-09
tumor B-Disease 0 1.6177667703232146e-06
formation O 0 1.774983715563394e-08
. O 0 1.7270727070695102e-09

This O 0 3.263234404915494e-10
is O 0 2.3569817972357576e-11
corrected O 0 3.293292971662254e-09
by O 0 1.335920442194563e-13
the O 0 1.3324873160153877e-13
reintroduction O 0 2.1179748233013385e-10
of O 0 4.116889121275058e-12
wild O 0 1.7192981260905071e-07
- O 0 0.004222451243549585
type O 0 0.00046618192573077977
VHL B-Disease 0 0.00011181567242601886
, O 0 6.251890671826743e-11
implicating O 0 3.5765542634180747e-06
VHL B-Disease 0 1.6127027265611105e-05
as O 0 6.747848807497903e-11
the O 0 1.1101526599041622e-12
first O 0 2.562475787115659e-10
tumor B-Disease 0 7.569096460713354e-09
suppressor O 0 1.331359578138347e-09
involved O 0 1.643915559235154e-09
in O 0 2.596850902716885e-12
the O 0 2.6282988372511307e-12
regulation O 0 7.542373947622139e-10
of O 0 2.441009634007729e-12
cell O 0 3.82417439936944e-08
cycle O 0 1.4092796618569992e-07
exit O 0 1.0389811677669059e-07
, O 0 1.0850163822961889e-10
which O 0 1.3790278814707069e-11
is O 0 1.4994066752094248e-11
consistent O 0 1.3064999082601503e-10
with O 0 4.724371241437986e-11
its O 0 1.0653746634892158e-10
gatekeeper O 0 1.0502117220312357e-06
function O 0 1.1116200321348302e-10
in O 0 6.8928083726826905e-12
the O 0 4.931920982720328e-10
kidney O 0 7.19532920356869e-07
. O 0 1.0194452920719854e-11
. O 0 2.814543875739872e-10

Piebaldism B-Disease 1 0.999985933303833
with O 0 0.007852028124034405
deafness B-Disease 1 0.9999996423721313
: O 0 5.703194583261961e-10
molecular O 0 8.983241928106622e-10
evidence O 0 1.0382650295071016e-09
for O 0 7.051779715716577e-10
an O 0 8.467100798270621e-08
expanded O 0 0.03878539055585861
syndrome O 1 0.9998517036437988
. O 0 8.111075366912246e-09

In O 0 2.0359052221863294e-09
a O 0 1.7983153854927991e-09
South O 0 7.760751152829926e-09
African O 0 2.766620266214659e-10
girl O 0 4.836552136566752e-08
of O 0 2.367812976938888e-12
Xhosa O 0 2.448550731060095e-07
stock O 0 2.4984805691019574e-07
with O 0 1.8744765739597824e-09
severe O 0 5.071451596450061e-06
piebaldism B-Disease 0 6.585189839825034e-05
and O 0 2.559587244377326e-07
profound O 0 3.5042194213019684e-05
congenital O 1 0.999996542930603
sensorineural B-Disease 1 0.9999610185623169
deafness I-Disease 1 1.0
we O 0 2.9908646865806077e-06
identified O 0 2.4244497964787115e-08
a O 0 1.014827978595978e-11
novel O 0 5.467555574956151e-11
missense O 0 3.7541873609825416e-08
substitution O 0 1.6716637796232447e-10
at O 0 6.397761209697705e-10
a O 0 1.790090124742516e-11
highly O 0 5.470497665971408e-11
conserved O 0 1.0451033094494022e-10
residue O 0 1.3117849029242734e-08
in O 0 3.14579373834889e-12
the O 0 9.027806280315076e-12
intracellular O 0 1.0172018960474816e-07
kinase O 0 5.6959169825177014e-08
domain O 0 7.833111381749802e-10
of O 0 1.3961140403473404e-11
the O 0 2.1200805000454181e-10
KIT O 0 1.003154739009915e-05
proto O 0 4.076783443451859e-05
- O 0 1.0198540621786378e-05
oncogene O 0 4.350868039182387e-06
, O 0 2.8399857465721823e-10
R796G O 0 4.694798150239876e-08
. O 0 2.227744932969955e-10

Though O 0 4.2063195593300406e-08
auditory B-Disease 0 8.497648195771035e-06
anomalies I-Disease 0 0.00017951118934433907
have O 0 8.876149593106675e-09
been O 0 5.096771893420282e-10
observed O 0 3.834600692531609e-10
in O 0 9.347820260907636e-12
mice O 0 2.478569172126299e-07
with O 0 5.386530110840226e-10
dominant O 0 7.147078576963395e-06
white O 0 9.618224794394337e-07
spotting O 0 0.0001262154255528003
( O 0 4.9828148718233933e-08
W O 1 0.8930690884590149
) O 0 9.73485805855212e-11
due O 0 1.28052152215119e-10
to O 0 8.574775611780439e-11
KIT O 0 7.221108535304666e-05
mutations O 0 1.5563891793135554e-05
, O 0 9.146792478986754e-08
deafness B-Disease 1 1.0
is O 0 7.773124366394768e-08
not O 0 2.420575129225e-10
typical O 0 1.2182664876903004e-09
in O 0 3.390107292111644e-11
human O 0 1.2542853866648329e-08
piebaldism B-Disease 0 2.0426745322765782e-05
. O 0 2.1725197196786894e-09

Thus O 0 1.630656853990331e-08
, O 0 1.989136112767742e-11
the O 0 4.592861681251836e-12
occurrence O 0 7.199516716127619e-08
of O 0 1.0955482743213452e-08
sensorineural B-Disease 1 0.9998829364776611
deafness I-Disease 1 1.0
in O 0 1.4223817679237527e-08
this O 0 5.075833850454181e-11
patient O 0 6.420012077512638e-09
extends O 0 2.7040680805612283e-10
considerably O 0 2.6549448750579074e-10
the O 0 1.458622502295559e-12
phenotypic O 0 7.403411217410394e-09
range O 0 9.222555164001278e-09
of O 0 5.659715751615835e-11
piebaldism B-Disease 0 1.5639447155990638e-05
due O 0 5.042208872652054e-10
to O 0 2.7294091466123493e-12
KIT O 0 7.82566687007602e-08
gene O 0 7.783502176117452e-10
mutation O 0 2.080245531388414e-09
in O 0 3.949594991337069e-12
humans O 0 1.6149878101501258e-09
and O 0 3.694641259599507e-10
tightens O 0 6.376268174790312e-06
the O 0 2.3915522340267614e-11
clinical O 0 1.0000412720145846e-09
similarity O 0 1.8354381903229466e-10
between O 0 1.8865559114900066e-10
piebaldism B-Disease 0 8.710458700988966e-07
and O 0 7.35209740310161e-11
the O 0 9.218386687673275e-13
various O 0 2.9581660471872384e-12
forms O 0 8.72884253766415e-09
of O 0 1.3721421510126675e-06
Waardenburg B-Disease 1 0.9999483823776245
syndrome I-Disease 1 0.999962568283081
. O 0 1.3828452272157676e-10
. O 0 1.1111329634161393e-09

Cycloheximide O 0 1.190369289361115e-06
facilitates O 0 4.813799581171452e-09
the O 0 4.900120240125538e-12
identification O 0 1.8019427963644752e-11
of O 0 1.5321902817680422e-12
aberrant O 0 7.292042170092827e-08
transcripts O 0 6.652180672972463e-08
resulting O 0 4.331801584100958e-09
from O 0 3.5040775836492344e-11
a O 0 2.7306655200898255e-11
novel O 0 4.227049266170013e-10
splice O 0 1.482589232182363e-05
- O 0 2.853655814760714e-06
site O 0 4.760224570077298e-08
mutation O 0 5.970704108904101e-08
in O 0 2.7631223697976992e-11
COL17A1 O 0 4.437535153556382e-06
in O 0 7.401875119772416e-12
a O 0 2.075092875308826e-10
patient O 0 2.1274995987141665e-08
with O 0 5.84058401642551e-09
generalized O 0 8.711103146197274e-05
atrophic B-Disease 1 0.9968864321708679
benign I-Disease 1 0.9211252927780151
epidermolysis I-Disease 1 0.9698856472969055
bullosa I-Disease 1 0.5946815609931946
. O 0 5.999563654768281e-07

Patients O 0 5.5927997891558334e-05
with O 0 4.692810406936587e-08
generalized O 0 0.00048375059850513935
atrophic B-Disease 1 0.9983641505241394
benign I-Disease 1 0.9743768572807312
epidermolysis I-Disease 1 0.9672150611877441
bullosa I-Disease 0 0.43286317586898804
often O 0 3.385148602319532e-06
show O 0 3.436013855662168e-07
decreased O 0 4.237681139329652e-07
expression O 0 4.605410774960461e-10
of O 0 9.705490577882614e-11
type O 0 6.572404527105391e-05
XVII O 0 0.0019238237291574478
collagen O 0 0.00018596828158479184
, O 0 5.296065808124695e-10
a O 0 6.71831423826319e-10
transmembrane O 0 4.217478135615238e-07
hemidesmosomal O 0 6.175917519612995e-07
protein O 0 3.8509384570062366e-10
encoded O 0 2.2808831212639546e-10
by O 0 7.887453884469764e-11
COL17A1 O 0 3.254695548093878e-05
. O 0 8.630370307294299e-10

This O 0 2.1195346866509368e-10
report O 0 1.343070932247059e-10
documents O 0 9.67014246455733e-11
a O 0 4.9422202441640195e-11
novel O 0 5.929456925457544e-10
splice O 0 1.4760530575586017e-05
- O 0 2.687319920369191e-06
site O 0 2.76297384971258e-08
mutation O 0 4.003445042144449e-08
in O 0 4.140729079060712e-11
COL17A1 O 0 2.2489884941023774e-06
in O 0 1.99712598888957e-12
a O 0 8.899941894568997e-11
patient O 0 1.9185048216741052e-08
with O 0 1.1921262865755011e-09
generalized O 0 3.0691484425915405e-05
atrophic B-Disease 1 0.9903301000595093
benign I-Disease 0 0.02660873904824257
epidermolysis I-Disease 0 0.0034822027664631605
bullosa I-Disease 0 0.002148018917068839
, O 0 6.9867982510629645e-09
and O 0 1.9983995361294582e-11
applies O 0 1.2312910240008801e-11
a O 0 2.8351121363762166e-12
new O 0 4.7176785047953196e-12
methodology O 0 1.5409657924680964e-11
to O 0 4.798291104723962e-12
define O 0 1.4286564153920267e-09
and O 0 1.8532725701292385e-11
characterize O 0 2.5881211063172316e-10
the O 0 2.5042118986101647e-12
resulting O 0 5.922942691860555e-11
mRNA O 0 5.402045477609363e-10
splice O 0 5.02338934893487e-06
variants O 0 4.313492354413029e-07
. O 0 5.149305426499495e-09

Mutational O 0 5.046446403866867e-06
analysis O 0 7.732175788532913e-09
of O 0 1.6208687170227165e-10
COL17A1 O 0 3.621286305133253e-05
identified O 0 5.022728544190613e-08
a O 0 1.436301300117293e-09
maternally O 0 7.764754263916984e-05
inherited O 0 0.004446576349437237
G O 0 0.0003457218990661204
- O 0 2.045920155069325e-06
to O 0 1.2921177017233276e-08
- O 0 0.0005092973005957901
T O 0 0.0006138283642940223
transversion O 0 1.1429904844817429e-07
at O 0 3.650302005109296e-10
the O 0 1.1644556846546195e-12
- O 0 1.632984947264049e-08
1 O 0 4.1256949245838115e-11
position O 0 6.192961941875463e-12
of O 0 3.748768602398339e-13
exon O 0 2.4989684987986038e-08
32 O 0 2.126834175442127e-08
. O 0 3.6199754305243914e-10

This O 0 2.151799849414715e-10
acceptor O 0 4.972064981956237e-09
splice O 0 1.4160037835608819e-06
- O 0 7.604740517308528e-07
site O 0 1.0758122392928726e-08
mutation O 0 3.696978367884185e-08
led O 0 1.6012586812053087e-09
to O 0 7.407256231994896e-12
the O 0 2.6821214520189596e-12
formation O 0 4.9203800756014715e-11
of O 0 1.1905044007901044e-12
aberrant O 0 1.0714444442783133e-08
transcripts O 0 4.17390166873588e-09
present O 0 9.235872483470686e-11
at O 0 1.3962725420313404e-09
extremely O 0 3.910360479864039e-09
low O 0 1.906046094291014e-07
levels O 0 1.0355678092821563e-08
. O 0 2.4836083190038494e-10

Based O 0 2.8194400147896204e-09
on O 0 1.8516869981777262e-10
our O 0 7.933513221369815e-12
recent O 0 3.978074814003918e-12
finding O 0 1.185698414452041e-11
that O 0 1.2146688169178965e-11
cycloheximide O 0 7.771209880047536e-07
stabilized O 0 2.326159346921486e-06
mutant O 0 1.018553064113803e-07
COL17A1 O 0 8.188503102246614e-07
transcripts O 0 3.2810232308833065e-09
in O 0 6.077663112363796e-12
keratinocytes O 0 1.3161097767167007e-09
homozygous O 0 2.987805913789998e-08
for O 0 3.9012135535920756e-12
a O 0 3.8769591703680106e-11
frameshift O 0 5.139466452419583e-07
mutation O 0 3.8950506109358685e-07
, O 0 3.616371091474946e-11
the O 0 1.5896600008558082e-11
effects O 0 3.520912272847454e-08
of O 0 1.0625573337863514e-11
the O 0 1.6974251171308907e-10
splice O 0 8.775435708230361e-05
- O 0 4.470338353712577e-06
site O 0 1.0644454206953924e-08
mutation O 0 7.552941050370521e-10
on O 0 5.9210652873786795e-12
splicing O 0 5.798465180228973e-11
of O 0 2.009345164213916e-12
COL17A1 O 0 5.4232977220181056e-08
transcripts O 0 3.271473369981237e-10
were O 0 2.539793245506794e-12
determined O 0 3.7259575307903303e-13
using O 0 2.4666436428122385e-12
reverse O 0 7.356341313879966e-09
transcriptase O 0 5.141084216120362e-07
polymerase O 0 7.169848004195956e-08
chain O 0 3.090478983835965e-08
reaction O 0 2.2859034110034315e-11
of O 0 5.831674796926214e-14
total O 0 2.1596635070564307e-12
RNA O 0 1.1660837573312932e-10
from O 0 1.621714481453429e-12
keratinocytes O 0 2.0292592606274695e-10
incubated O 0 2.87930013165294e-10
for O 0 7.0907242750994914e-12
2 O 0 3.110043056420153e-10
. O 0 1.1729252291647896e-10

5 O 0 6.856841139324388e-08
h O 0 8.854609063746466e-07
in O 0 2.7299155991311608e-11
the O 0 8.365471509952371e-12
presence O 0 8.10321587607632e-10
or O 0 2.019475003889326e-10
absence O 0 8.547147711812642e-11
of O 0 7.32356666630074e-13
10 O 0 2.7678340175363303e-10
microg O 0 1.2118894687773718e-07
cycloheximide O 0 6.832219412444829e-08
per O 0 4.326382863073519e-10
ml O 0 5.806098783978086e-07
. O 0 1.4450504126628516e-09

Using O 0 8.669537310268538e-10
this O 0 1.3009540493491567e-11
approach O 0 2.2285522038867356e-10
, O 0 7.5601686369553e-12
an O 0 9.132446535109473e-12
abnormally O 0 8.311650390169234e-08
spliced O 0 6.423177183023654e-06
transcript O 0 5.056958343629958e-06
was O 0 6.759070174666704e-07
identified O 0 1.1843616087858777e-09
that O 0 1.7666770824043e-13
contains O 0 3.2630804525438095e-13
an O 0 4.632450022537538e-13
extra O 0 4.300333700246739e-11
264 O 0 1.6286968995693485e-10
bases O 0 5.969431893237953e-11
upstream O 0 7.693742865022557e-11
from O 0 1.5113157036603098e-12
exon O 0 7.024800741106674e-09
32 O 0 5.622215137890407e-09
, O 0 2.7792475352367285e-12
resulting O 0 2.058856730935421e-11
in O 0 3.667914062754907e-12
a O 0 1.1861068793805885e-09
premature O 0 3.0562637221009936e-07
termination O 0 2.224545347928597e-08
codon O 0 7.285049719030212e-08
27 O 0 4.387279872730687e-09
bp O 0 3.839640072555994e-08
downstream O 0 6.549395248356404e-09
from O 0 3.729799021717772e-12
the O 0 1.6756778256632465e-12
cryptic O 0 2.970541590485709e-09
splice O 0 1.1371707842044998e-06
site O 0 8.008145613302986e-08
. O 0 1.8989829708715433e-09

Three O 0 6.319391121500928e-10
other O 0 1.2227161123867791e-11
splice O 0 1.4079298580327304e-06
variants O 0 1.5296565436528908e-07
, O 0 2.355283156008081e-11
including O 0 1.811673966227445e-12
one O 0 2.251050908175234e-12
derived O 0 2.5774235176689864e-12
from O 0 1.0812820907743492e-12
the O 0 2.6010086012079325e-13
skipping O 0 2.769962592630293e-10
of O 0 1.8075802356645743e-12
exon O 0 7.882005803594438e-08
32 O 0 6.133866037316693e-08
, O 0 2.174851791714172e-11
were O 0 1.0810770334490627e-10
also O 0 1.3399902021316024e-10
identified O 0 2.162086065737867e-09
. O 0 4.0383821287015564e-10

These O 0 2.739749538349656e-10
results O 0 1.0877162365252602e-10
indicate O 0 1.0173615422326421e-10
the O 0 1.4347163864933399e-12
usefulness O 0 4.91601148677745e-10
of O 0 3.3898728008657786e-12
cycloheximide O 0 5.543283236875141e-07
treatment O 0 4.841937961685971e-10
in O 0 3.29385634436144e-14
evaluating O 0 1.0690340106200846e-11
the O 0 2.851315754684447e-12
abnormal O 0 9.51122403058946e-10
processing O 0 9.696281555449104e-10
of O 0 8.190937077906524e-13
mRNA O 0 6.785561001976248e-11
due O 0 6.305193173128387e-11
to O 0 5.498401213499537e-13
splice O 0 1.7514762475911994e-06
- O 0 3.487112962829997e-06
site O 0 1.3289378841818689e-07
mutations O 0 3.783848967486847e-07
, O 0 5.875595843196635e-11
because O 0 3.2936747773604225e-10
( O 0 1.3235877671657903e-11
i O 0 5.532264424346067e-09
) O 0 1.440897097818028e-13
aberrant O 0 1.5604698089255464e-10
splicing O 0 7.769930254752921e-10
often O 0 7.699114956682962e-11
generates O 0 8.49543005387865e-11
a O 0 6.901418880822519e-10
premature O 0 1.435124943327537e-07
termination O 0 2.5552258975380937e-08
codon O 0 2.484709860084422e-08
, O 0 1.9387051686248213e-10
( O 0 5.41789009489424e-12
ii O 0 7.81529596594055e-09
) O 0 1.0043425509656534e-12
transcripts O 0 7.973144922068798e-10
with O 0 1.7983041444846748e-10
premature O 0 5.3369369368283515e-08
termination O 0 2.3975743612680844e-09
codons O 0 6.544513375672523e-09
can O 0 2.2546152445013234e-10
occur O 0 1.833177186438828e-11
at O 0 1.0182841236883178e-09
low O 0 9.334402193417191e-07
or O 0 6.255048390357842e-08
undetectable O 0 0.002596814651042223
levels O 0 7.650146471860353e-08
due O 0 7.43354267029872e-11
to O 0 3.2296886519345147e-12
nonsense O 0 4.151782917460878e-08
- O 0 1.3238246054925185e-08
mediated O 0 5.515123024935065e-09
mRNA O 0 8.228020695333349e-12
decay O 0 3.6618641452434986e-10
, O 0 8.692178921076987e-12
and O 0 1.3132599174792148e-11
( O 0 1.1348502432922958e-12
iii O 0 5.491703980453622e-09
) O 0 1.7002294754389635e-12
the O 0 6.293666976464607e-12
levels O 0 6.439753730269615e-10
of O 0 7.808660537839476e-14
these O 0 1.120473546302285e-13
transcripts O 0 2.1007751094259675e-10
can O 0 7.758286374448531e-11
be O 0 5.497187340747223e-12
increased O 0 9.096633168947932e-12
by O 0 6.631127071055065e-12
cycloheximide O 0 8.601363106208737e-07
. O 0 4.3634432178585314e-10

A O 0 3.269056136900872e-08
deletion O 0 1.0696719527913956e-06
mutation O 0 2.6458665161044337e-06
in O 0 4.678238907374066e-10
COL17A1 O 0 3.480115265119821e-05
in O 0 8.32485469448585e-11
five O 0 1.1577735437029446e-09
Austrian O 0 2.3969729227246717e-05
families O 0 1.3629735118314557e-09
with O 0 4.243676521298312e-09
generalized O 0 0.00011464089766377583
atrophic B-Disease 1 0.9989902377128601
benign I-Disease 1 0.5055945515632629
epidermolysis I-Disease 0 0.15192559361457825
bullosa I-Disease 0 0.0018985059577971697
represents O 0 1.3326280523529022e-08
propagation O 0 7.2949146723289e-10
of O 0 1.553158469891347e-11
an O 0 1.948878697310974e-10
ancestral O 0 2.5187847541019437e-07
allele O 0 3.966267286159564e-06
. O 0 1.1091898066695194e-08

Patients O 0 4.859264663537033e-05
with O 0 7.39737373578464e-08
generalized O 0 0.0008705137297511101
atrophic B-Disease 1 0.9994396567344666
benign I-Disease 1 0.9977951049804688
epidermolysis I-Disease 1 0.9823005795478821
bullosa I-Disease 1 0.5004783868789673
, O 0 2.093345585763018e-08
a O 0 2.1747366407698365e-10
usually O 0 8.148685198827721e-11
nonlethal O 0 1.0897441171664468e-08
form O 0 1.3464599435408786e-09
of O 0 7.106708554971419e-10
junctional B-Disease 0 0.0007151571335271001
epidermolysis I-Disease 0 0.007561201695352793
bullosa I-Disease 0 0.003630569903180003
, O 0 6.268494168182315e-09
have O 0 6.53759768542983e-10
generalized O 0 1.3591892056297183e-08
blistering B-Disease 0 2.7550559025257826e-05
, O 0 5.397107827320724e-08
nail B-Disease 1 0.9999556541442871
dystrophy I-Disease 1 0.9998784065246582
, O 0 6.231565663483707e-08
patchy B-Disease 0 0.0051168398931622505
alopecia I-Disease 1 0.9998507499694824
, O 0 5.312298512194502e-08
and O 0 2.2032050139841886e-07
dental B-Disease 0 0.04723634198307991
abnormalities I-Disease 1 0.9925640225410461
. O 0 2.7599400098665683e-08

Skin B-Disease 1 0.995235025882721
fragility I-Disease 0 0.004995034076273441
in O 0 1.6288211057702284e-10
most O 0 6.2618408722125984e-12
cases O 0 2.961917933141933e-10
is O 0 4.3893702561526027e-10
due O 0 4.0839186199459476e-11
to O 0 2.668186852017307e-12
mutations O 0 5.863138308193072e-10
in O 0 2.0865038483867254e-13
the O 0 2.222547666741459e-12
gene O 0 3.549100568989161e-09
encoding O 0 4.875331782727699e-08
type O 0 0.004113439936190844
XVII O 0 0.009619726799428463
collagen O 0 0.00022263615392148495
( O 0 4.8514898765006365e-09
COL17A1 O 0 2.736151327553671e-05
) O 0 2.7239768773945627e-10
. O 0 2.2205076666281798e-10

Recently O 0 6.666439730906859e-06
, O 0 5.5606422244558473e-11
we O 0 1.1257616366888712e-11
reported O 0 6.094653115518156e-10
five O 0 6.913906253069868e-11
Austrian O 0 1.8200057638750877e-06
families O 0 4.4441780810977605e-10
with O 0 1.4490413313694717e-09
generalized O 0 5.034126661485061e-05
atrophic B-Disease 1 0.9961431622505188
benign I-Disease 0 0.06364180147647858
epidermolysis I-Disease 0 0.016539566218852997
bullosa I-Disease 0 0.004154382739216089
who O 0 1.7535487586428644e-06
share O 0 1.8915002897301747e-09
the O 0 1.1180751637029918e-11
same O 0 4.378683804429073e-10
COL17A1 O 0 6.561895861523226e-05
mutation O 0 2.679381907455536e-07
. O 0 1.863170062677e-09

Affected O 0 7.207457315416832e-07
individuals O 0 1.003480409877966e-09
in O 0 5.942879001408219e-12
three O 0 4.0398972361854746e-11
families O 0 1.8430498446853072e-11
are O 0 1.2150413054162756e-12
homozygous O 0 5.7552127508131434e-09
for O 0 3.773896126157972e-11
4003delTC O 0 5.6948415760871285e-08
, O 0 7.540651046286651e-13
whereas O 0 8.562280116690413e-13
those O 0 3.424686966305157e-12
in O 0 7.120916811938216e-13
two O 0 1.63123282242994e-11
others O 0 1.2118740733146893e-10
are O 0 5.836276340681623e-12
compound O 0 9.599135375459866e-11
heterozygotes O 0 2.512340380178557e-08
. O 0 3.217340005523539e-10

To O 0 2.6089821969499383e-10
determine O 0 2.7319482787113714e-10
if O 0 4.206032397369164e-11
the O 0 9.537095505690596e-13
occurrence O 0 1.7960565257268968e-09
of O 0 1.2927592156486423e-11
4003delTC O 0 1.2803242555037286e-07
in O 0 6.586500550694041e-13
these O 0 9.636746695768084e-14
unrelated O 0 1.1838731384106183e-10
families O 0 2.4630750997817197e-12
signifies O 0 2.7506744711830455e-12
propagation O 0 2.492603562789797e-12
of O 0 2.8569230314801075e-12
an O 0 1.0389301918767302e-10
ancestral O 0 6.260705731619964e-08
allele O 0 2.1546446760112303e-07
or O 0 5.350796250525036e-09
a O 0 9.942973111520814e-10
mutational O 0 8.871564318724268e-07
hot O 0 5.424362257144821e-07
spot O 0 1.3623292716147262e-06
, O 0 3.4324376674277346e-11
haplotypes O 0 3.299473583240342e-09
were O 0 3.357253364200119e-10
determined O 0 1.0294343155692331e-10
for O 0 6.814791786435848e-12
polymorphisms O 0 1.0856079057930401e-07
both O 0 2.967131540465573e-10
within O 0 1.1519402098869591e-10
and O 0 2.0730929861656477e-08
flanking O 0 7.488150004064664e-05
COL17A1 O 0 0.0349416621029377
. O 0 1.1126180865517199e-08

Five O 0 7.226508813573673e-08
intragenic O 0 5.677494755218504e-06
polymorphisms O 0 8.284700925287325e-06
were O 0 1.5409203912852831e-09
chosen O 0 1.3696540429597448e-11
based O 0 1.1711875393116689e-11
on O 0 7.313178951307009e-10
their O 0 4.048369417475328e-10
informativeness O 0 4.831047590414528e-06
. O 0 8.849250221487637e-10

One O 0 2.736888715659802e-09
of O 0 7.167140578939746e-12
these O 0 1.7316945403675343e-12
, O 0 6.292655198997243e-13
not O 0 1.1313706048399208e-12
previously O 0 1.4735851427971625e-09
reported O 0 1.077925837478233e-08
, O 0 2.6191122187713134e-11
was O 0 1.2742513710861658e-08
2988 O 0 1.0482786194643268e-08
A O 0 4.595041680488521e-09
or O 0 5.875892661322268e-09
C O 0 1.086193961441495e-07
that O 0 7.76358231174834e-12
introduces O 0 2.109431657126848e-10
a O 0 1.1075813009797653e-11
new O 0 9.958716143398938e-12
restriction O 0 3.4796265261510806e-12
site O 0 2.0319267102220095e-11
for O 0 2.3599329088130894e-11
Eco0109 O 0 7.876983509902402e-09
I O 0 8.432498788124576e-08
. O 0 1.3272033472233602e-10

All O 0 1.1992686010930953e-10
the O 0 1.353015529476087e-11
4003delTC O 0 3.583293883835381e-09
alleles O 0 5.346447728982184e-10
showed O 0 7.2277193119418826e-09
the O 0 7.189235101331959e-13
same O 0 1.0014253966003639e-12
haplotype O 0 5.538194902676707e-10
for O 0 1.0139104182974035e-12
these O 0 1.456394954722079e-13
five O 0 3.59325555421286e-11
polymorphic O 0 8.595780798259511e-08
markers O 0 4.120191533729667e-06
. O 0 5.732556651594223e-09

Fourteen O 0 4.849725243616376e-08
microsatellite O 0 5.644379598379601e-06
polymorphisms O 0 1.306655667576706e-05
were O 0 2.4239767970613e-09
selected O 0 2.8968709375742918e-11
based O 0 1.5355966498376006e-11
on O 0 8.625663516781401e-10
their O 0 1.6508651390356732e-10
high O 0 1.9507925230755063e-07
heterozygosity O 0 4.7079709020181326e-08
and O 0 3.353872041200745e-11
their O 0 6.385048739732113e-13
location O 0 3.9913541222125204e-11
within O 0 2.3189269948709068e-11
10q23 O 0 1.8859857675579406e-08
- O 0 9.307583468398661e-07
q25 O 0 2.042600897311786e-07
near O 0 2.6956769261232694e-08
COL17A1 O 0 4.1613839130150154e-05
. O 0 2.157986678241741e-09

Three O 0 5.41461275815891e-09
families O 0 8.814801111256543e-10
shared O 0 7.608753627152964e-10
microsatellite O 0 3.0204805625544395e-06
polymorphisms O 0 2.772043808363378e-05
covering O 0 1.6659299944876693e-05
at O 0 9.018071409627737e-07
most O 0 1.698890028656308e-09
19 O 0 3.8363456411616426e-08
cM O 0 2.467815640727622e-08
, O 0 3.653767392808316e-12
whereas O 0 8.884809554743356e-12
the O 0 6.910184230379812e-12
others O 0 1.7047774303335927e-10
shared O 0 4.35466107617799e-11
smaller O 0 3.3272026800368337e-10
regions O 0 1.171228392049528e-10
consistent O 0 2.1401724836778158e-09
with O 0 2.3075537314287686e-10
cross O 0 4.1471935219306033e-07
- O 0 0.001366717042401433
over O 0 4.1756797486414143e-07
events O 0 7.579639138555194e-10
during O 0 1.0136329969823166e-10
passage O 0 1.006910809071837e-12
of O 0 5.112973439818161e-14
this O 0 9.346296387649153e-14
mutation O 0 1.0793581306511868e-11
through O 0 8.018488759260756e-13
several O 0 8.294736425495941e-12
generations O 0 2.3810406979407617e-09
. O 0 4.749663440328789e-10

These O 0 6.69781730078256e-10
results O 0 5.720506290884941e-10
indicate O 0 3.94740906628499e-09
that O 0 1.645586861220849e-10
4003delTC O 0 5.607406023955264e-07
occurs O 0 4.8145681885714e-10
on O 0 5.368639213743087e-11
a O 0 1.950149243479249e-11
single O 0 1.3471714854773609e-09
ancestral O 0 5.818689974290692e-09
allele O 0 1.2749029387748578e-08
. O 0 2.2956032907917034e-11
. O 0 2.2557379575349756e-10

The O 0 3.853077856774689e-09
haptoglobin O 0 2.0518289147730684e-06
- O 0 1.2508163536040229e-06
gene O 0 4.036946066321434e-08
deletion O 0 4.0363460129810846e-07
responsible O 0 4.070486525620254e-08
for O 0 4.459649316501668e-10
anhaptoglobinemia B-Disease 0 1.0717329132603481e-05
. O 0 1.2461628395854518e-09

We O 0 6.215528713937601e-08
have O 0 1.192901333268992e-10
found O 0 2.3044033695129862e-11
an O 0 1.012032363294224e-12
allelic O 0 2.490544881439405e-09
deletion O 0 2.0034447345551598e-07
of O 0 2.867188431121548e-10
the O 0 1.3028326195652085e-09
haptoglobin O 0 1.9758192593144486e-06
( O 0 2.87497976814155e-11
Hp O 0 2.532546172773209e-09
) O 0 2.1225856901112283e-13
gene O 0 6.959442570841912e-12
from O 0 1.363949209652604e-12
an O 0 6.530063816068132e-12
individual O 0 1.0528120042430089e-10
with O 0 1.4208715093388946e-08
anhaptoglobinemia B-Disease 0 0.0002288424439029768
. O 0 3.6524421265227147e-09

The O 0 1.1811807087980242e-09
Hp O 0 3.2652991421855404e-07
gene O 0 4.083994298298421e-08
cluster O 0 5.891064525087586e-09
consists O 0 8.435296731945652e-12
of O 0 2.4609619897475454e-12
coding O 0 4.341829935583519e-07
regions O 0 3.708988394190982e-10
of O 0 3.3538256807158495e-12
the O 0 2.6593425378473867e-11
alpha O 0 1.491862050562176e-10
chain O 0 1.6480440478972014e-07
and O 0 2.4266944356754472e-11
beta O 0 1.6224013235296986e-12
chain O 0 1.1521913423351293e-09
of O 0 1.5746462293797503e-12
the O 0 2.556645520290779e-11
haptoglobin O 0 5.170980443836015e-08
gene O 0 2.266914433945999e-09
( O 0 2.801269849764254e-12
Hp O 0 1.6521259915691644e-09
) O 0 4.333883512480652e-13
and O 0 2.7047756937827183e-13
of O 0 9.012433269291187e-14
the O 0 2.0177106513363796e-11
alpha O 0 9.815739193674844e-11
chain O 0 3.29888450778526e-07
and O 0 1.852018954862089e-10
beta O 0 4.1725026211913985e-12
chain O 0 4.6872798975527985e-09
of O 0 1.9813497630777333e-12
the O 0 4.200460465564326e-11
haptoglobin O 0 2.073408182923231e-07
- O 0 2.3382023073281744e-07
related O 0 2.2046464209779515e-08
gene O 0 2.2965307877598207e-08
( O 0 5.483618420454306e-11
Hpr O 0 5.2176609699472465e-09
) O 0 1.9636449584414795e-12
, O 0 4.419286117607335e-13
in O 0 4.915291264284694e-13
tandem O 0 1.1818973177923908e-07
from O 0 9.394440780852165e-11
the O 0 6.130711216467688e-11
5 O 0 3.2858955556491765e-09
side O 0 2.932532616739536e-08
. O 0 2.512559715839302e-09

Southern O 0 2.5728217778464568e-08
blot O 0 5.213294571149163e-06
and O 0 5.3369589997354083e-11
PCR O 0 1.159254647831176e-08
analyses O 0 2.1320063769980635e-10
have O 0 1.0781467385534427e-10
indicated O 0 7.72880578980839e-11
that O 0 2.824466734715342e-13
the O 0 8.399682316882762e-13
individual O 0 8.658803708760932e-12
with O 0 1.6072922159882097e-10
anhaptoglobinemia B-Disease 0 1.1077931958425324e-06
was O 0 6.537227204006513e-09
homozygous O 0 3.4510321267333666e-09
for O 0 8.505895640609218e-13
the O 0 1.272145691740001e-12
gene O 0 3.955743232975095e-10
deletion O 0 3.927411995618968e-08
and O 0 3.5850969415385237e-10
that O 0 3.5869538676097656e-12
the O 0 2.460868097839408e-12
gene O 0 3.1298785785338623e-09
deletion O 0 3.366779992575175e-07
was O 0 2.97239182600606e-07
included O 0 5.5820972844067285e-11
at O 0 2.7195384832978675e-10
least O 0 1.598955234709265e-12
from O 0 5.591254998056627e-13
the O 0 1.6564399591550982e-12
promoter O 0 8.06962763277852e-09
region O 0 8.621575675604731e-12
of O 0 4.988164829106134e-13
Hp O 0 9.369022890837186e-09
to O 0 6.900201330456435e-12
Hpr O 0 1.822921147365264e-09
alpha O 0 2.4468738667182688e-12
but O 0 2.550716365554151e-12
not O 0 2.1530949766146446e-12
to O 0 6.233955192336271e-12
Hpr O 0 2.683344746401417e-08
beta O 0 1.0712102732624018e-10
( O 0 1.563710792795714e-11
Hpdel O 0 7.085087361247133e-08
) O 0 2.349288992509191e-11
. O 0 5.440467173989383e-11

In O 0 9.193800165618882e-10
addition O 0 1.0701871333562707e-10
, O 0 2.9131484551025988e-12
we O 0 1.494737168240834e-12
found O 0 1.4141776291665131e-11
seven O 0 2.194075997274947e-11
individuals O 0 3.326907326017814e-12
with O 0 2.8960531889277163e-11
hypohaptoglobinemia B-Disease 0 5.906875344408036e-07
in O 0 3.208881077521042e-11
three O 0 3.100122658583615e-10
families O 0 8.732380790688055e-11
, O 0 1.4158238817452151e-11
and O 0 7.348673752849422e-12
the O 0 2.1424971172190332e-12
genotypes O 0 4.940545195175616e-10
of O 0 3.463278492113475e-12
six O 0 1.4108921808642094e-09
of O 0 4.786581721261118e-12
the O 0 1.852760861398295e-10
seven O 0 4.7865249541700905e-09
individuals O 0 8.856777811150351e-11
were O 0 5.327216098804932e-11
found O 0 7.893458109364815e-11
to O 0 5.908094846684975e-11
be O 0 1.2130129789511557e-08
Hp2 O 0 3.077320570810116e-06
/ O 0 3.1066346650732157e-07
Hpdel O 0 2.0963277620467125e-06
. O 0 4.831826605489198e-10

The O 0 2.062580994888208e-09
phenotypes O 0 2.0842904291384912e-07
and O 0 2.5282445581531476e-10
genotypes O 0 1.0704189534749275e-08
in O 0 1.0193830154991979e-11
one O 0 9.17695433533261e-12
of O 0 2.36045720729966e-13
these O 0 3.692705321210743e-13
three O 0 1.1348644246567119e-10
families O 0 8.628159992030149e-11
showed O 0 4.518130580777324e-08
the O 0 1.073410943464026e-10
father O 0 6.998310198014224e-08
to O 0 2.2559573653602172e-10
be O 0 2.474757510029235e-09
hypohaptoglobinemic B-Disease 0 2.214250969245768e-07
( O 0 1.5997796837252665e-11
Hp2 O 0 2.605066562466618e-08
) O 0 5.51703994988717e-12
and O 0 1.4607169640523665e-11
Hp2 O 0 7.30455695929777e-08
/ O 0 1.5965326838340843e-08
Hpdel O 0 2.2396640986244165e-07
, O 0 1.7158932694855134e-12
the O 0 3.34885710742e-13
mother O 0 2.6290849497456747e-09
to O 0 2.777832217720766e-12
be O 0 6.873474012181191e-11
Hp2 O 0 1.5864063840353992e-08
- O 0 6.81077665376506e-08
1 O 0 1.0019695073637536e-09
and O 0 1.685153960817587e-10
Hp1 O 0 6.46946674009996e-08
/ O 0 1.921254044745524e-09
Hp2 O 0 1.3866261028283589e-08
, O 0 2.336996427539789e-13
one O 0 8.849350966637706e-14
of O 0 6.035781276907473e-14
the O 0 8.794773936893208e-12
two O 0 1.0686471846321766e-10
children O 0 5.495138233335695e-10
to O 0 2.721996933408022e-11
be O 0 4.0126527101058684e-10
hypohaptoglobinemic B-Disease 0 6.890127224323805e-08
( O 0 4.4474467511546045e-12
Hp2 O 0 1.1565779445277258e-08
) O 0 2.317484528932545e-12
and O 0 1.1258517555734482e-11
Hp2 O 0 1.922615524563298e-07
/ O 0 4.453533719583902e-08
Hpdel O 0 8.156439434969798e-07
, O 0 1.5873030320689985e-11
and O 0 6.874030966837197e-13
the O 0 1.1655749336623306e-13
other O 0 1.5696803665893322e-12
child O 0 3.4700832429734874e-08
to O 0 1.1655494278062228e-11
be O 0 4.388097663010626e-10
Hp1 O 0 1.0246852610862334e-07
and O 0 2.3044353925083527e-10
Hp1 O 0 1.4648280455276108e-07
/ O 0 1.0109385328860299e-08
Hpdel O 0 7.412782565552334e-08
, O 0 3.186763136361903e-12
showing O 0 5.08836028867421e-10
an O 0 2.58463563052036e-12
anomalous O 0 1.0054768129208469e-09
inheritance O 0 1.4092281119815198e-08
of O 0 5.065913244450826e-10
Hp O 0 2.758114533207845e-06
phenotypes O 0 3.310109164544883e-08
in O 0 2.2268770161204543e-11
the O 0 7.892314579649451e-11
child O 0 3.34287210534967e-06
with O 0 1.4079349908158179e-09
Hp1 O 0 1.888552105810959e-05
. O 0 1.2804977078673119e-09

The O 0 1.0232513503183327e-08
Hp2 O 0 1.4231602108338848e-05
/ O 0 2.7040841814596206e-06
Hpdel O 0 5.047250397183234e-06
individuals O 0 1.87534210382978e-09
had O 0 2.0050106019908753e-09
an O 0 1.4582394319839764e-11
extremely O 0 1.8224213249595778e-08
low O 0 4.1917911630662275e-07
level O 0 7.019938852437235e-09
of O 0 1.3838232643115234e-11
Hp O 0 2.2088960349719855e-07
( O 0 5.608069130608184e-12
mean O 0 1.4682650928410368e-10
+ O 0 1.219600392898812e-10
/ O 0 3.779518475965915e-09
- O 0 3.113518971531448e-07
SD O 0 0.00010623186244629323
= O 0 1.109045921765528e-08
0 O 0 4.954943400026224e-11
. O 0 2.8819714626912574e-13
049 O 0 2.9378719457184843e-09
+ O 0 8.733996165188884e-11
/ O 0 7.78517972310766e-10
- O 0 1.2562199280807818e-08
0 O 0 5.606788991419087e-11
. O 0 4.0216267815917917e-13
043 O 0 1.2189915743476831e-09
mg O 0 4.4396561982296134e-09
/ O 0 5.922923818069137e-10
ml O 0 5.5170903401347005e-09
; O 0 4.950708679812843e-12
n O 0 3.436909201681715e-09
= O 0 3.7419609633104756e-09
6 O 0 2.39735370444194e-10
) O 0 1.2236270482100797e-13
, O 0 4.4905302620888016e-14
compared O 0 2.8555841719013486e-11
with O 0 2.690474579236657e-11
the O 0 4.1673450801305023e-10
level O 0 9.386698707203323e-08
( O 0 7.50857796077975e-12
1 O 0 5.658072968484085e-12
. O 0 1.9195688333133176e-13
64 O 0 7.832703929899765e-11
+ O 0 3.8685235570490306e-11
/ O 0 5.045470707898403e-10
- O 0 2.5491603494742776e-08
1 O 0 2.642526752971719e-10
. O 0 7.714689347418369e-13
07 O 0 5.23913912253704e-10
mg O 0 1.3992825786957042e-09
/ O 0 6.014185677249984e-11
ml O 0 6.244382788622715e-11
) O 0 1.0500483640962007e-14
obtained O 0 9.37996018747847e-14
from O 0 2.3663850826777244e-13
52 O 0 4.344525295074675e-10
healthy O 0 4.905333916838117e-10
volunteers O 0 4.496442107537746e-11
having O 0 5.46455602989937e-10
phenotype O 0 3.6603715614091925e-09
Hp2 O 0 1.3614638305625704e-07
, O 0 5.797931145606894e-12
whereas O 0 7.896104776972113e-12
the O 0 8.545251312108704e-12
serum O 0 2.598080470761488e-07
Hp O 0 5.4995265230672885e-08
level O 0 7.221184206152031e-10
of O 0 1.0483924926113497e-12
an O 0 3.72439822038384e-11
individual O 0 1.5556912702496817e-10
with O 0 3.0169871045870877e-09
Hp1 O 0 3.271823879913427e-05
/ O 0 9.998281029766076e-07
Hpdel O 0 5.204769877309445e-06
was O 0 3.414785965105693e-08
0 O 0 2.418504285728318e-09
. O 0 4.4112588581946e-10

50 O 0 7.334572416084484e-08
mg O 0 3.708179519890109e-06
/ O 0 4.1469087364021107e-07
ml O 0 1.1527237120390055e-06
, O 0 5.1034620973666733e-11
which O 0 2.1465221093641684e-12
was O 0 6.830320337103402e-11
approximately O 0 9.419011794478682e-13
half O 0 4.485486634897562e-11
the O 0 4.8702660827848465e-12
level O 0 2.4471563664363316e-10
of O 0 9.963498125500903e-13
Hp O 0 3.689025973585558e-08
in O 0 1.3592337325118997e-11
control O 0 2.7091080490038166e-09
sera O 0 1.6998964724734833e-07
from O 0 1.0353984163102847e-11
the O 0 4.3206081073998703e-11
Hp1 O 0 6.367976652654761e-07
phenotype O 0 2.7368991517562336e-09
( O 0 1.3164518303590556e-12
1 O 0 4.150698014460108e-12
. O 0 3.476208307751777e-13
26 O 0 6.612740216516144e-11
+ O 0 2.3845106444930764e-11
/ O 0 3.3673985821991437e-10
- O 0 8.256896499858613e-09
0 O 0 4.139299666916507e-11
. O 0 1.993965837712372e-13
33 O 0 2.373294095969758e-11
mg O 0 1.0117714444035641e-09
/ O 0 2.0059237604286295e-10
ml O 0 1.161691076667637e-09
; O 0 2.392171530307685e-12
n O 0 9.056120298112091e-09
= O 0 5.316958873180511e-09
9 O 0 2.8151236897144827e-10
) O 0 7.446188712281407e-14
, O 0 1.2475199502983217e-14
showing O 0 2.6721758486503155e-11
a O 0 2.0064738065483922e-11
gene O 0 2.0026256208893756e-09
- O 0 7.464959708158858e-07
dosage O 0 2.8200662427479983e-07
effect O 0 7.58859730609629e-09
. O 0 2.1749607670429327e-10

The O 0 4.012063736791305e-10
other O 0 4.1711283732537296e-11
allele O 0 1.1434915236918641e-08
( O 0 3.9896492359803304e-11
Hp2 O 0 2.204822990847788e-08
) O 0 4.2045121724509915e-13
of O 0 1.231628053667208e-13
individuals O 0 1.9893864333653255e-11
with O 0 8.583747046486678e-10
Hp2 O 0 1.858043106039986e-05
/ O 0 4.1741748191270744e-07
Hpdel O 0 2.5905962957040174e-06
was O 0 1.8470293738914734e-08
found O 0 3.20198006997785e-10
to O 0 9.233776243622316e-11
have O 0 8.334344325788834e-10
, O 0 3.2344170744491585e-12
in O 0 3.766995667221079e-13
all O 0 1.6795760962584616e-11
exons O 0 4.73748968943255e-08
, O 0 2.947174448930667e-11
no O 0 2.9649910998630347e-11
mutation O 0 1.8423196301853295e-10
, O 0 4.8405242758942785e-14
by O 0 4.5076670938644717e-14
DNA O 0 2.5711524020977095e-09
sequencing O 0 1.337062371931097e-07
. O 0 2.286965727904544e-09

On O 0 3.3091669404683444e-09
the O 0 1.1531129783665106e-12
basis O 0 1.8758542896096797e-12
of O 0 2.4240090728926134e-13
the O 0 7.303790384993736e-12
present O 0 2.5741969320036695e-11
study O 0 4.457144722747053e-12
, O 0 4.810026617459162e-13
the O 0 1.9368690408038541e-13
mechanism O 0 2.7356189535865383e-10
of O 0 3.479993376798163e-11
anhaptoglobinemia B-Disease 0 2.355982132939971e-06
and O 0 1.202413307810346e-10
the O 0 1.349658991338376e-12
mechanism O 0 1.1364932606117151e-10
of O 0 6.388191299729062e-13
anomalous O 0 1.1451147807761686e-09
inheritance O 0 4.090892069541496e-09
of O 0 2.86072110444735e-10
Hp O 0 3.3315927794319578e-06
phenotypes O 0 5.7894009586334505e-08
were O 0 6.242147354562633e-10
well O 0 1.0976679981622439e-10
explained O 0 8.147668317803891e-09
. O 0 4.4331213699955185e-10

However O 0 2.679320054710388e-08
, O 0 1.282755065362684e-11
the O 0 1.8700564100720962e-12
mechanism O 0 3.8105987809622377e-10
of O 0 5.991869500565628e-11
hypohaptoglobinemia B-Disease 0 5.628529834211804e-05
remains O 0 2.3467583787351032e-07
unknown O 0 1.4783344681745803e-07

ATM O 0 0.0015992281259968877
mutations O 0 0.00044323658221401274
and O 0 4.2334921346309784e-08
phenotypes O 0 2.6335706934332848e-05
in O 0 6.238022933757748e-07
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999984502792358
telangiectasia I-Disease 1 1.0
families O 0 4.710513894679025e-05
in O 0 6.470780578027302e-10
the O 0 2.30322361183255e-09
British O 0 7.425259354931768e-06
Isles O 0 2.094688085207963e-07
: O 0 1.122399829328602e-11
expression O 0 2.892827687464572e-12
of O 0 1.4932974019658818e-13
mutant O 0 1.0801279870520375e-08
ATM O 0 1.792958528312738e-06
and O 0 3.7381214790244144e-10
the O 0 2.829279345528679e-11
risk O 0 1.7660927653651015e-07
of O 0 3.161076067570434e-09
leukemia B-Disease 1 0.7937536239624023
, O 0 1.4188439081408433e-06
lymphoma B-Disease 1 1.0
, O 0 9.771295594873664e-08
and O 0 6.161445753605221e-07
breast B-Disease 1 0.5825608968734741
cancer I-Disease 0 9.110213431995362e-05
. O 0 8.064334089397107e-09

We O 0 1.1782376185820453e-09
report O 0 1.5375426626329514e-11
the O 0 1.816302371091677e-13
spectrum O 0 3.2038600938921746e-11
of O 0 1.054215634059552e-12
59 O 0 4.568449174513489e-09
ATM O 0 5.3360898164100945e-05
mutations O 0 2.7555011001823004e-06
observed O 0 2.6823349799087737e-06
in O 0 5.610027642433124e-07
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999990463256836
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.0008640531450510025
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999992847442627
T I-Disease 1 1.0
) O 0 4.384343554875159e-09
patients O 0 3.497195588675339e-10
in O 0 4.1429129549706845e-13
the O 0 9.083375024365736e-11
British O 0 2.4241135179181583e-06
Isles O 0 7.937273039715365e-06
. O 0 3.769094814032314e-09

Of O 0 1.877747290990328e-09
51 O 0 1.7710547695060086e-07
ATM O 0 9.534160199109465e-05
mutations O 0 2.672698201422463e-06
identified O 0 9.019613145255789e-08
in O 0 6.5351352801501505e-12
families O 0 4.617200718981529e-12
native O 0 1.4527260470964531e-11
to O 0 9.421137481258057e-12
the O 0 3.9168598919836484e-10
British O 0 1.208916637551738e-05
Isles O 0 8.770582553552231e-07
, O 0 3.142187066096369e-10
11 O 0 1.2118284153928016e-09
were O 0 3.709771725923794e-11
founder O 0 8.418493124828785e-10
mutations O 0 1.3738370441274128e-08
, O 0 3.7049564804991775e-11
and O 0 1.642415890790172e-11
2 O 0 1.2470413590648377e-11
of O 0 2.318429465335975e-13
these O 0 3.4738837240838594e-12
11 O 0 3.7437866695633204e-10
conferred O 0 1.0634758698668811e-11
a O 0 1.5261944485978063e-11
milder O 0 1.224071422001316e-08
clinical O 0 4.058777758331189e-09
phenotype O 0 2.061605774983377e-09
with O 0 7.147022557107974e-11
respect O 0 4.9349104663809484e-11
to O 0 5.675217587541859e-11
both O 0 3.5340437243291944e-09
cerebellar B-Disease 0 3.3564356272108853e-06
degeneration I-Disease 0 9.988935198634863e-05
and O 0 9.295101577322384e-09
cellular O 0 6.975175438128645e-06
features O 0 8.727778890715854e-07
. O 0 8.93158080828016e-09

We O 0 1.3934796427861329e-08
report O 0 3.8040484651169493e-10
, O 0 7.17674021339515e-13
in O 0 2.1339600551027738e-13
two O 0 3.69671349087497e-10
A B-Disease 1 0.9999948740005493
- I-Disease 1 0.9999990463256836
T I-Disease 1 1.0
families O 0 4.5973056472803364e-08
, O 0 2.850576328802812e-12
an O 0 1.8277612496425677e-12
ATM O 0 7.986964919837192e-05
mutation O 0 1.4249891933104664e-07
( O 0 1.3270281574995213e-11
7271T O 0 1.1354126527862718e-09
- O 0 3.659578169390443e-07
- O 0 4.914857981930254e-06
> O 0 6.757710480087553e-08
G O 0 4.114654529985273e-06
) O 0 2.4491524260039643e-12
that O 0 7.922293897288935e-12
may O 0 1.9517951144187862e-10
be O 0 1.574034479145947e-11
associated O 0 2.822518911302363e-12
with O 0 1.9357620974908007e-12
an O 0 1.7221211956464089e-10
increased O 0 2.928883304775809e-07
risk O 0 1.4564370758307632e-06
of O 0 1.6765275834274007e-09
breast B-Disease 0 0.015457376837730408
cancer I-Disease 0 3.4730010156636126e-06
in O 0 2.634975918014426e-11
both O 0 3.454211361386683e-10
homozygotes O 0 5.796416644443525e-07
and O 0 9.879908002830007e-10
heterozygotes O 0 4.337690739930622e-08
( O 0 5.0846712257301974e-11
relative O 0 5.012256387715297e-09
risk O 0 8.376902087547933e-07
12 O 0 3.004365423109334e-09
. O 0 6.469737939829301e-12
7 O 0 1.7827661569214115e-09
; O 0 5.935360536390988e-11
P O 0 4.810539030586369e-05
= O 0 5.078979725681165e-08
. O 0 2.565622627542785e-12
0025 O 0 8.54819948159502e-09
) O 0 1.057413488367298e-12
, O 0 1.3464134863451493e-13
although O 0 2.636934182294326e-13
there O 0 4.2626503455461817e-13
is O 0 1.1515743870635364e-12
a O 0 3.693343200716903e-11
less O 0 9.33906640909754e-09
severe O 0 0.001940236077643931
A B-Disease 1 0.9999985694885254
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
phenotype O 0 1.8339129610467353e-06
in O 0 1.9412426527365412e-11
terms O 0 2.7526231294316972e-11
of O 0 1.340126197946906e-13
the O 0 1.3174497083545678e-11
degree O 0 3.5100997108905574e-10
of O 0 7.44651673656449e-10
cerebellar B-Disease 0 0.0002688829554244876
degeneration I-Disease 0 0.031135961413383484
. O 0 4.314636115054782e-08

This O 0 5.07001163274623e-10
mutation O 0 5.4690140416369104e-08
( O 0 6.85578468995196e-11
7271T O 0 5.377448264454188e-09
- O 0 7.282533829311433e-07
- O 0 8.135214557114523e-06
> O 0 6.548985709287081e-08
G O 0 8.289362995128613e-06
) O 0 1.1129766813028352e-12
also O 0 2.525806712221079e-13
allows O 0 2.0505229729895352e-13
expression O 0 1.7520537971826844e-12
of O 0 2.773616568623599e-13
full O 0 3.2345312539483473e-10
- O 0 7.4976009045713e-07
length O 0 7.399941637231677e-08
ATM O 0 1.8222970538772643e-05
protein O 0 3.0395421735107675e-09
at O 0 1.400809190865715e-10
a O 0 1.0317573184703832e-11
level O 0 2.516995223356133e-10
comparable O 0 8.791462557944385e-10
with O 0 9.079282464741212e-12
that O 0 2.182148212126478e-11
in O 0 4.062274475136185e-11
unaffected O 0 7.605206775451734e-08
individuals O 0 8.874820323079291e-11
. O 0 1.6568492411384028e-10

In O 0 8.008779750490191e-10
addition O 0 1.3340736848554968e-10
, O 0 2.7541497728267306e-12
we O 0 7.601754295483154e-12
have O 0 2.8335875312812675e-12
studied O 0 2.9274885293695263e-10
18 O 0 1.93790867797361e-08
A B-Disease 1 0.9999911785125732
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
patients O 0 9.407576726516709e-07
, O 0 9.56555147590965e-13
in O 0 1.0432295625235552e-13
15 O 0 1.1511533913599603e-11
families O 0 2.0354516683251944e-12
, O 0 1.0983837103739624e-11
who O 0 5.174295480969704e-08
developed O 0 3.8943367144383956e-06
leukemia B-Disease 0 0.41395482420921326
, O 0 9.910280596159282e-07
lymphoma B-Disease 1 1.0
, O 0 6.940735097771267e-09
preleukemic O 0 8.597548003308475e-05
T O 0 0.0011319784680381417
- O 0 5.087078534415923e-06
cell O 0 0.00013182006659917533
proliferation O 0 0.008596320636570454
, O 0 1.6753489262555377e-08
or O 0 0.00029042985988780856
Hodgkin B-Disease 1 0.9999988079071045
lymphoma I-Disease 1 1.0
, O 0 8.066241896642623e-09
mostly O 0 6.61115120981215e-11
in O 0 3.403356069187069e-11
childhood O 0 2.1108188263951888e-07
. O 0 6.028015309134105e-10

A O 0 6.035740796050959e-08
wide O 0 3.468354048408173e-09
variety O 0 6.552774989287968e-11
of O 0 2.2361119032809906e-12
ATM O 0 0.00015863786393310875
mutation O 0 5.052554001849785e-07
types O 0 5.987685369746032e-08
, O 0 2.7019837756103726e-11
including O 0 1.3190789606432052e-11
missense O 0 4.004774609711603e-07
mutations O 0 8.803793321021658e-07
and O 0 1.8865604634044075e-09
in O 0 7.161213982920245e-11
- O 0 2.628131551318802e-05
frame O 0 0.002367964945733547
deletions O 0 1.7096102737923502e-06
, O 0 7.778203636732428e-10
were O 0 3.0250754678995406e-10
seen O 0 6.0636162757532475e-09
in O 0 1.7957659014314342e-12
these O 0 2.8624443093594465e-11
patients O 0 4.2891623586172045e-10
. O 0 5.4806909011162475e-11

We O 0 3.728760944454734e-08
also O 0 1.672033761446201e-10
show O 0 2.8551117026154316e-10
that O 0 2.119370868039483e-12
25 O 0 6.562177450736284e-12
% O 0 1.8342935541792657e-14
of O 0 1.4239118510585985e-13
all O 0 1.4668046777188692e-09
A B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 0 1.5964434396664728e-07
carried O 0 4.4669024035215443e-10
in O 0 6.9603446270494196e-12
- O 0 3.403313542094111e-07
frame O 0 1.633658575883601e-05
deletions O 0 2.7705050342774484e-07
or O 0 5.4315347775002465e-09
missense O 0 2.5561138272678363e-07
mutations O 0 8.672787288332984e-08
, O 0 2.1823218145783363e-12
many O 0 5.013065903689516e-14
of O 0 1.1254819775805003e-12
which O 0 1.5271277575834574e-09
were O 0 1.8530913692416107e-08
also O 0 1.13201181761724e-08
associated O 0 3.769047920987312e-11
with O 0 2.6654871018716442e-11
expression O 0 1.0964083807518676e-10
of O 0 7.719594061206259e-12
mutant O 0 1.4024956271896372e-06
ATM O 0 0.0032163679134100676
protein O 0 6.875147846585605e-07
. O 0 1.05102082592623e-09

The O 0 2.2810104916004548e-09
DMPK O 0 1.8075653542837244e-06
gene O 0 6.236940208736996e-08
of O 0 4.93115193123117e-09
severely O 1 0.9806751608848572
affected O 0 0.011171444319188595
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
patients O 0 0.0006017576088197529
is O 0 1.969206353535924e-09
hypermethylated O 0 4.931775379191095e-07
proximal O 0 9.041781368068769e-08
to O 0 9.532268030465474e-11
the O 0 2.290538418658894e-11
largely O 0 5.499007360576513e-10
expanded O 0 9.582845628131054e-09
CTG O 0 6.479095191025408e-06
repeat O 0 9.488778118793562e-07
. O 0 1.5588582646941518e-09

Using O 0 1.8199611817593109e-09
methylation O 0 7.805036261743226e-08
- O 0 1.1056675248255488e-05
sensitive O 0 9.281732491217554e-05
restriction O 0 1.4377162571577173e-08
enzymes O 0 1.2607615396120764e-08
, O 0 3.3870417321529844e-12
we O 0 8.053004877522918e-13
characterized O 0 4.4675431431530355e-13
the O 0 3.0017804106101387e-14
methylation O 0 4.741914638728417e-10
pattern O 0 6.996948798132507e-08
on O 0 7.074389518635371e-09
the O 0 1.599640142568859e-10
5 O 0 5.150795900910055e-10
side O 0 7.892569930945115e-11
of O 0 3.475293241118199e-13
the O 0 5.999219350460994e-12
CTG O 0 8.870467382848801e-08
repeat O 0 2.4949950994113124e-09
in O 0 3.5451017663980233e-13
the O 0 4.2883871367166426e-13
DMPK O 0 3.795435077336151e-08
gene O 0 3.819109958835831e-11
of O 0 2.8232442967658644e-13
normal O 0 5.4113449832193794e-11
individuals O 0 2.2687622180245226e-12
and O 0 2.7017351030000913e-12
of O 0 1.1445197220516512e-11
patients O 0 7.169599136602756e-09
affected O 0 4.2200447580853506e-08
with O 0 3.551504050847143e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.9609980306256602e-09
showing O 0 1.951037731373617e-08
expansions O 0 7.404653779019554e-09
of O 0 3.0109868591476907e-12
the O 0 2.2578073091694684e-11
repetitive O 0 1.669454604780185e-06
sequence O 0 1.5255972485306302e-08
. O 0 2.054634018477941e-09

The O 0 2.3181764841062602e-10
gene O 0 2.2135737687278834e-09
segment O 0 3.786142066530829e-09
analyzed O 0 2.9936841894340205e-10
corresponds O 0 4.7664316937812146e-11
to O 0 1.6386788844260924e-12
the O 0 2.0394194145956224e-12
genomic O 0 1.1349867712340256e-08
SacI O 0 4.345837623986881e-06
- O 0 1.4295179653345258e-06
HindIII O 0 3.8539772617696144e-07
fragment O 0 6.3989604726089055e-09
carrying O 0 1.0151773865985092e-09
exons O 0 2.270152066330411e-08
11 O 0 2.859642300734322e-09
- O 0 2.1737193378612574e-07
15 O 0 4.415385834732888e-09
. O 0 2.1678618622456014e-10

There O 0 1.3635766960007345e-09
is O 0 3.759011157900005e-11
constitutive O 0 2.123331066528067e-09
methylation O 0 3.607928178439579e-09
in O 0 3.666223227782872e-11
intron O 0 1.1406398243707372e-06
12 O 0 8.528217243508607e-09
at O 0 9.075270396285973e-11
restriction O 0 1.644383414156625e-12
sites O 0 7.968424531323848e-12
of O 0 1.3404183362222821e-12
SacII O 0 1.3565738754550694e-07
and O 0 1.5920184615048072e-10
HhaI O 0 3.485405741798786e-08
, O 0 7.426462873480477e-13
localized O 0 3.5548081839253953e-11
1 O 0 6.405254798780291e-11
, O 0 6.945276059995564e-13
159 O 0 2.712643165647677e-10
- O 0 4.543555220948292e-08
1 O 0 1.6583763529087747e-10
, O 0 1.7074952291928208e-13
232 O 0 9.198071124205676e-12
bp O 0 1.0531860938911564e-09
upstream O 0 5.822781146136435e-11
of O 0 2.2450938948637839e-13
the O 0 1.361345064454511e-12
CTG O 0 1.0752116708090398e-07
repeat O 0 8.516594540708411e-09
, O 0 5.742788514694064e-13
whereas O 0 9.818538126635246e-13
most O 0 9.769035623843902e-13
, O 0 3.368421264571958e-13
if O 0 3.196832555618645e-12
not O 0 3.4791885084733964e-12
all O 0 2.706397606022648e-12
, O 0 1.4121384996675784e-13
of O 0 5.655107899159035e-15
the O 0 1.694120104617225e-13
other O 0 3.476195026275164e-13
sites O 0 2.939169393978425e-11
of O 0 4.272616115075234e-12
SacII O 0 1.32219611259643e-07
, O 0 1.8237191271031072e-11
HhaI O 0 7.140966484797673e-09
, O 0 2.9645487453766606e-12
and O 0 8.138243551281121e-12
HpaII O 0 2.531871245992079e-08
in O 0 1.976348988977361e-12
this O 0 1.0276715459514585e-12
region O 0 1.5389097982043687e-11
are O 0 5.901005053522701e-13
unmethylated O 0 3.139540849517175e-09
, O 0 8.035119444804728e-12
in O 0 3.319616174828066e-13
normal O 0 1.9555650501712485e-11
individuals O 0 1.3623769647141959e-11
and O 0 9.383691740305622e-12
most O 0 2.98190617163685e-13
of O 0 5.437308047383238e-13
the O 0 5.924053469996693e-10
patients O 0 2.378789165646822e-09
. O 0 1.3318414426866099e-10

In O 0 2.1091542401485697e-10
a O 0 1.9729488875963597e-11
number O 0 7.473343992259185e-12
of O 0 2.1618899379016732e-11
young O 0 4.4904155060976336e-07
and O 0 1.530464288634903e-08
severely O 0 0.0012769907480105758
affected O 0 3.4027300976902097e-09
patients O 0 8.73386363231532e-11
, O 0 6.186335623457884e-13
however O 0 1.708890624493864e-12
, O 0 7.447694398048446e-14
complete O 0 2.0828934551523487e-13
methylation O 0 2.3283153183228933e-10
of O 0 1.5729780325490772e-11
these O 0 6.713285743281672e-12
restriction O 0 1.3220921579737421e-10
sites O 0 5.026700722332578e-10
was O 0 8.366409787186058e-09
found O 0 8.067864432081961e-11
in O 0 3.4866269485282764e-13
the O 0 5.618454486377988e-12
mutated O 0 3.8091418019803314e-08
allele O 0 3.310500673592287e-08
. O 0 1.1819830669779208e-09

In O 0 1.2048191611047088e-10
most O 0 3.129838185497724e-12
of O 0 1.5260005986703767e-13
these O 0 2.4963147868262148e-12
patients O 0 7.563316639647155e-11
, O 0 2.5312564544410776e-13
the O 0 2.024548497597811e-12
onset O 0 2.1926904736346842e-08
of O 0 7.015715092206776e-11
the O 0 1.6109744649384083e-07
disease O 0 0.10576394945383072
was O 0 0.0037990203127264977
congenital O 1 0.999716579914093
. O 0 4.141232778920312e-08

Preliminary O 0 7.821980574362897e-08
in O 0 1.0996928923034943e-09
vivo O 0 2.8804490170841746e-07
footprinting O 0 1.918001999001717e-06
data O 0 6.295525878385888e-09
gave O 0 9.001074191550273e-11
evidence O 0 2.6741645356431754e-11
for O 0 7.207921867875833e-13
protein O 0 2.925544875798103e-11
- O 0 1.2429635987132315e-08
DNA O 0 1.3079818472760962e-06
contact O 0 1.2497844181780238e-07
in O 0 4.123993681270921e-12
normal O 0 2.659789055670103e-11
genes O 0 2.778454966101407e-10
at O 0 2.694226175492531e-09
an O 0 1.0550775531026346e-10
Sp1 O 0 3.620739050802513e-07
consensus O 0 7.851441718997876e-12
binding O 0 5.169670941329585e-11
site O 0 5.266277344762038e-11
upstream O 0 1.5745275916412282e-10
of O 0 3.983987890022328e-13
the O 0 3.6753373781894805e-12
CTG O 0 1.318509248449118e-07
repeat O 0 1.4240323586989234e-08
and O 0 3.671959871581754e-12
for O 0 3.626194464601169e-14
a O 0 3.6370225949856894e-13
significant O 0 1.5715436764429658e-12
reduction O 0 2.5364699229868393e-10
of O 0 3.682836641986237e-13
this O 0 3.33499964840292e-13
interaction O 0 6.653602148409821e-12
in O 0 1.413093058365289e-12
cells O 0 3.20170348566684e-11
with O 0 1.519281922490734e-11
a O 0 1.3975808288435587e-09
hypermethylated O 0 1.01392497526831e-05
DMPK O 0 3.150020575048984e-06
gene O 0 3.875558540755719e-09
. O 0 1.809844288325202e-11
. O 0 9.695777514195925e-11

The O 0 2.3546668614926602e-08
hemochromatosis B-Disease 1 0.9999637603759766
gene O 0 2.041274001385318e-06
product O 0 7.010200420154433e-08
complexes O 0 3.2441964670226753e-09
with O 0 1.6981690359463286e-11
the O 0 4.17829451593299e-11
transferrin O 0 8.290504069918825e-07
receptor O 0 1.6378074008116528e-08
and O 0 1.6348873643767803e-10
lowers O 0 3.4027326023533533e-07
its O 0 9.725346613101427e-13
affinity O 0 1.808353640442295e-11
for O 0 7.466331155767114e-13
ligand O 0 2.0503657105486184e-10
binding O 0 4.7112291845508025e-09
. O 0 5.779057787869135e-10

We O 0 2.699644063852702e-08
recently O 0 2.977475155319098e-08
reported O 0 6.830870868945738e-10
the O 0 4.0193106547008195e-13
positional O 0 1.3140580845671934e-09
cloning O 0 2.120028819163622e-09
of O 0 5.31143380146093e-13
a O 0 1.746343000763595e-11
candidate O 0 3.8273009761446986e-10
gene O 0 2.792980069443729e-07
for O 0 3.9440428736270405e-06
hereditary B-Disease 1 0.9999998807907104
hemochromatosis I-Disease 1 1.0
called O 1 0.5193657875061035
HFE O 1 0.7123130559921265
. O 0 5.488764642791466e-08

The O 0 6.160413845712753e-11
gene O 0 2.344251237573758e-09
product O 0 3.636261780570749e-08
, O 0 8.969980140605127e-12
a O 0 1.3382883343182606e-11
member O 0 1.620286890768874e-11
of O 0 4.593017047423154e-13
the O 0 2.953691111140522e-11
major O 0 2.4538320264611002e-09
histocompatibility O 0 1.8988174588230322e-08
complex O 0 6.32783381249169e-10
class O 0 6.162747201443608e-09
I O 0 1.1312498600091203e-06
- O 0 3.1867944016994443e-07
like O 0 4.0142722923519614e-08
family O 0 2.254513242760936e-09
, O 0 6.733753311893853e-12
was O 0 9.037187109761646e-10
found O 0 3.193019113001405e-11
to O 0 6.158813042889122e-12
have O 0 3.218762409384901e-11
a O 0 1.8971999318773136e-11
mutation O 0 2.400264875745961e-09
, O 0 2.8732311668777655e-11
Cys O 0 4.3930262449976e-07
- O 0 7.440808076353278e-07
282 O 0 3.018686356881517e-06
- O 0 7.246590394061059e-05
- O 0 3.2883901440072805e-05
> O 0 1.85705069100095e-08
Tyr O 0 2.237736111965205e-07
( O 0 6.197333445034925e-12
C282Y O 0 8.027724318626639e-11
) O 0 7.361656179398143e-14
, O 0 8.89106767810316e-15
in O 0 9.815007828836361e-15
85 O 0 5.426856880541564e-12
% O 0 2.1583692407130262e-13
of O 0 4.32774866290786e-12
patient O 0 7.083195185941804e-08
chromosomes O 0 1.354564005850989e-06
. O 0 5.060816210544772e-09

This O 0 9.718309490480692e-11
mutation O 0 9.450486615492082e-09
eliminates O 0 6.58863967828438e-08
the O 0 1.3355402894710267e-10
ability O 0 2.316851377415219e-09
of O 0 4.358730824188806e-12
HFE O 0 6.875921826576814e-06
to O 0 2.1170780406531975e-10
associate O 0 2.978734370273628e-09
with O 0 6.359764936902934e-10
beta2 O 0 2.405941268079914e-05
- O 0 9.171455894829705e-05
microglobulin O 0 8.485050784656778e-05
( O 0 4.773437201066599e-11
beta2m O 0 3.658761116298592e-08
) O 0 6.715408394294964e-13
and O 0 1.3944466241422315e-13
prevents O 0 7.663834844517936e-11
cell O 0 1.4162669970119168e-07
- O 0 0.0006126894732005894
surface O 0 3.1300674891099334e-05
expression O 0 4.748092123918468e-07
. O 0 1.967832119476043e-09

A O 0 3.6288277271978586e-08
second O 0 2.686887601299759e-09
mutation O 0 3.898275835467757e-08
that O 0 3.749804078356789e-10
has O 0 1.0120803084490149e-09
no O 0 9.213298179933105e-11
effect O 0 1.4033610939989671e-09
on O 0 2.6626050697586834e-08
beta2m O 0 3.9433631172869354e-05
association O 0 8.036016296841808e-10
, O 0 4.4896269861538496e-12
H63D O 0 4.480905886339315e-07
, O 0 1.1959809011197198e-11
was O 0 1.883475597708184e-09
found O 0 3.405137005696446e-10
in O 0 1.8927604709256807e-12
eight O 0 7.115114053490856e-11
out O 0 4.79610906545247e-10
of O 0 5.797256771855608e-12
nine O 0 8.123987704777846e-09
patients O 0 7.401568247189516e-11
heterozygous O 0 2.590159510484913e-11
for O 0 4.356617334683871e-13
the O 0 6.7304278469904055e-12
C282Y O 0 2.479852234671398e-08
mutant O 0 2.323650960533996e-07
. O 0 1.0082883417084076e-09

In O 0 9.54854084689316e-10
this O 0 3.6574632211738844e-12
report O 0 4.885759505302012e-11
, O 0 4.582237367323216e-13
we O 0 4.820368279881415e-13
demonstrate O 0 1.3126282829775682e-12
in O 0 1.389776152233707e-13
cultured O 0 1.0425315055684337e-09
293 O 0 3.9955913577749413e-10
cells O 0 2.1088000790037142e-10
overexpressing O 0 3.868005649110273e-08
wild O 0 4.561459832075343e-08
- O 0 2.505835254851263e-05
type O 0 1.9936072931159288e-05
or O 0 3.6903400335575043e-09
mutant O 0 1.9612799917467783e-07
HFE O 0 5.949037813479663e-07
proteins O 0 6.300540644765817e-11
that O 0 1.9253121232715165e-12
both O 0 1.6148806467400356e-12
the O 0 3.6055834966991496e-12
wild O 0 7.512804245379812e-08
- O 0 0.0008526413585059345
type O 0 0.00014343524526339024
and O 0 8.698449249777696e-08
H63D O 0 0.0004909145063720644
HFE O 0 6.48842251393944e-05
proteins O 0 3.094838163519853e-08
form O 0 1.750366407371473e-09
stable O 0 3.191654229794949e-08
complexes O 0 6.935094165605449e-10
with O 0 1.032943175438561e-10
the O 0 7.350699493535728e-10
transferrin O 0 4.830020770896226e-05
receptor O 0 1.3488300965036615e-06
( O 0 6.685232922798434e-10
TfR O 0 4.686339707404841e-06
) O 0 8.626416247992097e-11
. O 0 1.7182530398507367e-10

The O 0 1.2710442698349311e-09
C282Y O 0 1.2430304252575297e-07
mutation O 0 1.3747641958161694e-07
nearly O 0 3.1026561320146584e-09
completely O 0 7.719149763829591e-09
prevents O 0 1.9490737912519762e-08
the O 0 2.0940821299220147e-10
association O 0 6.821388592870292e-11
of O 0 1.0793226121880162e-12
the O 0 8.89108578427944e-11
mutant O 0 2.668961542440229e-06
HFE O 0 1.410821369063342e-05
protein O 0 6.614588876630023e-09
with O 0 6.325972384813028e-11
the O 0 1.1129995813874416e-09
TfR O 0 0.0001402470952598378
. O 0 5.531375357747947e-10

Studies O 0 7.421338210633621e-09
on O 0 8.978479626442493e-10
cell O 0 8.935314212976664e-07
- O 0 1.707746741885785e-05
associated O 0 6.586915901607426e-09
transferrin O 0 4.702828348968069e-08
at O 0 1.3141006061090366e-09
37 O 0 6.975715560741946e-10
degrees O 0 2.8279196692682085e-11
C O 0 1.727778631277488e-08
suggest O 0 7.652645878097886e-11
that O 0 1.3143418645111815e-12
the O 0 6.7382887464217944e-12
overexpressed O 0 8.07149092452164e-07
wild O 0 1.4497338440833119e-07
- O 0 8.079925464699045e-05
type O 0 1.318417980655795e-05
HFE O 0 5.4597865528194234e-05
protein O 0 3.1742185768735e-08
decreases O 0 3.089628775043707e-09
the O 0 6.89369893634717e-13
affinity O 0 8.427984005132672e-11
of O 0 6.291914472073001e-12
the O 0 2.9338498297448723e-10
TfR O 0 6.933909844519803e-06
for O 0 2.6142574216514447e-10
transferrin O 0 8.122702865875908e-07
. O 0 1.1130717458840422e-09

The O 0 1.2165579654777048e-08
overexpressed O 0 2.922729981946759e-05
H63D O 0 5.1322553190402687e-05
protein O 0 4.742896209108949e-08
does O 0 2.2558584167331475e-10
not O 0 4.102998323041174e-12
have O 0 6.999414611276455e-13
this O 0 7.006357028837423e-14
effect O 0 4.1449725596276465e-11
, O 0 1.5754024061849503e-13
providing O 0 1.8121154533520811e-13
the O 0 3.64836877072075e-13
first O 0 1.050566838384226e-11
direct O 0 9.740198014460133e-13
evidence O 0 2.619273409276701e-10
for O 0 1.0683287587909263e-11
a O 0 6.034581168101738e-11
functional O 0 2.0295534697289952e-10
consequence O 0 9.015025531633469e-11
of O 0 3.9579806446199406e-12
the O 0 1.4407955939432782e-09
H63D O 0 0.0007231588242575526
mutation O 0 9.365146524942247e-07
. O 0 2.6822382093172337e-09

Addition O 0 6.750069392325031e-09
of O 0 1.194734311482648e-10
soluble O 0 9.865717487400616e-08
wild O 0 3.137510589112935e-07
- O 0 0.0037348715122789145
type O 0 0.0007434485014528036
HFE O 0 0.30087658762931824
/ O 0 4.0882336179492995e-05
beta2m O 0 2.0423454770934768e-05
heterodimers O 0 1.9543176676961593e-07
to O 0 3.9237595811369985e-11
cultured O 0 3.578951535132546e-08
cells O 0 1.1103539421242203e-08
also O 0 3.8280822955982785e-10
decreased O 0 3.201706677558036e-09
the O 0 2.0985424769442984e-12
apparent O 0 3.091360223361761e-10
affinity O 0 1.1036006136722065e-10
of O 0 3.3201625043027816e-12
the O 0 3.455349548153741e-11
TfR O 0 1.5096081540377781e-07
for O 0 2.9705356013529083e-13
its O 0 6.564111640306944e-14
ligand O 0 2.770990251491079e-12
under O 0 2.3289391248848546e-12
steady O 0 1.4673595671865769e-08
- O 0 7.422120518185693e-08
state O 0 6.854075640383428e-10
conditions O 0 5.6201859832683e-10
, O 0 1.1378841391265077e-13
both O 0 8.752143432731729e-14
in O 0 2.3161488460661517e-13
293 O 0 5.485116805203916e-10
cells O 0 1.876443028736574e-10
and O 0 2.8290958117849208e-11
in O 0 6.185300535643812e-12
HeLa O 0 7.563571671198588e-07
cells O 0 1.150031447849642e-08
. O 0 8.017216335254318e-10

Furthermore O 0 1.1465714067071531e-07
, O 0 1.5007636799957425e-10
at O 0 6.792310602854457e-10
4 O 0 1.097867574628708e-09
degrees O 0 5.170856520742007e-10
C O 0 5.322349352354649e-07
, O 0 9.33631037064453e-12
the O 0 1.1742026621852641e-11
added O 0 1.0858828503046425e-08
soluble O 0 4.365774408654488e-10
complex O 0 4.3262487342543565e-11
of O 0 1.2904564916649264e-10
HFE O 0 0.0005091677303425968
/ O 0 1.84379302936577e-06
beta2m O 0 1.2717149502350367e-06
inhibited O 0 5.6694675620860835e-09
binding O 0 1.7355783477057685e-10
of O 0 2.057552479090008e-12
transferrin O 0 1.8716480809644054e-08
to O 0 1.4099061328154416e-11
HeLa O 0 7.881164520995299e-08
cell O 0 5.871581834071549e-07
TfR O 0 2.904859456975828e-06
in O 0 2.464625942569243e-12
a O 0 5.002776665152808e-11
concentration O 0 5.395758648774063e-07
- O 0 3.415305172893568e-06
dependent O 0 5.946202463746886e-08
manner O 0 1.0306770548140776e-08
. O 0 3.065174225547196e-10

Scatchard O 0 3.4744984986900818e-06
plots O 0 3.9747607871731816e-08
of O 0 1.2247093963968503e-11
these O 0 2.8191709492038364e-13
data O 0 8.493296066447442e-10
indicate O 0 3.3673347443752277e-10
that O 0 1.1948887192192448e-11
the O 0 5.2223350643920696e-11
added O 0 3.026821815410585e-08
heterodimer O 0 4.6078554305495345e-09
substantially O 0 8.676821039443894e-09
reduced O 0 4.797234276487927e-10
the O 0 2.1926273730682455e-12
affinity O 0 2.7466404151077484e-10
of O 0 4.326883989991259e-11
TfR O 0 2.599776053102687e-06
for O 0 3.686544472469855e-11
transferrin O 0 3.365861687143479e-07
. O 0 4.754829863173882e-10

These O 0 9.984054555323141e-11
results O 0 1.8814748370399315e-10
establish O 0 1.7233074689482208e-10
a O 0 4.5337660709021677e-11
molecular O 0 1.3212263283435277e-08
link O 0 1.1931506378459744e-05
between O 0 5.610916176124192e-08
HFE O 0 0.0013195951469242573
and O 0 2.6834356958715944e-09
a O 0 1.5567092059853849e-10
key O 0 2.300454582382372e-08
protein O 0 3.8287251147295365e-10
involved O 0 4.312706303188918e-10
in O 0 3.3612751471068236e-11
iron O 0 1.4493770322587807e-05
transport O 0 8.354194669379922e-09
, O 0 3.1370218922521786e-12
the O 0 8.02629664120591e-12
TfR O 0 1.0708068884923705e-06
, O 0 3.235194664247265e-12
and O 0 2.1144206177603486e-12
raise O 0 4.144893456237142e-11
the O 0 1.1198760018274467e-12
possibility O 0 7.738777674237696e-11
that O 0 3.571050052886271e-11
alterations O 0 1.8737686957592814e-09
in O 0 2.1885078384936696e-12
this O 0 1.097095504720702e-12
regulatory O 0 6.511244432516605e-09
mechanism O 0 1.7966179655104497e-07
may O 0 1.663319793010487e-08
play O 0 3.166209516791696e-10
a O 0 1.4661376279700988e-11
role O 0 7.567447779521785e-10
in O 0 3.4832436956490354e-13
the O 0 1.4292437025553717e-11
pathogenesis O 0 9.319710159161332e-08
of O 0 1.942214566952316e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.4847321381239453e-06
. O 0 4.0235454967785245e-09

Genomic O 0 3.4264260762029153e-07
organization O 0 2.6886508575074686e-09
of O 0 3.238999346510951e-11
the O 0 1.0085070972776222e-10
UBE3A O 0 0.00011231686221435666
/ O 0 8.109034865810827e-07
E6 O 0 1.751922354742419e-05
- O 0 4.3160371205885895e-06
AP O 0 2.1076136818010127e-06
gene O 0 2.889407824113732e-09
and O 0 2.3043242661224816e-11
related O 0 3.3101374419253204e-10
pseudogenes O 0 3.5196472936149803e-07
. O 0 1.7460083379106095e-09

The O 0 2.566654444535743e-09
UBE3A O 0 3.0780981887801317e-06
gene O 0 6.922093565009391e-09
encodes O 0 1.8007352275972721e-09
the O 0 8.298380732574273e-11
E6 O 0 5.286803570925258e-06
- O 0 1.779337617335841e-05
AP O 0 3.186136609656387e-06
ubiquitin O 0 2.2227812479513887e-08
- O 0 1.8195940754139883e-08
protein O 0 3.280256621884803e-11
ligase O 0 1.4926183553032324e-11
and O 0 1.2918767618164129e-11
has O 0 2.656270689516127e-11
recently O 0 1.2978721430911833e-09
been O 0 4.498500877359035e-11
shown O 0 1.1122875190339165e-11
to O 0 1.759115856453386e-12
be O 0 8.003954166113658e-10
mutated O 0 1.3401571777649224e-05
in O 0 8.047607116168365e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 4.762771823152434e-06
who O 0 1.1664007537603993e-08
lack O 0 2.340073135265186e-10
15q11 O 0 1.1865487259399288e-08
- O 0 6.791247528781241e-07
q13 O 0 8.115845417933087e-08
deletions O 0 3.950345330849814e-07
or O 0 5.874730391042249e-08
chromosome O 0 0.007039282005280256
15 O 0 9.422481639376201e-07
paternal O 0 0.00011636210547294468
uniparental B-Disease 0 0.11687670648097992
disomy I-Disease 0 0.0034829440992325544
. O 0 3.786013991202708e-08

Previous O 0 5.675908099078697e-08
UBE3A O 0 1.5360873248937423e-06
cDNA O 0 4.470978698378758e-09
analysis O 0 2.5058020103330136e-09
has O 0 1.7068214619442301e-09
shown O 0 4.353208071794512e-11
a O 0 3.8069773028448495e-12
coding O 0 1.2658262882325744e-08
region O 0 2.3655299941083285e-11
of O 0 1.5812908437089906e-13
approximately O 0 1.026242701929192e-10
2 O 0 3.3359863760296093e-09
. O 0 3.000332204905476e-10

6 O 0 1.1277854810032295e-06
kb O 0 0.00014713236305397004
and O 0 8.540996354611252e-09
a O 0 1.0718137488652246e-09
3 O 0 1.542356109496268e-08
- O 0 0.00018658106273505837
untranslated O 0 0.0020286107901483774
region O 0 2.0768370134760517e-08
( O 0 1.7904589269535087e-11
UTR O 0 2.689440892211792e-09
) O 0 3.0148466730918477e-13
of O 0 4.720499707268344e-14
< O 0 2.062560400251101e-10
50 O 0 6.574708832918219e-11
bp O 0 2.6047386469940648e-08
, O 0 4.885754886600757e-13
whereas O 0 9.236972081314021e-13
Northern O 0 2.5918367929297914e-13
analysis O 0 5.792095102152839e-12
has O 0 1.555976181233376e-10
indicated O 0 1.596219684207867e-11
mRNA O 0 1.0090179559940626e-12
sizes O 0 1.7278857511460188e-10
of O 0 9.810981020652587e-12
5 O 0 2.6734328084643266e-09
- O 0 2.139036496373592e-06
8 O 0 1.2612352939811444e-08
kb O 0 1.093350238079438e-05
. O 0 7.644975763554385e-10

We O 0 2.359912709692935e-09
have O 0 1.5570789015789677e-12
analyzed O 0 3.953822946128893e-12
additional O 0 2.737019053240808e-13
cDNA O 0 8.880843976877273e-12
clones O 0 2.9500414555627685e-08
and O 0 4.386087326668786e-11
provide O 0 7.349384772634138e-13
evidence O 0 1.3057718101228133e-11
for O 0 6.051402868384459e-13
an O 0 2.8451876271651244e-12
additional O 0 6.121059908936743e-11
0 O 0 2.615894834079313e-09
. O 0 3.0856697752490447e-10

5 O 0 3.4095663181687996e-08
kb O 0 5.68171981285559e-06
of O 0 2.048235608897997e-10
5 O 0 5.314869877537376e-09
- O 0 8.392916242883075e-06
UTR O 0 1.0427128245282802e-06
and O 0 4.982949816656479e-11
> O 0 7.299142540384551e-11
2 O 0 3.4216525446328916e-11
kb O 0 2.489535120275832e-07
of O 0 2.747886293508195e-11
3 O 0 6.792404860789247e-09
- O 0 1.4018528418091591e-05
UTR O 0 4.789258582604816e-06
. O 0 1.0246627990539992e-09

We O 0 6.57150920346794e-08
have O 0 6.892957038484582e-11
established O 0 8.284013123908973e-13
the O 0 1.5800637979002802e-13
genomic O 0 3.8113617817359113e-10
organization O 0 5.208190129168955e-11
of O 0 1.9238215621247834e-12
UBE3A O 0 2.0329318886069814e-06
and O 0 5.182671132530903e-12
the O 0 1.2371555704524233e-14
sequence O 0 7.168299157381264e-13
of O 0 1.8973655112330956e-12
intron O 0 4.4065855036024e-06
- O 0 3.35174918291159e-05
exon O 0 9.705375305202324e-06
borders O 0 3.882819328282494e-07
. O 0 2.1408745887185887e-09

We O 0 2.3139320148857223e-07
have O 0 1.0280298834430823e-09
also O 0 5.095309157238104e-12
mapped O 0 7.4371948599605275e-09
two O 0 3.0242263554525195e-11
highly O 0 9.04527008849243e-11
homologous O 0 7.594714440672945e-11
processed O 0 1.0210697176660233e-08
pseudogenes O 0 1.0309051390322566e-08
, O 0 1.4599425834926905e-11
UBE3AP1 O 0 5.583078745985404e-07
and O 0 5.87230125637106e-11
UBE3AP2 O 0 3.1550663948110014e-07
, O 0 9.376494806284663e-13
to O 0 4.978698117837077e-13
chromosomes O 0 5.616855869305937e-09
2 O 0 5.130042168843829e-09
and O 0 1.2480229072409088e-09
21 O 0 4.835313482942638e-09
, O 0 4.309174544969707e-12
respectively O 0 1.679311134594741e-10
, O 0 1.2220027073572837e-11
and O 0 2.0139619139047937e-11
determined O 0 1.0879300238464396e-10
their O 0 8.154060759935078e-12
genomic O 0 7.067618934541997e-09
organization O 0 4.722565449810645e-09
. O 0 2.5816279669577114e-10

These O 0 1.8196452122865026e-09
results O 0 5.6383773205936905e-09
will O 0 3.2492911139492264e-10
form O 0 3.048897505991688e-12
the O 0 1.8050136038616493e-12
basis O 0 3.522331037952853e-11
for O 0 2.4685214809749834e-12
studies O 0 2.301247300356968e-13
of O 0 1.577362643712804e-13
mutation O 0 1.518559167301703e-09
and O 0 6.140963432210711e-11
imprinting O 0 2.502460461073497e-07
of O 0 2.6667001939983948e-09
UBE3A O 0 0.001886847079731524
. O 0 5.443410167060847e-09

Mutation O 0 1.9031131159863435e-05
spectrum O 0 4.540223983440228e-07
and O 0 5.4512336866707756e-09
genotype O 0 1.021394950839749e-06
- O 0 2.3510428945883177e-05
phenotype O 0 7.848609584470978e-07
analyses O 0 2.144095923028999e-08
in O 0 1.318293030294626e-09
Cowden B-Disease 0 0.15336212515830994
disease I-Disease 0 0.16821828484535217
and O 0 4.6396419151051305e-08
Bannayan B-Disease 0 0.3313581347465515
- I-Disease 1 0.9999567270278931
Zonana I-Disease 1 0.9999676942825317
syndrome I-Disease 1 0.9999954700469971
, O 0 5.931470314912701e-10
two O 0 2.6511004502793867e-09
hamartoma B-Disease 0 0.128263458609581
syndromes I-Disease 0 0.002965201623737812
with O 0 4.067651548922413e-09
germline O 0 0.0004502305528149009
PTEN O 0 0.20985735952854156
mutation O 0 0.00015387049643322825
. O 0 2.8157227660585704e-08

The O 0 2.4384419816669833e-07
tumour B-Disease 1 0.9999663829803467
suppressor O 0 0.00015240850916597992
gene O 0 3.993224891019054e-05
PTEN O 0 0.003340743714943528
, O 0 9.187221816642221e-11
which O 0 1.1304172658696543e-12
maps O 0 2.456782333126739e-09
to O 0 1.6180340400850923e-09
10q23 O 0 1.0911594472418074e-06
. O 0 1.1523276777225533e-09

3 O 0 1.990137121765656e-08
and O 0 1.2751442263203572e-11
encodes O 0 4.316901350276403e-11
a O 0 8.485126663793086e-12
403 O 0 1.485850331661709e-10
amino O 0 1.2043258612592922e-09
acid O 0 4.790269514387546e-09
dual O 0 3.145878793020529e-07
specificity O 0 2.1044484128651675e-06
phosphatase O 1 0.8503041863441467
( O 0 2.0966970382119143e-09
protein O 0 1.1300642910327952e-07
tyrosine O 0 1.0688194151953212e-06
phosphatase O 0 0.0022644924465566874
; O 0 4.807227393932578e-10
PTPase O 0 4.7148631665550056e-07
) O 0 1.8958976749638978e-11
, O 0 1.8729228237757134e-12
was O 0 2.3408823768278353e-09
shown O 0 9.053283678284174e-10
recently O 0 2.036108170955231e-08
to O 0 3.9842500826337e-11
play O 0 1.4695042960255478e-09
a O 0 6.904944671592972e-11
broad O 0 4.622785709784694e-09
role O 0 3.724119679304749e-08
in O 0 2.6610474240795767e-11
human O 0 8.338291834775191e-09
malignancy B-Disease 0 2.0125949959037825e-05
. O 0 2.036145918538068e-09

Somatic O 0 0.00032494193874299526
PTEN O 0 0.0026025315746665
deletions O 0 4.361935225460911e-06
and O 0 4.035327183515847e-09
mutations O 0 2.121045667990984e-07
were O 0 5.550864212722217e-10
observed O 0 9.775835696501645e-10
in O 0 5.087833626626903e-11
sporadic B-Disease 0 3.32727449858794e-06
breast I-Disease 1 0.85677570104599
, I-Disease 0 3.516490210131451e-07
brain I-Disease 0 0.2661760747432709
, I-Disease 0 3.559577237410849e-07
prostate I-Disease 1 0.977784276008606
and I-Disease 0 2.4811810362734832e-05
kidney I-Disease 0 0.003752973861992359
cancer I-Disease 0 1.421825231773255e-06
cell O 0 2.872238383133663e-06
lines O 0 1.3408282939053606e-05
and O 0 1.196633014899362e-08
in O 0 1.0800047488268572e-11
several O 0 4.7434139949231735e-11
primary O 0 9.308320159107097e-07
tumours B-Disease 1 0.9999984502792358
such O 0 4.702790157296022e-09
as O 0 2.032478278124472e-06
endometrial B-Disease 1 0.996459424495697
carcinomas I-Disease 1 0.9999998807907104
, O 1 0.8804325461387634
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999022483825684
thyroid B-Disease 1 0.9999974966049194
tumours I-Disease 1 0.9999990463256836
. O 0 1.1268716662016232e-06

In O 0 1.1981624581380856e-09
addition O 0 4.4659739795172015e-10
, O 0 1.776085008231565e-11
PTEN O 0 4.74305034003919e-06
was O 0 8.001791229617083e-09
identified O 0 6.51345199997877e-10
as O 0 7.05710143100724e-12
the O 0 9.848247434565693e-13
susceptibility O 0 2.621033834415698e-09
gene O 0 1.4358191302576984e-09
for O 0 5.070621145186749e-10
two O 0 4.925674375044764e-07
hamartoma B-Disease 1 0.9974034428596497
syndromes I-Disease 1 0.9987609386444092
Cowden B-Disease 1 0.9889109134674072
disease I-Disease 1 0.9941288232803345
( O 0 3.1463807115272857e-09
CD B-Disease 0 1.0325509720132686e-05
; O 0 8.170450982447619e-09
MIM O 0 0.00014001633098814636
158350 O 0 6.788339987906511e-07
) O 0 3.124829214828928e-11
and O 0 1.4426537742195933e-10
Bannayan B-Disease 0 1.8657545297173783e-05
- I-Disease 0 0.0010263723088428378
Zonana I-Disease 0 0.0019874763675034046
( I-Disease 0 6.444619837786547e-10
BZS I-Disease 0 3.4201445942017017e-07
) I-Disease 0 2.5577758227396385e-12
or I-Disease 0 1.8241783084071983e-11
Ruvalcaba I-Disease 0 6.061988528927031e-07
- I-Disease 0 3.226182161597535e-05
Riley I-Disease 0 0.00021464587189257145
- I-Disease 1 0.9994165897369385
Smith I-Disease 1 0.9997498393058777
syndrome I-Disease 1 0.999937891960144
( O 0 1.8588891537163477e-09
MIM O 0 6.803832366131246e-05
153480 O 0 4.2429098812135635e-07
) O 0 1.681493694283276e-10
. O 0 1.0225108953987316e-10

Constitutive O 0 1.877578625908427e-07
DNA O 0 7.750146551188664e-07
from O 0 8.781373961319616e-10
37 O 0 3.528399350472e-09
CD B-Disease 0 2.895100408295548e-07
families O 0 1.718722608679002e-09
and O 0 1.0679707118654846e-10
seven O 0 2.2933156762494633e-10
BZS B-Disease 0 2.217434257545392e-06
families O 0 6.054849677195051e-11
was O 0 2.43682102274434e-10
screened O 0 4.348540194598627e-09
for O 0 9.714196114174456e-11
germline O 0 1.3057559726803447e-06
PTEN O 0 0.0001398463500663638
mutations O 0 3.7922404771961737e-06
. O 0 3.547097504608132e-09

PTEN O 0 0.0011581371072679758
mutations O 0 6.576187843165826e-06
were O 0 1.950519523674643e-09
identified O 0 3.222611288933308e-09
in O 0 5.138348514038826e-12
30 O 0 4.710901113647026e-11
of O 0 3.968563758866006e-12
37 O 0 4.8455458312446353e-08
( O 0 2.2646648445423523e-11
81 O 0 1.3910836926811498e-09
% O 0 2.5823247620099243e-12
) O 0 2.838129308391918e-13
CD B-Disease 0 8.173849153081392e-09
families O 0 3.614600840862181e-10
, O 0 2.5243244994310743e-12
including O 0 1.082619931203066e-11
missense O 0 4.786587055605196e-07
and O 0 1.887586309479161e-09
nonsense O 0 5.203090154282108e-07
point O 0 1.2876842703235525e-08
mutations O 0 2.4288189237609004e-08
, O 0 1.9208554018212975e-12
deletions O 0 1.130832982809693e-09
, O 0 1.379827675729306e-11
insertions O 0 1.3226837403124136e-08
, O 0 5.491384777456254e-11
a O 0 1.418278827713948e-10
deletion O 0 9.883550546874176e-07
/ O 0 7.717414405306045e-07
insertion O 0 5.055908403051035e-08
and O 0 4.560846145196251e-10
splice O 0 5.111241989652626e-06
site O 0 3.775097638936131e-07
mutations O 0 3.044782715733163e-06
. O 0 4.905251760334295e-09

These O 0 3.853487806626532e-10
mutations O 0 2.688673816919618e-07
were O 0 3.1223879037867164e-10
scattered O 0 5.3065787875006265e-11
over O 0 8.892226399659364e-10
the O 0 2.05707464950855e-11
entire O 0 7.968493087595618e-10
length O 0 1.0504141556566537e-08
of O 0 3.568217596394696e-11
PTEN O 0 1.1676900612656027e-05
, O 0 9.885326064662525e-12
with O 0 1.4503719406033788e-12
the O 0 5.133754098912702e-12
exception O 0 1.276836275598825e-10
of O 0 2.6093480674782565e-12
the O 0 1.0399849037501241e-10
first O 0 5.100725886109103e-08
, O 0 2.38464831214813e-10
fourth O 0 1.3437799850635201e-07
and O 0 9.99770377596576e-10
last O 0 3.0167859321750257e-09
exons O 0 9.010918233798293e-07
. O 0 1.928210702217825e-09

A O 0 7.34624876486123e-08
hot O 0 3.717186203289202e-08
spot O 0 5.79369796582796e-08
for O 0 9.425419472686158e-11
PTEN O 0 5.255866653897101e-06
mutation O 0 1.9960332053869934e-08
in O 0 7.317734092293637e-12
CD B-Disease 0 5.26156156865909e-07
was O 0 1.3863409265013615e-07
identified O 0 9.932207278851024e-10
in O 0 5.070206949599199e-13
exon O 0 8.15335710058207e-09
5 O 0 4.833319300345806e-10
that O 0 2.2472028578246483e-12
contains O 0 2.693841677503528e-12
the O 0 3.079201130185005e-11
PTPase O 0 6.85563747993001e-08
core O 0 8.520559369173952e-09
motif O 0 7.512253041852546e-10
, O 0 9.880043831678176e-13
with O 0 1.0701024484929822e-12
13 O 0 2.693606622472533e-11
of O 0 1.1858087211810697e-12
30 O 0 1.0128333727266181e-09
( O 0 7.666141159379247e-12
43 O 0 2.0521468968581758e-09
% O 0 7.878815330188138e-13
) O 0 7.140825880906296e-14
CD B-Disease 0 3.38171513014629e-09
mutations O 0 2.9616256114195494e-09
identified O 0 6.384254791491628e-10
in O 0 3.7492405013939134e-13
this O 0 2.299313734202557e-12
exon O 0 1.2038484555887408e-06
. O 0 5.4555608919315546e-09

Seven O 0 2.9098114140424514e-08
of O 0 9.67160032616654e-11
30 O 0 2.916666685948144e-09
( O 0 8.49831056221051e-12
23 O 0 1.4600547160181776e-10
% O 0 2.2000158856130825e-13
) O 0 7.252364534653458e-14
were O 0 7.409230564150993e-13
within O 0 5.62430317433988e-14
the O 0 1.2050368515537091e-11
core O 0 1.2592826692525705e-07
motif O 0 5.1308348680834115e-09
, O 0 2.594756657800512e-12
the O 0 8.993754634263607e-13
majority O 0 8.037234072721944e-12
( O 0 1.2888266842647766e-12
five O 0 8.587897754042118e-12
of O 0 2.5525610271304178e-12
seven O 0 1.337799870881895e-09
) O 0 6.342662397899879e-13
of O 0 3.3161039018902994e-13
which O 0 1.6183356044141561e-10
were O 0 2.98281510602294e-10
missense O 0 1.7624853398956475e-07
mutations O 0 4.839218945562607e-07
, O 0 3.4517132208033985e-11
possibly O 0 9.944641776726826e-10
pointing O 0 2.6006935627265193e-07
to O 0 1.3484664773688593e-10
the O 0 1.7563573859180615e-11
functional O 0 8.118929833988986e-11
significance O 0 7.2081455387840165e-12
of O 0 1.331365139661811e-12
this O 0 1.7785257641622643e-11
region O 0 1.577384112216862e-09
. O 0 5.626953902826415e-10

Germline O 0 0.002479841001331806
PTEN O 0 0.003662220435217023
mutations O 0 4.12932422477752e-05
were O 0 8.674984286471954e-09
identified O 0 1.1606087646498509e-08
in O 0 4.4754941939950665e-12
four O 0 8.137440027367049e-11
of O 0 3.2950052408775576e-11
seven O 0 6.303674382479585e-08
( O 0 5.494823485108213e-10
57 O 0 5.771495992235032e-08
% O 0 4.0413002805328446e-11
) O 0 2.2495196677629892e-11
BZS B-Disease 0 1.3620499430544442e-06
families O 0 1.776485625271107e-10
studied O 0 3.674291315647338e-09
. O 0 9.033826464666106e-10

Interestingly O 0 3.1901512898002693e-07
, O 0 1.9899870640216477e-10
none O 0 4.7205791359195004e-11
of O 0 3.0757346539470043e-13
these O 0 2.318722470973089e-12
mutations O 0 3.086485023118257e-08
was O 0 1.0885418078032671e-07
observed O 0 1.3267055232191183e-09
in O 0 4.185631008457591e-12
the O 0 1.2528328374727948e-10
PTPase O 0 1.0082090739160776e-05
core O 0 8.635892072561546e-07
motif O 0 2.6206959091723547e-07
. O 0 1.2872956034470917e-09

It O 0 4.309534507029866e-09
is O 0 5.439089734160518e-10
also O 0 2.4095095710330305e-11
worthy O 0 1.0399725351717404e-11
of O 0 3.7971726457586286e-12
note O 0 1.651275449709999e-09
that O 0 4.820554112133779e-12
a O 0 1.600466287277058e-11
single O 0 5.3573825375963224e-09
nonsense O 0 2.908325029693515e-07
point O 0 3.6003524606087467e-09
mutation O 0 6.304802457890446e-09
, O 0 7.395271027499373e-12
R233X O 0 5.893107113408291e-10
, O 0 7.809413705983648e-12
was O 0 1.6077742470699263e-09
observed O 0 1.4879829313141357e-10
in O 0 2.373576866738364e-13
the O 0 2.6298272370536835e-13
germline O 0 6.75962508189798e-10
DNA O 0 3.542711013437838e-08
from O 0 3.3995087994620476e-11
two O 0 6.650379465872325e-12
unrelated O 0 2.297708245890817e-09
CD B-Disease 0 5.405779575085035e-06
families O 0 1.13381837252291e-08
and O 0 1.84888582221987e-09
one O 0 4.5982946339506725e-09
BZS B-Disease 0 6.90924352966249e-05
family O 0 1.474879507412652e-08
. O 0 4.184246005234371e-10

Genotype O 0 0.00013786611089017242
- O 0 0.0001092220118152909
phenotype O 0 2.9346028895815834e-06
studies O 0 2.6207740422279358e-09
were O 0 2.603733895156779e-09
not O 0 2.058817526184864e-11
performed O 0 3.0971028519566346e-10
on O 0 7.278566638291295e-11
this O 0 2.4196391960364105e-13
small O 0 3.0673366624434095e-11
group O 0 6.242942274248264e-11
of O 0 3.3966052193079577e-11
BZS B-Disease 0 2.8590508009074256e-05
families O 0 1.9322017319467477e-09
. O 0 2.2115848041792674e-10

However O 0 3.6094218724969096e-09
, O 0 4.678656073675569e-11
genotype O 0 3.509902413156851e-08
- O 0 2.690587052711635e-06
phenotype O 0 1.6237457600709604e-07
analysis O 0 2.9475694107716777e-10
inthe O 0 6.891111752338475e-07
group O 0 1.3828853617781078e-09
of O 0 3.6451154594718815e-12
CD B-Disease 0 9.218582022185728e-07
families O 0 5.315191620169912e-10
revealed O 0 4.765273065032716e-09
two O 0 1.0853138700250842e-11
possible O 0 3.712838925196138e-10
associations O 0 1.9629119510367055e-11
worthy O 0 2.9483436525534756e-11
of O 0 6.483854794216148e-13
follow O 0 2.5451436097556623e-11
- O 0 6.020425757924386e-08
up O 0 1.0765943692092605e-08
in O 0 8.760048350771321e-13
independent O 0 1.7490162096400752e-11
analyses O 0 3.910054502398452e-09
. O 0 7.141276459066148e-10

The O 0 1.0405012407233016e-09
first O 0 1.2407654459423156e-08
was O 0 3.70907713431734e-08
an O 0 8.676778739946656e-11
association O 0 3.9642855664823173e-10
noted O 0 9.676605072783673e-10
in O 0 1.3557970935176855e-12
the O 0 1.0643504307072948e-11
group O 0 3.4970203816042655e-11
of O 0 1.4372746699395367e-12
CD B-Disease 0 2.6354985038778977e-06
families O 0 5.377960743402355e-09
with O 0 1.1596011972869746e-07
breast B-Disease 0 0.3654933571815491
disease I-Disease 0 0.0017291286494582891
. O 0 4.762274574687808e-09

A O 0 1.4468823472668646e-08
correlation O 0 6.426851228980013e-08
was O 0 1.4161453520955547e-07
observed O 0 1.3305169188626564e-09
between O 0 7.920590572307873e-11
the O 0 4.477146708925517e-10
presence O 0 3.74406887715395e-08
/ O 0 6.267719498964652e-08
absence O 0 9.60820756290559e-10
of O 0 9.231512039173384e-13
a O 0 5.857638818440591e-10
PTEN O 0 4.776756759383716e-05
mutation O 0 5.244012868388381e-08
and O 0 9.489202479340264e-11
the O 0 1.2146641331645114e-11
type O 0 2.7562794002733426e-07
of O 0 4.206268666706592e-09
breast O 0 0.02307487651705742
involvement O 0 1.6501622667419724e-05
( O 0 3.2295766061452014e-09
unaffected O 0 2.294165824423544e-06
versus O 0 7.5925825512968e-05
benign O 0 0.32412683963775635
versus O 0 0.03769886866211891
malignant O 1 0.9389414191246033
) O 0 4.660304586678876e-09
. O 0 8.279823493495542e-10

Specifically O 0 2.3220023237513487e-08
and O 0 1.7030279964025397e-11
more O 0 1.9990724299447787e-13
directly O 0 1.8985538835503135e-11
, O 0 2.008043384349456e-11
an O 0 2.2150423162337063e-10
association O 0 4.549067789128003e-09
was O 0 2.1019029645685805e-06
also O 0 4.270552800278438e-09
observed O 0 3.0046043431042335e-10
between O 0 1.4222846858591431e-11
the O 0 1.2533220988819593e-11
presence O 0 1.4100735856725777e-10
of O 0 1.3361096083686075e-12
a O 0 5.969950311879302e-09
PTEN O 0 0.03493547439575195
mutation O 0 0.00021880523127038032
and O 0 1.0394194760010578e-05
malignant B-Disease 1 0.9999301433563232
breast I-Disease 1 0.9999595880508423
disease I-Disease 1 0.9957475066184998
. O 0 6.741657188058525e-08

Secondly O 0 0.0002149764623027295
, O 0 1.7591788026294353e-09
there O 0 5.483775239456534e-11
appeared O 0 2.546010513526653e-09
to O 0 7.052472321411596e-12
be O 0 2.048298058943132e-10
an O 0 3.2219457657411965e-10
interdependent O 0 0.03604404255747795
association O 0 6.157859111510788e-09
between O 0 7.980108934768637e-11
mutations O 0 2.009640454048167e-08
upstream O 0 3.389607883264034e-08
and O 0 1.471840149758208e-10
within O 0 2.4122674344151385e-12
the O 0 4.488199048524599e-11
PTPase O 0 6.649783017564914e-07
core O 0 1.0119692461785235e-07
motif O 0 1.4838295925301281e-08
, O 0 2.590019778508923e-12
the O 0 6.220886436189565e-13
core O 0 3.41462125241776e-09
motif O 0 1.6334131269779562e-10
containing O 0 3.688450239680563e-11
the O 0 1.5350920404624824e-12
majority O 0 1.3523956260419467e-12
of O 0 1.2074244598939132e-12
missense O 0 3.9884540115053824e-07
mutations O 0 9.604511888028355e-07
, O 0 1.2080014766269187e-10
and O 0 1.4634946032821006e-11
the O 0 3.1984610272817182e-12
involvement O 0 6.354069714831212e-09
of O 0 9.10019108679716e-12
all O 0 1.3143480748212255e-10
major O 0 4.517215046462297e-09
organ O 0 5.434801551018609e-07
systems O 0 1.8187566297456215e-07
( O 0 1.2761301737551634e-10
central O 0 4.2736306160584547e-10
nervous O 0 4.766257291066722e-07
system O 0 1.212635947211993e-08
, O 0 2.5443986917395023e-09
thyroid O 0 0.02794446051120758
, O 0 1.0954180895694776e-09
breast O 0 0.014600706286728382
, O 0 3.9425613067578524e-06
skin O 1 0.999427080154419
and O 0 0.037633832544088364
gastrointestinal O 1 0.9713322520256042
tract O 0 0.07770176976919174
) O 0 1.2098936075233269e-08
. O 0 3.7380663009400905e-09

However O 0 3.7061194113618967e-09
, O 0 1.7304432626402688e-12
these O 0 4.111266177758005e-14
observations O 0 3.921492644498592e-11
would O 0 3.760648181749815e-10
need O 0 3.2606323890904676e-11
to O 0 2.7672560423686043e-12
be O 0 1.5180769835643204e-11
confirmed O 0 6.1053623094664555e-12
by O 0 5.832620763321708e-14
studying O 0 1.502056400266849e-12
a O 0 1.149638760924998e-12
larger O 0 3.5945901203510155e-12
number O 0 4.424500696376121e-12
of O 0 1.647290377021493e-12
CD B-Disease 0 3.1649196898797527e-06
families O 0 7.545183144941348e-09
. O 0 4.809134757088884e-10

Molecular O 0 0.00022454262943938375
defects O 1 0.9995521903038025
leading O 0 2.0612942535080947e-06
to O 0 3.5204922310683173e-10
human O 0 3.038065443661253e-08
complement B-Disease 0 5.048044386057882e-06
component I-Disease 0 0.4356023371219635
C6 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999997615814209
in O 0 2.0562442026861305e-10
an O 0 6.161004484361854e-10
African O 0 6.248702000277717e-09
- O 0 6.675442364212358e-06
American O 0 4.164719769050862e-07
family O 0 2.216528116605332e-08
. O 0 6.113140549324214e-10

Complement B-Disease 0 0.008317938074469566
component I-Disease 1 0.9976512789726257
C6 I-Disease 1 0.9999991655349731
deficiency I-Disease 1 0.9999997615814209
( O 0 4.9489344178255124e-08
C6D B-Disease 0 0.00010050053970189765
) O 0 3.885926580515786e-10
was O 0 6.280464504015981e-08
diagnosed O 0 4.2158198994002305e-06
in O 0 1.2795851617869447e-12
a O 0 1.1461652460464933e-10
16 O 0 2.70776467914402e-09
- O 0 4.88989769564796e-07
year O 0 3.415033589249106e-08
- O 0 7.285240826604422e-06
old O 0 0.001837754505686462
African O 0 5.575579997696423e-09
- O 0 5.586110418676071e-08
American O 0 1.3497363227088499e-08
male O 0 1.829700657651756e-08
with O 0 7.821976844013534e-09
meningococcal B-Disease 1 0.9999798536300659
meningitis I-Disease 1 0.9999570846557617
. O 0 6.354930359719901e-09

The O 0 1.8181994576593752e-08
patients O 0 1.512484431032135e-07
father O 0 1.531796556264453e-07
and O 0 3.2991195886289404e-10
two O 0 1.3862121173158215e-10
brothers O 0 5.53232166566886e-06
also O 0 2.9486576735848757e-08
had O 0 9.602720041357315e-08
C6D B-Disease 0 1.2239894203958102e-05
, O 0 1.2434406802819264e-11
but O 0 1.5203942705516171e-12
gave O 0 6.30700908166304e-11
no O 0 5.255369750489791e-11
history O 0 1.9233135917229305e-10
of O 0 5.339316544450412e-09
meningitis B-Disease 1 0.9999978542327881
or O 0 1.5554139309870152e-08
other O 0 4.917551699179512e-09
neisserial B-Disease 0 0.00649246945977211
infection I-Disease 0 0.0013241242850199342
. O 0 1.9407411233629546e-09

By O 0 6.152147541405029e-11
using O 0 4.548524751291083e-11
exon O 0 2.0144643286812425e-08
- O 0 3.149018112935664e-08
specific O 0 3.2383446618711176e-11
polymerase O 0 8.922612693140763e-08
chain O 0 3.15136503559188e-07
reaction O 0 2.7598423546493223e-10
( O 0 6.509119957441578e-13
PCR O 0 4.716218970912678e-09
) O 0 4.1439245155976134e-13
/ O 0 1.248378744128642e-11
single O 0 8.359207770425314e-11
- O 0 8.507555548931123e-08
strand O 0 1.3842378621120588e-07
conformation O 0 4.011838328210615e-08
polymorphism O 0 3.1665692290516745e-08
as O 0 2.0437465955702727e-11
a O 0 7.633511878157861e-13
screening O 0 5.997861235451651e-11
step O 0 4.1303405140524774e-11
and O 0 4.82018159381984e-14
nucleotide O 0 1.0909502468070542e-12
sequencing O 0 6.451992586031796e-12
of O 0 6.973656678163631e-13
target O 0 5.2888604606948775e-09
exons O 0 3.190461228541608e-08
, O 0 9.001893848392672e-12
we O 0 7.02020950052451e-12
determined O 0 1.8346532626445367e-11
that O 0 4.108511274247828e-12
the O 0 5.1426356229011816e-11
proband O 0 3.6380038181960117e-06
was O 0 1.4105377310613676e-08
a O 0 7.46109597715705e-12
compound O 0 8.464145183351146e-12
heterozygote O 0 5.485200627042275e-10
for O 0 6.839216692977601e-13
two O 0 1.9064316097994194e-11
C6 O 0 5.186019916436635e-05
gene O 0 7.296925730315706e-08
mutations O 0 5.298162477629376e-07
. O 0 2.325174275341624e-09

The O 0 5.965826166409727e-10
first O 0 5.066009833853968e-10
, O 0 7.651591166224492e-12
1195delC O 0 1.1030961699631803e-09
located O 0 3.3444181452013666e-11
in O 0 5.265447908416043e-13
exon O 0 2.828048017988749e-08
7 O 0 2.3455406505945575e-08
, O 0 2.150296000286156e-12
is O 0 8.057875113681723e-13
a O 0 6.543363940958447e-13
novel O 0 8.634251646988389e-11
mutation O 0 2.379283881026595e-09
, O 0 1.9090552055844867e-11
while O 0 4.162370101368218e-11
the O 0 6.029492877202003e-12
second O 0 1.486486755908345e-08
, O 0 2.2095261384413867e-11
1936delG O 0 1.3132537279858525e-09
in O 0 4.252678125014203e-13
exon O 0 1.4059607700289689e-08
12 O 0 1.3756567440736944e-08
, O 0 2.0784587592692638e-11
has O 0 1.6042171757657542e-10
been O 0 3.8842296046226465e-10
described O 0 3.802829717791667e-10
before O 0 1.6067863706226149e-10
to O 0 6.023047338654663e-11
cause O 0 3.978404827797988e-10
C6D B-Disease 0 4.848180310546013e-07
in O 0 1.6499506838921207e-12
an O 0 1.1320317946927894e-11
unrelated O 0 2.920214114965347e-08
African O 0 3.827894445862512e-09
- O 0 2.2023984058705537e-07
American O 0 7.213575514697368e-09
individual O 0 3.0536087547439195e-10
. O 0 5.261370228382134e-10

Both O 0 2.2906643692977013e-08
mutations O 0 7.365775218204362e-06
result O 0 2.1375218040020627e-08
in O 0 2.1545884520968173e-10
premature O 0 4.2652965248635155e-07
termination O 0 1.1929587628856098e-07
codons O 0 3.4561662687337957e-07
and O 0 4.890314375671778e-09
C6 O 0 0.00011516573431435972
null O 0 1.0719420515670208e-06
alleles O 0 2.0362485031455435e-07
. O 0 5.973709082951473e-09

Allele O 0 4.921598701912444e-07
- O 0 1.4418401406146586e-07
specific O 0 1.5096059124974914e-10
PCR O 0 3.057998299027531e-07
indicated O 0 3.08661318726422e-09
that O 0 1.372367605841085e-12
the O 0 1.549671740756764e-12
probands O 0 4.007582674603327e-07
two O 0 9.89510806626015e-10
brothers O 0 5.027740826335503e-06
also O 0 1.4435305395466003e-08
inherited O 0 3.446426717346185e-07
the O 0 4.5744696225424875e-11
1195delC O 0 6.174845168516185e-08
mutation O 0 4.147159060607919e-09
from O 0 4.3683872491540043e-11
their O 0 7.137868074380549e-11
heterozygous O 0 5.8460816632077695e-08
mother O 0 6.020586340582668e-08
and O 0 1.1216080147979923e-11
the O 0 3.213252363840069e-12
1936delG O 0 5.5731479875476e-08
mutation O 0 2.1270196715050815e-09
from O 0 2.7575573768867656e-11
their O 0 9.097558123505323e-11
homozygous O 0 3.9211326452459616e-07
father O 0 2.3063151388669212e-08
. O 0 9.881518346632756e-12
. O 0 1.240158531423674e-10

PAX6 O 0 0.0025014420971274376
mutations O 0 0.00017821945948526263
reviewed O 0 4.0110758163791616e-06
. O 0 5.356741539230825e-08

Mutations O 0 5.6237659009639174e-05
in O 0 6.548680486773151e-10
PAX6 O 0 4.185777925158618e-06
are O 0 1.985625899814103e-11
responsible O 0 1.6509975331313598e-10
for O 0 4.02110914010656e-11
human O 0 2.3632788170857566e-08
aniridia B-Disease 1 0.9999997615814209
and O 0 7.020704373417175e-08
have O 0 3.3827149970022674e-09
also O 0 4.322968094605528e-10
been O 0 2.558368517036058e-10
found O 0 4.1999337341280807e-10
in O 0 3.4169958529339794e-11
patients O 0 2.989079816995144e-10
with O 0 2.4352098115798526e-09
Peters B-Disease 1 0.9999998807907104
anomaly I-Disease 1 0.9999996423721313
, O 0 7.188298809523985e-07
with O 0 4.3741129047703e-05
congenital B-Disease 1 0.9999992847442627
cataracts I-Disease 1 0.9999911785125732
, O 0 7.279215452626886e-08
with O 0 6.96228354968298e-08
autosomal B-Disease 1 0.9233400225639343
dominant I-Disease 1 0.6642640829086304
keratitis I-Disease 1 0.9954220652580261
, O 0 5.891516963174581e-08
and O 0 9.879347118157966e-09
with O 0 1.0336344047345847e-07
isolated B-Disease 0 0.03201696276664734
foveal I-Disease 1 0.9999986886978149
hypoplasia I-Disease 1 0.9999951124191284
. O 0 2.706161126297957e-07

No O 0 1.6325480967083195e-09
locus O 0 8.41011971175476e-09
other O 0 1.2223080186890556e-11
than O 0 1.4608451601172412e-11
chromosome O 0 3.3773255836422322e-06
11p13 O 0 7.70194574784e-08
has O 0 2.4488291394675343e-09
been O 0 6.410073027929286e-10
implicated O 0 8.171644481080875e-07
in O 0 2.4323689729044418e-09
aniridia B-Disease 1 0.9999997615814209
, O 0 1.6624150944721805e-09
and O 0 1.9395189621018716e-10
PAX6 O 0 1.6222796830334119e-06
is O 0 1.0722963628140292e-09
clearly O 0 1.0359585411734429e-09
the O 0 5.037234084709352e-12
major O 0 4.65987781694821e-09
, O 0 1.9025484312984453e-11
if O 0 4.8549001624431654e-11
not O 0 2.8251903854553673e-12
only O 0 1.705185471989612e-12
, O 0 9.551987022529684e-13
gene O 0 2.0929322164242592e-10
responsible O 0 3.2073685929390194e-08
. O 0 1.1936825972114207e-09

Twenty O 0 3.4363473844223336e-08
- O 0 4.913541715723113e-07
eight O 0 1.9967252296027027e-09
percent O 0 6.503003469049418e-09
of O 0 8.364270647626126e-13
identified O 0 2.456009395856995e-09
PAX6 O 0 1.4833324257779168e-06
mutations O 0 8.161000408790642e-08
are O 0 3.5162980860370396e-10
C O 0 6.9476113822020125e-06
- O 0 0.002240171190351248
T O 0 0.009866690263152122
changes O 0 3.0525487693111586e-10
at O 0 5.086555621147681e-10
CpG O 0 2.770594242917923e-08
dinucleotides O 0 1.31521886714836e-07
, O 0 2.236973627167682e-12
20 O 0 4.066923880996498e-12
% O 0 2.6284967177001364e-14
are O 0 6.831387635208765e-15
splicing O 0 8.289680053508164e-11
errors O 0 4.955778081239259e-07
, O 0 5.4908477938042655e-12
and O 0 6.766967628607512e-13
more O 0 6.858992269553194e-14
than O 0 4.2176704836971446e-12
30 O 0 2.709478474915983e-10
% O 0 4.4162186386108304e-13
are O 0 4.769428125009356e-13
deletion O 0 2.501065132776148e-09
or O 0 8.728306410965558e-10
insertion O 0 3.151137129009385e-09
events O 0 4.740650538792579e-09
. O 0 5.347041476255754e-09

There O 0 2.8215862979408257e-09
is O 0 3.2017340168000175e-11
a O 0 7.692260023395292e-11
noticeably O 0 2.039673034914813e-07
elevated O 0 1.7299074670518166e-06
level O 0 2.1061561383817207e-09
of O 0 1.6555366019049833e-12
mutation O 0 1.0902243552379787e-08
in O 0 1.2751393690946244e-11
the O 0 1.2756307295191949e-11
paired O 0 1.2457594955606055e-08
domain O 0 7.117374689613598e-09
compared O 0 3.337056853069953e-08
with O 0 6.564333798753097e-11
the O 0 8.667081809188293e-12
rest O 0 1.5234546263398485e-11
of O 0 9.851605750794967e-14
the O 0 4.29828178258318e-12
gene O 0 1.6385250933836915e-09
. O 0 2.917043551153853e-10

Increased O 0 2.014647577652795e-07
mutation O 0 1.3850976756657474e-06
in O 0 3.933673525802206e-11
the O 0 5.350318712377122e-12
homeodomain O 0 2.3978591556783613e-08
is O 0 3.558390040958592e-11
accounted O 0 3.1089590901700603e-09
for O 0 1.4700065166864396e-12
by O 0 1.506722047475706e-12
the O 0 3.13095036008626e-11
hypermutable O 0 2.438159071971313e-06
CpG O 0 8.83534525542018e-08
dinucleotide O 0 3.998706077368297e-08
in O 0 7.16653949725532e-12
codon O 0 8.780440374778209e-09
240 O 0 4.403795550445011e-09
. O 0 8.399182460649968e-10

Very O 0 8.158954623027626e-10
nearly O 0 2.2236652796880918e-10
all O 0 1.6247184153606042e-11
mutations O 0 3.678535520634796e-08
appear O 0 2.631713735823382e-09
to O 0 1.4700529682443175e-10
cause O 0 6.9150472015167e-09
loss O 0 8.885398194991012e-09
of O 0 1.715428580434386e-12
function O 0 1.2008198255197833e-11
of O 0 1.2777047215389858e-12
the O 0 2.405340336630868e-11
mutant O 0 2.345398115721764e-07
allele O 0 3.1679929790584538e-09
, O 0 1.134688436960074e-11
and O 0 5.577791375478702e-13
more O 0 1.3436959674811323e-14
than O 0 4.03681265932071e-13
80 O 0 1.230516209760335e-11
% O 0 2.1206190828956112e-13
of O 0 9.822659179092863e-13
exonic O 0 8.795358894531091e-07
substitutions O 0 6.369370808556596e-09
result O 0 2.2485771578040215e-10
in O 0 2.3301799725872208e-11
nonsense O 0 1.2293730833334848e-06
codons O 0 3.104389634245308e-07
. O 0 8.67344085442312e-10

In O 0 5.941343528270693e-10
a O 0 5.491468391127796e-11
gene O 0 9.392905342409108e-10
with O 0 1.7450178455002963e-11
such O 0 1.7042164120878445e-12
extraordinarily O 0 1.829505258399422e-08
high O 0 1.6540715463975175e-09
sequence O 0 8.106515458905506e-12
conservation O 0 2.361052759553006e-12
throughout O 0 1.0426646254290545e-13
evolution O 0 6.39004734542814e-12
, O 0 4.763266604063121e-12
there O 0 3.049920992842514e-12
are O 0 2.982493375533468e-12
presumed O 0 9.9087484883853e-09
undiscovered O 0 1.961947236850392e-05
missense O 0 2.589398263808107e-06
mutations O 0 1.4206960941010038e-06
, O 0 1.4145445231816822e-11
these O 0 3.662095854426589e-13
are O 0 1.705465087729896e-12
hypothesized O 0 9.93409660088318e-11
to O 0 7.994013437317982e-12
exist O 0 7.829044357254844e-11
in O 0 1.0835888610005728e-11
as O 0 1.87980053745207e-09
- O 0 3.0448086363321636e-06
yet O 0 3.6556830895762005e-09
unidentified O 0 4.644033424483496e-08
phenotypes O 0 6.133781482731138e-09
. O 0 1.0521309518063404e-11
. O 0 1.5977220935159409e-10

Genetic O 0 9.6591429610271e-06
heterogeneity O 0 1.8929539464807021e-06
and O 0 1.018392925544731e-09
penetrance O 0 1.631371446819685e-07
analysis O 0 1.7776856375828487e-10
of O 0 2.101916210528465e-11
the O 0 7.41796624126323e-10
BRCA1 O 0 0.005560585763305426
and O 0 1.3721721359161165e-07
BRCA2 O 0 0.00026751391123980284
genes O 0 3.827009550150251e-06
in O 0 3.603260267937003e-08
breast B-Disease 1 0.9159213900566101
cancer I-Disease 0 0.0013817916624248028
families O 0 8.140929708133626e-08
. O 0 9.636329956208556e-09

The O 0 9.938862785929814e-05
Breast B-Disease 1 0.9999954700469971
Cancer I-Disease 1 0.9999871253967285
Linkage O 0 0.06446993350982666
Consortium O 0 4.334027471486479e-05
. O 0 3.996022357455331e-08

The O 0 1.363903850970516e-10
contribution O 0 3.265301640187346e-10
of O 0 4.31013835733296e-11
BRCA1 O 0 0.0007269231136888266
and O 0 1.5544461007266364e-07
BRCA2 O 0 0.4324199855327606
to O 0 0.0003213372838217765
inherited B-Disease 1 1.0
breast I-Disease 1 0.9999998807907104
cancer I-Disease 1 1.0
was O 0 9.33991395868361e-05
assessed O 0 2.159462297868231e-07
by O 0 2.6949531148345862e-11
linkage O 0 9.135091545431351e-07
and O 0 2.12908066177242e-10
mutation O 0 3.30163757444879e-10
analysis O 0 5.97242671984688e-11
in O 0 1.2127751060353464e-11
237 O 0 4.301191403044413e-09
families O 0 5.561586260971474e-11
, O 0 6.013984340906553e-13
each O 0 7.917953944412692e-13
with O 0 1.6696427226903232e-11
at O 0 1.0802345684624015e-09
least O 0 2.41249750211614e-12
four O 0 3.0042364429494484e-11
cases O 0 6.038386679563246e-09
of O 0 2.474843796562709e-08
breast B-Disease 1 0.7901932001113892
cancer I-Disease 0 7.246450422826456e-06
, O 0 2.9980469062190762e-12
collected O 0 1.0178487219736354e-10
by O 0 1.9477572887893757e-09
the O 0 3.8875201425980777e-05
Breast B-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999946355819702
Linkage O 0 0.0004926174296997488
Consortium O 0 1.2439784313755808e-06
. O 0 1.295137863621676e-08

Families O 0 9.835112280143221e-08
were O 0 1.2599242760202856e-09
included O 0 4.004332282425693e-11
without O 0 1.7394948328974813e-11
regard O 0 4.817171835036493e-12
to O 0 3.5841482234379163e-13
the O 0 2.668242796849407e-12
occurrence O 0 9.96652573803658e-08
of O 0 2.985618507977961e-08
ovarian B-Disease 1 0.952339231967926
or I-Disease 0 1.376583895762451e-07
other I-Disease 0 2.0967942049310295e-08
cancers I-Disease 0 0.0016059123445302248
. O 0 8.257716288539996e-09

Overall O 0 0.0001626019220566377
, O 0 5.706672112637534e-08
disease O 0 0.00021562661277130246
was O 0 2.572817550117179e-07
linked O 0 4.4230432649783324e-06
to O 0 8.656830807751703e-10
BRCA1 O 0 1.1591016118472908e-05
in O 0 2.580926141207418e-12
an O 0 4.867442820327694e-12
estimated O 0 8.464412504238794e-10
52 O 0 2.0670521294618993e-08
% O 0 1.9303423876709802e-12
of O 0 2.8642888841995395e-12
families O 0 3.6963751504082154e-10
, O 0 9.420957070016556e-12
to O 0 7.993937109485039e-12
BRCA2 O 0 1.9553374386305222e-07
in O 0 7.511471479537679e-12
32 O 0 1.531789473041556e-09
% O 0 8.801230143989924e-13
of O 0 9.640096880481064e-13
families O 0 9.289367886022859e-11
, O 0 1.5556845742170644e-11
and O 0 1.267709028029973e-11
to O 0 1.1436462670974534e-12
neither O 0 2.06458235924023e-11
gene O 0 1.1478542422116433e-10
in O 0 6.468701442552405e-12
16 O 0 5.589216867107893e-10
% O 0 5.075770533047308e-13
( O 0 3.9765708629603547e-13
95 O 0 4.1483752544202446e-10
% O 0 1.2570143537171674e-10
confidence O 0 2.0570405467879027e-06
interval O 0 7.247352584727196e-08
[ O 0 3.913994017779032e-09
CI O 0 2.7825738015962997e-06
] O 0 2.7118260415015527e-10
6 O 0 2.681643518354093e-10
% O 0 3.7695059747211435e-12
- O 0 1.0978679938489222e-06
28 O 0 6.426483167842889e-08
% O 0 8.484571552280773e-13
) O 0 7.255228183641535e-14
, O 0 2.721561921680861e-14
suggesting O 0 1.2858465160692223e-11
other O 0 8.112826382911109e-12
predisposition O 0 2.3537155868780246e-07
genes O 0 4.561024979921058e-08
. O 0 1.610048316891266e-09

The O 0 3.6651990331648676e-09
majority O 0 1.820655404216609e-09
( O 0 1.3380542507324122e-10
81 O 0 1.1107516018071806e-09
% O 0 6.822279828740119e-13
) O 0 3.258998566889673e-14
of O 0 1.4562263070741488e-12
the O 0 1.0735225259850267e-06
breast B-Disease 1 0.9999986886978149
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 6.787590223211737e-08
were O 0 1.890602119303253e-09
due O 0 1.0463079708200596e-10
to O 0 3.831455291924968e-11
BRCA1 O 0 3.0072392291913275e-06
, O 0 6.102568537308395e-12
with O 0 2.6832986787378443e-12
most O 0 9.481567614377795e-11
others O 0 1.4673755543981315e-09
( O 0 2.4236090565010748e-11
14 O 0 9.479040885551626e-10
% O 0 1.377870365547318e-12
) O 0 1.7650342992725498e-12
due O 0 4.187197810701093e-11
to O 0 2.7372268340819517e-10
BRCA2 O 0 4.091420123586431e-05
. O 0 2.196808512877624e-09

Conversely O 0 3.246275355195394e-07
, O 0 2.167654077067649e-11
the O 0 1.003279815996183e-12
majority O 0 2.862912381121352e-12
of O 0 2.033208887711191e-12
families O 0 6.266061280957302e-11
with O 0 3.9661915418598426e-10
male B-Disease 0 2.68150387228161e-07
and I-Disease 0 3.8111114264438584e-08
female I-Disease 0 2.3927523216116242e-05
breast I-Disease 0 0.00022075300512369722
cancer I-Disease 0 5.9898034123762045e-06
were O 0 5.916479306478095e-09
due O 0 1.3117792407868478e-09
to O 0 1.5092267435790063e-09
BRCA2 O 0 8.140187128446996e-05
( O 0 6.177819367181314e-10
76 O 0 9.185202287653738e-08
% O 0 4.1241215303911005e-11
) O 0 4.1933199967925106e-11
. O 0 9.678852858074904e-11

The O 0 1.0178725640130892e-09
largest O 0 5.367500932607072e-08
proportion O 0 3.3304441870996015e-08
( O 0 2.1223582613583147e-10
67 O 0 7.81748799028037e-09
% O 0 3.420306572687881e-12
) O 0 1.4931834252124992e-13
of O 0 2.8524947161268077e-13
families O 0 9.098355402414882e-11
due O 0 1.0741708217354429e-10
to O 0 3.681834351287883e-12
other O 0 3.653677187187565e-12
genes O 0 5.33524169288313e-10
was O 0 1.00344109910111e-07
found O 0 3.960388461621278e-09
in O 0 1.2171851200559747e-11
families O 0 7.602667627393256e-12
with O 0 1.4176100397722546e-11
four O 0 1.3489913353037508e-10
or O 0 1.7758115811172814e-10
five O 0 5.5403476945103947e-11
cases O 0 4.63456939492346e-10
of O 0 1.1801853938564477e-09
female O 0 0.008343602530658245
breast B-Disease 0 0.02928129769861698
cancer I-Disease 0 5.1560682550189085e-06
only O 0 1.6776311451138781e-09
. O 0 3.494296851869194e-09

These O 0 8.177084703797632e-11
estimates O 0 9.33434329830618e-10
were O 0 1.1309921055246974e-10
not O 0 3.3847685938781513e-12
substantially O 0 1.0080883905416727e-09
affected O 0 3.8908713057006494e-11
either O 0 6.839034547012623e-13
by O 0 1.95600317626915e-13
changing O 0 9.445215443104615e-11
the O 0 5.335216209795268e-12
assumed O 0 7.056220052703566e-10
penetrance O 0 6.299633703577001e-09
model O 0 1.088034817797734e-08
for O 0 3.4092637046789775e-10
BRCA1 O 0 6.309463515208336e-06
or O 0 2.529985942967272e-10
by O 0 1.0260562365027592e-11
including O 0 1.2698368745400757e-10
or O 0 1.8519317190879292e-09
excluding O 0 5.693689786312461e-07
BRCA1 O 0 1.2779464668710716e-05
mutation O 0 4.918117113561493e-08
data O 0 8.582770192333555e-07
. O 0 1.0739691802541529e-08

Among O 0 1.7773484017880037e-08
those O 0 2.206579363672745e-10
families O 0 2.5099525235994236e-10
with O 0 2.709211077700502e-09
disease O 0 0.00012871884973719716
due O 0 8.758023195554188e-10
to O 0 1.1010355821516882e-10
BRCA1 O 0 1.028735550789861e-05
that O 0 4.487568372457673e-10
were O 0 3.701991768689794e-10
tested O 0 4.3627963464132336e-09
by O 0 1.3991275314966661e-13
one O 0 1.7499030653331249e-12
of O 0 1.165134883105573e-13
the O 0 1.0352123889015297e-12
standard O 0 7.747846114680712e-11
screening O 0 1.2824418610390964e-11
methods O 0 3.4791286605134752e-12
, O 0 1.2551223081691543e-13
mutations O 0 1.595063144066433e-11
were O 0 8.977545269683862e-12
detected O 0 7.350815067752592e-09
in O 0 3.761388444635527e-13
the O 0 3.230791502384367e-12
coding O 0 2.1317646314855665e-08
sequence O 0 5.317138396243593e-10
or O 0 1.5412723874952405e-10
splice O 0 5.275825998296568e-08
sites O 0 2.294432421834358e-09
in O 0 1.2258399590542313e-12
an O 0 1.5221614116725513e-12
estimated O 0 9.148197754882403e-10
63 O 0 2.7547701009211778e-08
% O 0 4.098415183617643e-12
( O 0 4.739050406439571e-13
95 O 0 7.028411880272145e-11
% O 0 7.954787002717456e-12
CI O 0 3.340124976602965e-06
51 O 0 1.1718999104459726e-08
% O 0 2.068583325465223e-11
- O 0 1.3766340316578862e-06
77 O 0 1.2714988883999467e-07
% O 0 5.848626444260319e-11
) O 0 1.2008907757099507e-11
. O 0 6.507177435777223e-11

The O 0 2.380885211206163e-10
estimated O 0 2.9727975636717474e-09
sensitivity O 0 3.17521586801206e-09
was O 0 9.955268831518538e-10
identical O 0 2.3127078377371824e-11
for O 0 1.185263231963038e-13
direct O 0 1.5929515735993438e-13
sequencing O 0 1.6940872316073552e-10
and O 0 7.135713894768081e-12
other O 0 5.122317500716456e-13
techniques O 0 1.5158997390685158e-09
. O 0 3.764164258068803e-10

The O 0 2.2322714787748055e-09
penetrance O 0 7.030666893115267e-06
of O 0 1.0592197119407842e-09
BRCA2 O 0 4.880060441792011e-05
was O 0 3.284504446199321e-09
estimated O 0 6.322205779729639e-12
by O 0 3.5613059810174486e-13
maximizing O 0 3.9131115014967577e-10
the O 0 4.242474427318399e-11
LOD O 0 3.447650669841096e-06
score O 0 1.3096848938687344e-08
in O 0 5.886105491903493e-11
BRCA2 O 0 1.001655800791923e-05
- O 0 1.6403497284045443e-05
mutation O 0 2.1610046587738907e-06
families O 0 1.2074492516944701e-09
, O 0 2.4644661311690186e-12
over O 0 1.1648204970016174e-11
all O 0 8.610203695857965e-12
possible O 0 2.9098862208698506e-10
penetrance O 0 9.612962230676203e-07
functions O 0 2.659730879983613e-09
. O 0 1.5724936908156906e-09

The O 0 6.336792895966781e-11
estimated O 0 1.3731125958482693e-10
cumulative O 0 2.242360608306626e-08
risk O 0 4.929395799990743e-06
of O 0 3.143933113847197e-09
breast B-Disease 0 0.4464584290981293
cancer I-Disease 0 0.00032709212973713875
reached O 0 1.0281088407282368e-06
28 O 0 2.51812679152863e-07
% O 0 6.7079102689104886e-12
( O 0 6.63876668482305e-13
95 O 0 6.28088692167239e-11
% O 0 7.074135548179594e-12
CI O 0 2.7171618057764135e-06
9 O 0 2.6721278523211822e-09
% O 0 1.207456660698436e-12
- O 0 3.9151309749740903e-08
44 O 0 3.951635463295133e-09
% O 0 1.4785653983714203e-13
) O 0 6.060405964640166e-15
by O 0 2.5481561508728344e-14
age O 0 1.5510743731073084e-11
50 O 0 1.053263379291458e-11
years O 0 5.197373781351544e-11
and O 0 8.778153898214569e-11
84 O 0 1.3174812352190202e-09
% O 0 4.5298283895579827e-13
( O 0 1.5563714054513123e-13
95 O 0 1.7863452037025773e-11
% O 0 5.8484449921847315e-12
CI O 0 9.157962495009997e-07
43 O 0 1.1823303447400235e-09
% O 0 2.370682426408588e-12
- O 0 3.9454388200965695e-08
95 O 0 5.285532900245471e-09
% O 0 2.4517792310274622e-12
) O 0 3.351648047099885e-14
by O 0 1.5546476595223319e-13
age O 0 2.1374460534850925e-10
70 O 0 6.404912711310828e-11
years O 0 1.6142108483219175e-10
. O 0 6.088805848403211e-11

The O 0 1.5626090998921427e-06
corresponding O 1 0.5217777490615845
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999997615814209
risks O 1 0.9833712577819824
were O 0 9.016223856406214e-08
0 O 0 1.3603665749428728e-08
. O 0 8.421094932486994e-10

4 O 0 4.4812861688114936e-07
% O 0 2.90753365828067e-10
( O 0 6.860883389192551e-12
95 O 0 1.8278152602579922e-10
% O 0 2.8967162002402347e-11
CI O 0 9.689427997727762e-07
0 O 0 1.0369701625156935e-10
% O 0 8.385579557124156e-13
- O 0 1.3880603333404906e-08
1 O 0 3.147189453489574e-10
% O 0 6.361135441090501e-14
) O 0 2.7646403656639675e-15
by O 0 1.574578514177815e-14
age O 0 3.983718216415966e-11
50 O 0 1.3006514268387726e-11
years O 0 6.852490103126385e-11
and O 0 8.596588024767371e-11
27 O 0 5.057359531157601e-10
% O 0 8.067451464895473e-14
( O 0 4.8744337152782993e-14
95 O 0 1.3941209298096169e-11
% O 0 2.5238045160691502e-12
CI O 0 8.609939072812267e-07
0 O 0 1.2923752346072348e-10
% O 0 1.181480802948942e-12
- O 0 1.24666797773898e-07
47 O 0 1.3237468010629527e-07
% O 0 9.439190965312982e-13
) O 0 1.9732769224504142e-14
by O 0 8.944413135494877e-14
age O 0 9.346685231337304e-11
70 O 0 5.772400960002422e-11
years O 0 2.681142252658475e-10
. O 0 8.508792281869404e-11

The O 0 1.772675450872896e-09
lifetime O 0 7.22327058610972e-07
risk O 0 1.2428979061951395e-05
of O 0 2.1680448547556352e-09
breast B-Disease 0 0.44383805990219116
cancer I-Disease 0 6.22739753453061e-05
appears O 0 5.970997918325338e-09
similar O 0 4.2208250783382084e-12
to O 0 2.1989063347938043e-11
the O 0 4.2416511969456394e-10
risk O 0 2.690089502266346e-07
in O 0 1.2960756079483104e-10
BRCA1 O 0 9.512530596111901e-06
carriers O 0 7.160636528169562e-08
, O 0 1.3137734823642777e-11
but O 0 1.4040023484096498e-11
there O 0 1.752141487454395e-11
was O 0 7.062390672274432e-09
some O 0 1.906062520274851e-13
suggestion O 0 2.4989454949775336e-11
of O 0 4.726277420645519e-13
a O 0 1.0509506598310736e-09
lower O 0 1.1474064649519278e-06
risk O 0 9.211603924086376e-07
in O 0 4.409237558400392e-11
BRCA2 O 0 4.863518370257225e-07
carriers O 0 1.2264544935192134e-09
< O 0 3.492282851791373e-10
50 O 0 7.144678598747234e-11
years O 0 6.772669230992179e-11
of O 0 8.21130750200405e-12
age O 0 2.9962521352899785e-08
. O 0 7.91292420476708e-10

Eye B-Disease 1 0.9944806098937988
movement I-Disease 0 1.3131428204360418e-05
abnormalities I-Disease 0 0.29061663150787354
correlate O 0 2.289941960498254e-07
with O 0 2.3866162379704292e-08
genotype O 0 0.00016838264127727598
in O 0 7.409432356553225e-08
autosomal O 1 0.9995835423469543
dominant O 1 0.9985709190368652
cerebellar B-Disease 1 0.9978858828544617
ataxia I-Disease 1 0.9999312162399292
type I-Disease 1 0.9977142810821533
I I-Disease 0 0.20851483941078186
. O 0 2.827719036702092e-08

We O 0 3.2544175354587423e-08
compared O 0 9.454853255874696e-08
horizontal O 0 0.0001025223100441508
eye O 1 0.9326223731040955
movements O 0 2.979019882332068e-06
( O 0 1.4797299496827065e-10
visually O 0 1.1136797262167875e-08
guided O 0 1.2704309426680993e-07
saccades O 0 1.1321033525746316e-05
, O 0 2.7785293510440567e-10
antisaccades O 0 2.925287958532863e-07
, O 0 1.184532073122968e-11
and O 0 1.2680903419340361e-12
smooth O 0 5.473962602642324e-11
pursuit O 0 5.263078861617032e-09
) O 0 8.794405308154563e-12
in O 0 9.029437354063363e-13
control O 0 7.803911961090648e-10
subjects O 0 7.451592232143867e-09
( O 0 3.701339928996461e-11
n O 0 2.846527138444799e-07
= O 0 1.623905205860865e-07
14 O 0 5.16750731094362e-09
) O 0 4.042153764483025e-12
and O 0 2.8402662166637782e-11
patients O 0 6.3950706709337e-12
with O 0 2.618934799927808e-13
three O 0 1.696026305508802e-11
forms O 0 7.425809411820694e-10
of O 0 2.295510448391269e-08
autosomal O 1 0.9737961292266846
dominant O 0 0.2858910858631134
cerebellar B-Disease 0 0.005505294073373079
ataxias I-Disease 0 0.1046023741364479
type I-Disease 0 0.012977255508303642
I I-Disease 0 0.00040096297743730247
spinocerebellar B-Disease 0 0.0008769645937718451
ataxias I-Disease 0 3.5590001061791554e-05
1 I-Disease 0 2.995839354369423e-09
and I-Disease 0 5.6759971722719627e-11
2 I-Disease 0 1.8950273295015307e-10
( O 0 1.3101469778856178e-12
SCA1 B-Disease 0 1.0235758196586175e-07
, O 0 7.177373279043664e-12
n O 0 2.6123212037987287e-08
= O 0 1.547675232416168e-08
11 O 0 7.626829168216887e-10
; O 0 2.9266092587548753e-12
SCA2 B-Disease 0 1.7135035079718364e-07
, O 0 8.525553527038987e-12
n O 0 1.750113476362003e-08
= O 0 1.3843190593831878e-08
10 O 0 2.579029489968576e-10
) O 0 3.215631103406502e-12
and O 0 3.647824264874089e-10
SCA3 B-Disease 1 0.9999942779541016
/ O 0 9.68347876550979e-07
Machado B-Disease 0 1.8622705511006643e-06
- I-Disease 0 2.6894047550740652e-05
Joseph I-Disease 0 6.421603029593825e-05
disease I-Disease 0 0.004530646372586489
( O 0 1.370319080429283e-09
MJD B-Disease 1 0.999994158744812
) O 0 2.26098445521572e-10
( O 0 1.1345607613122421e-11
n O 0 2.8566734044943587e-07
= O 0 1.7647070649218222e-07
16 O 0 1.451957443165952e-09
) O 0 2.4741224693980435e-11
. O 0 8.98220872680433e-11

In O 0 3.4757050570988213e-09
SCA1 B-Disease 0 1.4828486882834113e-06
, O 0 4.523157022540136e-12
saccade O 0 7.559224912689899e-10
amplitude O 0 8.547994950758309e-11
was O 0 1.6405015124121292e-09
significantly O 0 3.289468419875874e-10
increased O 0 8.368731402308427e-11
, O 0 4.13180178005651e-13
resulting O 0 1.2330607021548978e-11
in O 0 1.9320670063827095e-11
hypermetria B-Disease 0 1.0429324902361259e-05
. O 0 6.851513800754105e-10

The O 0 8.728638367649921e-10
smooth O 0 5.243720568870458e-09
pursuit O 0 1.1442719483056862e-07
gain O 0 6.293091132647533e-07
was O 0 2.637137583860749e-07
decreased O 0 1.0844205462490208e-06
. O 0 5.215668452684952e-10

In O 0 1.974720387210027e-09
SCA2 B-Disease 0 1.1378346016499563e-06
, O 0 5.8151638886172474e-12
saccade O 0 2.881977101409916e-09
velocity O 0 8.652064842351592e-09
was O 0 2.308181201726711e-08
markedly O 0 1.5773254347095644e-07
decreased O 0 9.223207371178432e-07
. O 0 8.774676540923565e-10

The O 0 3.2686539586102015e-10
percentage O 0 2.345983673990304e-08
of O 0 1.1024682035343236e-11
errors O 0 5.863317369403376e-07
in O 0 2.118709027665311e-11
antisaccades O 0 4.1574259057597374e-07
was O 0 1.185239106860081e-08
greatly O 0 8.087214925511788e-11
increased O 0 2.1584301013177765e-10
and O 0 2.6955802173711518e-11
was O 0 3.3403158017364376e-09
significantly O 0 2.0838264447320398e-10
correlated O 0 1.0074944212234982e-09
with O 0 6.151869014203726e-10
age O 0 1.740775985581422e-07
at O 0 1.4659700582342339e-06
disease O 0 6.83100224705413e-05
onset O 0 3.69939493793936e-06
. O 0 3.022124550611238e-09

In O 0 1.507198588157621e-09
addition O 0 1.3811239651939644e-10
, O 0 4.822234733921349e-13
a O 0 7.668945231457946e-13
correlation O 0 9.533108746850871e-10
between O 0 1.1994080728605638e-10
smooth O 0 4.491818028640182e-09
pursuit O 0 3.639738466176823e-08
gain O 0 1.5197036873360048e-06
and O 0 4.836381295447723e-10
the O 0 1.449904432626603e-12
number O 0 2.363275200534254e-11
of O 0 1.808767545463663e-11
trinucleotide O 0 6.596626917598769e-06
repeats O 0 7.64294782129582e-07
was O 0 4.3251660031273786e-08
found O 0 1.1266176880297962e-09
. O 0 1.1044154479833423e-10

In O 0 1.785967072009953e-07
SCA3 B-Disease 1 0.9999532699584961
, O 0 6.737772118015073e-09
gaze B-Disease 0 0.0002415690541965887
- I-Disease 0 0.00034768550540320575
evoked I-Disease 0 1.509086177975405e-05
nystagmus I-Disease 0 0.0002521566639188677
was O 0 2.1215817014308413e-07
often O 0 6.711919908752861e-11
present O 0 5.4537420586531216e-12
as O 0 5.692313634342305e-11
was O 0 1.5338914582940788e-09
saccade O 0 5.410638159730752e-09
hypometria O 0 2.875780182876042e-07
and O 0 6.687955744766327e-12
smooth O 0 1.1196571447769088e-10
pursuit O 0 5.260780699956058e-09
gain O 0 3.329104458771326e-07
was O 0 3.481944474970078e-07
markedly O 0 2.7606515118350217e-07
decreased O 0 6.032046826476289e-07
. O 0 6.170647881553748e-10

Three O 0 5.7422191446221404e-09
major O 0 2.095385864819832e-09
criteria O 0 2.6592425483862314e-10
, O 0 4.831763786815324e-13
saccade O 0 1.404543981120554e-10
amplitude O 0 1.1362607035825256e-11
, O 0 4.756972268350756e-13
saccade O 0 2.3902310686274575e-10
velocity O 0 2.975055313214625e-09
, O 0 5.068266119290232e-12
and O 0 1.86348354282162e-12
presence O 0 1.3626965875146446e-11
of O 0 3.643203794201355e-12
gaze B-Disease 0 0.005765634123235941
- I-Disease 0 0.0003900191222783178
evoked I-Disease 0 2.4258295070467284e-06
nystagmus I-Disease 0 4.743756107927766e-06
, O 0 4.59193317051132e-12
permitted O 0 1.6384600924276849e-12
the O 0 1.0670487388640681e-13
correct O 0 6.847499650630695e-11
assignment O 0 1.0823170137896909e-10
of O 0 1.1107747480056801e-13
90 O 0 3.187602308843407e-12
% O 0 7.253374197926585e-14
of O 0 1.6217508293312616e-13
the O 0 6.473888786162618e-11
SCA1 B-Disease 0 4.049114068038762e-06
, O 0 2.542813182238035e-12
90 O 0 2.725137010581996e-13
% O 0 1.6689906699512633e-14
of O 0 3.365452651261057e-14
the O 0 5.896263338689423e-11
SCA2 B-Disease 0 2.9442537197610363e-05
, O 0 1.8410118915457296e-11
and O 0 4.797970614561775e-12
93 O 0 2.8346483146868273e-11
% O 0 6.886178639028268e-14
of O 0 1.6405357161717454e-13
the O 0 9.442261555969722e-11
patients O 0 9.511241794157854e-10
with O 0 4.4167311474829773e-10
SCA3 B-Disease 1 0.9999994039535522
to O 0 1.5134633823965515e-10
their O 0 7.128761990438104e-12
genetically O 0 2.3115900305015202e-09
confirmed O 0 7.848514615993452e-10
patient O 0 2.329835657732815e-09
group O 0 6.418266612628898e-11
and O 0 3.86671111796133e-10
, O 0 6.636922348507435e-12
therefore O 0 3.4698906074825953e-12
, O 0 3.293043138521967e-12
may O 0 2.0470482253731603e-10
help O 0 1.8958034794791523e-11
orient O 0 8.996654976556329e-09
diagnoses O 0 1.589052232020549e-07
of O 0 7.099470317184498e-11
SCA1 B-Disease 0 3.539133467711508e-05
, O 0 7.115059930118406e-11
SCA2 B-Disease 0 8.614406965534727e-07
, O 0 3.37280307849408e-11
and O 0 3.454626307242137e-10
SCA3 B-Disease 1 0.9999979734420776
at O 0 1.2883083932990758e-08
early O 0 1.829596717184412e-11
clinical O 0 1.4188848707075152e-10
stages O 0 1.1478257233576983e-10
of O 0 9.066269436586172e-12
the O 0 3.398073378235722e-09
diseases O 0 3.9017827475618105e-06
. O 0 2.235946670869904e-11
. O 0 5.099436428679383e-10

Genetic O 0 8.722386724002718e-07
basis O 0 2.5427151495449607e-09
and O 0 2.2821493306235396e-10
molecular O 0 2.2901144802744966e-07
mechanism O 0 6.3084349676501e-05
for O 0 3.075752465520054e-05
idiopathic B-Disease 1 0.999998927116394
ventricular I-Disease 1 0.999901294708252
fibrillation I-Disease 1 0.9999732971191406
. O 0 1.157804945250973e-06

Ventricular B-Disease 1 0.6655635237693787
fibrillation I-Disease 0 0.002161922864615917
causes O 0 6.181183920261901e-08
more O 0 4.924076771328778e-12
than O 0 9.936991333947542e-12
300 O 0 1.9717524488149785e-11
, O 0 7.245220591013679e-13
000 O 0 4.558980363361664e-12
sudden O 0 6.952758507816625e-11
deaths O 0 5.673499448022312e-10
each O 0 4.067872427793162e-11
year O 0 1.764491774913779e-09
in O 0 4.5551470581606246e-12
the O 0 1.2783592240328545e-10
USA O 0 4.418169191922061e-05
alone O 0 1.9271938356268947e-07
. O 0 2.9398772305455623e-10

In O 0 4.749518001112563e-10
approximately O 0 3.9690825626159665e-10
5 O 0 2.0010182399943233e-09
- O 0 6.177648970151495e-07
12 O 0 2.783102859282849e-09
% O 0 6.617651576463351e-14
of O 0 7.173721930072222e-15
these O 0 1.0735301672138223e-13
cases O 0 1.501290342043049e-10
, O 0 2.196847087923559e-12
there O 0 3.0322821076983475e-12
are O 0 6.318637019858686e-12
no O 0 2.597770054624249e-10
demonstrable O 0 0.00013732189836446196
cardiac O 0 5.028244049753994e-05
or O 0 9.904879050282034e-08
non O 0 5.7553817896405235e-05
- O 1 0.5639997124671936
cardiac O 0 0.003606389742344618
causes O 0 1.4787545632444221e-09
to O 0 4.6086398586275834e-12
account O 0 1.4132911507758195e-10
for O 0 2.952029592995231e-11
the O 0 1.1416591630397654e-11
episode O 0 3.292371530960736e-08
, O 0 7.418921380009103e-12
which O 0 1.1246793427122093e-12
is O 0 6.033795425103294e-12
therefore O 0 3.204110587962106e-11
classified O 0 1.0303624549123924e-05
as O 0 0.003914362750947475
idiopathic B-Disease 1 0.9999995231628418
ventricular I-Disease 1 0.9999411106109619
fibrillation I-Disease 1 0.9999954700469971
( O 0 2.649348289196496e-06
IVF B-Disease 1 0.9999929666519165
) O 0 1.5927003715887622e-08
. O 0 1.3156229439204026e-09

A O 0 2.0628064589800488e-08
distinct O 0 3.3850366953913635e-10
group O 0 1.888723344389831e-10
of O 0 7.314179817363708e-11
IVF B-Disease 1 0.9999994039535522
patients O 0 1.0898605751208379e-06
has O 0 3.465689069059863e-09
been O 0 4.90009699483096e-10
found O 0 8.345367730200337e-10
to O 0 3.3930441789564725e-11
present O 0 2.15460774222187e-11
with O 0 8.547244856327296e-11
a O 0 3.3694305123788126e-09
characteristic O 0 8.03351056788415e-08
electrocardiographic O 0 6.631400174228474e-05
pattern O 0 1.0980629667756148e-05
. O 0 1.0924599891382059e-08

Because O 0 8.52029913289698e-09
of O 0 2.1446232376792773e-12
the O 0 9.781266508551711e-13
small O 0 5.995890416110594e-12
size O 0 2.919370023501955e-10
of O 0 1.1724945016625132e-12
most O 0 8.902587000925166e-12
pedigrees O 0 2.728726133938153e-09
and O 0 7.720319522563912e-11
the O 0 1.55853576572218e-11
high O 0 1.4860309249797865e-07
incidence O 0 4.514935881161364e-06
of O 0 7.777966604116671e-10
sudden B-Disease 0 4.232870765008556e-07
death I-Disease 0 1.3218645733559242e-07
, O 0 1.8368591370165888e-11
however O 0 7.661196438531193e-13
, O 0 2.9963688865167204e-14
molecular O 0 1.2603796478716234e-11
genetic O 0 2.022243483779107e-09
studies O 0 6.80216993842464e-12
of O 0 3.479302956854724e-11
IVF B-Disease 1 0.9999996423721313
have O 0 4.4946482091745565e-08
not O 0 8.796938004429489e-12
yet O 0 2.3331151247085735e-11
been O 0 6.288561893441624e-10
done O 0 1.8146992797341e-09
. O 0 1.9407400686510812e-10

Because O 0 1.8724782421486452e-05
IVF B-Disease 1 0.9999881982803345
causes O 0 0.06108155474066734
cardiac O 1 0.8024502396583557
rhythm O 0 0.0010876338928937912
disturbance O 0 1.580632851982955e-05
, O 0 1.1894494937603195e-11
we O 0 2.274282108125081e-12
investigated O 0 7.026190740333504e-10
whether O 0 1.3128523268512993e-10
malfunction O 0 2.4373585461034963e-07
of O 0 1.1171110694471742e-12
ion O 0 3.719730745643801e-09
channels O 0 5.454637062030088e-07
could O 0 3.1231052162183914e-06
cause O 0 1.999031695731901e-08
the O 0 7.781379429694368e-10
disorder O 0 6.423297804758477e-07
by O 0 2.516650624874439e-13
studying O 0 1.0604152972382153e-11
mutations O 0 1.5133084785290407e-09
in O 0 1.6797098651225029e-12
the O 0 8.225529285477151e-11
cardiac O 0 1.958668889301407e-07
sodium O 0 1.076478794992397e-09
channel O 0 3.8551238645823105e-08
gene O 0 2.9028266013142456e-08
SCN5A O 0 3.6148103390587494e-05
. O 0 1.2938038418397468e-09

We O 0 9.355918706432931e-08
have O 0 1.2955762851429853e-10
now O 0 1.6456865384317787e-11
identified O 0 6.216112347079417e-11
a O 0 3.893811315047735e-11
missense O 0 2.2822969185654074e-06
mutation O 0 8.489447509418824e-07
, O 0 3.729111117123374e-11
a O 0 9.959424257521832e-11
splice O 0 0.004722520709037781
- O 0 0.07575061917304993
donor O 0 4.858437137045257e-07
mutation O 0 5.386278303376457e-07
, O 0 1.060727339297074e-10
and O 0 3.829599484750368e-11
a O 0 1.6098632149574854e-10
frameshift O 0 1.1963804809056455e-06
mutation O 0 1.0187609689182864e-07
in O 0 4.7502921735054215e-12
the O 0 5.106205389071583e-12
coding O 0 2.2482583972305292e-07
region O 0 2.7195540264202123e-10
of O 0 4.602753941873594e-12
SCN5A O 0 7.272266884683631e-06
in O 0 1.508232427838152e-11
three O 0 1.0346907775016234e-09
IVF B-Disease 1 0.999970555305481
families O 0 8.739037937743888e-09
. O 0 6.09410688579004e-10

We O 0 9.028956249323983e-09
show O 0 1.98213156998861e-09
that O 0 6.252444850925187e-13
sodium O 0 1.256673411165199e-11
channels O 0 3.3480815342379344e-11
with O 0 1.8787261243241593e-12
the O 0 3.2422304858253925e-12
missense O 0 2.732561767970765e-07
mutation O 0 5.9130865537326827e-08
recover O 0 6.05324146363273e-08
from O 0 3.8658373377464805e-12
inactivation O 0 1.2898671464256495e-08
more O 0 6.600267749880262e-14
rapidly O 0 2.4407689411254374e-11
than O 0 5.486039682429944e-13
normal O 0 8.546686795785075e-12
and O 0 3.565419660900293e-12
that O 0 9.26608833065612e-13
the O 0 1.1355263083989708e-11
frameshift O 0 1.776269186848367e-06
mutation O 0 2.888809547130222e-07
causes O 0 2.1446020515014652e-09
the O 0 2.2481728284562408e-11
sodium O 0 2.269713750280289e-09
channel O 0 2.9177252613976634e-08
to O 0 1.9552602592565194e-10
be O 0 1.0248661919121105e-09
non O 0 2.090285278200099e-08
- O 0 1.3323048051461228e-06
functional O 0 1.7187725021017286e-08
. O 0 6.721569412171391e-10

Our O 0 1.0848229869964143e-08
results O 0 4.796310570931439e-10
indicate O 0 2.0964401048484405e-10
that O 0 5.984876223080748e-12
mutations O 0 5.434498628886786e-09
in O 0 3.030710751805721e-11
cardiac O 0 1.519809416095086e-07
ion O 0 1.5832746669275366e-08
- O 0 1.154382243839791e-05
channel O 0 2.0252328170045075e-07
genes O 0 2.477817950818917e-09
contribute O 0 1.4502453925258063e-11
to O 0 5.490206271378806e-13
the O 0 3.662566343959339e-12
risk O 0 6.005144714826827e-10
of O 0 1.723193961654379e-12
developing O 0 2.5167048889329635e-08
IVF B-Disease 1 0.9996167421340942
. O 0 5.207613854030235e-11
. O 0 1.3853398983521004e-10

Molecular O 0 9.163134109257953e-07
heterogeneity O 0 1.032546265378187e-06
in O 0 3.5333023173933498e-09
mucopolysaccharidosis B-Disease 0 1.9302897271700203e-05
IVA I-Disease 0 0.011127898469567299
in O 0 7.678591096293985e-09
Australia O 0 2.6089207949553384e-07
and O 0 1.7060590440376444e-10
Northern O 0 8.793503425419402e-11
Ireland O 0 5.3510945008383715e-08
: O 0 4.516656579994782e-12
nine O 0 1.135000166768707e-11
novel O 0 6.191016449497155e-11
mutations O 0 2.2799837573472814e-09
including O 0 2.2614533509712764e-11
T312S O 0 2.4494271055885974e-09
, O 0 8.0975645026099e-13
a O 0 3.045299689502512e-12
common O 0 6.382595840737082e-11
allele O 0 5.026604688040948e-10
that O 0 6.376001115970809e-11
confers O 0 1.692712991996359e-08
a O 0 5.3320530213341044e-08
mild O 0 2.078505167446565e-05
phenotype O 0 1.747102260196698e-06
. O 0 3.815356919290025e-09

Mucopolysaccharidosis B-Disease 1 0.7688608169555664
IVA I-Disease 1 0.9991241097450256
( O 0 0.00039749607094563544
MPS B-Disease 1 0.9999798536300659
IVA I-Disease 1 0.999997615814209
) O 0 1.0078316137196452e-07
is O 0 8.595891998197658e-09
an O 0 5.906796829435734e-08
autosomal B-Disease 1 0.9999661445617676
recessive I-Disease 1 0.9999940395355225
lysosomal I-Disease 1 0.999997615814209
storage I-Disease 1 0.9999979734420776
disorder I-Disease 1 0.9999947547912598
caused O 0 9.013608064378786e-07
by O 0 4.1932561589685946e-11
a O 0 4.1881786927433495e-08
genetic B-Disease 1 0.9999988079071045
defect I-Disease 1 0.9999990463256836
in O 0 1.0065480893217682e-08
N O 0 0.00013055113959126174
- O 0 0.0004066930850967765
acetylgalactosamine O 0 0.004468393046408892
- O 0 0.0004142140387557447
6 O 0 6.885968559799949e-06
- O 0 0.0012560951290652156
sulfate O 0 4.502633964875713e-05
sulfatase O 0 4.3846033804584295e-05
( O 0 3.077722798838778e-10
GALNS O 0 8.695733981767262e-07
) O 0 5.615286360893812e-11
. O 0 8.425782294096962e-11

Previous O 0 8.284534835922841e-09
studies O 0 1.9731191680527616e-10
of O 0 8.3298697800549e-12
patients O 0 3.2905916880210384e-10
from O 0 5.692668992446359e-12
a O 0 1.1110821152016115e-09
British O 0 5.717201929655857e-06
- O 0 0.0004231168713886291
Irish O 0 1.9587300812418107e-06
population O 0 4.3806361316178766e-11
showed O 0 1.504290203513392e-08
that O 0 3.897732830937528e-12
the O 0 3.6761644076066524e-12
I113F O 0 1.2176298858079804e-09
mutation O 0 7.535975177219711e-10
is O 0 6.185064613251079e-12
the O 0 3.5371860063367067e-13
most O 0 2.5294139612691557e-12
common O 0 7.65731401897174e-12
single O 0 2.1274590977782282e-08
mutation O 0 1.0445728548802435e-05
among O 0 8.676046491018496e-06
MPS B-Disease 1 0.9999979734420776
IVA I-Disease 1 0.9999997615814209
patients O 0 7.082759839249775e-05
and O 0 3.9195652279389037e-10
produces O 0 7.0801937646081115e-09
a O 0 2.4021298727916474e-08
severe O 0 6.244857650017366e-05
clinical O 0 7.190815267676953e-07
phenotype O 0 1.5939834838718525e-06
. O 0 4.836051559209409e-09

We O 0 1.5053608137804986e-08
studied O 0 4.7742068076672695e-09
mutations O 0 2.9140434065766385e-08
in O 0 6.724537593427726e-12
the O 0 4.9436414163717135e-12
GALNS O 0 5.011188477510586e-07
gene O 0 3.4309602381377147e-10
from O 0 1.6615002776387833e-11
23 O 0 8.212161506371274e-10
additional O 0 3.3662443943427434e-09
MPS B-Disease 1 0.999988317489624
IVA I-Disease 1 0.9999996423721313
patients O 0 2.23121219278255e-06
( O 0 5.577773486142856e-12
15 O 0 3.41816921989313e-11
from O 0 1.24835974890658e-11
Australia O 0 1.2366260904173032e-08
, O 0 1.5376064137206935e-12
8 O 0 1.408476200254194e-11
from O 0 1.3756119724220306e-12
Northern O 0 2.6953437745613762e-11
Ireland O 0 3.529936165591607e-08
) O 0 1.4255457708375885e-12
, O 0 4.359026025335319e-14
with O 0 3.43965632886023e-13
various O 0 1.1952488478128576e-11
clinical O 0 1.494360475362555e-07
phenotypes O 0 3.104967163380934e-07
( O 0 2.9295570413978567e-09
severe O 0 1.8171335796068888e-06
, O 0 1.520476279603944e-11
16 O 0 2.4754268079796304e-10
cases O 0 2.1498307301026642e-10
; O 0 3.2931938426239427e-12
intermediate O 0 1.4954944227429934e-10
, O 0 3.164837142355381e-11
4 O 0 1.3144541011200772e-09
cases O 0 1.0870952138475332e-08
; O 0 2.6437179112548392e-09
mild O 0 4.938194706483046e-07
, O 0 3.623323863166661e-11
3 O 0 3.5425049005333165e-10
cases O 0 1.2163672291620742e-09
) O 0 8.910557708352584e-11
. O 0 2.927321163248564e-10

We O 0 8.656554584263176e-09
found O 0 5.49291667706342e-10
two O 0 5.861399473422457e-12
common O 0 5.578989006882473e-11
mutations O 0 2.208774274592429e-09
that O 0 1.212802861610962e-11
together O 0 4.5113555252607185e-11
accounted O 0 6.405191044223102e-08
for O 0 2.4637825113416056e-10
32 O 0 2.0814878709529694e-09
% O 0 2.521272578735745e-13
of O 0 2.266092722540483e-13
the O 0 3.432326645125272e-11
44 O 0 2.392599451894739e-09
unrelated O 0 1.4114089896821724e-09
alleles O 0 3.363136713563364e-10
in O 0 9.6283961706356e-12
these O 0 9.518986293644005e-11
patients O 0 1.9812773643934634e-09
. O 0 2.2056283188742754e-10

One O 0 9.61890300743562e-09
is O 0 1.3443934854251438e-10
the O 0 4.297002857700516e-12
T312S O 0 1.439683749993037e-08
mutation O 0 4.504243023006893e-08
, O 0 4.20850984270138e-12
a O 0 2.793501324357961e-12
novel O 0 2.379859087575653e-10
mutation O 0 9.186302385444378e-09
found O 0 5.508486444760763e-10
exclusively O 0 5.742862851931818e-10
in O 0 5.887329512788142e-11
milder O 0 4.2598699678819685e-07
patients O 0 1.7403667840198978e-08
. O 0 2.61233840115338e-10

The O 0 5.698453930946812e-10
other O 0 1.3921626004775867e-11
is O 0 1.0026758937020652e-11
the O 0 1.1158589243581707e-12
previously O 0 9.732083583458007e-09
described O 0 8.684764019051272e-10
I113F O 0 4.187759028440041e-10
that O 0 1.5095295890013571e-12
produces O 0 5.029894833974424e-10
a O 0 9.905763320716687e-09
severe O 0 1.1824834473372903e-05
phenotype O 0 2.521524891108129e-07
. O 0 1.778914349159777e-09

The O 0 1.241238223315122e-09
I113F O 0 4.31582130033803e-08
and O 0 2.223837780590543e-11
T312S O 0 9.915418486272642e-10
mutations O 0 1.5899284111497991e-09
accounted O 0 5.992678353550218e-08
for O 0 3.8620232012398503e-10
8 O 0 9.548946522386359e-09
( O 0 8.581413357688916e-12
18 O 0 5.085158960582703e-10
% O 0 8.261842815784903e-13
) O 0 1.982499017380568e-12
and O 0 4.4342884919501557e-10
6 O 0 2.5175115325737352e-08
( O 0 9.72511047386826e-12
14 O 0 1.145717132278179e-10
% O 0 9.110723650116934e-14
) O 0 1.758111072090035e-14
of O 0 1.252451105066693e-13
44 O 0 2.422995692974439e-10
unrelated O 0 1.815970041008086e-09
alleles O 0 2.1866333188569342e-09
, O 0 9.823305363587664e-11
respectively O 0 1.1748743311557064e-08
. O 0 1.3630723216806473e-09

The O 0 2.7740176822277363e-10
relatively O 0 1.3292840161938102e-09
high O 0 1.370091666785811e-07
residual O 0 1.3484493592841318e-06
GALNS O 0 1.2178997167211492e-05
activity O 0 1.0540406769621313e-08
seen O 0 2.246516306314561e-09
when O 0 1.632184404992687e-12
the O 0 3.428075152304283e-14
T312S O 0 1.10326747737588e-11
mutant O 0 2.652918683343497e-11
cDNA O 0 6.66312708133554e-12
is O 0 1.0150835033639893e-11
overexpressed O 0 7.595649442748709e-09
in O 0 2.5623851998557434e-12
mutant O 0 3.2444205544379656e-08
cells O 0 1.5805214081954233e-10
provides O 0 8.47936196084198e-13
an O 0 4.517894847295978e-13
explanation O 0 1.1452092529493085e-12
for O 0 1.0317356344269335e-11
the O 0 3.9830516662675564e-10
mild O 0 2.3096636425634642e-07
phenotype O 0 3.97528188145202e-09
in O 0 6.558523689415008e-12
patients O 0 1.5588507915054173e-11
with O 0 2.7140570064802805e-13
this O 0 4.5308500874752244e-12
mutation O 0 1.1323599125034889e-07
. O 0 7.098691856555206e-09

The O 0 1.0282805162908915e-10
distribution O 0 2.146290783988647e-10
and O 0 4.341174555250182e-12
relative O 0 2.6941756117726534e-12
frequencies O 0 1.1825321104275144e-11
of O 0 4.4074675007756137e-13
the O 0 1.0182093883315257e-11
I113F O 0 3.812418380988447e-09
and O 0 9.013027303661492e-12
T312S O 0 8.834759313014473e-11
mutations O 0 2.0449798798782837e-10
in O 0 1.8101334233605604e-12
Australia O 0 1.9313090016126466e-10
corresponded O 0 1.1059158797066537e-11
to O 0 6.295332636262196e-13
those O 0 1.8144681720663747e-12
observed O 0 1.5010298559658963e-10
in O 0 7.0442722835406535e-12
Northern O 0 1.0818051315863997e-10
Ireland O 0 2.4157722577911045e-07
and O 0 6.041909195175776e-10
are O 0 9.28863214642861e-13
unique O 0 1.1529628163656214e-13
to O 0 2.2866601732778047e-13
these O 0 5.113041880080299e-14
two O 0 3.256280228097763e-12
populations O 0 3.6448597612315226e-11
, O 0 8.975452217389879e-13
suggesting O 0 7.811264829404863e-11
that O 0 6.024721953962198e-12
both O 0 2.3072313157235236e-11
mutations O 0 1.4034850615018968e-08
were O 0 2.967059042902065e-09
probably O 0 8.952008578866355e-10
introduced O 0 4.627864758077749e-10
to O 0 1.1450181081062993e-10
Australia O 0 2.924565922768352e-09
by O 0 3.4751361944335146e-12
Irish O 0 6.92452362116569e-09
migrants O 0 5.2058066191129626e-11
during O 0 7.484042899297272e-12
the O 0 2.423404575971344e-12
19th O 0 2.821597400171072e-09
century O 0 2.684665645347195e-08
. O 0 6.577411948427425e-09

Haplotype O 0 2.0726306502183434e-06
analysis O 0 4.117036489503789e-09
using O 0 2.444656921340993e-09
6 O 0 9.979951975935819e-09
RFLPs O 0 2.0528919009166202e-08
provides O 0 2.1839917027643985e-12
additional O 0 2.593755830775091e-13
data O 0 2.3504556634357243e-10
that O 0 6.564806424164127e-12
the O 0 5.3205421839119804e-12
I113F O 0 2.675993870937532e-09
mutation O 0 7.527829470888037e-10
originated O 0 7.930341106021643e-11
from O 0 4.719442284889519e-12
a O 0 6.359338056149966e-11
common O 0 7.411531943724015e-10
ancestor O 0 8.8028805578233e-08
. O 0 1.166899199489535e-08

The O 0 6.63404331469053e-10
other O 0 1.4611126544772368e-11
9 O 0 4.660682256796278e-11
novel O 0 8.303854999447413e-12
mutations O 0 3.551938076995498e-09
identified O 0 1.1470959293546912e-08
in O 0 5.299576749662194e-12
these O 0 9.430162380141827e-12
23 O 0 1.8946858304502712e-08
patients O 0 1.2061826537568265e-10
were O 0 1.1215673355324807e-11
each O 0 8.860608427530003e-12
limited O 0 3.486239907868338e-10
to O 0 2.3686181488402624e-11
a O 0 3.745929677556603e-10
single O 0 3.684648959279002e-07
family O 0 7.41405514759208e-08
. O 0 1.415280004302133e-09

These O 0 2.8702184726170366e-11
data O 0 3.2390812254590173e-10
provide O 0 4.07484376102607e-12
further O 0 4.785794156803025e-13
evidence O 0 5.55679070465831e-12
for O 0 5.165250280443623e-13
extensive O 0 7.637421944872713e-11
allelic O 0 3.9818250030521085e-08
heterogeneity O 0 7.104288215487031e-07
in O 0 7.776935717629385e-08
MPS B-Disease 1 0.9999897480010986
IVA I-Disease 1 0.9999988079071045
in O 0 6.379829642355617e-08
British O 0 8.523881115252152e-05
- O 0 0.07437921315431595
Irish O 0 0.0007316734408959746
patients O 0 1.0634713554225073e-08
and O 0 4.128367298624619e-13
provide O 0 3.625295254424364e-14
evidence O 0 1.554615811083515e-12
for O 0 5.864930394637591e-13
their O 0 1.629739420673515e-12
transmission O 0 3.2498707724926135e-08
to O 0 2.142114263747885e-11
Australia O 0 1.4794543368168434e-09
by O 0 5.1289779715024686e-12
British O 0 3.762575033761095e-07
- O 0 7.66800712881377e-06
Irish O 0 2.351839754055618e-07
migrants O 0 4.3711737007789964e-10
. O 0 1.1916743633544336e-12
. O 0 1.851519979001459e-11

Identification O 0 5.782346601534982e-09
of O 0 1.5775365735937186e-10
constitutional O 0 2.7879709207923042e-08
WT1 O 0 8.216788410209119e-05
mutations O 0 5.790196155430749e-06
, O 0 4.485016177890877e-11
in O 0 5.456384909868772e-12
patients O 0 5.023231275380624e-10
with O 0 4.2373735076317587e-10
isolated O 0 3.513826595735736e-05
diffuse B-Disease 0 0.25964683294296265
mesangial I-Disease 1 0.9999992847442627
sclerosis I-Disease 1 0.9999998807907104
, O 0 5.830266047723853e-09
and O 0 8.092086896394068e-12
analysis O 0 8.645453276889814e-12
of O 0 6.208742547864077e-11
genotype O 0 4.36414029536536e-06
/ O 0 4.3576360440056305e-06
phenotype O 0 9.578463533443937e-08
correlations O 0 8.77140138300092e-09
by O 0 3.212688361869942e-12
use O 0 1.4386851952818969e-11
of O 0 3.044363264086136e-13
a O 0 2.8485668684963272e-11
computerized O 0 7.393221949314466e-06
mutation O 0 9.81112933118311e-08
database O 0 3.9720026734357816e-07
. O 0 4.643977646878739e-09

Constitutional O 0 9.163976244508376e-08
mutations O 0 2.429227379252552e-07
of O 0 1.7820368444776413e-11
the O 0 1.0588994958649067e-11
WT1 O 0 6.392125442289398e-07
gene O 0 1.5266092834309575e-09
, O 0 6.270059883621559e-13
encoding O 0 4.04469305270716e-11
a O 0 9.3385326138673e-09
zinc O 0 0.0033836225047707558
- O 0 4.330565934651531e-05
finger O 0 0.0011779092019423842
transcription O 0 1.106228069147619e-07
factor O 0 3.2619669187994305e-09
involved O 0 2.4231725515022617e-09
in O 0 1.9252918703749344e-10
renal O 0 2.8641461540246382e-05
and O 0 4.9209387675830385e-09
gonadal O 0 0.00011114426888525486
development O 0 1.7208440228344557e-10
, O 0 2.173809526481718e-12
are O 0 1.3714483921341974e-13
found O 0 1.5299365940801835e-11
in O 0 1.2238681205631319e-12
most O 0 8.357198960640133e-11
patients O 0 8.234120607575335e-10
with O 0 8.583898924996447e-09
Denys B-Disease 1 0.9999798536300659
- I-Disease 1 0.9999992847442627
Drash I-Disease 1 0.999996542930603
syndrome I-Disease 1 0.9999985694885254
( O 0 2.84076335788086e-08
DDS B-Disease 1 0.9999963045120239
) O 0 1.3252234865035462e-09
, O 0 3.35291273911853e-11
or O 0 6.34609094163352e-08
diffuse B-Disease 0 0.4633728861808777
mesangial I-Disease 1 0.9999996423721313
sclerosis I-Disease 1 1.0
( O 0 3.1883432711765636e-06
DMS B-Disease 1 0.9510078430175781
) O 0 2.295254264428337e-10
associated O 0 2.2918769659874272e-10
with O 0 3.5643576978827696e-09
pseudohermaphroditism B-Disease 1 0.9999997615814209
and O 0 1.6824952808747184e-06
/ O 0 0.00017840783402789384
or O 0 2.032151496678125e-05
Wilms B-Disease 1 0.9995538592338562
tumor I-Disease 0 0.37895992398262024
( O 0 6.660204121544666e-08
WT B-Disease 1 0.9999570846557617
) O 0 1.1771593699805294e-09
. O 0 2.472982096879406e-10

Most O 0 6.489596415804044e-09
mutations O 0 8.890384378901217e-06
in O 0 2.6520931228901645e-08
DDS B-Disease 1 0.9999994039535522
patients O 0 3.424725582590327e-05
lie O 0 1.7216015635312942e-07
in O 0 2.7276774589024555e-11
exon O 0 3.5759160255111055e-07
8 O 0 1.1577830250075749e-08
or O 0 1.023150869583489e-10
exon O 0 5.832615812551012e-08
9 O 0 1.3989575720074754e-08
, O 0 2.466554087712791e-12
encoding O 0 1.5981740375536901e-09
zinc O 0 0.018720852211117744
finger O 0 0.13401028513908386
2 O 0 7.462027156179829e-07
or O 0 2.387778010870534e-07
zinc O 0 0.0012021762086078525
finger O 0 0.0014394958270713687
3 O 0 1.7453931633326647e-08
, O 0 1.2631375979899051e-11
respectively O 0 3.394003689205505e-10
, O 0 1.497199608214983e-12
with O 0 6.442965952424551e-12
a O 0 1.0852818643769524e-09
hot O 0 3.602817969294847e-06
spot O 0 2.2362786694429815e-05
( O 0 2.421138567409997e-10
R394W O 0 8.140891294416974e-10
) O 0 3.4720734317164603e-13
in O 0 1.4098993511308527e-13
exon O 0 5.090656429729279e-08
9 O 0 6.549335296313075e-08
. O 0 6.364704319139491e-10

We O 0 1.7294791154753852e-09
analyzed O 0 7.999864104490939e-10
a O 0 8.275962380677182e-12
series O 0 1.191889226204168e-10
of O 0 2.358897799314974e-11
24 O 0 1.823415729518274e-08
patients O 0 1.3480730420845077e-10
, O 0 6.949065888689487e-13
10 O 0 2.2164358889908975e-11
with O 0 5.958094018154725e-10
isolated B-Disease 0 2.289706935698632e-05
DMS I-Disease 1 0.9951592087745667
( O 0 3.084329680547171e-09
IDMS B-Disease 0 3.822962025878951e-05
) O 0 8.085360506115968e-12
, O 0 9.313876709812763e-13
10 O 0 2.5901100708658475e-11
with O 0 5.179533468790964e-10
DDS B-Disease 1 0.9999998807907104
, O 0 6.308014111056082e-09
and O 0 5.870758879034099e-10
4 O 0 6.510424643835222e-09
with O 0 1.643709524046244e-08
urogenital B-Disease 0 0.30321356654167175
abnormalities I-Disease 1 0.9998016953468323
and O 0 1.3142033594704117e-07
/ O 0 0.00027549415244720876
or O 0 3.9273239963222295e-05
WT B-Disease 1 0.9999871253967285
. O 0 2.0904288078327227e-08

We O 0 9.756691454754218e-09
report O 0 2.212662053580061e-09
WT1 O 0 1.7699753698252607e-06
heterozygous O 0 2.3446466457244242e-07
mutations O 0 7.133141366466589e-07
in O 0 2.634414353330783e-10
16 O 0 2.3808784277434825e-08
patients O 0 7.913905086809336e-10
, O 0 1.1439298943857756e-12
4 O 0 4.9163648846439756e-11
of O 0 9.322661566335544e-12
whom O 0 3.1539226341692483e-08
presented O 0 2.895051309792507e-09
with O 0 5.83220094441117e-09
IDMS B-Disease 0 0.0411527082324028
. O 0 4.122065355716131e-09

One O 0 3.949753235588105e-08
male O 0 4.531032118393341e-07
and O 0 2.248705804897e-10
two O 0 8.504221216121266e-10
female O 0 8.110155249596573e-06
IDMS B-Disease 0 0.3052586019039154
patients O 0 6.267013930028043e-08
with O 0 6.615973324741731e-10
WT1 O 0 0.007151708472520113
mutations O 0 0.00025006942451000214
underwent O 0 5.37033474756754e-06
normal O 0 2.697652519145777e-07
puberty O 0 6.751243927283213e-05
. O 0 5.445954354144078e-09

Two O 0 6.219501358373236e-08
mutations O 0 7.291187648661435e-05
associated O 0 3.749342880610129e-08
with O 0 1.6905858934990192e-09
IDMS B-Disease 0 0.013641408644616604
are O 0 3.1177921355762805e-11
different O 0 1.5550538287611992e-13
from O 0 1.8912738129067685e-12
those O 0 2.2606944094505366e-11
described O 0 1.0184692200709833e-08
in O 0 2.3665251980276025e-09
DDS B-Disease 1 0.9999984502792358
patients O 0 2.5080250907194568e-06
. O 0 9.007261603244388e-10

No O 0 3.909228851739499e-08
WT1 O 0 9.746993782755453e-06
mutations O 0 1.260994395124726e-06
were O 0 7.914659483354569e-10
detected O 0 2.875983113881375e-07
in O 0 8.329838555032332e-12
the O 0 7.717253919237166e-12
six O 0 4.4346033511999394e-09
other O 0 1.4047323304566817e-09
IDMS B-Disease 0 0.055684320628643036
patients O 0 3.6989018514788086e-09
, O 0 2.289566648251695e-13
suggesting O 0 7.182896638591174e-11
genetic O 0 7.986782346591781e-10
heterogeneity O 0 2.1720516496515074e-09
of O 0 5.988430584746851e-11
this O 0 3.916264201819786e-09
disease O 0 0.00027165585197508335
. O 0 7.0540702168386815e-09

We O 0 4.610686499262329e-09
analyzed O 0 5.237026101667652e-08
genotype O 0 1.5003294038251624e-06
/ O 0 1.626186190151202e-06
phenotype O 0 2.5168111505990964e-07
correlations O 0 5.250418553259806e-07
, O 0 1.0205936790130821e-10
on O 0 1.168118379801797e-10
the O 0 1.7917835184316777e-12
basis O 0 5.669007624442557e-11
of O 0 4.5649495468425005e-12
the O 0 6.80604045344424e-11
constitution O 0 2.847574120945495e-10
of O 0 2.980814380049157e-13
a O 0 3.4586923602919484e-11
WT1 O 0 3.616976584908116e-08
mutation O 0 9.593772998250927e-11
database O 0 5.582440620877094e-10
of O 0 5.245695891553659e-11
84 O 0 1.6945712388860557e-07
germ O 0 0.0001355161366518587
- O 0 0.0001383333292324096
line O 0 1.0273433872498572e-05
mutations O 0 5.2130879168998945e-08
, O 0 7.253392222787702e-13
to O 0 5.336207956627495e-14
compare O 0 1.478623300188442e-11
the O 0 6.886260767342833e-13
distribution O 0 6.450470019236931e-11
and O 0 3.371581139277602e-11
type O 0 3.444929230767002e-09
of O 0 1.2674333804696403e-11
mutations O 0 1.3884256411245133e-08
, O 0 2.465218350636289e-12
according O 0 1.1748421517316504e-13
to O 0 2.4005038408436707e-12
the O 0 5.203106695494952e-11
different O 0 1.7274054409099904e-09
symptoms O 0 1.361175634428946e-07
. O 0 8.351303676379374e-11

This O 0 6.438599098324005e-10
demonstrated O 0 8.73230643350098e-09
( O 0 1.3442080781800314e-11
1 O 0 6.181305467478637e-11
) O 0 7.313962803456864e-13
the O 0 4.340098159333339e-12
association O 0 2.990731967633664e-11
between O 0 6.650189079970836e-12
mutations O 0 4.713584189630637e-09
in O 0 2.5304286443983415e-11
exons O 0 3.501484684420575e-07
8 O 0 5.666702307394189e-08
and O 0 1.4676442283700908e-09
9 O 0 4.7547981552042984e-08
and O 0 6.185663536939501e-09
DMS B-Disease 0 0.011724819429218769
; O 0 5.150557411126577e-11
( O 0 1.6976824676953606e-12
2 O 0 8.052859767904152e-11
) O 0 2.0032376365358706e-12
among O 0 3.1936894101525226e-11
patients O 0 1.7049138489877436e-10
with O 0 6.804093399814803e-11
DMS B-Disease 0 0.0005564393359236419
, O 0 2.3868832800012785e-13
a O 0 1.1287964242793699e-13
higher O 0 2.6296829297445257e-12
frequency O 0 1.4610458676234117e-11
of O 0 8.436032363119683e-13
exon O 0 4.334663827876284e-08
8 O 0 1.8952415192785566e-09
mutations O 0 1.3314459534896628e-09
among O 0 4.742979620164789e-11
46 O 0 3.988070762517282e-09
, O 0 1.4585517515985913e-10
XY O 0 0.02398044429719448
patients O 0 3.6366831768219754e-09
with O 0 3.113145158328834e-11
female O 0 1.3212415161945046e-08
phenotype O 0 4.1374390025161745e-10
than O 0 1.1126291728225102e-11
among O 0 1.8283242975147829e-10
46 O 0 9.175921888981975e-08
, O 0 1.2208204447361481e-09
XY O 0 0.13277201354503632
patients O 0 4.2795957888586145e-09
with O 0 1.4549556004439523e-11
sexual O 0 2.5543974047081974e-08
ambiguity O 0 1.6026957538883835e-08
or O 0 1.7909398408733068e-08
male O 0 9.399060019177341e-08
phenotype O 0 1.4897622691023571e-08
; O 0 5.3616604211992325e-11
and O 0 6.407579467015978e-10
( O 0 4.07940313473798e-11
3 O 0 1.1370483027350886e-10
) O 0 1.202707367291972e-13
statistically O 0 4.492636124231453e-11
significant O 0 3.5150072956458e-12
evidence O 0 9.892201502381681e-10
that O 0 6.860942369790735e-10
mutations O 0 5.15584339666475e-08
in O 0 9.637864117895134e-11
exons O 0 1.0752460184448864e-06
8 O 0 6.464446755671815e-08
and O 0 2.87278312249839e-10
9 O 0 3.4168803897394184e-10
preferentially O 0 3.646307700222451e-10
affect O 0 1.8414976488134727e-10
amino O 0 2.79007338066517e-11
acids O 0 5.192060323344627e-12
with O 0 5.489187527912484e-14
different O 0 4.5073746980910795e-14
functions O 0 6.085435107217041e-12
. O 0 7.1628224185271705e-12
. O 0 1.3129500264774663e-10

The O 0 1.716688835529112e-08
185delAG O 0 1.0150085472560022e-05
BRCA1 O 0 5.3243074944475666e-05
mutation O 0 7.287439984793309e-08
originated O 0 4.641743656108588e-10
before O 0 1.781622245566883e-11
the O 0 6.102262792295754e-13
dispersion O 0 1.630671597752098e-09
of O 0 2.4714327806485414e-12
Jews O 0 3.578033425100102e-10
in O 0 4.036622164999004e-12
the O 0 1.693227155707966e-11
diaspora O 0 4.882399484706923e-10
and O 0 2.2158198886845781e-10
is O 0 4.5909019641410254e-11
not O 0 7.09319972549971e-12
limited O 0 2.6413968234884067e-11
to O 0 1.284249095956369e-10
Ashkenazim O 0 1.5759491361677647e-05
. O 0 2.4327260206291612e-09

The O 0 2.246469010813712e-09
185delAG O 0 1.3083063095109537e-06
mutation O 0 1.1384120170987444e-06
in O 0 1.4398168768359199e-10
BRCA1 O 0 4.3097930756630376e-05
is O 0 1.0917553527889368e-09
detected O 0 5.524837547454808e-07
in O 0 1.1963139680271073e-11
Ashkenazi O 0 1.0450803777928286e-08
Jews O 0 6.924318757262071e-11
both O 0 3.146917795793236e-11
in O 0 5.384619972126359e-10
familial B-Disease 1 0.7518324851989746
breast I-Disease 1 0.9999949932098389
and I-Disease 1 0.9999605417251587
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 3.146868365888622e-08
in O 0 4.34546582744888e-12
the O 0 1.1254825196815865e-11
general O 0 1.282080691611398e-10
population O 0 9.98218868675238e-11
. O 0 1.2988349284981382e-10

All O 0 6.156954945879534e-09
tested O 0 5.084818440082017e-06
Ashkenazi O 0 3.853617158711131e-07
mutation O 0 4.5857454722408875e-08
carriers O 0 2.259542597471409e-08
share O 0 8.20921775002148e-10
the O 0 2.5350069265961395e-12
same O 0 8.854476180042425e-12
allelic O 0 1.1979043312848603e-09
pattern O 0 1.707877395062951e-08
at O 0 9.99339500040719e-10
the O 0 3.2152541740160245e-10
BRCA1 O 0 2.1327594367903657e-05
locus O 0 2.335553290322423e-06
. O 0 1.6031787453130164e-08

Our O 0 1.9088239877618207e-09
previous O 0 1.4447795737559943e-10
study O 0 1.6830651455856938e-11
showed O 0 2.760175199512105e-09
that O 0 3.1645820946363257e-12
this O 0 5.0615232491391104e-12
Ashkenazi O 0 6.463299655479204e-07
mutation O 0 2.3240542645908135e-07
also O 0 6.1523879324454356e-09
occurs O 0 4.9632294801815746e-11
in O 0 2.0285760918281603e-12
Iraqi O 0 1.0302598774103444e-09
Jews O 0 4.7044361461967554e-11
with O 0 2.8156255538897e-12
a O 0 6.454457801563507e-11
similar O 0 1.4635900824622183e-10
allelic O 0 7.629643050677259e-07
pattern O 0 1.8813059796229936e-05
. O 0 2.2626217344168253e-08

We O 0 8.138287377335018e-09
extended O 0 7.413888947205294e-11
our O 0 1.2602299846037335e-12
analysis O 0 2.59566619500301e-13
to O 0 1.5004580152140623e-13
other O 0 8.236841113687388e-13
non O 0 8.68817684462897e-10
- O 0 8.077144997287178e-08
Ashkenazi O 0 2.3351387490322395e-09
subsets O 0 2.201865252626778e-11
354 O 0 2.7207369690529504e-10
of O 0 3.849414276918539e-12
Moroccan O 0 2.6763421701048173e-08
origin O 0 8.067280177215252e-11
, O 0 2.035793408849962e-12
200 O 0 1.3725037816339491e-12
Yemenites O 0 6.235570282342451e-09
and O 0 1.1085536134880503e-11
150 O 0 9.959894020639126e-12
Iranian O 0 4.0473113749328604e-10
Jews O 0 9.169335291048242e-10
. O 0 2.9378144361658087e-10

Heteroduplex O 0 2.099172661473858e-06
analysis O 0 7.867654860937989e-10
complemented O 0 5.923443402444661e-10
by O 0 1.6680812276164553e-13
direct O 0 1.490559791480356e-13
DNA O 0 1.2366815904663042e-10
sequencing O 0 3.776641777086809e-10
of O 0 1.474292042613623e-11
abnormally O 0 3.783501867360428e-08
migrating O 0 2.6630594951448927e-10
bands O 0 5.158021787465827e-10
were O 0 5.806234312788483e-11
employed O 0 3.788807934057559e-09
. O 0 1.7967545506980542e-10

Four O 0 1.1194146942727912e-08
of O 0 2.0987366011748776e-10
Moroccan O 0 7.386220204352867e-07
origin O 0 1.5014228749166136e-09
( O 0 2.7570052144043622e-11
1 O 0 5.3867847682465e-11
. O 0 3.6601337195449335e-13
1 O 0 8.759388353540842e-11
% O 0 5.868096807082335e-13
) O 0 2.9422400930553816e-13
and O 0 3.989419038175068e-12
none O 0 2.47073065132164e-12
of O 0 2.5976570612422367e-13
the O 0 1.1315660214394896e-10
Yemenites O 0 7.857330075466962e-08
or O 0 4.553692423137079e-10
Iranians O 0 5.035846184497927e-10
was O 0 5.345835996095616e-10
a O 0 1.6943828068036182e-12
carrier O 0 2.2767061846895587e-10
of O 0 4.687046649236304e-13
the O 0 7.629924470009541e-11
185delAG O 0 1.9883593722624937e-06
mutation O 0 6.965750287690753e-08
. O 0 6.989432921322702e-10

BRCA1 O 0 0.014277786016464233
allelic O 0 4.547054231807124e-06
patterns O 0 2.0109573597437702e-06
were O 0 2.3475310584331055e-09
determined O 0 1.3997890346839625e-10
for O 0 1.607011615792353e-12
four O 0 6.804505743585043e-12
of O 0 8.765228668751457e-13
these O 0 5.979239672826431e-12
individuals O 0 3.686516023004849e-11
and O 0 8.075715790534232e-11
for O 0 9.214418290881543e-12
12 O 0 6.797763740795659e-11
additional O 0 1.1341756527005753e-11
non O 0 2.489520234405518e-08
- O 0 4.963330411555944e-06
Ashkenazi O 0 9.461958256906655e-07
185delAG O 0 2.2739916616387745e-08
mutation O 0 1.620394485257748e-08
carriers O 0 2.6052015300592757e-07
who O 0 1.1085763844675967e-06
had O 0 0.000215909443795681
breast B-Disease 1 0.9998160004615784
/ I-Disease 1 0.9999854564666748
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999923706054688
. O 0 2.424232832254347e-07

Six O 0 4.1230629221900017e-07
non O 0 2.9671002721443074e-06
- O 0 0.00031586509430781007
Ashkenazi O 0 4.201218325761147e-05
individuals O 0 4.368198025517245e-10
shared O 0 2.5785767965302853e-10
the O 0 8.85476761358639e-11
common O 0 4.303768008639963e-09
Ashkenazi O 0 2.2838027291527396e-07
haplotype O 0 2.268394894144876e-08
, O 0 2.9060576861583698e-11
four O 0 5.836813671278307e-11
had O 0 2.3979858099210105e-09
a O 0 2.4966099066575653e-12
closely O 0 3.1897948171710766e-10
related O 0 8.811170126854506e-10
pattern O 0 5.909320677233154e-08
, O 0 9.32364463412938e-11
and O 0 1.0303339431638747e-10
the O 0 5.816520529111635e-11
rest O 0 1.0000073658034125e-08
( O 0 7.850158023625653e-11
n O 0 1.4171574775900808e-06
= O 0 3.372345531715837e-07
6 O 0 9.38642674697121e-09
) O 0 1.109183274741743e-12
displayed O 0 2.3027438289524582e-10
a O 0 4.191992586388693e-11
distinct O 0 1.896478085683384e-09
BRCA1 O 0 0.00012386636808514595
allelic O 0 5.71004193261615e-06
pattern O 0 4.7547422582283616e-05
. O 0 2.3503952562009545e-08

We O 0 3.374099666331176e-09
conclude O 0 9.731336847451644e-10
that O 0 1.0632912085528634e-11
the O 0 7.946750028853256e-12
185delAG O 0 8.147420658133342e-07
BRCA1 O 0 2.4014691007323563e-05
mutation O 0 6.785259643038444e-08
occurs O 0 4.790715046887328e-10
in O 0 7.209503176744403e-13
some O 0 1.7252657635857815e-12
non O 0 2.1146185247289395e-08
- O 0 4.785519195138477e-06
Ashkenazi O 0 8.977140737442824e-07
populations O 0 7.606881791133446e-10
at O 0 7.133081347809878e-10
rates O 0 1.624336576355745e-08
comparable O 0 9.067834816356424e-10
with O 0 1.060492145488201e-11
that O 0 8.156720958385488e-12
of O 0 4.574940773438563e-11
Ashkenazim O 0 6.697072967654094e-05
. O 0 2.705952573123227e-09

The O 0 4.748557658196262e-10
majority O 0 6.183144968252563e-11
of O 0 5.592921958896824e-12
Jewish O 0 8.859603051192266e-10
185delAG O 0 1.0450887089064054e-07
mutation O 0 6.343864100699648e-08
carriers O 0 1.0775541170460201e-07
have O 0 6.341483588245822e-11
a O 0 5.5087223845007305e-12
common O 0 2.6400064426224112e-11
allelic O 0 1.1711842606842993e-09
pattern O 0 1.0383412529790803e-07
, O 0 3.217184851855848e-11
supporting O 0 1.1231285346191555e-10
the O 0 7.478819646911106e-12
founder O 0 3.5518976648774014e-09
effect O 0 2.767929219160692e-10
notion O 0 8.5015570971958e-11
, O 0 4.192606331554494e-12
but O 0 6.486192876201113e-13
dating O 0 2.4105495377568786e-10
the O 0 1.078491809747284e-11
mutations O 0 2.3203894361500943e-09
origin O 0 1.6114352907603546e-11
to O 0 1.4446712923166238e-11
an O 0 3.027937275912329e-11
earlier O 0 7.065401735895094e-11
date O 0 5.3435800922985166e-11
than O 0 6.967357680381925e-12
currently O 0 5.026288829590442e-10
estimated O 0 9.030518555164235e-10
. O 0 7.003311819353542e-10

However O 0 6.206818614629128e-09
, O 0 3.794269586021581e-12
the O 0 1.605148170413448e-13
different O 0 1.6081667247869191e-13
allelic O 0 3.3300360247068284e-09
pattern O 0 2.1138568229162047e-07
at O 0 1.157540108209787e-08
the O 0 8.114903887745939e-11
BRCA1 O 0 2.395094952589716e-06
locus O 0 4.75626755758185e-08
even O 0 5.962780935675482e-09
in O 0 3.2674477273147984e-12
some O 0 6.803489520888772e-13
Jewish O 0 1.2170650598442023e-10
mutation O 0 8.031791232099295e-09
carriers O 0 3.123177449992909e-08
, O 0 1.623788950522176e-11
might O 0 9.647575099913652e-11
suggest O 0 3.413803961738182e-11
that O 0 8.113414454169465e-12
the O 0 1.8341075186389943e-11
mutation O 0 1.1561324342324042e-08
arose O 0 9.540362250204382e-11
independently O 0 2.7062455054682744e-10
. O 0 2.686198138923679e-11
. O 0 2.76494271922445e-10

Crystal O 0 0.000270253571216017
structure O 0 4.85863210997195e-07
of O 0 1.0752804202596167e-09
the O 0 1.0163233810089878e-07
hemochromatosis B-Disease 1 0.9999997615814209
protein O 0 0.00012160901678726077
HFE O 0 9.988524834625423e-05
and O 0 5.401414732153498e-11
characterization O 0 8.713962190709523e-11
of O 0 7.663534520516158e-13
its O 0 1.9240344994314595e-12
interaction O 0 2.1469980307498027e-11
with O 0 1.086984183218398e-10
transferrin O 0 1.7967910252991715e-06
receptor O 0 5.408752912217096e-08
. O 0 5.136217562373702e-10

HFE O 0 0.002031248062849045
is O 0 1.3887546401747386e-07
an O 0 1.0626070023889156e-09
MHC O 0 1.2637752888622344e-06
- O 0 5.792277988803107e-06
related O 0 6.786476092202065e-08
protein O 0 4.5612660315441644e-09
that O 0 7.516717283329033e-12
is O 0 1.668304817209476e-12
mutated O 0 7.399059698265376e-10
in O 0 3.7330676744273816e-11
the O 0 1.453992304334406e-08
iron B-Disease 1 0.9987962245941162
- I-Disease 1 0.9999749660491943
overload I-Disease 1 0.9999529123306274
disease I-Disease 1 0.9999409914016724
hereditary B-Disease 1 0.9999996423721313
hemochromatosis I-Disease 1 1.0
. O 0 1.94308868231019e-05

HFE O 0 0.00023354364384431392
binds O 0 1.1257095593464328e-06
to O 0 4.489728144818628e-09
transferrin O 0 5.435565526568098e-06
receptor O 0 1.0747497753982316e-06
( O 0 3.396438685854264e-10
TfR O 0 2.5645083496783627e-06
) O 0 3.51766987934099e-12
and O 0 2.0459298318009633e-12
reduces O 0 2.490116168818446e-10
its O 0 2.29645599411632e-12
affinity O 0 2.481851668623136e-10
for O 0 1.1384155423899145e-10
iron O 0 2.1604650100925937e-05
- O 0 1.263816329810652e-06
loaded O 0 3.1270510589820333e-06
transferrin O 0 3.0676343953928153e-07
, O 0 2.2456186216102125e-11
implicating O 0 4.499701844906667e-06
HFE O 0 0.0005515153170563281
in O 0 9.487511221095701e-09
iron O 0 0.00022899109171703458
metabolism O 0 1.4754310541320592e-05
. O 0 1.5321721669181443e-09

The O 0 7.697639858861294e-09
2 O 0 2.9337632767578725e-08
. O 0 1.9606987144982213e-09

6 O 0 2.1634377844748087e-06
A O 0 2.2864898596708372e-07
crystal O 0 2.3599248379468918e-05
structure O 0 6.078880687709898e-08
of O 0 7.930749112983193e-11
HFE O 0 2.806998963933438e-05
reveals O 0 3.739907938893339e-08
the O 0 2.9990133640356298e-12
locations O 0 3.263570524936199e-10
of O 0 8.467835876935226e-10
hemochromatosis B-Disease 1 1.0
mutations O 0 0.00701740849763155
and O 0 7.359961973207874e-09
a O 0 2.696714407335321e-09
patch O 0 0.0006518736481666565
of O 0 1.6551152115518164e-10
histidines O 0 1.0885343726840802e-05
that O 0 7.33316740664236e-10
could O 0 2.7411257708109815e-09
be O 0 6.473172692311735e-11
involved O 0 1.6887351239613935e-10
in O 0 7.911153676598559e-11
pH O 0 2.019891809368346e-07
- O 0 6.173426640998514e-07
dependent O 0 2.8212488345502607e-08
interactions O 0 1.719270170674747e-09
. O 0 3.2908992197988596e-10

We O 0 3.826326633316057e-08
also O 0 3.5762867667266107e-10
demonstrate O 0 2.0698552594122788e-10
that O 0 1.730771775898532e-10
soluble O 0 5.194577283873514e-07
TfR O 0 6.370230403263122e-05
and O 0 7.22906678962687e-10
HFE O 0 1.5484642062801868e-05
bind O 0 1.572985581788089e-07
tightly O 0 8.570047071998488e-08
at O 0 8.938841666861208e-09
the O 0 5.494462090166463e-12
basic O 0 9.6355846912477e-11
pH O 0 6.234377458724794e-10
of O 0 4.647217465990512e-14
the O 0 1.1392920027525344e-12
cell O 0 3.084107547124404e-08
surface O 0 1.7772372018498572e-07
, O 0 8.296228287685281e-11
but O 0 1.59566561352964e-11
not O 0 1.3239286403288197e-11
at O 0 4.489058014200964e-10
the O 0 2.4638388551601054e-10
acidic O 0 1.4565688388756826e-07
pH O 0 2.1232430924555956e-08
of O 0 9.806901818398828e-12
intracellular O 0 1.6494747114847996e-06
vesicles O 0 4.885413318334031e-07
. O 0 5.5140394472630305e-09

TfR O 1 0.617163896560669
HFE O 0 0.0028800098225474358
stoichiometry O 0 1.1165752766828518e-05
( O 0 1.8806227686241073e-08
2 O 0 5.208652176236228e-09
1 O 0 3.3787797559803323e-10
) O 0 1.4602760190288167e-12
differs O 0 1.3701034230761966e-11
from O 0 1.9289234098884833e-10
TfR O 0 2.0033992768730968e-05
transferrin O 0 3.7280852183130264e-08
stoichiometry O 0 3.2654776660479e-09
( O 0 5.633996047471612e-11
2 O 0 6.221987369769977e-10
2 O 0 6.913896122284768e-10
) O 0 1.1776157306242485e-12
, O 0 7.683729276756687e-14
implying O 0 6.085284186274631e-12
a O 0 3.952275518578213e-13
different O 0 1.3436780103826505e-14
mode O 0 4.497197059194491e-11
of O 0 1.6275401165666281e-12
binding O 0 1.232241531035072e-09
for O 0 1.171988200932006e-10
HFE O 0 1.093604714696994e-05
and O 0 4.11060019356313e-10
transferrin O 0 2.9983787896981084e-08
to O 0 1.0737959826867538e-10
TfR O 0 2.27869963964622e-06
, O 0 1.0536889286441586e-12
consistent O 0 2.0539462491919735e-11
with O 0 3.726478327303884e-12
our O 0 4.960712049473237e-11
demonstration O 0 8.134042051022305e-11
that O 0 6.5655072524484215e-12
HFE O 0 8.011718364286935e-07
, O 0 4.685281676519715e-11
transferrin O 0 7.635482290879736e-08
, O 0 2.9847385674131033e-10
and O 0 2.5480799692445544e-09
TfR O 0 1.9242466805735603e-05
form O 0 8.661302230983381e-11
a O 0 1.5361539817959624e-10
ternary O 0 3.251352964639409e-08
complex O 0 2.5974706829856586e-08
. O 0 1.9813681806368777e-09

Identification O 0 2.1332522415207222e-09
of O 0 3.181462732149143e-11
three O 0 7.005472590915218e-11
novel O 0 6.810459418638004e-10
mutations O 0 9.027770886405051e-08
and O 0 8.534652151670485e-11
a O 0 1.522949127918949e-11
high O 0 4.8514898765006365e-09
frequency O 0 2.2170543179100832e-10
of O 0 4.502163832714734e-12
the O 0 1.5155837695957075e-10
Arg778Leu O 0 1.3141874433131306e-06
mutation O 0 3.037393625504592e-08
in O 0 1.2937934057433154e-10
Korean O 0 1.1475942329752797e-07
patients O 0 5.646823009186619e-10
with O 0 1.2318131237254448e-10
Wilson B-Disease 0 5.422058620752068e-06
disease I-Disease 0 2.187213976867497e-05
. O 0 1.1366477759011673e-09

Four O 0 2.998870840542622e-08
mutations O 0 1.4979702882556012e-06
- O 0 1.1531894415384158e-05
- O 0 3.7395526305772364e-05
R778L O 0 2.7653206302602484e-07
, O 0 1.0339618050636545e-11
A874V O 0 1.5697598776398536e-10
, O 0 2.0789679656615934e-13
L1083F O 0 1.3166609295900411e-11
, O 0 9.647063557065641e-14
and O 0 1.5777357447854107e-13
2304delC O 0 7.109894339940581e-10
- O 0 4.9024393433683144e-08
- O 0 1.9050465027703467e-07
in O 0 3.796392367139134e-11
the O 0 9.234652105505337e-12
copper O 0 3.8383296896427055e-07
- O 0 1.0747923662179915e-09
transporting O 0 4.223489113996948e-09
enzyme O 0 1.3904178919332821e-09
, O 0 2.8181617196115782e-12
P O 0 1.1530952406246797e-06
- O 0 2.8779443255189108e-06
type O 0 2.596703325252747e-06
ATPase O 0 2.929270749518764e-06
( O 0 2.009488825338579e-10
ATP7B O 0 3.1604631089976465e-07
) O 0 1.1439516868494426e-12
, O 0 9.215253614445335e-14
were O 0 1.5476898191854604e-12
identified O 0 2.962748379964353e-10
in O 0 1.278236717860981e-11
Korean O 0 1.4281836513418966e-07
Patients O 0 5.668123748137077e-10
with O 0 1.2723654074786594e-10
Wilson B-Disease 0 9.685994882602245e-06
disease I-Disease 0 2.6223657187074423e-05
. O 0 9.479077522911439e-10

Arg778Leu O 0 2.9711734896409325e-05
, O 0 1.6177770234548916e-10
the O 0 2.6656788755519134e-12
most O 0 2.3148956709850843e-12
frequently O 0 7.607995483605023e-11
reported O 0 2.8020419318153245e-10
mutation O 0 6.32419006052487e-10
of O 0 2.5546114702790224e-12
this O 0 3.4400915276122657e-12
enzyme O 0 1.3189853653727823e-08
, O 0 4.192072730613283e-11
was O 0 5.767333721706791e-09
found O 0 5.773769240491333e-10
in O 0 2.593133823988736e-12
six O 0 5.7775118023073446e-11
of O 0 1.6177908622114212e-12
eight O 0 2.843976831812256e-09
unrelated O 0 1.344549218629254e-07
patients O 0 1.5332801694967202e-09
studied O 0 1.5762102734129257e-10
, O 0 2.7054259440356665e-13
an O 0 8.125671766305229e-14
allele O 0 4.999924432813607e-11
frequency O 0 3.9463457501831556e-10
of O 0 2.352375239045301e-10
37 O 0 4.2618731299626234e-07
. O 0 2.1817758710795943e-09

5 O 0 1.8658172962204844e-07
% O 0 3.305865858838075e-10
, O 0 3.853601465708678e-12
which O 0 2.2358036374982987e-13
is O 0 2.8183320477728757e-13
considerably O 0 3.4528178927129005e-12
higher O 0 4.572251431633756e-12
than O 0 6.852012989118361e-13
those O 0 2.302091460168465e-12
in O 0 2.3104833476138287e-13
other O 0 4.970445496160769e-12
Asian O 0 5.554317006328802e-10
populations O 0 5.824994375736026e-10
. O 0 1.6003694203181595e-10

The O 0 2.342122606968644e-10
novel O 0 3.5108632667757433e-10
single O 0 1.378576919286445e-09
nucleotide O 0 3.3216384309753266e-08
deletion O 0 1.1027117352568894e-06
, O 0 1.2535571192184847e-10
2304delC O 0 3.996113662196876e-08
, O 0 1.8321144948374446e-11
was O 0 6.992726953036765e-10
found O 0 1.054445905590562e-10
in O 0 2.665658709391505e-12
one O 0 1.7942931584968846e-09
patient O 0 1.2190217546503845e-07
. O 0 1.1873608762869026e-09

Since O 0 9.208142692784804e-09
a O 0 2.1778955028306513e-10
mutation O 0 6.49452491785496e-09
at O 0 8.515388394414458e-10
cDNA O 0 3.7429890298312785e-09
nucleotide O 0 3.949814413317654e-07
2302 O 0 3.037677288375562e-06
( O 0 3.6458610436218564e-11
2302insC O 0 6.5002998539398504e-09
) O 0 2.877276758864178e-12
had O 0 3.3052857673077085e-10
been O 0 5.343256948009412e-10
previously O 0 1.2311168084977453e-08
described O 0 5.977994543826526e-09
, O 0 2.130179279496991e-12
this O 0 2.2860408227867723e-13
region O 0 2.9062112959221675e-12
of O 0 6.025879665041978e-13
the O 0 1.4149122151696503e-10
ATP7B O 0 3.1502091587753966e-05
gene O 0 3.3312318237221916e-08
may O 0 3.0851416976673818e-09
be O 0 3.6281713744479305e-11
susceptible O 0 2.2533566124138815e-09
to O 0 3.161686190633617e-12
gene O 0 4.1943080120177e-09
rearrangements O 0 5.749779575126013e-06
causing O 0 2.9142689527361654e-05
Wilson B-Disease 0 0.00040271395118907094
disease I-Disease 0 0.0011974209919571877
. O 0 4.827646726823787e-09

Disruption O 0 1.263206627299951e-06
of O 0 7.86827721033223e-12
splicing O 0 3.187898833800773e-09
regulated O 0 2.098114215698388e-08
by O 0 7.720536883415452e-12
a O 0 1.0358711111102537e-10
CUG O 0 3.541192927514203e-05
- O 0 2.062503426714102e-06
binding O 0 3.4398760817566654e-07
protein O 0 1.5513361972807616e-07
in O 0 9.243442455897366e-09
myotonic B-Disease 1 0.9999884366989136
dystrophy I-Disease 1 0.9999920129776001
. O 0 3.686620431153642e-08

Myotonic B-Disease 1 0.999976396560669
dystrophy I-Disease 1 0.9999985694885254
( O 0 0.004687529522925615
DM B-Disease 1 0.9999995231628418
) O 0 2.5159232563964906e-07
is O 0 1.2882536148950408e-09
caused O 0 7.94409094062587e-10
by O 0 1.381997381116884e-12
a O 0 4.045850807155027e-11
CTG O 0 1.0846015356946737e-06
expansion O 0 1.0640246461690595e-09
in O 0 5.2189173121997e-12
the O 0 7.89791235883408e-12
3 O 0 5.925138157891752e-10
untranslated O 0 8.60398259305839e-08
region O 0 1.7591268719474584e-11
of O 0 1.2913538511086231e-12
the O 0 4.03463484843769e-09
DM B-Disease 1 0.9999971389770508
gene O 0 4.277256095974735e-07
. O 0 1.0897497348949514e-09

One O 0 5.437886807513337e-10
model O 0 9.236815756707983e-09
of O 0 3.5046676671868227e-10
DM B-Disease 1 0.9999978542327881
pathogenesis O 0 2.186811343563022e-06
suggests O 0 6.103217931041627e-09
that O 0 1.0660998125966437e-11
RNAs O 0 7.154732917236117e-10
from O 0 1.244578984142819e-12
the O 0 3.076321207322319e-13
expanded O 0 3.6775971157254617e-11
allele O 0 2.6010112466612334e-11
create O 0 8.15213261479153e-12
a O 0 8.501686854511803e-11
gain O 0 5.637036082362101e-08
- O 0 9.171736792268348e-07
of O 0 4.027789490823608e-10
- O 0 1.7471371620558784e-06
function O 0 4.5148609850720334e-10
mutation O 0 4.758931027026847e-10
by O 0 2.987828517583835e-12
the O 0 5.252430868712965e-12
inappropriate O 0 3.2072320355069905e-09
binding O 0 6.798113461048416e-11
of O 0 2.2489467428089827e-13
proteins O 0 9.600651003360827e-12
to O 0 3.1768285918554184e-12
the O 0 5.016211057640163e-11
CUG O 0 1.938964669534471e-05
repeats O 0 6.403883503480756e-07
. O 0 6.14952255784118e-10

Data O 0 2.5974611617129995e-07
presented O 0 3.2282341244638246e-09
here O 0 4.703144124151848e-11
indicate O 0 8.457565897623809e-11
that O 0 6.153267457197076e-13
the O 0 6.464344576122272e-13
conserved O 0 1.3285389455219843e-09
heterogeneous O 0 1.2436352392342087e-07
nuclear O 0 5.251097263681004e-06
ribonucleoprotein O 0 4.641323414489307e-07
, O 0 2.1738107841562382e-11
CUG O 0 4.4581574343283137e-07
- O 0 7.382911348940979e-08
binding O 0 5.945541392549103e-09
protein O 0 1.481029632266484e-09
( O 0 2.5845716625921833e-12
CUG O 0 1.0668605909813778e-07
- O 0 5.232877242633549e-07
BP O 0 1.9930368580389768e-05
) O 0 7.55503732491336e-12
, O 0 2.306979260402464e-12
may O 0 7.848451055725292e-11
mediate O 0 5.38401634386787e-09
the O 0 1.4185601304728124e-10
trans O 0 7.441865363944089e-07
- O 0 2.0568935724440962e-05
dominant O 0 2.1777789243060397e-06
effect O 0 8.010964114291141e-10
of O 0 2.2246246999483438e-13
the O 0 2.3092595544116357e-12
RNA O 0 1.1310837599864954e-08
. O 0 4.0107245302678507e-10

CUG O 0 0.0009076876449398696
- O 0 0.0006086815265007317
BP O 0 0.0023177932016551495
was O 0 5.377563638830907e-08
found O 0 6.540064323434791e-11
to O 0 3.591456288181555e-13
bind O 0 2.0639535913691276e-10
to O 0 2.2520858875690886e-12
the O 0 4.889190441392799e-11
human O 0 7.735955165344421e-08
cardiac O 0 5.007747859053779e-06
troponin O 0 0.00013110542204231024
T O 0 0.0001732734526740387
( O 0 1.7900217766375626e-11
cTNT O 0 1.3587970748574207e-09
) O 0 1.206243546887642e-12
pre O 0 3.859514041693046e-09
- O 0 1.3165755774480203e-07
messenger O 0 1.3021328015838662e-08
RNA O 0 3.583319474476099e-10
and O 0 1.6108383073601407e-12
regulate O 0 1.5066078593028998e-11
its O 0 2.128435773983417e-13
alternative O 0 4.2803486449694006e-12
splicing O 0 3.311294571872736e-09
. O 0 2.509770724579141e-10

Splicing O 0 1.906244193605744e-07
of O 0 8.63198346134908e-10
cTNT O 0 1.4868944617774105e-06
was O 0 9.287662550150344e-08
disrupted O 0 6.665403361694189e-06
in O 0 1.2174168340095548e-08
DM B-Disease 1 0.9999995231628418
striated O 1 0.9748896956443787
muscle O 0 0.016893256455659866
and O 0 1.029945573272073e-09
in O 0 1.0980947054428647e-11
normal O 0 9.096447206591307e-11
cells O 0 1.5359957750149533e-10
expressing O 0 2.130459437338361e-12
transcripts O 0 2.434047685628826e-10
that O 0 3.775537521510941e-11
contain O 0 2.200809312569163e-09
CUG O 0 5.3924930398352444e-05
repeats O 0 2.0960519577784e-06
. O 0 1.6103278710488667e-09

Altered O 0 2.0923869215039304e-06
expression O 0 5.075645237440085e-09
of O 0 9.996930366851231e-12
genes O 0 4.030965783385909e-09
regulated O 0 9.266923939321714e-08
posttranscriptionally O 0 3.7856827361792966e-07
by O 0 5.3563042889948065e-11
CUG O 0 1.7818407286540605e-05
- O 0 8.366303518414497e-06
BP O 0 5.291689376463182e-05
therefore O 0 3.6867853214772595e-10
may O 0 1.0384348936298693e-10
contribute O 0 1.0645615465543212e-11
to O 0 1.8381708655201834e-10
DM B-Disease 1 0.9999896287918091
pathogenesis O 0 1.769226685155445e-07
. O 0 9.330080111280559e-12
. O 0 1.2501807922227215e-10

Identification O 0 1.676639493908283e-09
of O 0 1.786924427871206e-11
a O 0 1.9225397662747667e-10
novel O 0 3.705765916350856e-09
nonsense O 0 3.3120591069746297e-06
mutation O 0 8.99154599665053e-08
and O 0 1.7256418516353733e-11
a O 0 4.4084111361364364e-12
missense O 0 2.2283324074834354e-09
substitution O 0 5.931452811552829e-12
in O 0 4.979381707306829e-13
the O 0 2.59079064625356e-12
vasopressin O 0 1.1395897558941215e-08
- O 0 1.476091711083427e-06
neurophysin O 0 4.4595194594876375e-06
II O 0 6.431486667679565e-07
gene O 0 9.483273055721497e-10
in O 0 3.689869590428607e-12
two O 0 4.83051584843075e-11
Spanish O 0 5.172124772911957e-08
kindreds O 0 1.5147497833822854e-05
with O 0 2.0577338943894574e-07
familial B-Disease 1 0.975348174571991
neurohypophyseal I-Disease 1 0.9996553659439087
diabetes I-Disease 1 0.9996864795684814
insipidus I-Disease 1 0.7158650159835815
. O 0 4.403638698136092e-08

Familial B-Disease 1 0.999319314956665
neurohypophyseal I-Disease 1 0.9996277093887329
diabetes I-Disease 1 0.9999783039093018
insipidus I-Disease 1 0.9996544122695923
( O 0 0.00010720369755290449
FNDI B-Disease 1 0.9999986886978149
) O 0 2.1657222681881194e-09
is O 0 2.400620813247656e-10
an O 0 3.6915721590702333e-09
autosomal B-Disease 1 0.9999473094940186
dominant I-Disease 1 0.9999963045120239
disease I-Disease 1 0.9999946355819702
caused O 0 0.0001277895353268832
by O 0 1.3257265152333275e-07
deficiency O 0 0.10922299325466156
in O 0 1.3166459242319739e-11
the O 0 2.318177427795831e-09
antidiuretic O 0 0.0065087671391665936
hormone O 0 8.153770068020094e-06
arginine O 0 8.240380822144289e-08
vasopressin O 0 2.8404221197320112e-08
( O 0 1.716774812587918e-11
AVP O 0 3.2200507149582336e-08
) O 0 1.1466556057524585e-13
encoded O 0 1.106482743970516e-12
by O 0 5.843602511601542e-13
the O 0 4.4464990717196784e-11
AVP O 0 0.0001859182957559824
- O 0 0.0002174639521399513
neurophysin O 0 0.0003344293509144336
II O 0 9.503798355581239e-05
( O 0 2.6339821990184475e-10
AVP O 0 4.552517566480674e-06
- O 0 2.0007003058708506e-06
NPII O 0 5.733112175221322e-06
) O 0 1.262390365852628e-12
gene O 0 3.168026257993617e-11
on O 0 2.093634987598847e-10
chromosome O 0 5.230325768934563e-06
20p13 O 0 5.801516067549528e-07
. O 0 1.219265910457068e-09

In O 0 1.6965456817175095e-09
this O 0 2.9052912419585963e-12
study O 0 1.8610753129560953e-12
, O 0 4.790670898174865e-13
we O 0 1.247658660413764e-13
analyzed O 0 1.8049698888300547e-11
two O 0 3.426156927610613e-12
families O 0 1.648435207779464e-11
with O 0 9.240065657056817e-11
FNDI B-Disease 1 0.9999428987503052
using O 0 2.9698247333564964e-11
direct O 0 4.049253553989329e-12
automated O 0 1.673298655191502e-08
fluorescent O 0 5.925661294980955e-09
, O 0 4.5177598641255035e-12
solid O 0 1.5927201224563703e-10
phase O 0 8.616417995765957e-11
, O 0 2.2457717109569675e-12
single O 0 1.0795213334358067e-10
- O 0 9.609312456859698e-09
stranded O 0 3.9497322079640185e-11
DNA O 0 1.0969767628987714e-11
sequencing O 0 1.4192469248441864e-11
of O 0 9.879252364092261e-13
PCR O 0 3.318662891160784e-07
- O 0 3.250764279982832e-07
amplified O 0 1.0114807764693978e-06
AVP O 0 8.887078365660273e-06
- O 0 2.665512397470593e-07
NPII O 0 3.0294495445559733e-06
DNA O 0 3.790299274442077e-07
. O 0 1.6725256735128369e-09

In O 0 4.5905543255564396e-10
one O 0 1.2462019263748125e-11
of O 0 5.465225169122567e-13
the O 0 1.771115545889934e-11
families O 0 1.2566045426432026e-10
, O 0 1.4041175340484546e-11
affected O 0 8.774119625298837e-11
individuals O 0 1.0155826917282451e-12
presented O 0 4.936301367663987e-12
a O 0 1.2766725177026927e-11
novel O 0 7.007186497709483e-10
nonsense O 0 1.1878715611146617e-07
mutation O 0 1.4461146724542573e-09
in O 0 7.319879836813203e-13
exon O 0 2.2962622914235453e-09
3 O 0 1.7688375764102204e-10
of O 0 5.075228431961065e-13
the O 0 4.93133268594792e-12
gene O 0 5.958843973807859e-10
, O 0 2.102011490215383e-12
consisting O 0 5.209655406721025e-13
in O 0 6.575655818463755e-13
a O 0 1.415819267380769e-10
G O 0 3.7893846638326067e-06
to O 0 5.195195384999352e-10
T O 0 1.9488419638946652e-05
transition O 0 5.132456681877784e-10
at O 0 1.5172592071621693e-09
nucleotide O 0 2.3681370198147533e-09
2101 O 0 1.634043456100187e-09
, O 0 5.688172372356193e-13
which O 0 5.870097566666385e-14
produces O 0 5.161431611971912e-12
a O 0 4.340255585488784e-12
stop O 0 1.651899061982931e-09
signal O 0 7.441551375109157e-09
in O 0 1.471140570474816e-11
codon O 0 1.0033148356569654e-07
82 O 0 5.2264489625031274e-08
( O 0 5.7481200355091744e-11
Glu O 0 1.2836158020945732e-06
) O 0 4.950255483304744e-12
of O 0 9.117165356009593e-12
NPII O 0 5.850433444720693e-05
. O 0 1.3227108297542145e-09

The O 0 1.7688047693198428e-09
premature O 0 1.0441104336678109e-07
termination O 0 1.1921951426074884e-08
eliminates O 0 4.7933518487752735e-08
part O 0 9.243732168595642e-11
of O 0 3.4456597731297167e-12
the O 0 9.659543304119111e-11
C O 0 3.0200865808183153e-07
- O 0 1.8260283241033903e-07
terminal O 0 3.183888042102012e-09
domain O 0 7.702170151668852e-11
of O 0 8.542074166062452e-12
NPII O 0 1.9479089132801164e-06
, O 0 5.545564550103743e-13
including O 0 8.397242726469398e-14
a O 0 2.3922251441051146e-13
cysteine O 0 6.535347350095089e-12
residue O 0 9.568307923757402e-09
in O 0 1.8100064849702058e-11
position O 0 7.1083934294335904e-09
85 O 0 6.838392629937573e-10
, O 0 6.060693179960053e-12
which O 0 3.042398624697462e-11
could O 0 6.410122432853882e-10
be O 0 6.955105935624317e-11
involved O 0 9.18350742673546e-11
in O 0 3.3355991579941957e-12
the O 0 3.628115863296699e-11
correct O 0 3.083672339698751e-08
folding O 0 5.781262188975234e-07
of O 0 4.27079309417433e-11
the O 0 5.03626917947031e-10
prohormone O 0 0.0001004530131467618
. O 0 2.0192449934341994e-09

In O 0 4.0198018247394884e-09
the O 0 1.0210531031784598e-10
second O 0 8.474561496996103e-09
family O 0 7.60077611960952e-10
, O 0 3.1867493669943125e-13
a O 0 2.926289581744318e-13
G279A O 0 1.8601429424558447e-11
substitution O 0 1.1705526955715917e-12
at O 0 6.651477146846219e-10
position O 0 2.9408042667711243e-09
- O 0 3.960012051607009e-08
1 O 0 7.763112375158698e-11
of O 0 1.4834211333261682e-13
the O 0 1.8668844681962726e-12
signal O 0 1.3285870181789505e-09
peptide O 0 2.6760230142919283e-10
was O 0 6.525812112911922e-10
observed O 0 1.197718053208563e-11
in O 0 8.96184846168116e-14
all O 0 2.0758943609228142e-12
affected O 0 1.321592973946295e-10
individuals O 0 3.3802734916710264e-11
. O 0 1.0639531616840614e-10

This O 0 6.004548525062603e-10
missense O 0 1.938590685313102e-06
mutation O 0 8.487759259878658e-06
, O 0 1.6532545332736959e-09
which O 0 3.8987330031048373e-10
replaces O 0 1.3432304513116833e-05
Ala O 0 2.0190668692521285e-06
with O 0 6.168435762177182e-10
Thr O 0 9.633399895392358e-05
, O 0 8.295785586254212e-11
is O 0 8.389903355388029e-12
frequent O 0 4.705013045835926e-10
among O 0 1.8870796480996432e-08
FNDI B-Disease 1 0.9999998807907104
patients O 0 4.341535770890914e-07
and O 0 5.3521170134684937e-11
is O 0 2.351503540498623e-11
thought O 0 8.623553954256735e-11
to O 0 7.954059286219284e-12
reduce O 0 1.0699122698909491e-09
the O 0 1.5827914066207649e-12
efficiency O 0 1.4181922303180272e-10
of O 0 4.3834318228137825e-13
cleavage O 0 9.773121689704567e-08
by O 0 3.480039867387319e-11
signal O 0 7.797220646921232e-09
peptidases O 0 5.4732609555685485e-08
. O 0 1.1493850142485496e-11
. O 0 7.505603777380188e-11

Genetic O 0 2.9396276204352034e-06
heterogeneity O 0 1.2549767234304454e-06
of O 0 2.8219860226386118e-08
Saethre B-Disease 1 0.8763988018035889
- I-Disease 1 0.9999667406082153
Chotzen I-Disease 1 0.999968409538269
syndrome I-Disease 1 0.9999973773956299
, O 0 2.0578529158488124e-10
due O 0 3.0070109596769257e-11
to O 0 1.489060394085917e-12
TWIST O 0 6.590229304492823e-07
and O 0 6.985065859055339e-09
FGFR O 0 4.43932440248318e-05
mutations O 0 2.435025976410543e-07
. O 0 1.5763914618105446e-09

Thirty O 0 1.6669919489231688e-07
- O 0 1.3909325389249716e-06
two O 0 2.206579363672745e-10
unrelated O 0 2.8929992623716316e-08
patients O 0 3.8838887661540866e-10
with O 0 1.0126039546795584e-12
features O 0 1.0527824167994027e-09
of O 0 1.5820059706683764e-09
Saethre B-Disease 1 0.7450909614562988
- I-Disease 1 0.9999473094940186
Chotzen I-Disease 1 0.999962568283081
syndrome I-Disease 1 0.9999912977218628
, O 0 1.9376986126751206e-11
a O 0 2.351460137717254e-10
common O 0 6.507794836352332e-08
autosomal B-Disease 1 0.5712782740592957
dominant I-Disease 1 0.7237112522125244
condition I-Disease 0 7.3195810728066135e-06
of O 0 1.2546252037282102e-08
craniosynostosis B-Disease 1 0.9833226799964905
and O 0 2.112225502060028e-06
limb B-Disease 0 0.044083766639232635
anomalies I-Disease 0 0.0005580252618528903
, O 0 9.632791786451378e-11
were O 0 2.1812909117846502e-11
screened O 0 3.7030667421333874e-09
for O 0 1.2052851772192952e-11
mutations O 0 1.5681117515597975e-09
in O 0 6.903413170972206e-12
TWIST O 0 6.7917136448159e-07
, O 0 6.439213051656623e-10
FGFR2 O 0 6.102386578277219e-06
, O 0 7.185403660958656e-11
and O 0 4.1710587761478735e-10
FGFR3 O 0 3.5336703149368986e-05
. O 0 4.788704988101244e-10

Nine O 0 3.0200862255469474e-08
novel O 0 5.431390004417835e-09
and O 0 1.1199715599374827e-09
three O 0 2.2865936921689922e-10
recurrent O 0 1.4576098692486994e-06
TWIST O 0 3.837524673144799e-06
mutations O 0 4.270817953511141e-06
were O 0 3.1452946913645974e-09
found O 0 1.1077346817600642e-09
in O 0 1.2972868439209417e-11
12 O 0 1.3814802635181422e-09
families O 0 1.2551744366096074e-10
. O 0 4.3570061447617547e-10

Seven O 0 8.426163589092539e-08
families O 0 7.524901257660588e-10
were O 0 4.2660222576706985e-11
found O 0 5.7786359031197776e-11
to O 0 2.587126476591428e-12
have O 0 2.992809125523799e-11
the O 0 1.0516976178820414e-11
FGFR3 O 0 3.7041465930087725e-06
P250R O 0 1.282184025619415e-09
mutation O 0 6.353754855581428e-09
, O 0 2.0843502271383763e-11
and O 0 1.2787000625014144e-11
one O 0 1.1727187797239136e-11
individual O 0 4.005157316910868e-11
was O 0 8.321993760773694e-08
found O 0 1.076277622580335e-09
to O 0 9.987596860661085e-11
have O 0 4.565328393102419e-10
an O 0 8.46195405412864e-11
FGFR2 O 0 2.193482214352116e-05
VV269 O 0 1.0255472027154156e-08
- O 0 2.1228382607318963e-08
270 O 0 3.0283102692152397e-09
deletion O 0 5.59612374217977e-07
. O 0 3.0993496658027198e-09

To O 0 6.068530122860238e-10
date O 0 6.622765669206387e-10
, O 0 3.538569177258255e-13
our O 0 2.097736860520033e-13
detection O 0 7.065104751236007e-11
rate O 0 1.368653279598675e-08
for O 0 2.639975044127496e-12
TWIST O 0 1.0970855157665937e-07
or O 0 2.396486120659347e-09
FGFR O 0 3.3133765100501478e-06
mutations O 0 3.509420665182006e-08
is O 0 1.1510749298171419e-10
68 O 0 2.282241950979369e-09
% O 0 1.214246693644061e-12
in O 0 4.5767014310305054e-12
our O 0 5.5090065842478e-08
Saethre B-Disease 0 0.006965692155063152
- I-Disease 1 0.9990729093551636
Chotzen I-Disease 1 0.9998950958251953
syndrome I-Disease 1 0.9999905824661255
patients O 0 8.480447455383455e-09
, O 0 3.672140174403038e-13
including O 0 5.381100296256158e-13
our O 0 2.494364437222174e-11
five O 0 1.1234327357279028e-10
patients O 0 8.263190132140608e-11
elsewhere O 0 1.992736010925089e-11
reported O 0 2.425224465696374e-10
with O 0 3.1306637837680285e-11
TWIST O 0 9.51512538449606e-06
mutations O 0 4.036109658045461e-06
. O 0 2.692253531222377e-09

More O 0 1.2371338328764914e-11
than O 0 3.250844038404921e-12
35 O 0 1.7254642159514333e-11
different O 0 2.590176608353173e-13
TWIST O 0 4.181410062642499e-08
mutations O 0 1.817674615267606e-07
are O 0 2.3385340885972994e-10
now O 0 1.8513877098058629e-09
known O 0 3.6707734074603593e-10
in O 0 1.673320770140263e-12
the O 0 3.140723445205218e-11
literature O 0 2.3678062288645663e-10
. O 0 8.06913036388579e-10

The O 0 2.0469974326697837e-10
most O 0 1.509746321015637e-11
common O 0 1.2657181726327682e-11
phenotypic O 0 8.511138460676193e-09
features O 0 2.3837683826855027e-08
, O 0 5.129537766768166e-11
present O 0 5.048150265862805e-12
in O 0 3.5093713417026773e-13
more O 0 1.73857754364945e-13
than O 0 1.1713992406278684e-12
a O 0 2.470015685041016e-11
third O 0 2.246333075106577e-08
of O 0 2.963036760394999e-10
our O 0 3.562048789262917e-08
patients O 0 1.8495162346088279e-10
with O 0 2.3143923843366165e-12
TWIST O 0 2.76268991683537e-07
mutations O 0 4.900803105556406e-07
, O 0 5.682973189258256e-11
are O 0 3.430642922519489e-12
coronal B-Disease 0 2.675168957466667e-07
synostosis I-Disease 0 6.614593985432293e-06
, O 0 6.196002044767113e-11
brachycephaly B-Disease 0 1.15423290480976e-06
, O 0 1.380666247996487e-09
low B-Disease 0 0.00032844863017089665
frontal I-Disease 1 0.9999774694442749
hairline I-Disease 1 0.9999988079071045
, O 0 1.9681895082612755e-06
facial B-Disease 0 0.1732271909713745
asymmetry I-Disease 0 3.706049392349087e-05
, O 0 1.1641630948133752e-07
ptosis B-Disease 1 0.9266891479492188
, O 0 2.640534368936187e-08
hypertelorism B-Disease 0 0.0003982043417636305
, O 0 7.282823233367708e-09
broad B-Disease 0 2.787000994430855e-06
great I-Disease 0 1.9466890080366284e-05
toes I-Disease 1 0.960520327091217
, O 0 2.2697686785644322e-10
and O 0 1.1249057241258242e-10
clinodactyly B-Disease 0 3.199638058504206e-06
. O 0 3.6412761694748497e-10

Significant O 0 3.995686981284052e-08
intra O 0 5.054551729699597e-05
- O 0 0.00010036023741122335
and O 0 8.6560101308919e-09
interfamilial O 0 3.0980804694991093e-06
phenotypic O 0 2.6719311563283554e-07
variability O 0 3.570089006643684e-07
is O 0 2.0037212167256513e-10
present O 0 5.938754696344084e-12
for O 0 3.6038923581505067e-12
either O 0 2.1027514451876783e-10
TWIST O 0 4.449163043318549e-06
mutations O 0 2.255085746583063e-06
or O 0 1.3153406541732693e-07
FGFR O 0 0.0018805464496836066
mutations O 0 6.394731371983653e-06
. O 0 7.254209233309439e-09

The O 0 5.415663473229415e-10
overlap O 0 8.576747312361022e-09
in O 0 9.904350777023563e-12
clinical O 0 1.0307669162656907e-09
features O 0 3.370356216336745e-09
and O 0 6.405820318633459e-10
the O 0 7.144433655792426e-11
presence O 0 3.342686571983222e-09
, O 0 5.630770155695686e-12
in O 0 1.3839618470332105e-13
the O 0 7.289785637111523e-13
same O 0 4.5906022039243766e-12
genes O 0 8.672973450529753e-11
, O 0 1.2658304309257074e-13
of O 0 1.4158839268944064e-14
mutations O 0 2.0539306366806898e-11
for O 0 4.697652856988643e-13
more O 0 2.0483457595019128e-13
than O 0 2.025059113452965e-11
one O 0 2.576488578043268e-09
craniosynostotic B-Disease 0 2.71699063887354e-05
condition I-Disease 0 4.8188888435163335e-09
- O 0 7.825140535544506e-09
such O 0 1.0866608307624759e-10
as O 0 2.1646238135275553e-09
Saethre B-Disease 0 2.42883828605045e-07
- I-Disease 0 3.457807906670496e-07
Chotzen I-Disease 0 7.34418847514462e-07
, I-Disease 0 1.4077080646990314e-11
Crouzon I-Disease 0 2.0165517256032217e-08
, I-Disease 0 1.559445454712982e-11
and I-Disease 0 2.7525456913757296e-10
Pfeiffer I-Disease 0 0.00024931810912676156
syndromes I-Disease 0 1.1711931620084215e-05
- O 0 9.067859707556636e-08
support O 0 4.316884696931034e-11
the O 0 1.344899885902251e-12
hypothesis O 0 6.035501959322787e-11
that O 0 2.7126986421044386e-11
TWIST O 0 2.0942226797160401e-07
and O 0 1.0087616297838053e-09
FGFRs O 0 2.3925505132638136e-08
are O 0 8.030135801098681e-13
components O 0 1.1105603936467645e-10
of O 0 5.113882949915605e-13
the O 0 3.4275557652535538e-12
same O 0 1.9150206594098496e-12
molecular O 0 3.8481533931600254e-11
pathway O 0 7.077378266773238e-11
involved O 0 3.232395948127298e-11
in O 0 2.5181679658148326e-13
the O 0 1.815195021202809e-12
modulation O 0 1.187369869093402e-09
of O 0 1.8934565026995642e-09
craniofacial O 0 0.003807893255725503
and O 0 5.5088388961621604e-08
limb O 0 4.85666760141612e-06
development O 0 3.7466710289812966e-11
in O 0 1.357222819374504e-12
humans O 0 2.587306757728669e-10
. O 0 5.378250362425563e-12
. O 0 9.422435748307478e-11

Mutation O 0 2.032226348092081e-06
analysis O 0 2.5415671345285773e-08
of O 0 1.788403558578011e-08
UBE3A O 1 0.991949200630188
in O 0 0.0014151122886687517
Angelman B-Disease 1 0.9999991655349731
syndrome I-Disease 1 1.0
patients O 0 0.00037338692345656455
. O 0 1.0548331097481878e-08

Angelman B-Disease 1 0.9999984502792358
syndrome I-Disease 1 1.0
( O 0 0.00032223673770204186
AS B-Disease 1 0.9999759197235107
) O 0 2.980022895116008e-10
is O 0 1.2952625083606506e-10
caused O 0 5.011441261970617e-10
by O 0 2.7695753676559853e-11
chromosome O 0 0.00018589558021631092
15q11 O 0 1.0952755928883562e-06
- O 0 1.7667105112195713e-06
q13 O 0 4.266980724310088e-08
deletions O 0 1.5314338241978476e-08
of O 0 1.595776011331651e-10
maternal O 0 1.9409180822549388e-06
origin O 0 8.21307022391693e-10
, O 0 3.435522699657412e-11
by O 0 1.3563390688364763e-10
paternal O 0 3.149143230984919e-05
uniparental B-Disease 0 0.43754979968070984
disomy I-Disease 1 0.651680052280426
( O 0 1.325990695022483e-07
UPD B-Disease 1 0.9999728202819824
) O 0 5.953640358491441e-10
15 O 0 1.9912818616241168e-10
, O 0 1.9817117781831262e-13
by O 0 1.399734169717226e-12
imprinting O 0 7.903781079221517e-05
defects O 1 0.9999252557754517
, O 0 3.9952863239989256e-10
and O 0 8.586063283966272e-12
by O 0 2.8737886636348575e-12
mutations O 0 2.1858410637065617e-09
in O 0 5.346238209080756e-12
the O 0 3.235851864236139e-10
UBE3A O 0 0.00010493009176570922
gene O 0 5.903936184381564e-08
. O 0 1.5282757281909198e-09

UBE3A O 0 0.0002349431160837412
encodes O 0 1.830308491435062e-07
a O 0 2.7186581874616422e-09
ubiquitin O 0 3.480038301972854e-08
- O 0 2.9787312882945116e-07
protein O 0 9.928494693056678e-10
ligase O 0 2.618074645965862e-10
and O 0 1.657781030506289e-11
shows O 0 6.390970863634493e-09
brain O 0 4.140469627600396e-06
- O 0 6.749028216290753e-07
specific O 0 8.73553451796738e-10
imprinting O 0 1.579713716637343e-05
. O 0 7.428221149297087e-09

Here O 0 3.082400779064187e-09
we O 0 2.95138774530912e-11
describe O 0 1.8747045582578892e-10
UBE3A O 0 1.1046694226024556e-06
coding O 0 1.1864149200846441e-06
- O 0 7.3123874244629405e-06
region O 0 1.7248144024151202e-09
mutations O 0 1.2850982500367536e-08
detected O 0 4.487161930910588e-08
by O 0 5.468606470437898e-12
SSCP O 0 1.8507714116822171e-07
analysis O 0 8.9147231263631e-11
in O 0 2.5180120141743423e-11
13 O 0 1.0505885050804409e-08
AS B-Disease 1 0.9996641874313354
individuals O 0 9.336764694722888e-10
or O 0 1.6191608054327844e-09
families O 0 6.444300093555455e-10
. O 0 5.12803410845919e-10

Two O 0 4.401662589970101e-09
identical O 0 2.0189385452340503e-07
de O 0 7.200923732852971e-07
novo O 0 3.362694940278743e-07
5 O 0 3.4339868726362965e-09
- O 0 1.2355113199191692e-07
bp O 0 7.117404265954974e-08
duplications O 0 8.946363649897648e-09
in O 0 7.2338732226562286e-12
exon O 0 3.942046689076051e-08
16 O 0 2.730058845656913e-09
were O 0 7.43130279534654e-11
found O 0 6.4618266293337e-10
. O 0 4.102297945784983e-10

Among O 0 4.890463589646288e-09
the O 0 6.1673001774953384e-12
other O 0 2.686750344774169e-12
11 O 0 6.12728617843672e-11
unique O 0 2.9536895932574803e-12
mutations O 0 8.675479890030147e-09
, O 0 3.250795813092289e-11
8 O 0 6.56969811885233e-10
were O 0 2.2808688965314516e-11
small O 0 7.163587865260945e-12
deletions O 0 9.323511740433332e-09
or O 0 1.593112752829029e-09
insertions O 0 1.4132069736660924e-07
predicted O 0 2.7842727376992116e-06
to O 0 3.952290938968872e-09
cause O 0 1.1530580934504542e-08
frameshifts O 0 1.1412056437620777e-06
, O 0 2.0585779608728316e-11
1 O 0 4.305882039812303e-11
was O 0 2.5554389715409798e-09
a O 0 2.2967070953394675e-11
mutation O 0 7.691280945465451e-10
to O 0 6.33173895259187e-12
a O 0 3.7709460554147256e-11
stop O 0 1.4580683327380939e-09
codon O 0 1.4132622849771792e-09
, O 0 1.7401774465852782e-12
1 O 0 4.251155417273056e-12
was O 0 1.3692054434688572e-10
a O 0 3.3153341183478346e-12
missense O 0 3.369175161083149e-08
mutation O 0 8.035518561655408e-08
, O 0 6.535450652878083e-11
and O 0 1.0251276216788341e-10
1 O 0 1.2881159472399872e-09
was O 0 1.5206590830985078e-07
predicted O 0 2.3870807552839324e-08
to O 0 8.720929534078437e-11
cause O 0 2.8300457463603657e-11
insertion O 0 1.0761005975190585e-10
of O 0 3.537492868077585e-11
an O 0 1.4917689306059856e-09
isoleucine O 0 1.5208173863356933e-05
in O 0 3.54104384703291e-11
the O 0 1.0138606100495995e-11
hect O 0 4.4956170341947654e-08
domain O 0 1.669229476863876e-10
of O 0 4.047461584638645e-12
the O 0 1.4048147367606845e-10
UBE3A O 0 3.508053396217292e-06
protein O 0 3.827222538888009e-09
, O 0 9.787051811344094e-13
which O 0 1.2186032619185966e-13
functions O 0 6.840678197506112e-13
in O 0 1.3242006232858095e-12
E2 O 0 1.7079695169286424e-07
binding O 0 3.7565421884266925e-09
and O 0 3.7197696312052386e-11
ubiquitin O 0 1.5565051469934588e-09
transfer O 0 2.485192274193082e-09
. O 0 1.9176333854176164e-09

Eight O 0 5.6089337618914215e-09
of O 0 6.992973474589936e-12
the O 0 4.900811527430715e-12
cases O 0 3.952841165499876e-09
were O 0 5.336608488448746e-09
familial O 0 1.6988282141028321e-06
, O 0 1.5307670686581787e-09
and O 0 1.1389019588525784e-10
five O 0 1.5905433914387146e-10
were O 0 4.261128949689663e-10
sporadic O 0 3.446271890084063e-08
. O 0 1.0280515327920625e-09

In O 0 1.3652579067269244e-09
two O 0 6.364433285943605e-11
familial O 0 4.0579715232524904e-07
cases O 0 1.344880047327024e-07
and O 0 6.770851657122989e-10
one O 0 6.069175717549058e-11
sporadic O 0 7.129874468603248e-09
case O 0 2.663986897744053e-08
, O 0 1.5716015294708896e-11
mosaicism O 0 5.6746415566522046e-08
for O 0 4.498157749055487e-11
UBE3A O 0 1.778659452611464e-06
mutations O 0 1.9237081261280764e-08
was O 0 1.195341869930644e-08
detected O 0 1.6641963895835943e-07
in O 0 2.046301669778039e-11
the O 0 8.878816432078551e-11
mother O 0 1.3882713290058746e-07
of O 0 1.4351715128813058e-11
three O 0 6.93586699185289e-08
AS B-Disease 1 0.9999998807907104
sons O 0 2.417854375380557e-06
, O 0 1.6267029390171217e-11
in O 0 7.578847488823315e-13
the O 0 6.513199701796424e-11
maternal O 0 6.251446507121727e-07
grandfather O 0 8.400558044741047e-07
of O 0 1.6759472282190657e-11
two O 0 5.5490039230221555e-09
AS B-Disease 1 0.9999980926513672
first O 0 5.3794511956084534e-08
cousins O 0 4.202504896966275e-06
, O 0 4.798368924419094e-10
and O 0 8.839428494722412e-11
in O 0 5.427529519569374e-12
the O 0 2.1704353592166825e-10
mother O 0 4.3847222741533187e-07
of O 0 1.705361893367119e-11
an O 0 9.64287920623974e-08
AS B-Disease 1 0.9999996423721313
daughter O 0 0.006328253075480461
. O 0 4.1618184454250695e-09

The O 0 1.2561802986699178e-10
frequencies O 0 1.1960573642610939e-09
with O 0 5.0458429101674085e-11
which O 0 1.1961017246098216e-11
we O 0 2.0540088727094563e-11
detected O 0 5.464986241321412e-09
mutations O 0 2.9555820013627e-09
were O 0 3.0257218952556286e-10
5 O 0 2.796819997819e-10
( O 0 2.206951852171124e-12
14 O 0 4.0051725824774564e-11
% O 0 8.65488101109077e-14
) O 0 1.2203005465383047e-14
of O 0 4.3722902224761426e-14
35 O 0 3.013431448817272e-10
in O 0 1.7211606489000997e-12
sporadic O 0 3.883935395521121e-09
cases O 0 2.863945169906401e-08
and O 0 7.330289708562532e-09
8 O 0 1.2381081937462568e-08
( O 0 6.292586677419942e-12
80 O 0 3.2045505138356134e-11
% O 0 7.98450118955768e-13
) O 0 1.2358119898508296e-13
of O 0 3.684713124896266e-13
10 O 0 3.053241826034281e-10
in O 0 2.7576294112791055e-12
familial O 0 6.340283675854153e-08
cases O 0 2.1612830636286162e-08
. O 0 6.731214197142066e-11
. O 0 4.874750048067256e-10

The O 0 1.6086761434053187e-07
hemochromatosis B-Disease 1 0.9998815059661865
845 O 0 0.00030104024335741997
G O 0 0.001038089976646006
- O 0 2.29680813390587e-06
- O 0 3.854539727399242e-07
> O 0 1.5126445651603149e-09
A O 0 7.560522763405686e-10
and O 0 2.0728290611726763e-11
187 O 0 2.0401139111392297e-10
C O 0 2.7607296004816817e-08
- O 0 2.670799688075931e-07
- O 0 2.195753268097178e-06
> O 0 2.2147995437649115e-08
G O 0 4.958164481649874e-06
mutations O 0 2.4843261670071115e-08
: O 0 2.2509704170059486e-11
prevalence O 0 2.5337826059512736e-07
in O 0 5.5560941264465313e-11
non O 0 2.408415866739233e-07
- O 0 4.0898987208493054e-05
Caucasian O 0 8.974608135758899e-06
populations O 0 5.220550747253583e-08
. O 0 5.569423255913364e-10

Hemochromatosis B-Disease 1 0.9197354316711426
, O 0 3.6452482277127274e-07
the O 0 2.1409507553471485e-06
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 8.867252290656324e-06
iron I-Disease 1 0.9960058331489563
metabolism I-Disease 0 0.0011778706684708595
, O 0 1.1435994512476455e-10
leads O 0 2.4912478746585975e-09
, O 0 2.250523899183232e-11
if O 0 1.1446169567719267e-09
untreated O 0 6.357737220241688e-06
, O 0 3.111756338713967e-11
to O 0 2.0424033297938848e-10
progressive O 0 9.696046845419914e-07
iron B-Disease 1 0.8800933361053467
overload I-Disease 0 0.0015576451551169157
and O 0 6.889086634487285e-09
premature B-Disease 0 7.192132045474864e-08
death I-Disease 0 5.717509132807663e-09
. O 0 4.916461682213935e-10

The O 0 2.9527896572290047e-07
hemochromatosis B-Disease 1 0.9999552965164185
gene O 0 8.658712613396347e-05
, O 0 1.763623580508522e-09
HFE O 0 2.3448559659300372e-05
, O 0 2.0340101825055967e-10
recently O 0 5.306597117282763e-08
has O 0 1.8427915859930977e-09
been O 0 5.136491787460784e-10
identified O 0 2.5639437239988183e-09
, O 0 6.350800961507641e-12
and O 0 8.920905463991047e-13
characterization O 0 1.1059095479659664e-11
of O 0 2.3323964287724763e-13
this O 0 3.774353063163566e-13
gene O 0 2.35612129806384e-09
has O 0 7.5917672148762e-09
shown O 0 2.5248469981420385e-10
that O 0 6.1243614346562225e-12
it O 0 4.216045915161892e-12
contains O 0 3.5071782717582822e-12
two O 0 1.189444983479282e-11
mutations O 0 4.7526742541492695e-09
that O 0 1.169246366394816e-10
result O 0 1.1873919902871677e-10
in O 0 3.108562886267041e-12
amino O 0 6.461380042122045e-11
acid O 0 2.7629695406594657e-11
substitutions O 0 1.2296857108962111e-11
- O 0 1.8807785884256134e-10
cDNA O 0 7.565827131461589e-11
nucleotides O 0 5.781924383718717e-10
845 O 0 1.429821150367161e-08
G O 0 7.637272005922568e-07
- O 0 1.56464906808651e-07
- O 0 4.333911647336208e-07
> O 0 1.1433797242332844e-09
A O 0 1.7585246592233261e-09
( O 0 1.1244841863211619e-12
C282Y O 0 3.095430162192159e-11
) O 0 4.007932901577485e-14
and O 0 1.7048007157436512e-13
187 O 0 5.822248239084615e-11
C O 0 3.907186041374189e-08
- O 0 2.1325511170289246e-06
- O 0 4.8248828534269705e-05
> O 0 2.5028566597029567e-07
G O 0 3.346083394717425e-05
( O 0 6.38736910585358e-11
H63D O 0 4.345425566043559e-07
) O 0 2.0712206255657506e-11
. O 0 6.532559215788325e-11

Although O 0 5.661793238687096e-06
hemochromatosis B-Disease 1 0.999995231628418
is O 0 1.5494244109959254e-07
common O 0 8.651367400247523e-10
in O 0 4.330027222193555e-12
Caucasians O 0 9.192454797357641e-09
, O 0 8.202448269212237e-12
affecting O 0 4.035387024536874e-10
> O 0 2.1286786222596277e-10
= O 0 6.065166147095624e-09
1 O 0 2.5193042096915974e-11
/ O 0 2.226326067944484e-10
300 O 0 3.369811157546976e-12
individuals O 0 1.8735694419513838e-12
of O 0 1.9306147392567086e-12
northern O 0 6.634194860133391e-10
European O 0 9.685048318885947e-09
origin O 0 3.473680024179693e-11
, O 0 5.299192508412265e-12
it O 0 4.062127370585422e-11
has O 0 1.1770246999276424e-09
not O 0 1.087182687625754e-11
been O 0 3.003275406143757e-10
recognized O 0 6.9008067489495506e-12
in O 0 4.4685143172490394e-13
other O 0 1.0461478905376964e-11
populations O 0 1.6524096535519561e-09
. O 0 7.067372798097438e-10

The O 0 1.8352211417216324e-10
present O 0 7.165678207049497e-12
study O 0 9.675465723751886e-13
used O 0 1.5177295184520823e-11
PCR O 0 3.907753125531599e-07
and O 0 2.2554884349101911e-10
restriction O 0 4.289947841407127e-10
- O 0 2.665867526729926e-08
enzyme O 0 2.3656046010955833e-09
digestion O 0 7.023735065780912e-11
to O 0 3.1324626865916055e-14
analyze O 0 3.328398754526285e-12
the O 0 1.8185313552330357e-13
frequency O 0 4.885328686726753e-12
of O 0 1.611744049855035e-13
the O 0 3.1914529612792064e-12
845 O 0 7.011843106141669e-09
G O 0 1.171207557604248e-07
- O 0 9.880477769286244e-09
- O 0 1.2708824215224013e-08
> O 0 4.3238069374895716e-11
A O 0 7.583366573582495e-11
and O 0 3.23362734158672e-12
187 O 0 4.0786561628092244e-11
C O 0 4.5623451683241e-09
- O 0 9.326983274604572e-08
- O 0 4.310811334562459e-07
> O 0 2.2195476567787864e-09
G O 0 1.290907505335781e-07
mutations O 0 6.295978738357633e-10
in O 0 2.191347011617703e-13
HLA O 0 9.455584093487346e-10
- O 0 6.542488217853304e-10
typed O 0 4.902714900723026e-10
samples O 0 9.245195581319976e-11
from O 0 1.5162587982051057e-12
non O 0 2.592544179336187e-09
- O 0 2.1907176517288462e-07
Caucasian O 0 4.175560164298986e-08
populations O 0 6.469645930096135e-10
, O 0 3.542533291451405e-13
comprising O 0 1.3243774566601418e-12
Australian O 0 3.5476319659721867e-09
Aboriginal O 0 1.5719350821008504e-10
, O 0 3.762665634794715e-13
Chinese O 0 5.90648610208043e-14
, O 0 9.909673992850032e-13
and O 0 1.560373878717325e-11
Pacific O 0 4.030596301163314e-09
Islanders O 0 1.924620676163613e-07
. O 0 3.80547093836725e-10

Results O 0 3.5548680443753256e-08
showed O 0 5.785305745575897e-08
that O 0 5.311133043778282e-12
the O 0 2.9555099687050834e-12
845 O 0 7.241024491122516e-08
G O 0 4.693831670010695e-06
- O 0 4.868288669968024e-07
- O 0 5.274593490867119e-07
> O 0 4.1531098005087586e-10
A O 0 5.756428111958201e-10
mutation O 0 5.1016666446912495e-09
was O 0 2.215467098665158e-08
present O 0 1.2623259208754956e-11
in O 0 1.9691873457371167e-13
these O 0 1.4428330763222724e-13
populations O 0 1.6761262516817865e-11
( O 0 8.82763778525461e-14
allele O 0 5.57903940059945e-12
frequency O 0 1.2435955043521574e-10
0 O 0 1.1937480171031467e-10
. O 0 1.1072322529323553e-12
32 O 0 3.3153249590078815e-10
% O 0 1.2070145230524965e-12
) O 0 9.21286701441315e-13
, O 0 1.963352874376212e-12
and O 0 3.2116670434234607e-11
, O 0 1.6487991527647239e-12
furthermore O 0 3.914630338636149e-12
, O 0 1.4809313714572725e-12
it O 0 1.7905896210201888e-10
was O 0 2.967797456676635e-07
always O 0 2.4848176849445736e-09
seen O 0 9.775206422091287e-09
in O 0 4.3406757680407304e-13
conjunction O 0 8.010482901998905e-12
with O 0 5.033337288629092e-11
HLA O 0 5.725468099626596e-08
haplotypes O 0 1.495553014763118e-08
common O 0 6.278003672477439e-10
in O 0 3.025511048290741e-12
Caucasians O 0 8.250532479436856e-10
, O 0 5.408409180576723e-13
suggesting O 0 9.831627872936011e-11
that O 0 2.5785053345966924e-12
845 O 0 1.5233059258434878e-08
G O 0 7.773858669679612e-06
- O 0 2.4244789074145956e-06
- O 0 7.370209004875505e-06
> O 0 1.1433781921255104e-08
A O 0 1.0032708530616219e-07
may O 0 2.2356772433340666e-08
have O 0 1.672932278817818e-11
been O 0 1.7475691033164154e-11
introduced O 0 3.944919477888442e-12
into O 0 1.8032611807852067e-13
these O 0 3.9969877451209723e-13
populations O 0 1.4387345481647884e-11
by O 0 4.957834056490418e-12
Caucasian O 0 7.51337765336757e-08
admixture O 0 1.1492863905004924e-07
. O 0 1.3187054781482743e-09

187 O 0 1.4370563121701707e-06
C O 0 1.4247027138480917e-05
- O 0 2.252766535093542e-06
- O 0 8.736816198506858e-06
> O 0 1.9539797335710318e-08
G O 0 2.7531475552677875e-06
was O 0 8.613793567313621e-10
present O 0 6.315199556870821e-13
at O 0 8.254050221090381e-12
an O 0 2.943272795624674e-13
allele O 0 2.9711282045763454e-11
frequency O 0 2.0859261540273621e-10
of O 0 4.627756511332848e-11
2 O 0 2.307467994455692e-08
. O 0 7.735859730573225e-10

68 O 0 7.5177522376179695e-06
% O 0 4.893110916448506e-10
in O 0 2.9064552414109768e-12
the O 0 6.21071390930622e-13
two O 0 3.2670799659378913e-12
populations O 0 5.950822473677064e-11
analyzed O 0 5.3462461124809124e-09
( O 0 1.2153554551641577e-10
Australian O 0 1.8670650092644792e-07
Aboriginal O 0 4.571456546642594e-09
and O 0 1.3894892181287588e-10
Chinese O 0 3.1051318200719935e-12
) O 0 6.1393199551895705e-12
. O 0 2.1753371673427502e-11

In O 0 4.703065714650734e-10
the O 0 2.6429490540547107e-11
Australian O 0 4.5274535231953905e-09
Aboriginal O 0 9.628029276620431e-12
samples O 0 4.274784085739336e-12
, O 0 1.455997865676406e-13
187 O 0 3.173517351684474e-11
C O 0 7.775241783747333e-09
- O 0 1.306303687442778e-07
- O 0 1.0580490652500885e-06
> O 0 7.740114327248193e-09
G O 0 1.6147627093232586e-06
was O 0 2.5373907419634634e-09
found O 0 1.0426935356799838e-11
to O 0 1.0352379760728003e-12
be O 0 2.8067263790898522e-11
associated O 0 5.558190192822554e-12
with O 0 1.0285270898857668e-11
HLA O 0 6.770625304852729e-08
haplotypes O 0 1.613036815228952e-08
common O 0 2.559057854512048e-09
in O 0 4.493936039268176e-12
Caucasians O 0 4.22505230801562e-09
, O 0 3.105155672519788e-12
suggesting O 0 1.998263499114472e-10
that O 0 2.558849182890399e-12
it O 0 1.615756486939013e-11
was O 0 2.612239979882247e-09
introduced O 0 5.065002237070182e-11
by O 0 1.7677296258733488e-12
recent O 0 2.036813079309141e-10
admixture O 0 3.748513321966129e-08
. O 0 1.1149862144677058e-09

In O 0 1.9443635590477015e-10
the O 0 1.1020766547617522e-12
Chinese O 0 3.860350963045579e-14
samples O 0 4.139445676423076e-13
analyzed O 0 5.684878349315747e-12
, O 0 4.808354642183918e-14
187 O 0 9.511631066105863e-12
C O 0 4.218763116625723e-09
- O 0 1.1792729281978609e-07
- O 0 6.59273780456715e-07
> O 0 3.3458760206883653e-09
G O 0 4.9332807066093665e-06
was O 0 1.6949066150573344e-08
present O 0 1.831174795130508e-11
in O 0 1.6613387748831698e-11
association O 0 1.3211437152604866e-11
with O 0 2.086222470817911e-12
a O 0 4.327998723296922e-11
wide O 0 2.595443637787298e-09
variety O 0 3.660984015940727e-10
of O 0 2.1912069381180288e-11
HLA O 0 9.566888792278405e-08
haplotypes O 0 1.3655659714117974e-08
, O 0 9.444129506208654e-12
showing O 0 6.530618268385524e-10
this O 0 2.582190375150645e-13
mutation O 0 5.042737893923288e-10
to O 0 4.8627036425274994e-11
be O 0 5.757339605061418e-10
widespread O 0 6.574248367918756e-10
and O 0 5.697585181430043e-10
likely O 0 1.6441280281664916e-10
to O 0 4.571813847636941e-13
predate O 0 1.4092212119454217e-10
the O 0 1.5419521941836128e-13
more O 0 1.2849405784179369e-13
genetically O 0 1.2594598974846605e-10
restricted O 0 1.8969718157402227e-11
845 O 0 2.952426747526715e-09
G O 0 8.687172226018447e-07
- O 0 6.775016458959726e-07
- O 0 1.2339635304670082e-06
> O 0 1.9728680911157426e-09
A O 0 6.744638625377775e-09
mutation O 0 1.242544556134817e-07
. O 0 7.961291625946387e-10

Genotype O 0 0.0017468258738517761
- O 0 0.003164567518979311
phenotype O 0 0.00042105052853003144
correlations O 0 0.0009484422625973821
in O 0 2.034754970736685e-06
attenuated B-Disease 1 0.9945057034492493
adenomatous I-Disease 1 0.999954104423523
polyposis I-Disease 1 0.9996308088302612
coli I-Disease 1 0.9999802112579346
. O 0 1.863403895185911e-06

Germ O 0 0.004496023058891296
- O 0 0.0006303155096247792
line O 0 2.784835714919609e-06
mutations O 0 1.1429523283368326e-07
of O 0 8.3188829089198e-12
the O 0 6.066710328545e-11
tumor B-Disease 0 4.3063326415904157e-07
suppressor O 0 4.730112834749889e-07
APC O 0 1.9724566300283186e-06
are O 0 5.698954086419405e-10
implicated O 0 6.216456677066162e-05
in O 0 2.472169171596761e-07
attenuated B-Disease 1 0.9994663596153259
adenomatous I-Disease 1 0.999997615814209
polyposis I-Disease 1 0.9999756813049316
coli I-Disease 1 0.9999997615814209
( O 0 7.459754851879552e-05
AAPC B-Disease 1 0.9999860525131226
) O 0 6.533895646754218e-10
, O 0 2.1606522994377375e-12
a O 0 2.72445510596242e-10
variant O 0 0.00028662336990237236
of O 0 0.000128318220959045
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.9999904632568359
polyposis I-Disease 1 0.9999974966049194
( O 0 2.7249313916399842e-06
FAP B-Disease 0 1.0376674254075624e-05
) O 0 2.0141215362201592e-09
. O 0 5.461242014170864e-10

AAPC B-Disease 1 0.9998792409896851
is O 0 3.598133844207041e-07
recognized O 0 1.9743426338258985e-10
by O 0 1.65148710679075e-12
the O 0 1.0754551546185431e-12
occurrence O 0 5.708552297534197e-09
of O 0 1.893230711091931e-11
< O 0 3.3189408554790134e-08
100 O 0 3.038491402929111e-10
colonic B-Disease 0 4.190492290945258e-07
adenomas I-Disease 0 1.1324143088131677e-05
and O 0 1.3000170384636078e-10
a O 0 7.318240458076275e-11
later O 0 4.353710725268911e-09
onset O 0 1.8004282537731342e-05
of O 0 0.0001342587493127212
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.211498539850254e-08
age O 0 1.3027315226565861e-08
> O 0 8.839146636852035e-10
40 O 0 1.0925386151328098e-09
years O 0 8.62908633436632e-10
) O 0 1.204177556279884e-11
. O 0 4.787606769363073e-11

The O 0 4.22924251175516e-10
aim O 0 1.315251685340968e-09
of O 0 9.116934637787288e-13
this O 0 7.66586975647042e-14
study O 0 5.879221263473122e-13
was O 0 3.130528059003268e-10
to O 0 8.229491849261195e-13
assess O 0 3.322511377135129e-09
genotype O 0 1.0218766988145944e-07
- O 0 5.14734301759745e-06
phenotype O 0 2.390357281001343e-07
correlations O 0 1.1980304179814993e-06
in O 0 1.469006161158859e-08
AAPC B-Disease 1 0.9998921155929565
families O 0 2.958273626063601e-08
. O 0 6.471039815103552e-10

By O 0 1.1489543760845322e-09
protein O 0 1.6406900726906315e-08
- O 0 1.6419428447989048e-06
truncation O 0 9.629021405999083e-06
test O 0 4.3161771827726625e-06
( O 0 1.9615722240962086e-11
PTT O 0 2.7670029822957076e-08
) O 0 5.794125487561252e-13
assay O 0 1.3047045388514533e-10
, O 0 2.9724343104074735e-13
the O 0 5.972850794684625e-14
entire O 0 1.810279356972977e-11
coding O 0 1.8394528567000634e-08
region O 0 2.19224378233962e-11
of O 0 3.2162673132413166e-13
the O 0 1.0397740828060886e-11
APC B-Disease 0 7.57802354200976e-09
gene O 0 6.46883102639606e-10
was O 0 2.6724948920531233e-09
screened O 0 3.970795692254114e-09
in O 0 2.8006607449837517e-12
affected O 0 2.8284713460280386e-10
individuals O 0 1.064533183825489e-11
from O 0 1.585376274704231e-10
11 O 0 2.7014575607609004e-06
AAPC B-Disease 1 0.9999916553497314
kindreds O 0 4.068611360708019e-06
, O 0 8.224211589524799e-11
and O 0 4.0977113195672654e-12
their O 0 2.847902469405028e-12
phenotypic O 0 2.6231356642369974e-08
differences O 0 1.4210287169191815e-08
were O 0 1.1785949993736722e-09
examined O 0 1.1004072320019986e-07
. O 0 1.290831219691313e-09

Five O 0 8.180633059851061e-09
novel O 0 1.759861056882528e-08
germ O 0 0.00045533914817497134
- O 0 0.00021782875410281122
line O 0 7.626437309227185e-06
APC B-Disease 0 6.783175194868818e-07
mutations O 0 5.014946324877201e-08
were O 0 6.93367585569149e-11
identified O 0 4.910969408911114e-10
in O 0 5.092588243466034e-12
seven O 0 5.191988616815024e-09
kindreds O 0 1.3441504961519968e-05
. O 0 1.7655084061374282e-09

Mutations O 0 7.752930105198175e-05
were O 0 1.686898620789634e-08
located O 0 1.0578123932347694e-09
in O 0 1.2038140666595365e-12
three O 0 1.7869985005636302e-12
different O 0 1.855509561103641e-13
regions O 0 2.145506862449853e-12
of O 0 5.892917989518132e-13
the O 0 1.15533548006308e-10
APC B-Disease 0 6.184320966440282e-08
gene O 0 2.2642436814379607e-09
( O 0 7.20563018974385e-12
1 O 0 3.8266348423299235e-11
) O 0 2.5064279536406164e-13
at O 0 9.261962724549377e-11
the O 0 7.886954110636335e-12
5 O 0 3.8569514249076065e-10
end O 0 5.186166496251587e-10
spanning O 0 4.354831606434573e-09
exons O 0 5.358136832001037e-07
4 O 0 1.0529556782046257e-08
and O 0 8.404182350041367e-10
5 O 0 2.1978718844906098e-10
, O 0 6.0296537728044e-12
( O 0 4.969761039329279e-13
2 O 0 1.1260021560988154e-11
) O 0 4.412461268219446e-14
within O 0 3.000315043611389e-14
exon O 0 2.4135886178555666e-08
9 O 0 1.52381801399315e-07
, O 0 4.942823580988964e-11
and O 0 2.5846383366889825e-10
( O 0 8.652777279405388e-12
3 O 0 1.5263959540767758e-10
) O 0 9.122744877229638e-13
at O 0 4.470292191971481e-11
the O 0 7.73906980167105e-12
3 O 0 8.403989726346595e-10
distal O 0 1.469633836848061e-08
end O 0 1.174109809376489e-09
of O 0 8.957665880750254e-13
the O 0 1.720567438523446e-11
gene O 0 5.911166667260659e-09
. O 0 1.0331525635010053e-09

Variability O 0 1.08089070636197e-05
in O 0 1.468494770229256e-10
the O 0 4.654842917367619e-12
number O 0 4.017063626182704e-10
of O 0 8.608486155026185e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 0.0007387371151708066
most O 0 3.603208564850746e-10
apparent O 0 5.47935830041979e-09
in O 0 1.0673469920396972e-11
individuals O 0 8.548463152624475e-12
with O 0 1.5293305510866162e-10
mutations O 0 1.1192891946620875e-07
in O 0 2.330047821352821e-10
region O 0 8.169916965172774e-10
1 O 0 1.3341769466990172e-08
, O 0 9.44232025901215e-10
and O 0 5.989775075931902e-08
upper O 0 0.0007000656332820654
- O 1 0.9998674392700195
gastrointestinal O 0 0.18792836368083954
manifestations O 0 8.564815061617992e-07
were O 0 6.854637968345401e-10
more O 0 1.1888642847956987e-11
severe O 0 9.682281643108581e-08
in O 0 5.530353735724858e-13
them O 0 5.160154248340376e-11
. O 0 4.640008932632611e-10

In O 0 1.672295968369042e-09
individuals O 0 8.480309510172646e-11
with O 0 2.422647846223036e-11
mutations O 0 2.90669373015362e-08
in O 0 3.702286047180259e-11
either O 0 1.9149650754002323e-09
region O 0 2.213269789663741e-09
2 O 0 7.565487791794112e-09
or O 0 1.0753097079430063e-08
region O 0 1.7808551855402754e-10
3 O 0 2.1170498687439476e-10
, O 0 1.901828168690209e-13
the O 0 2.1593821565926707e-13
average O 0 6.023409770961052e-09
number O 0 3.3953746064741e-11
of O 0 7.023785632970236e-12
adenomas B-Disease 0 2.0537552245514235e-06
tended O 0 1.6463326701909864e-08
to O 0 8.878472609885613e-12
be O 0 2.791297575022167e-11
lower O 0 6.185421619342435e-11
than O 0 6.979781336236002e-12
those O 0 5.4791722374492036e-12
in O 0 7.382118462524734e-13
individuals O 0 1.1697805267843475e-12
with O 0 1.0345673102929442e-11
mutations O 0 8.465223189091375e-09
in O 0 1.957932427298914e-10
region O 0 9.322973504310994e-10
1 O 0 1.6410459657834053e-09
, O 0 2.7323639878451544e-11
although O 0 5.472396841232907e-11
age O 0 2.4991770875004704e-09
at O 0 3.935553216649623e-09
diagnosis O 0 3.95409585962625e-07
was O 0 9.783641274907495e-08
similar O 0 1.7992887735296392e-10
. O 0 1.942229710394372e-09

In O 0 2.881995087022915e-08
all O 0 1.6530881552512255e-08
AAPC B-Disease 1 0.999879002571106
kindreds O 0 4.665946562454337e-06
, O 0 1.579779189408992e-11
a O 0 9.056037170163123e-12
predominance O 0 2.363026219143194e-08
of O 0 1.2299777862878614e-09
right O 0 0.00792907364666462
- O 1 0.9999901056289673
sided O 1 0.9999988079071045
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
and O 0 0.001542871817946434
rectal B-Disease 1 0.9997535347938538
polyp I-Disease 1 0.9314563274383545
sparing O 0 2.0231764210620895e-06
was O 0 2.1983044007356511e-07
observed O 0 1.1781843056724028e-08
. O 0 7.637979693164709e-10

No O 0 1.4405221918423194e-05
desmoid B-Disease 1 0.7697539925575256
tumors I-Disease 1 0.9999997615814209
were O 0 1.4548834315064596e-07
found O 0 2.955948597005431e-09
in O 0 4.760595997271855e-12
these O 0 4.2865110766454606e-11
kindreds O 0 2.855343609553529e-06
. O 0 1.4874219633753683e-09

Our O 0 8.138779650224137e-10
data O 0 1.0502994030048285e-09
suggest O 0 3.3274311084241504e-10
that O 0 4.597772509939979e-11
, O 0 6.041790678867898e-11
in O 0 3.0644844994931475e-10
AAPC B-Disease 1 0.9999966621398926
families O 0 6.995221069061586e-10
, O 0 2.7706558835410844e-13
the O 0 3.0122646456180735e-14
location O 0 3.7703704741653965e-11
of O 0 2.9734621882770984e-12
the O 0 1.9547092833249735e-09
APC B-Disease 0 1.4797824405832216e-05
mutation O 0 1.2371189086479717e-06
may O 0 3.895912215057251e-08
partially O 0 1.1006713762640175e-08
predict O 0 8.832989895068977e-11
specific O 0 2.7132627741788262e-11
phenotypic O 0 2.713759386097081e-07
expression O 0 3.2663884041994606e-08
. O 0 7.267916268816066e-10

This O 0 5.624786192370834e-10
should O 0 5.901899802207566e-11
help O 0 6.6179353663819995e-12
in O 0 4.739535925724937e-14
the O 0 6.999838263275354e-14
design O 0 9.813661688840014e-11
of O 0 2.5871362344109805e-12
tailored O 0 5.540905334555646e-08
clinical O 0 4.600384428954385e-08
- O 0 9.940514473782969e-07
management O 0 1.4455796559786904e-09
protocols O 0 1.943414457139525e-10
in O 0 4.2938685240875504e-14
this O 0 6.425431425127618e-15
subset O 0 1.7485784955389994e-12
of O 0 7.42428601235856e-12
FAP B-Disease 0 2.733719099978771e-07
patients O 0 9.343802398475987e-10
. O 0 2.744239297608475e-12
. O 0 9.893461050403118e-11

Wilms B-Disease 1 0.9926039576530457
' I-Disease 0 0.00013987941201776266
tumor I-Disease 0 3.309082967462018e-05
1 O 0 4.590556379469035e-09
and O 0 2.4511551122152753e-10
Dax O 0 0.36988046765327454
- O 0 5.834490821143845e-06
1 O 0 6.858247303398457e-10
modulate O 0 5.168758754336977e-09
the O 0 3.5437194845222564e-11
orphan O 0 1.253312689186714e-07
nuclear O 0 3.810369975099093e-08
receptor O 0 2.6161678379210684e-10
SF O 0 2.7601063266047277e-06
- O 0 1.0998846988741207e-07
1 O 0 6.260147955572393e-11
in O 0 1.8884468099521212e-13
sex O 0 5.523089208203658e-10
- O 0 9.861645944297948e-10
specific O 0 4.449347574403406e-12
gene O 0 5.892679677543811e-10
expression O 0 3.2828431639764233e-10
. O 0 8.499968784381196e-11

Products O 0 2.7737434038499487e-07
of O 0 4.5151257732634065e-11
steroidogenic O 0 2.8045476483384846e-06
factor O 0 3.27522862164642e-08
1 O 0 1.6570682603855857e-09
( O 0 1.916669774282287e-11
SF O 0 5.275409421301447e-05
- O 0 3.434131576796062e-05
1 O 0 2.7079881448344167e-08
) O 0 2.101166809986843e-11
and O 0 3.3587582715099984e-10
Wilms B-Disease 0 0.0009925974300131202
tumor I-Disease 0 2.0124010916333646e-05
1 O 0 9.336181605590355e-09
( O 0 1.4309512776089495e-11
WT1 O 0 6.936171104143796e-08
) O 0 6.529873755427296e-13
genes O 0 8.661215841754277e-12
are O 0 2.0627618536883663e-13
essential O 0 9.12956776150109e-13
for O 0 6.269175174648811e-13
mammalian O 0 6.602484670104047e-10
gonadogenesis O 0 3.126801217945285e-08
prior O 0 2.20598470046518e-11
to O 0 1.1871014587994111e-11
sexual O 0 7.582072747425173e-09
differentiation O 0 1.1953829037736341e-08
. O 0 9.658478461460618e-10

In O 0 7.892153042199368e-10
males O 0 2.164342927102325e-09
, O 0 4.488721894180259e-11
SF O 0 9.692029561847448e-05
- O 0 1.0682971151254606e-05
1 O 0 3.1027862501531445e-09
participates O 0 6.068565094885514e-10
in O 0 9.335593279327647e-13
sexual O 0 1.172135721816403e-10
development O 0 8.087943563581806e-14
by O 0 7.593094718521404e-14
regulating O 0 1.4186536390070614e-08
expression O 0 6.280970882288628e-11
of O 0 4.93970858141124e-13
the O 0 3.0491853486580567e-10
polypeptide O 0 0.0011790026910603046
hormone O 0 2.473229142196942e-05
Mullerian O 0 2.152747811123845e-06
inhibiting O 0 1.4399468000192428e-06
substance O 0 1.5945262248351355e-06
( O 0 2.1214840995043005e-10
MIS O 0 0.00040858006104826927
) O 0 1.9150078744978316e-10
. O 0 1.807533844822018e-10

Here O 0 8.342952106943358e-09
, O 0 7.535090607024841e-12
we O 0 1.950550181442634e-12
show O 0 2.1502941094375672e-10
that O 0 6.930591517351203e-12
WT1 O 0 9.36384253691358e-07
- O 0 1.8081619828080875e-06
KTS O 0 3.581246346584521e-05
isoforms O 0 8.294270825714989e-10
associate O 0 1.7666335061505833e-09
and O 0 1.4775689352597432e-11
synergize O 0 2.5391213398506807e-07
with O 0 1.2736506294075411e-09
SF O 0 0.013705912046134472
- O 0 2.7880781999556348e-05
1 O 0 1.5558967447759642e-09
to O 0 9.315836296819313e-12
promote O 0 9.161450487127354e-10
MIS O 0 0.0020576799288392067
expression O 0 2.522414099814796e-08
. O 0 2.1458446131106257e-10

In O 0 1.120604165016914e-09
contrast O 0 6.587494105758651e-09
, O 0 1.202530297561566e-10
WT1 O 0 1.5697167327743955e-05
missense O 0 4.798406735062599e-05
mutations O 0 2.4494867830071598e-05
, O 0 1.781694514146892e-10
associated O 0 2.0026934277606045e-10
with O 0 1.4960658267781923e-09
male B-Disease 0 1.942784911079798e-05
pseudohermaphroditism I-Disease 1 0.9999978542327881
in O 0 2.1439348074636655e-07
Denys B-Disease 1 0.9999384880065918
- I-Disease 1 0.9999969005584717
Drash I-Disease 1 0.9999933242797852
syndrome I-Disease 1 0.9999983310699463
, O 0 3.14823389579999e-10
fail O 0 1.3301869605797378e-09
to O 0 4.761867549579746e-12
synergize O 0 1.7351353562844452e-06
with O 0 1.874069122109745e-09
SF O 0 0.13369569182395935
- O 0 0.00016788483480922878
1 O 0 2.4651575003531434e-08
. O 0 7.120942169258626e-10

Additionally O 0 1.9488172853243668e-08
, O 0 3.4525299286158884e-11
the O 0 6.345110201144699e-12
X O 0 0.0014738908503204584
- O 0 6.000139910611324e-05
linked O 0 0.00013452375424094498
, O 0 4.547952639488706e-11
candidate O 0 1.081259994734074e-11
dosage O 0 2.250736486075766e-09
- O 0 3.33682770303767e-08
sensitive O 0 1.8458817407918104e-07
sex O 0 1.3834717371707939e-08
- O 0 1.4226523292748539e-09
reversal O 0 1.155999518331896e-09
gene O 0 2.518344699442565e-10
, O 0 4.391291150152021e-12
Dax O 0 0.0004691079375334084
- O 0 8.626640237707761e-07
1 O 0 4.696745770083055e-10
, O 0 8.270782604798133e-13
antagonizes O 0 1.821899076048794e-09
synergy O 0 5.339680364535582e-10
between O 0 9.594797872880534e-11
SF O 0 9.962051990441978e-05
- O 0 8.804189747024793e-06
1 O 0 5.966831029269315e-09
and O 0 7.356754788689912e-11
WT1 O 0 2.690124567550356e-08
, O 0 2.852249957486369e-13
most O 0 3.017227242249447e-14
likely O 0 4.361581083280053e-13
through O 0 2.528875986927432e-14
a O 0 2.5325470887072044e-12
direct O 0 8.22052235310844e-12
interaction O 0 1.2235847057784355e-10
with O 0 1.1442240488435118e-09
SF O 0 0.14478789269924164
- O 0 0.0002584210014902055
1 O 0 5.4434440954764796e-08
. O 0 1.2327115994636983e-09

We O 0 2.1093964353013916e-09
propose O 0 1.8726755701692355e-09
that O 0 2.6742460676465463e-11
WT1 O 0 1.3820919093632256e-06
and O 0 2.8848756716826074e-09
Dax O 0 0.17251329123973846
- O 0 3.3220997011085274e-06
1 O 0 2.1505854042036532e-10
functionally O 0 3.0137303763666523e-10
oppose O 0 1.5228910146825037e-11
each O 0 5.107839064905084e-13
other O 0 6.279239281314908e-13
in O 0 7.551604740835272e-13
testis O 0 6.2442699899634135e-09
development O 0 1.0048655700936604e-12
by O 0 1.8209305591154745e-12
modulating O 0 7.696835524484413e-08
SF O 0 0.002831533085554838
- O 0 3.612949149101041e-05
1 O 0 3.7387383855502776e-08
- O 0 2.1472446860570926e-06
mediated O 0 6.123392495283042e-07
transactivation O 0 3.379290774319088e-06
. O 0 1.0544941309031941e-10
. O 0 2.45493569916988e-10

A O 0 7.209781216488409e-08
mouse O 0 7.530639322794741e-06
model O 0 6.61889635011903e-06
for O 0 3.3646142583165783e-06
Prader B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999996423721313
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999980926513672
imprinting O 0 0.15329580008983612
- O 1 0.8297354578971863
centre O 0 4.278164487914182e-05
mutations O 0 1.3398350347415544e-05
. O 0 6.541567731943587e-09

Imprinting O 0 1.6148088661793736e-06
in O 0 4.662080721473671e-10
the O 0 2.1487391727026406e-11
15q11 O 0 2.113465136233117e-08
- O 0 2.7195005714020226e-07
q13 O 0 2.2153615830688977e-08
region O 0 3.4084429723080234e-11
involves O 0 1.6548996548126915e-11
an O 0 1.6463802543498218e-11
imprinting O 0 1.0926642062258907e-06
centre O 0 4.206512187465705e-07
( O 0 3.82192263947978e-11
IC O 0 9.334760164847467e-08
) O 0 2.0372928604545093e-12
, O 0 4.696351136755303e-14
mapping O 0 8.46017908506802e-11
in O 0 7.712515522062535e-12
part O 0 4.048923002430982e-11
to O 0 1.7766475790548242e-11
the O 0 1.6436317584744842e-11
promoter O 0 7.571338045408993e-08
and O 0 1.3981552027253485e-11
first O 0 7.3761404970063e-12
exon O 0 8.255148564728643e-09
of O 0 8.70742089542631e-10
SNRPN O 0 0.0003294974158052355
. O 0 1.7439547583819603e-09

Deletion O 0 8.455365900772449e-07
of O 0 1.0663829541623926e-10
this O 0 3.504197973458467e-11
IC O 0 5.897041774005629e-06
abolishes O 0 7.3360411079193e-07
local O 0 1.5847111123346025e-10
paternally O 0 2.7867269380976722e-08
derived O 0 1.2708811780726137e-10
gene O 0 2.710834223762504e-09
expression O 0 7.428415660371002e-10
and O 0 1.4504314416186048e-10
results O 0 8.57180815216907e-09
in O 0 5.183658231544541e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
( O 0 3.2245670809061266e-06
PWS B-Disease 1 0.9999839067459106
) O 0 5.177925643806702e-09
. O 0 8.997594891368976e-10

We O 0 6.362815696547841e-08
have O 0 8.289901404223698e-11
created O 0 1.2420136100144141e-11
two O 0 3.33824699653984e-12
deletion O 0 2.0921486054703564e-07
mutations O 0 2.067038394670817e-06
in O 0 2.3712501406869535e-10
mice O 0 3.217434141333797e-06
to O 0 1.497896029434287e-09
understand O 0 2.758201560482121e-07
PWS B-Disease 1 0.9999982118606567
and O 0 9.48027101266291e-10
the O 0 2.1387815563739254e-12
mechanism O 0 1.289305051610512e-10
of O 0 1.1227417650097604e-12
this O 0 1.6164869789947467e-11
IC O 0 2.818812572513707e-05
. O 0 2.2616799544294963e-09

Mice O 0 0.0016719851410016418
harbouring O 0 4.2454154026927426e-05
an O 0 8.365942938404203e-10
intragenic O 0 4.787431862496305e-06
deletion O 0 5.486045665747952e-06
in O 0 5.077462894576001e-10
Snrpn O 0 2.4219923488999484e-06
are O 0 8.898515951871744e-11
phenotypically O 0 5.838300509708461e-09
normal O 0 2.192805381717733e-10
, O 0 1.59356013627876e-12
suggesting O 0 1.3532640286140207e-10
that O 0 3.171773173965553e-12
mutations O 0 1.4146485094457262e-09
of O 0 3.456588834604979e-11
SNRPN O 0 0.000419990043155849
are O 0 4.7596544761052684e-11
not O 0 4.781818170596086e-12
sufficient O 0 1.2258311553325907e-11
to O 0 6.618721543061312e-11
induce O 0 3.362887355251587e-07
PWS B-Disease 1 0.9998555183410645
. O 0 5.733289398790475e-09

Mice O 0 0.00019598747894633561
with O 0 1.3852606561837177e-10
a O 0 2.3358578959964404e-11
larger O 0 3.7078902448417494e-11
deletion O 0 5.158979021757659e-09
involving O 0 2.3524448167222545e-08
both O 0 1.6968044747045496e-09
Snrpn O 0 3.077387873418047e-06
and O 0 7.425323550469543e-11
the O 0 4.7565413413552804e-11
putative O 0 4.1851271816994995e-05
PWS O 1 0.9999977350234985
- O 0 0.01232307031750679
IC O 0 0.020950768142938614
lack O 0 8.345308444290822e-09
expression O 0 3.135850953905894e-11
of O 0 2.8504661738620873e-13
the O 0 1.3082748426263002e-11
imprinted O 0 9.552431038173381e-06
genes O 0 1.721227391726643e-07
Zfp127 O 0 1.1049181694033905e-06
( O 0 1.7071127497714222e-11
mouse O 0 3.132113590709196e-08
homologue O 0 2.132260767950811e-08
of O 0 2.5385607504979646e-10
ZNF127 O 0 6.976590520935133e-05
) O 0 3.627590242083478e-11
, O 0 2.442211363695712e-12
Ndn O 0 1.1604973337853153e-07
and O 0 7.11519898555224e-10
Ipw O 0 1.8692169305722928e-06
, O 0 7.650500372102798e-11
and O 0 1.7959893988672704e-11
manifest O 0 7.44668715579877e-10
several O 0 3.076252360484366e-12
phenotypes O 0 3.250949731636865e-08
common O 0 2.7141261682572804e-08
to O 0 1.2186265507807548e-07
PWS B-Disease 1 0.9999972581863403
infants O 0 0.01356919389218092
. O 0 1.3031009604702604e-09

These O 0 4.043806262066241e-11
data O 0 4.730044689260637e-10
demonstrate O 0 8.388899991329524e-11
that O 0 3.2513835374059497e-12
both O 0 4.217027334968426e-12
the O 0 1.4186677006755577e-11
position O 0 2.0339800954616294e-09
of O 0 2.506815284866737e-13
the O 0 7.061275609371309e-12
IC O 0 1.2732670029436122e-06
and O 0 6.838676153142487e-11
its O 0 2.8956210259417636e-12
role O 0 1.0364487046388149e-09
in O 0 3.093567611280046e-13
the O 0 2.961845720940437e-13
coordinate O 0 8.504492943206543e-11
expression O 0 1.4870346273787582e-11
of O 0 1.8342384631563763e-13
genes O 0 1.1061947885471213e-10
is O 0 2.2237689120685467e-12
conserved O 0 1.0642738773603e-10
between O 0 6.485286752067054e-10
mouse O 0 0.00038030598079785705
and O 0 2.955329847509347e-08
human O 0 6.041739109008404e-09
, O 0 1.2304975614829683e-11
and O 0 7.498002219108457e-12
indicate O 0 2.3828100950695763e-11
that O 0 9.311253157395782e-12
the O 0 1.1092050021532796e-11
mouse O 0 2.800843049044488e-06
is O 0 1.7060981793992624e-10
a O 0 3.7364495178437984e-12
suitable O 0 4.304822817657872e-11
model O 0 4.038592127386664e-09
system O 0 6.827536314091276e-10
in O 0 5.032480508704307e-12
which O 0 1.0354755247687919e-11
to O 0 9.32946970545745e-13
investigate O 0 1.3092239792289462e-10
the O 0 7.361590178590893e-13
molecular O 0 1.5494074079303033e-10
mechanisms O 0 2.8962093834294933e-10
of O 0 1.6513989611541269e-12
imprinting O 0 7.310605809607296e-08
in O 0 4.7670496022833575e-11
this O 0 1.0122485532074177e-12
region O 0 1.973787452924647e-12
of O 0 6.643425094982405e-14
the O 0 2.593351531784971e-12
genome O 0 1.5001404563008691e-09
. O 0 2.4165239254081428e-11
. O 0 1.533823484889396e-10

Mutations O 0 1.6106470184240607e-06
of O 0 2.2739100533075707e-11
the O 0 9.478307895494087e-12
ATM O 0 1.1276272743998561e-05
gene O 0 9.35789969958023e-08
detected O 0 5.241615781415021e-06
in O 0 1.198176224903591e-09
Japanese O 0 0.006305950693786144
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999990463256836
telangiectasia I-Disease 1 0.9999998807907104
patients O 0 0.0018448284827172756
: O 0 9.97327654489455e-12
possible O 0 8.328503685317568e-12
preponderance O 0 3.745017185252664e-09
of O 0 6.0576422350466785e-12
the O 0 2.4859576203128952e-11
two O 0 1.2398038151673063e-10
founder O 0 1.2535564053450798e-07
mutations O 0 3.5418327826164386e-08
4612del165 O 0 1.4604823128649969e-08
and O 0 1.764288853900453e-10
7883del5 O 0 3.315302876671922e-08
. O 0 4.0878872509253483e-10

The O 0 3.1565754454732087e-09
ATM O 0 0.003919694572687149
( O 0 2.0822560031774628e-07
A O 1 0.9999858140945435
- O 1 0.9999978542327881
T O 1 1.0
, O 0 1.1233239893826408e-09
mutated O 0 1.6782009115701157e-09
) O 0 4.13489229834918e-13
gene O 0 1.6214956460869345e-11
on O 0 1.8842472027102986e-10
human O 0 1.9353663116561393e-09
chromosome O 0 9.360339390696026e-06
11q22 O 0 1.0521825970499776e-06
. O 0 1.2644936209227353e-09

3 O 0 8.109351483653882e-07
has O 0 1.7878374336532943e-08
recently O 0 1.8429682668852365e-08
been O 0 4.0746148122217107e-10
identified O 0 4.827975241816773e-10
as O 0 2.8772604958315906e-12
the O 0 1.4605371491220598e-13
gene O 0 1.0043645776169896e-10
responsible O 0 5.206921560585442e-10
for O 0 1.261736288366011e-11
the O 0 9.41800193388076e-10
human O 0 9.486051567364484e-05
recessive B-Disease 1 0.9999796152114868
disease I-Disease 1 0.9999958276748657
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999994039535522
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.0017559202387928963
A B-Disease 1 0.9999991655349731
- I-Disease 1 0.999998927116394
T I-Disease 1 0.9999997615814209
) O 0 1.961807072348165e-08
. O 0 7.3406397627096e-10

In O 0 9.639155029717017e-10
order O 0 2.690536161920054e-11
to O 0 2.652673274181755e-13
define O 0 5.5236131640823416e-11
the O 0 1.9709357843705755e-12
types O 0 2.1017581008919706e-09
of O 0 5.527831525853344e-10
disease O 0 0.00013255038356874138
- O 0 4.2404849409649614e-06
causing O 0 1.2868773637819686e-06
ATM O 0 0.0004069172136951238
mutations O 0 7.574125220344285e-07
in O 0 5.898771748835685e-11
Japanese O 0 9.891433592201793e-07
A B-Disease 1 0.9999938011169434
- I-Disease 1 0.9999990463256836
T I-Disease 1 1.0
patients O 0 1.0822539024957223e-06
as O 0 9.236558740077783e-11
well O 0 3.851206246269223e-12
as O 0 1.4401779465170184e-12
to O 0 1.2672435529322706e-13
look O 0 2.2485503042846133e-11
for O 0 1.2092677391124101e-13
possible O 0 1.91038742984595e-12
mutational O 0 2.749891869768817e-09
hotspots O 0 1.7546692987480128e-08
, O 0 4.35763361159025e-12
reverse O 0 3.065865783469235e-09
- O 0 1.0927354310297233e-07
transcribed O 0 5.159946070421029e-08
RNA O 0 2.6008650788611476e-09
derived O 0 1.3632788474493562e-11
from O 0 1.5226666498849295e-12
ten O 0 7.365034797313097e-12
patients O 0 5.9153081738427815e-12
belonging O 0 1.9614511837656723e-12
to O 0 5.487191105137124e-13
eight O 0 1.0023551433313571e-10
unrelated O 0 2.3096960788393517e-08
Japanese O 0 5.7372799346921965e-06
A B-Disease 1 0.999988317489624
- I-Disease 1 0.9999978542327881
T I-Disease 1 1.0
families O 0 2.7358517229458812e-08
was O 0 1.815703365437571e-09
analyzed O 0 2.9242855359434827e-10
for O 0 2.8980741417772293e-12
mutations O 0 5.59609442118969e-11
by O 0 1.4244360628089953e-13
the O 0 1.8669939726156937e-13
restriction O 0 1.3425273046041575e-11
endonuclease O 0 9.485611407455963e-09
fingerprinting O 0 1.6681967807130604e-08
method O 0 5.246219014765074e-10
. O 0 2.0976560766161612e-10

As O 0 2.9383329547272297e-08
has O 0 9.00241825529946e-10
been O 0 1.2036592555997316e-10
reported O 0 3.4953348548860674e-10
by O 0 2.2946653258082428e-12
others O 0 8.144925012221194e-11
, O 0 9.004809159614269e-13
mutations O 0 1.700098256618432e-10
that O 0 2.6347550877159343e-11
lead O 0 1.9985617605300376e-09
to O 0 9.166493085410732e-12
exon O 0 1.2612791522315092e-07
skipping O 0 1.0476528586877976e-06
or O 0 3.5728401570622736e-08
premature O 0 7.932769108265347e-09
protein O 0 8.16514564294657e-11
truncation O 0 4.838376810312184e-09
were O 0 4.918939922049503e-09
also O 0 4.046717405614686e-10
predominant O 0 1.1021056289806097e-09
in O 0 4.6039218444537955e-12
our O 0 4.3155040652109733e-10
mutants O 0 2.7142142755565146e-08
. O 0 1.7777669614194025e-10

Six O 0 3.4452842800902772e-09
different O 0 6.145048879468984e-12
mutations O 0 8.086884939473293e-09
were O 0 2.337294247034549e-10
identified O 0 3.160617767505869e-09
on O 0 5.165821992392239e-09
12 O 0 8.155344732863057e-10
of O 0 6.876679130643493e-13
the O 0 3.067945203438782e-11
16 O 0 1.39806599630532e-09
alleles O 0 7.772479326817461e-10
examined O 0 3.3705291002661397e-07
. O 0 1.6581178652330664e-09

Four O 0 5.517321710613032e-09
were O 0 4.404648520917043e-11
deletions O 0 1.50358092643188e-09
involving O 0 1.3676302756948644e-08
a O 0 8.373625348667701e-09
loss O 0 7.111867716957931e-08
of O 0 5.430281333103359e-13
a O 0 1.786539319259539e-11
single O 0 5.550462311987303e-10
exon O 0 3.390383795931484e-08
exon O 0 5.093570507597178e-07
7 O 0 1.6251579637582836e-08
, O 0 3.0154060672027416e-12
exon O 0 5.437598815660749e-09
16 O 0 8.971854925654554e-10
, O 0 6.12124066712294e-13
exon O 0 7.969317650236007e-09
33 O 0 5.4160178564188755e-09
or O 0 7.67217123165409e-11
exon O 0 1.8501060594644514e-07
35 O 0 3.994696129439035e-08
. O 0 1.6003611769122017e-09

The O 0 1.4008393334208336e-09
others O 0 3.307840112931615e-10
were O 0 6.594549125521487e-12
minute O 0 4.5852405206048275e-11
deletions O 0 9.141801093903723e-09
, O 0 1.4963924196975675e-11
4649delA O 0 1.3834974277315837e-09
in O 0 3.983653413652116e-13
exon O 0 1.4210367993428008e-08
33 O 0 8.135399909292573e-09
and O 0 1.9022800695767117e-11
7883del5 O 0 3.2152114304295765e-10
in O 0 8.999828876934957e-13
exon O 0 4.574441803129048e-08
55 O 0 3.2693119322857456e-08
. O 0 2.1913471037748877e-09

The O 0 2.798112630486571e-09
mutations O 0 1.889134608745735e-07
4612del165 O 0 6.738134317174627e-08
and O 0 1.8154565351036211e-10
7883del5 O 0 1.3732233128394e-09
were O 0 6.499323215031216e-12
found O 0 3.641501596790553e-12
in O 0 1.645668295374974e-14
more O 0 1.2740920514800469e-14
than O 0 1.5579871377388588e-13
two O 0 7.408198945783873e-13
unrelated O 0 6.342938951853228e-10
families O 0 1.1948073086465172e-10
; O 0 6.765603702274525e-12
44 O 0 1.872475507980198e-09
% O 0 7.449691037664241e-12
( O 0 3.857410918461923e-12
7 O 0 1.6580917194808364e-10
of O 0 6.241081436375584e-12
16 O 0 1.073819144714605e-09
) O 0 8.566914945452517e-14
of O 0 2.435064377513587e-14
the O 0 6.503588466377774e-12
mutant O 0 2.2221840367819823e-07
alleles O 0 2.3068331689302113e-09
had O 0 3.9476894642120897e-08
one O 0 1.0839526325134852e-11
of O 0 2.6994210903033555e-13
the O 0 1.1177980416277045e-11
two O 0 3.540626958287163e-10
mutations O 0 7.377843758149538e-08
. O 0 1.3495813355746122e-09

The O 0 9.854538296494297e-10
4612del165 O 0 1.9891162494900527e-08
mutations O 0 6.300849975104938e-08
in O 0 3.2225448438200077e-12
three O 0 1.306752882984652e-12
different O 0 4.5230854651967523e-13
families O 0 1.4322590856374884e-11
were O 0 2.590277992098322e-11
all O 0 5.143110872081469e-13
ascribed O 0 2.436578022679825e-11
to O 0 2.8590051333321487e-12
the O 0 1.1341065239700576e-11
same O 0 1.628026824462836e-09
T O 0 0.00017842503439169377
- O 0 4.6421914134953113e-07
- O 0 9.49176808262564e-08
> O 0 1.472499205901201e-11
A O 0 2.0173644005305746e-11
substitution O 0 3.258976855741169e-12
at O 0 2.7381548417526602e-11
the O 0 9.065158020939157e-13
splice O 0 4.2186124460386054e-07
donor O 0 3.1743302431053166e-10
site O 0 2.5091198563309547e-10
in O 0 9.212801528601933e-12
intron O 0 2.3104907995730173e-06
33 O 0 5.148625632500625e-07
. O 0 1.6601875429955726e-09

Microsatellite O 0 1.495222113589989e-05
genotyping O 0 5.375028194976039e-06
around O 0 5.222480226052539e-09
the O 0 2.8760273676486925e-11
ATM O 0 1.1074140275013633e-05
locus O 0 7.140483830880839e-06
also O 0 7.885028452392362e-08
indicated O 0 1.680295569350676e-09
that O 0 7.354506760537394e-12
a O 0 8.833933584639908e-11
common O 0 1.4279671889383394e-09
haplotype O 0 2.8296781806602667e-07
was O 0 1.277824850376419e-07
shared O 0 2.7070184635547e-11
by O 0 1.1337490191457023e-12
the O 0 4.187331904825786e-12
mutant O 0 5.012899606526844e-08
alleles O 0 2.480086414013982e-10
in O 0 1.0593519117474415e-11
both O 0 3.8716702066565745e-10
mutations O 0 3.2857349197001895e-07
. O 0 2.7938675817296144e-09

This O 0 8.397176010088714e-11
suggests O 0 4.377681550593593e-10
that O 0 2.9081743523756698e-12
these O 0 4.829451725682499e-13
two O 0 3.8043367067697176e-11
founder O 0 2.30658415034668e-07
mutations O 0 2.7108208087156527e-06
may O 0 1.3845144586355218e-08
be O 0 4.143407145162925e-11
predominant O 0 6.008673003599085e-10
among O 0 1.0679171956462508e-11
Japanese O 0 3.3876286220646534e-09
ATM O 0 8.575704669055995e-06
mutant O 0 5.35813171609334e-07
alleles O 0 1.864159138165178e-08
. O 0 2.219255446078705e-09

W474C O 0 3.1482786653214134e-06
amino O 0 3.1094529617803346e-08
acid O 0 2.170527535483302e-09
substitution O 0 4.245566745386675e-11
affects O 0 2.172672042277668e-10
early O 0 4.186634491778335e-13
processing O 0 1.7798186535689098e-11
of O 0 2.93993311412024e-14
the O 0 1.1255972824815441e-13
alpha O 0 5.490394380455732e-13
- O 0 6.086506992852847e-11
subunit O 0 6.536665739936831e-13
of O 0 3.6501850804102065e-13
beta O 0 1.2817572524193022e-11
- O 0 3.1057957983193774e-08
hexosaminidase O 0 1.3861691172678547e-07
A O 0 1.6932998336827154e-09
and O 0 3.4621576439075596e-11
is O 0 1.5084137064413916e-11
associated O 0 2.7231288404760967e-11
with O 0 9.886542695625167e-10
subacute O 0 0.003956104628741741
G B-Disease 0 0.00072405458195135
( I-Disease 0 1.430676410674181e-10
M2 I-Disease 0 2.5353503588121384e-05
) I-Disease 0 7.04914460136763e-10
gangliosidosis I-Disease 0 3.6537719552143244e-06
. O 0 1.6971023475420566e-09

Mutations O 0 3.6716486647492275e-05
in O 0 4.48933196173229e-10
the O 0 2.2815126524133866e-11
HEXA O 0 1.3259064871817827e-05
gene O 0 2.249770814088947e-09
, O 0 3.013426910346978e-13
encoding O 0 7.027278607109333e-13
the O 0 3.0186042467711394e-13
alpha O 0 1.7776092013296885e-12
- O 0 1.5881666814987483e-10
subunit O 0 3.6270075484678976e-12
of O 0 1.7254534389818388e-12
beta O 0 6.238549954407091e-11
- O 0 2.15718799267961e-07
hexosaminidase O 0 1.017701151795336e-06
A O 0 5.232211108818774e-09
( O 0 3.6044008489694024e-12
Hex O 0 2.635553109087141e-08
A O 0 7.755094344474855e-10
) O 0 4.796906686969915e-13
, O 0 4.227169422875779e-14
that O 0 2.585605883044517e-13
abolish O 0 8.009700458444513e-09
Hex O 0 1.591736804584798e-06
A O 0 2.515177621731368e-09
enzyme O 0 7.047550525385304e-07
activity O 0 7.659840548512875e-07
cause O 0 2.5747573090484366e-05
Tay B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9943130016326904
( O 0 2.0025367475362543e-10
TSD B-Disease 0 2.147703526134137e-06
) O 0 6.507658995014154e-12
, O 0 3.230913258288337e-13
the O 0 1.658084607114585e-11
fatal O 0 0.002104886807501316
infantile B-Disease 0 0.004630168899893761
form I-Disease 0 6.740396685245287e-08
of I-Disease 0 9.18253650894485e-09
G I-Disease 0 0.011149401776492596
( I-Disease 0 1.465383370202744e-10
M2 I-Disease 0 4.863066351390444e-05
) I-Disease 0 1.7497045479153428e-10
gangliosidosis I-Disease 0 3.4908686075141304e-07
, I-Disease 0 4.211161627742932e-11
Type I-Disease 0 7.408750946069631e-09
1 I-Disease 0 2.586365566159543e-09
. O 0 5.060070695783736e-10

Less O 0 3.813078365055844e-06
severe O 0 0.0013092027511447668
, O 0 6.409315300714979e-10
subacute O 0 8.582296140957624e-05
( O 0 7.326652062822347e-10
juvenile O 0 0.0005477488739416003
- O 1 0.7476362586021423
onset O 0 0.10288147628307343
) O 0 1.6094288568524462e-08
and O 0 6.468491875466498e-08
chronic O 0 0.0008274299907498062
( O 0 4.859365687615025e-11
adult O 0 8.737025325444847e-08
- O 0 8.736651216167957e-05
onset O 0 1.2773006346833427e-05
) O 0 7.645055595528749e-12
variants O 0 1.0905976816077967e-10
are O 0 3.626218682967197e-12
characterized O 0 1.872466418029184e-11
by O 0 5.371501854423144e-13
a O 0 5.0748082819351836e-11
broad O 0 2.585749170336271e-09
spectrum O 0 1.7250554762426873e-08
of O 0 1.0639288061664587e-10
clinical O 0 6.145869946294624e-08
manifestations O 0 7.279881941713029e-08
and O 0 7.397182866242247e-10
are O 0 3.182828306469432e-11
associated O 0 3.275055227014434e-11
with O 0 2.2336760219232588e-10
residual O 0 2.9049566364847124e-05
levels O 0 7.26402831219275e-08
of O 0 3.078314339544086e-11
Hex O 0 1.3891262824472506e-05
A O 0 7.973422810891861e-09
enzyme O 0 5.1181704208147494e-08
activity O 0 8.58456949970332e-09
. O 0 2.0614512874495006e-10

We O 0 9.01916230588995e-09
identified O 0 7.323190498453869e-09
a O 0 3.1559654889434796e-10
1422 O 0 3.354138243594207e-06
G O 0 7.864250801503658e-05
- O 0 9.658994713390712e-06
- O 0 8.258129673777148e-05
> O 0 2.332892279355292e-07
C O 0 1.8138024415748077e-06
( O 0 2.260279420226996e-12
amino O 0 5.069851656547275e-12
acid O 0 8.778886471938474e-12
W474C O 0 6.649288758486804e-12
) O 0 2.521096793988201e-15
substitution O 0 9.056610950281593e-15
in O 0 1.4297733190535983e-14
the O 0 2.4286367188153246e-13
first O 0 6.688447018454724e-10
position O 0 5.790863899512999e-10
of O 0 9.343893931160197e-13
exon O 0 7.043586691679593e-08
13 O 0 1.1770830976587376e-09
of O 0 2.6838819795066415e-12
HEXA O 0 5.713517566618975e-06
of O 0 1.6812556555279023e-11
a O 0 7.652095068699794e-10
non O 0 7.548857894335015e-08
- O 0 1.977153715415625e-06
Jewish O 0 6.542955333088685e-08
proband O 0 1.7967404346563853e-05
who O 0 3.283479088622698e-08
manifested O 0 3.5266030096181566e-09
a O 0 5.602801556037207e-11
subacute O 0 4.3944610297330655e-06
variant O 0 1.0768889069368015e-06
of O 0 4.012494336791406e-09
G B-Disease 0 0.003210101742297411
( I-Disease 0 2.678116617360615e-10
M2 I-Disease 0 7.109408034011722e-05
) I-Disease 0 9.53065515396645e-10
gangliosidosis I-Disease 0 2.7351502467354294e-06
. O 0 1.4999373965096652e-09

On O 0 6.97780855318797e-09
the O 0 7.728275658314132e-11
second O 0 4.610794235304638e-08
maternally O 0 7.532969175372273e-05
inherited O 0 0.00013586327258963138
allele O 0 6.953901561246312e-07
, O 0 1.1202872657323226e-10
we O 0 2.0405137649004423e-11
identified O 0 3.1271799039167547e-10
the O 0 4.0306022408564957e-10
common O 0 3.0491880806948757e-06
infantile O 1 0.9648829102516174
disease O 1 0.7504447102546692
- O 0 0.00032008669222705066
causing O 0 3.167191971442662e-05
4 O 0 1.631882717845201e-08
- O 0 1.0979622402373934e-06
bp O 0 5.35362687514862e-07
insertion O 0 3.6913607726063447e-09
, O 0 3.4078448396535066e-11
+ O 0 3.409335314064066e-10
TATC O 0 2.247482342454532e-07
1278 O 0 2.1840502739678413e-08
, O 0 9.975098004544325e-13
in O 0 3.9400747204806907e-13
exon O 0 2.979190583118907e-08
11 O 0 9.917048515717397e-09
. O 0 2.0753382345972682e-10

Pulse O 0 1.0681488902264391e-06
- O 0 1.1528188537113238e-07
chase O 0 4.4182691283367603e-08
analysis O 0 5.016851864492189e-11
using O 0 1.309069241894889e-10
proband O 0 8.684308738793334e-08
fibroblasts O 0 1.1635160612755158e-09
revealed O 0 5.611459297227839e-09
that O 0 1.3587716021778995e-12
the O 0 4.82215233455624e-13
W474C O 0 3.984966800985035e-10
- O 0 5.898909694046495e-10
containing O 0 3.338064200053559e-11
alpha O 0 1.9967183288727153e-12
- O 0 6.893745990721456e-11
subunit O 0 6.64163299010645e-12
precursor O 0 2.4686183652811167e-10
was O 0 1.1586218651160607e-09
normally O 0 1.3511349157557806e-12
synthesized O 0 1.203036628649734e-11
, O 0 1.7337724951462657e-13
but O 0 2.800402867497026e-13
not O 0 2.977172002850692e-13
phosphorylated O 0 6.938265934008925e-11
or O 0 4.36770446199386e-11
secreted O 0 1.0718730347747396e-09
, O 0 5.075831248368967e-12
and O 0 2.061968217698107e-12
the O 0 6.835386857223513e-12
mature O 0 1.829284390630903e-09
lysosomal O 0 3.018565664092421e-08
alpha O 0 1.7967400137153255e-11
- O 0 4.3905696855972565e-09
subunit O 0 2.716122327051096e-10
was O 0 2.1913859171718286e-08
not O 0 3.930096525994742e-11
detected O 0 2.5014577076376554e-08
. O 0 1.1829996704459944e-10

When O 0 1.0417845253130054e-08
the O 0 2.3941812074546043e-11
W474C O 0 1.0351921542195441e-09
- O 0 5.257638213684857e-10
containing O 0 1.5581076359683088e-11
alpha O 0 5.904441865989263e-12
- O 0 3.413961890963435e-10
subunit O 0 4.700435873861153e-11
was O 0 4.6223624927677065e-09
transiently O 0 7.51493711703688e-09
co O 0 6.468195579145686e-08
- O 0 5.7217672377873896e-08
expressed O 0 9.738753206645079e-12
with O 0 2.375198291087316e-13
the O 0 6.509713151555199e-14
beta O 0 8.298372297481371e-13
- O 0 1.761581991388539e-10
subunit O 0 1.9583935167988287e-12
to O 0 2.7745652997346326e-12
produce O 0 6.058130386232818e-11
Hex O 0 1.5036668798984465e-07
A O 0 1.7995610557264285e-09
( O 0 2.356477209544683e-12
alphabeta O 0 2.531068243882828e-09
) O 0 6.722803195212401e-13
in O 0 5.984644745916923e-13
COS O 0 3.3323078241664916e-05
- O 0 4.61720105704444e-07
7 O 0 4.198798642107704e-09
cells O 0 3.947999913100908e-11
, O 0 1.0933243785142543e-13
the O 0 4.6594926674621215e-14
mature O 0 4.750174645989924e-12
alpha O 0 5.190391573570846e-14
- O 0 1.1993805948407044e-10
subunit O 0 1.2658630220430123e-11
was O 0 2.5185201479871466e-08
present O 0 1.0167111944014984e-11
, O 0 2.3403910645418413e-13
but O 0 1.8985808476583432e-13
its O 0 4.1128683575183955e-13
level O 0 2.406236043750454e-10
was O 0 1.2981643537912646e-09
much O 0 2.1088061852303497e-12
lower O 0 3.642788501401206e-11
than O 0 2.8550911092793674e-13
that O 0 1.265258243229178e-13
from O 0 1.4336898638764306e-13
normal O 0 1.2765306390064013e-12
alpha O 0 9.540624583762036e-13
- O 0 9.9384234175659e-10
subunit O 0 2.6231617572536337e-11
transfections O 0 1.4412085747039782e-08
, O 0 4.60788145920793e-13
although O 0 1.0845140161353656e-13
higher O 0 5.258252600698343e-13
than O 0 4.1404325714505807e-13
in O 0 1.7585177834299887e-13
those O 0 2.599224654953325e-12
cells O 0 2.7236744110092914e-11
transfected O 0 2.5420994198555036e-09
with O 0 9.302288973833672e-12
an O 0 8.388735886488696e-12
alpha O 0 5.0836630044459596e-11
- O 0 9.096546449427478e-08
subunit O 0 9.548649648749574e-10
associated O 0 3.5852218971399452e-09
with O 0 4.7698289762365675e-09
infantile O 0 0.012979631312191486
TSD B-Disease 0 0.00260219001211226
. O 0 6.346402514623151e-09

Furthermore O 0 8.075265611751092e-08
, O 0 2.0025852504046426e-11
the O 0 6.336519850491662e-13
precursor O 0 2.3791510428416984e-10
level O 0 4.5290060590730263e-10
of O 0 1.2274958881373227e-13
the O 0 6.400021571734138e-13
W474C O 0 6.17768752819714e-11
alpha O 0 2.4516562282909937e-13
- O 0 4.52810532125536e-11
subunit O 0 4.8494749882443955e-12
was O 0 1.090259216240952e-09
found O 0 1.2850839316291829e-11
to O 0 8.253038552043235e-13
accumulate O 0 5.841093719816115e-10
in O 0 9.017728919277421e-14
comparison O 0 3.3125340578171736e-12
to O 0 1.0007532996736401e-12
the O 0 1.0645732342537406e-12
normal O 0 6.45321122927367e-12
alpha O 0 2.187497795749782e-12
- O 0 9.290524460858762e-10
subunit O 0 1.414947325972804e-10
precursor O 0 4.968311095865374e-09
levels O 0 1.2968632390197854e-08
. O 0 1.3886361505122125e-10

We O 0 1.5865991853658556e-09
conclude O 0 4.60727317408427e-10
that O 0 5.922985192585717e-12
the O 0 1.4718141636005377e-11
1422 O 0 9.154522331300541e-07
G O 0 9.087257240025792e-06
- O 0 1.6840139096530038e-06
- O 0 1.7789745470508933e-05
> O 0 8.891437630609289e-08
C O 0 1.2323394003033172e-06
mutation O 0 1.8913857147140334e-08
is O 0 1.6244279532617867e-10
the O 0 2.4018285624261004e-11
cause O 0 1.0520075921505168e-09
of O 0 3.1424507440647176e-10
Hex B-Disease 1 0.8811333775520325
A I-Disease 0 0.3925493061542511
enzyme I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999986886978149
in O 0 1.4245300251902737e-11
the O 0 1.0730016181126345e-10
proband O 0 1.2717046956822742e-05
. O 0 7.470273843956932e-10

The O 0 2.617755179290526e-10
resulting O 0 9.26638543674585e-10
W474C O 0 2.5062369957140618e-09
substitution O 0 1.5962935140390044e-10
clearly O 0 3.714198948401304e-10
interferes O 0 1.6918655365572022e-10
with O 0 3.801823222557288e-13
alpha O 0 3.3182235171375085e-13
- O 0 4.9429554199731385e-11
subunit O 0 2.3829087574672725e-12
processing O 0 1.0585753384972918e-09
, O 0 4.82092013878721e-13
but O 0 3.8626633629915835e-14
because O 0 3.4843316925291246e-14
the O 0 7.355649699362574e-14
base O 0 3.685616395410207e-11
substitution O 0 6.5067898985526895e-12
falls O 0 2.2071742478146916e-06
at O 0 3.7144540221412115e-10
the O 0 1.5965658699615415e-12
first O 0 5.52709378265348e-10
position O 0 7.369538868040593e-10
of O 0 3.350710279983321e-13
exon O 0 2.806666365984256e-08
13 O 0 1.3805399046162847e-09
, O 0 2.811256002294149e-13
aberrant O 0 5.235013533777533e-10
splicing O 0 3.760630207239046e-08
may O 0 1.76817408714669e-07
also O 0 2.0456314420158606e-10
contribute O 0 1.044827765972478e-11
to O 0 7.66719743250377e-11
Hex B-Disease 0 0.0031321800779551268
A I-Disease 0 1.0996714991051704e-05
deficiency I-Disease 0 4.8123012675205246e-05
in O 0 2.4619374464421306e-13
this O 0 4.3478263524188154e-13
proband O 0 1.5295952948690683e-07
. O 0 1.1751391526537702e-11
. O 0 1.5756451698933915e-10

Two O 0 6.573825483968676e-09
frequent O 0 2.2420148582114052e-07
missense O 0 0.001440996304154396
mutations O 0 0.18937477469444275
in O 0 6.137473246781155e-05
Pendred B-Disease 1 0.9999985694885254
syndrome I-Disease 1 0.9999996423721313
. O 0 5.124119297761354e-07

Pendred B-Disease 1 0.9999897480010986
syndrome I-Disease 1 0.9999998807907104
is O 0 0.0006253275787457824
an O 0 0.002246462507173419
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.5811784863471985
by O 0 8.484625624305409e-08
early O 0 2.3141337806009687e-06
childhood O 1 0.8261553645133972
deafness B-Disease 1 0.9999998807907104
and O 0 0.07818645238876343
goiter B-Disease 1 0.9999983310699463
. O 0 3.50154181205653e-07

A O 0 2.889888683910158e-08
century O 0 6.839462329821799e-10
after O 0 9.337347561810816e-11
its O 0 1.9967983429930447e-12
recognition O 0 1.563704721263548e-11
as O 0 1.214215950007258e-09
a O 0 3.8739830188205815e-07
syndrome O 1 0.8112404942512512
by O 0 1.6955321868739048e-10
Vaughan O 0 7.4040813160536345e-06
Pendred O 0 1.383167841595423e-06
, O 0 4.023786859264078e-11
the O 0 9.303818826467136e-11
disease O 0 5.275013791106176e-06
gene O 0 1.1365415275577107e-07
( O 0 2.049313913010664e-10
PDS O 0 3.921454378996714e-07
) O 0 1.1989294106118376e-11
was O 0 9.724081539985718e-10
mapped O 0 2.719002623052802e-07
to O 0 5.017890547520665e-09
chromosome O 0 0.00019165211415383965
7q22 O 0 1.6168830825336045e-06
- O 0 6.416252745111706e-06
q31 O 0 7.258903451656806e-07
. O 0 1.2436079943611844e-09

1 O 0 5.151405844117107e-07
and O 0 3.931389880307279e-09
, O 0 1.7037265695463155e-11
recently O 0 3.0119504668135733e-09
, O 0 3.960017535241389e-13
found O 0 1.7774939506387533e-12
to O 0 1.641743923967709e-13
encode O 0 1.2092510326411343e-10
a O 0 3.5729204039824936e-09
putative O 0 1.238905042555416e-05
sulfate O 0 1.3631449292006437e-05
transporter O 0 9.312337351730093e-05
. O 0 4.073917647673397e-09

We O 0 6.602361768415221e-09
performed O 0 3.133891202100614e-10
mutation O 0 7.260679557585803e-11
analysis O 0 4.929602299280633e-12
of O 0 2.243091780027018e-12
the O 0 1.8053279357554963e-11
PDS B-Disease 0 1.3972049828225863e-06
gene O 0 8.564062348170864e-09
in O 0 6.386342843445192e-12
patients O 0 4.135543296701627e-11
from O 0 1.8157421096190451e-12
14 O 0 3.3460148540775947e-10
Pendred B-Disease 0 5.113727663541567e-09
families O 0 1.0333638241974419e-12
originating O 0 8.344405028060109e-12
from O 0 2.6556930265986267e-11
seven O 0 1.8368538912127974e-09
countries O 0 1.1553111939344163e-10
and O 0 1.3427372928809245e-11
identified O 0 1.2214300404433942e-10
all O 0 2.7291190141109922e-11
mutations O 0 2.3595537967935343e-08
. O 0 5.298136929177133e-10

The O 0 7.801679302588127e-10
mutations O 0 1.905849842387397e-07
include O 0 2.2150127565456756e-10
three O 0 9.507971493460943e-11
single O 0 2.9359465969491794e-08
base O 0 4.3219500867053284e-08
deletions O 0 5.379923351256366e-08
, O 0 2.5392375702093517e-11
one O 0 1.021126672801076e-11
splice O 0 3.6922047002008185e-06
site O 0 3.79109451387194e-07
mutation O 0 4.968252369508264e-07
and O 0 1.4088591404615158e-09
10 O 0 8.363214010209674e-10
missense O 0 5.425079507404007e-06
mutations O 0 1.6044816220528446e-05
. O 0 9.486787355683646e-09

One O 0 5.0951925345543714e-08
missense O 0 6.403704173862934e-05
mutation O 0 4.978360448149033e-05
( O 0 2.8932074513932093e-09
L236P O 0 3.073420273835836e-08
) O 0 1.1774164108968588e-11
was O 0 4.094668493159759e-10
found O 0 5.676278544419766e-11
in O 0 4.904895933854903e-13
a O 0 1.784625398848494e-11
homozygous O 0 7.553826719686185e-08
state O 0 4.40332076356853e-11
in O 0 1.9604040613074858e-12
two O 0 3.657318198291293e-11
consanguineous O 0 1.5875344843152561e-06
families O 0 2.2134216681735097e-09
and O 0 8.883085239608235e-11
in O 0 2.612374292582098e-13
a O 0 5.673309478454458e-12
heterozygous O 0 1.7229007109875738e-09
state O 0 7.677847940756877e-12
in O 0 3.854952110565052e-13
five O 0 1.657041170943785e-11
additional O 0 2.181732988715268e-10
non O 0 9.956586382031674e-07
- O 0 2.9327755328267813e-05
consanguineous O 0 6.063110413379036e-05
families O 0 9.165021630508363e-09
. O 0 7.302460303115765e-10

Another O 0 1.383187395731511e-07
missense O 0 0.0001629415201023221
mutation O 0 0.00015121269098017365
( O 0 2.796976206198565e-09
T416P O 0 2.6942272413066348e-08
) O 0 2.904201358566727e-11
was O 0 5.508171141421769e-10
found O 0 2.7218305734266757e-11
in O 0 2.3932792596673136e-13
a O 0 8.555086326855754e-12
homozygous O 0 1.1371042063501591e-07
state O 0 1.3002848797682987e-10
in O 0 5.279439212191317e-12
one O 0 6.50729248263815e-10
family O 0 5.966694693881891e-09
and O 0 8.561705788778795e-10
in O 0 1.7369013128806787e-12
a O 0 1.9326677411224402e-11
heterozygous O 0 4.9508295241196265e-09
state O 0 2.1436755148762643e-11
in O 0 9.084734917466641e-13
four O 0 4.750140558673621e-11
families O 0 4.293639888075518e-10
. O 0 5.951404369319846e-10

Pendred B-Disease 0 0.0004717334231827408
patients O 0 2.5003209884744138e-06
in O 0 5.5545047727978414e-11
three O 0 2.4059287895283887e-10
non O 0 4.841115810449992e-07
- O 0 5.886326835025102e-05
consanguineous O 0 9.668610437074676e-05
families O 0 1.9071620727117988e-08
were O 0 1.9619098012846337e-10
shown O 0 4.4845710478469414e-11
to O 0 4.612946309656696e-13
be O 0 3.8537194269050445e-12
compound O 0 2.6363672529783333e-12
heterozygotes O 0 2.886987870986957e-10
for O 0 3.465373170710717e-12
L236P O 0 1.9095451886386172e-09
and O 0 7.12577566397421e-11
T416P O 0 2.183962699575659e-08
. O 0 3.690387440080656e-10

In O 0 1.3744444471441852e-09
total O 0 7.123400758146659e-10
, O 0 8.791989705714265e-12
one O 0 9.52433965029087e-12
or O 0 9.013306073724081e-11
both O 0 3.085607724190309e-12
of O 0 3.7472244274541766e-13
these O 0 3.9574597938962786e-12
mutations O 0 8.665094419768593e-09
were O 0 1.0484980661473742e-09
found O 0 1.4336107856394165e-09
in O 0 7.1838381597577605e-12
nine O 0 3.6720756990682446e-10
of O 0 2.5947664156200645e-12
the O 0 1.0279392614886973e-10
14 O 0 1.1660576948457901e-09
families O 0 4.139336876735067e-12
analyzed O 0 3.7107736883257303e-09
. O 0 5.878468267717096e-10

The O 0 3.434599132878802e-11
identification O 0 4.452507806895767e-11
of O 0 2.3931026431334157e-12
two O 0 7.500509241475939e-11
frequent O 0 1.98473522061704e-08
PDS B-Disease 0 6.308031515800394e-06
mutations O 0 1.937624602987853e-07
will O 0 2.3391573400477483e-11
facilitate O 0 6.4910845795629335e-12
the O 0 1.6583248663160077e-11
molecular O 0 2.890391215260024e-07
diagnosis O 0 0.0001645421580178663
of O 0 1.7552907593199052e-05
Pendred B-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999997615814209
. O 0 7.054921269400438e-08

Insertional O 0 4.110630106879398e-05
mutation O 0 7.312278853532916e-07
by O 0 1.2558977469101507e-10
transposable O 0 2.710815749651374e-07
element O 0 7.47786472743428e-08
, O 0 2.1066373645517444e-10
L1 O 0 1.6502111975569278e-05
, O 0 3.9623485048601026e-11
in O 0 1.043484851477594e-12
the O 0 1.1434053009962142e-10
DMD B-Disease 1 0.999996542930603
gene O 0 8.128997563972007e-08
results O 0 2.0505035447371256e-09
in O 0 1.074091593444848e-09
X B-Disease 1 0.9999430179595947
- I-Disease 1 0.9999922513961792
linked I-Disease 1 0.9999914169311523
dilated I-Disease 1 0.9998196959495544
cardiomyopathy I-Disease 1 0.9999743700027466
. O 0 6.937561636277678e-08

X B-Disease 1 0.9998793601989746
- I-Disease 1 0.9999872446060181
linked I-Disease 1 0.999995231628418
dilated I-Disease 1 0.9999825954437256
cardiomyopathy I-Disease 1 0.9999994039535522
( O 0 5.834997196529912e-08
XLDCM B-Disease 0 0.00016787783533800393
) O 0 2.4760485328734205e-11
is O 0 2.463427682328212e-12
a O 0 2.8904685936415042e-11
clinical O 0 5.002428693501315e-09
phenotype O 0 3.217452082537875e-09
of O 0 4.6536555858844864e-11
dystrophinopathy B-Disease 0 0.00021029413619544357
which O 0 1.0039940434580785e-08
is O 0 6.713588018847361e-10
characterized O 0 2.0897650276907598e-10
by O 0 3.862661926423705e-11
preferential O 0 6.692880560876802e-07
myocardial B-Disease 0 0.0004032906435895711
involvement I-Disease 0 6.062843738163792e-08
without O 0 1.3877306248577526e-10
any O 0 1.6581793230163733e-11
overt O 0 1.2670733440245385e-07
clinical O 0 5.255297992334818e-07
signs O 0 4.917994829156669e-06
of O 0 1.2011176409032487e-07
skeletal B-Disease 1 0.9999996423721313
myopathy I-Disease 1 1.0
. O 0 9.922396202455275e-06

To O 0 4.914117446297439e-10
date O 0 2.4826138367295414e-10
, O 0 2.7689967831666384e-13
several O 0 1.179921909960288e-13
mutations O 0 2.780333296925619e-09
in O 0 1.7065471258348452e-10
the O 0 1.0545152235863497e-06
Duchenne B-Disease 1 0.999994158744812
muscular I-Disease 1 0.9999158382415771
dystrophy I-Disease 1 0.998367965221405
gene O 0 3.74475603166502e-05
, O 0 2.451456815322217e-08
DMD O 1 0.9999992847442627
, O 0 2.083008876496706e-09
have O 0 1.5612319770319516e-10
been O 0 5.28155907897343e-10
identified O 0 3.5445140156298294e-09
in O 0 8.948658480889549e-11
patients O 0 4.4084327854854166e-10
with O 0 1.1455029980123044e-10
XLDCM B-Disease 0 0.0004180886026006192
, O 0 2.4166528153624078e-11
but O 0 1.0359371780538362e-12
a O 0 1.5051423649103945e-12
pathogenic O 0 2.586457992226343e-10
correlation O 0 2.842972246508424e-10
of O 0 4.052166154705494e-12
these O 0 1.9040951107496262e-11
cardiospecific O 0 2.8997528715990484e-06
mutations O 0 8.355885938726715e-07
in O 0 4.98159291595357e-10
DMD O 1 0.9999961853027344
with O 0 4.126328612130692e-09
the O 0 1.284396700107493e-09
XLDCM B-Disease 0 0.02204740419983864
phenotype O 0 3.619852350311703e-06
has O 0 6.515421091535245e-08
remained O 0 3.893421585132728e-09
to O 0 7.592625313190826e-12
be O 0 4.726419255973724e-10
elucidated O 0 5.541332370739838e-07
. O 0 1.764404178317136e-09

We O 0 1.4961550220959907e-08
report O 0 2.5242113954604406e-10
here O 0 5.670883684513739e-13
the O 0 1.0837194484088642e-14
identification O 0 8.129008534016324e-13
of O 0 3.520882858269042e-13
a O 0 7.542255708870016e-11
unique O 0 1.2585882336324516e-10
de O 0 5.494001698025386e-08
novo O 0 8.068676038419653e-08
L1 O 0 1.7636248230701312e-06
insertion O 0 2.5418860349901706e-09
in O 0 9.256730798545831e-12
the O 0 1.2385457243135889e-11
muscle O 0 3.6411045289952426e-09
exon O 0 9.481106566511244e-09
1 O 0 3.005500071040501e-09
in O 0 2.046786629072983e-10
DMD O 1 0.9999951124191284
in O 0 9.293603386861804e-11
three O 0 2.184782355030279e-09
XLDCM B-Disease 0 0.000889283197466284
patients O 0 4.987250057375547e-10
from O 0 1.750523012135352e-13
two O 0 1.3089281178033096e-12
unrelated O 0 2.9227478215432257e-09
Japanese O 0 8.044612087587666e-08
families O 0 4.514887075313112e-10
. O 0 3.1659921906346256e-10

The O 0 6.64965082997071e-10
insertion O 0 2.6761789229112765e-08
was O 0 8.126533401764391e-08
a O 0 1.34912497840034e-10
5 O 0 9.17563358626694e-10
- O 0 2.748221561432729e-07
truncated O 0 1.1327677462702468e-08
form O 0 1.1830650348265692e-10
of O 0 2.7496043636388023e-12
human O 0 1.8045920313625174e-10
L1 O 0 3.0410171802941477e-07
inversely O 0 6.368860550054478e-09
integrated O 0 1.9712590670906138e-08
in O 0 5.04377182380944e-12
the O 0 1.034642423819454e-11
5 O 0 1.1447391923269379e-09
- O 0 9.588177363184514e-07
untranslated O 0 5.428034455690067e-06
region O 0 4.078852533506705e-10
in O 0 1.038800339150936e-12
the O 0 8.678363583314308e-12
muscle O 0 4.503209805051256e-09
exon O 0 1.0337089406675659e-08
1 O 0 1.8007181301626929e-09
, O 0 1.1289843842784975e-12
which O 0 2.1965537028156845e-12
affected O 0 1.4106378391776087e-11
the O 0 4.122009808135707e-13
transcription O 0 1.8419621383714002e-09
or O 0 5.979291506363893e-10
the O 0 1.8893862863134103e-10
stability O 0 2.4328432601805616e-08
of O 0 1.77248424271248e-11
the O 0 7.56537321677797e-09
muscle O 0 1.3353196663956624e-06
form O 0 2.8323784290185117e-11
of O 0 3.871740168054361e-12
dystrophin O 0 4.4709449475988094e-09
transcripts O 0 2.933258302917352e-09
but O 0 4.0879709339858294e-11
not O 0 5.811702031080501e-13
that O 0 2.533584507555947e-13
of O 0 1.6894969581335295e-12
the O 0 5.365942357116182e-09
brain O 0 0.0013645892031490803
or O 0 4.579015566719136e-08
Purkinje O 0 2.0245646737748757e-05
cell O 0 0.00012808253814000636
form O 0 3.2693404250494495e-07
, O 0 1.3328339321105886e-08
probably O 0 1.8365822995747294e-07
due O 0 6.798129836838029e-10
to O 0 3.933056571397975e-12
its O 0 2.280324149991908e-12
unique O 0 7.134594022344121e-13
site O 0 1.8190370043580373e-10
of O 0 1.1744758811327305e-11
integration O 0 2.4139110266219177e-08
. O 0 7.427480297472755e-10

We O 0 1.1382033093809696e-09
speculate O 0 3.826476357993158e-10
that O 0 5.39155905251304e-13
this O 0 1.1928329621247423e-14
insertion O 0 1.1803102765994833e-11
of O 0 1.7008911640248314e-12
an O 0 3.522794556065634e-11
L1 O 0 6.1101554820197634e-06
sequence O 0 7.858375283831265e-09
in O 0 2.4024724432081257e-09
DMD O 1 0.9999983310699463
is O 0 1.1440995928424513e-09
responsible O 0 1.4924113334036093e-10
for O 0 1.5521624784076149e-12
some O 0 6.741174729974625e-14
of O 0 4.504890858676551e-14
the O 0 2.251046571366544e-12
population O 0 8.219075918990126e-13
of O 0 1.5107624352916904e-12
Japanese O 0 2.5049820351341623e-07
patients O 0 1.475102956449703e-10
with O 0 5.187051742988613e-12
XLDCM B-Disease 0 1.2920927474624477e-06
. O 0 7.0456960578335615e-12
. O 0 9.452100213636072e-11

Severe O 0 0.006705724634230137
early O 0 4.663721426823031e-07
- O 1 0.9897915124893188
onset O 1 0.9999110698699951
obesity B-Disease 1 1.0
, O 0 0.00044541663373820484
adrenal B-Disease 1 0.9999990463256836
insufficiency I-Disease 1 0.9999990463256836
and O 0 3.5737613757191866e-07
red O 0 1.8397673784420476e-06
hair O 1 0.969543993473053
pigmentation O 0 0.0017508724704384804
caused O 0 3.0481803037218924e-07
by O 0 1.6437455563345083e-10
POMC O 0 0.00016293933731503785
mutations O 0 8.606105552644294e-07
in O 0 4.0083211055863543e-11
humans O 0 7.67976349180799e-09
. O 0 6.254219919732407e-10

Sequential O 0 1.1564493007654164e-07
cleavage O 0 1.7311787814833224e-05
of O 0 1.7300126609054445e-10
the O 0 1.3043480358299053e-11
precursor O 0 6.856586409753618e-10
protein O 0 1.022295026409381e-09
pre O 0 4.0385256738773023e-07
- O 0 3.3982891181949526e-05
pro O 0 8.412917850364465e-06
- O 0 0.0001234296360053122
opiomelanocortin O 0 2.374961150053423e-05
( O 0 1.8999664688768014e-11
POMC O 0 2.5812317616669134e-08
) O 0 2.1052281554308216e-13
generates O 0 5.229759333924555e-12
the O 0 1.1548105353920146e-11
melanocortin O 0 3.890264906658558e-06
peptides O 0 1.1238586949957607e-07
adrenocorticotrophin O 0 1.3313725730768056e-06
( O 0 5.25550991614665e-11
ACTH O 0 8.774618009965707e-08
) O 0 2.1602815022947475e-12
, O 0 1.4763230785433401e-12
melanocyte O 0 6.652142019447638e-07
- O 0 0.000332612544298172
stimulating O 0 0.003416921943426132
hormones O 0 8.779527706792578e-05
( O 0 7.466049480042702e-12
MSH O 0 4.173975298726873e-08
) O 0 1.025767605621411e-13
alpha O 0 7.723665186153833e-14
, O 0 1.103472087332245e-14
beta O 0 2.045420582040547e-14
and O 0 7.066118252584824e-14
gamma O 0 8.332264999494354e-13
as O 0 1.60378203772904e-11
well O 0 8.128605752909246e-13
as O 0 3.2986063967094248e-12
the O 0 1.7872848383573836e-12
opioid O 0 1.3876466642415153e-09
- O 0 1.871148391785482e-08
receptor O 0 3.6902765288004957e-09
ligand O 0 4.042751688970725e-10
beta O 0 5.603562613920587e-10
- O 0 1.2056776768076816e-06
endorphin O 0 4.0838418499333784e-05
. O 0 2.0354080643159023e-09

While O 0 2.7980699979224255e-09
a O 0 1.902443307055801e-11
few O 0 3.1604441286248175e-12
cases O 0 1.047949643728785e-10
of O 0 4.93651342026169e-10
isolated O 0 0.03666085749864578
ACTH B-Disease 1 0.9981324076652527
deficiency I-Disease 1 0.7733442187309265
have O 0 1.5259077335016968e-09
been O 0 4.346881521399837e-09
reported O 0 5.102340949747486e-08
( O 0 6.543283276316814e-11
OMIM O 0 2.0909486920572817e-05
201400 O 0 5.531670126401877e-07
) O 0 8.700240181069852e-12
, O 0 1.5024519172193718e-12
an O 0 1.747403333141051e-10
inherited O 0 0.04581229016184807
POMC O 1 0.9594222903251648
defect O 0 0.4107520878314972
has O 0 1.2132957749599882e-07
not O 0 9.827803154616177e-11
been O 0 5.802229807727599e-10
described O 0 3.534399162230528e-10
so O 0 1.6237176533873132e-11
far O 0 1.1298190855102419e-10
. O 0 2.419227596028861e-10

Recent O 0 2.1944183359323688e-08
studies O 0 3.1490868246386583e-10
in O 0 1.5416794360220698e-12
animal O 0 6.490393639202452e-11
models O 0 1.9975632259416898e-09
elucidated O 0 8.708637366794392e-09
a O 0 5.233583011410303e-11
central O 0 9.516912431728475e-12
role O 0 1.265443722031634e-10
of O 0 3.5559979982315026e-13
alpha O 0 3.034991355455041e-11
- O 0 2.4583664526289795e-07
MSH O 0 3.1006577501102583e-06
in O 0 1.9627986302256373e-12
the O 0 4.578227445588279e-13
regulation O 0 5.3469135369299536e-11
of O 0 4.1324799485153996e-13
food O 0 3.170008699981963e-11
intake O 0 3.3945183903344445e-12
by O 0 1.1572540208016832e-14
activation O 0 1.7951460630494243e-12
of O 0 3.633902261133276e-13
the O 0 1.8524888567572617e-10
brain O 0 1.7855425085144816e-06
melanocortin O 0 4.942180567013565e-07
- O 0 5.372406803871854e-07
4 O 0 1.5605726488843175e-08
- O 0 5.954350399406394e-07
receptor O 0 7.03263003387633e-09
( O 0 1.0725018963209099e-11
MC4 O 0 1.8480093899597705e-07
- O 0 9.209671816279297e-07
R O 0 1.0111477422469761e-05
; O 0 1.2057519045705067e-11
refs O 0 4.7214236076342786e-08
3 O 0 3.213010413283257e-10
- O 0 3.7256469909152656e-08
5 O 0 2.2120445752893403e-10
) O 0 8.486850003146251e-14
and O 0 2.8637943389310874e-14
the O 0 1.8880782828574298e-14
linkage O 0 1.1865373572561566e-08
of O 0 5.028052973976571e-10
human O 0 4.796461780642858e-06
obesity B-Disease 1 0.9999996423721313
to O 0 2.1037873665363804e-09
chromosome O 0 2.1378544261096977e-05
2 O 0 2.5236737144496146e-09
in O 0 1.3870174540159264e-12
close O 0 2.9404492729590004e-10
proximity O 0 7.976684590627059e-11
to O 0 1.5457730581647233e-11
the O 0 3.990364635941823e-11
POMC O 0 1.812205141504819e-07
locus O 0 5.677410541693462e-09
, O 0 2.235013042695133e-11
led O 0 3.5515552304632436e-11
to O 0 1.9402051579936463e-12
the O 0 3.2357192012583136e-12
proposal O 0 5.002261452280443e-11
of O 0 1.6693042347720732e-12
an O 0 6.41051323135855e-10
association O 0 1.1237156344323651e-10
of O 0 8.503693409156465e-12
POMC O 0 1.5029707356006838e-05
with O 0 5.939670089105675e-09
human O 0 6.231272436707513e-06
obesity B-Disease 1 0.9999954700469971
. O 0 4.0050338157016085e-08

The O 0 4.134630415819629e-10
dual O 0 5.166268124412454e-08
role O 0 6.075030256624814e-09
of O 0 2.5367286396460464e-12
alpha O 0 1.0852895665491857e-10
- O 0 7.980012242114753e-07
MSH O 0 8.599914508522488e-06
in O 0 2.7038124343625736e-12
regulating O 0 4.962798616503505e-09
food O 0 3.820887703454012e-11
intake O 0 1.7595428586369977e-11
and O 0 5.611982775190205e-13
influencing O 0 2.2975943370084906e-09
hair O 0 0.00022905156947672367
pigmentation O 0 6.620170012183735e-08
predicts O 0 2.089504036462131e-08
that O 0 4.274819040417377e-11
the O 0 5.593159962957728e-11
phenotype O 0 2.3581817387707815e-08
associated O 0 2.7057292517618237e-10
with O 0 7.300075127725236e-11
a O 0 1.4819516280795142e-08
defect O 0 2.8599535653484054e-05
in O 0 7.951393710126098e-11
POMC O 0 8.004578376130667e-06
function O 0 5.220517795834212e-09
would O 0 8.049643618335267e-09
include O 0 9.128527267421305e-08
obesity B-Disease 1 0.9999995231628418
, O 0 1.0985565790377905e-09
alteration O 0 2.533847691665869e-07
in O 0 2.203060622818498e-09
pigmentation O 0 0.0021672670263797045
and O 0 9.088971273740754e-05
ACTH B-Disease 1 0.99755859375
deficiency I-Disease 0 0.39789846539497375
. O 0 1.8828469894316413e-09

The O 0 6.574311095519647e-10
observation O 0 8.684950536519409e-09
of O 0 6.163940191594719e-11
these O 0 9.066139505797821e-10
symptoms O 0 1.4812145820997102e-07
in O 0 1.1695483990992184e-12
two O 0 1.018815500714032e-11
probands O 0 1.3479643712344114e-07
prompted O 0 1.1557783896609664e-10
us O 0 9.636173109450752e-11
to O 0 5.2263128856111854e-14
search O 0 1.918581613025161e-12
for O 0 4.2368925208535746e-12
mutations O 0 4.462959168893832e-10
within O 0 3.8902167077969896e-12
their O 0 1.8898332898587e-10
POMC O 0 9.70601467997767e-06
genes O 0 4.2783163678450364e-08
. O 0 7.484164954441042e-10

Patient O 0 0.00020221559680067003
1 O 0 8.176659349601323e-08
was O 0 3.957980965196839e-08
found O 0 4.3868089716347924e-10
to O 0 3.6587889835904e-12
be O 0 7.0603596753759934e-12
a O 0 1.7816483965232832e-12
compound O 0 3.33813272163086e-12
heterozygote O 0 1.6759098275809237e-10
for O 0 1.0278088059464952e-12
two O 0 6.312277089914886e-12
mutations O 0 1.213845579606243e-09
in O 0 4.8451290722562046e-12
exon O 0 3.282080172084534e-07
3 O 0 4.7345267262244306e-08
( O 0 2.1167741171002064e-11
G7013T O 0 1.5506499417838882e-09
, O 0 5.821023350838228e-12
C7133delta O 0 3.018818972577719e-08
) O 0 2.1804871276620563e-12
which O 0 6.578867225298657e-13
interfere O 0 9.119495956999568e-12
with O 0 3.3498472550540226e-13
appropriate O 0 5.842822428138439e-13
synthesis O 0 9.17723449317398e-12
of O 0 1.1779308431436597e-11
ACTH O 0 1.5849325336603215e-06
and O 0 1.2696213524954203e-10
alpha O 0 3.751892962977621e-10
- O 0 1.1505223483254667e-05
MSH O 0 0.0004049077979288995
. O 0 1.280263228764511e-09

Patient O 0 0.00011014658957719803
2 O 0 6.167323363115429e-08
was O 0 6.852183709327164e-09
homozygous O 0 1.9445474563895004e-08
for O 0 3.89199740144508e-12
a O 0 3.611105511835966e-11
mutation O 0 4.41875558365723e-09
in O 0 3.0399856243423784e-11
exon O 0 1.9966557829320664e-06
2 O 0 1.934441655748742e-07
( O 0 1.1904760510716983e-10
C3804A O 0 7.628927711778033e-09
) O 0 7.29691133904975e-12
which O 0 1.0889508045286433e-11
abolishes O 0 4.876973775935767e-07
POMC O 0 2.7790689273388125e-05
translation O 0 2.341499616420606e-08
. O 0 2.5802509018291175e-09

These O 0 1.9279965124407994e-10
findings O 0 2.460805170745317e-10
represent O 0 1.369904883974371e-11
the O 0 2.56409628772436e-12
first O 0 2.2148141654021458e-10
examples O 0 1.4071181719810255e-10
of O 0 5.591591772935445e-11
a O 0 5.754781113864738e-07
genetic B-Disease 1 0.9999996423721313
defect I-Disease 1 0.999998927116394
within O 0 7.723033879081243e-10
the O 0 1.0233147662574993e-10
POMC O 0 1.7195224017996225e-06
gene O 0 3.4429323836349113e-09
and O 0 1.512094963129762e-11
define O 0 5.250502810305591e-10
a O 0 1.8084382880090288e-09
new O 0 7.189780149019498e-07
monogenic B-Disease 1 0.9925240874290466
endocrine I-Disease 1 0.9985419511795044
disorder I-Disease 0 0.0018633868312463164
resulting O 0 1.1809959676867265e-09
in O 0 5.3725524029601956e-11
early O 0 8.115489436022472e-08
- O 1 0.9994481205940247
onset O 1 0.9999444484710693
obesity B-Disease 1 1.0
, O 0 0.0005291986744850874
adrenal B-Disease 1 0.9999992847442627
insufficiency I-Disease 1 0.999998927116394
and O 0 1.9774545023665269e-07
red O 0 5.055165956946439e-07
hair O 0 0.034166738390922546
pigmentation O 0 1.0807031685544644e-05
. O 0 5.72551346611494e-11
. O 0 3.121316261012197e-10

A O 0 1.316878524448839e-06
European O 0 4.89140859372128e-07
multicenter O 0 0.00013328090426512063
study O 0 1.6147965880008996e-06
of O 0 6.274424231378362e-05
phenylalanine B-Disease 1 0.9999998807907104
hydroxylase I-Disease 1 0.999998927116394
deficiency I-Disease 1 0.9999998807907104
: O 0 4.233996486746605e-10
classification O 0 4.834628808403352e-10
of O 0 2.6300138282475682e-12
105 O 0 1.0063478939059678e-09
mutations O 0 2.5421297067396154e-08
and O 0 1.0647367709726296e-10
a O 0 2.0258742600143265e-11
general O 0 9.190793091862215e-12
system O 0 5.402496158768422e-11
for O 0 3.753227763303446e-12
genotype O 0 6.843886013463418e-10
- O 0 1.7683301933857365e-08
based O 0 2.72198263928658e-10
prediction O 0 2.711564839330549e-08
of O 0 1.7596310519785163e-10
metabolic O 0 0.00031506031518802047
phenotype O 0 7.648577025065606e-07
. O 0 1.273730787509919e-09

Phenylketonuria B-Disease 0 0.29674437642097473
( O 0 1.4010237237016554e-07
PKU B-Disease 0 3.522707993397489e-05
) O 0 4.076809112518731e-09
and O 0 4.5339454857185046e-08
mild B-Disease 0 0.0050761825405061245
hyperphenylalaninemia I-Disease 1 0.9999998807907104
( O 0 8.912132216210011e-06
MHP B-Disease 1 0.9999992847442627
) O 0 9.961500513355759e-10
are O 0 7.505808197194597e-10
allelic B-Disease 0 0.00013619546371046454
disorders I-Disease 1 0.9968576431274414
caused O 0 2.1434866326330848e-08
by O 0 5.339348754795914e-12
mutations O 0 1.1266783950247827e-08
in O 0 5.384347048081883e-12
the O 0 8.399434620054436e-11
gene O 0 1.0195400363954832e-06
encoding O 0 9.763572961674072e-06
phenylalanine O 1 0.5525241494178772
hydroxylase O 1 0.907628059387207
( O 0 8.542661333876822e-08
PAH O 0 0.0003558544849511236
) O 0 4.46928855035722e-10
. O 0 2.1381475756587776e-10

Previous O 0 4.9626500242538896e-08
studies O 0 1.8549153324443068e-09
have O 0 1.7566197108020987e-10
suggested O 0 1.6344781431087974e-11
that O 0 3.8276310289700466e-13
the O 0 5.277274710974167e-12
highly O 0 3.543069482248029e-08
variable O 0 2.2462020297098206e-06
metabolic O 0 0.06695867329835892
phenotypes O 0 3.985852163168602e-05
of O 0 3.7606125715683447e-06
PAH B-Disease 1 0.999941349029541
deficiency I-Disease 1 0.997697651386261
correlate O 0 3.104456709479564e-06
with O 0 5.532193085855397e-07
PAH O 0 0.21578343212604523
genotypes O 0 3.890212610713206e-05
. O 0 7.853819816716623e-09

We O 0 9.573492221193192e-09
identified O 0 7.658055523052099e-09
both O 0 3.621098906836373e-11
causative O 0 2.6807010726770386e-06
mutations O 0 1.980509296117816e-06
in O 0 1.815335382016059e-10
686 O 0 5.679461082763737e-06
patients O 0 6.339908509289671e-08
from O 0 5.063012856187932e-11
seven O 0 4.354101079684369e-09
European O 0 8.6917651742624e-08
centers O 0 8.267644346915404e-09
. O 0 4.818297982822628e-10

On O 0 1.450161213334411e-09
the O 0 6.815490554736015e-13
basis O 0 6.302986019397772e-13
of O 0 6.258538744760914e-14
the O 0 3.091921792382213e-13
phenotypic O 0 1.4849500518110403e-09
characteristics O 0 3.627188827071137e-11
of O 0 7.478288279426371e-13
297 O 0 1.617186384805791e-08
functionally O 0 1.2947407412866596e-07
hemizygous O 0 4.409759185364237e-06
patients O 0 4.731292246873409e-09
, O 0 1.6136174156838184e-13
105 O 0 1.6375540246721387e-12
of O 0 8.160214447520617e-14
the O 0 1.6371988834085194e-11
mutations O 0 3.853256558272733e-08
were O 0 2.4298278944456797e-09
assigned O 0 1.0496225000267145e-09
to O 0 4.134736823757645e-12
one O 0 2.1231900786122804e-12
of O 0 7.229493289824876e-14
four O 0 1.042920264038294e-11
arbitrary O 0 3.8354071030255454e-09
phenotype O 0 1.0441125652960181e-07
categories O 0 5.06582189530036e-08
. O 0 2.6623852011908866e-09

We O 0 6.4574687819174414e-09
proposed O 0 1.0270402306389315e-09
and O 0 7.892886344507133e-11
tested O 0 9.350011431763505e-09
a O 0 5.842867422528597e-13
simple O 0 7.285364802753214e-13
model O 0 5.85323844948249e-10
for O 0 5.723018088078791e-13
correlation O 0 3.891066080452532e-10
between O 0 4.5697775424846654e-11
genotype O 0 6.85610546113935e-09
and O 0 3.454743435771235e-11
phenotypic O 0 8.795794315119565e-09
outcome O 0 2.8564806076047944e-09
. O 0 1.4208301202245366e-09

The O 0 4.4860792858258947e-10
observed O 0 1.2456400355631558e-09
phenotype O 0 3.6158367411331938e-09
matched O 0 8.87246009995124e-09
the O 0 4.825229799054753e-11
predicted O 0 9.320580574012638e-08
phenotype O 0 4.367161210439008e-08
in O 0 8.341480284279612e-11
79 O 0 2.3705153395781053e-08
% O 0 1.611668155702961e-12
of O 0 4.907497476967781e-13
the O 0 1.0984555626203374e-10
cases O 0 3.117939684216253e-08
, O 0 4.299745559599444e-10
and O 0 1.3769417550602014e-10
in O 0 2.3655738826122708e-12
only O 0 9.396730789312802e-12
5 O 0 4.9679435912275416e-12
of O 0 2.682713534825354e-13
184 O 0 7.862452910956108e-09
patients O 0 8.951906993459602e-10
was O 0 2.3611284039048996e-09
the O 0 5.46715667529285e-12
observed O 0 3.9155972908488934e-10
phenotype O 0 4.050684440648489e-11
more O 0 1.0354981168315611e-13
than O 0 1.4606799927582848e-12
one O 0 2.3802617862833664e-11
category O 0 5.698954086419405e-10
away O 0 1.5550148668719288e-10
from O 0 2.7014362968813543e-12
that O 0 8.038875121130218e-12
expected O 0 4.427552491303999e-10
. O 0 1.1759514195741616e-10

Among O 0 2.3765125423125255e-09
the O 0 1.4331090134045432e-11
seven O 0 7.698233717157166e-11
contributing O 0 5.25782861693358e-10
centers O 0 4.7345734971449005e-11
, O 0 1.9916852184425488e-13
the O 0 1.0339468945732774e-13
proportion O 0 1.2341884458866303e-10
of O 0 5.189307750869121e-12
patients O 0 1.1947479117146997e-10
for O 0 4.487803358099729e-12
whom O 0 5.577225903330429e-10
the O 0 8.049967810397352e-12
observed O 0 4.6032351264102545e-09
phenotype O 0 7.051030870286468e-09
did O 0 1.6948056291710145e-09
not O 0 2.8142255886765e-11
match O 0 2.56189558456299e-09
the O 0 3.8358788367887087e-11
predicted O 0 3.0495026948074155e-08
phenotype O 0 6.373818361993244e-09
was O 0 3.0017549335070726e-08
4 O 0 2.011219191189184e-09
% O 0 1.019367402987914e-11
- O 0 2.0543448044918478e-06
23 O 0 2.663514919731824e-07
% O 0 1.8856987152315874e-11
( O 0 9.17368177949518e-12
P O 0 2.8050878881913377e-06
< O 0 9.69702207420653e-10
. O 0 7.476790996226168e-13
0001 O 0 3.8283379244496984e-10
) O 0 8.561671472695834e-14
, O 0 5.156267750147875e-15
suggesting O 0 2.9277316248438323e-12
that O 0 1.8126832500298118e-12
differences O 0 3.240025261974644e-11
in O 0 3.1567118846187806e-14
methods O 0 1.558142503910176e-12
used O 0 1.3834063235240723e-11
for O 0 1.4173823790000761e-12
mutation O 0 3.9613981539510235e-10
detection O 0 6.039033451088471e-08
or O 0 1.561625850854398e-07
phenotype O 0 3.2207177014242916e-07
classification O 0 2.3278096250578528e-07
may O 0 6.488829473738633e-09
account O 0 2.2985870151703836e-11
for O 0 2.426600587135397e-12
a O 0 1.669337064413856e-11
considerable O 0 2.089190279108699e-11
proportion O 0 5.026298266486151e-10
of O 0 7.405988322606305e-11
genotype O 0 2.680406851141015e-06
- O 0 0.0003501921019051224
phenotype O 0 5.631787644233555e-06
inconsistencies O 0 5.958615929557709e-06
. O 0 4.41496483816195e-09

Our O 0 2.6305546629856735e-09
data O 0 4.063549496891028e-09
indicate O 0 5.982189188458165e-10
that O 0 1.7500775134626778e-11
the O 0 5.351905585371242e-10
PAH O 0 0.0021305091213434935
- O 0 7.796756108291447e-06
mutation O 0 1.7231621995961177e-07
genotype O 0 3.1696025359906344e-08
is O 0 2.534790606578685e-11
the O 0 9.228027413391016e-13
main O 0 5.399014568752136e-11
determinant O 0 1.0605730693669102e-07
of O 0 8.359383324441083e-11
metabolic O 0 4.338464714237489e-05
phenotype O 0 3.7641541439370485e-08
in O 0 2.7274070155125507e-11
most O 0 1.4485882493531221e-09
patients O 0 8.023052089356497e-08
with O 0 9.488869068263739e-07
PAH B-Disease 1 0.9998440742492676
deficiency I-Disease 1 0.9751753807067871
. O 0 2.2629831342158013e-09

In O 0 1.7064438750935551e-09
the O 0 2.349136683788e-11
present O 0 6.088175102947346e-12
study O 0 3.6323103812935242e-12
, O 0 7.093128710257413e-13
the O 0 2.517956546391198e-13
classification O 0 2.989786751506074e-10
of O 0 1.8540538895828185e-11
105 O 0 1.8356647046857688e-07
PAH O 0 2.8343307349132374e-05
mutations O 0 1.3977660273667425e-07
may O 0 2.0470170003505928e-10
allow O 0 3.902662969266363e-13
the O 0 1.229628107234787e-13
prediction O 0 1.3595766179541613e-10
of O 0 6.628417432985589e-13
the O 0 2.5328043481986917e-11
biochemical O 0 8.647382543358617e-08
phenotype O 0 1.1467627958339222e-09
in O 0 9.471310454672865e-13
> O 0 4.562192290613609e-11
10 O 0 3.3783481567795093e-10
, O 0 3.3526998451799406e-12
000 O 0 5.590653287534941e-11
genotypes O 0 4.966141720075257e-09
, O 0 6.85390216803583e-11
which O 0 3.2054692233884907e-10
may O 0 1.1455735249299437e-09
be O 0 4.027647139415169e-12
useful O 0 4.500747430996599e-12
for O 0 8.404714641266353e-13
the O 0 3.537551978780029e-12
management O 0 2.794100784075937e-10
of O 0 1.1390208221051523e-11
hyperphenylalaninemia B-Disease 1 0.9999901056289673
in O 0 4.133449582610638e-09
newborns O 0 3.460843799985014e-06
. O 0 1.5969542355165345e-10

Somatic O 0 0.00021442865545395762
instability O 0 3.6178724258206785e-05
of O 0 8.098622467089811e-11
the O 0 5.234401800890964e-11
CTG O 0 1.5343332506745355e-06
repeat O 0 2.1940374850260014e-08
in O 0 1.3532059587456624e-12
mice O 0 6.227139914827262e-10
transgenic O 0 1.9847192778144063e-09
for O 0 6.523643431011195e-11
the O 0 3.424753458602936e-07
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
region O 0 1.236168486684619e-06
is O 0 9.33415211790134e-09
age O 0 9.389971467044234e-09
dependent O 0 2.2953472456066493e-09
but O 0 4.46434252412975e-12
not O 0 1.4894921233910008e-12
correlated O 0 8.798906048212984e-11
to O 0 4.110894350622951e-12
the O 0 1.0076221107491179e-11
relative O 0 2.27472679581453e-10
intertissue O 0 1.351194782728271e-07
transcription O 0 6.021344489681724e-08
levels O 0 1.5427739086248948e-08
and O 0 1.0110500214821627e-09
proliferative O 0 7.853922579670325e-05
capacities O 0 1.531976295154891e-06
. O 0 1.202198340877203e-09

A O 0 1.0347583838665741e-06
( O 0 6.37574826267695e-10
CTG O 0 4.3921508563471434e-07
) O 0 2.142240725089284e-11
nexpansion O 0 1.7949751907053724e-08
in O 0 3.5002951058460408e-12
the O 0 6.1969197134859044e-12
3 O 0 2.412778421501116e-08
- O 0 0.00017909266171045601
untranslated O 0 0.000926816079299897
region O 0 1.1074943628841538e-08
( O 0 2.189502398830534e-11
UTR O 0 2.57482324350633e-09
) O 0 1.8207143963073352e-13
of O 0 2.2701896514997627e-13
the O 0 1.9328503242377337e-09
DM O 1 0.9999997615814209
protein O 0 2.224084710178431e-06
kinase O 0 1.7122013105108636e-06
gene O 0 7.663714285399692e-08
( O 0 7.984631011925813e-11
DMPK O 0 3.810192765740794e-07
) O 0 8.369137631178414e-13
is O 0 1.3135249181742137e-12
responsible O 0 2.5733699615670957e-09
for O 0 7.061301943167564e-08
causing O 1 0.8608790636062622
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
( O 0 3.6017070669913664e-05
DM B-Disease 1 0.999996542930603
) O 0 1.266751326056692e-08
. O 0 5.39638222996075e-10

Major O 0 1.5360317775048316e-05
instability O 0 3.501560422591865e-05
, O 0 5.868919933371686e-11
with O 0 1.4307402918661838e-12
very O 0 6.250095926918497e-13
large O 0 1.4369566734423467e-12
expansions O 0 1.502236446349059e-09
between O 0 2.0669032457787395e-11
generations O 0 1.374884872618054e-09
and O 0 9.171539083752123e-10
high O 0 5.75335015184919e-08
levels O 0 4.124234009861283e-10
of O 0 5.614509508353183e-13
somatic O 0 2.6916181283809237e-08
mosaicism O 0 7.848340715099766e-07
, O 0 9.236202080931122e-12
is O 0 2.737892378090745e-12
observed O 0 9.50775430608175e-11
in O 0 2.0400001132792056e-11
patients O 0 9.197816952521976e-10
. O 0 1.7677886932077058e-10

There O 0 9.40657063353001e-09
is O 0 1.2567459573009643e-10
a O 0 1.8727878622892824e-11
good O 0 6.934984531081767e-11
correlation O 0 3.2388219883827674e-10
between O 0 1.9276730212069992e-10
repeat O 0 1.0502682812330022e-07
size O 0 5.645116374353165e-08
( O 0 1.8036759585893236e-11
at O 0 2.9087651731707354e-10
least O 0 5.192832708972306e-12
in O 0 4.787567911557211e-12
leucocytes O 0 1.5196819447282905e-07
) O 0 4.576491963170781e-12
, O 0 1.0593797974273178e-12
clinical O 0 4.297531497332585e-10
severity O 0 1.3118955166646629e-07
and O 0 7.914795485675086e-10
age O 0 2.3286672590216995e-09
of O 0 1.3043437163684501e-10
onset O 0 1.1772578545787837e-05
. O 0 5.608677078328128e-09

The O 0 2.818552946592945e-09
trinucleotide O 0 4.517218258115463e-05
repeat O 0 4.987582087778719e-06
instability O 0 8.796685051493114e-07
mechanisms O 0 3.127505010525056e-08
involved O 0 7.775448729319123e-09
in O 0 1.2499239421259745e-09
DM B-Disease 1 0.9999998807907104
and O 0 1.7287741016502878e-08
other O 0 1.2341037913810027e-10
human O 0 3.9150830843937e-07
genetic B-Disease 1 0.999998927116394
diseases I-Disease 1 0.9999995231628418
are O 0 1.7947174857368964e-09
unknown O 0 5.043894635292645e-09
. O 0 1.0884577683611951e-09

We O 0 3.11018268916996e-08
studied O 0 3.6402016956316174e-09
somatic O 0 3.122126486232446e-07
instability O 0 4.170960323790496e-07
by O 0 1.6064576752183868e-11
measuring O 0 1.5508730939473026e-05
the O 0 6.7263375425064e-11
CTG O 0 8.051187023738748e-07
repeat O 0 3.010734417330241e-08
length O 0 3.365101752805799e-09
at O 0 3.081352950573546e-10
several O 0 1.0108633765118502e-12
ages O 0 3.5818911725549185e-10
in O 0 1.2531494938960996e-12
various O 0 4.774069594509767e-13
tissues O 0 2.6203927916412795e-10
of O 0 1.5935287757309208e-13
transgenic O 0 1.075884483725531e-07
mice O 0 1.7573830746187014e-07
carrying O 0 4.25908330825564e-09
a O 0 1.1735925564693162e-09
( O 0 5.503768274461862e-11
CTG O 0 2.2695508050674107e-07
) O 0 3.255913767763463e-12
55expansion O 0 2.3741431043333705e-09
surrounded O 0 4.7392176988347856e-11
by O 0 6.296497611496532e-13
45 O 0 3.520623029218406e-12
kb O 0 3.270278625677747e-08
of O 0 6.434738158977993e-12
the O 0 2.249100350404376e-10
human O 0 1.6378642442305136e-07
DM B-Disease 1 0.9999997615814209
region O 0 1.165859631058197e-09
, O 0 1.0288989170208207e-13
using O 0 4.669764575027102e-12
small O 0 1.1555828516307542e-09
- O 0 0.00012314727064222097
pool O 0 1.0022396281783585e-06
PCR O 0 3.331255811644951e-06
. O 0 6.272007357921439e-10

These O 0 1.1562861779168543e-09
mice O 0 3.478871803963557e-06
have O 0 7.994860329318954e-10
been O 0 3.02151192954625e-10
shown O 0 2.608493282485469e-11
to O 0 6.776370914049479e-13
reproduce O 0 9.728849947876483e-10
the O 0 1.3632132532179209e-12
intergenerational O 0 2.808674537391198e-08
and O 0 1.7859133616404677e-10
somatic O 0 4.082141202843559e-08
instability O 0 5.671936520457166e-08
of O 0 4.7353301835251216e-12
the O 0 5.099414293607829e-11
55 O 0 1.6066431518524382e-09
CTG O 0 3.4234723500503605e-08
repeat O 0 4.3568757490675125e-09
suggesting O 0 5.354662269141386e-10
that O 0 2.494457277454204e-13
surrounding O 0 9.133713750608674e-13
sequences O 0 3.378423582556245e-11
and O 0 5.328750288247086e-11
the O 0 1.5635071362596342e-12
chromatin O 0 4.0873335271918165e-10
environment O 0 3.010203197817418e-10
are O 0 5.365450379997416e-13
involved O 0 4.888015339710172e-11
in O 0 1.6830717375349025e-11
instability O 0 1.8677951629797462e-07
mechanisms O 0 1.4066075948448997e-07
. O 0 1.598613019737627e-09

As O 0 1.0094357349998972e-08
observed O 0 4.982543266862649e-10
in O 0 1.9038279795973584e-13
some O 0 1.51838160507246e-14
of O 0 1.0068161582221791e-13
the O 0 8.668640111286763e-11
tissues O 0 1.414857564441263e-07
of O 0 1.7446067923643227e-09
DM B-Disease 1 1.0
patients O 0 2.0757775018864777e-06
, O 0 4.319864778390414e-12
there O 0 2.7042096860385723e-12
is O 0 1.7071778019017714e-11
a O 0 9.554001340061902e-11
tendency O 0 2.4657769159830423e-09
for O 0 2.3514946934088954e-11
repeat O 0 1.0090854374311675e-08
length O 0 1.767949164843685e-08
and O 0 8.68943181298043e-11
somatic O 0 8.397520900871314e-09
mosaicism O 0 4.821925472242583e-07
to O 0 1.8950165048270406e-10
increase O 0 2.3560584594406464e-09
with O 0 5.016880313957195e-11
the O 0 2.2797378568251148e-11
age O 0 9.315082039051958e-10
of O 0 9.775522405441883e-13
the O 0 1.1402886967992742e-10
mouse O 0 1.518770932307234e-05
. O 0 5.296795890785688e-09

Furthermore O 0 7.977866403052758e-07
, O 0 2.3477583765973975e-10
we O 0 1.281644755601885e-11
observed O 0 1.6861144425117658e-11
no O 0 8.649968219996695e-13
correlation O 0 1.922554476729843e-10
between O 0 2.4779999233115468e-11
the O 0 1.6868381691459433e-11
somatic O 0 6.459238761635788e-07
mutation O 0 3.0840042199997697e-06
rate O 0 7.853451097616926e-05
and O 0 1.5339537640102208e-08
tissue O 0 2.5487152015557513e-05
proliferation O 0 0.0009620920172892511
capacity O 0 4.412496537042898e-07
. O 0 7.119190237325768e-10

The O 0 2.72198263928658e-10
somatic O 0 4.367515487047058e-07
mutation O 0 6.494071385532152e-06
rates O 0 6.67637186779757e-06
in O 0 1.4944956730489345e-11
different O 0 5.829467551038414e-12
tissues O 0 4.1049005972126906e-08
were O 0 9.890956942371076e-10
also O 0 1.1336787758553513e-10
not O 0 1.9487354438463278e-12
correlated O 0 1.7115607542361744e-10
to O 0 1.1823087647799824e-11
the O 0 2.0119703125764943e-10
relative O 0 3.7037892752778134e-08
inter O 0 2.8231706892256625e-06
- O 0 0.0008496599621139467
tissue O 0 4.27397208113689e-05
difference O 0 3.800105563556144e-09
in O 0 7.819142468917795e-13
transcriptional O 0 2.6689070398155934e-10
levels O 0 1.1419080264696291e-10
of O 0 4.7503599903513105e-14
the O 0 7.495038660890185e-13
three O 0 2.613019869923683e-11
genes O 0 5.568987493376198e-10
( O 0 1.9131377038128505e-11
DMAHP O 0 1.4736106095369905e-06
, O 0 6.846272160299094e-11
DMPK O 0 4.275170340406476e-06
and O 0 7.205155916345518e-10
59 O 0 4.989316515491282e-09
) O 0 1.9257371305231308e-13
surrounding O 0 1.1898619025826895e-12
the O 0 4.35045012167623e-12
repeat O 0 1.8311692429051618e-07
. O 0 4.026973199344752e-11
. O 0 1.3256576392173258e-10

A O 0 2.355583283986107e-08
novel O 0 6.703380073247445e-09
missense O 0 1.650993544899393e-05
mutation O 0 8.391682968067471e-06
in O 0 1.775249391933187e-10
patients O 0 1.3211601812557205e-09
from O 0 6.858528068393044e-12
a O 0 7.144328462160843e-10
retinoblastoma B-Disease 0 1.819851968321018e-05
pedigree O 0 6.0974882217124104e-05
showing O 0 8.241601608460769e-05
only O 0 2.7051335393935005e-08
mild O 0 2.841956359134201e-07
expression O 0 8.123979267082859e-11
of O 0 2.0312824772911187e-12
the O 0 8.322081357370337e-10
tumor B-Disease 0 5.927955862716772e-05
phenotype O 0 3.021821157744853e-07
. O 0 2.2531847498896695e-09

We O 0 4.433565692352204e-08
have O 0 2.4035058665550224e-11
used O 0 2.712459597209449e-12
single O 0 5.539406780497025e-11
strand O 0 5.532792002327369e-09
conformation O 0 7.259413514759672e-09
polymorphism O 0 3.9749479263662124e-09
analysis O 0 4.0565835413008955e-11
to O 0 6.297101295266172e-12
study O 0 2.0196116914256157e-12
the O 0 1.7579661684696823e-11
27 O 0 4.1405967543539646e-10
exons O 0 3.475185972323658e-10
of O 0 5.861977570020827e-13
the O 0 1.9054901753690068e-11
RB1 O 0 1.9038657228520606e-06
gene O 0 1.7862720191885728e-09
in O 0 1.665325863320355e-12
individuals O 0 4.077052064010989e-12
from O 0 3.809316143771335e-12
a O 0 4.4613848726449135e-10
family O 0 5.3372421149333604e-08
showing O 0 5.7751247368287295e-05
mild O 0 2.3007323761703447e-06
expression O 0 2.0379166409956184e-10
of O 0 2.880999909124493e-12
the O 0 1.0156034901953603e-09
retinoblastoma B-Disease 0 7.182909030234441e-05
phenotype O 0 1.5182405377345276e-06
. O 0 2.9725253369861093e-09

In O 0 2.481657379593827e-10
this O 0 3.1921409959778657e-12
family O 0 1.0564630420484278e-10
affected O 0 3.319076680163846e-10
individuals O 0 2.8822656067406527e-11
developed O 0 1.564726659353255e-07
unilateral B-Disease 0 0.046188872307538986
tumors I-Disease 1 1.0
and O 0 3.660031779872952e-07
, O 0 7.928283723979135e-11
as O 0 7.00045021950757e-11
a O 0 4.457078803254966e-11
result O 0 3.149806110380737e-11
of O 0 1.1702245075739803e-12
linkage O 0 8.819838370754951e-08
analysis O 0 3.6803584624323094e-09
, O 0 2.116819636244216e-10
unaffected O 0 6.38179908918346e-09
mutation O 0 1.3337698057114267e-08
carriers O 0 6.975429300837277e-08
were O 0 2.675585530909075e-09
also O 0 3.4584368702184065e-10
identified O 0 1.1476111727581895e-10
within O 0 2.086449285912395e-12
the O 0 5.070253661365598e-10
pedigree O 0 5.996250547468662e-05
. O 0 5.630220734076374e-09

A O 0 3.9945131646845766e-08
single O 0 4.75234784858003e-09
band O 0 8.233083659270335e-10
shift O 0 1.6792310597590898e-10
using O 0 7.283371822319751e-11
SSCP O 0 1.5984147694325657e-06
was O 0 7.592197981409754e-10
identified O 0 3.3699928264629975e-11
in O 0 3.854378567615807e-13
exon O 0 5.750519349589922e-08
21 O 0 1.2154818485043961e-08
which O 0 3.3789763521918648e-12
resulted O 0 2.5020647012596875e-11
in O 0 6.029236354967993e-13
a O 0 4.0123293576499464e-11
missense O 0 1.351576202068827e-07
mutation O 0 7.101061960668176e-09
converting O 0 5.373746780890087e-09
a O 0 1.2840837726457721e-08
cys O 0 0.0002508962352294475
- O 0 3.2011284929467365e-05
- O 0 5.061937827122165e-06
> O 0 3.37377792369864e-09
arg O 0 6.955792741791811e-08
at O 0 5.3954557488467e-10
nucleotide O 0 6.780418448926184e-09
position O 0 8.272833973421712e-09
28 O 0 1.1706968727764888e-10
in O 0 9.983163520030716e-14
the O 0 1.848519818117844e-12
exon O 0 3.493752842587128e-07
. O 0 2.7726281270901154e-09

The O 0 4.61663507422827e-09
mutation O 0 1.1562071904336335e-06
destroyed O 0 4.6645575935144734e-07
an O 0 1.5008901899093985e-09
NdeI O 0 1.528560278529767e-05
restriction O 0 7.3719044202391615e-09
enzyme O 0 1.90932034627167e-08
site O 0 7.271330648705998e-09
. O 0 4.742167769578032e-10

Analysis O 0 5.173681039138955e-09
of O 0 8.075223822956445e-11
all O 0 6.690306642020971e-11
family O 0 4.378942486393811e-10
members O 0 1.3105494337320445e-12
demonstrated O 0 5.2980003197034e-12
that O 0 2.3076294564453037e-13
the O 0 1.895303792381897e-12
missense O 0 4.5597550979437074e-07
mutation O 0 4.4645261709774786e-07
co O 0 4.806269771506777e-06
- O 0 1.2039702141919406e-06
segregated O 0 6.249306352401618e-07
with O 0 6.958536857837316e-09
patients O 0 2.8553163389233305e-08
with O 0 4.2813695699805976e-08
tumors B-Disease 1 1.0
or O 0 1.692230853223009e-06
who O 0 4.843059741688194e-06
, O 0 1.524583237433319e-10
as O 0 1.728686777058286e-10
a O 0 3.7884063941451274e-11
result O 0 2.245790012289639e-11
of O 0 6.241661376117646e-13
linkage O 0 4.07230373866696e-08
analysis O 0 3.612231624927631e-09
had O 0 2.984184277465829e-07
been O 0 1.6831857019283802e-09
predicted O 0 4.2656417287290083e-10
to O 0 1.8704452049711495e-12
carry O 0 4.392217423099254e-10
the O 0 6.879992409114521e-11
predisposing O 0 2.6974726097250823e-07
mutation O 0 1.1575957614695653e-07
. O 0 1.8285065683798507e-09

These O 0 9.108565290905091e-11
observations O 0 2.6443822132016237e-10
point O 0 2.066144366708045e-09
to O 0 4.1793127118772144e-12
another O 0 1.0721771387389722e-10
region O 0 1.7059149232112603e-11
of O 0 2.3913401640818233e-13
the O 0 1.491443080148258e-11
RB1 O 0 1.763781369845674e-06
gene O 0 1.186975961964265e-09
where O 0 3.866295825161181e-11
mutations O 0 9.416708524057071e-10
only O 0 6.0598956408419724e-12
modify O 0 8.201298529186829e-10
the O 0 2.946938179593239e-11
function O 0 2.569007506725285e-11
of O 0 9.188965777520708e-13
the O 0 1.0640216138724234e-11
gene O 0 3.5539913234572396e-09
and O 0 3.164488671103527e-10
raise O 0 6.19791939993064e-10
important O 0 1.0503084513224792e-11
questions O 0 6.302968563742795e-11
for O 0 3.9484951766532994e-12
genetic O 0 3.716950525145535e-09
counseling O 0 1.027202878312039e-09
in O 0 3.876121645873809e-12
families O 0 2.3174357398347833e-12
with O 0 2.7455167046080975e-12
these O 0 3.9506570757852355e-12
distinctive O 0 3.819681904104755e-09
phenotypes O 0 4.476721660040539e-09
. O 0 2.4810880780434807e-11
. O 0 3.6269282022161065e-10

Maternal B-Disease 0 0.46407338976860046
disomy I-Disease 1 0.9654293656349182
and O 0 0.004694290924817324
Prader B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999998807907104
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999996423721313
consistent O 0 1.12637633264967e-06
with O 0 3.1569649672213984e-10
gamete O 0 5.595921592771447e-08
complementation O 0 1.3449853213387541e-05
in O 0 1.8908886609270148e-11
a O 0 3.23001070334783e-11
case O 0 3.831166939249897e-09
of O 0 1.5413752219028964e-10
familial O 0 7.260362053784775e-06
translocation O 0 4.3832234950968996e-05
( O 0 2.3996971076911677e-09
3 O 0 4.3038501651437855e-09
; O 0 6.008808034474455e-11
15 O 0 4.594495894849615e-10
) O 0 1.5238723911209506e-12
( O 0 2.993708254385441e-13
p25 O 0 4.670978534515591e-11
; O 0 1.2590960175515309e-12
q11 O 0 2.3173277186039343e-10
. O 0 8.562150012429715e-13
2 O 0 8.803086037900698e-11
) O 0 1.1566291327480549e-11
. O 0 4.5590867886469155e-11

Maternal B-Disease 1 0.7362168431282043
uniparental I-Disease 1 0.9868854284286499
disomy I-Disease 1 0.9710940718650818
( I-Disease 0 4.597779934556456e-06
UPD I-Disease 1 0.9999569654464722
) I-Disease 0 1.0957901253050295e-09
for I-Disease 0 6.434446725434029e-11
chromosome I-Disease 0 4.2594343540258706e-05
15 I-Disease 0 1.6284873893823715e-08
is O 0 1.098823722983644e-11
responsible O 0 3.486716818046354e-11
for O 0 1.7858671355966416e-12
an O 0 3.640952990491275e-12
estimated O 0 3.2427240892474174e-09
30 O 0 7.402772284059722e-10
% O 0 1.296815438237356e-13
of O 0 4.882029025835011e-13
cases O 0 3.713345364531051e-08
of O 0 3.6736877518706024e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999997615814209
( O 0 8.215699381253216e-06
PWS B-Disease 1 0.999970555305481
) O 0 4.6978949619358445e-09
. O 0 5.812574865871056e-10

We O 0 1.999653420625691e-08
report O 0 7.358471054708104e-10
on O 0 1.8742387850045894e-11
an O 0 4.1850057490647186e-13
unusual O 0 2.516805340524453e-12
case O 0 2.0692986213433073e-10
of O 0 1.769295647491287e-11
maternal B-Disease 0 1.8737341633823235e-06
disomy I-Disease 0 1.4062997252040077e-05
15 I-Disease 0 8.935108652963208e-09
in O 0 1.2122831904992637e-10
PWS B-Disease 1 0.999995231628418
that O 0 9.060590611120745e-10
is O 0 4.1317116394878894e-11
most O 0 4.4170131961729364e-12
consistent O 0 2.3503121671097915e-10
with O 0 3.2850527853511835e-11
adjacent O 0 1.2478372779511915e-09
- O 0 1.6472674815304345e-06
1 O 0 1.7425648701774321e-09
segregation O 0 1.5816319365313802e-09
of O 0 1.0731565809607435e-11
a O 0 4.753761828624192e-09
paternal O 0 8.206943675759248e-06
t O 0 0.00010341256711399183
( O 0 4.14391299052852e-11
3 O 0 1.17337722871369e-10
; O 0 1.1845201468990707e-12
15 O 0 3.498481365715733e-11
) O 0 2.2534467239258837e-13
( O 0 3.7728754988903754e-14
p25 O 0 4.523191283328787e-12
; O 0 2.00172018717526e-13
q11 O 0 7.906266613622037e-11
. O 0 4.288256490354858e-13
2 O 0 1.5854843479767844e-11
) O 0 7.25430119078406e-14
with O 0 3.625511620520411e-13
simultaneous O 0 1.9615666868588733e-09
maternal O 0 2.1152170575078344e-06
meiotic O 0 4.594404799718177e-06
nondisjunction O 0 2.1185976947890595e-05
for O 0 7.535285173609907e-10
chromosome O 0 3.434478639974259e-05
15 O 0 3.53996902902054e-08
. O 0 1.2221297307490886e-09

The O 0 1.15732383676459e-08
patient O 0 1.5794913679201272e-06
( O 0 2.3817389727120997e-10
J O 0 2.557782681833487e-05
. O 0 3.929623987319886e-11
B O 0 1.8361893339147173e-08
. O 0 3.479830356159508e-13
) O 0 9.0862891212809e-14
, O 0 1.889969876835238e-14
a O 0 1.6502275891269735e-12
17 O 0 3.045244889587906e-10
- O 0 4.2327332749891866e-08
year O 0 9.206931217420333e-09
- O 0 3.0474611776298843e-06
old O 0 0.0002456846123095602
white O 0 5.011814323552244e-07
male O 0 3.6447541873485534e-08
with O 0 7.31562033173816e-10
PWS B-Disease 1 0.9999916553497314
, O 0 1.63668759101121e-10
was O 0 8.193699607694782e-10
found O 0 5.020489579621312e-11
to O 0 3.293635156276231e-11
have O 0 5.992467078108632e-10
47 O 0 2.4451887181697884e-09
chromosomes O 0 8.80662121005571e-09
with O 0 4.867586889112374e-10
a O 0 1.8742129626048154e-08
supernumerary O 0 0.06908374279737473
, O 0 2.3302634488686635e-08
paternal O 0 1.0940699212369509e-05
der O 1 0.9195224046707153
( O 0 2.213379479698574e-09
15 O 0 2.5388319224717293e-10
) O 0 3.9021469567948955e-14
consisting O 0 7.528647030883434e-14
of O 0 7.69802028111749e-13
the O 0 1.7114016870323212e-09
short O 0 9.26693610381335e-06
arm O 0 0.3988865315914154
and O 0 9.793135191671354e-10
the O 0 2.219752680276965e-11
proximal O 0 4.817586045646749e-07
long O 0 4.354781594884116e-06
arm O 0 0.000708062550984323
of O 0 2.0970319924984437e-10
chromosome O 0 0.0005385885015130043
15 O 0 2.650566557349521e-07
, O 0 2.8699134735354903e-10
and O 0 8.707686238729195e-10
distal O 0 0.00023038015933707356
chromosome O 1 0.9907376170158386
arm O 1 0.9756284952163696
3p O 0 0.03279421851038933
. O 0 3.845077856112766e-08

The O 0 4.540895304216974e-08
t O 0 0.00011264162458246574
( O 0 6.98935007092949e-11
3 O 0 1.5664758379330124e-10
; O 0 1.4734930940327184e-12
15 O 0 1.2416086388189473e-11
) O 0 3.035370349166455e-13
was O 0 2.025145190431843e-10
present O 0 2.411489844617032e-12
in O 0 2.980478819476773e-13
the O 0 1.0136937947033409e-12
balanced O 0 4.457370306187869e-10
state O 0 2.0619299670454616e-11
in O 0 2.909650168372857e-12
the O 0 1.3941189869193238e-10
patients O 0 9.973857295619837e-10
father O 0 3.414224014619549e-09
and O 0 3.1142813328166596e-10
a O 0 5.235385458490782e-09
sister O 0 3.3457516110502183e-05
. O 0 3.177905938400727e-09

Fluorescent O 0 1.0489410584568759e-07
in O 0 3.7757390963788495e-11
situ O 0 5.479627307458657e-10
hybridization O 0 1.9472808088227822e-10
analysis O 0 1.471859856216895e-10
demonstrated O 0 6.986261569252861e-10
that O 0 9.430593458925607e-12
the O 0 6.417510967082762e-10
PWS B-Disease 1 0.9999984502792358
critical O 0 2.1802902949730196e-07
region O 0 2.9893079678267043e-10
resided O 0 1.4100205447675762e-09
on O 0 6.046358969058474e-10
the O 0 2.419060091130021e-11
derivative O 0 6.445781508546133e-08
chromosome O 0 1.652029823162593e-05
3 O 0 2.5191015495806823e-08
and O 0 3.9271980112332017e-10
that O 0 3.116448765716484e-11
there O 0 4.3387016201990036e-11
was O 0 1.8545659230539968e-08
no O 0 1.822727906108934e-11
deletion O 0 3.079333232847148e-09
of O 0 1.5996096114356817e-10
the O 0 4.719740331893263e-08
PWS B-Disease 1 0.9999994039535522
region O 0 3.7506215910809715e-09
on O 0 3.937128123521205e-10
the O 0 3.677013121067274e-12
normal O 0 2.5419027993578425e-11
pair O 0 4.2423631274601803e-10
of O 0 4.513858037347163e-12
15s O 0 3.767297585000051e-09
present O 0 9.321013405561018e-11
in O 0 5.419845822141056e-11
J O 0 0.00017491617472842336
. O 0 3.6827951799267566e-09

B O 0 0.0001933198655024171
. O 0 1.5510906337112829e-07

Methylation O 0 1.597440402179018e-08
analysis O 0 5.024256566343865e-10
at O 0 2.842896196231237e-10
exon O 0 1.8565575743423324e-09
alpha O 0 1.3223638330173149e-11
of O 0 4.3462927484458347e-13
the O 0 3.2794478938003024e-12
small O 0 8.018394281883445e-10
nuclear O 0 1.924074240378104e-05
ribonucleoprotein O 0 2.7824146400234895e-06
- O 0 4.034724497614661e-06
associated O 0 2.102657248315154e-08
polypeptide O 0 1.4865923958495841e-06
N O 0 1.237853939528577e-05
( O 0 3.6226254634952326e-11
SNRPN O 0 1.0388007609662964e-07
) O 0 1.8714825696097837e-13
gene O 0 1.865749915674897e-11
showed O 0 7.874575991273502e-10
a O 0 2.7890091278126583e-11
pattern O 0 8.344102297996869e-08
characteristic O 0 8.681256602471876e-09
of O 0 2.072410125453228e-11
only O 0 4.880136850182737e-10
the O 0 1.863113219258139e-09
maternal O 0 1.0949342140520457e-05
chromosome O 0 0.00028071904671378434
15 O 0 4.533669084594294e-08
in O 0 3.132122616822386e-10
J O 0 0.0016584257828071713
. O 0 7.545831515187729e-09

B O 0 0.0005165149341337383
. O 0 3.9481119529227726e-07

Maternal B-Disease 0 0.016198668628931046
disomy I-Disease 0 0.0008156057447195053
was O 0 2.1249127257760847e-07
confirmed O 0 2.902613149835531e-10
by O 0 7.722226178820402e-13
polymerase O 0 7.122942680126698e-09
chain O 0 6.283279674335063e-08
reaction O 0 7.458406288407549e-12
analysis O 0 8.614469814566261e-13
of O 0 4.9123671710255e-13
microsatellite O 0 1.4756552957351232e-07
repeats O 0 1.480785272178764e-07
at O 0 3.9605371759954267e-10
the O 0 2.149611218194014e-12
gamma O 0 7.597094064948351e-10
- O 0 5.844492079631891e-06
aminobutyric O 0 4.4311269448371604e-05
acid O 0 2.5973317718808175e-08
receptor O 0 1.9809751616861604e-09
beta3 O 0 2.196520476616115e-08
subunit O 0 9.943617040875097e-10
( O 0 1.1472522931654794e-10
GABRB3 O 0 3.697239776556671e-07
) O 0 1.8650738939363087e-11
locus O 0 2.5145553195216053e-08
. O 0 3.1189255622621204e-09

A O 0 2.2427598196372855e-06
niece O 0 0.00047605688450857997
( O 0 4.205578996163695e-09
B O 0 1.3560577372118132e-07
. O 0 3.6114613903570625e-12
B O 0 3.2404485761361457e-09
. O 0 1.5421050666899333e-13
) O 0 1.7635385204028617e-14
with O 0 1.5205211764159066e-13
45 O 0 2.9762993285220585e-12
chromosomes O 0 7.018662873115034e-10
and O 0 2.610892405052745e-11
the O 0 3.1845635069943645e-12
derivative O 0 6.544014219400651e-09
3 O 0 5.857292428856908e-10
but O 0 3.404817053298537e-11
without O 0 5.3467709426602283e-11
the O 0 2.791181730188441e-10
der O 0 0.05904202163219452
( O 0 1.7602386215287424e-10
15 O 0 3.348892690935301e-11
) O 0 9.488355332551782e-14
demonstrated O 0 1.4906629533170679e-12
a O 0 1.6941824462421429e-12
phenotype O 0 3.9511888205723267e-10
consistent O 0 1.6755262455259157e-10
with O 0 6.846921467296152e-12
that O 0 3.8306219307671086e-11
reported O 0 4.778680118278089e-09
for O 0 1.2113371937461093e-11
haploinsufficiency O 0 1.0019283536166768e-07
of O 0 4.217799286915236e-12
distal O 0 1.965526280400809e-06
3 O 0 9.657512123339984e-08
p O 0 1.542273093946278e-05
. O 0 1.213340983241551e-09

Uniparental B-Disease 1 0.9996271133422852
disomy I-Disease 1 0.9998999834060669
associated O 0 7.154722879931796e-06
with O 0 1.2584160380413323e-09
unbalanced O 0 1.933856310643023e-06
segregation O 0 5.452796614235922e-08
of O 0 1.8895943837415885e-11
non O 0 7.157728987294831e-08
- O 0 2.893214514188003e-06
Robertsonian O 0 1.984983100555837e-06
translocations O 0 1.3900998965254985e-06
has O 0 5.058635288435198e-09
been O 0 2.3892737788244744e-10
reported O 0 8.652951688503663e-10
previously O 0 3.6367384659286017e-09
but O 0 1.9648757620949198e-10
has O 0 7.671853152757535e-10
not O 0 1.0452662173310312e-11
, O 0 5.95129306078801e-13
to O 0 7.602518332754105e-13
our O 0 1.1092832381820461e-11
knowledge O 0 2.677490824540274e-12
, O 0 7.935386289043e-13
been O 0 3.878845508675788e-11
observed O 0 1.8600045115224617e-11
in O 0 8.425672540311041e-14
a O 0 5.657231193917367e-12
case O 0 6.0122760103809014e-09
of O 0 7.440075222575615e-09
PWS B-Disease 1 0.9999914169311523
. O 0 3.6935883684918736e-08

Furthermore O 0 2.9540430546148855e-07
, O 0 9.771766729116393e-11
our O 0 1.749536800155216e-11
findings O 0 1.808622696053419e-11
are O 0 1.4450481826758232e-12
best O 0 1.706358387920659e-10
interpreted O 0 7.565394144481985e-11
as O 0 9.11683489118742e-12
true O 0 4.674561432382873e-11
gamete O 0 8.838155984847162e-09
complementation O 0 8.247586265497375e-06
resulting O 0 1.3201977822063782e-07
in O 0 9.744770324005003e-09
maternal B-Disease 0 0.008918394334614277
UPD I-Disease 1 0.9999954700469971
15 I-Disease 0 1.980626257136464e-05
and O 0 8.73800615863729e-07
PWS B-Disease 1 0.9998537302017212

Schwartz B-Disease 0 0.43513351678848267
- I-Disease 1 0.9997121691703796
Jampel I-Disease 1 0.999612033367157
syndrome I-Disease 1 0.9999855756759644
type I-Disease 0 3.374501466169022e-05
2 I-Disease 0 1.09953020910325e-07
and O 0 5.009687953361208e-08
Stuve B-Disease 1 0.6659533381462097
- I-Disease 1 0.9999905824661255
Wiedemann I-Disease 1 0.9999984502792358
syndrome I-Disease 1 0.9999960660934448
: O 0 7.841564203525664e-12
a O 0 3.094595760200214e-12
case O 0 6.214183612129887e-10
for O 0 1.5281808804501473e-11
" O 0 8.054856087680307e-11
lumping O 0 3.4970589979366196e-08
" O 0 1.112725800389569e-09
. O 0 8.518015459646477e-11

Recent O 0 1.2854070696732833e-08
studies O 0 3.205499754521668e-10
demonstrated O 0 2.9631386233575085e-10
the O 0 6.424212290606635e-13
existence O 0 5.986691611198358e-12
of O 0 3.5310583667083617e-13
a O 0 4.547432222445913e-11
genetically O 0 2.886704564275533e-08
distinct O 0 3.01053453000133e-11
, O 0 1.036938070131388e-11
usually O 0 5.5778372372305984e-12
lethal O 0 1.537660831996135e-10
form O 0 6.52737412731863e-12
of O 0 1.4294181290008812e-11
the O 0 1.0695250907133413e-08
Schwartz B-Disease 1 0.7434918880462646
- I-Disease 1 0.9999923706054688
Jampel I-Disease 1 0.999974250793457
syndrome I-Disease 1 0.9999932050704956
( O 0 1.8397080525645038e-09
SJS B-Disease 0 0.36405882239341736
) O 0 5.664121949244816e-11
of O 0 4.066437464533834e-11
myotonia B-Disease 0 0.07345528155565262
and O 0 2.3822373407256237e-07
skeletal B-Disease 1 0.7239869236946106
dysplasia I-Disease 1 0.5787718296051025
, O 0 1.8947272917291258e-10
which O 0 2.0717313975460172e-10
we O 0 5.0668047535396e-09
called O 0 9.615953189268112e-08
SJS B-Disease 1 0.9897809028625488
type I-Disease 0 1.639930246710719e-06
2 I-Disease 0 8.159330988632973e-09
. O 0 4.127082564586715e-10

This O 0 1.3030575019001844e-07
disorder O 0 0.03691655397415161
is O 0 1.156623061215889e-10
reminiscent O 0 9.254162436356239e-10
of O 0 8.85371550379821e-12
another O 0 2.5976820694495473e-09
rare O 0 7.63484138133208e-08
condition O 0 5.056358887145507e-09
, O 0 7.184084490491349e-12
the O 0 4.0653636013132655e-09
Stuve B-Disease 1 0.9817102551460266
- I-Disease 1 0.9999964237213135
Wiedemann I-Disease 1 0.9999985694885254
syndrome I-Disease 1 0.9999985694885254
( O 0 3.7700007560204085e-09
SWS B-Disease 0 9.745010174810886e-05
) O 0 1.7734242893641117e-11
, O 0 9.15064573593638e-13
which O 0 4.121163046238996e-12
comprises O 0 1.6283240034109525e-10
campomelia B-Disease 0 1.8222218614027952e-06
at O 0 3.0493513492046986e-08
birth O 0 3.683977638502256e-07
with O 0 8.243053173373482e-08
skeletal B-Disease 1 0.9868156313896179
dysplasia I-Disease 1 0.9185757040977478
, O 0 1.5033428946154004e-09
contractures B-Disease 0 3.3150907256640494e-05
, O 0 1.383977238367251e-10
and O 0 8.634482018265999e-11
early B-Disease 0 1.556943879377215e-10
death I-Disease 0 4.2785860188132574e-08
. O 0 1.2922181102936747e-09

To O 0 9.600586992064564e-10
test O 0 2.619404693149363e-09
for O 0 5.762604477800581e-13
possible O 0 6.543180060269993e-12
nosologic O 0 5.097729882663771e-08
identity O 0 4.299854250433555e-09
between O 0 5.19834042478351e-09
these O 0 5.382383871932461e-09
disorders O 0 0.00021972173999529332
, O 0 5.91973258606826e-12
we O 0 6.78982954929741e-12
reviewed O 0 6.2068128414694e-11
the O 0 7.905353888865152e-13
literature O 0 5.755179319222314e-13
and O 0 2.2039230249820685e-12
obtained O 0 1.436162061670132e-12
a O 0 4.549911229029258e-12
follow O 0 1.783805221589052e-11
- O 0 1.8977081595039635e-07
up O 0 4.717895052408494e-08
of O 0 1.2031943366977438e-12
the O 0 1.6662980674084227e-12
only O 0 2.776672338236641e-12
two O 0 3.712792660121034e-12
surviving O 0 7.365664078662348e-09
patients O 0 8.136912671430352e-11
, O 0 2.4075687732501294e-13
one O 0 8.776977408753162e-12
with O 0 2.46917486457221e-09
SJS B-Disease 1 0.9762744307518005
type I-Disease 0 8.723210953576199e-07
2 I-Disease 0 1.3757137651282392e-09
at O 0 1.2599537413393591e-08
age O 0 2.078175187492093e-09
10 O 0 1.0678444239964335e-10
years O 0 4.336542236416108e-11
and O 0 5.478033391487225e-12
another O 0 3.484270511000531e-11
with O 0 1.0633592895104016e-09
SWS B-Disease 0 0.0011812919983640313
at O 0 2.1844923026037577e-07
age O 0 1.6329007479498614e-08
7 O 0 2.170693180758576e-09
years O 0 3.127633152466558e-10
. O 0 1.3547568622485073e-10

Patients O 0 7.898567673692014e-06
reported O 0 8.609235635503865e-08
as O 0 4.75622652373886e-10
having O 0 2.1879236200561536e-08
either O 0 2.0325720129221736e-07
neonatal O 1 0.999657154083252
SJS B-Disease 1 0.9999768733978271
or O 0 1.5442805079146638e-06
SWS B-Disease 0 0.00043602983350865543
presented O 0 3.901961531660447e-10
a O 0 9.636793099621066e-12
combination O 0 9.847919008043604e-11
of O 0 5.408184750727019e-12
a O 0 1.519860859389155e-08
severe O 0 1.3203266462369356e-05
, O 0 6.534904839483602e-10
prenatal O 0 0.0003933332918677479
- O 1 0.808233916759491
onset O 1 0.9849189519882202
neuromuscular B-Disease 1 0.9999701976776123
disorder I-Disease 1 0.9999538660049438
( O 0 2.3069752330684423e-08
with O 0 5.422282924882893e-07
congenital B-Disease 1 0.9999929666519165
joint I-Disease 0 0.0018306769197806716
contractures I-Disease 1 0.9997844099998474
, O 0 9.40565405471716e-06
respiratory O 0 0.22866913676261902
and O 0 7.540665869498753e-09
feeding O 0 1.0410901268187445e-05
difficulties O 0 1.3644600471707236e-07
, O 0 3.7341765964094e-12
tendency O 0 2.8101665439095314e-10
to O 0 1.376321279167314e-11
hyperthermia B-Disease 0 2.7639444510896283e-07
, O 0 1.1513822534281459e-10
and O 0 9.209785017949557e-11
frequent O 0 2.1756298984598743e-09
death O 0 1.0007251205479406e-07
in O 0 5.998276320084983e-10
infancy O 0 5.847095962963067e-08
) O 0 1.6822426698176463e-12
with O 0 9.442504287152098e-13
a O 0 2.5544921733455794e-10
distinct O 0 7.249616906790379e-09
campomelic B-Disease 0 0.005662404932081699
- I-Disease 1 0.9664567708969116
metaphyseal I-Disease 1 0.9634121656417847
skeletal I-Disease 1 0.974785327911377
dysplasia I-Disease 1 0.5031124353408813
. O 0 1.643339508916597e-08

The O 0 1.5747318726777593e-10
similarity O 0 6.858404399956441e-10
of O 0 2.5328608568159217e-12
the O 0 1.5757978255592775e-11
clinical O 0 8.8147045218534e-09
and O 0 1.9712045884467955e-10
radiographic O 0 1.0091954294466632e-07
findings O 0 1.6177007511330999e-09
is O 0 9.471283479722814e-11
so O 0 4.325470970983902e-12
extensive O 0 1.4948842164130838e-10
that O 0 8.919834648679625e-09
these O 0 1.7040736821627434e-08
disorders O 0 0.0013387537328526378
appear O 0 6.694343968050021e-10
to O 0 3.0892958330364095e-11
be O 0 4.814467158276159e-10
a O 0 1.7544030117555565e-10
single O 0 8.128579054300644e-08
entity O 0 1.731990892039903e-06
. O 0 1.7679894881439395e-08

The O 0 4.003044007383494e-10
follow O 0 1.352211398408798e-10
- O 0 1.0045747700360153e-07
up O 0 1.401719362803533e-08
observation O 0 4.3154793627486754e-10
of O 0 1.5485629814050716e-13
an O 0 2.433873632148864e-12
identical O 0 3.0895346281312186e-09
and O 0 2.7251931267180396e-10
unique O 0 2.130192550131582e-11
pattern O 0 3.585826107155299e-07
of O 0 7.005105828739033e-09
progressive O 0 6.05558707320597e-05
bone B-Disease 1 0.9999067783355713
dysplasia I-Disease 1 0.8596500754356384
in O 0 2.650199226739147e-10
the O 0 1.3870081472244777e-10
two O 0 4.533130759654114e-09
patients O 0 9.760929842173027e-10
( O 0 6.354734989090505e-13
one O 0 6.323173928901582e-11
with O 0 7.969834570076273e-09
SJS B-Disease 1 0.9994662404060364
type I-Disease 0 1.523107766843168e-05
2 I-Disease 0 9.631387243302925e-09
, O 0 1.0299562418214503e-11
one O 0 9.350108187700101e-11
with O 0 2.566453716212891e-09
SWS B-Disease 0 0.008113733492791653
) O 0 3.482682545130622e-11
surviving O 0 8.074195756435643e-10
beyond O 0 9.170017523096874e-10
infancy O 0 2.400742005193024e-08
adds O 0 1.0282104057068864e-09
to O 0 1.0629398836808912e-12
the O 0 3.420343977662832e-13
evidence O 0 4.6562663447158315e-11
in O 0 4.976894005422061e-13
favor O 0 1.6517391837958528e-12
of O 0 6.884894672605502e-13
identity O 0 1.41466536263124e-08
. O 0 1.8148030855869024e-09

The O 0 9.084107355228355e-10
hypothesis O 0 1.12439426658284e-08
that O 0 5.77718428651508e-10
SWS B-Disease 0 0.001169123686850071
and O 0 5.561149052368819e-08
SJS B-Disease 1 0.9984716773033142
type I-Disease 0 7.213307071651798e-06
2 I-Disease 0 2.981474178653798e-09
are O 0 1.3147437132043915e-11
the O 0 5.570015282341245e-11
same O 0 4.721063717738616e-08
disorder O 0 0.0008114514057524502
should O 0 6.713571365501991e-11
be O 0 1.551504692949568e-13
testable O 0 9.502777254324912e-13
by O 0 1.786765010849522e-14
molecular O 0 1.2330254872683355e-11
methods O 0 3.5939973219711874e-10
. O 0 2.0383432788873e-11
. O 0 1.6603704522388796e-10

A O 0 2.6585150081359643e-08
mouse O 0 1.2300086382310838e-05
model O 0 8.145337233145256e-06
of O 0 2.3615174882252177e-07
severe O 1 0.9996373653411865
von B-Disease 1 1.0
Willebrand I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
: O 0 0.00010538665083004162
defects O 1 0.9998739957809448
in O 0 1.208311584122157e-08
hemostasis O 0 0.4331090450286865
and O 0 1.5496576452278532e-05
thrombosis B-Disease 1 0.6261813640594482
. O 0 3.7447332346118856e-08

von B-Disease 1 0.8943765163421631
Willebrand I-Disease 1 0.9824559688568115
factor I-Disease 0 0.0009013565722852945
( I-Disease 0 4.880174628851819e-07
vWf I-Disease 0 0.0019779358990490437
) I-Disease 0 3.4741900890367106e-05
deficiency I-Disease 1 0.9998180270195007
causes O 0 0.043041493743658066
severe O 1 0.9999063014984131
von B-Disease 1 1.0
Willebrand I-Disease 1 0.9999992847442627
disease I-Disease 1 1.0
in O 0 4.308673595687651e-08
humans O 0 8.203149945984478e-07
. O 0 3.813145355024972e-09

We O 0 1.6571874428272793e-10
generated O 0 1.9385637192725902e-11
a O 0 3.305391377272926e-11
mouse O 0 3.9087595382625295e-07
model O 0 5.463727603682855e-08
for O 0 3.463994022179229e-11
this O 0 7.253533711171212e-12
disease O 0 2.84423173901871e-09
by O 0 2.216018269221836e-14
using O 0 8.40071241736684e-12
gene O 0 9.835534608981789e-10
targeting O 0 5.096641331192586e-08
. O 0 1.436092911255571e-09

vWf B-Disease 0 0.0005609267973341048
- I-Disease 0 0.45890355110168457
deficient I-Disease 0 0.3370439410209656
mice O 0 0.0005502622225321829
appeared O 0 7.541331825677844e-08
normal O 0 4.891581029120573e-10
at O 0 2.8280737751629204e-09
birth O 0 1.1650977960186992e-08
; O 0 4.2316671000630635e-12
they O 0 5.809000416107102e-12
were O 0 3.71028832657494e-11
viable O 0 2.479765948137924e-09
and O 0 4.978800149935125e-10
fertile O 0 1.968583873690477e-08
. O 0 3.162631934117144e-09

Neither O 0 3.041956006200053e-06
vWf O 0 4.1562678234186023e-05
nor O 0 1.0170598443437484e-06
vWf O 0 2.441927426843904e-05
propolypeptide O 0 0.0003693152393680066
( O 0 3.477258303519193e-08
von B-Disease 0 0.007557237986475229
Willebrand I-Disease 0 0.03230661898851395
antigen O 0 5.312302891979925e-05
II O 0 8.402944513363764e-05
) O 0 1.7629224469128957e-11
were O 0 4.512110303445116e-12
detectable O 0 2.27690710730144e-09
in O 0 1.5099557888753612e-12
plasma O 0 2.3864023646069654e-08
, O 0 3.089756783758446e-10
platelets O 0 9.938772649320526e-08
, O 0 1.2630508618161063e-11
or O 0 1.7196463697466413e-10
endothelial O 0 1.0620969881358633e-08
cells O 0 6.80811795827907e-11
of O 0 1.138866128139182e-12
the O 0 6.702260968438623e-11
homozygous O 0 1.526568848930765e-05
mutant O 0 2.1678904886357486e-05
mice O 0 3.115707659162581e-05
. O 0 3.67758667962903e-09

The O 0 5.350571541384852e-09
mutant O 0 4.963547326042317e-05
mice O 0 0.0042997184209525585
exhibited O 0 0.0001048586709657684
defects O 1 0.8966442346572876
in O 0 1.2046307007462786e-10
hemostasis O 0 5.203876753512304e-06
with O 0 2.0889492358122652e-09
a O 0 1.7840937616142583e-08
highly O 0 4.105506832274841e-06
prolonged O 0 0.049151673913002014
bleeding O 1 0.9573711156845093
time O 0 9.579742510368305e-08
and O 0 4.184256052752744e-09
spontaneous O 0 6.104989580535403e-08
bleeding O 0 0.002943030558526516
events O 0 1.2781058156274838e-10
in O 0 3.862667997955871e-12
approximately O 0 7.328506551607106e-11
10 O 0 2.610575089434519e-10
% O 0 1.6681328627449199e-12
of O 0 3.097331419121829e-11
neonates O 0 1.2003395568171982e-05
. O 0 8.211598068186277e-10

As O 0 9.996640848441984e-09
in O 0 7.14854607800075e-12
the O 0 9.291985583748108e-12
human O 0 7.260091638983113e-09
disease O 0 2.78900614603117e-07
, O 0 9.699670537252625e-13
the O 0 5.279801769397796e-12
factor O 0 6.848368538925342e-09
VIII O 0 2.2595222617383115e-06
level O 0 3.436203144246974e-08
in O 0 3.5327578536137327e-12
these O 0 1.8028287196436565e-12
mice O 0 2.465656621097878e-07
was O 0 4.786828711189628e-08
reduced O 0 1.9554999841631115e-09
strongly O 0 6.895498061432193e-10
as O 0 3.638969334196496e-11
a O 0 6.137130734162888e-12
result O 0 1.2020526067579862e-11
of O 0 1.3289195048213354e-12
the O 0 7.282218578152921e-11
lack O 0 3.511356830299128e-11
of O 0 2.383662386397367e-13
protection O 0 9.243961152094471e-11
provided O 0 5.1820878317621055e-12
by O 0 9.311946179424435e-12
vWf O 0 6.26586640350979e-08
. O 0 1.3059175962837344e-09

Defective O 1 0.978312611579895
thrombosis B-Disease 1 0.9324288368225098
in O 0 5.429484417618369e-09
mutant O 0 1.9088007320533507e-05
mice O 0 0.0001393979327986017
was O 0 5.987405984342331e-07
also O 0 6.061705026816355e-10
evident O 0 2.304835350352974e-10
in O 0 8.075615913830103e-13
an O 0 9.231992774416664e-12
in O 0 1.3585702875185124e-11
vivo O 0 1.820952064690573e-07
model O 0 1.0711995912515704e-07
of O 0 1.4381989821288244e-08
vascular B-Disease 1 0.987073540687561
injury I-Disease 0 0.010262961499392986
. O 0 1.1059785975930936e-08

In O 0 2.485788241912701e-10
this O 0 2.3123538674119093e-12
model O 0 1.7385809458758672e-09
, O 0 2.398046388199515e-12
the O 0 3.7012112125145435e-12
exteriorized O 0 9.99957819658448e-07
mesentery O 0 6.273774943110766e-06
was O 0 3.5155042610313103e-07
superfused O 0 1.0925516562565463e-06
with O 0 4.535757602841528e-10
ferric O 0 1.4378183266217093e-07
chloride O 0 6.15109463364405e-10
and O 0 9.797666150612727e-12
the O 0 1.3509054985760827e-12
accumulation O 0 7.685634906273719e-10
of O 0 1.0062470821858849e-11
fluorescently O 0 2.2125097530079074e-05
labeled O 0 6.954134278203128e-06
platelets O 0 8.123369639179145e-07
was O 0 4.767709338437953e-09
observed O 0 2.5456484142871716e-11
by O 0 2.52903275578531e-12
intravital O 0 4.808112308296586e-08
microscopy O 0 8.292993847192065e-09
. O 0 1.0657064120067616e-09

We O 0 5.071774555887032e-09
conclude O 0 5.66542146529514e-10
that O 0 3.2210638236523925e-12
these O 0 3.317135249206876e-13
mice O 0 6.382236961144372e-09
very O 0 8.538148486836317e-12
closely O 0 2.0748297302475294e-08
mimic O 0 0.0003519586462061852
severe O 0 0.0027290324214845896
human O 0 0.00011025723506463692
von B-Disease 1 1.0
Willebrand I-Disease 1 0.9999994039535522
disease I-Disease 1 1.0
and O 0 1.4909874153090641e-05
will O 0 7.094712817234949e-09
be O 0 6.56215567995666e-11
very O 0 1.4924545703020459e-13
useful O 0 5.86862264513599e-13
for O 0 7.691778800261034e-14
investigating O 0 1.0007734224659615e-10
the O 0 6.687330376953238e-12
role O 0 7.73839825551903e-10
of O 0 6.196491345207555e-13
vWf O 0 5.469362740484485e-10
in O 0 5.088490826615777e-12
normal O 0 1.4682875748572854e-10
physiology O 0 2.691981304536739e-09
and O 0 2.3025856221714491e-10
in O 0 1.651277031777809e-11
disease O 0 4.3824982753903896e-08
models O 0 1.8773111065684134e-08
. O 0 1.729259617444523e-11
. O 0 2.0005821999014017e-10

Oral O 0 5.077675268694293e-06
contraceptives O 0 0.0005514855729416013
and O 0 2.631774131955922e-09
the O 0 3.471257725706778e-10
risk O 0 1.1792917575803585e-05
of O 0 6.323465413515805e-07
hereditary B-Disease 1 0.9999990463256836
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
. O 0 7.421765531034907e-07

Hereditary B-Disease 1 0.9999616146087646
Ovarian I-Disease 1 0.9999898672103882
Cancer I-Disease 1 0.9982195496559143
Clinical O 0 9.080100426217541e-05
Study O 0 7.218739028758137e-08
Group O 0 9.350120677709128e-08
. O 0 3.8761793774710895e-09

BACKGROUND O 0 1.4505192666547373e-05
Women O 0 3.7141600017776e-08
with O 0 1.55833429493768e-10
mutations O 0 1.2708393626326142e-07
in O 0 1.6834825200540138e-11
either O 0 5.314887974172677e-10
the O 0 8.428374109747949e-10
BRCA1 O 0 0.0002533415681682527
or O 0 6.668464447301403e-09
the O 0 3.2115890502559807e-10
BRCA2 O 0 3.060695235035382e-05
gene O 0 1.0189456389753104e-07
have O 0 5.893051047145548e-10
a O 0 4.0384515176405955e-10
high O 0 2.167388402085635e-06
lifetime O 0 7.3436253842373844e-06
risk O 0 0.0006338066887110472
of O 0 1.8624694348545745e-05
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999916553497314
. O 0 1.9139314133553853e-07

Oral O 0 1.0443378414493054e-05
contraceptives O 0 0.3466799259185791
protect O 0 0.0493738129734993
against O 1 0.625947892665863
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 9.918997179170219e-09
general O 0 4.788960894508421e-10
, O 0 2.96358909634975e-11
but O 0 4.945253841842634e-12
it O 0 1.8210495611459265e-11
is O 0 1.1978375236143535e-10
not O 0 2.4991266001084256e-11
known O 0 1.5652452944880935e-10
whether O 0 3.5049885216409393e-10
they O 0 4.872547365586399e-10
also O 0 7.174506544416204e-10
protect O 0 4.0773088016976544e-08
against O 0 9.1555897085982e-08
hereditary B-Disease 0 0.0012811766937375069
forms I-Disease 0 1.0493524314370006e-05
of I-Disease 0 0.01088146585971117
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999969005584717
. O 0 7.681334324161071e-08

METHODS O 0 1.2503733159974217e-07
We O 0 6.703824162457295e-10
enrolled O 0 3.126370273776047e-09
207 O 0 6.012858193571446e-07
women O 0 1.315445956606709e-07
with O 0 1.4008087418915238e-06
hereditary B-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 9.677075496483667e-08
161 O 0 4.3533805893503086e-08
of O 0 1.9251891747451566e-10
their O 0 3.746817522909396e-09
sisters O 0 1.8215183672509738e-07
as O 0 8.543268176230967e-11
controls O 0 1.2749509226139821e-09
in O 0 9.413085545403876e-13
a O 0 1.691180702423356e-11
case O 0 1.479390121517099e-08
- O 0 4.282033842173405e-06
control O 0 5.4513613179096865e-08
study O 0 5.202712149987576e-10
. O 0 5.724064555678865e-10

All O 0 7.748116037653574e-10
the O 0 3.240340287757881e-11
patients O 0 1.8719174821324458e-10
carried O 0 3.7431276828092663e-11
a O 0 1.4438835543861828e-11
pathogenic O 0 1.0705292652346543e-08
mutation O 0 1.2370554358653862e-08
in O 0 3.2649015435648465e-11
either O 0 3.861023500917327e-09
BRCA1 O 0 0.000211336140637286
( O 0 4.3837478092001447e-10
179 O 0 9.403668599361481e-08
women O 0 2.0213304807725763e-08
) O 0 5.7338633840942066e-11
or O 0 7.45149364433928e-09
BRCA2 O 0 0.000343907653586939
( O 0 7.180863015321393e-09
28 O 0 2.2987885017755616e-07
women O 0 3.873947385102383e-09
) O 0 6.442576333531846e-11
. O 0 8.985979321751714e-11

The O 0 1.8988997041446964e-09
control O 0 9.865962624644453e-08
women O 0 1.1843978020564805e-09
were O 0 1.2008244225369946e-11
enrolled O 0 9.633521411145374e-12
regardless O 0 1.9869054318499835e-12
of O 0 3.023167653715131e-13
whether O 0 2.6575808220741237e-09
or O 0 1.977958463683649e-09
not O 0 8.764702852381845e-11
they O 0 7.578305344368985e-11
had O 0 2.197047210827918e-09
either O 0 2.1045651332762816e-10
mutation O 0 9.054310368128426e-08
. O 0 2.885403915797724e-09

Lifetime O 0 1.9140026097375085e-07
histories O 0 4.0084728425426874e-08
of O 0 9.340981460548292e-11
oral O 0 4.814607379444169e-09
- O 0 5.223095627115981e-07
contraceptive O 0 1.0929101108558825e-06
use O 0 2.36299674272189e-10
were O 0 6.211937214617436e-12
obtained O 0 5.452283589890694e-13
by O 0 2.224032156356026e-12
interview O 0 2.9673154600118323e-08
or O 0 1.81581333302816e-10
by O 0 1.5377236159755392e-12
written O 0 2.8001266669935854e-12
questionnaire O 0 1.2577339170150026e-10
and O 0 2.19049539791627e-12
were O 0 5.420866880379016e-12
compared O 0 5.549400522442127e-11
between O 0 3.1442955877869494e-11
patients O 0 1.3986146962796653e-10
and O 0 2.20226947789115e-10
control O 0 2.312662772396834e-08
women O 0 6.198794255674045e-10
, O 0 1.1943024694205384e-12
after O 0 2.3408353380660607e-11
adjustment O 0 1.2873274668478984e-09
for O 0 2.6020917191782456e-12
year O 0 5.4092601925459505e-11
of O 0 1.2874557106176687e-12
birth O 0 1.7920127604043046e-08
and O 0 5.135120662025372e-10
parity O 0 5.875738224858651e-07
. O 0 1.7233937610328098e-09

RESULTS O 0 7.529944667794553e-09
The O 0 1.6950172168628264e-11
adjusted O 0 2.353837317059515e-06
odds O 0 2.7104668333777227e-05
ratio O 0 1.4170969734550454e-05
for O 0 0.001233176444657147
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
associated O 0 6.358012427654103e-08
with O 0 4.760199179276725e-11
any O 0 2.0264770764222284e-11
past O 0 1.4250965962858686e-09
use O 0 2.196673398735527e-10
of O 0 1.576696585792181e-11
oral O 0 2.0515999565873244e-08
contraceptives O 0 2.0203930034767836e-05
was O 0 1.399838964744049e-07
0 O 0 3.6961866900497853e-09
. O 0 4.1547734697111594e-10

5 O 0 2.7310550265724487e-08
( O 0 3.3613140049126855e-11
95 O 0 3.529999625939695e-10
percent O 0 3.8242114897002466e-07
confidence O 0 2.2202604554877325e-07
interval O 0 6.2974350178990335e-09
, O 0 9.395619698926438e-12
0 O 0 4.726198165466711e-12
. O 0 4.727654086354033e-14
3 O 0 5.398960358643512e-12
to O 0 3.3683845643284194e-12
0 O 0 1.1128079707711791e-10
. O 0 9.810768733867214e-13
8 O 0 1.6958459636562395e-10
) O 0 5.170378448299262e-12
. O 0 2.4126827272152873e-11

The O 0 1.2169478758039531e-08
risk O 0 4.815450665773824e-06
decreased O 0 1.4095995481966384e-07
with O 0 6.500637268064269e-12
increasing O 0 5.81647612019065e-11
duration O 0 8.968821518795522e-11
of O 0 3.85515079061316e-13
use O 0 2.499995765958829e-10
( O 0 6.265974284574982e-12
P O 0 3.2672300420699685e-08
for O 0 4.494090863338407e-12
trend O 0 3.0787870031190323e-09
, O 0 5.165981791649399e-12
< O 0 6.263062291012034e-11
0 O 0 3.6174129663946175e-11
. O 0 9.668708298186598e-14
001 O 0 7.67424943037831e-11
) O 0 5.884692960787113e-14
; O 0 3.5862502542811404e-15
use O 0 1.4173300662452537e-13
for O 0 1.5019075393085668e-12
six O 0 1.0409097195296368e-10
or O 0 3.628863529114845e-11
more O 0 5.281332662865346e-12
years O 0 7.856153505514385e-10
was O 0 3.9731915535412554e-08
associated O 0 6.6456120120794715e-12
with O 0 6.550969077097346e-13
a O 0 1.9069516798975172e-11
60 O 0 1.8321992534264808e-10
percent O 0 1.121725201613799e-08
reduction O 0 5.702958549846926e-09
in O 0 7.332589396780165e-11
risk O 0 1.4217341970379493e-07
. O 0 3.3341143734766376e-10

Oral O 0 1.1272177289356478e-06
- O 0 1.3640005818160716e-05
contraceptive O 0 7.935681787785143e-05
use O 0 1.1392631904527661e-07
protected O 0 0.0006519162561744452
against O 0 0.45738017559051514
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999980926513672
both O 0 4.6011083831842825e-10
for O 0 2.197334328379874e-11
carriers O 0 9.678322587802768e-10
of O 0 8.495583793746708e-13
the O 0 4.263055186637388e-10
BRCA1 O 0 0.00017495655629318208
mutation O 0 6.374258987307257e-07
( O 0 7.005124952330632e-11
odds O 0 9.163485970020702e-08
ratio O 0 9.410770829276771e-09
, O 0 1.717485355323678e-11
0 O 0 1.8464275247653816e-11
. O 0 1.0025180419972676e-13
5 O 0 2.9679943398808195e-12
; O 0 1.41952150988639e-13
95 O 0 1.1842707370313121e-10
percent O 0 7.303692086679803e-07
confidence O 0 4.168661860148859e-07
interval O 0 1.2472233246185738e-09
, O 0 2.612759401193765e-12
0 O 0 2.8969797481043225e-12
. O 0 5.703118234829177e-14
3 O 0 7.486869631201376e-12
to O 0 5.86473144353894e-12
0 O 0 1.1287723533648375e-10
. O 0 9.108174284233606e-13
9 O 0 8.513142968347154e-11
) O 0 1.5465640852935052e-14
and O 0 4.744338602535869e-14
for O 0 5.56389075166263e-14
carriers O 0 1.2307509178466347e-11
of O 0 2.181991973172412e-13
the O 0 5.281539094958987e-10
BRCA2 O 0 2.6451665689819492e-05
mutation O 0 7.576581850798902e-08
( O 0 2.2259256937662286e-11
odds O 0 5.6030664552508824e-08
ratio O 0 9.75754677057239e-09
, O 0 1.4984031376785723e-11
0 O 0 1.8654688904717887e-11
. O 0 5.797461442120719e-14
4 O 0 1.0569341409027988e-11
; O 0 1.4159845713491992e-13
95 O 0 7.209029206922679e-11
percent O 0 6.192064461174596e-07
confidence O 0 4.2613041273398267e-07
interval O 0 1.5969155997552775e-09
, O 0 5.438990837575153e-12
0 O 0 4.801623508521313e-12
. O 0 3.489346466390049e-14
2 O 0 6.0118654846008646e-12
to O 0 1.9527240067984675e-12
1 O 0 3.812239759981573e-11
. O 0 5.895706015404678e-13
1 O 0 2.0911395878786543e-11
) O 0 5.920365326456123e-12
. O 0 3.598536399418428e-11

CONCLUSIONS O 0 1.2672413163272722e-07
Oral O 0 1.3822354105741397e-07
- O 0 5.2355458137753885e-06
contraceptive O 0 1.4675823877041694e-05
use O 0 4.554780552723514e-09
may O 0 1.2375434010891695e-09
reduce O 0 4.101875505924113e-10
the O 0 2.383270247818814e-10
risk O 0 2.652674083947204e-05
of O 0 6.3309394136013e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 7.522565681483684e-09
women O 0 7.672995017138362e-10
with O 0 5.844118591835645e-12
pathogenic O 0 3.91109900022002e-09
mutations O 0 6.054405865540957e-09
in O 0 5.501026283799559e-12
the O 0 1.5808386821802856e-09
BRCA1 O 0 0.0008739940822124481
or O 0 1.937345132319024e-06
BRCA2 O 0 0.005328860599547625
gene O 0 7.676853419980034e-05

A O 0 3.6360543731461803e-07
Japanese O 0 6.616925247726613e-07
family O 0 1.6543530989565625e-08
with O 0 2.704709123335647e-09
adrenoleukodystrophy B-Disease 1 0.9999990463256836
with O 0 1.1950266332050319e-09
a O 0 2.2110029085364857e-10
codon O 0 2.2449796688306378e-08
291 O 0 5.541367809058784e-09
deletion O 0 5.489884813414392e-08
: O 0 3.016247668297112e-11
a O 0 6.530765511714165e-11
clinical O 0 6.409025310460947e-09
, O 0 2.899939142986252e-11
biochemical O 0 4.238824757862858e-08
, O 0 7.592455136817833e-11
pathological O 0 2.3193382503450266e-07
, O 0 4.6975048850761425e-11
and O 0 7.275915286930612e-11
genetic O 0 2.8283229980274882e-08
report O 0 5.4525575166053386e-08
. O 0 1.2941321347881285e-09

We O 0 4.4098897866717834e-09
report O 0 1.6698409321946883e-10
a O 0 3.9615172253704145e-11
Japanese O 0 1.086168754937944e-08
family O 0 3.827324679406274e-09
with O 0 6.016970388600384e-08
adrenoleukodystrophy B-Disease 1 0.9999997615814209
( O 0 7.349037218773447e-07
ALD B-Disease 1 0.9999990463256836
) O 0 1.6217407972085596e-10
with O 0 4.308451598961094e-12
a O 0 8.302560722261987e-11
three O 0 2.1790351745210046e-09
base O 0 9.603543560388061e-08
pair O 0 1.032635381648106e-07
deletion O 0 1.0234006140308338e-06
( O 0 3.470741472000327e-10
delGAG O 0 1.469376087470664e-08
291 O 0 5.980549389050793e-09
) O 0 2.2870188815665715e-12
in O 0 2.093233572586506e-12
the O 0 2.714803049030934e-09
ALD B-Disease 1 0.9999953508377075
gene O 0 4.734527010441525e-06
. O 0 6.2616947182903004e-09

A O 0 1.9657324656918718e-08
variety O 0 3.6947328529990386e-10
of O 0 1.0459163916898273e-11
phenotypes O 0 4.022066590891882e-08
were O 0 4.937389386228119e-10
observed O 0 3.734130504806643e-10
within O 0 2.1608747777235315e-12
this O 0 1.174422191441149e-11
family O 0 1.0506767011975171e-08
. O 0 1.62064706099585e-09

While O 0 4.974913281330373e-08
the O 0 5.148399484511401e-10
proband O 0 1.405771490681218e-05
( O 0 1.7969327414935066e-10
patient O 0 7.016150327388004e-09
1 O 0 2.1859566934345764e-10
) O 0 1.623066698402953e-12
was O 0 9.400324962882678e-10
classified O 0 4.829564659303287e-08
as O 0 6.939768315561423e-09
having O 0 2.0309174342258984e-09
a O 0 2.2048238235150563e-11
rare O 0 3.1890629026420925e-11
intermediate O 0 3.334138173882728e-11
type O 0 1.040799446627716e-08
of O 0 3.747737675752205e-10
adult O 0 1.1757319043681491e-05
cerebral O 0 0.0001965942356036976
and O 0 1.5748655712854998e-08
cerebello O 0 0.00016295613022521138
- O 0 0.02963162772357464
brain O 0 0.05073314532637596
stem O 0 5.820779733767267e-07
forms O 0 1.6019369164510522e-09
, O 0 1.164481289173125e-10
his O 0 3.5783560559110583e-09
younger O 0 7.969425723786117e-07
brother O 0 2.548910970290308e-06
( O 0 2.070637133977371e-10
patient O 0 3.515785351737577e-08
2 O 0 8.110189742005502e-10
) O 0 2.6350666440522197e-11
and O 0 8.852036326167934e-10
nephew O 0 5.063027492724359e-05
( O 0 1.4317389496198984e-09
patient O 0 8.679340623984899e-08
3 O 0 1.5793558683085962e-09
) O 0 7.884110898859209e-12
had O 0 4.602857650581882e-09
a O 0 3.6762351385277725e-08
childhood O 0 0.0003652045561466366
ALD B-Disease 1 0.9999980926513672
type O 0 0.0002737926843110472
. O 0 1.6903834776371696e-08

Another O 0 1.1245828090977739e-06
nephew O 0 0.0006670451839454472
( O 0 1.1580922887333145e-08
patient O 0 4.3378398117965844e-07
4 O 0 3.806154946772722e-09
) O 0 1.0620584273146605e-12
of O 0 1.486047070987928e-12
patient O 0 7.51767785800439e-08
1 O 0 5.24219723185837e-10
was O 0 1.655527270827406e-08
classified O 0 1.6621169152131188e-07
as O 0 3.5610025150845104e-08
having O 0 4.625486482723318e-08
an O 0 4.1526839744676636e-09
adolescent O 0 1.4453659787250217e-05
form O 0 4.166766487401219e-09
. O 0 9.96229765348744e-10

The O 0 2.2221599560445782e-10
tau O 0 1.2798920812073789e-09
level O 0 3.8917882250188995e-09
in O 0 1.8925881695164293e-11
the O 0 3.060839637303303e-10
cerebrospinal O 0 0.018286414444446564
fluid O 0 7.409015233861282e-05
( O 0 2.892568673473761e-08
CSF O 1 0.9406859278678894
) O 0 7.377552041498703e-11
in O 0 7.784577669978088e-12
patient O 0 1.623717160725846e-08
1 O 0 6.06736161312682e-10
was O 0 5.835419969457689e-08
as O 0 1.2647879410465634e-09
high O 0 1.9314803978431883e-08
as O 0 6.449805967090327e-11
that O 0 6.016626433180683e-12
of O 0 3.6305597417296553e-11
patients O 0 9.229770725482922e-09
with O 0 1.9791329464169394e-08
Alzheimers B-Disease 1 0.9993478655815125
disease I-Disease 0 0.099822498857975
( O 0 1.437950591931525e-10
AD B-Disease 0 1.3274398042995017e-06
) O 0 1.897552781571221e-09
. O 0 4.742710668637073e-10

His O 0 8.709771037729297e-08
brain O 0 1.2722578503598925e-05
magnetic O 0 3.360818823239242e-08
resonance O 0 2.432482233416522e-07
image O 0 1.5032172996143345e-05
( O 0 1.1607762528953458e-09
MRI O 0 1.503631574450992e-05
) O 0 1.3143230948031714e-10
showed O 0 1.0301276915924973e-06
abnormalities B-Disease 0 0.0102906608954072
in I-Disease 0 6.272063424184182e-11
the I-Disease 0 7.440841720551816e-09
bilateral I-Disease 0 7.751200610073283e-05
cerebellar I-Disease 0 0.00017337145982310176
hemispheres I-Disease 0 3.20868675771635e-05
and O 0 1.9616560109625425e-07
brain O 0 4.237374378135428e-05
stem O 0 2.3173969054823829e-07
, O 0 5.544206066465662e-11
but O 0 2.6026340804730097e-11
not O 0 2.4794133759997727e-11
in O 0 1.468723753728085e-11
the O 0 1.4444063722862666e-08
cerebral O 0 0.0003855674003716558
white O 0 1.7743607472198164e-08
matter O 0 7.102581977419531e-12
, O 0 2.7756226136932405e-13
where O 0 2.770016475309861e-13
marked O 0 1.558024369241462e-11
reductions O 0 9.388163135781724e-09
of O 0 7.446353429696462e-12
the O 0 1.5183717394506857e-08
cerebral O 0 0.002219561953097582
blood O 0 7.897920113464352e-06
flow O 0 1.7856264378224296e-07
and O 0 6.339893943163588e-09
oxygen O 0 8.81399397911764e-10
metabolism O 0 4.456632840543762e-09
were O 0 1.3269521766112735e-11
clearly O 0 1.1726314363968982e-11
demonstrated O 0 6.60192007399113e-13
by O 0 3.1059109142006144e-14
positron O 0 2.3416191208269765e-09
emission O 0 8.004752416468364e-09
tomography O 0 4.5198197540230467e-07
( O 0 9.90662774036366e-10
PET O 0 2.59673811342509e-06
) O 0 1.429348028825217e-10
. O 0 1.748547001634293e-10

In O 0 2.3240934510226907e-08
patients O 0 3.5210465654245127e-08
2 O 0 5.189533247573763e-09
and O 0 3.402903514526656e-10
3 O 0 1.6170519090419333e-10
, O 0 2.539913266687288e-13
the O 0 1.0814362372182224e-13
autopsy O 0 3.2604503985567135e-08
findings O 0 2.312754432409747e-09
showed O 0 2.8464864954003133e-07
massive O 0 6.23943890332157e-07
demyelination B-Disease 1 0.9999911785125732
of I-Disease 0 7.954131575615975e-09
the I-Disease 0 1.645400971028721e-07
cerebral I-Disease 0 0.00037899904418736696
white I-Disease 0 7.84046871871169e-09
matter I-Disease 0 1.8228764851746515e-12
with O 0 5.146064780900406e-13
sparing O 0 5.874796742827426e-12
of O 0 1.5792842294332088e-12
the O 0 2.188781378364979e-10
U O 0 7.344396180997137e-06
- O 0 3.167859904351644e-05
fibers O 0 2.6667414203984663e-05
, O 0 7.317511180326974e-12
compatible O 0 9.947633689000313e-11
with O 0 8.821671691749966e-12
the O 0 4.357002172244995e-12
findings O 0 5.027813165803252e-10
of O 0 7.388031852961774e-10
childhood O 0 0.00013064529048278928
ALD B-Disease 1 0.999983549118042
. O 0 3.535380344033001e-08

Oleic O 0 0.04195171594619751
and O 0 2.165740369264313e-07
erucic O 0 0.0004011327400803566
acids O 0 2.020897653665088e-07
( O 0 6.48619907783754e-11
Lorenzos O 0 1.755342964315787e-07
Oil O 0 2.9220581510003285e-08
) O 0 9.334187069109934e-13
were O 0 5.265176857872922e-13
administered O 0 1.868537442828444e-12
to O 0 8.262933740010858e-12
patients O 0 5.728768848189958e-11
1 O 0 3.874874379694582e-11
and O 0 3.4157596195960593e-10
4 O 0 1.070430744043449e-09
, O 0 1.7327021978666424e-12
but O 0 9.071107580360671e-13
sufficient O 0 2.9322692277761186e-12
effectiveness O 0 2.55505755442087e-10
was O 0 1.0459453303468536e-09
not O 0 1.959122100658739e-12
obtained O 0 6.440020738907037e-11
. O 0 3.29542171328967e-10

The O 0 5.726215612789076e-10
findings O 0 5.46790224209559e-10
in O 0 2.8975988275448117e-12
this O 0 2.761617974231245e-13
family O 0 3.180413224446177e-11
suggest O 0 2.2714132658085973e-11
that O 0 3.59064514232621e-11
delGAG291 O 0 4.4075878946614466e-08
is O 0 8.702701059792872e-11
part O 0 9.159502149802545e-12
of O 0 3.687667358975855e-12
the O 0 1.0567028502217468e-10
cause O 0 3.6952194082395806e-10
of O 0 6.920819473066331e-11
Japanese O 0 7.4935078373528086e-06
ALD B-Disease 1 0.9999951124191284
with O 0 1.3342551508088718e-09
phenotypic O 0 2.721124587878876e-07
variations O 0 4.015789158984262e-07
. O 0 4.463498015638834e-09

Moreover O 0 7.92208183497678e-08
, O 0 4.156784985664963e-11
although O 0 3.5200993595690955e-12
the O 0 5.69414307372007e-13
scale O 0 1.0101329550593618e-08
of O 0 5.0477556162720205e-12
the O 0 8.748697946647788e-12
study O 0 1.3138812954283097e-11
is O 0 3.279820304236125e-10
limited O 0 4.648882667712684e-11
, O 0 1.398922752811338e-12
there O 0 2.855571898732756e-12
is O 0 5.703667572964921e-12
a O 0 3.938415999577005e-12
possibility O 0 2.2253240916647599e-10
that O 0 5.170262828979588e-11
PET O 0 2.056875928246882e-06
can O 0 1.5988051993431895e-09
detect O 0 9.448179980608984e-07
an O 0 2.810854216050984e-09
insidious B-Disease 0 0.00011054084461648017
lesion I-Disease 0 0.02260967530310154
which O 0 3.1516000920106535e-09
is O 0 1.9139781426424918e-10
undetectable O 0 8.95821656854423e-08
by O 0 7.907540724647055e-13
computed O 0 1.2460446008333292e-08
tomogram O 0 1.2847895050072111e-05
( O 0 1.2048859132640644e-10
CT O 0 4.6895006562408525e-06
) O 0 6.234502063912073e-12
or O 0 7.30388752950839e-12
MRI O 0 1.571582863846288e-08
analysis O 0 6.433354543533554e-11
, O 0 1.077786384445778e-11
and O 0 6.228036749517107e-12
that O 0 9.855876965253474e-13
the O 0 5.6457403856124966e-12
higher O 0 3.529860403972407e-09
level O 0 1.0876649580993103e-09
of O 0 4.726178216146737e-13
tau O 0 2.530808678943841e-12
reflects O 0 3.359280301845624e-12
the O 0 9.117660511141767e-14
process O 0 1.3090479221433693e-12
of O 0 4.268005653756957e-12
neuronal B-Disease 0 3.726923409885785e-07
degeneration I-Disease 0 0.001464775181375444
in O 0 7.698950099666035e-08
ALD B-Disease 1 0.999996542930603
. O 0 9.165286485313118e-08

Lorenzos O 0 0.00028968017431907356
Oil O 0 1.3631008187076077e-05
should O 0 5.138500736023843e-10
be O 0 3.61193670458948e-12
given O 0 4.406153922081012e-14
in O 0 1.745228039775476e-14
the O 0 2.1505860243672958e-13
early O 0 1.7780780320331147e-11
stage O 0 6.7597323294421585e-09
. O 0 1.3914458994734868e-11
. O 0 1.260524601365276e-10

Nonsense O 0 1.8492681192583404e-05
mutation O 0 1.5204357168840943e-06
in O 0 5.898771748835685e-11
exon O 0 1.6359597054815822e-07
4 O 0 2.6765758498470404e-09
of O 0 5.798971112330742e-12
human O 0 1.607501465272776e-09
complement O 0 1.4741220466518712e-09
C9 O 0 4.573857097511791e-07
gene O 0 4.918923934837949e-08
is O 0 2.5396651448517105e-10
the O 0 1.5210593201642197e-11
major O 0 6.7579524198890795e-09
cause O 0 6.390492024443972e-10
of O 0 2.2701585056239537e-10
Japanese O 0 1.5607321984134614e-05
complement B-Disease 0 2.205619057349395e-05
C9 I-Disease 1 0.5455304980278015
deficiency I-Disease 0 0.11217869818210602
. O 0 7.618395914121834e-10

Deficiency B-Disease 1 0.9980261921882629
of I-Disease 0 4.664392760922453e-10
the I-Disease 0 4.618559354407914e-11
ninth I-Disease 0 2.7422251136499654e-08
component I-Disease 0 4.42844205750248e-09
of I-Disease 0 2.016956393569025e-11
human I-Disease 0 5.121741697422522e-09
complement I-Disease 0 8.560273379032424e-09
( O 0 2.104720564499729e-11
C9 O 0 5.379820677831049e-08
) O 0 6.348592983783374e-13
is O 0 5.010372542205155e-13
the O 0 3.85154408366617e-12
most O 0 2.5443986917395023e-09
common O 0 9.92243440123275e-06
complement B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999998807907104
in O 0 1.8221482656066712e-10
Japan O 0 2.3350418487666502e-08
but O 0 2.819119937491621e-11
is O 0 1.1763591836744247e-11
rare O 0 1.24969383799578e-11
in O 0 7.830170973416317e-13
other O 0 1.986084213756456e-11
countries O 0 3.529508352251298e-10
. O 0 3.3870453663986666e-10

We O 0 1.3483314909024102e-08
studied O 0 3.1935082356326916e-10
the O 0 3.680758226421582e-13
molecular O 0 1.9123799765985439e-10
basis O 0 1.924881587456184e-09
of O 0 1.6623555865180606e-08
C9 B-Disease 1 0.996263325214386
deficiency I-Disease 1 0.6502415537834167
in O 0 9.653239145535064e-12
four O 0 4.2723269366717886e-10
Japanese O 0 1.87161816711523e-07
C9 B-Disease 0 4.639668622985482e-05
- I-Disease 0 0.0009714682819321752
deficient I-Disease 0 0.0031980080530047417
patients O 0 3.7434478628028955e-08
who O 0 2.6018685872486458e-08
had O 0 9.615794169803848e-07
suffered O 0 0.0003053669643122703
from O 0 1.1230866903133574e-06
meningococcal B-Disease 1 0.9999983310699463
meningitis I-Disease 1 0.9999967813491821
. O 0 6.424767917678764e-08

Direct O 0 1.0683114393117421e-09
sequencing O 0 4.949460397085659e-09
of O 0 1.51779394608198e-10
amplified O 0 6.007807940022758e-08
C9 O 0 1.9885895596871705e-07
cDNA O 0 1.0531600036500777e-09
and O 0 6.911612254745236e-11
DNA O 0 5.995867979891045e-08
revealed O 0 6.827958998201211e-08
a O 0 7.300451215774828e-11
nonsense O 0 1.1790654674825873e-08
substitution O 0 2.026140887012584e-11
( O 0 1.1643356634741253e-12
CGA O 0 6.835185195619431e-10
- O 0 7.881990882196988e-08
- O 0 5.295121923154511e-07
> O 0 5.278931181074142e-10
TGA O 0 1.175919379647894e-07
) O 0 1.0096416975038935e-12
at O 0 1.4468408025478108e-12
codon O 0 2.8248467801028632e-11
95 O 0 9.244767278093757e-12
in O 0 2.043970597160119e-13
exon O 0 2.7827788962042632e-09
4 O 0 8.998332079457327e-10
in O 0 1.0947293418994697e-12
the O 0 9.921423925474127e-12
four O 0 4.033280376347648e-09
C9 B-Disease 0 0.0005072952480986714
- I-Disease 0 0.010750527493655682
deficient I-Disease 0 0.0003359606780577451
individuals O 0 3.7016687493007794e-09
. O 0 4.1313036325263397e-10

An O 0 5.775565026233664e-10
allele O 0 1.6168378635939007e-08
- O 0 4.369093886680275e-08
specific O 0 3.9847212335297755e-11
polymerase O 0 3.153983030301788e-08
chain O 0 3.197769729013089e-07
reaction O 0 1.8453512329319466e-10
system O 0 4.1944638734525697e-11
designed O 0 1.1387982778998662e-09
to O 0 1.8740161332464478e-12
detect O 0 5.651652923432948e-09
exclusively O 0 1.792748414997103e-11
only O 0 7.478531140713007e-13
one O 0 5.269628049892061e-13
of O 0 1.2761527132341272e-13
the O 0 8.67286971406589e-12
normal O 0 1.2855921882604093e-10
and O 0 1.102781494594085e-11
mutant O 0 3.8803884550020484e-09
alleles O 0 2.3801405291123956e-10
indicated O 0 3.5034799505950787e-09
that O 0 6.175846292699738e-12
all O 0 2.431669449132201e-12
the O 0 2.2618836057614056e-12
four O 0 2.670995091769157e-10
patients O 0 5.532258678941915e-11
were O 0 5.750628272183089e-12
homozygous O 0 7.489648345959665e-10
for O 0 8.561006721238829e-13
the O 0 2.5310547928369953e-12
mutation O 0 2.047806813010311e-09
in O 0 2.3033399840222124e-11
exon O 0 5.213436224948964e-07
4 O 0 6.820410192176496e-08
and O 0 4.659431174225404e-10
that O 0 1.3701635312446392e-11
the O 0 1.2529779297443255e-11
parents O 0 2.063181986367013e-10
of O 0 2.622920543954299e-12
patient O 0 1.1131041866008218e-08
2 O 0 1.541225203016694e-10
were O 0 2.1644037950796502e-10
heterozygous O 0 3.755433297669697e-08
. O 0 4.440568468488948e-10

The O 0 5.776853995165254e-10
common O 0 5.132878011515629e-10
mutation O 0 5.030578176246081e-09
at O 0 5.074471398636149e-10
codon O 0 3.160461004014792e-09
95 O 0 2.1371650282819843e-10
in O 0 6.662412050002786e-13
exon O 0 8.039838128581778e-09
4 O 0 2.7046005435238385e-09
might O 0 1.0550795653818668e-10
be O 0 2.3160084960949234e-12
responsible O 0 2.593224246449921e-11
for O 0 1.3324252291779803e-11
most O 0 8.698556874797703e-10
Japanese O 0 4.407001142681111e-06
C9 B-Disease 0 0.008294903673231602
deficiency I-Disease 0 0.0001172238917206414
. O 0 6.128498316465558e-12
. O 0 1.33871802532326e-10

BRCA1 O 0 0.0009688289137557149
required O 0 3.2876257272107523e-09
for O 0 3.7997244239917904e-11
transcription O 0 1.6279368253435678e-07
- O 0 7.312914385693148e-05
coupled O 0 1.8463056221662555e-06
repair O 0 3.3638186778262025e-06
of O 0 4.990813318173082e-12
oxidative O 0 1.374221625383143e-07
DNA O 0 4.211053601466119e-05
damage O 0 1.9026667359867133e-05
. O 0 5.3392348320358e-09

The O 0 1.771654069671058e-06
breast B-Disease 1 0.999789297580719
and I-Disease 1 0.9905891418457031
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
susceptibility O 0 0.000263535650447011
gene O 0 4.3658197682816535e-05
BRCA1 O 0 0.011040299199521542
encodes O 0 2.2660090053250315e-06
a O 0 2.631565621413756e-06
zinc O 1 0.8935295939445496
finger O 0 0.06800559908151627
protein O 0 3.646158930337151e-08
of O 0 1.3926034804490062e-11
unknown O 0 2.0903321296117383e-09
function O 0 2.4861024350286698e-09
. O 0 3.0035975928655034e-09

Association O 0 1.2587676678776916e-07
of O 0 3.061807404836081e-11
the O 0 1.1239557201614403e-10
BRCA1 O 0 5.6149374358938076e-06
protein O 0 1.4249199598026507e-09
with O 0 4.745020023601276e-13
the O 0 8.939880628312802e-13
DNA O 0 1.6720342728149262e-06
repair O 0 0.0002338471240364015
protein O 0 1.1869056493196695e-07
Rad51 O 0 1.1186932624696055e-06
and O 0 1.502103857964343e-10
changes O 0 5.833538947036532e-12
in O 0 8.076443566663524e-14
the O 0 6.705076896268078e-14
phosphorylation O 0 1.6877456029962268e-11
and O 0 2.266761917057991e-10
cellular O 0 1.0593519306212329e-07
localization O 0 4.605237524657468e-09
of O 0 4.4422924540266084e-12
the O 0 6.248311330142586e-12
protein O 0 4.3107326042068905e-10
after O 0 5.457178806067553e-11
exposure O 0 4.836445688383151e-10
to O 0 3.1578090294547e-13
DNA O 0 3.807202730854442e-08
- O 0 5.276762067296659e-07
damaging O 0 2.60017259279266e-06
agents O 0 9.275160195443277e-09
are O 0 1.3792007900331749e-12
consistent O 0 4.202734514568984e-12
with O 0 7.343905214854396e-13
a O 0 2.884058269980727e-11
role O 0 2.2118264997317283e-09
for O 0 1.2744293467759071e-11
BRCA1 O 0 7.283938430191483e-08
in O 0 2.0351489590786365e-12
DNA O 0 8.660305184093886e-07
repair O 0 0.000505862117279321
. O 0 9.933613931423224e-09

Here O 0 6.360460158560954e-09
, O 0 5.5489640660155715e-12
it O 0 2.1678668517439992e-13
is O 0 4.45486448294799e-13
shown O 0 2.2995023853805696e-12
that O 0 1.4086177970579206e-12
mouse O 0 7.447879397659563e-07
embryonic O 0 2.0127704374317545e-06
stem O 0 3.2754996937001124e-06
cells O 0 1.155474862457595e-07
deficient B-Disease 0 2.2237093162402743e-06
in I-Disease 0 1.2397604644276417e-11
BRCA1 I-Disease 0 2.3780112314852886e-06
are O 0 2.6803842131939426e-11
defective O 0 1.0953183391393395e-06
in O 0 1.5372200040664197e-11
the O 0 4.2525361704237596e-11
ability O 0 5.0395096984345855e-09
to O 0 7.903156427901958e-12
carry O 0 7.294079784614382e-10
out O 0 1.4795699110337068e-09
transcription O 0 1.3230551587639638e-07
- O 0 6.512403615488438e-06
coupled O 0 3.0717768595422967e-07
repair O 0 4.94965206598863e-07
of O 0 2.323778539384258e-12
oxidative O 0 1.4439739182137146e-08
DNA O 0 1.5954381524352357e-05
damage O 0 2.4356988433282822e-05
, O 0 8.948846524914345e-11
and O 0 4.907043868462857e-11
are O 0 3.814419700237659e-12
hypersensitive O 0 4.289559996095704e-08
to O 0 1.3357866895935544e-11
ionizing O 0 2.7232474053562328e-08
radiation O 0 1.582728259563737e-08
and O 0 3.199084747107506e-11
hydrogen O 0 4.013724630436144e-10
peroxide O 0 1.674561872277991e-06
. O 0 4.637513706384766e-10

These O 0 1.4987841523428358e-10
results O 0 5.709257511199439e-10
suggest O 0 1.6358271404115499e-09
that O 0 2.5958085680954923e-10
BRCA1 O 0 9.192611287289765e-06
participates O 0 1.2670147597759751e-08
, O 0 9.866414109327426e-12
directly O 0 4.380285370531034e-11
or O 0 1.063564125658445e-09
indirectly O 0 7.881975960799537e-08
, O 0 4.8612013719973035e-11
in O 0 5.0111781044193116e-12
transcription O 0 2.579824922577245e-07
- O 0 0.000252229772740975
coupled O 0 3.056641389775905e-06
repair O 0 4.045559307996882e-06
of O 0 9.310595697198387e-12
oxidative O 0 1.909925018139802e-08
DNA O 0 4.537334007181926e-06
damage O 0 1.6088110896816943e-06
. O 0 5.5084416195061436e-11
. O 0 8.284530839119952e-10

Truncation O 0 7.03279192748596e-06
mutations O 0 3.858784111798741e-05
in O 0 2.2248063114016503e-10
the O 0 2.8401142548872826e-11
transactivation O 0 8.022905603866093e-06
region O 0 1.559090190283996e-09
of O 0 8.24744092464691e-12
PAX6 O 0 1.3521165783458855e-05
result O 0 1.2032443930110048e-09
in O 0 1.1117636325441715e-11
dominant O 0 4.769084966937953e-07
- O 0 7.620087126269937e-05
negative O 0 4.1828181451819546e-07
mutants O 0 6.935615601832978e-07
. O 0 7.510390087617225e-10

PAX6 O 0 0.0005123604205437005
is O 0 6.6314909119569165e-09
a O 0 8.475361384929769e-11
transcription O 0 6.318707335140061e-09
factor O 0 8.743402113431387e-10
with O 0 1.8634265137873474e-12
two O 0 1.9930238015497537e-12
DNA O 0 1.3842658290741383e-06
- O 0 0.00017335329903289676
binding O 0 3.6241494854039047e-06
domains O 0 1.2987936770514352e-06
( O 0 1.5272491604712002e-10
paired O 0 2.1605329081353375e-08
box O 0 1.260882527276408e-06
and O 0 7.235084975576456e-09
homeobox O 0 9.395385802690726e-08
) O 0 5.7799338232245034e-12
and O 0 5.221515927966713e-12
a O 0 7.42428965527786e-11
proline O 0 5.373600515667931e-07
- O 0 6.076527938603249e-07
serine O 0 2.401732217549579e-07
- O 0 6.693729801554582e-07
threonine O 0 1.0198414202022832e-06
( O 0 3.365740325333988e-11
PST O 0 8.252398231434199e-08
) O 0 4.778626713081158e-12
- O 0 4.374820505859134e-09
rich O 0 2.2824367396090395e-10
transactivation O 0 3.360133575824875e-07
domain O 0 2.4233957063302114e-08
. O 0 9.627579844462275e-10

PAX6 O 0 0.006194483954459429
regulates O 0 0.0014755171723663807
eye O 0 0.002099242527037859
development O 0 6.105927430333224e-10
in O 0 6.44108637953833e-12
animals O 0 1.2783056557719163e-10
ranging O 0 3.636029255460471e-10
from O 0 5.426307840561417e-12
jellyfish O 0 3.37273375894398e-10
to O 0 9.288667925100302e-13
Drosophila O 0 9.827011600294089e-12
to O 0 2.399611108774846e-12
humans O 0 9.862360927925806e-10
. O 0 2.7824484383209835e-10

Heterozygous O 0 2.6201732907793485e-05
mutations O 0 2.123205194948241e-05
in O 0 9.684743285109931e-11
the O 0 2.1599610988687346e-11
human O 0 9.069460182864475e-10
PAX6 O 0 2.89659374175244e-06
gene O 0 1.3018471634040907e-08
result O 0 1.4391304814509454e-10
in O 0 9.36396576597942e-13
various O 0 1.3058210112174007e-12
phenotypes O 0 2.873825843963118e-09
, O 0 2.174378732622273e-11
including O 0 2.8365443327516005e-09
aniridia B-Disease 1 0.9999997615814209
, O 0 2.936580472123751e-07
Peters B-Disease 1 0.9999994039535522
anomaly I-Disease 1 0.9999982118606567
, O 0 1.9803229633907904e-07
autosomal B-Disease 0 0.2672652006149292
dominant I-Disease 0 0.09901963919401169
keratitis I-Disease 1 0.9956766963005066
, O 0 2.591345094060671e-07
and O 0 1.530424071916059e-07
familial B-Disease 0 0.399640828371048
foveal I-Disease 1 0.9972561001777649
dysplasia I-Disease 1 0.996884286403656
. O 0 2.1482465584199417e-08

It O 0 3.27713300940502e-09
is O 0 8.73276381763155e-11
believed O 0 8.470108642244512e-11
that O 0 1.8159350976057476e-13
the O 0 2.5645596215227717e-13
mutated O 0 2.795210729544806e-09
allele O 0 4.684035825874844e-09
of O 0 7.647071864624877e-11
PAX6 O 0 2.6122270355699584e-05
produces O 0 3.1516737664105676e-08
an O 0 2.8819813202574096e-10
inactive O 0 1.503417365711357e-06
protein O 0 1.2741863031351386e-07
and O 0 5.3862070359400605e-08
aniridia B-Disease 1 0.9999994039535522
is O 0 8.189520173118581e-08
caused O 0 9.006613232998006e-09
due O 0 1.0686430212958342e-10
to O 0 2.1541272238190246e-11
genetic O 0 2.483327250502043e-07
haploinsufficiency O 0 7.484201341867447e-05
. O 0 4.5797388104062975e-09

However O 0 3.816528870714819e-09
, O 0 1.989161656570926e-12
several O 0 1.5717947234560048e-13
truncation O 0 3.5154702260342674e-08
mutations O 0 2.340665787414764e-06
have O 0 6.024651000302583e-09
been O 0 1.5554308951948315e-09
found O 0 5.658661317298197e-10
to O 0 6.673225774050939e-12
occur O 0 8.202604394325075e-12
in O 0 5.393924781653403e-13
the O 0 8.296497516768753e-11
C O 0 2.553835656726733e-06
- O 0 2.7753892481996445e-06
terminal O 0 3.869961417990453e-08
half O 0 2.552797140342733e-10
of O 0 7.659972482698674e-12
PAX6 O 0 7.50880701616552e-07
in O 0 2.1208193187738367e-11
patients O 0 1.0436133207614162e-10
with O 0 3.379119900559502e-11
Aniridia B-Disease 1 0.9999839067459106
resulting O 0 2.912963870116414e-09
in O 0 1.4698382485092698e-12
mutant O 0 5.136906011671272e-09
proteins O 0 2.593699040265296e-11
that O 0 2.9489947810101835e-12
retain O 0 4.266209260861409e-11
the O 0 3.752318768202034e-12
DNA O 0 1.916497240017634e-06
- O 0 3.974802439188352e-06
binding O 0 7.331495055495907e-08
domains O 0 7.653605393898033e-08
but O 0 2.311408009436633e-10
have O 0 5.392253310532169e-11
lost O 0 2.180369662596604e-09
most O 0 6.653675006795812e-13
of O 0 3.325192497651702e-13
the O 0 3.2006470390699704e-11
transactivation O 0 1.4509637367154937e-06
domain O 0 1.128733018163075e-07
. O 0 3.0408002782422727e-09

It O 0 3.4497820156076386e-09
is O 0 9.205218531871395e-11
not O 0 4.357814022831752e-13
clear O 0 3.2063203004098484e-13
whether O 0 3.657212119950737e-12
such O 0 1.451185525913612e-12
mutants O 0 5.0902876580494194e-08
really O 0 1.7531471385723307e-08
behave O 0 8.903954240579992e-10
as O 0 1.9338662615719926e-11
loss O 0 6.121717022189443e-10
- O 0 2.8353500880484717e-08
of O 0 1.452804404555863e-10
- O 0 2.2046142476028763e-06
function O 0 8.64223081986637e-10
mutants O 0 5.882912379462368e-09
as O 0 9.876053967683429e-12
predicted O 0 2.564055079368188e-10
by O 0 3.83661817593417e-11
haploinsufficiency O 0 3.249718247388955e-06
. O 0 4.698358924137835e-10

Contrary O 0 2.111587527053871e-08
to O 0 2.7468381735840097e-11
this O 0 1.365713640268107e-13
theory O 0 1.9568775853212594e-12
, O 0 4.525847199180616e-13
our O 0 1.7795452069389872e-13
data O 0 1.2843372199089487e-10
showed O 0 4.599504777047514e-09
that O 0 3.8494709264820515e-13
these O 0 3.243767559245325e-14
mutants O 0 1.31051380858338e-09
are O 0 6.8389599539031565e-12
dominant O 0 7.88534126883178e-09
- O 0 4.952107701683417e-07
negative O 0 3.36271499534746e-09
in O 0 4.1725404056371096e-13
transient O 0 3.3541537602932436e-11
transfection O 0 1.12993880918566e-08
assays O 0 3.4127086934176987e-08
when O 0 5.121758572812496e-10
they O 0 1.5573113978928355e-11
are O 0 6.754202232228668e-13
coexpressed O 0 6.116910977738144e-09
with O 0 8.164862015658247e-12
wild O 0 6.466986945952158e-08
- O 0 0.00016903172945603728
type O 0 1.623866774025373e-05
PAX6 O 0 0.00014643225586041808
. O 0 2.6830775379238503e-09

We O 0 3.875477272430317e-09
found O 0 1.1197873878154851e-10
that O 0 1.1595862074373353e-12
the O 0 4.7333977015728834e-12
dominant O 0 6.623289436902269e-07
- O 0 0.00012471068475861102
negative O 0 1.9734906686608156e-07
effects O 0 1.9674804008218416e-08
result O 0 6.05343769902178e-12
from O 0 4.879456959468696e-14
the O 0 3.876524548953632e-14
enhanced O 0 1.1083426537661367e-10
DNA O 0 8.63083560176392e-09
binding O 0 2.460552872562971e-09
ability O 0 1.4384499147368501e-10
of O 0 3.273253250477698e-13
these O 0 1.0810002198935464e-11
mutants O 0 4.8660140805623087e-08
. O 0 2.746996519142897e-10

Kinetic O 0 8.996830302976377e-08
studies O 0 3.968418482713787e-09
of O 0 4.748156728906494e-11
binding O 0 4.7755570165008976e-08
and O 0 2.792598374767863e-10
dissociation O 0 3.541047233213135e-09
revealed O 0 1.7359566006902583e-09
that O 0 1.4116806953002464e-13
various O 0 5.695965210996204e-14
truncation O 0 1.1824392132098183e-08
mutants O 0 3.5672167086886475e-07
have O 0 8.48390524499365e-10
3 O 0 1.830711277017727e-10
- O 0 1.7161330845283373e-07
5 O 0 2.7624453835528584e-09
- O 0 1.4492499644802592e-07
fold O 0 1.0818186346739367e-08
higher O 0 3.5861022484873217e-10
affinity O 0 4.2575500416863754e-12
to O 0 3.459723013719135e-14
various O 0 6.911861270912081e-15
DNA O 0 7.948122160428284e-10
- O 0 2.6266591124368688e-09
binding O 0 3.724092562107373e-11
sites O 0 1.530485287115635e-11
when O 0 3.324675951210665e-11
compared O 0 4.2574461317501644e-11
with O 0 4.0371360226186537e-13
the O 0 1.597016681224861e-12
wild O 0 2.4345052196395045e-08
- O 0 5.022225377615541e-05
type O 0 6.1165274019003846e-06
PAX6 O 0 0.00014583322627004236
. O 0 3.049128727283801e-09

These O 0 1.0184041110417041e-10
results O 0 1.0798507921183642e-10
provide O 0 5.832982534481612e-12
a O 0 8.585228881974327e-12
new O 0 1.3881533943160829e-11
insight O 0 8.527736850005851e-11
into O 0 1.013519780254657e-12
the O 0 4.127534685566259e-12
role O 0 3.2348090872602597e-10
of O 0 1.2502988011239835e-12
mutant O 0 1.286003481482112e-07
PAX6 O 0 4.905272817268269e-06
in O 0 1.6345007292084546e-10
causing O 0 5.823528113069187e-07
aniridia B-Disease 1 0.9999653100967407
. O 0 3.385385582976852e-10
. O 0 2.459810133359497e-10

Reversal O 0 0.0003829860652331263
of O 0 1.6712543583707884e-05
severe O 1 0.9995096921920776
hypertrophic B-Disease 1 0.9998736381530762
cardiomyopathy I-Disease 1 0.9999986886978149
and O 0 1.2369933699574176e-07
excellent O 0 6.590211398815882e-08
neuropsychologic O 0 1.007594960356073e-06
outcome O 0 1.331512011759628e-09
in O 0 2.8558239106857286e-11
very B-Disease 0 3.40628053541181e-10
- I-Disease 0 6.816379755036905e-05
long I-Disease 0 9.46069212659495e-06
- I-Disease 0 0.0006795420194976032
chain I-Disease 0 0.00018588708189781755
acyl I-Disease 0 1.2527701187536877e-07
- I-Disease 0 2.7629532723949524e-06
coenzyme I-Disease 0 6.265580054787279e-08
A I-Disease 0 2.1381717942858813e-06
dehydrogenase I-Disease 0 0.0007018482428975403
deficiency I-Disease 0 0.0034880354069173336
. O 0 4.5113060509471836e-10

Very B-Disease 0 1.4497932454560214e-07
- I-Disease 0 4.89520825794898e-05
long I-Disease 0 6.140460300230188e-06
- I-Disease 0 5.797671474283561e-05
chain I-Disease 0 1.2618686014320701e-05
acyl I-Disease 0 2.5983625917547215e-08
- I-Disease 0 2.2686678846639552e-07
coenzyme I-Disease 0 3.5276257470684413e-09
A I-Disease 0 1.5176045309317487e-08
dehydrogenase I-Disease 0 9.289855711358541e-07
( I-Disease 0 9.853090565670186e-10
VLCAD I-Disease 0 0.00015342979168053716
) I-Disease 0 3.982445928585321e-09
deficiency I-Disease 0 1.7274449419346638e-05
is O 0 1.289452572494909e-10
a O 0 2.855436065374306e-08
disorder O 0 0.011552300304174423
of O 0 1.8911962273993055e-10
fatty O 0 5.235009439275018e-07
acid O 0 1.0150651430507196e-09
beta O 0 2.844818781586045e-12
oxidation O 0 6.419687004211028e-11
that O 0 1.888834054442068e-11
reportedly O 0 1.416801893583397e-07
has O 0 6.364610172227003e-09
high O 0 8.165998366393978e-08
rates O 0 9.822380206969683e-07
of O 0 5.573652650525673e-10
morbidity O 0 0.002393346978351474
and O 0 5.4205674615559474e-08
mortality O 0 8.589808203396387e-06
. O 0 1.6161278981741134e-09

We O 0 1.6774039934830398e-09
describe O 0 8.525558037320025e-11
the O 0 7.71373253900115e-13
outcome O 0 4.543129761280795e-12
of O 0 5.893367933419713e-13
a O 0 6.130523866332283e-11
5 O 0 2.1649322612393718e-10
- O 0 7.831340553821065e-08
year O 0 7.618196740111216e-09
- O 0 1.0469383596500847e-05
old O 0 0.001417553168721497
girl O 0 0.0009177299798466265
with O 0 1.0527708127483493e-06
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999997615814209
who O 0 2.020679801262304e-07
was O 0 6.252970585762796e-09
first O 0 3.634455236767309e-10
seen O 0 2.762641670983612e-08
at O 0 3.798943937205479e-10
5 O 0 1.2556910372607533e-11
months O 0 4.6146763493792875e-11
of O 0 5.748599946758803e-12
age O 0 7.791253437972046e-07
with O 0 1.0764038052002434e-05
severe O 1 0.9981163740158081
hypertrophic B-Disease 1 0.9998852014541626
cardiomyopathy I-Disease 1 0.9999995231628418
, O 0 1.7928638044395484e-05
hepatomegaly B-Disease 1 0.9999997615814209
, O 0 1.0245636985928286e-05
encephalopathy B-Disease 1 0.9999880790710449
, O 0 1.034914287600941e-08
and O 0 2.027589829367571e-08
hypotonia B-Disease 0 0.0014355274615809321
. O 0 2.351474570616574e-09

Biochemical O 0 0.001088523305952549
studies O 0 3.956675573135726e-05
indicated O 1 0.6899992227554321
VLCAD B-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
caused O 0 2.0653693354688585e-05
by O 0 9.661533378890752e-11
a O 0 4.711642631605173e-09
stable O 0 4.760737795095338e-07
yet O 0 1.5466069314129527e-08
inactive O 0 1.1497220384626416e-06
enzyme O 0 2.1200871458404436e-07
. O 0 3.8938727242587845e-10

Molecular O 0 1.4641059919995314e-07
genetic O 0 2.538208434543776e-07
analysis O 0 2.9456601602362298e-09
of O 0 3.707276985398522e-10
her O 0 7.377815336440108e-08
VLCAD O 0 0.0003554353606887162
gene O 0 1.7472909519256064e-07
revealed O 0 3.4210941635137715e-07
a O 0 1.6098763433447516e-09
T1372C O 0 1.4069176756947854e-07
( O 0 5.667537272824319e-11
F458L O 0 4.069599324196815e-09
) O 0 4.632531771381343e-12
missense O 0 8.501667281279879e-08
mutation O 0 3.631851086538518e-06
and O 0 7.343083296973418e-08
a O 0 1.2541487421913189e-06
1668 O 0 0.09035102277994156
ACAG O 0 0.04845968633890152
1669 O 0 2.7512526230566436e-06
splice O 0 1.8203551007900387e-05
site O 0 3.561336257007497e-07
mutation O 0 3.165532461935072e-06
. O 0 1.0446359333116106e-08

After O 0 6.632667304273809e-09
initial O 0 6.203548785777002e-10
treatment O 0 7.112366695594119e-09
with O 0 1.018235148975144e-10
intravenous O 0 6.954425657568208e-07
glucose O 0 1.124531354435021e-05
and O 0 4.197819314377682e-10
carnitine O 0 1.3366468465392245e-07
, O 0 2.1165025027719553e-12
the O 0 2.8489456887353937e-12
patient O 0 1.9843000131913868e-08
has O 0 4.171727130408698e-10
thrived O 0 3.6007645753954876e-09
on O 0 3.348025745530947e-10
a O 0 2.2977522107225923e-09
low O 0 1.915326720336452e-05
- O 0 0.00021084825857542455
fat O 0 4.584662747220136e-06
diet O 0 1.2809074634301254e-10
supplemented O 0 2.4899249329024542e-11
with O 0 2.594964607777195e-12
medium O 0 4.24477741844953e-09
- O 0 2.3346403850155184e-06
chain O 0 3.5600496630650014e-06
triglyceride O 0 2.099028506563627e-06
oil O 0 3.2752043921391305e-07
and O 0 1.0746524503613131e-10
carnitine O 0 8.356604297432568e-08
and O 0 1.457655350589615e-11
avoidance O 0 3.12809400604408e-09
of O 0 2.698661780153877e-11
fasting O 0 8.911132454159088e-08
. O 0 1.349742817513544e-10

Her O 0 0.00013933163427282125
ventricular O 0 0.033662572503089905
hypertrophy O 0 0.0003691703896038234
resolved O 0 8.322803068949725e-08
significantly O 0 3.547444293872104e-08
over O 0 1.4247922841548188e-09
1 O 0 7.056166761998384e-10
year O 0 4.0560363401276334e-10
, O 0 4.9265847477941715e-12
and O 0 2.2755327136469994e-11
cognitively O 0 9.18523710424779e-08
, O 0 4.244560432298261e-12
she O 0 5.917210055272903e-10
is O 0 3.960971307892525e-12
in O 0 8.59408301901593e-14
the O 0 2.174452458370002e-12
superior O 0 6.398761520642893e-10
range O 0 3.9858633060774196e-10
for O 0 2.999428205807675e-10
age O 0 5.925415536012224e-08
. O 0 8.198530743186438e-10

Clinical O 0 1.203328702104045e-05
recognition O 0 4.873147645412246e-07
of O 0 1.1441477909102105e-05
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
is O 0 8.090451331099757e-08
important O 0 1.9974709386527678e-10
because O 0 9.317920046658656e-11
it O 0 2.1935236613201958e-11
is O 0 1.4459367730923489e-11
one O 0 5.026101496802271e-12
of O 0 6.239125969337289e-13
the O 0 6.251807405099896e-11
few O 0 4.406213449659191e-10
directly O 0 9.693645353081592e-08
treatable O 0 0.0027209282852709293
causes O 0 5.224963928185389e-08
of O 0 6.811855257637944e-08
cardiomyopathy B-Disease 1 0.9999982118606567
in O 0 1.6944241565397533e-09
children O 0 7.92316701136997e-09
. O 0 1.609702648952549e-11
. O 0 2.1065972577449799e-10

Cloning O 0 6.720767942169914e-07
of O 0 2.1482936263250707e-10
a O 0 3.962773442722778e-10
novel O 0 9.684193447156986e-10
member O 0 4.578222870255111e-11
of O 0 2.485045047344314e-13
the O 0 3.4923210157078444e-11
low O 0 3.831413778243586e-06
- O 0 0.0005298210307955742
density O 0 6.464630928348924e-07
lipoprotein O 0 0.03699004277586937
receptor O 0 3.606420705182245e-06
family O 0 2.2108745056925727e-08
. O 0 1.039152541792987e-09

A O 0 8.917113270001664e-09
gene O 0 7.3083019636044355e-09
encoding O 0 4.5924304359346024e-09
a O 0 3.423862526830135e-09
novel O 0 1.8769460652379166e-08
transmembrane O 0 4.704071670857957e-06
protein O 0 5.2459437682728094e-08
was O 0 3.5055385261273386e-09
identified O 0 1.0245915227358182e-11
by O 0 7.196856093927631e-15
DNA O 0 2.433637839860392e-11
sequence O 0 1.9081442155510775e-12
analysis O 0 2.9949090082914687e-12
within O 0 1.226612301313823e-11
the O 0 1.058804155462667e-08
insulin B-Disease 0 0.05459688603878021
- I-Disease 1 0.9999455213546753
dependent I-Disease 1 0.9998749494552612
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999997615814209
( O 0 3.296921988749091e-07
IDDM B-Disease 0 0.0001360669411951676
) O 0 7.939512242094438e-11
locus O 0 8.80012720472223e-08
IDDM4 O 0 0.00016819698794279248
on O 0 1.4884108168189414e-07
chromosome O 0 0.00039763079257681966
11q13 O 0 4.521847586147487e-06
. O 0 4.055775271183393e-09

Based O 0 4.020162425177887e-09
on O 0 1.726430554072067e-09
its O 0 5.820827153613095e-11
chromosomal O 0 0.00023409990535583347
position O 0 6.21973867964698e-07
, O 0 1.425377177399767e-12
this O 0 3.113603667427578e-14
gene O 0 5.1256648231357005e-11
is O 0 5.6329511367858576e-12
a O 0 2.3576910822969976e-12
candidate O 0 7.092482851023263e-12
for O 0 1.0842566428026501e-11
conferring O 0 7.238673660481254e-09
susceptibility O 0 6.51727305012173e-07
to O 0 4.2149686407810805e-08
diabetes B-Disease 0 0.03626713901758194
. O 0 8.825034036874513e-09

The O 0 2.155056966213209e-10
gene O 0 1.3044297197950527e-08
, O 0 3.7079186943067555e-11
termed O 0 2.539474053264712e-08
low O 0 1.524857339063601e-06
- O 0 1.8481801816960797e-05
density O 0 1.271631049348798e-07
lipoprotein O 0 0.0006952809053473175
receptor O 0 3.5527742170415877e-07
related O 0 2.1099531011259387e-08
protein O 0 6.536543395441186e-08
5 O 0 3.1477431772231057e-09
( O 0 9.166493085410732e-12
LRP5 O 0 4.2502077235440083e-07
) O 0 6.66454684408041e-13
, O 0 1.756344669581831e-14
encodes O 0 6.5924366660086164e-12
a O 0 8.157487185744827e-11
protein O 0 1.5245346096648404e-09
of O 0 3.986143012890686e-11
1615 O 0 1.3134378207269037e-07
amino O 0 3.7788824847062585e-10
acids O 0 4.035492426335274e-11
that O 0 1.81162471634376e-13
contains O 0 2.9797854721874684e-13
conserved O 0 2.803002795148668e-11
modules O 0 7.681048019847481e-10
which O 0 1.8243531685335768e-10
are O 0 6.236285793326246e-12
characteristic O 0 3.395309727816098e-11
of O 0 2.5356307765261876e-12
the O 0 1.4011679594361226e-09
low O 0 0.0010021801572293043
- O 0 0.2785471975803375
density O 0 1.3571832823799923e-05
lipoprotein O 1 0.976802408695221
( O 0 1.476016961987625e-07
LDL O 0 0.0005521119455806911
) O 0 1.7335899382686648e-10
receptor O 0 6.297399046673036e-09
family O 0 3.726732700215507e-09
. O 0 5.602227015621963e-10

These O 0 1.5321334478901605e-10
modules O 0 1.519979031527896e-09
include O 0 4.9556050235599614e-11
a O 0 1.034385858217357e-11
putative O 0 4.592596969388296e-09
signal O 0 5.3054911575145525e-09
peptide O 0 9.561147013004145e-11
for O 0 2.0833860895144718e-13
protein O 0 3.2989212490203146e-12
export O 0 1.7627482806759076e-10
, O 0 1.8573861795389418e-13
four O 0 4.2799075915256335e-12
epidermal O 0 1.1235645160923013e-06
growth O 0 2.0671450329246e-06
factor O 0 1.1230679319851333e-07
( O 0 1.888211809131235e-10
EGF O 0 6.601599125133362e-06
) O 0 2.4527907482863043e-11
repeats O 0 2.3749052502353152e-08
with O 0 1.1593109805474455e-10
associated O 0 6.61829202552866e-11
spacer O 0 1.2707229757324967e-07
domains O 0 8.697965654391737e-07
, O 0 1.7541790242603383e-10
three O 0 7.062251894396354e-10
LDL O 0 0.009230413474142551
- O 0 0.0009274891344830394
receptor O 0 5.872432780051895e-07
( O 0 1.4834998507406993e-10
LDLR O 0 8.179106316674734e-07
) O 0 2.1447049865230827e-12
repeats O 0 1.3712290192202659e-09
, O 0 1.3008541726450273e-12
a O 0 6.4711200807587854e-12
single O 0 2.0398788436182258e-08
transmembrane O 0 1.7460533285884594e-07
spanning O 0 9.09779629409968e-08
domain O 0 7.266660873028741e-07
, O 0 7.366924847929113e-10
and O 0 3.8965896481668594e-11
a O 0 7.92873752764045e-11
cytoplasmic O 0 1.2476789379434194e-07
domain O 0 2.6185475121565105e-07
. O 0 4.627072947016586e-09

The O 0 7.576224370087203e-11
encoded O 0 7.984162775365178e-10
protein O 0 9.796428557251602e-09
has O 0 7.76666647661628e-11
a O 0 1.833872246767565e-12
unique O 0 6.0214480970821604e-12
organization O 0 4.008963300217161e-11
of O 0 2.3306776647524785e-11
EGF O 0 0.0024852820206433535
and O 0 3.5484998051060757e-08
LDLR O 0 5.004707782063633e-05
repeats O 0 1.450700608529587e-07
; O 0 6.154984074496772e-12
therefore O 0 2.7022813240545895e-12
, O 0 1.3521376943451124e-12
LRP5 O 0 6.59291345073143e-07
likely O 0 5.165721184141603e-10
represents O 0 8.384416425033514e-12
a O 0 2.94519061916354e-11
new O 0 4.678488707554607e-10
category O 0 2.289178180348017e-09
of O 0 1.8033113197146733e-11
the O 0 2.3883912625422e-09
LDLR O 0 0.0009066361817531288
family O 0 3.294281114563091e-08
. O 0 6.527330898009609e-10

Both O 0 6.1028102571469844e-09
human O 0 7.343892161060239e-09
and O 0 2.794783016124569e-10
mouse O 0 8.442606485914439e-06
LRP5 O 0 0.0005415457999333739
cDNAs O 0 9.018028208629403e-07
have O 0 4.1003600514955e-09
been O 0 9.808969192448558e-10
isolated O 0 3.6373493106367505e-09
and O 0 4.554721617228141e-12
the O 0 1.1025427397231766e-13
encoded O 0 7.372853022546977e-11
mature O 0 1.0905269048899768e-10
proteins O 0 1.7526486989147272e-12
are O 0 2.8357053033847834e-13
95 O 0 1.262578843558293e-11
% O 0 2.151796536092876e-13
identical O 0 2.079685312850188e-10
, O 0 1.664237497811527e-11
indicating O 0 1.553883022253899e-09
a O 0 1.4977246109992848e-09
high O 0 9.406123240296438e-07
degree O 0 1.730876553196481e-11
of O 0 7.992378460441874e-13
evolutionary O 0 5.998516683369814e-10
conservation O 0 3.663303271839169e-10
. O 0 3.415990580679651e-12
. O 0 1.2485056044564402e-10

The O 0 7.035121374343589e-10
APC B-Disease 0 8.438532006493915e-08
variants O 0 5.802343050476111e-09
I1307K O 0 2.8104269134132664e-08
and O 0 2.020306144601136e-11
E1317Q O 0 3.065865783469235e-09
are O 0 1.6669823507675652e-11
associated O 0 1.1168427960228655e-08
with O 0 0.05561404302716255
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 2.868617775675375e-05
but O 0 1.3148508948290782e-08
not O 0 1.587852516138355e-09
always O 0 1.6488992393703938e-09
with O 0 2.2849225983501142e-11
a O 0 4.1959941077251983e-10
family O 0 4.462510805325337e-09
history O 0 8.280443886121702e-09
. O 0 5.125357471769121e-09

Classical O 1 0.6769618391990662
familial B-Disease 1 0.9999904632568359
adenomatous I-Disease 1 0.9999310970306396
polyposis I-Disease 1 0.9999953508377075
( O 0 3.6067579003429273e-06
FAP B-Disease 0 3.104616780547076e-06
) O 0 1.1164433960653142e-10
is O 0 1.3049701076683906e-11
a O 0 1.0189621368894564e-09
high O 0 0.0004715724498964846
- O 1 0.9948556423187256
penetrance O 1 0.9996955394744873
autosomal B-Disease 1 0.9999747276306152
dominant I-Disease 1 0.9904453754425049
disease I-Disease 0 0.15475216507911682
that O 0 4.1366791936336966e-11
predisposes O 0 1.8977674542952627e-08
to O 0 2.475423945685895e-12
hundreds O 0 9.261145669792192e-12
or O 0 4.8915781147851334e-11
thousands O 0 2.1677543093900908e-10
of O 0 1.0236066145807854e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.7638896107673645
carcinoma I-Disease 1 1.0
and O 0 7.833041877347569e-07
that O 0 1.9292986652708066e-10
results O 0 1.3838505341645657e-10
from O 0 1.1662432304604398e-11
truncating O 0 5.2509491865748714e-08
mutations O 0 2.8584713263057893e-08
in O 0 3.141248979682265e-12
the O 0 1.9587009097987718e-11
APC B-Disease 0 1.5537214892447082e-07
gene O 0 2.2688620759936384e-08
. O 0 1.0723475440954644e-09

A O 0 5.8299242766679527e-08
variant O 0 7.058527558001515e-07
of O 0 5.072468556299725e-10
FAP B-Disease 0 6.55791736789979e-05
is O 0 9.86417148851615e-07
attenuated B-Disease 1 0.8571999669075012
adenomatous I-Disease 1 0.9999955892562866
polyposis I-Disease 1 0.9999438524246216
coli I-Disease 1 0.9999995231628418
, O 0 1.3495639272775861e-08
which O 0 3.57035546960649e-11
results O 0 5.3334076738353886e-11
from O 0 1.1117748388578264e-10
germ O 0 7.719128188909963e-05
- O 0 3.25670771417208e-05
line O 0 4.508997790253488e-06
mutations O 0 1.3902428008805146e-07
in O 0 2.001955198838168e-11
the O 0 3.085467992214319e-11
5 O 0 1.6510990352713861e-09
and O 0 4.9241732219540424e-11
3 O 0 1.1723898761528684e-11
regions O 0 1.5103754835363303e-13
of O 0 3.30083758991271e-14
the O 0 9.533426131858036e-12
APC B-Disease 0 1.67764710568008e-07
gene O 0 5.876856778996853e-09
. O 0 2.591504788540533e-10

Attenuated B-Disease 1 0.9968833327293396
adenomatous I-Disease 1 0.9999372959136963
polyposis I-Disease 1 0.9999353885650635
coli I-Disease 1 0.9999984502792358
patients O 0 0.4706256091594696
have O 0 9.202351947124043e-08
" O 0 1.939712390708337e-09
multiple O 0 1.697500238151406e-06
" O 0 0.022599004209041595
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
( O 0 1.1039553271530167e-08
typically O 0 1.0525509630543439e-10
fewer O 0 4.914733897631862e-11
than O 0 8.977750834415765e-12
100 O 0 1.2047519232227799e-11
) O 0 3.176893427145333e-13
without O 0 1.177638173609219e-12
the O 0 5.339991036162894e-12
florid O 0 4.05606044751039e-07
phenotype O 0 3.5464953196395754e-09
of O 0 4.283778626962276e-12
classical O 0 4.923915053467454e-09
FAP B-Disease 0 7.823127816664055e-07
. O 0 7.222548115137783e-10

Another O 0 1.47493848245972e-08
group O 0 9.444138804326485e-10
of O 0 9.072236885343532e-12
patients O 0 5.708244432689469e-10
with O 0 7.736545779013504e-12
multiple O 0 4.109852014266835e-08
adenomas B-Disease 0 0.01678740419447422
has O 0 4.035907181787479e-07
no O 0 7.507253707572659e-10
mutations O 0 8.455574018739753e-09
in O 0 3.4189370085035975e-12
the O 0 1.5348645965307384e-11
APC B-Disease 0 3.672317205882791e-08
gene O 0 2.286965727904544e-09
, O 0 8.968885530091786e-12
and O 0 1.3765891204720049e-11
their O 0 1.1242381157960946e-11
phenotype O 0 1.2553091899292212e-09
probably O 0 1.8992282746488343e-10
results O 0 8.653471168795779e-12
from O 0 5.723567453319589e-12
variation O 0 1.8476307150905313e-09
at O 0 9.575702009101406e-09
a O 0 7.336902752008712e-10
locus O 0 2.5648458290561393e-07
, O 0 8.986771882213418e-10
or O 0 1.322162795913684e-10
loci O 0 5.197653973887384e-10
, O 0 6.216050243978977e-12
elsewhere O 0 1.7779085495495117e-11
in O 0 8.782796538653326e-14
the O 0 1.1241110039333924e-12
genome O 0 3.209840571116729e-08
. O 0 3.012513571931663e-09

Recently O 0 5.045310444984352e-06
, O 0 7.266692803042929e-11
however O 0 1.9589837564615298e-12
, O 0 1.9185439912097757e-13
a O 0 4.724900158625811e-12
missense O 0 2.095255524636741e-07
variant O 0 1.5667484376535867e-06
of O 0 1.8173456073355965e-09
APC B-Disease 0 1.4727066627528984e-05
( O 0 2.026002976496244e-10
I1307K O 0 2.7684214920498107e-09
) O 0 3.1671063341343064e-12
was O 0 2.561332257400295e-10
described O 0 4.2946288886236417e-11
that O 0 2.197333027337267e-12
confers O 0 4.4457357933902486e-11
an O 0 8.315365757072257e-11
increased O 0 3.4504355994613434e-07
risk O 0 0.00282957311719656
of O 0 0.004734023008495569
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.7058988532880903e-07
including O 0 3.7275268982561727e-10
multiple O 0 9.274881307419491e-08
adenomas B-Disease 0 0.0009230337454937398
, O 0 9.247105303700209e-10
in O 0 7.722174982793817e-11
Ashkenazim O 0 0.00030787280411459506
. O 0 1.8284517011579737e-08

We O 0 7.099453114278731e-08
have O 0 1.1503242802746172e-10
studied O 0 2.1711214423514313e-11
a O 0 2.0096363809174456e-12
set O 0 2.7237989641548666e-11
of O 0 1.7314237066648475e-12
164 O 0 1.9627806580047036e-07
patients O 0 1.902354496152725e-09
with O 0 1.9594723621452204e-09
multiple O 1 0.5419878959655762
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.0033036984968930483
/ I-Disease 0 0.19355812668800354
or I-Disease 0 0.011922692880034447
carcinoma I-Disease 1 1.0
and O 0 4.201877175091795e-07
analyzed O 0 1.107390744436998e-06
codons O 0 2.5612066565372515e-06
1263 O 0 1.412063284078613e-06
- O 0 7.137256488931598e-06
1377 O 0 1.4703930446557933e-06
( O 0 3.3214181405227805e-11
exon O 0 2.8586729428070612e-08
15G O 0 1.609690656323437e-07
) O 0 7.161835144028905e-13
of O 0 4.4387809535828895e-14
the O 0 4.4321591210517985e-13
APC B-Disease 0 1.4043787244233386e-09
gene O 0 4.199274955540844e-11
for O 0 6.83927307149057e-12
germ O 0 4.4816288209403865e-06
- O 0 1.1437495231803041e-05
line O 0 3.897691840393236e-06
variants O 0 1.5497924721330492e-07
. O 0 1.777266001035116e-09

Three O 0 3.710917084731591e-08
patients O 0 2.9682098556804704e-08
with O 0 7.857524526866388e-12
the O 0 6.914219197184934e-12
I1307K O 0 7.71856001335891e-09
allele O 0 1.6216056275553115e-09
were O 0 2.6981984355134436e-11
detected O 0 3.673408688342761e-09
, O 0 2.1021426515731995e-13
each O 0 4.582778926308373e-13
of O 0 8.644104876331937e-11
Ashkenazi O 0 1.2355942999420222e-05
descent O 0 1.323829224020301e-06
. O 0 4.659131302986452e-09

Four O 0 8.926068062464765e-08
patients O 0 1.570196275224589e-07
had O 0 2.280097000095793e-09
a O 0 4.082674198713221e-10
germ O 0 0.00041573503403924406
- O 0 0.0006225247052498162
line O 0 4.285363047529245e-06
E1317Q O 0 1.985833364415157e-08
missense O 0 2.159651302235943e-08
variant O 0 1.5837668954077344e-08
of O 0 3.827202443851263e-12
APC O 0 3.062886477778193e-08
that O 0 1.2502857082985486e-10
was O 0 2.2258358711724213e-08
not O 0 1.1421121860755168e-11
present O 0 8.265456895306666e-12
in O 0 1.269366469575095e-11
controls O 0 1.1016756928938776e-07
; O 0 4.808836488734425e-12
one O 0 1.0944814499147526e-11
of O 0 1.4036106261647308e-12
these O 0 4.302138506551145e-11
individuals O 0 4.034217127024675e-10
had O 0 2.3859108466695034e-08
an O 0 5.243765144324897e-11
unusually O 0 9.59963553093246e-10
large O 0 1.8117646272131083e-11
number O 0 5.7856504309672374e-11
of O 0 1.1812342770589623e-10
metaplastic B-Disease 0 5.310333290253766e-05
polyps I-Disease 0 1.1089951840403955e-05
of I-Disease 0 2.9806296319989656e-11
the I-Disease 0 1.0656068250014528e-09
colorectum I-Disease 0 8.677533332956955e-05
. O 0 1.9466059875128394e-09

There O 0 1.8724184425167323e-09
is O 0 3.820435981460868e-11
increasing O 0 6.029561832460173e-12
evidence O 0 6.501322397101106e-11
that O 0 1.8300120099845607e-11
there O 0 9.159921085521994e-12
exist O 0 6.897388910021007e-11
germ O 0 2.2630979401583318e-06
- O 0 7.612761692143977e-06
line O 0 7.386495326500153e-07
variants O 0 8.174718124642766e-10
of O 0 7.649369419132634e-13
the O 0 7.127416278701615e-12
APC B-Disease 0 2.2628192652973667e-09
gene O 0 2.2436321897578715e-11
that O 0 2.076514958246345e-13
predispose O 0 2.188926297164162e-11
to O 0 6.214718952131382e-13
the O 0 3.1838572576992075e-13
development O 0 2.5591909234151666e-12
of O 0 5.660172330834712e-10
multiple O 1 0.898736298084259
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9528189897537231
carcinoma I-Disease 1 1.0
, O 0 5.5386230712883844e-08
but O 0 1.4501189138371728e-10
without O 0 1.079158377242928e-11
the O 0 2.8257509179785423e-12
florid O 0 3.302271238680987e-07
phenotype O 0 3.2585465437051653e-09
of O 0 1.730822841820856e-12
classical O 0 2.0835244640693418e-10
FAP B-Disease 0 1.4253774160977173e-08
, O 0 6.303638167004522e-12
and O 0 7.291621191389541e-13
possibly O 0 1.5555598475991417e-11
with O 0 8.025287032142892e-12
importance O 0 8.431834785938008e-09
for O 0 0.00021592449047602713
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 0.00027615102590061724
in O 0 7.936677356989996e-12
the O 0 7.77193847473212e-12
general O 0 2.2752029427142162e-11
population O 0 1.2146178160477028e-11
. O 0 4.549650586826992e-12
. O 0 1.7647297512191074e-10

Genomic O 0 3.123392389170476e-07
structure O 0 3.628910505426575e-08
of O 0 3.504233014872682e-10
the O 0 1.4069578924136295e-07
human O 0 0.24746473133563995
congenital B-Disease 1 0.9999992847442627
chloride I-Disease 1 0.9999083280563354
diarrhea I-Disease 1 1.0
( O 0 3.028485480172094e-07
CLD B-Disease 0 0.001201067352667451
) O 0 7.364943654941669e-10
gene O 0 3.570415429976492e-08
. O 0 2.893428163730505e-09

Congenital B-Disease 1 0.9999961853027344
chloride I-Disease 1 0.9999440908432007
diarrhea I-Disease 1 0.9999998807907104
( O 0 1.6146725101862103e-05
CLD B-Disease 1 0.5275902152061462
) O 0 1.5493144545075666e-08
is O 0 1.0323232269016103e-09
caused O 0 1.4316815510895253e-09
by O 0 1.8910147753237183e-11
mutations O 0 1.4310359119917848e-07
in O 0 2.2748905190161928e-11
a O 0 1.565352708565726e-10
gene O 0 7.191718776056177e-09
which O 0 1.0163316715994242e-10
encodes O 0 4.539985809515201e-08
an O 0 2.6033634981104115e-07
intestinal O 0 0.04633988067507744
anion O 0 2.0683596630988177e-06
transporter O 0 0.0013133316533640027
. O 0 1.632374591054031e-08

We O 0 3.476004906133312e-08
report O 0 6.238148331227933e-10
here O 0 1.1317418356637798e-12
the O 0 3.037604483268133e-14
complete O 0 1.3394037398292702e-12
genomic O 0 2.7835048155289144e-10
organization O 0 2.9865027117992327e-11
of O 0 1.4601535041833258e-12
the O 0 4.3913941927264943e-11
human O 0 9.010457380220771e-10
CLD B-Disease 0 5.367817266233033e-07
gene O 0 1.7938859286914521e-09
which O 0 4.14301795995109e-12
spans O 0 5.642979417075367e-10
approximately O 0 5.786679468933187e-10
39kb O 0 8.811379302642308e-06
, O 0 1.1395234061906123e-10
and O 0 1.667319581011295e-11
comprises O 0 6.877277219929923e-11
21 O 0 1.3907467399931761e-09
exons O 0 1.4742767007192015e-07
. O 0 8.659621353324098e-10

All O 0 3.895746836235503e-09
exon O 0 1.9122305729979416e-06
/ O 0 2.376433485551388e-06
intron O 0 1.3549834875448141e-05
boundaries O 0 1.96355163240014e-08
conform O 0 8.14462275400274e-09
to O 0 6.550372657482262e-12
the O 0 6.4545035982632726e-12
GT O 0 2.983603053507977e-06
/ O 0 2.1337432372092735e-06
AG O 1 0.8578327894210815
rule O 0 3.0159185371303465e-08
. O 0 5.775090961002149e-10

An O 0 9.503312026204469e-11
analysis O 0 2.550299381398613e-11
of O 0 9.754774028467028e-13
the O 0 3.4814122071291642e-12
putative O 0 1.556936624069749e-08
promoter O 0 1.0462515120934768e-07
region O 0 2.2241604391570746e-11
sequence O 0 5.8068657521337386e-11
shows O 0 4.046827317694124e-09
a O 0 2.4156496247762504e-10
putative O 0 4.142726766076521e-07
TATA O 0 0.0005662511684931815
box O 0 1.5531688859482529e-06
and O 0 3.7053046741952755e-10
predicts O 0 3.1029403491089624e-09
multiple O 0 2.428682255306569e-10
transcription O 0 1.6968959570817788e-08
factor O 0 5.393150925847578e-10
binding O 0 1.3849417168643186e-09
sites O 0 1.3794035247371994e-08
. O 0 1.7266248431013764e-09

The O 0 6.591059920069142e-10
genomic O 0 3.790363933831031e-08
structure O 0 6.123683959913251e-08
was O 0 1.919411740658461e-09
determined O 0 1.2617620706936727e-12
using O 0 8.905809032941359e-13
DNA O 0 5.246721723750625e-09
from O 0 2.6641338874561216e-12
several O 0 1.5775853117339783e-13
sources O 0 1.1063196935163014e-13
including O 0 5.360264641006418e-13
multiple O 0 9.263764755296222e-11
large O 0 3.577509843921689e-09
- O 0 0.0002064504224108532
insert O 0 1.7105863662436604e-05
libaries O 0 1.0088141380037996e-06
and O 0 1.258654205166243e-12
genomic O 0 6.512194256069748e-11
DNA O 0 8.858395261768237e-08
from O 0 4.3032077901017374e-10
Finnish O 0 7.104537417035317e-06
CLD B-Disease 0 0.0007114431937225163
patients O 0 1.4938858328150673e-07
and O 0 6.714698241871986e-11
controls O 0 2.2344073613567161e-07
. O 0 1.8253774047849447e-09

Exon O 0 6.767551781194925e-07
- O 0 3.7176337741584575e-07
specific O 0 2.0799112432356992e-10
primers O 0 7.69727478200366e-07
developed O 0 3.892406397199011e-08
in O 0 1.3961666024686625e-12
this O 0 4.628826347826548e-14
study O 0 2.328045254403749e-13
will O 0 2.0097359106768797e-12
facilitate O 0 7.106697500446069e-13
mutation O 0 2.4134560669408778e-11
screening O 0 1.0737386674231075e-10
studies O 0 2.078703528751724e-12
of O 0 1.539208430850758e-12
patients O 0 1.239751773463027e-10
with O 0 8.79084912502881e-12
the O 0 6.097760518741779e-09
disease O 0 0.00021303964604157954
. O 0 2.1800370397784263e-09

Genomic O 0 2.9665685019608645e-08
sequencing O 0 2.3830502016153332e-08
of O 0 2.71685784980491e-10
a O 0 2.4222575056853657e-09
BAC O 0 2.386469532211777e-06
clone O 0 0.002105202293023467
H O 1 0.9999985694885254
_ O 0 1.2467721077769056e-08
RG364P16 O 0 2.527233311511168e-09
revealed O 0 2.576336477488894e-09
the O 0 2.8032311714942804e-12
presence O 0 2.3065405488353896e-11
of O 0 1.5694220825267918e-13
another O 0 4.248409957163801e-11
, O 0 1.7931784529467976e-12
highly O 0 2.2951905133405948e-12
homologous O 0 2.25050672542082e-11
gene O 0 4.964254562977999e-10
3 O 0 3.7538808866921514e-11
of O 0 5.926530425269527e-13
the O 0 4.246781398764554e-11
CLD B-Disease 0 7.321165412577102e-06
gene O 0 2.847821534146533e-08
, O 0 6.1542563579986e-12
with O 0 8.825806838835826e-13
a O 0 1.0633602505472073e-11
similar O 0 5.7903278526116875e-12
genomic O 0 1.0369948455490885e-08
structure O 0 1.1211759698426249e-07
, O 0 7.876043567334179e-11
recently O 0 6.565041399397842e-09
identified O 0 1.830737517138914e-08
as O 0 3.844586515810988e-08
the O 0 1.0741230653366074e-05
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 5.099216195958434e-06
( O 0 6.379884953666703e-10
PDS B-Disease 0 1.4301668898042408e-06
) O 0 1.3065590276362116e-11
. O 0 2.4224665242517096e-12
. O 0 9.88682122282647e-11

The O 0 4.269583797622545e-09
APCI1307K O 0 4.442974750418216e-05
allele O 0 2.5906927021424053e-06
and O 0 7.954924541309083e-08
cancer B-Disease 0 2.6266356144333258e-05
risk O 0 9.445927844353719e-07
in O 0 1.2204420633821211e-11
a O 0 1.6197128360762036e-10
community O 0 1.670623708815988e-11
- O 0 3.197089171180778e-08
based O 0 1.0270573974624497e-10
study O 0 1.2424497194962747e-11
of O 0 1.615589953485319e-11
Ashkenazi O 0 1.7468977375756367e-07
Jews O 0 1.5414730603069415e-09
. O 0 2.39776531962832e-10

Mutations O 0 0.0003435294784139842
in O 0 3.912038692988062e-09
APC O 0 5.388433692132821e-06
are O 0 3.221640287875971e-09
classically O 0 0.0006155287264846265
associated O 0 1.8345671151109855e-06
with O 0 0.00025535994791425765
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.9999942779541016
polyposis I-Disease 1 0.9999984502792358
( O 0 4.3715451170101005e-07
FAP B-Disease 0 4.401934177167277e-07
) O 0 2.1524350010682092e-11
, O 0 2.498439172562983e-12
a O 0 3.179905505579228e-10
highly O 0 8.935749065130949e-06
penetrant O 1 0.99986732006073
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999995231628418
disorder I-Disease 1 1.0
characterized O 0 6.89989155944204e-06
by O 0 1.5914060069732727e-09
multiple O 0 5.622853495879099e-05
intestinal O 1 0.9989686012268066
polyps B-Disease 1 0.9773216843605042
and O 0 5.836856331598028e-08
, O 0 5.2305694497878363e-11
without O 0 1.3762380124404672e-10
surgical O 0 1.2119119219278218e-06
intervention O 0 2.3102764146187837e-09
, O 0 1.025764217489622e-12
the O 0 3.4593174678965166e-12
development O 0 1.264127025280004e-09
of O 0 0.0001554914197186008
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.0605303297525097e-07
CRC B-Disease 0 0.00014405531692318618
) O 0 9.89722304112206e-10
. O 0 2.6448865320105597e-10

APC B-Disease 0 2.7116249839309603e-05
is O 0 1.0721639576161124e-08
a O 0 2.8315886524410416e-08
tumour O 1 0.9999948740005493
- O 0 8.799522220215295e-06
suppressor O 0 2.0990744360460667e-06
gene O 0 3.3252462117161485e-07
, O 0 1.2570287866164875e-10
and O 0 5.5820761207803216e-11
somatic O 0 1.6132280507008545e-06
loss O 0 2.791254246403696e-06
occurs O 0 2.2567601121181724e-08
in O 0 3.1760940544245386e-09
tumours B-Disease 1 0.9999977350234985
. O 0 1.6904100164083502e-07

The O 0 4.113504648017852e-09
germline O 0 2.9212642402853817e-05
T O 0 0.0006787917809560895
- O 0 6.317432053037919e-07
to O 0 2.796675946381555e-10
- O 0 7.57158318265283e-08
A O 0 1.4874615983373474e-09
transversion O 0 1.619461365010011e-08
responsible O 0 5.2641679210152503e-11
for O 0 1.657140543493904e-13
the O 0 5.489986178337791e-13
APC O 0 1.2429535178881679e-09
I1307K O 0 1.1555932599716101e-10
allele O 0 1.0787448191662552e-11
converts O 0 1.2434928087223796e-11
the O 0 1.721498811557698e-12
wild O 0 1.138324878802166e-09
- O 0 7.536601032143153e-08
type O 0 2.5876829568005633e-09
sequence O 0 8.081171148921484e-11
to O 0 1.7196923052242852e-10
a O 0 3.354901068064464e-08
homopolymer O 0 0.008545723743736744
tract O 0 0.0013624051352962852
( O 0 3.5568989420475816e-10
A8 O 0 1.0043484508059919e-05
) O 0 8.145075759691256e-12
that O 0 2.9575118395963607e-12
is O 0 6.396293911192785e-11
genetically O 0 4.74577376508023e-07
unstable O 0 2.6120127586182207e-05
and O 0 4.439334233552472e-09
prone O 0 3.4883769330917858e-06
to O 0 2.0795543065332822e-10
somatic O 0 2.5055271635210374e-06
mutation O 0 2.355970764256199e-06
. O 0 5.416100012922698e-09

The O 0 1.800900095716429e-09
I1307K O 0 1.4680530568966788e-07
allele O 0 9.67508242410986e-08
was O 0 7.331019702405683e-08
found O 0 1.3061218773202654e-09
in O 0 2.905514370765694e-11
6 O 0 1.724285780824175e-08
. O 0 4.896042460345029e-10

1 O 0 2.8223306358654554e-08
% O 0 5.927531382399209e-11
of O 0 8.673332885233975e-12
unselected O 0 4.255264502717182e-05
Ashkenazi O 0 9.34024228627095e-06
Jews O 0 3.1138907008454453e-09
and O 0 8.302322718201083e-11
higher O 0 3.1320865345740856e-10
proportions O 0 2.7693049631238864e-08
of O 0 1.877968197616653e-10
Ashkenazim O 0 4.763610559166409e-05
with O 0 7.624127995597973e-09
family O 0 2.5190292518573187e-08
or O 0 5.4872439925190974e-09
personal O 0 7.611416918962277e-08
histories O 0 3.3108483421528945e-07
of O 0 3.034971163273781e-09
CRC B-Disease 0 0.0004031305434182286
( O 0 4.316031143591914e-10
ref O 0 2.394551302131731e-05
. O 0 2.0961113053608038e-11
2 O 0 2.163330625748472e-10
) O 0 1.0093764366003732e-11
. O 0 3.417791050175367e-11

To O 0 2.778433871863939e-10
evaluate O 0 1.6568342253719948e-09
the O 0 8.062691139731903e-12
role O 0 4.3695400075982604e-10
of O 0 1.1691871429353462e-12
I1307K O 0 6.294241128301792e-09
in O 0 1.864853410582512e-11
cancer B-Disease 0 3.12150980619208e-08
, O 0 1.1148170928065859e-11
we O 0 2.623753714292576e-10
genotyped O 0 3.754195176952635e-07
5 O 0 8.359100078791926e-10
, O 0 9.96650678652955e-12
081 O 0 1.7663757034824812e-07
Ashkenazi O 0 5.173486172793673e-08
volunteers O 0 4.8796692381225526e-11
in O 0 6.473622636213316e-13
a O 0 2.2224555529248846e-11
community O 0 5.015120263518469e-11
survey O 0 2.9314476179820304e-08
. O 0 8.896518521872565e-10

Risk O 0 4.784242628375068e-05
of O 0 1.243043556975465e-09
developing O 0 7.341351738432422e-05
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 2.319776086778802e-07
breast I-Disease 0 0.0008166750776581466
and I-Disease 0 1.4685634042166384e-08
other I-Disease 0 3.5341227166973965e-10
cancers I-Disease 0 5.525092547031818e-06
were O 0 8.614631230585701e-10
compared O 0 4.990972968244023e-09
between O 0 3.754283828261151e-10
genotyped O 0 1.879158048723184e-06
I1307K O 0 1.790225923059552e-08
carriers O 0 5.3161475221941146e-09
and O 0 2.79431790206619e-11
non O 0 3.0511648763109633e-09
- O 0 9.069050861398864e-07
carriers O 0 8.19237939708728e-08
and O 0 3.988355826156642e-11
their O 0 8.526362125019227e-13
first O 0 4.9317869232901046e-11
- O 0 3.733525772986468e-07
degree O 0 8.42324709982023e-10
relatives O 0 3.201401588270869e-09
. O 0 2.655856645716881e-10

Sperm O 0 1.0928313542990509e-07
DNA O 0 8.637690029900114e-08
analysis O 0 1.1307553782202717e-09
in O 0 8.120230182706578e-11
a O 0 8.720322242083967e-09
Friedreich B-Disease 0 0.010399390012025833
ataxia I-Disease 1 0.9674748778343201
premutation O 0 0.014750129543244839
carrier O 0 3.906660367647419e-06
suggests O 0 2.1158599317061544e-09
both O 0 9.912344382800864e-12
meiotic O 0 1.8795260814385983e-07
and O 0 8.531283318680138e-11
mitotic O 0 1.4836485817681933e-08
expansion O 0 2.4406037191226915e-09
in O 0 4.066163638433151e-12
the O 0 1.4353110713849482e-11
FRDA B-Disease 0 8.38424421090167e-06
gene O 0 1.0610764711316278e-08
. O 0 2.972988799587739e-10

Friedreich B-Disease 1 0.5985608100891113
ataxia I-Disease 1 0.9995369911193848
is O 0 2.8749171178787947e-05
usually O 0 3.9095713333381354e-08
caused O 0 1.6440535599571149e-09
by O 0 8.092669329801128e-13
an O 0 8.13275054939444e-12
expansion O 0 1.5238921236004899e-09
of O 0 2.6700770067167312e-11
a O 0 1.297563478885877e-08
GAA O 0 3.840234421659261e-05
trinucleotide O 0 6.005040631862357e-06
repeat O 0 1.5080138382472796e-07
in O 0 1.0597056218641931e-11
intron O 0 9.87238166771931e-08
1 O 0 7.535670004665818e-11
of O 0 5.10216218232995e-13
the O 0 3.6120974267195294e-11
FRDA B-Disease 0 1.3933640730101615e-05
gene O 0 8.104795945484966e-09
. O 0 5.473547726175809e-10

Occasionally O 0 4.767034909036738e-07
, O 0 3.775911874837057e-11
a O 0 1.641213380476625e-11
fully O 0 2.2649943032249098e-10
expanded O 0 2.1293039553782478e-10
allele O 0 1.6153450799194502e-09
has O 0 1.7865241508374652e-09
been O 0 2.211783117767041e-10
found O 0 9.85133849495945e-11
to O 0 1.1585897172206039e-11
arise O 0 1.8204600327198506e-10
from O 0 5.866507908798557e-13
a O 0 1.3746527353919458e-11
premutation O 0 2.492342332516273e-08
of O 0 1.414020484903633e-12
100 O 0 2.5010247345358394e-11
or O 0 2.1152778140187678e-10
less O 0 2.464402848456615e-10
triplet O 0 8.924331632442772e-05
repeats O 0 3.0236883503675926e-06
. O 0 2.7044562145306372e-09

We O 0 4.595026581455386e-08
have O 0 5.749545631261732e-11
examined O 0 1.9761435543497186e-10
the O 0 1.6574536068712092e-13
sperm O 0 5.856552048877361e-11
DNA O 0 1.2553810213589145e-09
of O 0 4.090621071040079e-12
a O 0 1.428874463194063e-09
premutation O 0 5.662663170369342e-05
carrier O 0 1.137496155934059e-06
. O 0 6.806251673374675e-10

This O 0 1.526870713197681e-10
mans O 0 1.5466010694353827e-08
leucocyte O 0 2.2454385373293917e-07
DNA O 0 7.861959261390439e-07
showed O 0 4.2062234228978923e-07
one O 0 3.146551769139805e-11
normal O 0 7.927587752920573e-11
allele O 0 1.0829824814706512e-09
and O 0 2.2446851669077894e-11
one O 0 1.2900933576628915e-12
allele O 0 9.712263979166913e-12
of O 0 1.6032359088317266e-13
approximately O 0 6.078802738951339e-11
100 O 0 5.015208803804683e-10
repeats O 0 2.4486840288773237e-07
. O 0 9.883376339558936e-10

His O 0 1.2260458426283094e-08
sperm O 0 3.371265222540387e-07
showed O 0 1.3498758733021532e-07
an O 0 9.869519264349425e-12
expanded O 0 6.818023368104775e-10
allele O 0 4.8927213391891655e-09
in O 0 2.069384420766429e-11
a O 0 1.4373919832166848e-09
tight O 0 5.082691814095597e-07
range O 0 1.2253438264053784e-09
centering O 0 1.6094341415140434e-09
on O 0 5.202830943851211e-10
a O 0 5.361044073948218e-12
size O 0 8.600310741346817e-11
of O 0 5.397608900635509e-13
approximately O 0 1.6320865492414072e-10
320 O 0 2.5110278301099243e-08
trinucleotide O 0 7.906254722911399e-06
repeats O 0 2.8935899081261596e-06
. O 0 3.6062355324162354e-09

His O 0 5.410732910604565e-07
affected O 0 3.9396380202560977e-07
son O 0 1.109665845433483e-06
has O 0 7.04161950970672e-10
repeat O 0 1.6378250977666653e-09
sizes O 0 9.659639754744376e-10
of O 0 3.656912012789393e-12
1040 O 0 3.513653368258929e-08
and O 0 8.774090898278075e-10
540 O 0 3.088322131361565e-08
. O 0 3.579624097138634e-10

These O 0 4.3714382808035523e-11
data O 0 3.4235084211964306e-10
suggest O 0 7.03897010123633e-11
that O 0 3.468686058868964e-12
expansion O 0 1.3015503952384933e-10
occurs O 0 1.5839850264764976e-11
in O 0 8.309807377794576e-13
two O 0 2.782431229864102e-11
stages O 0 4.1966528030457084e-09
, O 0 1.1655384123121504e-11
the O 0 3.398100377471902e-12
first O 0 6.008810671254139e-10
during O 0 1.4837651940435848e-11
meiosis O 0 1.763413373656597e-11
followed O 0 1.8397412065995766e-11
by O 0 5.47696491024624e-13
a O 0 4.09839913742549e-12
second O 0 2.7955612824648313e-10
mitotic O 0 6.477764031842526e-07
expansion O 0 7.733918323538091e-07
. O 0 4.110022544523417e-09

We O 0 4.573360001813853e-08
also O 0 2.427760492640374e-10
show O 0 2.6069227332392586e-10
that O 0 5.257751157193569e-13
in O 0 5.919184820025666e-14
all O 0 2.9137025366228475e-13
informative O 0 5.082055887228876e-10
carrier O 0 2.3885109001753335e-08
father O 0 1.7941048646719082e-09
to O 0 1.0943645295524718e-11
affected O 0 1.5746418058348866e-10
child O 0 6.474660807498367e-09
transmissions O 0 2.446584979054478e-08
, O 0 3.1306500360844813e-12
with O 0 2.7949704725117874e-13
the O 0 7.668037754239576e-13
notable O 0 2.2292187193406754e-11
exception O 0 5.56865595302547e-11
of O 0 2.5987883719991167e-12
the O 0 1.6527304524949216e-10
premutation O 0 4.6723139348614495e-06
carrier O 0 1.3799930975721963e-08
, O 0 1.9223461527034108e-13
the O 0 2.6503555887501598e-14
expansion O 0 6.150023545981043e-11
size O 0 6.0783453825763445e-09
decreases O 0 4.49689494530503e-08
. O 0 1.9336855033857958e-11
. O 0 3.1037200587391567e-10

The O 0 2.2960959800144565e-09
R496H O 0 9.220641317142508e-08
mutation O 0 5.0599698653286396e-08
of O 0 2.450602221149012e-11
arylsulfatase O 0 4.0174845707952045e-06
A O 0 3.154608663180625e-08
does O 0 4.943733422635432e-09
not O 0 8.490999903187912e-09
cause O 0 1.4466749007624458e-06
metachromatic B-Disease 1 0.999983549118042
leukodystrophy I-Disease 1 0.9999582767486572
. O 0 2.1062382415948377e-07

Deficiency B-Disease 1 0.9991925358772278
of I-Disease 0 7.776072230569753e-09
arylsulfatase I-Disease 0 0.0005198362632654607
A I-Disease 0 1.884574430732755e-06
( O 0 5.5492792583322625e-09
ARSA O 0 0.0020635819528251886
) O 0 3.3810812483103803e-10
enzyme O 0 1.1783233730966458e-06
activity O 0 6.570971436303807e-06
causes O 0 0.00024590487009845674
metachromatic B-Disease 1 0.9999977350234985
leukodystrophy I-Disease 1 0.9999982118606567
( O 0 1.3510905773728155e-05
MLD B-Disease 1 0.9999349117279053
) O 0 8.14583422936721e-09
. O 0 1.0868312916301193e-09

A O 0 9.35168653626306e-09
number O 0 5.142959322301799e-11
of O 0 3.545612414779242e-11
ARSA O 0 0.0013354661641642451
gene O 0 2.5766087219381006e-07
mutations O 0 5.413272674559266e-07
responsible O 0 3.962989225669844e-08
for O 0 4.95392793453675e-09
MLD B-Disease 1 0.9999988079071045
have O 0 1.2774003188553706e-08
been O 0 6.11284911578025e-10
identified O 0 2.573075530420965e-09
. O 0 3.2635269486824825e-10

Recently O 0 5.381142273108708e-06
, O 0 1.8315694447212927e-11
the O 0 1.6110594846033277e-12
R496H O 0 1.2300059859526868e-09
mutation O 0 1.3757400774139228e-09
of O 0 4.2729111915384976e-11
ARSA O 0 0.0022498799953609705
was O 0 6.791461260036158e-08
proposed O 0 2.3095339876655352e-11
to O 0 6.598650879180434e-12
be O 0 3.191557781945242e-11
a O 0 1.1318725817721642e-10
cause O 0 2.427335665800001e-09
of O 0 2.449763503165059e-09
MLD B-Disease 1 0.9999984502792358
( O 0 1.1479182049356496e-09
Draghia O 0 4.642589601644431e-07
et O 0 2.949732191837029e-08
al O 0 5.217126286538587e-08
. O 0 3.9281852076689106e-11
, O 0 6.676039061848105e-12
1997 O 0 1.632808888096804e-10
) O 0 1.2095133054834672e-11
. O 0 4.746490700480166e-11

We O 0 1.12944107399926e-08
have O 0 4.59291701893072e-11
investigated O 0 5.661824342695354e-10
the O 0 7.355993418556306e-12
R496H O 0 4.761384619911269e-09
mutation O 0 3.760793454432587e-09
and O 0 2.5203809525531362e-11
found O 0 2.6936427047208333e-11
this O 0 9.697538589205704e-14
mutation O 0 8.923535521621062e-11
at O 0 1.967797452762099e-10
a O 0 2.329957754509948e-11
relatively O 0 1.434736357497357e-11
high O 0 4.311138113166635e-09
frequency O 0 5.474487529966154e-10
in O 0 6.022251707732407e-12
an O 0 1.1477425260197904e-10
African O 0 1.3098534756839086e-10
American O 0 2.7041197059318733e-10
population O 0 2.433098427595537e-12
( O 0 2.435336220879547e-12
f O 0 1.0787489657104743e-07
= O 0 6.177434119791769e-09
0 O 0 1.9059927247599973e-10
. O 0 3.001250723638771e-12
09 O 0 5.5738893500745235e-09
, O 0 2.996762213380855e-11
n O 0 3.335062785936316e-07
= O 0 6.142975195189138e-08
61 O 0 6.876693880997209e-09
subjects O 0 4.187457491866553e-09
) O 0 1.065785168452571e-10
. O 0 1.4040511808754985e-10

The O 0 1.47261660643494e-08
ARSA O 0 0.00031812809174880385
enzyme O 0 1.7008254644679255e-06
activity O 0 3.371142298647101e-08
in O 0 1.180332828004671e-11
subjects O 0 1.6700710814276931e-09
with O 0 1.7442465527484075e-10
and O 0 9.793242605748986e-11
without O 0 8.239672832921485e-12
the O 0 1.8212883458323947e-12
R496H O 0 1.3095643458527206e-09
mutation O 0 5.308366191059122e-09
was O 0 4.11581382309123e-08
determined O 0 2.518173003451807e-09
and O 0 1.9995902156288992e-10
found O 0 7.245024025159807e-10
to O 0 2.7899455315449906e-11
be O 0 4.6563217170891846e-10
normal O 0 4.060471958666767e-10
. O 0 1.8433460313715955e-10

It O 0 6.6974630286154024e-09
is O 0 2.29517099770149e-10
therefore O 0 4.64499836164145e-12
concluded O 0 2.7069770036636243e-11
that O 0 5.116419982999221e-13
the O 0 9.527423338109853e-13
R496H O 0 1.1661110965732746e-09
mutation O 0 3.5358757588532796e-10
of O 0 1.3845202762041708e-11
ARSA O 0 0.00017457678040955216
does O 0 1.4652108415447174e-09
not O 0 5.333079464153734e-12
negatively O 0 6.217689557663775e-11
influence O 0 8.509952183037572e-13
the O 0 3.047529405480337e-13
activity O 0 2.71414418717697e-10
of O 0 9.34735708973955e-12
ARSA O 0 0.0005586942424997687
and O 0 8.544869811721867e-10
is O 0 3.7781597295172276e-11
not O 0 5.351318780461023e-12
a O 0 1.442587715949628e-10
cause O 0 4.466921943446778e-09
of O 0 9.681691182095165e-08
MLD B-Disease 1 0.9999741315841675

Down O 0 2.8993108571739867e-05
- O 0 1.1403504686313681e-05
regulation O 0 9.713689763657385e-08
of O 0 2.1057013077641074e-10
transmembrane O 0 1.607574085937813e-05
carbonic O 0 2.8376816771924496e-05
anhydrases O 0 2.8976799512747675e-05
in O 0 3.0385913785124785e-09
renal B-Disease 0 0.02298629842698574
cell I-Disease 1 0.9438869953155518
carcinoma I-Disease 1 1.0
cell O 0 0.044001489877700806
lines O 0 9.41840255563875e-07
by O 0 2.4113588903418304e-10
wild O 0 1.7891733250507968e-06
- O 0 0.0836264118552208
type O 0 0.013967080041766167
von B-Disease 1 0.9992026686668396
Hippel I-Disease 1 0.6712322235107422
- I-Disease 1 0.5008586049079895
Lindau I-Disease 0 0.15882958471775055
transgenes O 0 0.00036079477285966277
. O 0 7.969899229465227e-08

To O 0 2.8997634848870746e-10
discover O 0 5.524092738795616e-09
genes O 0 1.0798765437414204e-08
involved O 0 1.5368062378229297e-08
in O 0 7.425171588693047e-10
von B-Disease 1 0.9851255416870117
Hippel I-Disease 1 0.9994668364524841
- I-Disease 1 0.9999408721923828
Lindau I-Disease 1 0.9997848868370056
( O 0 1.9507871229507145e-07
VHL B-Disease 0 7.404728967230767e-05
) O 0 3.839839210484364e-11
- O 0 2.2967373070059693e-07
mediated O 0 1.038618052007223e-06
carcinogenesis O 0 1.942506969498936e-05
, O 0 5.254430224255202e-10
we O 0 9.45461042789475e-10
used O 0 1.0373692305165605e-07
renal B-Disease 0 0.06722625344991684
cell I-Disease 1 0.9920698404312134
carcinoma I-Disease 1 1.0
cell O 1 0.9622331261634827
lines O 0 0.0011046971194446087
stably O 0 0.0015833579236641526
transfected O 0 7.321719749597833e-05
with O 0 5.920012480231662e-09
wild O 0 2.7195521852263482e-06
- O 0 0.05618882179260254
type O 0 0.0010776771232485771
VHL O 0 0.0015563804190605879
- O 0 1.664518094912637e-05
expressing O 0 3.168484141724548e-08
transgenes O 0 1.6644803508825134e-06
. O 0 4.059273361889382e-09

Large O 0 8.586895638984515e-09
- O 0 1.627935262149549e-07
scale O 0 6.816625841565838e-08
RNA O 0 1.7681301978100805e-09
differential O 0 4.109473650260043e-09
display O 0 6.588520840011824e-10
technology O 0 1.0786718185329391e-09
applied O 0 4.391947222570636e-11
to O 0 4.892786479790412e-13
these O 0 7.697957397391486e-14
cell O 0 1.8847656768627985e-09
lines O 0 5.556799020922654e-09
identified O 0 4.3838985219757376e-10
several O 0 1.6174144272171342e-12
differentially O 0 1.4317451224599154e-08
expressed O 0 2.479777667929728e-11
genes O 0 5.885397724725294e-11
, O 0 6.615205887412767e-13
including O 0 8.074137062066833e-13
an O 0 2.6975449651800432e-11
alpha O 0 4.495552818895021e-10
carbonic O 0 5.017395565687366e-08
anhydrase O 0 6.779024630532149e-08
gene O 0 2.4224471317779717e-09
, O 0 1.7540340707666857e-11
termed O 0 2.350260608352528e-08
CA12 O 0 5.416065687313676e-05
. O 0 4.374177908772481e-09

The O 0 1.3084924810335963e-10
deduced O 0 1.0740894840211013e-09
protein O 0 3.3979549729501457e-10
sequence O 0 6.2950394896788e-11
was O 0 1.9778565452099883e-09
classified O 0 4.172373557764786e-09
as O 0 1.7043351452361577e-10
a O 0 7.850128186381866e-11
one O 0 1.0249995519018285e-08
- O 0 0.00621369993314147
pass O 0 4.9368660256732255e-05
transmembrane O 0 3.7856530980207026e-05
CA O 0 8.097156751318835e-06
possessing O 0 1.20490582844468e-07
an O 0 1.279908540263719e-10
apparently O 0 4.03149602590247e-09
intact O 0 1.9954791985465903e-10
catalytic O 0 2.9550915048304205e-09
domain O 0 5.2907171976812606e-09
in O 0 1.8012761421326573e-11
the O 0 2.6766292307578432e-11
extracellular O 0 1.8493864217816736e-07
CA O 0 9.82433084573131e-06
module O 0 1.378204785851267e-07
. O 0 6.574912836398994e-10

Reintroduced O 0 2.4051985292317113e-06
wild O 0 3.5569000829127617e-06
- O 0 0.007382460404187441
type O 0 0.0001548017462482676
VHL B-Disease 0 0.00041648655314929783
strongly O 0 1.2702177087930977e-09
inhibited O 0 1.7631863746814247e-09
the O 0 7.793904410746677e-13
overexpression O 0 9.070805218058808e-11
of O 0 2.60226925728399e-13
the O 0 4.1870838393687215e-12
CA12 O 0 4.728696865186066e-07
gene O 0 5.599898322827812e-10
in O 0 1.6263794781409824e-12
the O 0 2.0002999256973908e-10
parental O 0 0.00020213195239193738
renal B-Disease 0 0.19588644802570343
cell I-Disease 1 0.9058002829551697
carcinoma I-Disease 1 0.9999998807907104
cell O 0 0.1390468031167984
lines O 0 0.00019657738448586315
. O 0 2.432003576302577e-08

Similar O 0 4.053950064530909e-09
results O 0 1.180966768821179e-09
were O 0 4.22125390198147e-11
obtained O 0 2.2397583787636677e-11
with O 0 8.903337789245569e-11
CA9 O 0 1.230838279298041e-05
, O 0 6.118511947095229e-12
encoding O 0 1.327403464923549e-10
another O 0 1.0947757544954584e-07
transmembrane O 0 0.00024295563343912363
CA O 0 0.0010257599642500281
with O 0 6.337883551310597e-10
an O 0 1.3161795264782228e-10
intact O 0 1.3630054418456439e-08
catalytic O 0 1.5799734853771952e-07
domain O 0 6.898675053435e-08
. O 0 1.979675756658139e-09

Although O 0 1.0482865242522621e-08
both O 0 7.179239147614425e-11
domains O 0 4.766400163447315e-09
of O 0 3.865315012507864e-11
the O 0 1.8673315671513535e-10
VHL B-Disease 0 4.517838988249423e-06
protein O 0 5.01025609889183e-10
contribute O 0 9.728393438046545e-12
to O 0 1.3285240962890299e-12
regulation O 0 9.686184493373773e-11
of O 0 1.2191624446100668e-11
CA12 O 0 3.187469701515511e-05
expression O 0 5.664870794674925e-10
, O 0 1.952313229700367e-13
the O 0 3.2514499447890144e-13
elongin O 0 2.873805371450544e-08
binding O 0 1.9656178074090036e-10
domain O 0 1.4070813403321836e-09
alone O 0 7.55278595221398e-09
could O 0 2.2443791269921576e-09
effectively O 0 1.5950899268091234e-08
regulate O 0 2.85399380572926e-07
CA9 O 0 3.732142431545071e-05
expression O 0 2.3651995917362e-08
. O 0 5.61044988245385e-10

We O 0 6.46016928840254e-08
mapped O 0 5.9770786720036995e-06
CA12 O 0 0.001121697248890996
and O 0 1.5085100946166108e-09
CA9 O 0 4.860494755121181e-06
loci O 0 1.555758188942491e-08
to O 0 2.4333374204488223e-10
chromosome O 0 4.459452975424938e-05
bands O 0 7.239809463044367e-08
15q22 O 0 2.7269123847872834e-07
and O 0 6.459978107997699e-10
17q21 O 0 1.964642279972395e-07
. O 0 7.954643610474932e-10

2 O 0 4.463670961740718e-07
respectively O 0 8.634000892016047e-08
, O 0 7.655244493864899e-11
regions O 0 9.320372945653688e-11
prone O 0 4.6143000531628786e-07
to O 0 1.2663411985691653e-11
amplification O 0 6.758742188139877e-08
in O 0 2.7423974549578567e-12
some O 0 4.715915158381989e-12
human O 0 1.69389515747298e-08
cancers B-Disease 0 5.248969318927266e-05
. O 0 1.5136027986528688e-09

Additional O 0 1.1131013888387997e-09
experiments O 0 2.6031279354299386e-09
are O 0 1.1096790153430902e-11
needed O 0 3.5229826000904296e-11
to O 0 4.4761918238829523e-13
define O 0 9.124388744563561e-11
the O 0 1.4632517419954638e-11
role O 0 2.5968498462702883e-09
of O 0 1.9034487527824773e-11
CA O 0 2.882114495150745e-05
IX O 0 8.909021744329948e-06
and O 0 5.930605340154216e-08
CA O 0 2.5765300506463973e-06
XII O 0 1.106666971395498e-07
enzymes O 0 5.62129010006629e-10
in O 0 1.373241527002217e-13
the O 0 2.5724669790172516e-13
regulation O 0 2.4690796629478484e-10
of O 0 6.391265988670014e-12
pH O 0 9.648210230750465e-09
in O 0 3.3225806546181846e-13
the O 0 6.657761906884996e-13
extracellular O 0 8.137165385946332e-10
microenvironment O 0 5.037299466437162e-09
and O 0 4.004315108663281e-12
its O 0 3.446328509029706e-13
potential O 0 2.369007767732967e-10
impact O 0 1.2076473154820633e-09
on O 0 2.5121487112755858e-08
cancer B-Disease 0 2.60930391959846e-07
cell O 0 4.4267088128435716e-07
growth O 0 2.393706836301135e-06
. O 0 1.4423958694109729e-09

A O 0 8.626902747721488e-09
gene O 0 2.5578541951176703e-08
encoding O 0 6.607325797602925e-09
a O 0 3.3637670426855948e-09
transmembrane O 0 3.9315872868428414e-07
protein O 0 7.51324513714735e-09
is O 0 8.329361506076438e-12
mutated O 0 1.811518579586391e-08
in O 0 7.200842144783337e-10
patients O 0 5.252261416899273e-07
with O 0 9.670427243690938e-05
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9381904006004333
optic B-Disease 1 0.9999997615814209
atrophy I-Disease 1 0.999993085861206
( O 0 0.03818695992231369
Wolfram B-Disease 1 0.9999991655349731
syndrome I-Disease 1 1.0
) O 0 8.950101992866166e-09
. O 0 1.081050804430106e-09

Wolfram B-Disease 1 0.9999551773071289
syndrome I-Disease 1 0.9999998807907104
( O 0 3.68434630217962e-05
WFS B-Disease 0 0.05000845342874527
; O 0 2.4247549745837205e-08
OMIM O 0 0.0008645987254567444
222300 O 0 8.910364158509765e-06
) O 0 1.088905701718268e-10
is O 0 1.198415672254427e-10
an O 0 1.1024214430221946e-08
autosomal B-Disease 1 0.9999812841415405
recessive I-Disease 1 0.9999983310699463
neurodegenerative I-Disease 1 0.9999958276748657
disorder I-Disease 1 0.9998775720596313
defined O 0 6.870534718927956e-08
by O 0 9.310410220564336e-10
young O 0 8.142185379256262e-07
- O 0 0.0025810429360717535
onset O 0 0.018557626754045486
non O 0 0.0007668266771361232
- O 1 0.8178112506866455
immune O 0 0.2095363438129425
insulin B-Disease 0 0.01632315292954445
- I-Disease 1 0.8040568232536316
dependent I-Disease 1 0.9681261777877808
diabetes I-Disease 1 0.9999997615814209
mellitus I-Disease 1 0.9999997615814209
and O 0 5.287696239975048e-06
progressive O 0 3.0069239073782228e-05
optic B-Disease 1 0.9999847412109375
atrophy I-Disease 1 0.9967300891876221
. O 0 2.5134676207017037e-07

Linkage O 0 6.12850317338598e-06
to O 0 1.1478832329103739e-09
markers O 0 2.1045104858785635e-06
on O 0 9.987648752485256e-08
chromosome O 0 0.012079757638275623
4p O 0 0.05696563795208931
was O 0 7.638743682036875e-07
confirmed O 0 1.2068482879712406e-09
in O 0 5.726381283217841e-13
five O 0 5.939312930358653e-11
families O 0 2.1307786091107062e-10
. O 0 2.1956511608856033e-10

On O 0 1.3651328956143516e-09
the O 0 2.758271258965217e-12
basis O 0 8.77952224809242e-12
of O 0 2.4152045381004017e-12
meiotic O 0 1.8418335457681678e-05
recombinants O 0 0.024659207090735435
and O 0 7.008448505985143e-07
disease O 0 0.0006924505578354001
- O 0 6.351776391966268e-05
associated O 0 1.872958499404831e-08
haplotypes O 0 5.249507140092646e-08
, O 0 2.309111062082092e-11
the O 0 1.066524819848258e-11
WFS B-Disease 0 1.2909337101518759e-06
gene O 0 3.502684808864842e-09
was O 0 1.0149954210447731e-09
localized O 0 3.7391481577664365e-10
to O 0 2.356307683692993e-11
a O 0 1.0180899456813108e-09
BAC O 0 2.907318616962584e-07
/ O 0 2.1376889591806503e-08
P1 O 0 8.7653148739264e-07
contig O 0 2.6411877129817185e-09
of O 0 4.176296285250507e-14
less O 0 1.3381620301861769e-13
than O 0 5.391702709300894e-13
250 O 0 3.450851063235838e-11
kb O 0 5.645747478411067e-06
. O 0 1.408273497816026e-09

Mutations O 0 6.528975791297853e-05
in O 0 1.5832489486111712e-10
a O 0 7.15593001521242e-11
novel O 0 1.0427940733137575e-09
gene O 0 8.316281707720918e-08
( O 0 9.335780759567314e-11
WFS1 O 0 5.014974817640905e-07
) O 0 6.153643133249842e-13
encoding O 0 2.0365167885394442e-11
a O 0 4.2129955080127957e-10
putative O 0 5.520514037016255e-07
transmembrane O 0 1.214628809975693e-06
protein O 0 2.0801511624313207e-08
were O 0 1.0320629073579113e-10
found O 0 5.789889054308439e-11
in O 0 4.2455459720730504e-13
all O 0 8.244420771075234e-12
affected O 0 1.4040620055499886e-10
individuals O 0 3.2233252525437628e-12
in O 0 2.8302278055891694e-12
six O 0 4.023982924650227e-09
WFS B-Disease 0 4.742443707073107e-06
families O 0 3.667966486098351e-10
, O 0 3.923540312089635e-12
and O 0 4.560250180946079e-12
these O 0 8.479750647320816e-13
mutations O 0 2.2865000559590953e-08
were O 0 6.113548556285764e-10
associated O 0 6.032877669648329e-11
with O 0 2.7742505515071514e-10
the O 0 7.192379314346908e-08
disease O 0 0.0013851322000846267
phenotype O 0 3.636498320247483e-07
. O 0 2.920223618474438e-09

WFS1 O 0 0.00041620965930633247
appears O 0 2.9310740501387045e-07
to O 0 5.0624334585469555e-11
function O 0 1.2501044643897785e-10
in O 0 5.624480482052663e-12
survival O 0 4.255851226986351e-09
of O 0 2.3357109649180252e-11
islet O 0 1.0475097042217385e-05
beta O 0 3.8414253999974335e-09
- O 0 9.494838195678312e-06
cells O 0 2.9021567371501078e-08
and O 0 5.906247019238364e-11
neurons O 0 2.668398280114559e-10
. O 0 3.5043298558107283e-12
. O 0 1.4732838560238548e-10

Stable O 0 5.14608757384849e-07
interaction O 0 2.53391724269747e-10
between O 0 3.8745048835941986e-11
the O 0 5.5078927529983446e-12
products O 0 1.4706938777919731e-08
of O 0 1.1113389939212959e-12
the O 0 1.7992957124235431e-10
BRCA1 O 0 0.0006051167729310691
and O 0 5.780474765515464e-08
BRCA2 O 0 7.526722765760496e-05
tumor B-Disease 0 2.941014258794894e-07
suppressor O 0 3.401511960987591e-08
genes O 0 3.144588234249568e-08
in O 0 1.3420638732275503e-11
mitotic O 0 2.771186473182752e-06
and O 0 2.3703570661837148e-08
meiotic O 0 0.00037464324850589037
cells O 0 3.645613560365746e-06
. O 0 2.0707131564989822e-09

BRCA1 O 1 0.8751997947692871
and O 0 1.3413473709533719e-07
BRCA2 O 0 4.948149944539182e-05
account O 0 9.94767712647615e-10
for O 0 1.3596694083128913e-11
most O 0 1.7867598676654661e-12
cases O 0 5.3702577107461735e-11
of O 0 1.8880631433293438e-11
familial O 0 4.092278686584905e-06
, O 0 6.017928932955385e-10
early O 0 2.3465953624679514e-09
onset O 0 6.248610588954762e-05
breast B-Disease 0 0.12524598836898804
and I-Disease 0 8.05793115432607e-06
/ I-Disease 1 0.8230752348899841
or I-Disease 1 0.9998583793640137
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
and O 0 2.2132475019365216e-10
encode O 0 8.445442956084293e-11
products O 0 9.910037590543652e-08
that O 0 4.543476272295122e-12
each O 0 4.72509878446381e-12
interact O 0 2.8124186313149835e-10
with O 0 4.5316242425208486e-10
hRAD51 O 0 4.18323952544597e-06
. O 0 7.52030993034225e-10

Results O 0 4.807890086055977e-09
presented O 0 1.3277080546103548e-09
here O 0 4.8451131995363994e-11
show O 0 2.812495347725985e-09
that O 0 1.226762719186425e-10
BRCA1 O 0 2.426524952170439e-05
and O 0 1.0020693608225884e-08
BRCA2 O 0 7.44487215342815e-06
coexist O 0 2.252825126447533e-08
in O 0 2.5160277507263462e-12
a O 0 1.9356006381032742e-11
biochemical O 0 5.2466241129423e-08
complex O 0 1.5691798971317894e-09
and O 0 9.309131243639968e-10
colocalize O 0 2.6336845166952116e-06
in O 0 5.869704028382827e-11
subnuclear O 0 5.035938102082582e-07
foci O 0 3.4236556700761867e-08
in O 0 4.1351783108822815e-12
somatic O 0 8.779937665792659e-09
cells O 0 4.080185078692011e-09
and O 0 3.690286964896927e-11
on O 0 5.412728251719123e-11
the O 0 4.029012908891849e-13
axial O 0 1.108334257704513e-10
elements O 0 6.9101582095276726e-12
of O 0 1.3165704637607689e-11
developing O 0 4.5222169120506805e-08
synaptonemal O 0 3.345317963976413e-06
complexes O 0 3.616514732129872e-08
. O 0 1.6987603546070318e-09

Like O 0 4.625725523510482e-06
BRCA1 O 0 0.006041634827852249
and O 0 3.3036311464229584e-08
RAD51 O 0 0.0014551474014297128
, O 0 3.7266598140739404e-10
BRCA2 O 0 7.50507012980961e-07
relocates O 0 2.756718631147237e-09
to O 0 1.672539884367552e-11
PCNA O 0 1.012611960504728e-06
+ O 0 2.3568648768734768e-11
replication O 0 5.503526800954006e-11
sites O 0 1.2618910083528334e-10
following O 0 1.3262588943740994e-11
exposure O 0 3.775022960894603e-09
of O 0 1.2198874722868513e-12
S O 0 4.809970164387778e-07
phase O 0 2.5590957131171876e-10
cells O 0 2.2406569655242237e-10
to O 0 7.438560184480636e-12
hydroxyurea O 0 1.5794024932347384e-07
or O 0 1.0395193594803231e-09
UV O 0 4.22610639816412e-07
irradiation O 0 4.728850200308443e-08
. O 0 9.555026769803021e-10

Thus O 0 1.6029410687679047e-07
, O 0 1.2313815522801974e-09
BRCA1 O 0 6.824197771493345e-05
and O 0 9.026080327600994e-09
BRCA2 O 0 1.2754784620483406e-05
participate O 0 3.041315255192245e-10
, O 0 1.1855718663744685e-11
together O 0 5.3061131877196743e-11
, O 0 3.9083189809496766e-12
in O 0 3.7654512212263735e-13
a O 0 1.5724088697766092e-10
pathway O 0 6.502460081492245e-08
( O 0 4.411191412145854e-10
s O 0 3.1530321393802296e-06
) O 0 8.411326322954604e-12
associated O 0 3.763557607922019e-12
with O 0 8.629253995390274e-13
the O 0 2.030627836019372e-12
activation O 0 4.185746749207908e-10
of O 0 7.218340074971463e-12
double O 0 8.497401609020017e-07
- O 0 0.00014424335677176714
strand O 0 0.00020888166909571737
break O 0 0.00027037059771828353
repair O 0 0.003689754055812955
and O 0 1.8309076477152075e-09
/ O 0 6.565792798340908e-09
or O 0 2.5906138345632712e-11
homologous O 0 9.164055070343124e-10
recombination O 0 1.6481392250966564e-08
. O 0 4.963395028312334e-09

Dysfunction O 0 0.022688500583171844
of O 0 6.952099451673632e-10
this O 0 2.4422684360980718e-11
pathway O 0 8.022945507946133e-08
may O 0 1.89761539814981e-08
be O 0 2.3075439128938946e-11
a O 0 1.2758326513317986e-11
general O 0 9.588334466681392e-12
phenomenon O 0 1.4658035896175647e-09
in O 0 1.8493308013428633e-12
the O 0 2.540544380771892e-12
majority O 0 4.826976492122714e-12
of O 0 3.256746001351063e-12
cases O 0 5.350051068830908e-09
of O 0 1.0447495313314903e-08
hereditary B-Disease 1 0.9991588592529297
breast I-Disease 1 0.9998143315315247
and I-Disease 0 0.001730379299260676
/ I-Disease 1 0.9793829321861267
or I-Disease 1 0.9994263648986816
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999918937683105
. O 0 1.2025354045874792e-09
. O 0 1.4566201578247728e-09

A O 0 4.1360621594321856e-08
novel O 0 1.5758931937170928e-08
Arg362Ser O 0 4.178949438937707e-06
mutation O 0 1.1415568934580733e-07
in O 0 3.478599353012868e-11
the O 0 4.860125843442198e-11
sterol O 0 2.188292273785919e-05
27 O 0 2.223994499672699e-07
- O 0 4.758931027026847e-06
hydroxylase O 0 4.668583278544247e-05
gene O 0 2.482096022049518e-07
( O 0 6.320038242746406e-11
CYP27 O 0 5.477228910422127e-07
) O 0 1.8731943079997038e-12
: O 0 7.004379037498995e-14
its O 0 1.4773729115069578e-13
effects O 0 2.2010895883717296e-10
on O 0 6.651423162251646e-11
pre O 0 1.1712965708454703e-08
- O 0 6.8555299215233845e-09
mRNA O 0 6.7903477979358584e-12
splicing O 0 2.8000224361335313e-10
and O 0 3.33453230305647e-11
enzyme O 0 1.6583741047071499e-09
activity O 0 1.4562978600807241e-09
. O 0 1.4225513822463398e-10

A O 0 3.312509022634913e-08
novel O 0 9.263138700532636e-09
C O 0 5.232723196968436e-07
to O 0 5.480917802946905e-12
A O 0 8.310069993244795e-11
mutation O 0 5.066067565451249e-10
in O 0 2.0306354254345793e-12
the O 0 2.6415076723185216e-11
sterol O 0 2.323130138393026e-05
27 O 0 7.423351888746765e-08
- O 0 6.860921644147311e-07
hydroxylase O 0 1.2844514458265621e-05
gene O 0 8.330648881837988e-08
( O 0 7.669918172803492e-11
CYP27 O 0 5.233681577010429e-07
) O 0 1.2095865758662838e-12
was O 0 1.872209332010044e-11
identified O 0 2.6775216158819726e-12
by O 0 3.46969496320057e-14
sequencing O 0 3.010398319513996e-10
amplified O 0 1.795066424392644e-07
CYP27 O 0 5.68159407521307e-07
gene O 0 5.296408867039304e-10
products O 0 7.152935133092342e-09
from O 0 9.442796371217366e-12
a O 0 6.615897829576056e-10
patient O 0 3.717739787134633e-07
with O 0 2.3558264672374207e-07
cerebrotendinous B-Disease 1 0.9999988079071045
xanthomatosis I-Disease 1 0.9999960660934448
( O 0 5.451826545765925e-09
CTX B-Disease 0 0.0001227051398018375
) O 0 1.690588224967371e-10
. O 0 2.047610414557255e-10

The O 0 1.4351401178558376e-09
mutation O 0 1.8782340305278922e-07
changed O 0 3.061401354642612e-09
the O 0 2.2418610370888992e-11
adrenodoxin O 0 1.4698137817958923e-07
cofactor O 0 2.1877097911016108e-09
binding O 0 1.0000870132031991e-09
residue O 0 1.972105323488904e-08
362Arg O 0 1.7213119818393352e-08
to O 0 4.455548777149154e-11
362Ser O 0 1.5566045874493284e-07
( O 0 4.449960885888338e-11
CGT O 0 1.0143514828087064e-06
362Arg O 0 1.8125001943758434e-08
to O 0 2.8301212068315706e-11
AGT O 0 1.9507458546286216e-06
362Ser O 0 1.7016935771607677e-07
) O 0 7.4954140116823e-12
, O 0 1.4340536137052995e-13
and O 0 5.390181031551811e-13
was O 0 5.38829758589543e-10
responsible O 0 4.3772829805277524e-09
for O 0 8.27867463470966e-09
deficiency O 0 3.5528591979527846e-06
in O 0 3.6869135132053255e-13
the O 0 1.843337982254667e-11
sterol O 0 4.677825018006843e-06
27 O 0 6.418202502800341e-08
- O 0 3.7631923532899236e-07
hydroxylase O 0 1.4442239262280054e-06
activity O 0 6.04278804772207e-09
, O 0 1.104728288015e-12
as O 0 9.65454279022726e-13
confirmed O 0 1.8531159679674447e-12
by O 0 2.3447774415998567e-14
expression O 0 7.095807773825624e-13
of O 0 3.608799795996355e-14
mutant O 0 2.2164031721061406e-10
cDNA O 0 2.6466466171437553e-11
into O 0 1.802060445310616e-10
COS O 0 0.006191813386976719
- O 0 3.339099521326716e-06
1 O 0 5.023004234772088e-09
cells O 0 2.1192365640132493e-09
. O 0 3.0977700959944343e-10

Quantitative O 0 1.214577309838205e-07
analysis O 0 5.8340150488334075e-09
showed O 0 1.1894155704794684e-07
that O 0 3.5622589947270633e-12
the O 0 1.0304980610151282e-12
expression O 0 2.191198611445344e-11
of O 0 9.326374308255003e-13
CYP27 O 0 1.755510368184332e-07
gene O 0 1.8080374697415635e-10
mRNA O 0 2.033737414586234e-11
in O 0 1.2037865279243554e-12
the O 0 1.16264532723509e-11
patient O 0 2.717109559569053e-08
represented O 0 1.097723023590902e-09
52 O 0 8.067445378401317e-08
. O 0 9.963400104950892e-10

5 O 0 1.5991940927051473e-07
% O 0 1.6203401120851169e-10
of O 0 2.574603290977917e-12
the O 0 2.0121380256421517e-11
normal O 0 2.9918649779858697e-09
level O 0 1.8611713059613066e-08
. O 0 8.919166516463406e-10

As O 0 4.302159517521886e-09
the O 0 9.158698972833168e-12
mutation O 0 1.1967875579443898e-09
occurred O 0 7.053098660669832e-10
at O 0 1.4496985556444741e-10
the O 0 3.610784631360997e-13
penultimate O 0 8.126711525946462e-10
nucleotide O 0 3.041471796638717e-10
of O 0 1.6915799273473087e-12
exon O 0 9.205740525430883e-08
6 O 0 6.445142020083949e-08
( O 0 7.429484978616063e-12
- O 0 2.291337253268466e-08
2 O 0 8.839820542227983e-10
position O 0 1.268819910249519e-10
of O 0 5.643939634224215e-13
exon O 0 1.3520300967684307e-07
6 O 0 4.44106404984268e-08
- O 0 4.55456557801881e-07
intron O 0 9.214545571012422e-06
6 O 0 1.437776564472415e-08
splice O 0 8.029879694504416e-08
site O 0 1.373993585573885e-09
) O 0 3.8568421460022373e-13
of O 0 1.303580063582695e-14
the O 0 4.958568820302711e-13
gene O 0 1.346107530997287e-10
, O 0 2.2257295832772694e-12
we O 0 5.432169471186743e-12
hypothesized O 0 2.3724159789462185e-11
that O 0 6.2094851829841424e-12
the O 0 1.5980482215294245e-10
mutation O 0 6.70131339575164e-06
may O 0 5.148689297129749e-07
partially O 0 1.3294703649080475e-07
affect O 0 5.171781405910458e-11
the O 0 1.2107493013811116e-13
normal O 0 7.111497805564748e-13
splicing O 0 7.755755759841776e-11
efficiency O 0 3.642957047134132e-10
in O 0 5.464880934932803e-13
exon O 0 1.4739232057081608e-08
6 O 0 9.397066236260798e-09
and O 0 1.0065387759383704e-11
cause O 0 1.4492271315294514e-12
alternative O 0 4.0472670787689013e-13
splicing O 0 8.562849318494159e-10
elsewhere O 0 2.044466151929214e-09
, O 0 1.0198376431541645e-12
which O 0 7.864026812555436e-13
resulted O 0 3.8362230059263425e-11
in O 0 8.631876463605082e-12
decreased O 0 3.749135402131287e-08
transcript O 0 8.393993833344382e-10
in O 0 6.6513691256153695e-12
the O 0 9.005642065407216e-11
patient O 0 9.082729235387887e-08
. O 0 4.4698170165169415e-10

Transfection O 0 4.848809112445451e-06
of O 0 1.6910115530066605e-09
constructed O 0 4.5550351046586e-07
minigenes O 0 1.935216823767405e-05
, O 0 8.824670855167582e-11
with O 0 9.883855019154897e-12
or O 0 3.3452365877373325e-10
without O 0 1.1765386408180145e-11
the O 0 1.0175196189093905e-12
mutation O 0 1.8563274251093276e-09
, O 0 1.540739584526829e-11
into O 0 1.4658865787886555e-10
COS O 0 0.055333346128463745
- O 0 1.6924374222071492e-06
1 O 0 7.263065704421479e-10
cells O 0 3.8870587304451476e-11
confirmed O 0 6.027816440434819e-11
that O 0 6.533873377241595e-13
the O 0 1.973117415982051e-12
mutant O 0 1.7678587482805597e-07
minigene O 0 1.1170279776706593e-06
was O 0 1.557907935989533e-08
responsible O 0 5.3817422740465304e-11
for O 0 3.310296372953381e-13
a O 0 4.203183374268393e-12
mRNA O 0 1.2790732882572708e-11
species O 0 2.5318080965064382e-12
alternatively O 0 1.2917264480272195e-11
spliced O 0 2.6376332584732154e-07
at O 0 6.692677345654374e-08
an O 0 5.431597394078835e-09
activated O 0 8.466714461974334e-06
cryptic O 0 9.89764181724695e-09
5 O 0 1.0949991781361579e-11
splice O 0 1.6422962545448172e-08
site O 0 1.1618971340610074e-09
88 O 0 5.639675393354082e-10
bp O 0 3.3155874490375936e-08
upstream O 0 9.517266974512495e-10
from O 0 5.813944378013636e-12
the O 0 1.9129543869095267e-12
3 O 0 3.0611707613203976e-11
end O 0 3.1112338400030026e-11
of O 0 7.287366239963622e-13
exon O 0 1.3202242143961485e-07
6 O 0 3.811613069615305e-08
. O 0 5.184940254920889e-10

Our O 0 9.890390728628518e-10
data O 0 7.891024500494837e-10
suggest O 0 1.9721335675626506e-10
that O 0 5.028220461528177e-12
the O 0 1.2913667531144757e-11
C O 0 1.2980837027498637e-07
to O 0 1.8625071970812535e-11
A O 0 5.481885501090744e-10
mutation O 0 2.0974570968945727e-09
at O 0 3.353554101082068e-10
the O 0 4.796650815257208e-13
penultimate O 0 4.829228128500063e-10
nucleotide O 0 9.772922054951394e-11
of O 0 3.023784564751275e-13
exon O 0 3.997407738154379e-09
6 O 0 5.99912286514126e-10
of O 0 6.694231215360891e-13
the O 0 1.6641995073674032e-11
CYP27 O 0 9.250567245544516e-07
gene O 0 1.1136791489008147e-09
not O 0 3.778058768610926e-11
only O 0 3.2643224928685655e-11
causes O 0 1.1390112186759893e-09
the O 0 2.5049814666999737e-08
deficiency B-Disease 0 4.967875429429114e-05
in I-Disease 0 1.8274509509808023e-12
the I-Disease 0 3.318973568200434e-11
sterol I-Disease 0 9.812861208047252e-06
27 I-Disease 0 1.003418148570745e-07
- I-Disease 0 6.596725370400236e-07
hydroxylase I-Disease 0 8.556123248126823e-06
activity I-Disease 0 3.956063920895758e-08
, O 0 1.1739182542713777e-11
but O 0 1.9937168235784064e-11
also O 0 3.4277422567008387e-10
partially O 0 2.2981300418223327e-08
leads O 0 7.985975214452878e-10
to O 0 6.440483996811297e-12
alternative O 0 2.6276134046376853e-11
pre O 0 1.227836055051057e-08
- O 0 1.426608720045408e-09
mRNA O 0 1.0025969854679517e-12
splicing O 0 1.710880916105939e-11
of O 0 3.545541410378966e-13
the O 0 2.1619468368316852e-12
gene O 0 1.373417268801802e-09
. O 0 1.781147451751508e-10

To O 0 2.8264772744535094e-09
our O 0 2.097132051348538e-10
knowledge O 0 1.970504315274013e-11
, O 0 7.886017143118873e-13
this O 0 2.238319969096684e-14
is O 0 5.193672098294244e-13
the O 0 1.1020024004654641e-13
first O 0 1.309598540721879e-10
report O 0 3.46547568419453e-10
regarding O 0 2.4127012887564803e-11
effects O 0 4.1769102065991603e-10
on O 0 8.57660747977107e-11
pre O 0 7.815012637024665e-09
- O 0 2.2856354586764382e-09
mRNA O 0 1.076421720855314e-12
splicing O 0 1.1824643694757775e-11
of O 0 2.2371515718492413e-13
a O 0 7.70435538283154e-12
mutation O 0 4.4138509514013435e-10
at O 0 1.5302475953049566e-09
the O 0 1.7899509652252732e-10
- O 0 7.94672541815089e-06
2 O 0 3.956539273985982e-08
position O 0 3.5657177210879354e-09
of O 0 7.092262974822683e-13
a O 0 3.66465711942876e-11
5 O 0 6.637076999105318e-11
splice O 0 3.763081224406051e-07
site O 0 7.0311841682269e-08
. O 0 2.3580815078361184e-09

ATM O 0 0.0007839350728318095
germline O 0 0.0009669509599916637
mutations O 0 0.0015317591605708003
in O 0 8.149490327014064e-08
classical O 0 0.00037212471943348646
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999992847442627
telangiectasia I-Disease 1 1.0
patients O 0 0.1813535988330841
in O 0 2.2259100118660058e-10
the O 0 1.606026422962259e-10
Dutch O 0 3.58814281753439e-06
population O 0 2.653569142196943e-09
. O 0 8.755283720240925e-10

Germline O 0 0.0003047349746339023
mutations O 0 6.672384188277647e-05
in O 0 8.723674560506822e-11
the O 0 5.276389134639681e-12
ATM O 0 1.5109667401702609e-05
gene O 0 1.1060081739344696e-08
are O 0 4.751615333836723e-12
responsible O 0 5.133837799320418e-10
for O 0 2.402536614098949e-09
the O 0 0.00480965431779623
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
telangiectasia I-Disease 1 1.0
( O 0 0.010301204398274422
A B-Disease 1 0.999998927116394
- I-Disease 1 0.9999988079071045
T I-Disease 1 0.9999997615814209
) O 0 2.793762376995801e-08
. O 0 1.205219701816418e-09

In O 0 3.778776402896256e-09
our O 0 3.0112712323671076e-10
study O 0 1.0721010017256116e-11
, O 0 2.1792771580375625e-12
we O 0 2.9976351262339662e-12
have O 0 4.91823649948625e-13
determined O 0 1.2919130825891911e-12
the O 0 4.827213390297402e-13
ATM O 0 4.016258571937215e-06
mutation O 0 6.460598278579255e-09
spectrum O 0 6.423417353573768e-09
in O 0 1.2671802496200257e-10
19 O 0 1.881174327422741e-09
classical O 0 2.983783886634228e-09
A B-Disease 1 0.9999978542327881
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
patients O 0 6.274740940170886e-07
, O 0 1.7163832475523139e-13
including O 0 7.361053091939698e-14
some O 0 7.243157625329982e-14
immigrant O 0 7.84977194356884e-10
populations O 0 7.34060798257552e-11
, O 0 1.8360946443807258e-12
as O 0 1.747229097515124e-11
well O 0 2.5816265791789306e-11
as O 0 2.679920452219875e-10
12 O 0 8.083451963347699e-11
of O 0 1.2183992963848977e-12
Dutch O 0 1.0193654986778711e-07
ethnic O 0 6.010951458801372e-11
origin O 0 3.540871817975244e-09
. O 0 2.041714797229588e-09

Both O 0 1.1411291911400667e-09
the O 0 2.6664125768460778e-11
protein O 0 6.389760942582257e-10
truncation O 0 1.2850557595811551e-07
test O 0 2.9849179554730654e-06
( O 0 3.4869298420892036e-11
PTT O 0 1.9407167428653338e-07
) O 0 5.806142892861299e-12
and O 0 4.750308219697574e-13
the O 0 8.80041956734072e-14
restriction O 0 1.4229385898734126e-11
endonuclease O 0 5.5102155727126956e-08
fingerprinting O 0 1.633203396522731e-06
( O 0 6.127882229423065e-11
REF O 0 3.870567013564141e-07
) O 0 6.712818777405982e-14
method O 0 9.5588034015881e-13
were O 0 5.7627284021088965e-12
used O 0 4.2271759009837595e-11
and O 0 5.614726565628114e-12
compared O 0 6.94154499505939e-12
for O 0 4.2289356559773936e-14
their O 0 1.776139829559164e-14
detection O 0 6.76463572657493e-12
efficiency O 0 2.7421792267445788e-11
, O 0 6.674847984446466e-14
identifying O 0 1.013250247594577e-10
76 O 0 7.633935261708302e-09
% O 0 1.4256463847991951e-12
and O 0 1.1407667345475492e-11
60 O 0 2.8581560729268318e-11
% O 0 1.3957690797421207e-13
of O 0 1.1068178844145585e-13
the O 0 9.901068853679362e-11
mutations O 0 7.914470501191317e-08
, O 0 4.730279501430346e-10
respectively O 0 2.0911066656026378e-08
. O 0 8.29654900336152e-10

Most O 0 2.1388228077512395e-08
patients O 0 5.8249781886843266e-08
were O 0 1.031565041720306e-10
found O 0 1.915157754606156e-10
to O 0 6.482435681992582e-12
be O 0 7.897012904711787e-11
compound O 0 2.3111963731725638e-10
heterozygote O 0 1.4523853053560742e-07
. O 0 8.701909193220558e-10

Seventeen O 0 1.2198415788589045e-07
mutations O 0 7.335156169574475e-06
were O 0 4.741880665903864e-09
distinct O 0 3.239740767324584e-11
, O 0 9.102048108278193e-12
of O 0 1.6630879616161276e-12
which O 0 3.670185266813064e-10
10 O 0 1.175573083322945e-09
were O 0 1.1637241170703305e-10
not O 0 2.508778775001108e-11
reported O 0 3.976351248269339e-09
previously O 0 4.8900467675139225e-08
. O 0 9.125716293745256e-10

Mutations O 0 0.0002792263694573194
are O 0 3.618994826037891e-10
small O 0 1.6071020902952426e-10
deletions O 0 1.5806517694727518e-07
or O 0 1.0453639021079653e-07
point O 0 6.250611477298662e-07
mutations O 0 7.644145625818055e-06
frequently O 0 4.595219138536777e-08
affecting O 0 2.2087668583026243e-08
splice O 0 1.0323461538064294e-05
sites O 0 1.0433096804263187e-06
. O 0 6.5721330599899375e-09

Moreover O 0 1.7656110173902562e-07
, O 0 1.4099579837001386e-10
a O 0 2.112145458532666e-10
16 O 0 3.087649469435405e-09
. O 0 2.906591078932763e-10

7 O 0 5.087298404760077e-07
- O 0 1.5511793662881246e-06
kb O 0 1.1339337106619496e-05
genomic O 0 1.9670563844442768e-08
deletion O 0 3.681147120460082e-07
of O 0 1.1994148729765897e-10
the O 0 1.1112850917260886e-10
3 O 0 5.557453386373368e-10
end O 0 4.966979605391941e-11
of O 0 1.28733232841044e-13
the O 0 6.748330193262486e-13
gene O 0 1.8584626892970135e-10
, O 0 1.4219231261186627e-12
most O 0 1.2374589200558894e-12
likely O 0 3.934694237095471e-11
a O 0 3.1521966026987203e-12
result O 0 1.2853946422877738e-12
of O 0 4.551590156750933e-14
recombination O 0 5.82454709463498e-11
between O 0 7.725862172236475e-10
two O 0 1.3105038165761584e-09
LINE O 0 0.00011497271771077067
elements O 0 2.4265349729546415e-09
, O 0 9.06279912227248e-11
was O 0 6.885513048615621e-09
identified O 0 3.6566034644636147e-09
. O 0 2.031048246253775e-10

The O 0 8.149497743303868e-10
most O 0 3.112978971819835e-11
frequently O 0 1.0224758539845169e-10
found O 0 6.123324763906979e-11
mutation O 0 1.661036419520201e-09
, O 0 1.1119077880650252e-11
identified O 0 7.261375944977999e-10
in O 0 1.2794264345888928e-12
three O 0 7.183320605008703e-11
unrelated O 0 9.111914778259234e-08
Turkish O 0 2.412422475117637e-07
A B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
individuals O 0 5.060901457909495e-07
, O 0 1.6957618642621242e-10
was O 0 1.2166021079451639e-08
previously O 0 4.630356986723427e-09
described O 0 7.461558593213624e-10
to O 0 1.2625811854349855e-11
be O 0 7.920665512362035e-11
a O 0 5.480233489230102e-10
Turkish O 0 1.853706521615095e-08
A B-Disease 1 0.9999895095825195
- I-Disease 1 0.9999966621398926
T I-Disease 1 0.9999996423721313
founder O 0 3.061687675653957e-05
mutation O 0 1.374497060169233e-06
. O 0 2.6893176574560584e-09

The O 0 1.4073175957918238e-09
presence O 0 9.357284946887034e-10
of O 0 5.997797744572431e-13
a O 0 5.6798628300658294e-11
founder O 0 6.271100971844135e-09
mutation O 0 1.5207541892436893e-08
among O 0 5.3520562981468345e-11
relatively O 0 5.087306877843423e-12
small O 0 5.614341023335578e-12
ethnic O 0 1.9795972586861277e-12
population O 0 1.727538771756354e-11
groups O 0 1.798659203348929e-12
in O 0 9.534517272924425e-12
Western O 0 4.9154180725707874e-11
Europe O 0 1.6730338003867473e-08
could O 0 3.4664673909112764e-10
indicate O 0 1.668095696294447e-11
a O 0 1.7827780918189262e-11
high O 0 6.944800290398234e-09
carrier O 0 1.1046794590185982e-09
frequency O 0 2.485408823194035e-10
in O 0 2.149549635510617e-12
such O 0 5.7038631630368375e-12
communities O 0 1.5079885951063687e-10
. O 0 1.8523546585491601e-10

In O 0 4.24086854522443e-09
patients O 0 5.7629017113924874e-09
of O 0 9.376105794545175e-12
Dutch O 0 4.701267926066066e-07
ethnic O 0 1.40379617652453e-11
origin O 0 5.743388542533978e-10
, O 0 5.548955739342887e-11
however O 0 5.543610709368707e-12
, O 0 7.558564776681542e-13
no O 0 8.777395477110872e-12
significant O 0 2.928012346470332e-11
founder O 0 9.314130267057408e-08
effect O 0 5.1227406316911583e-08
could O 0 3.1457267901657815e-09
be O 0 1.9485142666031408e-10
identified O 0 1.533245086449142e-09
. O 0 1.6513659883976572e-10

The O 0 4.2364442509601474e-10
observed O 0 1.6646074518789078e-09
genetic O 0 8.381663363365988e-09
heterogeneity O 0 1.5711991707689776e-08
including O 0 3.528646819184189e-10
the O 0 4.667950748160621e-11
relative O 0 3.269484905032982e-09
high O 0 1.651601451158058e-07
percentage O 0 3.1446072057406127e-07
of O 0 2.631023697519108e-11
splice O 0 0.0001694986567599699
- O 0 1.6234642316703685e-05
site O 0 4.326102782670205e-07
mutations O 0 6.851572834420949e-06
had O 0 1.4686887084280897e-07
no O 0 4.745024165253575e-11
reflection O 0 7.437485349814921e-11
on O 0 4.1826181407245144e-10
the O 0 1.574383540203783e-10
phenotype O 0 4.5755150779314135e-08
. O 0 5.639374522914409e-10

All O 0 1.544870542602439e-08
patients O 0 4.603728953611608e-08
manifested O 0 1.3451951552667651e-08
classical O 0 2.1041216768935556e-08
A B-Disease 1 0.9999837875366211
- I-Disease 1 0.9999970197677612
T I-Disease 1 1.0
and O 0 1.7583511535690377e-08
increased O 0 3.872962506257238e-10
cellular O 0 2.2453221504292742e-08
radioresistant O 0 2.1839669628320735e-08
DNA O 0 1.4337345533022017e-08
synthesis O 0 6.788855699824126e-09
. O 0 1.181014064322028e-09

Determination O 0 5.5132222342990644e-08
of O 0 1.6229033741876897e-11
the O 0 1.6902736805698981e-12
genomic O 0 1.8526735701129837e-09
structure O 0 3.5343539206422747e-09
of O 0 6.653894015634654e-12
the O 0 1.2917319991423426e-10
COL4A4 O 0 6.949135695322184e-06
gene O 0 1.5095175109891557e-09
and O 0 2.4929266550371976e-12
of O 0 8.061226924697962e-13
novel O 0 9.66711368732831e-08
mutations O 0 0.0018962313188239932
causing O 0 0.04413839429616928
autosomal B-Disease 1 0.9999785423278809
recessive I-Disease 1 0.9999946355819702
Alport I-Disease 1 0.9999973773956299
syndrome I-Disease 1 0.9999973773956299
. O 0 4.567031339774985e-07

Autosomal B-Disease 1 0.9999090433120728
recessive I-Disease 1 0.9999803304672241
Alport I-Disease 1 0.9999921321868896
syndrome I-Disease 1 0.9999991655349731
is O 0 1.1592732107601478e-06
a O 0 1.5062789771036478e-07
progressive O 0 0.00010174007184104994
hematuric B-Disease 1 0.9995977282524109
glomerulonephritis I-Disease 1 0.9999977350234985
characterized O 0 2.1672211005352437e-05
by O 0 3.3650182640343473e-09
glomerular B-Disease 0 0.23861612379550934
basement I-Disease 1 0.9778643250465393
membrane I-Disease 1 0.5542871356010437
abnormalities I-Disease 1 0.999966025352478
and O 0 7.82735032345272e-09
associated O 0 2.616287742007728e-10
with O 0 8.028198938969666e-11
mutations O 0 1.18550623540159e-07
in O 0 2.9641546162029186e-11
either O 0 3.865353870313726e-10
the O 0 9.46706157911592e-10
COL4A3 O 0 0.00029106272268109024
or O 0 1.8388029987548293e-09
the O 0 2.716089679555278e-11
COL4A4 O 0 9.983693871618016e-07
gene O 0 2.828395850862364e-10
, O 0 2.0201963474471285e-13
which O 0 2.8805245948920755e-14
encode O 0 1.7707507335429362e-11
the O 0 2.0223504815231053e-10
alpha3 O 0 1.0029118129750714e-05
and O 0 3.2379590120257262e-09
alpha4 O 0 1.5714465916971676e-05
type O 0 1.4418251339520793e-05
IV O 0 0.0010499691125005484
collagen O 0 0.0002335271710762754
chains O 0 4.888420880888589e-05
, O 0 1.4809610482391378e-10
respectively O 0 2.5959288052490592e-09
. O 0 4.645109297207739e-10

To O 0 6.400678320694908e-10
date O 0 6.159618370915609e-10
, O 0 1.7458957456834012e-12
mutation O 0 4.363390898598496e-11
screening O 0 4.3515252512449365e-10
in O 0 2.2398510997334586e-12
the O 0 1.111084748511848e-12
two O 0 7.681055444463958e-12
genes O 0 8.85744544376621e-09
has O 0 6.677070274463404e-08
been O 0 1.689970829943377e-08
hampered O 0 7.693812165143754e-08
by O 0 2.5630305169888068e-12
the O 0 1.9520322858124217e-11
lack O 0 1.1550836676033072e-11
of O 0 6.171906925421175e-14
genomic O 0 8.114567906503112e-10
structure O 0 3.214777555271553e-09
information O 0 2.628453232844663e-09
. O 0 1.4221558375382415e-09

We O 0 2.7329518204055603e-08
report O 0 7.766047804835807e-10
here O 0 1.203947315106535e-12
the O 0 3.8453229044953935e-14
complete O 0 7.334442298292942e-13
characterization O 0 3.2651006898198887e-11
of O 0 3.5861583342657044e-13
the O 0 3.5569156127401858e-12
48 O 0 1.7509665939385854e-10
exons O 0 4.513251161686327e-10
of O 0 1.4149782691028068e-12
the O 0 6.673496477649365e-11
COL4A4 O 0 2.3976683678483823e-06
gene O 0 8.929499362153592e-10
, O 0 3.248722363173584e-13
a O 0 3.7191270571036716e-13
comprehensive O 0 2.1256071902620022e-10
gene O 0 6.538324548444052e-09
screen O 0 9.953955668606795e-06
, O 0 2.586418579308969e-10
and O 0 8.643771462479855e-12
the O 0 8.574336986949538e-14
subsequent O 0 4.495708818240407e-13
detection O 0 7.285403946788449e-10
of O 0 5.677119798569441e-12
10 O 0 5.154114635086415e-11
novel O 0 1.1408848171745589e-10
mutations O 0 5.416451287487689e-09
in O 0 9.718861132546053e-12
eight O 0 6.312301081834448e-08
patients O 0 8.686989758643904e-07
diagnosed O 0 0.00021984642080496997
with O 0 6.333780220302287e-07
autosomal B-Disease 1 0.9999755620956421
recessive I-Disease 1 0.999997615814209
Alport I-Disease 1 0.9999979734420776
syndrome I-Disease 1 0.999996542930603
. O 0 5.436501737676736e-07

Furthermore O 0 3.2284177109431766e-07
, O 0 3.0854580002070975e-10
we O 0 1.0653131155002882e-11
identified O 0 6.654633788460984e-11
a O 0 2.5938216418469606e-12
glycine O 0 8.707956133946482e-09
to O 0 3.8475936846305014e-12
alanine O 0 1.2691376838347423e-09
substitution O 0 1.627733364761852e-11
in O 0 5.525545841190971e-13
the O 0 5.757968429311033e-13
collagenous O 0 1.5023747579334668e-08
domain O 0 5.483600240552278e-10
that O 0 4.313214022055867e-11
is O 0 1.8040964555599004e-10
apparently O 0 1.4590754160437314e-09
silent O 0 5.062071206651808e-09
in O 0 4.50778981199787e-13
the O 0 1.7555862362808594e-12
heterozygous O 0 3.9242351590473845e-09
carriers O 0 2.2516424280638603e-09
, O 0 1.0445023752164717e-12
in O 0 7.016376954264991e-13
11 O 0 6.453869660916212e-10
. O 0 1.245264030780291e-10

5 O 0 1.9951349017333087e-08
% O 0 1.7382576281144146e-11
of O 0 4.709099321424659e-13
all O 0 5.793509769147498e-12
control O 0 2.1176282949397773e-09
individuals O 0 8.433161807763767e-11
, O 0 5.601826294499013e-12
and O 0 1.1311295650129338e-11
in O 0 6.569537665604419e-13
one O 0 2.5626405511514072e-11
control O 0 7.613805697026521e-10
individual O 0 5.022134184212712e-12
homozygous O 0 4.655604790571033e-09
for O 0 8.223136798227171e-13
this O 0 4.627822105564283e-13
glycine O 0 2.9240094789884097e-08
substitution O 0 1.3106163931908554e-09
. O 0 5.950825388012504e-10

There O 0 1.5452418011818736e-08
has O 0 1.6412995407222297e-09
been O 0 1.0359244018154357e-10
no O 0 1.1278760043975655e-12
previous O 0 6.33077314529662e-12
finding O 0 2.0210539838916297e-11
of O 0 6.097887494428689e-13
a O 0 1.0393855047474698e-11
glycine O 0 1.3539772636406155e-09
substitution O 0 1.0950535617171298e-11
that O 0 4.028571226610822e-11
is O 0 5.622423707163371e-11
not O 0 1.1320555604044102e-11
associated O 0 3.914704931745616e-12
with O 0 1.6388007487502798e-12
any O 0 2.954085587258959e-11
obvious O 0 2.227125595055668e-09
phenotype O 0 4.95523222454608e-09
in O 0 1.2873140053937249e-11
homozygous O 0 8.65411266204319e-07
individuals O 0 2.808046462021707e-09
. O 0 1.3383664176913612e-09

Founder O 0 6.719084194628522e-05
BRCA1 O 0 0.08277536183595657
and O 0 3.5266118914023536e-08
BRCA2 O 0 0.0002629385853651911
mutations O 0 4.720172728411853e-05
in O 0 1.0607243972060587e-08
French O 0 0.0002636336430441588
Canadian O 1 0.828926682472229
breast B-Disease 1 0.999992847442627
and I-Disease 1 0.999932050704956
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
families O 0 2.2780686492751556e-07
. O 0 4.441832679447089e-09

We O 0 2.9259062728215213e-08
have O 0 8.564380454822995e-11
identified O 0 6.375806133052109e-11
four O 0 5.382745030951819e-12
mutations O 0 7.375332011783087e-10
in O 0 5.223745156053561e-13
each O 0 2.0642506801116234e-12
of O 0 4.089078381452893e-11
the O 0 1.4391338254426955e-07
breast B-Disease 1 0.9138221740722656
cancer I-Disease 0 5.1742332288995385e-05
- O 0 2.799003414111212e-05
susceptibility O 0 3.6144745081401197e-06
genes O 0 1.8425821224354877e-07
, O 0 4.4420930822575144e-10
BRCA1 O 0 1.4926859876140952e-05
and O 0 5.3274651357071434e-09
BRCA2 O 0 9.768099516804796e-06
, O 0 7.581283517632542e-11
in O 0 8.858382083420935e-11
French O 0 5.120259083923884e-05
Canadian O 0 0.016756178811192513
breast B-Disease 1 0.9986691474914551
cancer I-Disease 1 0.9569618701934814
and O 0 0.10916092246770859
breast B-Disease 1 0.9999970197677612
/ I-Disease 1 0.9999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 7.620554498544152e-08
from O 0 8.288944641776652e-09
Quebec O 0 1.2882157989224652e-06
. O 0 4.636560912985033e-09

To O 0 2.3239903335081635e-09
identify O 0 2.114166619548996e-08
founder O 0 1.229094692689614e-07
effects O 0 1.2577708048411296e-06
, O 0 3.3646491842675985e-11
we O 0 1.0251428178564836e-11
examined O 0 2.228934814496597e-10
independently O 0 1.988105235994908e-10
ascertained O 0 3.7031153965472186e-07
French O 0 1.2845836863561999e-05
Canadian O 0 1.3739565474679694e-05
cancer B-Disease 0 6.408100944099715e-06
families O 0 6.183298317807839e-11
for O 0 9.636089669251557e-13
the O 0 1.9174099157373559e-13
distribution O 0 4.772415101994554e-12
of O 0 6.290060567673214e-14
these O 0 2.36053364355282e-13
eight O 0 2.9875465989981365e-10
mutations O 0 5.8684140213927094e-08
. O 0 1.0822556184564291e-09

Mutations O 0 7.575514609925449e-05
were O 0 4.6042183399208625e-09
found O 0 5.795051660761885e-10
in O 0 2.216079533420845e-12
41 O 0 4.190955360527937e-10
of O 0 3.6018649000879588e-12
97 O 0 5.708435324436323e-08
families O 0 2.797514886410113e-09
. O 0 6.216234194056369e-10

Six O 0 5.494114052595478e-09
of O 0 3.161445064070456e-12
eight O 0 6.815539799198689e-10
mutations O 0 1.7108508387764232e-08
were O 0 9.020838936946163e-11
observed O 0 1.0036828312909307e-10
at O 0 2.465898318870785e-10
least O 0 1.462718661471296e-11
twice O 0 3.31510712214822e-08
. O 0 1.0091811830648112e-09

The O 0 5.5394018261267775e-09
BRCA1 O 0 0.00018873141380026937
C4446T O 0 3.8645845279461355e-07
mutation O 0 2.717208644753555e-06
was O 0 7.800630186238777e-08
the O 0 8.793901370984791e-12
most O 0 6.3814391271233e-11
common O 0 2.31784938464763e-10
mutation O 0 8.365053538739176e-09
found O 0 1.9201449319439234e-08
, O 0 1.0741682716919332e-11
followed O 0 1.0279779631694463e-11
by O 0 4.967526823912438e-12
the O 0 7.048041594792664e-10
BRCA2 O 0 9.268253779737279e-05
8765delAG O 0 4.69031510874629e-06
mutation O 0 6.185188681229192e-07
. O 0 3.8881453612304995e-09

Together O 0 9.342879359053313e-09
, O 0 3.6196128559706775e-12
these O 0 7.641782172329581e-14
mutations O 0 8.280676144778454e-10
were O 0 2.3696586359811533e-10
found O 0 6.136809393986198e-10
in O 0 1.3986940945731607e-11
28 O 0 2.3884867417223177e-09
of O 0 2.722675600599911e-12
41 O 0 1.5266566677496485e-08
families O 0 1.939007461537745e-11
identified O 0 2.256423270452501e-09
to O 0 1.1954387479917727e-10
have O 0 2.471586268981696e-10
a O 0 2.0628201924388634e-10
mutation O 0 2.2563799007002672e-07
. O 0 4.104319106801313e-09

The O 0 1.0691411089780445e-09
odds O 0 1.5719605173103446e-08
of O 0 4.962694751670105e-13
detection O 0 4.924626262337028e-10
of O 0 1.2401264910810728e-12
any O 0 7.055674620948249e-12
of O 0 8.565449781741674e-13
the O 0 2.554296010814916e-11
four O 0 3.766098100044246e-09
BRCA1 O 0 8.801801595836878e-05
mutations O 0 8.537234634786728e-07
was O 0 1.1717154393409146e-06
18 O 0 7.836630544488798e-08
. O 0 1.0926761717655609e-09

7x O 0 0.00011763853399315849
greater O 0 1.7648829953031964e-08
if O 0 1.8254252276417304e-10
one O 0 4.331712506050467e-12
or O 0 6.099333278025698e-12
more O 0 3.2932676225817803e-13
cases O 0 5.104236144859442e-09
of O 0 8.761749086261261e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 2.6532827632763656e-06
also O 0 5.724900375980724e-08
present O 0 4.61513396943225e-11
in O 0 4.988585933229928e-12
the O 0 2.5303914519270165e-10
family O 0 5.990255402821276e-08
. O 0 3.0992255428685667e-09

The O 0 5.05204711398477e-10
odds O 0 7.4184791643006065e-09
of O 0 7.597025222447207e-13
detection O 0 4.76326200704591e-10
of O 0 2.909050821411907e-12
any O 0 7.429711360029678e-12
of O 0 1.5603552521240016e-12
the O 0 1.1754491824333968e-10
four O 0 9.525952471278742e-09
BRCA2 O 0 1.69453469425207e-05
mutations O 0 4.194070584162546e-07
was O 0 1.9540064499778964e-07
5 O 0 6.259855744872311e-09
. O 0 8.52177384214059e-10

3x O 0 2.0457506252569146e-05
greater O 0 2.4836628753632795e-08
if O 0 1.5666110630974117e-09
there O 0 2.2402496524520643e-11
were O 0 9.262948047483732e-12
at O 0 4.958420393025298e-12
least O 0 4.8239251406335254e-14
five O 0 2.8863187881422725e-12
cases O 0 1.177086900172597e-10
of O 0 1.655343417894528e-09
breast B-Disease 0 0.40137869119644165
cancer I-Disease 0 2.8528333132271655e-05
in O 0 1.2204612320765307e-10
the O 0 1.2749655775579072e-09
family O 0 1.742652955272206e-07
. O 0 7.175495753131145e-09

Interestingly O 0 1.7540241969982162e-07
, O 0 3.579615076576559e-11
the O 0 8.56708367441561e-13
presence O 0 4.875519779568016e-11
of O 0 2.4456933873928666e-12
a O 0 2.9778272292446673e-08
breast B-Disease 0 0.014310861006379128
cancer I-Disease 0 1.9742633412533905e-06
case O 0 5.805763869659586e-09
< O 0 8.788683558691446e-09
36 O 0 5.175141204460942e-09
years O 0 1.458688031474864e-10
of O 0 8.799606876497279e-12
age O 0 3.334804787868961e-08
was O 0 2.31480772328041e-08
strongly O 0 9.430341056659852e-12
predictive O 0 7.92801546634081e-10
of O 0 2.2296045218417326e-12
the O 0 1.579098310444671e-11
presence O 0 1.4676435067251248e-10
of O 0 1.0389800321084983e-13
any O 0 5.515061497762819e-12
of O 0 6.339929124223043e-13
the O 0 2.5150407798046892e-11
eight O 0 3.2381008985282733e-09
mutations O 0 9.481341933792464e-09
screened O 0 9.558185638525174e-07
. O 0 1.3151111311060504e-09

Carriers O 0 3.3350215744576417e-07
of O 0 6.426078853066786e-12
the O 0 2.6996644936910785e-12
same O 0 7.113549766596394e-12
mutation O 0 4.230888417389167e-10
, O 0 1.8147414994340583e-12
from O 0 4.712387706613808e-13
different O 0 3.6827314743755057e-13
families O 0 1.0310530207391366e-11
, O 0 1.4949653927981421e-12
shared O 0 8.732759307350513e-12
similar O 0 6.79724158902939e-12
haplotypes O 0 8.67804494930624e-09
, O 0 2.0748545243032268e-11
indicating O 0 4.716747548094702e-10
that O 0 4.340743910147271e-12
the O 0 2.5480273273259524e-12
mutant O 0 4.541336906527249e-08
alleles O 0 5.241858058724347e-10
were O 0 2.1491513013671693e-09
likely O 0 5.078761300403301e-10
to O 0 3.506155218588325e-12
be O 0 2.9609786844631e-11
identical O 0 7.091918025059485e-11
by O 0 1.3432880675845471e-11
descent O 0 7.222096698455971e-09
for O 0 6.796790907870331e-11
a O 0 3.5556912969525456e-10
mutation O 0 3.776434720492716e-09
in O 0 6.167735593087809e-12
the O 0 2.883882369020263e-11
founder O 0 9.544142898221253e-08
population O 0 6.063150537194417e-10
. O 0 2.709086011076778e-10

The O 0 3.681513080500132e-11
identification O 0 4.035692613424402e-11
of O 0 1.68114029641675e-11
common O 0 4.2626449925364795e-08
BRCA1 O 0 0.007908271625638008
and O 0 6.990185852373543e-08
BRCA2 O 0 7.289019413292408e-05
mutations O 0 2.825151170782192e-07
will O 0 2.0217362506347314e-11
facilitate O 0 1.491471529613264e-11
carrier O 0 1.1724313742078607e-09
detection O 0 4.453785784619413e-09
in O 0 3.279676530354436e-10
French O 0 9.56960047915345e-06
Canadian O 0 0.0013788968790322542
breast B-Disease 1 0.990551233291626
cancer I-Disease 0 0.4963119626045227
and O 0 0.0024241702631115913
breast B-Disease 1 0.9999867677688599
/ I-Disease 1 0.9999979734420776
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
families O 0 4.90069112402125e-07
. O 0 3.1628129004701577e-09

Are O 0 2.5668516201449165e-08
Dp71 O 0 4.4513213651953265e-05
and O 0 3.484792676644588e-09
Dp140 O 0 3.8864720863784896e-07
brain O 0 5.706726369680837e-06
dystrophin O 0 5.5020237255121174e-08
isoforms O 0 2.752640337888579e-10
related O 0 3.8173366689875365e-09
to O 0 1.4052843333445253e-09
cognitive B-Disease 0 0.00028734677471220493
impairment I-Disease 0 0.015417320653796196
in O 0 7.136761155379645e-07
Duchenne B-Disease 1 0.9999701976776123
muscular I-Disease 1 0.9999583959579468
dystrophy I-Disease 1 0.9998173117637634
? O 0 0.00022731283388566226

Molecular O 0 6.206761895555246e-07
study O 0 5.70208857908483e-09
and O 0 6.454657919263695e-10
neuropsychological O 0 2.047762791335117e-06
analysis O 0 5.847380357693055e-10
were O 0 1.587070613817687e-10
performed O 0 4.949880436089238e-11
concurrently O 0 1.4392458058676283e-10
on O 0 3.5856186908489462e-09
49 O 0 3.486284185783006e-07
patients O 0 9.338925188728808e-09
with O 0 7.33459955881699e-07
Duchenne B-Disease 1 0.999997615814209
muscular I-Disease 1 0.9999971389770508
dystrophy I-Disease 1 0.9999861717224121
( O 0 1.3271499028633116e-06
DMD B-Disease 1 0.9999994039535522
) O 0 1.3211046701044893e-09
in O 0 5.4547200090127035e-12
order O 0 1.7741348320998718e-11
to O 0 1.6597227064929498e-12
find O 0 3.03927855105357e-11
a O 0 1.4202697178056223e-12
molecular O 0 2.6474898662254276e-11
explanation O 0 2.3575653148449893e-12
for O 0 3.813154219461934e-12
the O 0 4.0411171631227205e-10
cognitive B-Disease 0 8.360864740097895e-06
impairment I-Disease 0 3.8352561659849016e-07
observed O 0 3.417265082017451e-10
in O 0 6.152918886198622e-12
most O 0 5.153569571092476e-09
DMD B-Disease 1 0.9999973773956299
patients O 0 9.06944876533089e-07
. O 0 6.1201055334692e-10

Complete O 0 5.982177531116406e-10
analysis O 0 7.349602176853764e-11
of O 0 1.5956162172786614e-12
the O 0 6.826110423435727e-12
dystrophin O 0 1.3655919062216526e-08
gene O 0 8.281327623649304e-09
was O 0 1.580800379485936e-08
performed O 0 2.6365962191299275e-10
to O 0 6.081347990287422e-13
define O 0 1.3682813215787348e-10
the O 0 4.635501617972215e-12
localization O 0 1.0213380141621542e-09
of O 0 2.270342334270703e-12
deletions O 0 1.1361042773216923e-08
and O 0 2.9178726101974917e-10
duplications O 0 6.399329066653081e-08
in O 0 4.912128342970945e-11
relation O 0 8.014892638463778e-10
to O 0 1.1103141843438191e-11
the O 0 2.845091696956903e-11
different O 0 9.403122724904733e-10
DMD B-Disease 1 0.9999699592590332
promoters O 0 2.405143504802254e-06
. O 0 2.8141051711116916e-09

Qualitative O 0 3.289835603936808e-08
analysis O 0 7.907658416961283e-10
of O 0 1.3670258501574661e-11
the O 0 2.6203263517321496e-11
Dp71 O 0 6.950236297598167e-08
transcript O 0 1.8497782194870638e-09
and O 0 1.0841511716153107e-11
testing O 0 4.266534694985502e-11
for O 0 4.683192988139476e-14
the O 0 2.439327155523939e-14
specific O 0 6.913182727013092e-14
first O 0 4.485347423338615e-12
exon O 0 7.504319388118574e-10
of O 0 1.0668545040448674e-11
Dp140 O 0 4.8828021625979545e-09
were O 0 7.865295220677027e-11
also O 0 1.156739461161127e-11
carried O 0 1.1624596424342215e-10
out O 0 4.195564340392366e-09
. O 0 6.883749681385609e-10

Neuropsychological O 0 0.0001149431336671114
analysis O 0 3.1271827793943885e-08
assessed O 0 6.850127647339832e-07
verbal O 0 6.267289336392423e-07
and O 0 1.1346008577106659e-09
visuospatial O 0 5.599050382443238e-06
intelligence O 0 3.323502539842593e-07
, O 0 2.097171047932278e-11
verbal O 0 6.7730252517606004e-09
memory O 0 9.579986226526671e-07
, O 0 1.1765975693744934e-10
and O 0 9.427936903394496e-11
reading O 0 4.4857156211719484e-08
skills O 0 5.829901397191861e-07
. O 0 6.334281987818713e-10

Comparison O 0 9.727536998127562e-09
of O 0 4.928063165876573e-11
molecular O 0 2.6107022321752993e-08
and O 0 3.3259717202582806e-10
psychometric O 0 3.2409823802481696e-07
findings O 0 4.0636094489343577e-10
demonstrated O 0 7.117937489420356e-11
that O 0 8.208625836350625e-13
deletions O 0 1.355863865626361e-09
and O 0 6.030508037380145e-11
duplications O 0 5.178560869012472e-08
that O 0 1.0359704205598064e-09
were O 0 3.7271927211257605e-10
localized O 0 1.6094895416429722e-09
in O 0 4.4725268627532344e-11
the O 0 4.1556192514891066e-11
distal O 0 1.4396732694876846e-07
part O 0 7.44181660738974e-10
of O 0 3.146525791655752e-12
the O 0 7.57330222839192e-12
gene O 0 1.6601116037406882e-09
seemed O 0 1.0027165209258726e-10
to O 0 6.760646729941922e-13
be O 0 1.9233161938081444e-11
preferentially O 0 4.558237121088382e-10
associated O 0 7.988697897642894e-11
with O 0 1.3870221637901636e-09
cognitive B-Disease 0 8.787141996435821e-05
impairment I-Disease 0 5.127676558913663e-05
. O 0 1.0675231809642582e-09

Two O 0 3.2260183413512777e-09
altered O 0 4.789970375895791e-08
Dp71 O 0 2.646505095071916e-07
transcripts O 0 2.8815993147190966e-08
and O 0 2.9721142214000906e-11
two O 0 3.190075699259498e-13
deleted O 0 3.092020528505657e-10
Dp140 O 0 5.046449022549915e-11
DNA O 0 1.794555615219906e-10
sequences O 0 5.5434656864861154e-11
were O 0 1.1455773135660152e-10
found O 0 3.6708202449942107e-11
in O 0 4.431981853996597e-13
four O 0 3.594353981117848e-10
patients O 0 3.2362610369318645e-09
with O 0 6.50479208275101e-08
severe O 0 0.3051927089691162
cerebral B-Disease 1 0.6570142507553101
dysfunction I-Disease 0 0.0028361184522509575
. O 0 1.6312602824086753e-08

These O 0 5.807408373637024e-11
findings O 0 8.232356463189205e-11
suggest O 0 2.8987832967342086e-11
that O 0 1.289015416757952e-13
some O 0 3.0789128825013624e-15
sequences O 0 7.251676472849744e-13
located O 0 2.2058260773505367e-10
in O 0 2.7419633404079935e-12
the O 0 3.66054799319504e-12
distal O 0 2.7050973017139768e-08
part O 0 2.2283228040542724e-10
of O 0 2.9214393491155954e-12
the O 0 2.764804010735311e-11
gene O 0 3.119145608465601e-09
and O 0 4.6521494989626433e-10
, O 0 1.8021480575197701e-12
in O 0 2.688932789537274e-13
particular O 0 2.020274355793439e-12
, O 0 1.3300276678618328e-12
some O 0 2.5200620670101648e-12
DMD B-Disease 1 0.9999616146087646
isoforms O 0 7.042559313497065e-10
expressed O 0 1.1545621403374895e-10
in O 0 8.93906736826322e-12
the O 0 8.828666131499574e-10
brain O 0 0.0008793107699602842
may O 0 1.0078889722819895e-08
be O 0 7.406337695914367e-12
related O 0 2.893226457023612e-11
to O 0 4.1306871118029775e-11
the O 0 6.7619243537819784e-09
cognitive B-Disease 0 0.0015919383149594069
impairment I-Disease 0 5.191769014345482e-05
associated O 0 2.8291093912002907e-09
with O 0 2.3792079417717105e-08
DMD B-Disease 1 0.9999971389770508
. O 0 2.6459174851112266e-09
. O 0 2.6590205592924576e-09

I1307K O 0 2.6325034923502244e-05
APC O 0 1.498785331932595e-05
and O 0 2.1411237227653146e-09
hMLH1 O 0 1.5976527834027365e-07
mutations O 0 1.2293327245060937e-07
in O 0 1.3190438324928166e-11
a O 0 4.75836758884185e-10
non O 0 2.8603975010810245e-07
- O 0 1.2903865354019217e-05
Jewish O 0 9.843819270827225e-08
family O 0 2.0933494937480646e-08
with O 0 1.1457314208485059e-08
hereditary B-Disease 1 0.9849934577941895
non I-Disease 1 0.9967395663261414
- I-Disease 1 0.999994158744812
polyposis I-Disease 1 0.9999842643737793
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999960660934448
. O 0 3.3574622193555115e-07

We O 0 4.59501547922514e-09
describe O 0 2.399788590068397e-09
a O 0 3.5714216028992496e-09
French O 0 8.222424185078125e-06
Canadian O 0 0.0001615756773389876
hereditary B-Disease 1 0.9992371797561646
non I-Disease 1 0.9998214840888977
- I-Disease 1 0.9999991655349731
polyposis I-Disease 1 0.9999985694885254
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.2809237634646706e-05
HNPCC B-Disease 1 0.8961727619171143
) O 0 1.741574662261769e-09
kindred O 0 5.982182926800306e-08
which O 0 4.2396107458042565e-11
carries O 0 5.458711815897743e-10
a O 0 2.7167944977035674e-11
novel O 0 6.161474663812783e-10
truncating O 0 1.0397001233286574e-06
mutation O 0 1.1125619039376033e-06
in O 0 2.4717844437915915e-10
hMLH1 O 0 5.004558715882013e-06
. O 0 4.205370718324275e-09

Interestingly O 0 3.177035523549421e-07
, O 0 9.251439891944102e-11
the O 0 7.336293898763113e-12
I1307K O 0 8.258298933583319e-09
APC O 0 2.9209772378635535e-08
polymorphism O 0 2.137253289902219e-07
, O 0 1.7329577009506103e-11
associated O 0 3.4113159345927624e-12
with O 0 2.82148544979155e-12
an O 0 1.4758853861263077e-10
increased O 0 1.1504743042678456e-06
risk O 0 0.0009238519705832005
of O 0 4.5489479816751555e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.288289155354505e-07
is O 0 1.2329143928013764e-08
also O 0 6.23272811139941e-09
present O 0 1.0624930796288012e-10
in O 0 5.034390872932226e-12
this O 0 1.6844591693709887e-11
family O 0 3.9304075549750905e-09
. O 0 1.0176550713225652e-09

The O 0 1.0174571185572745e-09
I1307K O 0 5.8356203425091735e-08
polymorphism O 0 1.7689055766823003e-06
has O 0 3.2366759938895484e-08
previously O 0 6.628190885038521e-09
only O 0 2.983724031735413e-11
been O 0 5.163878769032237e-10
identified O 0 6.811212704960212e-10
in O 0 1.5549805366943392e-12
individuals O 0 1.9039280568788897e-11
of O 0 3.176194030007906e-11
self O 0 2.882748503907351e-06
- O 0 0.002129706321284175
reported O 0 2.435991700622253e-05
Ashkenazi O 0 5.085702241558465e-07
Jewish O 0 5.747684550527765e-10
origins O 0 1.7926922168953752e-09
. O 0 8.897265146856626e-10

In O 0 5.40365308054902e-10
addition O 0 1.282697004167943e-10
, O 0 4.39289143255861e-12
in O 0 3.5407768839319786e-13
this O 0 7.35986358663121e-13
family O 0 1.0456899790511898e-09
, O 0 1.7987217618142815e-11
there O 0 8.903418800831897e-12
appears O 0 6.908952854267625e-10
to O 0 5.1716731591655574e-11
be O 0 1.8303978333022997e-09
no O 0 1.703795715624068e-10
relationship O 0 3.7639058536598213e-10
between O 0 3.16391834606633e-12
the O 0 6.950037333836034e-12
I1307K O 0 1.148439454645711e-09
polymorphism O 0 3.373934021055902e-08
and O 0 8.974267995398577e-10
the O 0 1.0743491513087733e-10
presence O 0 8.6892422146434e-09
or O 0 2.9894577924238774e-09
absence O 0 1.5714681778078443e-09
of O 0 4.876226505912129e-11
cancer B-Disease 0 2.512053640657541e-07
. O 0 3.700824716124096e-11
. O 0 3.5275432574977117e-10

Identification O 0 4.393409192005038e-09
of O 0 1.60556637429643e-11
a O 0 1.811629839199025e-11
novel O 0 7.034232224478743e-11
mutation O 0 4.088013927372458e-09
of O 0 4.647284727182788e-12
the O 0 3.182962227121777e-11
CPO O 0 2.7889552711712895e-06
gene O 0 3.100317780280193e-10
in O 0 1.7117842516720105e-12
a O 0 3.308994744877225e-10
Japanese O 0 1.0488795396668138e-06
hereditary B-Disease 0 0.00029996587545610964
coproporphyria I-Disease 0 0.0003955095598939806
family O 0 2.835865018369077e-07
. O 0 1.9096544345842403e-09

Hereditary B-Disease 1 0.9984517097473145
coproporphyria I-Disease 1 0.846924364566803
( O 0 3.611789338719973e-07
HCP B-Disease 0 0.001027821097522974
) O 0 7.315564265475416e-10
is O 0 3.8712494321302415e-10
an O 0 5.387632562303679e-09
autosomal B-Disease 1 0.9999285936355591
dominant I-Disease 1 0.9999896287918091
disease I-Disease 1 0.9999397993087769
characterized O 0 2.478742089806474e-06
by O 0 1.259595716618378e-08
a O 0 1.6946154573815875e-05
deficiency B-Disease 0 0.22626154124736786
of I-Disease 0 1.4063615549897435e-10
coproporphyrinogen I-Disease 0 0.00012238773342687637
oxidase I-Disease 0 5.909038804929878e-07
( O 0 2.985029168289799e-10
CPO O 0 1.7228745491593145e-05
) O 0 7.636690758927589e-12
caused O 0 1.7136243812831964e-11
by O 0 1.6260343765894802e-13
a O 0 1.7099870130987682e-11
mutation O 0 3.6756371279977884e-09
in O 0 4.405511112165472e-12
the O 0 1.2520301462259908e-10
CPO O 0 3.3169093512697145e-05
gene O 0 1.0170501774098284e-08
. O 0 4.357056104797863e-10

Only O 0 4.104804496307679e-09
11 O 0 4.668238018368243e-10
mutations O 0 9.93171433982809e-10
of O 0 1.3067728323046257e-12
the O 0 1.01270485053373e-11
gene O 0 1.646816194522671e-08
have O 0 8.875603585423164e-10
been O 0 1.362279622441065e-09
reported O 0 8.597023537504356e-09
in O 0 4.903462635930111e-10
HCP B-Disease 0 0.2629804015159607
patients O 0 2.0255534138868825e-07
. O 0 3.8665928792092075e-10

We O 0 7.94709542617511e-09
report O 0 1.7024961995737442e-10
another O 0 3.7935765639929286e-11
mutation O 0 3.0028071140719703e-09
in O 0 3.965506742420466e-12
a O 0 9.62540810944823e-11
Japanese O 0 7.064306828397093e-08
family O 0 3.1863303107115826e-09
. O 0 3.5270653064856106e-10

Polymerase O 0 1.0923142326646484e-05
chain O 0 2.0030862287967466e-05
reaction O 0 8.174909638114514e-09
- O 0 6.632316029708818e-08
single O 0 5.5779945107303774e-09
strand O 0 8.241009652465436e-08
conformational O 0 6.558042442428302e-10
polymorphism O 0 4.3776356761782154e-08
and O 0 2.1356102650194053e-12
direct O 0 3.5406757820793944e-13
sequence O 0 8.039718196739543e-12
analyses O 0 2.7226837451266306e-10
demonstrated O 0 2.74647277143103e-10
a O 0 2.2561758017403122e-11
C O 0 1.503831192906091e-08
to O 0 1.1996796785151975e-11
T O 0 2.427762879619877e-08
substitution O 0 1.4374665737240666e-12
in O 0 1.7775234409378449e-13
exon O 0 2.8720928413328295e-10
1 O 0 7.502608777298914e-12
of O 0 4.499009061890817e-14
the O 0 1.618272356396222e-12
CPO O 0 1.3156567035821354e-07
gene O 0 1.4321908242687087e-11
at O 0 7.186167893385997e-12
nucleotide O 0 1.6384062995200566e-09
position O 0 1.3810620203003054e-08
85 O 0 7.567245718931304e-10
, O 0 5.192179151902732e-12
which O 0 7.777009071452401e-12
lies O 0 1.927317194727607e-09
in O 0 3.370325503057603e-12
the O 0 4.46710203549916e-12
putative O 0 7.051326189611018e-09
presequence O 0 2.2382158348932535e-08
for O 0 2.06569223532016e-12
targeting O 0 2.7493135545952896e-10
to O 0 3.230238646012573e-11
mitochondria O 0 1.6795018709103715e-08
. O 0 6.323502277361115e-10

This O 0 2.537457188811487e-10
mutation O 0 2.1589428911283903e-08
changes O 0 3.601743556180814e-11
the O 0 6.313838883144351e-13
codon O 0 1.0676814293786308e-10
for O 0 1.0649909909033264e-13
glutamine O 0 6.562052116965145e-12
to O 0 5.56703554782656e-13
a O 0 1.9294890338250603e-11
termination O 0 5.601898500628977e-09
codon O 0 5.436821215454302e-09
at O 0 6.271481112207766e-10
amino O 0 6.050777656696482e-10
acid O 0 3.2773204150515767e-09
position O 0 8.17101231120887e-09
29 O 0 1.0528231619844064e-08
. O 0 1.4350982902033849e-10

MaeI O 0 1.2265752047824208e-05
restriction O 0 4.348009507992856e-09
analysis O 0 1.353163275874536e-10
showed O 0 6.093609616897311e-09
two O 0 1.762934850185749e-12
other O 0 3.366766067325333e-12
carriers O 0 9.796068400902413e-10
in O 0 5.750087905820322e-13
the O 0 2.509817527418523e-11
family O 0 1.183553877126542e-08
. O 0 1.2476707444974977e-09

The O 0 4.294954791816963e-08
C O 0 0.0007396007422357798
- O 0 0.0117719117552042
T O 0 0.027704009786248207
mutation O 0 2.0042016046772915e-07
is O 0 3.056871977769049e-10
located O 0 3.239295984225343e-11
within O 0 2.8344306068905922e-12
a O 0 6.763387766506312e-11
recently O 0 2.363733919708011e-08
proposed O 0 2.248129980786384e-11
putative O 0 6.646176387015146e-10
alternative O 0 8.682502633527989e-12
translation O 0 3.115592853153437e-11
initiation O 0 2.2275366273749597e-10
codon O 0 3.2029909391440015e-08
( O 0 1.0710182740680807e-10
TIC O 0 1.941636355695664e-06
- O 0 9.958868218973294e-08
1 O 0 4.4407377775002033e-10
) O 0 9.505419319493988e-14
, O 0 1.9042845642372463e-14
supporting O 0 2.8932249391405707e-12
that O 0 2.2161737722736774e-11
TIC O 0 2.6552736017038114e-05
- O 0 2.48179304662699e-07
1 O 0 3.1546296130890994e-10
is O 0 5.872566755799058e-12
the O 0 2.138687664465788e-12
real O 0 2.2289370349426463e-08
TIC O 0 3.5020300401811255e-06
rather O 0 2.4334197851194617e-11
than O 0 4.6990283192327453e-11
TIC O 0 1.7362791595587623e-06
- O 0 1.1457620630039855e-08
2 O 0 1.2836857965492499e-10
. O 0 1.294987012588622e-12
. O 0 1.6740303587781113e-11

Human B-Disease 0 5.33281593106949e-07
complement I-Disease 0 9.131074875767808e-06
factor I-Disease 0 0.0017961746780201793
H I-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999632835388184
associated O 0 1.3251529708213639e-05
with O 0 0.00011541320418473333
hemolytic B-Disease 1 0.9999839067459106
uremic I-Disease 1 0.9999964237213135
syndrome I-Disease 1 0.9999938011169434
. O 0 1.508767581981374e-07

This O 0 6.417361086974438e-11
study O 0 1.082114172573645e-11
reports O 0 2.164844518925957e-11
on O 0 4.8130048557748495e-11
six O 0 1.6210974229657893e-10
cases O 0 1.7118847450703356e-09
of O 0 8.956351216227176e-09
deficiency B-Disease 0 0.0005315421149134636
in I-Disease 0 6.951611595390483e-13
the I-Disease 0 2.37773776362582e-12
human I-Disease 0 1.875677252405339e-10
complement I-Disease 0 1.8942504509400493e-10
regulatory I-Disease 0 1.2768053281320135e-09
protein I-Disease 0 1.0809666939337603e-08
Factor I-Disease 0 8.046899324654078e-08
H I-Disease 1 0.999997615814209
( O 0 1.3058597259085758e-10
FH O 0 3.801768002631434e-07
) O 0 3.6384382919724123e-13
in O 0 1.1826204552862866e-14
the O 0 6.387018735079519e-14
context O 0 9.76127338681021e-12
of O 0 6.90847518081128e-11
an O 0 1.1348717634973582e-05
acute B-Disease 1 0.9997829794883728
renal I-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999990463256836
. O 0 2.0154026003638137e-07

Five O 0 2.2241966046721018e-09
of O 0 3.6095538450547915e-12
the O 0 2.5693642092400326e-12
cases O 0 2.0840412728873048e-10
were O 0 8.458146683043566e-11
observed O 0 1.1383851500346154e-10
in O 0 3.6009927678604114e-12
children O 0 5.764680399700239e-10
presenting O 0 4.4513761565667664e-08
with O 0 3.5540215321816504e-06
idiopathic O 1 0.9999135732650757
hemolytic B-Disease 1 0.999996542930603
uremic I-Disease 1 0.9999995231628418
syndrome I-Disease 1 0.9999997615814209
( O 0 2.2208832888281904e-05
HUS B-Disease 1 0.9995972514152527
) O 0 3.312932506105426e-08
. O 0 3.9723562217375274e-09

Two O 0 2.8648380889784164e-10
of O 0 1.120893655670585e-11
the O 0 9.010969054257245e-11
children O 0 6.093598070577855e-09
exhibited O 0 1.8781803134970687e-07
a O 0 7.804901969166167e-08
homozygous O 1 0.9398313164710999
deficiency O 0 0.29419320821762085
characterized O 0 1.7215506797896296e-09
by O 0 1.6978710104531558e-11
the O 0 7.357456310863597e-11
absence O 0 3.9459693845778077e-10
of O 0 1.8374809052784657e-13
the O 0 1.9003932542199786e-12
150 O 0 2.1320542553660005e-11
- O 0 1.0970391706166538e-08
kD O 0 1.9166239706436272e-09
form O 0 2.0941611292291107e-11
of O 0 4.287031667160601e-12
Factor O 0 1.0790201621091455e-08
H O 1 0.9999967813491821
and O 0 6.580231914909973e-10
the O 0 1.2535205512476111e-11
presence O 0 2.356587425200729e-10
, O 0 1.1879791584051141e-13
upon O 0 6.86581122359177e-14
immunoblotting O 0 7.081608077719181e-10
, O 0 2.5611121974274467e-14
of O 0 1.0851217961563384e-14
the O 0 1.0168715912708959e-12
42 O 0 1.1479314165896426e-09
- O 0 7.390068645918291e-08
kD O 0 1.2870857801772217e-07
Factor O 0 1.2622766121239692e-07
H O 1 0.9999886751174927
- O 0 3.4595493048072967e-07
like O 0 1.4452047336632745e-09
protein O 0 1.4749848564754586e-10
1 O 0 2.137942600732856e-11
( O 0 7.817397445521179e-13
FHL O 0 5.5500199991342924e-09
- O 0 2.0356653251951684e-08
1 O 0 3.2949939998694333e-10
) O 0 1.533946987443066e-13
and O 0 1.8984069687349309e-13
other O 0 5.110996803732448e-13
FH O 0 2.4511352876288584e-06
- O 0 3.235423662317771e-07
related O 0 1.843896590969507e-08
protein O 0 7.3796138089221586e-09
( O 0 8.309622087643298e-12
FHR O 0 1.8492575293294067e-07
) O 0 2.057371851008072e-12
bands O 0 3.6217642773728187e-10
. O 0 2.5269766834590257e-10

Southern O 0 5.8600136298991856e-08
blot O 0 4.884258032689104e-06
and O 0 2.3678411661953724e-11
PCR O 0 6.098990756875367e-10
analysis O 0 4.533899839766209e-13
of O 0 9.201899123592334e-15
DNA O 0 1.911494740269859e-09
of O 0 1.040958812204007e-11
one O 0 4.9838004834157346e-09
patient O 0 2.555538571868965e-07
with O 0 1.7294865983785712e-08
homozygous O 1 0.6212788820266724
deficiency O 0 0.02973376400768757
ruled O 0 7.992013273394605e-09
out O 0 2.2941610833271397e-09
the O 0 5.285950843703091e-11
presence O 0 1.3636280993267746e-10
of O 0 1.832018288157669e-13
a O 0 5.323810402940721e-12
large O 0 7.2236288131688475e-12
deletion O 0 2.120999598176354e-09
of O 0 6.1227850046974286e-12
the O 0 3.69870072070011e-11
FH O 0 6.211615527718095e-06
gene O 0 2.2809409916391132e-09
as O 0 3.3288004297471474e-11
the O 0 3.036518736107552e-12
underlying O 0 1.0117067716919337e-07
defect O 0 1.1133014368169825e-06
for O 0 1.14944975759812e-09
the O 0 2.448756504236371e-07
deficiency O 0 0.002583583816885948
. O 0 8.613333379869914e-10

The O 0 2.632887241560411e-10
other O 0 7.154984504181838e-12
four O 0 7.272557556170511e-11
children O 0 1.6349903375623143e-10
presented O 0 2.130226134378077e-10
with O 0 2.7979845107495294e-09
heterozygous O 0 0.001451197313144803
deficiency O 0 0.056761234998703
and O 0 5.324191643119036e-10
exhibited O 0 8.848567034647203e-08
a O 0 3.148798444208012e-10
normal O 0 1.5689104460037129e-09
immunoblotting O 0 3.271944990501652e-07
pattern O 0 3.9231125015248836e-09
of O 0 5.557953728328735e-13
proteins O 0 1.0089067602192525e-11
of O 0 1.9767976318363356e-12
the O 0 6.281704600930027e-10
FH O 0 0.0023512421175837517
family O 0 3.232925038787471e-08
. O 0 5.218553922325952e-10

Factor B-Disease 1 0.636432945728302
H I-Disease 1 0.9999983310699463
deficiency I-Disease 1 0.9995819926261902
is O 0 3.920360036602233e-09
the O 0 5.709355765937119e-10
only O 0 4.7546942028020567e-07
complement B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999998807907104
associated O 0 4.2562916746646806e-08
with O 0 1.0605322842138776e-08
HUS B-Disease 1 0.9981939196586609
. O 0 4.9630475729145473e-08

These O 0 5.2738858419276724e-11
observations O 0 2.1886685519501015e-10
suggest O 0 2.7255467327513827e-10
a O 0 1.1716416725704448e-10
role O 0 3.4330043252595033e-09
for O 0 4.6370688538965865e-11
FH O 0 5.2093899284955114e-05
and O 0 7.797588685853896e-10
/ O 0 3.085154887116914e-08
or O 0 1.5054086865973204e-09
FH O 0 4.5504684749175794e-06
receptors O 0 3.164669637456541e-10
in O 0 1.113421963135075e-13
the O 0 2.0755894832719113e-12
pathogenesis O 0 6.990569900722221e-09
of O 0 2.1727258880943623e-10
idiopathic O 0 0.00013476176536642015
HUS B-Disease 1 0.9367287158966064
. O 0 7.365660303904065e-10
. O 0 2.152667155641552e-09

Further O 0 5.532894697957147e-10
evidence O 0 4.664784669650146e-10
for O 0 3.3578133763062512e-12
a O 0 3.323103944796735e-11
major O 0 4.6050066537794976e-10
ancient O 0 2.8955371433880828e-09
mutation O 0 0.45757776498794556
underlying O 1 0.9985585808753967
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999995231628418
from O 0 3.332134212996607e-08
linkage O 0 7.852204362279736e-06
disequilibrium O 0 5.3697040129918605e-05
studies O 0 5.979451378479439e-10
in O 0 1.7742894826977551e-12
the O 0 4.099556631664836e-12
Japanese O 0 6.9311041350772484e-09
population O 0 1.4368532405550916e-11
. O 0 9.175908644021291e-11

The O 0 0.0006098839221522212
myotonic B-Disease 1 0.9999963045120239
dystrophy I-Disease 1 0.9999996423721313
( O 0 0.00023498250811826438
DM B-Disease 1 0.9999992847442627
) O 0 5.683444825876904e-09
mutation O 0 2.533011809191521e-07
is O 0 7.655106770698694e-09
an O 0 4.149722787616383e-09
unstable O 0 0.0002350748545723036
( O 0 2.0672709377667076e-10
CTG O 0 9.236200071427447e-07
) O 0 9.582503193716896e-12
n O 0 8.264112949518676e-09
repeat O 0 1.1396151933240617e-07
, O 0 2.7904350705099112e-11
present O 0 2.2603397018677862e-12
at O 0 2.733646121966249e-11
a O 0 9.929995194168928e-13
copy O 0 3.6850275608735217e-10
number O 0 4.065064604374946e-11
of O 0 2.267334757444228e-12
5 O 0 1.0335940991978987e-09
- O 0 2.3494321510497684e-07
37 O 0 4.494363103901833e-09
repeats O 0 4.6913406492876675e-09
on O 0 1.0872330119537921e-10
normal O 0 4.205893879699607e-12
chromosomes O 0 1.5676175635359613e-10
but O 0 6.512075492563774e-13
amplified O 0 1.9463561318211475e-10
to O 0 4.5004191345787703e-13
50 O 0 3.542055320923665e-12
- O 0 4.737051306769047e-10
3000 O 0 6.4730741600183e-11
copies O 0 8.039067189713478e-10
on O 0 2.2026125634511118e-07
DM B-Disease 1 0.99998939037323
chromosomes O 0 9.364251127408352e-06
. O 0 3.3286959855161058e-09

Previous O 0 1.900150614631002e-08
findings O 0 3.0322981903196933e-09
in O 0 6.12243797326606e-11
Caucasian O 0 4.364479622154249e-08
populations O 0 5.530194080449746e-10
of O 0 5.7979532633312125e-12
a O 0 2.694168870220892e-07
DM B-Disease 1 1.0
founder O 0 3.0299261197797023e-05
chromosome O 0 0.03350719437003136
raise O 0 3.583063801215758e-07
a O 0 6.289617715538043e-10
question O 0 1.4402727621654066e-10
about O 0 4.434554719962014e-12
the O 0 1.264032959248998e-13
molecular O 0 2.2617813871805836e-11
events O 0 5.308833667810875e-12
involved O 0 1.0158626717604591e-10
in O 0 5.843870309538146e-13
the O 0 1.4119729691008942e-11
expansion O 0 1.749032385589544e-08
mutation O 0 2.189919996453682e-07
. O 0 2.973687740492892e-09

To O 0 5.586850426730905e-10
investigate O 0 4.150846777406514e-09
whether O 0 2.0332964478786408e-10
a O 0 5.936628966196622e-11
founder O 0 4.6807402398485465e-09
chromosome O 0 3.4301899631827837e-06
for O 0 8.207961393891239e-11
the O 0 1.797262783043152e-09
DM B-Disease 1 0.9999998807907104
mutation O 0 6.346090799524973e-07
exists O 0 1.3852341496090048e-10
in O 0 1.3174389964371036e-12
the O 0 2.5343976049752026e-12
Japanese O 0 7.303467164376798e-09
population O 0 3.763657788202757e-12
, O 0 7.081206281067676e-13
we O 0 4.473616789513191e-12
genotyped O 0 1.5046567325427418e-09
families O 0 1.0114028077502432e-13
using O 0 2.5580147808984544e-12
polymorphic O 0 6.496879034756375e-09
markers O 0 5.577528554567834e-07
near O 0 9.392842059696704e-08
the O 0 5.015151627318915e-10
( O 0 9.630513053693335e-11
CTG O 0 1.8930138878658909e-07
) O 0 4.729787742019376e-12
n O 0 3.3111116071182778e-09
repeat O 0 1.0331791600037832e-07
region O 0 1.0260671201578475e-09
and O 0 9.067484263436398e-11
constructed O 0 2.1138362171768676e-08
haplotypes O 0 3.8079804198787315e-07
. O 0 2.673697929722607e-09

Six O 0 3.450959740192161e-09
different O 0 9.818337115552467e-12
haplotypes O 0 1.993750231576996e-08
were O 0 1.927159321013505e-09
found O 0 8.152860608845458e-09
and O 0 2.0509505205268397e-08
DM B-Disease 1 0.9999996423721313
alleles O 0 2.3740498988900072e-07
were O 0 3.0468556566631833e-09
always O 0 9.274023216043759e-10
haplotype O 0 4.5778108415106544e-08
A O 0 1.7365801241453482e-08
. O 0 2.126727682849605e-09

To O 0 5.30417321176202e-10
find O 0 1.3107906426945704e-10
an O 0 1.0928121471978636e-12
origin O 0 1.3827831024312842e-12
of O 0 1.8124343172110091e-12
the O 0 1.2185819020515964e-10
( O 0 1.0059937258222185e-11
CTG O 0 3.1967474001248775e-08
) O 0 9.442432729808714e-13
n O 0 5.003265579617278e-10
repeat O 0 3.3721823111676485e-09
mutation O 0 2.4986526181436375e-09
and O 0 3.3346471417505796e-11
to O 0 2.056681431064633e-12
investigate O 0 3.517424962407034e-10
the O 0 3.4145381834493893e-12
mechanism O 0 4.9362854082080077e-11
of O 0 2.1258392453055858e-13
the O 0 1.1555348691794087e-12
expansion O 0 9.763830022269104e-11
mutation O 0 4.317199930881088e-10
in O 0 1.193812843719444e-12
the O 0 3.252816202156672e-12
Japanese O 0 2.9062989792549843e-09
population O 0 6.873152220976397e-13
we O 0 5.824555681516186e-12
have O 0 1.4816291639754842e-12
studied O 0 8.849764671081672e-12
90 O 0 1.7999367621368556e-11
Japanese O 0 9.182188875911379e-08
DM B-Disease 1 0.999988317489624
families O 0 8.868830669861438e-11
comprising O 0 6.931582478136855e-12
190 O 0 2.2023788348590756e-10
affected O 0 3.4425759465328554e-10
and O 0 8.33072760081377e-12
130 O 0 9.020890978650442e-11
unaffected O 0 7.707350313523875e-09
members O 0 1.5155425525659183e-11
. O 0 6.639926108942262e-11

The O 0 1.4571620576830924e-09
results O 0 7.036718430164512e-10
suggest O 0 9.633568387457103e-10
that O 0 7.752572889208054e-12
a O 0 2.324790533692056e-11
few O 0 1.1777061964535207e-11
common O 0 2.3426040621221667e-11
ancestral O 0 5.495305877012413e-10
mutations O 0 1.550442902953364e-07
in O 0 8.63423568753241e-11
both O 0 9.086030261507005e-10
Caucasian O 0 1.927557775616151e-07
and O 0 1.012211647832828e-09
Japanese O 0 1.1218621587261168e-08
populations O 0 5.07192447762872e-11
have O 0 3.390959171442609e-12
originated O 0 7.565905909591442e-13
by O 0 4.5561417729962986e-14
expansion O 0 8.427224196250194e-12
of O 0 5.447543457992587e-13
an O 0 4.913852658106066e-11
ancestral O 0 1.3602732273909623e-08
n O 0 4.8837268877832685e-06
= O 0 3.374268331413077e-08
5 O 0 1.5585482904256764e-10
repeat O 0 5.0625348357868916e-09
to O 0 1.5798883035156308e-10
n O 0 2.7568998461902083e-07
= O 0 6.166568589094368e-09
19 O 0 2.599901405275773e-10
- O 0 3.2541864758428574e-09
37 O 0 1.6857583384766173e-10
copies O 0 9.031948522419952e-10
. O 0 2.358278017311477e-10

These O 0 1.2969973185728012e-11
data O 0 1.1050034498527594e-10
support O 0 2.609547126997125e-12
multistep O 0 2.390121711659532e-10
models O 0 1.2841181451506145e-08
of O 0 1.9709026077840974e-11
triplet O 0 2.0958455934305675e-05
repeat O 0 4.2071377492902684e-08
expansion O 0 1.945982264217605e-09
that O 0 1.9851335852916208e-11
have O 0 4.326494457834729e-12
been O 0 1.766105274178531e-12
proposed O 0 8.540718045985107e-13
for O 0 1.1012786169106725e-11
both O 0 1.8728121276012644e-08
DM B-Disease 1 0.9999997615814209
and O 0 3.27829809521063e-07
Friedreichs B-Disease 0 2.9291502869455144e-05
ataxia I-Disease 0 6.405780732166022e-05
. O 0 1.7452815581631143e-10
. O 0 7.455072115192252e-10

The O 0 9.194513900245838e-11
molecular O 0 8.101086912404298e-09
basis O 0 5.610669973066251e-08
of O 0 1.3550519724958576e-05
C6 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
in O 0 1.885652883837352e-10
the O 0 2.0417362245339632e-11
western O 0 2.4840915435753175e-10
Cape O 0 5.701172312022607e-10
, O 0 2.8452583171467705e-12
South O 0 8.780196708579879e-11
Africa O 0 4.224953442655277e-10
. O 0 5.268195601981773e-11

Deficiency B-Disease 1 0.995140790939331
of I-Disease 0 1.5668792652245855e-10
the I-Disease 0 3.513125554355234e-11
sixth I-Disease 0 1.5585624169034418e-07
component I-Disease 0 8.148102637051124e-09
of I-Disease 0 1.602213500762062e-11
human I-Disease 0 3.230377743079771e-09
complement I-Disease 0 9.792580080159041e-09
( O 0 3.641552337452225e-11
C6 O 0 3.0089952929301944e-07
) O 0 4.997404833700925e-12
has O 0 5.978467720879621e-11
been O 0 4.2556380641656233e-10
reported O 0 1.8352220854112034e-09
in O 0 4.647885266766127e-13
a O 0 4.4999576981341605e-12
number O 0 1.433743401779708e-11
of O 0 6.47958954286959e-13
families O 0 8.670603297844526e-12
from O 0 6.268461010677795e-12
the O 0 3.610120535846306e-11
western O 0 3.4541056126435876e-10
Cape O 0 1.3678121968396795e-09
, O 0 9.367454728570479e-12
South O 0 3.189904174139002e-10
Africa O 0 1.6840366878767554e-09
. O 0 1.6038072259139113e-10

Meningococcal B-Disease 1 0.9864622950553894
disease I-Disease 1 0.995112955570221
is O 0 1.4684226812278212e-07
endemic O 0 1.2943075944349403e-06
in O 0 2.937443344119828e-11
the O 0 1.744572541984013e-10
Cape O 0 4.7650368095730755e-09
and O 0 2.6879496892173727e-12
almost O 0 6.217054865712002e-13
all O 0 4.0543130376373415e-13
pedigrees O 0 2.2502171237448465e-09
of O 0 9.89958226504939e-10
total O 0 0.022192349657416344
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 6.455289192075497e-09
C6Q0 O 0 1.4067745723878033e-05
) O 0 8.612273220964806e-12
have O 0 6.783228059109581e-12
been O 0 2.2841079722057955e-11
ascertained O 0 2.8442808108763984e-09
because O 0 6.308552014111513e-10
of O 0 1.8154471259634875e-09
recurrent O 0 0.43898510932922363
disease O 0 0.14010636508464813
. O 0 7.003662538807021e-09

We O 0 6.2732308236945755e-09
have O 0 5.474753463075022e-12
sequenced O 0 3.051279784394012e-10
the O 0 4.5210436956655276e-12
expressed O 0 1.3688174942474984e-12
exons O 0 1.1049612613778237e-10
of O 0 2.2344905331421472e-13
the O 0 4.107719806661914e-12
C6 O 0 3.3901972074090736e-07
gene O 0 1.664949705881824e-10
from O 0 2.0454850920698098e-12
selected O 0 2.4825507968784244e-11
cases O 0 3.801966796945777e-10
and O 0 3.018816030486704e-10
have O 0 2.1833357344291926e-10
found O 0 1.5537993114378423e-10
three O 0 6.339500452368085e-11
molecular O 0 1.7305213759755134e-06
defects O 1 0.9265305995941162
leading O 0 9.631644388718996e-07
to O 0 2.332936155369225e-08
total O 0 3.12422271235846e-05
deficiency O 0 0.02218565158545971
879delG O 0 1.1336522476312894e-07
, O 0 8.97984030884258e-12
which O 0 3.1361005372460005e-12
is O 0 1.1235650430874156e-11
the O 0 1.451366197363635e-11
common O 0 3.317787156120744e-09
defect O 0 4.310350618652592e-07
in O 0 1.8232321902234006e-11
the O 0 4.265438557915502e-10
Cape O 0 5.098991451291113e-09
and O 0 4.234648395828877e-11
hitherto O 0 4.5639638734940036e-09
unreported O 0 6.885739622930487e-08
, O 0 1.3707104895566147e-10
and O 0 1.1458614612713802e-10
1195delC O 0 2.0903650366221882e-08
and O 0 8.004286122798021e-11
1936delG O 0 7.043597705091997e-09
, O 0 1.2348699536882113e-12
which O 0 1.092591186795111e-12
have O 0 1.2548721610439184e-11
been O 0 8.781268073798643e-11
previously O 0 9.808370782238285e-10
reported O 0 2.8525386497335603e-09
in O 0 2.723071768073737e-11
African O 0 1.7184079714738232e-09
- O 0 1.4419573517443496e-06
Americans O 0 3.827180705684441e-08
. O 0 3.524846248215141e-10

We O 0 2.9686175295751127e-08
also O 0 1.3642315055406584e-10
show O 0 1.4972639794663678e-10
that O 0 1.4179744618064705e-12
the O 0 6.708703904900748e-12
879delG O 0 9.933643241311074e-07
and O 0 3.6584590912269732e-09
1195delC O 0 6.601410404982744e-06
defects O 0 0.16081693768501282
are O 0 1.1752676609688706e-10
associated O 0 3.611492771504743e-10
with O 0 1.8799584111661716e-09
characteristic O 0 5.104850970383268e-06
C6 O 1 0.8192100524902344
/ O 0 0.0005466431612148881
C7 O 0 0.0052570803090929985
region O 0 1.6860357554548955e-09
DNA O 0 3.523197165122838e-07
marker O 0 1.034507704389398e-06
haplotypes O 0 1.139696763630127e-07
, O 0 4.600219857819887e-11
although O 0 4.999864237908991e-12
small O 0 1.9468043496728704e-11
variations O 0 7.74687869409263e-09
were O 0 1.0828750118818675e-09
observed O 0 1.5742049441769268e-08
. O 0 1.175171737699543e-09

The O 0 1.4464243136558252e-08
1936delG O 0 1.0243868018733338e-05
defect O 0 0.00031604437390342355
was O 0 3.967277351080156e-08
observed O 0 4.0913114562890485e-10
only O 0 8.083047252360753e-12
once O 0 1.6384751333475833e-09
in O 0 4.139123939428391e-12
the O 0 4.6049691837524165e-11
Cape O 0 2.134290078004142e-09
, O 0 1.6185377690880465e-12
but O 0 6.041657517157073e-13
its O 0 1.9604266127126735e-12
associated O 0 4.297677144715628e-11
haplotype O 0 1.8771679322071577e-08
could O 0 1.1033743696486908e-08
be O 0 1.1722071924236133e-10
deduced O 0 6.870702229377912e-09
. O 0 5.310155648530213e-10

The O 0 1.0021563440210102e-10
data O 0 9.997169758690916e-10
from O 0 1.7649612674142112e-11
the O 0 2.896797602139345e-12
haplotypes O 0 3.1664706412470878e-09
indicate O 0 8.165523812664333e-10
that O 0 5.620287221730358e-12
these O 0 3.7951141795139476e-13
three O 0 2.4063589662559615e-11
molecular O 0 1.7383224815148424e-07
defects O 0 0.06070217490196228
account O 0 6.938560836999841e-10
for O 0 1.3417573996310495e-10
the O 0 1.674696381570584e-09
defects O 0 0.050484493374824524
in O 0 5.571914457602745e-12
all O 0 3.68332317771114e-12
the O 0 1.2297044459097517e-11
38 O 0 2.878153715357712e-09
unrelated O 0 1.14461755629236e-08
C6Q0 O 0 3.99516720790416e-05
individuals O 0 1.7503463123347274e-09
we O 0 2.7387323520144946e-09
have O 0 7.297625004287767e-11
studied O 0 3.8922372269656336e-11
from O 0 3.12439852635793e-12
the O 0 1.0956704293851871e-10
Cape O 0 4.158091115868956e-08
. O 0 4.5909398505017407e-10

We O 0 7.747709673822101e-08
have O 0 4.953935039964108e-10
also O 0 5.456863693548142e-12
observed O 0 1.585061075448646e-11
the O 0 4.0538050347094234e-12
879delG O 0 5.392054731601092e-07
defect O 0 2.5425429157621693e-06
in O 0 4.6140070930622556e-11
two O 0 2.0954027846187273e-08
Dutch O 1 0.9953811168670654
C6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999983310699463
deficient I-Disease 1 0.9999996423721313
kindreds O 0 5.344961209630128e-06
, O 0 8.660372766144953e-12
but O 0 3.058150521012548e-13
the O 0 8.270056731443653e-13
879delG O 0 4.5141163695916475e-08
defect O 0 2.3661884540615574e-07
in O 0 4.366136358707751e-12
the O 0 5.696408275635001e-11
Cape O 0 1.1610293171315789e-08
probably O 0 1.1437402136493802e-08
did O 0 2.7845137307025425e-10
not O 0 6.56838819446115e-12
come O 0 1.549594979242952e-12
from O 0 2.628016890476176e-13
The O 0 2.20108740262015e-12
Netherlands O 0 3.429406802979429e-08
. O 0 1.4780537904712787e-11
. O 0 1.21799167973613e-10

Complement B-Disease 1 0.9996121525764465
C7 I-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999998807907104
: O 0 2.429971557305066e-09
seven O 0 1.873317473366498e-10
further O 0 8.260889888811462e-11
molecular O 0 3.0685814635944553e-06
defects O 1 0.9998517036437988
and O 0 1.0703577579818102e-08
their O 0 2.3272583860034501e-10
associated O 0 2.962482759105711e-10
marker O 0 2.1178368569962913e-06
haplotypes O 0 1.4508276763081085e-05
. O 0 1.8443396143652535e-08

Seven O 0 3.831999606518366e-09
further O 0 1.6437015637471575e-10
molecular O 0 2.0389762767081265e-08
bases O 0 3.053908358197077e-06
of O 0 1.8067648852593265e-05
C7 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
are O 0 1.6005818892494972e-08
described O 0 3.614556121078749e-08
. O 0 1.117718140264401e-09

All O 0 5.386373291837998e-11
these O 0 7.582230741702556e-13
new O 0 1.911306703183957e-11
molecular O 0 8.925177930052541e-09
defects O 0 0.00027120995218865573
involve O 0 8.750075108920896e-10
single O 0 2.5025027383662746e-08
- O 0 1.6623562260065228e-06
nucleotide O 0 3.2825333562414016e-08
events O 0 6.670480140469337e-11
, O 0 2.588844286513514e-12
deletions O 0 8.903444093100177e-10
and O 0 3.5866698500086613e-10
substitutions O 0 4.602672909470584e-09
, O 0 2.736827257876495e-12
some O 0 5.5603897950850384e-14
of O 0 4.1162432078308e-13
which O 0 1.0219980417502939e-10
alter O 0 1.8920784938813995e-08
splice O 0 1.3118095694153453e-06
sites O 0 7.454850958765746e-08
, O 0 1.3556331057706927e-10
and O 0 3.6544104548008605e-11
others O 0 9.57468826445762e-11
codons O 0 6.285281983764435e-08
. O 0 2.2844139080380188e-10

They O 0 8.896993697327105e-10
are O 0 5.144405951576503e-13
distributed O 0 3.0186961329052575e-13
along O 0 1.5744698947384173e-11
the O 0 2.401750673342029e-11
C7 O 0 0.00015084790356922895
gene O 0 2.6014964404907914e-08
, O 0 5.406122164514082e-12
but O 0 7.033366402307839e-13
predominantly O 0 1.763855581775678e-13
towards O 0 1.794348523931344e-12
the O 0 8.797022138518074e-12
3 O 0 1.2077947530997335e-09
end O 0 1.4377491197592462e-08
. O 0 5.736753849738818e-10

All O 0 2.7265358859551725e-09
were O 0 5.156969296038483e-10
found O 0 1.5221018889732818e-10
in O 0 1.0780058486495325e-12
compound O 0 4.3109935760066165e-11
heterozygous O 0 1.2843509367144179e-08
individuals O 0 4.895893135348217e-10
. O 0 2.629404749487918e-10

The O 0 5.393834499045624e-07
C6 O 1 0.5995201468467712
/ O 0 0.0012432163348421454
C7 O 1 0.5056937336921692
marker O 0 2.679029967112001e-05
haplotypes O 0 1.4189848116075154e-05
associated O 0 2.0524205979199905e-07
with O 0 5.858881824138962e-09
most O 0 9.027736780353735e-08
C7 B-Disease 1 0.999911904335022
defects I-Disease 1 0.999962568283081
are O 0 2.7195037333171967e-09
tabulated O 0 6.763849341950845e-06
. O 0 4.61721147426708e-11
. O 0 1.171054087034662e-10

A O 0 1.4162663042327495e-08
genome O 0 1.5116041751639386e-08
- O 0 5.815292070110445e-07
wide O 0 9.97690152715336e-10
search O 0 6.376669331453755e-11
for O 0 2.739199665702241e-11
chromosomal O 0 5.211929601500742e-05
loci O 0 1.9166218123700673e-07
linked O 0 0.00011665028432616964
to O 0 1.1715415837443288e-07
mental O 0 0.0007431462872773409
health O 0 3.489230238074015e-08
wellness O 0 7.148583947014231e-09
in O 0 3.2265609455073285e-12
relatives O 0 4.8872697555601974e-11
at O 0 2.46030396056085e-09
high O 0 1.5449757029273314e-06
risk O 0 2.8483866572059924e-06
for O 0 3.996936825956254e-08
bipolar B-Disease 1 0.999756395816803
affective I-Disease 1 0.9971855282783508
disorder I-Disease 0 0.4634373188018799
among O 0 9.798086786361182e-10
the O 0 1.9240803394993122e-10
Old O 0 2.373593633819837e-05
Order O 0 5.762352373039903e-09
Amish O 0 2.414304981357418e-05
. O 0 3.3096971829849053e-09

Bipolar B-Disease 1 0.9997348189353943
affective I-Disease 1 0.9997683167457581
disorder I-Disease 1 0.9999587535858154
( O 0 0.00016941383364610374
BPAD B-Disease 1 0.9999984502792358
; O 0 0.0002208094228990376
manic B-Disease 1 0.9999949932098389
- I-Disease 1 0.9999992847442627
depressive I-Disease 1 0.9999997615814209
illness I-Disease 1 0.9996044039726257
) O 0 2.548875832619757e-10
is O 0 1.3909575748149994e-11
characterized O 0 4.111547213803135e-11
by O 0 1.5466951721124222e-12
episodes O 0 8.390636629940218e-09
of O 0 2.8420016340291454e-10
mania B-Disease 0 0.015588116832077503
and O 0 1.557899764748072e-07
/ O 0 4.348810307419626e-06
or O 0 9.484981688956395e-08
hypomania B-Disease 0 0.00014724195352755487
interspersed O 0 2.0894967178719526e-07
with O 0 2.6391822061100356e-10
periods O 0 3.314087448913483e-09
of O 0 9.063356176675086e-10
depression B-Disease 0 0.00023971794871613383
. O 0 1.5356098614915936e-09

Compelling O 0 2.2855580539271614e-08
evidence O 0 2.767244433599103e-09
supports O 0 2.293535583675066e-09
a O 0 4.344324552874035e-11
significant O 0 1.4084600673258674e-11
genetic O 0 2.3736044241218224e-09
component O 0 9.111146503926193e-09
in O 0 5.208326825378862e-12
the O 0 7.860237634382816e-12
susceptibility O 0 2.461314352331101e-08
to O 0 3.674709980749924e-10
develop O 0 2.4073571580629505e-07
BPAD B-Disease 1 0.9999858140945435
. O 0 7.547817482134178e-09

To O 0 9.193344419067273e-10
date O 0 1.2277487915213214e-09
, O 0 1.6222535467735888e-11
however O 0 9.457464108728053e-13
, O 0 7.648578087071992e-14
linkage O 0 9.694081093414297e-10
studies O 0 2.135179706652668e-11
have O 0 2.444831663506175e-11
attempted O 0 1.20918230983591e-09
only O 0 9.328229161331691e-12
to O 0 3.188477910517906e-12
identify O 0 3.151882754792723e-09
chromosomal O 0 2.7088928618468344e-05
loci O 0 5.754743881425384e-08
that O 0 5.9274696262434645e-09
cause O 0 8.042123411655666e-09
or O 0 1.7295879173317985e-09
increase O 0 2.9685591762529384e-09
the O 0 2.57822263538543e-10
risk O 0 1.81323898118535e-07
of O 0 2.1680189588035859e-10
developing O 0 4.182585598755395e-06
BPAD B-Disease 1 0.9999895095825195
. O 0 1.035453323083857e-08

To O 0 2.0259255384402763e-10
determine O 0 1.438480029536393e-10
whether O 0 3.8743072638958154e-10
there O 0 2.733677520461164e-11
could O 0 6.765197291258573e-10
be O 0 6.672732505430545e-11
protective O 0 1.4720962226988377e-09
alleles O 0 2.084405911761955e-11
that O 0 4.6309702600444425e-11
prevent O 0 6.1448708343903036e-09
or O 0 1.0227610980351187e-09
reduce O 0 6.536578833760132e-09
the O 0 6.454457801563507e-11
risk O 0 1.9531301020947467e-08
of O 0 4.460376512582798e-12
developing O 0 7.9045591405702e-08
BPAD B-Disease 1 0.999997615814209
, O 0 2.958843239864173e-12
similar O 0 5.44741558989887e-14
to O 0 3.2180714256563325e-13
what O 0 4.161415136094693e-12
is O 0 1.7316559644542373e-11
observed O 0 2.1605554845205432e-10
in O 0 9.061601295712318e-12
other O 0 9.727592065189583e-09
genetic B-Disease 1 0.9999998807907104
disorders I-Disease 1 1.0
, O 0 1.0330402089309132e-09
we O 0 2.6976196831896004e-09
used O 0 3.068570606501453e-07
mental O 0 8.464088023174554e-05
health O 0 1.3413672839135415e-08
wellness O 0 5.057786189865965e-09
( O 0 1.0659919995326117e-11
absence O 0 8.55739160088298e-11
of O 0 1.7121573256395628e-11
any O 0 6.270134917940595e-07
psychiatric B-Disease 0 0.1782640963792801
disorder I-Disease 0 0.0048776650801301
) O 0 1.3990249063400295e-11
as O 0 2.984600760980172e-11
the O 0 1.0031636979435099e-11
phenotype O 0 3.20673065878907e-09
in O 0 2.488328336783252e-12
our O 0 9.691838998016067e-11
genome O 0 1.974125307668828e-09
- O 0 1.169693405245198e-06
wide O 0 8.374875193339903e-08
linkage O 0 3.4748723010125104e-07
scan O 0 2.9613570973197056e-07
of O 0 5.513821170477495e-12
several O 0 2.6140953551107016e-12
large O 0 3.7552008724794916e-10
multigeneration O 0 9.721910828375258e-06
Old O 0 2.957861624963698e-06
Order O 0 1.9333286360723179e-10
Amish O 0 3.264333940933284e-07
pedigrees O 0 5.667199687309221e-08
exhibiting O 0 2.964520895432088e-08
an O 0 7.882505759226888e-11
extremely O 0 1.103972202542991e-08
high O 0 4.0432502146359184e-07
incidence O 0 3.3109012292698026e-05
of O 0 7.354520903390949e-08
BPAD B-Disease 1 0.9999974966049194
. O 0 3.12012886638513e-08

We O 0 7.417463621095521e-08
have O 0 2.382466168793229e-10
found O 0 3.567741241328193e-11
strong O 0 1.1494918515306263e-12
evidence O 0 5.166474453116576e-12
for O 0 5.746513833358724e-13
a O 0 7.598652609908108e-12
locus O 0 2.5474493625665673e-08
on O 0 1.4407267201477225e-07
chromosome O 0 0.00016568040882702917
4p O 0 0.00014657265273854136
at O 0 9.872490380757881e-09
D4S2949 O 0 1.8098599285920614e-09
( O 0 4.457966927464557e-13
maximum O 0 2.6547510717511713e-11
GENEHUNTER O 0 3.8722731687812484e-07
- O 0 4.504002504290838e-08
PLUS O 0 6.735305202454356e-09
nonparametric O 0 1.479745659338505e-08
linkage O 0 9.13011177772205e-08
score O 0 3.6264818703557467e-08
= O 0 8.483876712261917e-09
4 O 0 2.5461935337922625e-10
. O 0 1.6043746192684338e-12
05 O 0 2.4994498915020813e-08
, O 0 1.87031050369324e-11
P O 0 1.066510094460682e-06
= O 0 7.066995322269065e-10
5 O 0 9.345877370614541e-12
. O 0 8.747286884625352e-14
22 O 0 2.2594960624733318e-11
x O 0 2.7713921824101817e-08
10 O 0 4.408768905506122e-10
( O 0 4.134595010113484e-12
- O 0 4.340239811995161e-08
4 O 0 1.3937049292422898e-09
) O 0 5.087246270941981e-13
; O 0 1.0627853171086762e-13
SIBPAL O 0 4.450100732356077e-09
Pempirical O 0 1.1742822270122133e-09
value O 0 1.629870717556603e-11
< O 0 7.527539008789219e-11
3 O 0 3.291029254670619e-11
x O 0 1.1833804336447429e-07
10 O 0 1.4657727254174802e-09
( O 0 6.179051194321605e-12
- O 0 8.056266409539603e-08
5 O 0 1.2425031004070775e-09
) O 0 8.09949492457801e-13
) O 0 3.740859686363236e-14
and O 0 4.602784489269804e-14
suggestive O 0 3.784896354663836e-11
evidence O 0 6.803233323915414e-12
for O 0 6.756598861130947e-13
a O 0 6.406180273754725e-12
locus O 0 5.626262122859771e-08
on O 0 1.8112996258423664e-06
chromosome O 0 0.01732691377401352
4q O 0 0.004045373294502497
at O 0 2.4421323630008374e-08
D4S397 O 0 6.9108807565498864e-09
( O 0 1.4190891300600028e-12
maximum O 0 7.383126054971711e-11
GENEHUNTER O 0 5.533216267394891e-07
- O 0 4.482935977989655e-08
PLUS O 0 5.052434914887272e-09
nonparametric O 0 8.425597108896454e-09
linkage O 0 5.686278115035748e-08
score O 0 4.756032012664946e-08
= O 0 5.162286154103413e-09
3 O 0 6.370579064274295e-11
. O 0 5.211325078066653e-13
29 O 0 2.851160973982303e-10
, O 0 3.5397589807223406e-12
P O 0 8.103097570710815e-07
= O 0 6.550404108018881e-10
2 O 0 1.436765550283381e-11
. O 0 1.8829222577822213e-13
57 O 0 1.693912787814611e-10
x O 0 9.963655855926845e-08
10 O 0 8.615025359759443e-10
( O 0 2.292604691159217e-12
- O 0 4.132017039637503e-08
3 O 0 1.7436354582400782e-09
) O 0 9.256407489457996e-13
; O 0 1.1133242494142798e-13
SIBPAL O 0 5.488992371738277e-09
Pempirical O 0 7.615926223003555e-10
value O 0 2.5566503775165117e-11
< O 0 1.0332466826579179e-10
1 O 0 4.0519358701640584e-11
x O 0 1.8092919162882026e-07
10 O 0 1.969454377359625e-09
( O 0 1.4732099221093087e-11
- O 0 3.2993185072882625e-07
3 O 0 1.3099047180276102e-08
) O 0 9.947244850733172e-13
) O 0 1.918499132344889e-14
that O 0 6.062259526838643e-14
are O 0 2.790838306981902e-12
linked O 0 1.600838999138432e-07
to O 0 2.3429963746934845e-08
mental O 0 0.000360389007255435
health O 0 5.707096661922151e-08
wellness O 0 2.0547687995531305e-07
. O 0 4.2523440324515605e-10

These O 0 1.586211023640871e-10
findings O 0 8.239744442306574e-10
are O 0 1.1875113739567844e-11
consistent O 0 7.705196897189737e-11
with O 0 2.090233368334804e-12
the O 0 1.1892538820043597e-12
hypothesis O 0 1.6444103023705026e-10
that O 0 5.190951401362609e-12
certain O 0 1.935186386137211e-12
alleles O 0 5.652480150608596e-10
could O 0 1.7794786089098125e-08
prevent O 0 1.787418035803512e-08
or O 0 7.090109610530249e-10
modify O 0 3.442216733873238e-09
the O 0 4.893154978424796e-11
clinical O 0 3.1778453202235823e-09
manifestations O 0 1.4476656540196586e-09
of O 0 2.2983119574160327e-10
BPAD B-Disease 1 0.9999997615814209
and O 0 3.0271551931804197e-09
perhaps O 0 8.658758432478209e-11
other O 0 3.353053598664779e-11
related O 0 1.0960624194922275e-06
affective B-Disease 1 0.9922162294387817
disorders I-Disease 1 0.9197628498077393
. O 0 1.1066074279142413e-08

Segregation O 0 9.794647485250607e-05
distortion O 0 0.046758219599723816
in O 0 1.7346061213174835e-05
myotonic B-Disease 1 0.9999698400497437
dystrophy I-Disease 1 0.9999934434890747
. O 0 2.108803982991958e-06

Myotonic B-Disease 1 0.9999866485595703
dystrophy I-Disease 1 0.999998927116394
( O 0 0.00030582150793634355
DM B-Disease 1 0.9999992847442627
) O 0 1.1763429341726805e-08
is O 0 1.4343684018314207e-09
an O 0 3.0622775426536464e-09
autosomal B-Disease 1 0.9990975856781006
dominant I-Disease 1 0.9999526739120483
disease I-Disease 1 0.9999740123748779
which O 0 7.684059255552711e-08
, O 0 9.221279989590769e-11
in O 0 1.6470641040280953e-12
the O 0 2.126498283017142e-11
typical O 0 1.1055020010530825e-08
pedigree O 0 1.9278168110758997e-06
, O 0 6.6963539747944e-12
shows O 0 6.330413970800919e-11
a O 0 4.352450257844032e-12
three O 0 1.7525293716236234e-11
generation O 0 2.9902690101835105e-08
anticipation O 0 1.323920528761846e-08
cascade O 0 1.395732056153065e-06
. O 0 1.3305421209253154e-09

This O 0 4.913311979493074e-10
results O 0 4.2735921468306515e-09
in O 0 1.3312460467318488e-08
infertility B-Disease 1 0.9996664524078369
and O 1 0.937813937664032
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.9684505332406843e-06
CDM B-Disease 0 0.00023466527636628598
) O 0 2.5905942321879927e-11
with O 0 8.165963022964406e-13
the O 0 1.585961396932678e-12
disappearance O 0 2.046734692839891e-07
of O 0 2.2763870788367058e-08
DM B-Disease 1 0.9999998807907104
in O 0 1.092230195176569e-09
that O 0 4.870280290170115e-10
pedigree O 0 1.8610844563227147e-06
. O 0 1.7575489952292855e-09

The O 0 6.220275683421761e-11
concept O 0 2.346100744232693e-11
of O 0 1.7321801545205906e-12
segregation O 0 4.714384438386787e-09
distortion O 0 1.3907523452871828e-06
, O 0 2.1145869777416948e-11
where O 0 1.5232795493730356e-12
there O 0 1.3677833822153818e-13
is O 0 2.975304464608586e-13
preferential O 0 1.2120952679051111e-11
transmission O 0 3.675931781188524e-09
of O 0 1.732717973008252e-13
the O 0 8.823164096040392e-13
larger O 0 2.0840162928692507e-11
allele O 0 2.7585478346026093e-10
at O 0 3.06259284599264e-09
the O 0 4.1682692852873515e-09
DM B-Disease 1 0.9999992847442627
locus O 0 1.283579081245989e-06
, O 0 3.1916752574190355e-10
has O 0 9.144638934976967e-10
been O 0 7.441887661663316e-10
put O 0 1.595667264986389e-09
forward O 0 5.722735618718389e-09
to O 0 4.6117637486631224e-11
explain O 0 5.403550384919242e-10
partially O 0 1.5738356395900155e-08
the O 0 3.3750855842756833e-12
maintenance O 0 1.1293010970803152e-08
of O 0 2.2829156620662872e-10
DM B-Disease 1 0.9999995231628418
in O 0 3.843356188859559e-11
the O 0 9.189390567931888e-12
population O 0 6.044983263953085e-11
. O 0 1.8387179279155674e-10

In O 0 4.5933920556073815e-10
a O 0 8.39267683128142e-11
survey O 0 6.899079973976541e-09
of O 0 3.9649358796189915e-10
DM B-Disease 1 0.9999997615814209
in O 0 3.0240849824281213e-09
Northern O 0 4.943750409047709e-10
Ireland O 0 1.1741343541871174e-07
, O 0 1.6414012510290732e-11
59 O 0 3.821268856896154e-10
pedigrees O 0 6.000087093838147e-09
were O 0 3.340033805088183e-10
ascertained O 0 3.951094385001852e-08
. O 0 1.3217650307595363e-09

Sibships O 0 5.212396717979573e-05
where O 0 5.695479643463841e-09
the O 0 8.969980140605127e-12
status O 0 8.125276493298195e-12
of O 0 2.407936046736059e-13
all O 0 2.516459913712299e-12
the O 0 9.217652682802502e-12
members O 0 3.483112452976056e-12
had O 0 1.2069565347161415e-09
been O 0 1.8632792531114717e-10
identified O 0 6.883251191247552e-10
were O 0 8.648491645057987e-11
examined O 0 1.5956793664173574e-09
to O 0 8.63582371845445e-13
determine O 0 9.800600435372342e-12
the O 0 1.5323189765659162e-12
transmission O 0 3.8916194711191565e-08
of O 0 4.517466695858063e-12
the O 0 8.640169690821153e-10
DM B-Disease 1 0.9999988079071045
expansion O 0 1.0907902137091696e-08
from O 0 1.598645799072429e-10
affected O 0 1.0108976988831841e-09
parents O 0 1.6770217159400858e-11
to O 0 6.709391072237669e-13
their O 0 7.61841718183165e-12
offspring O 0 2.93095436809665e-09
. O 0 2.069630161694036e-10

Where O 0 3.053511221651206e-09
the O 0 6.627488141619509e-11
transmitting O 0 2.6962487027049065e-05
parent O 0 9.317785952589475e-06
was O 0 2.806549446177087e-07
male O 0 6.750481063022562e-09
, O 0 8.426677758355261e-12
58 O 0 2.02090189027615e-09
. O 0 1.5090646787729867e-10

3 O 0 6.165594612639325e-08
% O 0 5.1368513609428845e-11
of O 0 1.0459478335528294e-12
the O 0 5.192219050542679e-12
offspring O 0 1.435036889319008e-08
were O 0 2.047513936176415e-09
affected O 0 6.575088251636885e-10
, O 0 2.321793798887306e-12
and O 0 6.586805319924727e-12
in O 0 9.029449822388347e-14
the O 0 5.41416792041588e-13
case O 0 1.6018505966108876e-10
of O 0 2.6385252489824484e-12
a O 0 4.269208986329431e-09
female O 0 4.002285152182594e-07
transmitting O 0 6.54481555102393e-05
parent O 0 8.951638506005111e-07
, O 0 7.734085594179874e-11
68 O 0 7.573573768127062e-09
. O 0 4.62802351997027e-10

7 O 0 4.063466860770859e-07
% O 0 1.76653236483304e-09
were O 0 3.281109273167715e-10
affected O 0 2.244499031078817e-09
. O 0 3.5847413926148874e-10

Studies O 0 5.152783089101831e-09
on O 0 2.140689847607291e-10
meiotic O 0 1.7069761781840498e-07
drive O 0 1.1104365285063977e-06
in O 0 2.6774233941040393e-09
DM B-Disease 1 0.9999996423721313
have O 0 1.8860206729698348e-09
shown O 0 6.120464551839788e-11
increased O 0 1.8251806316316177e-11
transmission O 0 2.2344652794714648e-09
of O 0 1.474245665865695e-13
the O 0 1.1236116204127455e-12
larger O 0 1.5073064324466756e-11
allele O 0 1.8369442078558507e-10
at O 0 2.940742538370955e-09
the O 0 1.8653247835231923e-09
DM B-Disease 1 0.9999966621398926
locus O 0 7.995566875251825e-07
in O 0 8.238141835370527e-10
non O 0 1.7689594642433804e-06
- O 0 0.021564576774835587
DM O 1 0.9999934434890747
heterozygotes O 0 1.1117482472400297e-06
for O 0 2.838740353894309e-10
CTGn O 0 1.4785291568841785e-06
. O 0 8.477920032667896e-10

This O 0 5.255299667661362e-11
study O 0 3.2315742963529015e-12
provides O 0 7.431521760817295e-13
further O 0 2.549149042893606e-13
evidence O 0 1.5623334223557883e-11
that O 0 1.3136307146222048e-11
the O 0 2.691954159583787e-10
DM B-Disease 1 0.9999997615814209
expansion O 0 2.3583886843425717e-08
tends O 0 1.1553757950366617e-09
to O 0 1.5684354856548843e-12
be O 0 3.067875120610353e-11
transmitted O 0 1.3888141836559953e-07
preferentially O 0 1.792915327314404e-08
. O 0 6.6269861820345e-10

Diagnosis O 0 0.0037026095669716597
of O 0 1.0979789522025385e-06
hemochromatosis B-Disease 1 0.9999830722808838
. O 0 3.5918023968406487e-06

If O 0 4.140505097893765e-06
untreated O 0 0.03617065027356148
, O 0 2.1533546146201843e-07
hemochromatosis B-Disease 1 0.9999996423721313
can O 0 0.001258700038306415
cause O 0 7.190229371190071e-05
serious O 0 0.009276967495679855
illness O 0 0.000601144798565656
and O 0 1.5324118640691609e-09
early B-Disease 0 3.7911843109306176e-10
death I-Disease 0 4.043418755372841e-08
, O 0 6.194040419460478e-11
but O 0 2.823085515357704e-11
the O 0 1.369121760408376e-10
disease O 0 2.5584820377844153e-06
is O 0 3.7330125102208456e-10
still O 0 2.078571759156489e-09
substantially O 0 1.735494059573739e-08
under O 0 1.3565887968525203e-08
- O 1 0.989837646484375
diagnosed O 0 0.2309074103832245
. O 0 3.3055080894683897e-09

The O 0 1.0829948049462246e-09
cornerstone O 0 4.6075413706603285e-08
of O 0 1.7653237812526035e-12
screening O 0 4.2359432628202853e-10
and O 0 1.8390668762163775e-12
case O 0 1.5264323008704062e-12
detection O 0 1.4922406366135732e-10
is O 0 8.615099085507172e-12
the O 0 4.132337918030804e-13
measurement O 0 9.898359465410067e-09
of O 0 2.4470803855480838e-11
serum O 0 4.1890177726600086e-07
transferrin O 0 1.4250213453692595e-08
saturation O 0 1.0373425451959406e-09
and O 0 1.6886095299817327e-10
the O 0 1.4818878069089436e-10
serum O 0 2.569272055552574e-06
ferritin O 0 3.703821676026564e-06
level O 0 6.428187049323242e-08
. O 0 1.0866924027297387e-09

Once O 0 2.574778648067877e-07
the O 0 6.561780285796459e-11
diagnosis O 0 2.4868302261893405e-07
is O 0 2.495584017214725e-10
suspected O 0 5.823234232593677e-07
, O 0 1.2676733274208374e-10
physicians O 0 3.133305559455124e-10
must O 0 1.1742458394525812e-10
use O 0 3.4224263423254797e-09
serum O 0 2.922061139543075e-05
ferritin O 0 0.00039247178938239813
levels O 0 1.5266110494849272e-05
and O 0 1.1555916046290804e-07
hepatic O 0 0.008146217092871666
iron O 0 0.02350456826388836
stores O 0 3.5531911635189317e-06
on O 0 1.704334522401041e-07
liver O 0 1.0497229823158705e-06
biopsy O 0 3.987506715930067e-07
specimens O 0 2.392202436141133e-09
to O 0 1.1747268088835305e-11
assess O 0 5.82912074165165e-09
patients O 0 5.956681675689524e-11
for O 0 3.840054901664558e-13
the O 0 2.207529645192885e-11
presence O 0 3.4048921460083648e-09
of O 0 3.970362094651847e-10
iron B-Disease 0 0.020552663132548332
overload I-Disease 0 9.492495155427605e-05
. O 0 3.211137356018412e-09

Liver O 1 0.5570048093795776
biopsy O 0 0.0018136779544875026
is O 0 8.835227305326043e-08
also O 0 3.87415238778388e-10
used O 0 6.732497892514289e-11
to O 0 4.456906631949975e-12
establish O 0 1.1422849471864893e-10
the O 0 1.8409988811196598e-10
presence O 0 8.168207443759457e-09
or O 0 8.247893923396532e-09
absence O 0 1.1979872205358788e-08
of O 0 3.1975674885664773e-10
cirrhosis B-Disease 0 9.386639248987194e-06
, O 0 5.574309069888983e-11
which O 0 5.164486893693976e-11
can O 0 2.487164918463236e-09
affect O 0 2.185496406070797e-08
prognosis O 0 5.941655700780757e-08
and O 0 9.449756949164723e-11
management O 0 1.8630279541298478e-09
. O 0 8.911595072991219e-11

A O 0 3.120448788251906e-09
DNA O 0 1.03886819147192e-07
- O 0 1.488146779138333e-07
based O 0 5.714105300036465e-10
test O 0 2.7702966587384026e-09
for O 0 2.643097600594363e-13
the O 0 4.155131642404053e-13
HFE O 0 9.131783684779293e-08
gene O 0 1.1580821718260026e-10
is O 0 4.5100601313470545e-13
commercially O 0 1.8248185948421813e-11
available O 0 3.1290994101373926e-11
, O 0 6.198882119418103e-12
but O 0 1.2770080132229467e-12
its O 0 9.356771000362807e-13
place O 0 5.132865313339785e-11
in O 0 1.406140286673574e-12
the O 0 2.897235576448942e-11
diagnosis O 0 4.2267873823220725e-07
of O 0 3.849515373133272e-09
hemochromatosis B-Disease 1 0.9999998807907104
is O 0 1.9706263287844195e-07
still O 0 4.7372701317272e-09
being O 0 2.578804281228031e-09
evaluated O 0 6.560710641423384e-09
. O 0 1.8498760856466845e-10

Currently O 0 2.7384128316043643e-06
, O 0 2.5883517551505975e-11
the O 0 5.001617067561248e-13
most O 0 1.6112430129260752e-13
useful O 0 4.339469322073297e-12
role O 0 1.0662528499016943e-10
for O 0 5.628834529557147e-13
this O 0 1.663163286562061e-13
test O 0 4.9873758456442374e-09
is O 0 6.7981232622360555e-12
in O 0 3.55579281297036e-14
the O 0 1.647333528267958e-13
detection O 0 1.991879106100214e-09
of O 0 6.263352059221461e-10
hemochromatosis B-Disease 1 0.9999996423721313
in O 0 1.3812563315340753e-09
the O 0 1.175911173989519e-10
family O 0 1.0706512343361396e-09
members O 0 2.5446372439730247e-12
of O 0 3.587569477603303e-12
patients O 0 4.759708599477719e-11
with O 0 1.3772607186657293e-12
a O 0 1.1277178496582607e-10
proven O 0 8.765300663071685e-08
case O 0 1.3673532306412994e-09
of O 0 2.5605594033972778e-11
the O 0 2.743606408728283e-08
disease O 0 6.238750938791782e-05
. O 0 3.289708283560344e-09

It O 0 1.934034266071194e-09
is O 0 8.375534293891818e-11
crucial O 0 2.2257113929669003e-09
to O 0 3.914322643794321e-09
diagnose O 1 0.8016059398651123
hemochromatosis B-Disease 1 0.9999997615814209
before O 0 0.06514062732458115
hepatic B-Disease 1 0.999790370464325
cirrhosis I-Disease 1 0.9742237329483032
develops O 0 8.661899482831359e-05
because O 0 3.5839381240521107e-08
phlebotomy O 0 0.00038380094338208437
therapy O 0 4.8091956159623805e-06
can O 0 8.305977416966925e-08
avert O 0 0.4046631157398224
serious O 1 0.9886464476585388
chronic O 1 0.9999597072601318
disease O 0 0.039414580911397934
and O 0 2.5793946978325266e-09
can O 0 1.5098026162618794e-09
even O 0 2.390605935431722e-09
lead O 0 1.521685533134587e-08
to O 0 4.820869398125538e-11
normal O 0 2.394122955440281e-10
life O 0 5.601682451228385e-10
expectancy O 0 3.4540235560598376e-08
. O 0 4.102309637821211e-12
. O 0 8.007477320104428e-11

Prevalence O 0 0.0001734164252411574
of O 0 1.8993731587535478e-10
the O 0 3.620229116485518e-11
I1307K O 0 7.704117344076167e-09
APC B-Disease 0 9.524462996068905e-09
gene O 0 2.4754467364829225e-09
variant O 0 1.5606670444867632e-07
in O 0 2.0050735377585838e-11
Israeli O 0 2.356660644409203e-09
Jews O 0 1.9498368197812255e-11
of O 0 2.1060475412226776e-13
differing O 0 4.245694074089812e-12
ethnic O 0 5.060654152677646e-12
origin O 0 1.2242060698497426e-09
and O 0 1.5142676446089354e-08
risk O 0 7.076618203427643e-06
for O 0 1.0265167475154158e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
. O 0 3.7407144759527e-07

BACKGROUND O 0 2.7617468276730506e-06
& O 0 1.9127342909541767e-07
AIMS O 0 1.2904483526199328e-07
Israeli O 0 8.664157036264442e-08
Jews O 0 6.933308371870339e-10
of O 0 1.0494898700086353e-10
European O 0 3.0832495667709736e-07
birth O 0 3.024531167739042e-07
, O 0 1.626216661332336e-10
i O 0 6.777419070402857e-09
. O 0 1.6239143547664564e-13
e O 0 3.73690939303728e-10
. O 0 1.0592463321398848e-12
, O 0 9.75198329207505e-13
Ashkenazim O 0 9.971294900879002e-09
, O 0 4.896719314750886e-12
have O 0 2.799214852966525e-11
the O 0 1.3944122523312785e-09
highest O 1 0.9995390176773071
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.014336821623146534
of O 0 3.093064693260317e-10
any O 0 6.911588523728085e-10
Israeli O 0 6.158448684345785e-08
ethnic O 0 2.1450262399635989e-10
group O 0 2.5675664261370912e-08
. O 0 2.046666613964021e-09

The O 0 4.505082529249194e-09
I1307K O 0 1.7125428541930887e-07
APC B-Disease 0 1.6063137309174635e-07
gene O 0 4.70548435771434e-08
variant O 0 4.37997641711263e-06
was O 0 8.583067767631292e-08
found O 0 3.3394875753600672e-09
in O 0 3.59025448259942e-11
6 O 0 2.093181983298109e-08
. O 0 3.849337515404727e-10

1 O 0 3.554922045623243e-08
% O 0 7.853602490559553e-11
of O 0 2.2800760845348433e-12
American O 0 1.3491514572194774e-09
Jews O 0 2.081768646355897e-10
, O 0 9.699786113204212e-12
28 O 0 4.370404038667175e-11
% O 0 8.151223023378923e-14
of O 0 5.9990020763456275e-12
their O 0 1.5403737734231981e-06
familial O 1 0.9999909400939941
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 2.686523657757789e-05
, O 0 4.984007095920617e-10
but O 0 8.164429549095686e-11
not O 0 1.4005821502571791e-10
in O 0 2.0228433511570998e-11
non O 0 2.435655233057332e-07
- O 0 1.246301872015465e-05
Jews O 0 1.5063351099797728e-07
. O 0 7.933612100607945e-10

We O 0 4.586023116814886e-09
assessed O 0 3.439414086869874e-09
the O 0 2.1530673077752027e-11
I1307K O 0 1.8730336392991376e-08
prevalence O 0 1.5741561583126895e-06
in O 0 1.9983462801187457e-11
Israeli O 0 6.576844624461842e-10
Jews O 0 1.7762340209781513e-11
of O 0 1.4247269000417645e-13
differing O 0 1.8297529290334236e-12
ethnic O 0 3.945829774032461e-12
origin O 0 2.8972810262040127e-10
and O 0 5.576292760878232e-09
risk O 0 4.281526798877167e-06
for O 0 3.4884933484136127e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999979734420776
. O 0 9.500335806933435e-08

METHODS O 0 3.640736156995672e-09
DNA O 0 2.5511740275874217e-08
samples O 0 6.021546039569614e-10
from O 0 2.729711205337604e-12
500 O 0 8.910910204162903e-12
unrelated O 0 1.07087318179655e-10
Jews O 0 1.0061094318780661e-10
of O 0 7.343409214044527e-11
European O 0 3.2747951195233327e-07
or O 0 1.4030782757856741e-08
non O 0 2.7003193281416316e-07
- O 0 1.5904282918199897e-05
European O 0 1.4018401373050438e-07
origin O 0 9.791729926877935e-11
, O 0 4.5551470581606246e-12
with O 0 3.836718703159603e-12
or O 0 5.1124840472205335e-11
without O 0 9.00082959554016e-12
a O 0 4.602405262454923e-11
personal O 0 4.5683382410288687e-08
and O 0 2.5640233047852234e-08
/ O 0 1.556181672413004e-07
or O 0 5.020389437504491e-09
family O 0 8.723179401037839e-10
history O 0 3.326008218840215e-11
of O 0 1.0403335311270911e-11
neoplasia B-Disease 0 4.983898520549701e-07
, O 0 4.3617102984949696e-11
were O 0 2.3815923191894406e-11
examined O 0 9.769796083247684e-10
for O 0 2.9008616255626896e-12
the O 0 6.734601591673606e-12
I1307K O 0 9.298643521837846e-10
variant O 0 5.190520790954167e-10
by O 0 2.8349862062938824e-13
the O 0 1.8040601564711656e-12
allele O 0 7.797186785118981e-10
- O 0 1.187152420811799e-07
specific O 0 3.4719993546872274e-10
oligonucleotide O 0 1.9335243450768758e-06
( O 0 1.72474856618976e-09
ASO O 0 1.888375663838815e-05
) O 0 2.4815128250865737e-12
method O 0 1.5122803009859354e-10
. O 0 2.6303928479798344e-10

RESULTS O 0 2.5964507699427486e-07
In O 0 4.4177651120635986e-11
persons O 0 1.9432355030657433e-11
at O 0 2.674512833422682e-10
average O 0 1.260328303942515e-06
risk O 0 0.000126529936096631
for O 0 0.0008163591264747083
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.4973855044786433e-08
I1307K O 0 2.6503334638050546e-08
was O 0 2.4416944910399252e-08
found O 0 1.3506010754227304e-09
in O 0 2.6283501416979327e-11
5 O 0 1.645659941651445e-09
. O 0 4.0262992939688047e-10

0 O 0 1.0128497507366774e-07
% O 0 5.992806945132045e-11
of O 0 9.486406885722554e-13
120 O 0 9.996249661359258e-11
European O 0 1.2051536657509132e-08
and O 0 2.24509744128909e-10
1 O 0 4.762907845901054e-10
. O 0 1.4846152085468134e-10

6 O 0 2.1907804637066874e-07
% O 0 9.618360968799422e-11
of O 0 2.775253334433292e-12
188 O 0 3.5709719625742764e-09
non O 0 6.419561060511114e-08
- O 0 2.5948271286324598e-05
European O 0 1.4704800150866504e-06
Jews O 0 9.50667633503599e-09
( O 0 2.2336929528243843e-10
P O 0 1.515184612799203e-05
= O 0 1.727778631277488e-08
0 O 0 1.4295442607448194e-10
. O 0 9.302000359215357e-13
08 O 0 1.724366205380079e-10
) O 0 3.0044924881345025e-12
. O 0 3.239394863463474e-11

It O 0 8.445254495725862e-10
occurred O 0 2.324127779118612e-09
in O 0 1.726847137506482e-11
15 O 0 5.877593411973692e-10
. O 0 1.6376619504931966e-10

4 O 0 2.4799659215091197e-08
% O 0 7.052933931328553e-11
of O 0 6.692166352323392e-12
52 O 0 3.9526245387833114e-08
Ashkenazi O 0 1.6349939642168465e-06
Israelis O 0 2.9564725423369964e-07
with O 0 1.1141985112317343e-07
familial O 1 0.7159783244132996
cancer B-Disease 1 0.5305081605911255
( O 0 3.282577409891019e-08
P O 0 0.009783122688531876
= O 0 9.98020027509483e-07
0 O 0 3.0125593131202777e-09
. O 0 1.54090126075479e-11
02 O 0 7.7490955874282e-09
) O 0 2.1331757974613064e-12
and O 0 1.01291353776789e-11
was O 0 1.1600680416279374e-09
not O 0 2.2256192114961104e-12
detected O 0 4.868778269440099e-09
in O 0 1.0320328792945421e-11
51 O 0 4.44405543476023e-08
non O 0 6.765797166963239e-08
- O 0 1.6239234810200287e-06
European O 0 3.1162155522679313e-08
Jews O 0 1.814376565656417e-10
at O 0 2.370735607826191e-09
increased O 0 1.854654385624599e-08
cancer B-Disease 0 1.2787211289833067e-06
risk O 0 4.831628643842123e-07
. O 0 7.439503457717933e-10

Colorectal B-Disease 1 0.9646584391593933
neoplasia I-Disease 0 0.017773620784282684
occurred O 0 2.7742069505620748e-05
personally O 0 3.132205847578007e-06
or O 0 1.1003186806135545e-08
in O 0 1.6422717352693184e-11
the O 0 6.447121048830384e-12
families O 0 5.354361051757017e-12
of O 0 1.299643986180099e-12
13 O 0 2.381684571783893e-10
of O 0 2.539691547343015e-12
20 O 0 6.929422036172639e-10
Ashkenazi O 0 6.430858512374016e-09
I1307K O 0 6.308624178608113e-10
carriers O 0 1.735201149433152e-10
, O 0 2.9171502995313514e-13
8 O 0 6.90232029518234e-12
of O 0 2.044119864694216e-12
whom O 0 8.321723754534105e-08
also O 0 5.6889682298333355e-08
had O 0 7.159025017244858e-08
a O 0 5.732312957640318e-10
personal O 0 4.7578282647009473e-07
or O 0 6.805998253867074e-08
family O 0 2.5143718218600952e-09
history O 0 1.2758892553588197e-10
of O 0 2.728891279613066e-10
noncolonic O 0 0.00013119133654981852
neoplasia B-Disease 0 0.00014060529065318406
. O 0 3.800380898866251e-09

CONCLUSIONS O 0 1.4357190991631796e-07
The O 0 2.015366540319974e-09
I1307K O 0 2.2134803145945625e-07
APC O 0 6.084275696593977e-07
variant O 0 3.661784603536944e-06
may O 0 1.88904114573063e-09
represent O 0 5.0659372530237334e-12
a O 0 3.23965437809548e-11
susceptibility O 0 1.4646807322549193e-08
gene O 0 3.855116403883585e-08
for O 0 3.795876679646426e-08
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 1.994754406098309e-08
or I-Disease 0 3.888871891177814e-09
other I-Disease 0 1.0143723638833535e-09
, I-Disease 0 3.806532866690304e-09
cancers I-Disease 0 0.00016556527407374233
in O 0 1.8235539744893003e-09
Ashkenazi O 0 3.5768814541370375e-06
Jews O 0 5.5774016516352276e-08
, O 0 6.547368758269556e-10
and O 0 2.4248172914020927e-10
partially O 0 2.708380897331608e-08
explains O 0 1.2559007167567415e-09
the O 0 3.3959706574604454e-11
higher O 0 5.800973923442143e-08
incidence O 0 0.019861659035086632
of O 0 0.0037713029887527227
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 5.2432628905307865e-08
European O 0 2.3031823275232455e-06
Israelis O 0 4.567658606902114e-07
. O 0 2.797034825974265e-09

Systematic O 0 7.910437638258827e-09
analysis O 0 6.923938644654015e-10
of O 0 3.967649819802688e-11
coproporphyrinogen O 0 5.104899173602462e-06
oxidase O 0 1.1143530400659074e-06
gene O 0 1.5225646166072693e-05
defects O 1 0.9476943016052246
in O 0 1.6804238001100202e-09
hereditary B-Disease 0 0.07222893834114075
coproporphyria I-Disease 0 0.07097369432449341
and O 0 6.539524122217699e-08
mutation O 0 5.918232091062237e-07
update O 0 2.9925452054158086e-06
. O 0 9.844849380158394e-09

Hereditary B-Disease 1 0.9981149435043335
coproporphyria I-Disease 1 0.8629242181777954
( O 0 4.314924524351227e-07
HC B-Disease 0 0.393746554851532
) O 0 4.5062944487028744e-09
is O 0 2.9709494864249564e-09
an O 0 4.953675443175598e-07
acute O 1 0.9992817044258118
hepatic B-Disease 1 0.999976634979248
porphyria I-Disease 1 0.9999879598617554
with O 0 0.0005649686208926141
autosomal O 1 0.9998793601989746
dominant O 0 0.49104225635528564
inheritance O 0 0.029153961688280106
caused O 0 6.687327550025657e-05
by O 0 3.9747868885164905e-10
deficient B-Disease 0 7.854549039620906e-06
activity I-Disease 0 2.3113433389454485e-09
of I-Disease 0 5.270708522409073e-11
coproporphyrinogen I-Disease 0 6.249611760722473e-05
III I-Disease 0 7.125452248146757e-05
oxidase I-Disease 0 2.4257641939584573e-07
( O 0 1.9340147539015362e-10
CPO O 0 1.973615781025728e-06
) O 0 4.547206708394036e-11
. O 0 8.172094945191333e-11

Clinical O 0 2.313722507096827e-05
manifestations O 0 3.8129516610752034e-07
of O 0 2.722730374493665e-10
the O 0 1.3068053306142247e-08
disease O 0 0.001534885261207819
are O 0 7.510329164128748e-11
characterized O 0 8.030776044165577e-10
by O 0 3.7336891911543546e-10
acute O 0 7.407605608023005e-06
attacks O 0 8.44060650706524e-07
of O 0 5.085280463390518e-07
neurological B-Disease 1 0.9997535347938538
dysfunction I-Disease 0 0.0036585896741598845
often O 0 2.90100987676567e-09
precipitated O 0 7.355275499776326e-09
by O 0 7.855455869121286e-12
drugs O 0 1.3239659146790927e-08
, O 0 1.0182442562733929e-11
fasting O 0 3.291767081137209e-09
, O 0 2.6297844110678703e-11
cyclical O 0 2.4403490897384472e-05
hormonal O 0 9.504930858383887e-06
changes O 0 1.3664249731704103e-09
, O 0 1.6774193145607796e-10
or O 0 7.933604706522601e-08
infectious B-Disease 0 0.00026448917924426496
diseases I-Disease 0 3.337517409818247e-05
. O 0 1.8082175756717334e-09

Skin O 1 0.9997709393501282
photosensitivity O 1 0.99664306640625
may O 0 0.00011628700303845108
also O 0 4.379236973051093e-09
be O 0 1.166248347894694e-10
present O 0 1.1162262086861219e-10
. O 0 5.965303251365128e-10

The O 0 5.244427669914842e-10
seven O 0 2.2047744185904605e-10
exons O 0 1.0714914289167154e-08
, O 0 1.4580272753028645e-12
the O 0 5.216754762546461e-13
exon O 0 7.215050601416806e-08
/ O 0 4.2756408902278054e-07
intron O 0 6.741091510775732e-06
boundaries O 0 1.457538729709995e-07
and O 0 4.4112588581946e-10
part O 0 4.7268838149205905e-12
of O 0 3.756104585347919e-13
3 O 0 7.502050196339649e-12
noncoding O 0 7.699423737461686e-11
sequence O 0 1.2914745228104207e-12
of O 0 2.53679510123922e-13
the O 0 2.81162202894758e-12
CPO O 0 1.5656939922337187e-07
gene O 0 1.9377430215961056e-11
were O 0 2.910159092872622e-13
systematically O 0 6.323101070515591e-11
analyzed O 0 2.4668565801189146e-11
by O 0 6.369985918949772e-14
an O 0 2.815704483807857e-13
exon O 0 6.59362831001431e-09
- O 0 4.305133316506726e-08
by O 0 9.786407795253638e-11
- O 0 2.6478076620151114e-07
exon O 0 3.5108046176901553e-06
denaturing O 0 2.7836042136186734e-05
gradient O 0 3.304767687950516e-06
gel O 0 1.5760542737552896e-05
electrophoresis O 0 5.547396995098097e-07
( O 0 1.3279351229744663e-10
DGGE O 0 1.5442127221376722e-07
) O 0 6.806189184298261e-13
strategy O 0 2.0632744644755174e-12
followed O 0 1.2186357879837711e-13
by O 0 5.331870809124374e-15
direct O 0 1.8060966743981173e-14
sequencing O 0 5.009795009391915e-11
in O 0 1.7578245716659557e-12
seven O 0 1.9747785004464724e-11
unrelated O 0 6.393165552509572e-09
heterozygous O 0 5.157230589247774e-07
HC B-Disease 0 0.004093789495527744
patients O 0 5.7440082912307844e-08
from O 0 2.8007274277541683e-10
France O 0 1.852641048571968e-06
, O 0 4.0906561471487635e-10
Holland O 0 1.1961762993450975e-06
, O 0 6.911430316947076e-10
and O 0 7.10744074705616e-10
Czech O 0 3.532557229846134e-06
Republic O 0 6.533737106906301e-09
. O 0 1.5973330436125366e-09

Seven O 0 1.9089197778043854e-08
novel O 0 4.421554677946915e-09
mutations O 0 6.103360306042305e-07
and O 0 1.3431196432822645e-10
two O 0 8.842071172465715e-12
new O 0 2.7970975535751563e-10
polymorphisms O 0 8.552245276405301e-07
were O 0 9.78773839754865e-10
detected O 0 7.286549816853949e-07
. O 0 1.0228098368258998e-09

Among O 0 1.579039676791183e-09
these O 0 1.6579706357822133e-11
mutations O 0 3.244383606215706e-08
two O 0 3.0086533264750415e-10
are O 0 1.3182094305008718e-10
missense O 0 2.0605748431989923e-06
( O 0 1.3933135201149582e-10
G197W O 0 3.2609839273334273e-09
, O 0 8.949353411114025e-12
W427R O 0 3.877301257837473e-10
) O 0 7.852066436289662e-13
, O 0 1.0333672529868124e-13
two O 0 9.991511741233583e-13
are O 0 3.625114097793869e-11
nonsense O 0 2.2450467440648936e-07
( O 0 4.356927145454659e-12
Q306X O 0 2.062977427774726e-10
, O 0 1.7574858669072713e-12
Q385X O 0 1.6535059432776222e-10
) O 0 3.117158766351158e-13
, O 0 3.168854948950618e-14
two O 0 3.575885518681404e-13
are O 0 4.929075810705674e-12
small O 0 1.706494147379889e-11
deletions O 0 7.269392199305003e-08
( O 0 8.073579582656976e-10
662de14bp O 0 9.768421627143198e-09
; O 0 2.5700307767356767e-12
1168del3bp O 0 6.210229219760777e-09
removing O 0 1.9266668260797815e-09
a O 0 6.603539243199563e-11
glycine O 0 3.3103678021007e-08
at O 0 4.838542455587458e-09
position O 0 8.516622962417841e-10
390 O 0 5.848049822176904e-10
) O 0 8.801851391834759e-13
, O 0 2.0398113265759216e-13
and O 0 8.731921978012702e-13
one O 0 5.851703236553485e-12
is O 0 3.2811433691576353e-12
a O 0 3.530319482927813e-12
splicing O 0 1.6750231424111917e-08
mutation O 0 1.1557624191027571e-07
( O 0 6.748054198757458e-11
IVS1 O 0 2.1688460947189014e-06
- O 0 8.05843114903837e-07
15c O 0 1.1603290772654873e-07
- O 0 8.504098332196008e-07
- O 0 3.6469000406214036e-06
> O 0 2.4968436207473133e-08
g O 0 2.79235678135592e-07
) O 0 5.527390611187455e-13
which O 0 7.677692981161374e-14
creates O 0 7.068848111024817e-12
a O 0 9.654822948068631e-12
new O 0 2.3829660467100666e-10
acceptor O 0 5.60785029524169e-10
splice O 0 3.38129808596932e-07
site O 0 4.4021351897072236e-08
. O 0 8.969270881564739e-10

The O 0 9.991717453416982e-10
pathological O 0 7.912100841167558e-08
significance O 0 1.225700929641249e-10
of O 0 1.9009806749570313e-12
the O 0 1.1381586645375918e-11
point O 0 7.510594812742966e-09
mutations O 0 1.7115821648872043e-08
G197W O 0 3.245242297111872e-09
, O 0 4.455767785987996e-12
W427R O 0 3.0268532125177217e-10
, O 0 7.102144393422716e-13
and O 0 1.5041206127830442e-12
the O 0 1.7915100826437769e-12
in O 0 7.52446282364927e-12
- O 0 2.092704335154849e-06
frame O 0 0.0001309011859120801
deletion O 0 3.1790223147254437e-06
390delGly O 0 1.737303136906121e-07
were O 0 2.3576833194094426e-11
assessed O 0 1.0451790127818938e-10
by O 0 8.225286229034123e-13
their O 0 3.4487501830021694e-12
respective O 0 3.411219917648367e-11
expression O 0 2.6954929607803102e-11
in O 0 1.1049405883528998e-13
a O 0 1.236383066240132e-12
prokaryotic O 0 1.3349665123341126e-11
system O 0 3.689144909696518e-12
using O 0 3.987547271544489e-12
site O 0 4.724652891141545e-10
- O 0 2.324448189483519e-08
directed O 0 1.5605420289332983e-09
mutagenesis O 0 5.689380699891444e-08
. O 0 6.528650953185888e-10

These O 0 2.1742886657794003e-10
mutations O 0 9.958069568938299e-08
resulted O 0 7.060424245253216e-09
in O 0 1.1470160238280513e-10
the O 0 2.471501614476068e-10
absence O 0 4.027069344658685e-09
or O 0 3.705747861348918e-11
a O 0 1.1752646598972571e-11
dramatic O 0 1.1564980084699528e-09
decrease O 0 1.2223169143510404e-08
of O 0 1.632057683442767e-11
CPO O 0 0.0002818311331793666
activity O 0 6.820266662543872e-08
. O 0 7.629797349473222e-10

The O 0 2.1329582544638015e-10
two O 0 3.14866500927824e-11
polymorphisms O 0 2.1497349678156752e-07
were O 0 2.9465127560079907e-10
localized O 0 4.740361436716967e-09
in O 0 4.508129980429487e-11
noncoding O 0 2.345375662571314e-07
part O 0 1.0613993017827283e-10
of O 0 1.323089858160098e-12
the O 0 1.3294804493413359e-11
gene O 0 7.157995307593978e-10
1 O 0 1.0508399012065794e-10
) O 0 4.3736436456005834e-13
a O 0 7.127624185310211e-11
C O 0 1.2391403743094997e-06
/ O 0 1.3406119592218602e-07
G O 0 9.815487373998621e-07
polymorphism O 0 1.7688901010615155e-08
in O 0 1.8496352019448103e-11
the O 0 4.732912325944305e-11
promotor O 0 2.2488244155738357e-07
region O 0 8.05289029903733e-11
, O 0 3.7074409839875366e-13
142 O 0 9.752085944336741e-11
bp O 0 5.2276423190278365e-09
upstream O 0 3.23574056437792e-10
from O 0 1.6190347673639138e-12
the O 0 9.441598436236986e-14
transcriptional O 0 1.9836196921141358e-11
initiation O 0 8.039994017772223e-12
site O 0 1.9783383264915244e-10
( O 0 4.578054949022636e-12
- O 0 1.837226371037559e-08
142C O 0 1.6494190901994443e-08
/ O 0 1.2331755172567682e-08
G O 0 2.56252803865209e-07
) O 0 8.407023449792661e-13
, O 0 3.347363076826315e-13
and O 0 1.897702047587435e-12
2 O 0 4.0809595286406264e-11
) O 0 1.2615569125375842e-13
a O 0 2.596509379032552e-12
6 O 0 3.225622824398755e-10
bp O 0 5.547141412876044e-09
deletion O 0 1.3689815947515172e-09
polymorphism O 0 4.9315683980921676e-08
in O 0 4.091247132742559e-11
the O 0 1.1996522698842771e-11
3 O 0 1.86414661484946e-10
noncoding O 0 3.180701479976733e-09
part O 0 1.0156025326280016e-11
of O 0 4.966444464883646e-13
the O 0 5.70775978564475e-12
CPO O 0 6.18211061009788e-07
gene O 0 6.819034226168696e-11
, O 0 3.4582598828873656e-13
574 O 0 1.8869301954271833e-10
bp O 0 2.2665989085624005e-09
downstream O 0 2.1026952401470567e-10
of O 0 3.4957830358749165e-13
the O 0 2.133989599611974e-12
last O 0 5.502994171457942e-10
base O 0 1.1939665922611198e-10
of O 0 2.5652741107544397e-13
the O 0 1.540807238742392e-11
normal O 0 3.464167286360009e-10
termination O 0 1.1772722352532128e-08
codon O 0 1.7250785688815995e-08
( O 0 3.920251276379183e-11
+ O 0 8.225298220310151e-10
574 O 0 3.5075736093403975e-08
delATTCTT O 0 6.504494365344726e-08
) O 0 1.0483255236115596e-10
. O 0 1.4339737730573177e-10

Five O 0 7.90362406632994e-08
intragenic O 0 5.571459041675553e-06
dimorphisms O 0 4.460923264559824e-06
are O 0 2.673543608722184e-10
now O 0 4.084450000441109e-10
well O 0 1.5719762297417006e-11
characterized O 0 8.346987684371143e-11
and O 0 7.631390311346742e-12
the O 0 2.2899171708140598e-12
high O 0 9.612556972626862e-09
degree O 0 5.660382752792348e-12
of O 0 9.661855733880675e-13
allelic O 0 4.356958349660545e-09
heterogeneity O 0 8.460740019700097e-08
in O 0 1.389352077829642e-09
HC B-Disease 0 0.0028459893073886633
is O 0 3.8315031147817535e-09
demonstrated O 0 1.1054333837190455e-10
with O 0 8.351931884802155e-13
seven O 0 1.0484150006484505e-11
new O 0 2.5077969215137053e-12
different O 0 3.048632852241384e-14
mutations O 0 4.4631357637436864e-11
making O 0 3.2081771267344905e-11
a O 0 1.854425293879025e-11
total O 0 6.814900033180749e-11
of O 0 8.5066623883856e-12
nineteen O 0 9.293350444750104e-08
CPO O 0 0.000694215064868331
gene B-Disease 0 3.370625449861109e-07
defects I-Disease 0 0.0006182898650877178
reported O 0 1.6732755181436687e-09
so O 0 5.192545178556163e-12
far O 0 2.0430646757718662e-11
. O 0 5.301072948660224e-12
. O 0 1.6543072467456454e-10

Coincidence O 0 8.706495080446075e-09
of O 0 1.4079819775358882e-11
two O 0 2.9580535070017344e-12
novel O 0 4.3423881157522715e-10
arylsulfatase O 0 7.981625458342023e-07
A O 0 7.817975711255087e-10
alleles O 0 3.305394402630668e-09
and O 0 5.027007698998887e-10
mutation O 0 3.2471135114064964e-08
459 O 0 2.532804046495585e-07
+ O 0 1.0728840038609633e-08
1G O 0 3.9449082578357775e-06
> O 0 1.741833899338019e-09
A O 0 2.4505206752678532e-09
within O 0 1.9112777333019082e-11
a O 0 8.28507218386676e-09
family O 0 3.3191184911629534e-07
with O 0 6.479867806774564e-06
metachromatic B-Disease 1 0.9999997615814209
leukodystrophy I-Disease 1 0.9999947547912598
: O 0 2.7618945325214028e-11
molecular O 0 4.2609395178860865e-11
basis O 0 2.310062731381013e-11
of O 0 1.2938421167785208e-11
phenotypic O 0 3.6662572711065877e-07
heterogeneity O 0 3.361913741173339e-06
. O 0 1.8579543237251528e-08

In O 0 2.8150497488610426e-09
a O 0 1.0345447831738852e-09
family O 0 1.6541882308374056e-09
with O 0 6.756270543029075e-11
three O 0 5.193263596936504e-10
siblings O 0 1.4001807357999496e-07
, O 0 1.4614016377242911e-12
one O 0 2.1915236552566553e-12
developed O 0 6.626101334283874e-10
classical O 0 8.907151460846308e-09
late O 0 3.6654639643529663e-06
infantile O 1 0.9999079704284668
metachromatic B-Disease 1 0.9999992847442627
leukodystrophy I-Disease 1 0.9999979734420776
( O 0 1.067868765858293e-06
MLD B-Disease 1 0.999968409538269
) O 0 2.4289739664062893e-10
, O 0 2.5078350854301767e-12
fatal O 0 3.567155317796278e-07
at O 0 5.979114803267294e-08
age O 0 8.737191592445015e-08
5 O 0 2.0338792872109934e-09
years O 0 3.572809825769241e-10
, O 0 4.7019042305473935e-12
with O 0 1.7765738880015647e-10
deficient O 0 7.045237907732371e-06
arylsulfatase O 0 1.0302701412001625e-06
A O 0 3.130907089143875e-08
( O 0 1.902690921484762e-10
ARSA O 0 2.0062558178324252e-05
) O 0 8.722805464045358e-12
activity O 0 4.416748078384103e-10
and O 0 2.011034117010979e-10
increased O 0 1.4032388584439559e-08
galactosylsulfatide O 0 4.755368354381062e-05
( O 0 3.3953522216023657e-09
GS O 1 0.9999511241912842
) O 0 4.514766338559184e-10
excretion O 0 3.060095110640759e-08
. O 0 1.0772079894749709e-09

The O 0 2.443965863019315e-10
two O 0 8.16576875561914e-11
other O 0 8.178207416831285e-11
siblings O 0 1.5118773433187016e-07
, O 0 6.325634460679908e-11
apparently O 0 1.868921684078373e-09
healthy O 0 2.0116335264219742e-09
at O 0 5.490677690289658e-09
12 O 0 5.740150132993449e-09
( O 0 2.758429118801531e-12
1 O 0 3.943469509271047e-11
/ O 0 2.8645663618931394e-09
2 O 0 4.6171436118847e-10
) O 0 5.614445540425006e-13
and O 0 2.502569332318849e-12
15 O 0 1.1954403612846054e-11
years O 0 1.3469132059684696e-11
, O 0 7.539040463959423e-13
respectively O 0 5.2697839147963776e-11
, O 0 3.630731132409082e-12
and O 0 3.883101479251749e-11
their O 0 2.997951192851289e-11
father O 0 5.390214852241115e-08
, O 0 2.6947680198396995e-11
apparently O 0 9.953902146975224e-10
healthy O 0 3.1681124390559035e-10
as O 0 1.9787978547403107e-11
well O 0 1.1158679882883327e-11
, O 0 4.58758248403357e-12
presented O 0 3.2438357555619746e-10
ARSA O 0 0.0003729848831426352
and O 0 2.3036596630277018e-08
GS O 1 0.9999899864196777
values O 0 1.349516942639184e-09
within O 0 1.901568095694084e-12
the O 0 6.36396968109465e-12
range O 0 7.369935772771896e-09
of O 0 3.000728776569872e-09
MLD B-Disease 1 0.9999839067459106
patients O 0 5.816007160319714e-07
. O 0 4.141781639876996e-10

Mutation O 0 3.326798605485237e-06
screening O 0 6.9967221349998e-08
and O 0 1.0808867689782176e-11
sequence O 0 2.2097569000317785e-12
analysis O 0 3.4186369013422535e-12
disclosed O 0 6.617970615963031e-09
the O 0 6.7562413996746784e-12
involvement O 0 1.6869299290789286e-09
of O 0 1.1021186133858274e-12
three O 0 2.1820314652365447e-11
different O 0 8.062260928309861e-12
ARSA O 0 0.00016705352754797786
mutations O 0 8.707379350880728e-08
being O 0 5.300208605341084e-10
the O 0 1.1514332781507874e-13
molecular O 0 4.926258706516862e-11
basis O 0 4.240629722374045e-11
of O 0 1.064622435348328e-11
intrafamilial O 0 2.467929789418122e-06
phenotypic O 0 2.277790542848379e-07
heterogeneity O 0 9.828873999140342e-07
. O 0 9.796073285883722e-09

The O 0 6.779965922021347e-09
late O 0 1.375778140300099e-07
infantile O 0 0.1630532294511795
patient O 0 0.004513904917985201
inherited O 0 0.025470241904258728
from O 0 2.955904854218261e-08
his O 0 2.9460435868600143e-08
mother O 0 1.0426612107039546e-06
the O 0 5.012164988604795e-11
frequent O 0 4.824093569055776e-09
0 O 0 1.6418193471423592e-09
- O 0 4.1701509871927556e-06
type O 0 2.3758714178256923e-06
mutation O 0 1.0594873600666688e-07
459 O 0 3.208714360880549e-08
+ O 0 4.0835468340105763e-10
1G O 0 4.635236905414786e-08
> O 0 3.62828406208493e-10
A O 0 7.255011258422428e-09
, O 0 2.317397142237443e-11
and O 0 1.2515878090868515e-11
from O 0 1.855352330104587e-11
his O 0 1.018093831461897e-09
father O 0 5.241383149723333e-08
a O 0 6.386139533853807e-11
novel O 0 1.2703964269444867e-10
, O 0 2.032615612282407e-12
single O 0 5.517508672170379e-10
basepair O 0 2.375549144062461e-07
microdeletion O 0 1.3871815696120393e-08
of O 0 4.03514976423866e-13
guanine O 0 9.622108665396922e-10
at O 0 9.030635267359699e-11
nucleotide O 0 8.175435328716674e-10
7 O 0 4.656863783480958e-10
in O 0 3.2456893075960558e-12
exon O 0 3.533816439471593e-08
1 O 0 6.999909540894578e-09
( O 0 2.403712125176316e-11
7delG O 0 2.6857309265437834e-08
) O 0 1.6957414639140467e-11
. O 0 3.4815202804017176e-11

The O 0 1.8528502065962016e-09
two O 0 1.0134150185692192e-09
clinically O 0 2.2100997739471495e-05
unaffected O 0 1.0299027053406462e-06
siblings O 0 3.894159306128131e-07
carried O 0 7.315149375131114e-09
the O 0 1.8091100839612295e-10
maternal O 0 1.4532874956785236e-06
mutation O 0 1.0897009161681126e-07
459 O 0 7.051033179550359e-08
+ O 0 2.2632336005301568e-09
1G O 0 8.681424219503242e-07
> O 0 2.5118600532891833e-09
A O 0 2.1167087638218618e-08
and O 0 2.403520715787977e-10
, O 0 2.9009609384816892e-12
on O 0 1.0679707118654846e-10
their O 0 2.2381398817605813e-11
paternal O 0 2.0054246263612185e-08
allele O 0 9.663527755776613e-10
, O 0 2.5693333636882254e-13
a O 0 1.4954408696608856e-13
novel O 0 1.841580056852199e-12
cytosine O 0 5.789549395451843e-10
to O 0 3.1315935088149782e-12
thymidine O 0 4.56951232408187e-09
transition O 0 2.581401481460688e-10
at O 0 2.5233162781468366e-10
nucleotide O 0 1.6310541806063839e-09
2435 O 0 1.8869751983174865e-08
in O 0 1.5154839189124303e-12
exon O 0 7.852592354140597e-09
8 O 0 1.996999454689785e-09
, O 0 3.2613256713276417e-13
resulting O 0 1.4880836363487249e-12
in O 0 7.086471437867808e-14
substitution O 0 3.6920874343926435e-12
of O 0 6.837498883055515e-12
alanine O 0 2.9546151836257195e-07
464 O 0 4.0009794588513614e-08
by O 0 2.453035274907478e-10
valine O 0 8.903424713935237e-06
( O 0 2.8566315979361434e-10
A464V O 0 1.3052658509593584e-08
) O 0 3.434114451139614e-11
. O 0 7.11734005065523e-11

The O 0 7.298620818829704e-09
fathers O 0 1.0977490916275201e-07
genotype O 0 3.832360562228132e-07
thus O 0 1.8690358150053044e-09
was O 0 1.1070698135995372e-08
7delG O 0 9.142237900050532e-07
/ O 0 5.894877403989085e-07
A464V O 0 6.232986038412491e-07
. O 0 1.6292570625964231e-09

Mutation O 0 2.5361558073200285e-05
A464V O 0 2.0359370864753146e-06
was O 0 1.1444204517374601e-07
not O 0 9.526955613292643e-12
found O 0 1.3303334822634127e-10
in O 0 6.392997676379908e-12
18 O 0 2.390355247072762e-09
unrelated O 0 2.3204222543427022e-07
MLD B-Disease 1 0.9999971389770508
patients O 0 2.4646175234011025e-07
and O 0 4.2057513721660555e-11
50 O 0 2.1563810459479527e-10
controls O 0 2.804540031320357e-07
. O 0 3.1663862642972163e-09

A464V O 0 2.2551546408067225e-06
, O 0 3.0125121841528824e-10
although O 0 3.652417604471658e-11
clearly O 0 2.993273129359153e-10
modifying O 0 7.284577208110932e-08
ARSA O 0 0.021968647837638855
and O 0 1.9310131449401524e-07
GS O 1 0.9999994039535522
levels O 0 1.0370589734520763e-05
, O 0 3.480391669308247e-11
apparently O 0 3.8728370510554555e-10
bears O 0 7.866499118769354e-10
little O 0 1.587408850201033e-11
significance O 0 5.895371864295118e-12
for O 0 7.051194697571539e-12
clinical O 0 8.919183724920288e-10
manifestation O 0 4.545823717450048e-09
of O 0 9.146348123323378e-10
MLD B-Disease 1 0.9999943971633911
, O 0 8.158312220230002e-11
mimicking O 0 1.8605785356839988e-08
the O 0 1.2223110024134343e-10
frequent O 0 9.114730659121051e-08
ARSA O 0 0.005888689775019884
pseudodeficiency O 0 3.6150377127341926e-05
allele O 0 8.549570225113712e-07
. O 0 7.879718211256659e-09

Our O 0 8.175002896848582e-09
results O 0 1.5777443240772016e-10
demonstrate O 0 2.2665846977076853e-10
that O 0 1.4794801668494006e-12
in O 0 2.4502351102934083e-13
certain O 0 2.9786104138729286e-12
genetic O 0 3.333316840326006e-07
conditions O 0 3.761699645110639e-07
MLD B-Disease 1 0.9999830722808838
- O 0 7.890452252468094e-05
like O 0 1.5113929521248792e-06
ARSA O 0 0.057677604258060455
and O 0 5.568600158767367e-08
GS O 1 0.9999916553497314
values O 0 9.444396376068198e-09
need O 0 1.1106345010336582e-10
not O 0 3.7605132224317883e-13
be O 0 2.6921607304553063e-13
paralleled O 0 2.545309796264661e-10
by O 0 5.242097866897666e-10
clinical O 0 5.856549591953808e-07
disease O 0 5.677121407643426e-06
, O 0 5.603939079272535e-13
a O 0 1.3232135656279786e-12
finding O 0 1.0515978365877032e-10
with O 0 5.906070077443815e-10
serious O 0 1.262943811752848e-07
diagnostic O 0 1.6726976355130319e-06
and O 0 2.885172767363997e-09
prognostic O 0 1.3764275536232162e-05
implications O 0 3.781223085752572e-07
. O 0 2.803443921450821e-09

Moreover O 0 7.83921620950423e-08
, O 0 1.0559190327663615e-10
further O 0 1.3457351899504033e-10
ARSA O 0 4.337343852967024e-05
alleles O 0 2.5409857329350416e-08
functionally O 0 3.823591043783381e-08
similar O 0 1.53696291804728e-10
to O 0 3.0588653138208244e-11
A464V O 0 2.674403276614612e-08
might O 0 4.212772353184846e-09
exist O 0 4.744897530439829e-11
which O 0 2.548203835439633e-11
, O 0 9.80547565886114e-13
together O 0 1.1371540861726537e-11
with O 0 5.221229698593177e-11
0 O 0 4.883118798204578e-09
- O 0 3.149500480503775e-05
type O 0 0.00011699595779646188
mutations O 0 4.593905487126904e-06
, O 0 4.6470791659203314e-09
may O 0 3.096904777066811e-08
cause O 0 1.431566976073384e-09
pathological O 0 3.4144779874623055e-06
ARSA O 0 0.36565476655960083
and O 0 7.468213993888639e-07
GS O 1 0.9999991655349731
levels O 0 3.7071752103656763e-06
, O 0 8.95432252651096e-12
but O 0 3.1377877726668224e-12
not O 0 7.114540293701177e-12
clinical O 0 1.537684146679652e-10
outbreak O 0 6.127677920630958e-09
of O 0 6.069299576805243e-12
the O 0 1.4049661878345887e-08
disease O 0 4.715488830697723e-05
. O 0 3.67964582415059e-11
. O 0 3.091395472942793e-10

Human O 0 0.004556598141789436
MLH1 O 1 0.9966944456100464
deficiency O 1 0.999195396900177
predisposes O 0 0.00047428655670955777
to O 0 9.278844714799561e-08
hematological B-Disease 1 0.656200647354126
malignancy I-Disease 1 0.9233778715133667
and O 0 6.002676400385099e-07
neurofibromatosis B-Disease 1 0.904100239276886
type I-Disease 0 0.0001495378091931343
1 I-Disease 0 1.6959081960976619e-07
. O 0 3.505471690701256e-09

Heterozygous O 0 5.731190321967006e-05
germ O 0 0.0030190986581146717
- O 0 0.0008133251685649157
line O 0 2.7786015834863065e-06
mutations O 0 8.267096518466133e-08
in O 0 6.927151452278124e-13
the O 0 8.366424415241769e-13
DNA O 0 1.9336755485710455e-06
mismatch O 0 0.007179505191743374
repair O 0 7.408831152133644e-05
genes O 0 7.205437100310519e-07
lead O 0 1.1272737765466445e-06
to O 0 1.7534456731027603e-07
hereditary B-Disease 1 0.9999717473983765
nonpolyposis I-Disease 1 0.9999951124191284
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
. O 0 1.512915901002998e-06

The O 0 1.890931144998831e-08
disease O 0 2.414477785350755e-05
susceptibility O 0 5.199950123824237e-07
of O 0 2.869300075314385e-10
individuals O 0 5.25549772589784e-08
who O 0 2.2114493276603753e-06
constitutionally O 0 1.2838953807658982e-05
lack O 0 1.950474892709053e-09
both O 0 1.0248983953187185e-11
wild O 0 2.1519456439023088e-08
- O 0 3.8709469663444906e-05
type O 0 1.195628897221468e-06
alleles O 0 6.10178574333986e-09
is O 0 7.51801509935035e-10
unknown O 0 5.3681130651739295e-09
. O 0 1.2998837561895016e-09

We O 0 4.2098832864212454e-08
have O 0 3.3974215801757524e-11
identified O 0 1.5092567820507163e-11
three O 0 1.2568118204145384e-12
offspring O 0 1.2299825602468673e-09
in O 0 2.7381236167300926e-11
a O 0 1.3273925958401378e-07
hereditary B-Disease 1 0.9999908208847046
nonpolyposis I-Disease 1 0.9999992847442627
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0003300979733467102
who O 0 4.490210812946316e-06
developed O 0 2.9116608857293613e-07
hematological B-Disease 0 0.00021175568690523505
malignancy I-Disease 0 7.894878217484802e-05
at O 0 8.513200810966737e-09
a O 0 3.7187072865485504e-10
very O 0 6.281701547816709e-11
early O 0 2.238034341184303e-10
age O 0 4.269936226819482e-08
, O 0 3.209774807055865e-11
and O 0 1.379722464750488e-11
at O 0 8.463277995085505e-11
least O 0 8.489071533397674e-13
two O 0 9.756522846571247e-13
of O 0 7.189673661110729e-13
them O 0 8.616549140860741e-11
displayed O 0 6.061271733415197e-07
signs O 0 2.103654708207614e-07
of O 0 1.6670151370412611e-10
neurofibromatosis B-Disease 0 0.16012540459632874
type I-Disease 0 4.597609586198814e-05
1 I-Disease 0 1.168342862456484e-07
( O 0 4.2490033713704634e-10
NF1 B-Disease 0 1.6140359093697043e-06
) O 0 1.2972181662185278e-10
. O 0 1.1025401425168724e-10

DNA O 0 1.4442741225195732e-08
sequence O 0 1.7864074108864259e-10
analysis O 0 1.5537725273073733e-10
and O 0 1.6057224994092678e-11
allele O 0 3.022607164560043e-10
- O 0 1.1044797965098496e-08
specific O 0 3.6072228537520346e-11
amplification O 0 1.2094625390091096e-07
in O 0 4.992964808964162e-12
two O 0 5.747813336398622e-11
siblings O 0 1.56994474309613e-07
revealed O 0 2.4976150925226648e-08
a O 0 3.9345779967447925e-09
homozygous O 0 0.0001424002111889422
MLH1 O 0 0.001084195333532989
mutation O 0 2.083317667711526e-06
( O 0 4.2667483435288034e-10
C676T O 0 1.6418663051354088e-07
- O 0 3.05718021991197e-05
- O 0 0.00010352909157518297
> O 0 2.3746838451188523e-07
Arg226Stop O 0 8.930323019740172e-06
) O 0 1.766167767591753e-10
. O 0 1.212882294598927e-10

Thus O 0 1.6748250786235985e-08
, O 0 2.7790578865927174e-11
a O 0 2.1239973321818262e-11
homozygous O 0 4.883279984824185e-07
germ O 0 0.0004012342542409897
- O 0 0.004905663896352053
line O 0 0.00025721677229739726
MLH1 O 0 0.06951609253883362
mutation O 0 1.9570683434722014e-05
and O 0 2.91996897772151e-08
consequent O 0 3.309424209874123e-05
mismatch O 1 0.9994277358055115
repair O 1 0.999829888343811
deficiency O 1 0.9929007291793823
results O 0 1.2976840713108118e-09
in O 0 1.83103168044374e-11
a O 0 2.288322420440636e-09
mutator O 0 0.0002199351292802021
phenotype O 0 1.9653577965073055e-06
characterized O 0 2.3336481191904568e-08
by O 0 4.794519892215021e-09
leukemia B-Disease 1 0.5299656391143799
and O 0 4.6515506824107433e-07
/ O 0 0.24680057168006897
or O 1 0.8905757069587708
lymphoma B-Disease 1 1.0
associated O 0 9.836536264629103e-06
with O 0 2.8656370432145195e-07
neurofibromatosis B-Disease 1 0.9722070693969727
type I-Disease 0 0.00033670844277366996
1 I-Disease 0 4.445352175252992e-08
. O 0 5.951775877699461e-11
. O 0 3.4141442450952297e-10

Missense O 0 0.000503031478729099
mutations O 0 0.000235077110119164
in O 0 4.896695826595021e-10
the O 0 6.9322303973551325e-12
most O 0 8.746157010436351e-13
ancient O 0 6.459131189975875e-13
residues O 0 1.8424048953136207e-09
of O 0 7.310285189687793e-12
the O 0 1.3685577671118665e-10
PAX6 O 0 1.9147713828715496e-05
paired O 0 4.39951648445458e-08
domain O 0 1.1515651765492407e-09
underlie O 0 2.6161904642663103e-08
a O 0 1.8463756912279194e-10
spectrum O 0 2.6734545244266883e-08
of O 0 7.087340936351438e-09
human O 0 0.0010383323533460498
congenital B-Disease 1 0.999982476234436
eye I-Disease 1 0.9994266033172607
malformations I-Disease 1 0.9990183115005493
. O 0 8.470266266158433e-08

Mutations O 0 2.4205098725360585e-06
of O 0 6.84663714611844e-11
the O 0 9.061398853482672e-11
human O 0 1.2239733671037811e-08
PAX6 O 0 0.0007125010015442967
gene O 0 7.757974526612088e-05
underlie O 1 0.8818233013153076
aniridia B-Disease 1 0.9999997615814209
( O 0 4.3378320697229356e-05
congenital B-Disease 1 0.9999876022338867
absence I-Disease 0 6.127692131485674e-07
of I-Disease 0 4.84102098685657e-11
the I-Disease 0 4.6473780379585605e-10
iris I-Disease 0 5.207303911447525e-05
) O 0 9.887726054591539e-11
, O 0 2.1279091769882408e-12
a O 0 1.834675189549273e-10
rare O 0 1.3706079471376142e-07
dominant O 0 0.00147896574344486
malformation B-Disease 1 0.9997584223747253
of I-Disease 0 5.270774039445314e-09
the I-Disease 0 3.021025634097896e-07
eye I-Disease 1 0.822229266166687
. O 0 1.0470201061707485e-07

The O 0 4.354912541693068e-10
spectrum O 0 3.784899949010878e-09
of O 0 7.279899599810236e-11
PAX6 O 0 8.509814506396651e-05
mutations O 0 9.349794709123671e-06
in O 0 3.389140967868798e-09
aniridia B-Disease 1 0.999998927116394
patients O 0 1.309077219957544e-07
is O 0 3.072229970424445e-12
highly O 0 1.1917977021935755e-11
biased O 0 4.0643715060184604e-09
, O 0 8.986351593409658e-12
with O 0 8.106855464706797e-12
92 O 0 3.504696310940858e-09
% O 0 4.750036627053367e-13
of O 0 2.378076576804722e-13
all O 0 8.578145832549566e-11
reported O 0 1.9739944789876063e-08
mutations O 0 2.8168559040864238e-08
leading O 0 2.347908534261478e-08
to O 0 1.299761687167944e-10
premature O 0 1.486815737195002e-08
truncation O 0 7.887823727514842e-09
of O 0 5.5300646006894993e-11
the O 0 3.926456659808508e-10
protein O 0 2.2379426312113537e-08
( O 0 6.95710633200064e-12
nonsense O 0 2.311978164470929e-09
, O 0 4.4086086235621547e-14
splicing O 0 1.7345317890327117e-11
, O 0 6.441352984852544e-13
insertions O 0 1.652011860642233e-10
and O 0 3.275379967249137e-11
deletions O 0 3.844430551680489e-09
) O 0 3.2293515084269586e-11
and O 0 1.2796376458457104e-10
just O 0 2.65611133087873e-09
2 O 0 8.349825830755719e-10
% O 0 3.456927940518467e-13
leading O 0 1.1764629548327576e-10
to O 0 5.062061338677315e-13
substitution O 0 8.71814339470367e-13
of O 0 3.9798107301022845e-13
one O 0 4.194519731548496e-11
amino O 0 9.470470241357276e-11
acid O 0 2.3875550841934157e-11
by O 0 6.636563586008559e-13
another O 0 2.3465718257398294e-10
( O 0 2.940100246595634e-11
missense O 0 7.308626237545468e-08
) O 0 7.674718499606215e-11
. O 0 1.2532606896709098e-10

The O 0 5.618245868532767e-10
extraordinary O 0 1.0207867884304278e-09
conservation O 0 2.9159348546858865e-11
of O 0 6.209825405625868e-13
the O 0 6.331932374259441e-12
PAX6 O 0 8.194768383873452e-07
protein O 0 2.2787838283022666e-09
at O 0 1.5471217362783563e-10
the O 0 3.264357967963649e-12
amino O 0 5.721194074048697e-10
acid O 0 9.301623915547452e-10
level O 0 5.480066400664896e-10
amongst O 0 2.967243117879548e-11
vertebrates O 0 4.296556721516964e-10
predicts O 0 3.8017311965177214e-08
that O 0 6.389087869873578e-11
pathological O 0 4.6210689674808236e-07
missense O 0 8.164259270415641e-06
mutations O 0 4.5921329729026183e-05
should O 0 7.997338258292075e-08
in O 0 2.0020507821016942e-11
fact O 0 1.7938336926981435e-10
be O 0 5.177903661390815e-10
common O 0 1.4560166960997378e-10
even O 0 8.093113956775255e-10
though O 0 1.2778278435376933e-10
they O 0 1.1665547867967252e-11
are O 0 8.935857696151794e-13
hardly O 0 3.2916003256389104e-11
ever O 0 1.7549061093191654e-09
seen O 0 1.1793380849667301e-07
in O 0 7.092219589388549e-10
aniridia B-Disease 1 0.9999947547912598
patients O 0 1.7935964535809035e-07
. O 0 3.120964875424903e-10

This O 0 6.149378228847979e-11
indicates O 0 2.6474811232191087e-10
that O 0 1.822278656096743e-12
there O 0 1.2755984419784983e-12
is O 0 5.318999581060968e-12
a O 0 5.153348234254729e-11
heavy O 0 4.192670388647457e-08
ascertainment O 0 1.5965804323059274e-06
bias O 0 4.8416842446386e-07
in O 0 3.1458418769253482e-12
the O 0 1.3650988976363077e-13
selection O 0 8.150900202182065e-13
of O 0 2.2077936267378417e-12
patients O 0 4.924257529514975e-11
for O 0 1.7628474634906466e-12
PAX6 O 0 2.1407046801869e-07
mutation O 0 9.46244083088743e-10
analysis O 0 1.4474330067848484e-10
and O 0 1.6274359637691305e-10
that O 0 1.5835138755804223e-11
the O 0 1.390549758673032e-10
missing O 0 1.7261108951061033e-06
PAX6 O 0 0.0016071252757683396
missense O 0 0.0003819889680016786
mutations O 0 0.00015847003669478
frequently O 0 7.859935635678994e-07
may O 0 9.321520444416365e-09
underlie O 0 3.8721179862477584e-07
phenotypes O 0 7.35690548481216e-08
distinct O 0 2.414470012812586e-10
from O 0 4.578556977996584e-10
textbook O 0 0.00030070607317611575
aniridia B-Disease 1 0.9999843835830688
. O 0 2.4693223465988012e-08

Here O 0 4.640842821146407e-09
we O 0 6.39678171543423e-11
present O 0 1.3776285884628536e-12
four O 0 1.428924036386836e-12
novel O 0 2.90788892964855e-10
PAX6 O 0 6.1273458413779736e-06
missense O 0 1.1208568366782856e-06
mutations O 0 8.630375987195293e-07
, O 0 2.4020027286630885e-11
two O 0 3.21560833516088e-11
in O 0 1.3444088897696105e-10
association O 0 6.817945652493052e-10
with O 0 4.08851896782636e-10
atypical O 0 1.2669950137933483e-06
phenotypes O 0 5.274759473650192e-07
ectopia B-Disease 0 4.7711215302115306e-05
pupillae I-Disease 0 5.045055513619445e-05
( O 0 1.5072640358049227e-10
displaced B-Disease 0 1.0263450089809112e-09
pupils I-Disease 0 1.7292721921080556e-08
) O 0 2.506351570730203e-09
and O 0 7.481116313101666e-07
congenital B-Disease 1 0.9999569654464722
nystagmus I-Disease 0 0.0005894624046050012
( O 0 1.1102045671673721e-10
searching B-Disease 0 7.824692893620977e-09
gaze I-Disease 0 0.001263890997506678
) O 0 1.867559579205036e-10
, O 0 2.5631380698443174e-12
and O 0 6.651343538444099e-12
two O 0 1.179086255714834e-11
in O 0 4.447432006005059e-11
association O 0 1.1332826170551424e-11
with O 0 1.884022451936751e-12
more O 0 4.768195560611588e-11
recognizable O 0 5.1646988140419126e-05
aniridia B-Disease 1 0.9999730587005615
phenotypes O 0 9.687370948086027e-06
. O 0 3.9821421715657834e-09

Strikingly O 0 5.004998797630833e-07
, O 0 1.5978958434192947e-10
all O 0 2.4119452095294758e-12
four O 0 3.235554185687661e-11
mutations O 0 3.326334985231938e-09
are O 0 5.61929018941254e-12
located O 0 5.836780364587568e-11
within O 0 6.282896512083136e-12
the O 0 2.3321908293461036e-10
PAX6 O 0 3.2533487683394924e-05
paired O 0 5.277093961808532e-08
domain O 0 2.056991732501956e-08
and O 0 1.5514841633645915e-09
affect O 0 3.279857774263206e-10
amino O 0 6.43098699293354e-11
acids O 0 4.7278781584170204e-11
which O 0 1.4270501013519121e-12
are O 0 2.1514887582011616e-13
highly O 0 2.970287644316061e-12
conserved O 0 1.8306063609419e-10
in O 0 2.3278831987050275e-11
all O 0 1.0786795068273847e-10
known O 0 3.1921090215547565e-09
paired O 0 1.2016143635662502e-08
domain O 0 1.1339436944979298e-08
proteins O 0 6.1870091272453465e-09
. O 0 3.7042516276564186e-10

Our O 0 3.276209525893137e-08
results O 0 5.945254843986447e-10
support O 0 1.5588566895652356e-11
the O 0 3.058558723130489e-13
hypothesis O 0 2.6187326612747697e-11
that O 0 4.759007424248729e-12
the O 0 2.3459385475876893e-12
under O 0 1.72447806034981e-10
- O 0 5.645460987580009e-08
representation O 0 2.20252149851774e-10
of O 0 8.902977313707261e-12
missense O 0 1.0007859145844122e-06
mutations O 0 5.265893605610472e-07
is O 0 9.795583233440652e-10
caused O 0 1.0891472168594873e-09
by O 0 1.9320411590029174e-11
ascertainment O 0 1.5816100130905397e-05
bias O 0 3.309392195660621e-05
and O 0 5.938126657056841e-10
suggest O 0 8.117319316713889e-11
that O 0 1.1687768808332777e-12
a O 0 7.588137583558474e-12
substantial O 0 5.595157670512663e-10
burden O 0 2.7167525331606157e-06
of O 0 2.343186200626235e-10
PAX6 B-Disease 0 0.002368464134633541
- I-Disease 0 0.0009128367528319359
related I-Disease 0 5.6270917411893606e-05
disease I-Disease 0 0.0008056274382397532
remains O 0 1.5302102696068687e-08
to O 0 2.705062215890841e-11
be O 0 1.466020776996757e-10
uncovered O 0 4.854375106333464e-07
. O 0 6.059494572774327e-11
. O 0 1.84360637867087e-10

The O 0 1.6954069259611515e-09
chromosomal O 0 9.082127508008853e-05
order O 0 2.3560392525823204e-10
of O 0 2.8775512788542512e-12
genes O 0 3.5555440813794803e-09
controlling O 0 3.0573439744330244e-06
the O 0 4.0953088142892113e-10
major O 0 2.40463626788312e-09
histocompatibility O 0 1.0654082949201893e-08
complex O 0 1.4374075540946052e-10
, O 0 2.1176253025417813e-12
properdin O 0 3.7939585695312417e-08
factor O 0 1.6454913875918464e-08
B O 0 1.869797983999888e-06
, O 0 7.693438108802297e-10
and O 0 2.7142657899048572e-08
deficiency B-Disease 0 9.086538739211392e-07
of I-Disease 0 1.2587207751796337e-13
the I-Disease 0 5.1522449501240075e-12
second I-Disease 0 1.7799868246015649e-09
component I-Disease 0 3.240151924543966e-09
of I-Disease 0 8.965156741980174e-12
complement I-Disease 0 7.276436342351644e-09
. O 0 5.297480232258067e-10

The O 0 8.376240812069113e-10
relationship O 0 3.1846898451703964e-09
of O 0 4.938521380032368e-13
the O 0 2.9089106340710047e-13
genes O 0 1.3280308276686359e-11
coding O 0 7.219724262874649e-10
for O 0 3.631257620984041e-12
HLA O 0 6.518460216042854e-10
to O 0 5.331673145515803e-13
those O 0 2.076372385660663e-13
coding O 0 4.6198922465379155e-10
for O 0 8.562872633177676e-12
properdin O 0 5.2968186281532326e-08
Factor O 0 9.071069451138669e-10
B O 0 1.618355938148852e-08
allotypes O 0 1.5143145049023587e-07
and O 0 6.712383981977155e-10
for O 0 4.764307282023594e-10
deficiency B-Disease 0 2.534326313252677e-07
of I-Disease 0 7.075666685592633e-14
the I-Disease 0 2.1548904154122805e-12
second I-Disease 0 1.8862114092854654e-09
component I-Disease 0 5.224383148316747e-09
of I-Disease 0 7.42792979901985e-11
complement I-Disease 0 4.3683858308440904e-08
( O 0 6.289377352253211e-10
C2 O 0 2.4617756935185753e-06
) O 0 9.184291348274254e-12
was O 0 1.1505266739320064e-09
studied O 0 1.9806414841561093e-10
in O 0 7.817069474364002e-13
families O 0 2.5017292924756074e-12
of O 0 1.6174955472236796e-11
patients O 0 9.111198906452955e-09
with O 0 4.252908070156991e-08
connective O 1 0.9925808906555176
tissue O 1 0.9994439482688904
disorders O 1 0.9639363884925842
. O 0 1.3061375980782941e-08

Patients O 0 9.44823204918066e-06
were O 0 5.868295849253968e-10
selected O 0 8.725521694064042e-11
because O 0 6.728339413397677e-11
they O 0 6.7516036164616544e-12
were O 0 1.7702206020486777e-11
heterozygous O 0 4.8179882305987576e-09
or O 0 5.6890954169830366e-09
homozygous O 0 0.00028298000688664615
for O 0 0.00011142036964884028
C2 B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999983310699463
. O 0 1.4721420527052942e-08

12 O 0 1.9239031701090425e-07
families O 0 6.148490605539791e-10
with O 0 2.7339068509046882e-11
15 O 0 1.1670983623979225e-10
matings O 0 1.192425287399601e-07
informative O 0 7.025016202533152e-06
for O 0 0.008699747733771801
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
were O 0 9.17128062383199e-09
found O 0 3.1010352063987057e-09
. O 0 5.707438965885103e-10

Of O 0 7.127600176737303e-10
57 O 0 1.0215645218636382e-08
informative O 0 1.2980008179397373e-09
meioses O 0 7.803955099916493e-07
, O 0 1.3284406127217485e-12
two O 0 9.068231734098153e-14
crossovers O 0 5.240880618373467e-09
were O 0 4.2936645905378157e-10
noted O 0 1.6186689488772998e-10
between O 0 1.4413727988937808e-09
the O 0 5.657470319420099e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999991655349731
gene O 0 2.45519449215692e-09
and O 0 6.34305325278306e-12
the O 0 7.834836945885826e-12
HLA O 0 9.409729955223156e-07
- O 0 8.395424083573744e-05
B O 0 8.649276992400701e-07
gene O 0 1.059927035029773e-09
, O 0 2.7131928973488095e-13
with O 0 2.3193877984124985e-14
a O 0 9.332508724146926e-14
recombinant O 0 1.3775977754371116e-11
fraction O 0 7.251213518522093e-11
of O 0 1.8894176154193865e-11
0 O 0 1.1016563661314649e-08
. O 0 3.36813105183964e-10

035 O 0 0.01649819314479828
. O 0 1.168286530628393e-06

A O 0 6.086990822495864e-08
lod O 0 3.022759983650758e-06
score O 0 1.205038824281246e-08
of O 0 1.047185949065721e-11
13 O 0 1.6764532817514777e-10
was O 0 1.2411043547044809e-11
calculated O 0 2.4490135613897124e-11
for O 0 3.6031792133295326e-11
linkage O 0 0.0001884995581349358
between O 0 0.011695368215441704
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
and O 0 4.405005249452643e-09
HLA O 0 1.714847286393706e-07
- O 0 1.5484820323763415e-06
B O 0 9.110002707757303e-08
at O 0 1.4850363994067806e-11
a O 0 6.157420629144053e-14
maximum O 0 8.267028554775901e-13
likelihood O 0 1.378480229269341e-12
value O 0 3.835341061669134e-13
of O 0 1.9626532658193613e-15
the O 0 1.551015751651095e-14
recombinant O 0 1.4603158959847207e-11
fraction O 0 1.8116712990901007e-11
of O 0 6.524685739611735e-12
0 O 0 2.3250767977600617e-09
. O 0 2.851253400049103e-10

04 O 0 0.0019527736585587263
. O 0 2.8920095473949914e-07

18 O 0 1.1359935569998925e-06
families O 0 6.238243255296538e-10
with O 0 2.1469652444761067e-11
21 O 0 1.2829263693059367e-11
informative O 0 2.2318988671110596e-11
matings O 0 3.7104197492254798e-09
for O 0 4.214148561360043e-12
both O 0 9.735150185985475e-12
properdin O 0 1.6993178064694803e-07
Factor O 0 2.6481590253979448e-09
B O 0 8.331411294193458e-08
allotype O 0 1.1459876247954526e-07
and O 0 2.8581467748090006e-10
HLA O 0 3.311369312086754e-07
- O 0 1.8277203707839362e-05
B O 0 5.031022851653688e-07
were O 0 1.264131299638649e-10
found O 0 1.2977575958306176e-10
. O 0 5.082557291702372e-11

Of O 0 2.1071044908893555e-09
72 O 0 1.6724149176639003e-08
informative O 0 4.87932005910352e-09
meioses O 0 6.345125711959554e-06
, O 0 1.6844140665606133e-11
three O 0 9.273058883263463e-12
recombinants O 0 4.566282427731494e-07
were O 0 2.4559004829782793e-10
found O 0 4.516030258083781e-11
, O 0 6.925747274939484e-14
giving O 0 4.696198670824797e-14
a O 0 3.3022416317260786e-14
recombinant O 0 1.3044077970536527e-11
fraction O 0 4.034337794389664e-11
of O 0 1.4427521677351507e-11
0 O 0 5.945768322135336e-09
. O 0 9.72699365497931e-10

042 O 0 0.0007162071415223181
. O 0 6.307818125605991e-07

A O 0 2.750732441825221e-08
lod O 0 3.151794487621373e-07
score O 0 6.807082675308607e-10
of O 0 1.229914932919518e-12
16 O 0 1.9185751945482998e-11
between O 0 4.3219412423911585e-12
HLA O 0 4.073531201242986e-08
- O 0 7.034227564872708e-06
B O 0 5.061755814494973e-07
and O 0 6.840358834914184e-11
Factor O 0 1.5704845757191777e-10
B O 0 3.0785405336075655e-09
allotypes O 0 3.6022760330212122e-09
was O 0 4.436654862938205e-11
calculated O 0 5.38163654265067e-12
at O 0 1.7747813635393683e-11
a O 0 4.114689004016542e-13
maximum O 0 4.788873724653753e-12
likelihood O 0 1.2238127178321179e-11
value O 0 8.187318011054767e-12
of O 0 2.4913083816508093e-14
the O 0 1.8146393404843558e-14
recombinant O 0 6.0813511344737226e-12
fraction O 0 1.3688599732886164e-11
of O 0 3.578016138580664e-12
0 O 0 2.816677335815143e-09
. O 0 3.0528402028551227e-10

04 O 0 0.0036571905948221684
. O 0 7.018949759185489e-07

A O 0 2.2659762954901908e-09
crossover O 0 7.227333398418523e-09
was O 0 1.0797370464388223e-07
shown O 0 3.526897385253136e-10
to O 0 3.926640262941206e-12
have O 0 3.724282601064166e-12
occurred O 0 8.772387655696379e-13
between O 0 9.437853872983765e-14
genes O 0 7.45458122314302e-12
for O 0 4.955300059172885e-12
Factor O 0 7.315271166596915e-10
B O 0 2.6236209649255215e-08
and O 0 9.949151918986487e-11
HLA O 0 4.10475990975101e-08
- O 0 7.673668733332306e-06
D O 0 6.9129132498346735e-06
, O 0 8.67731613559547e-13
in O 0 6.298368266819884e-14
which O 0 4.271923093046581e-12
HLA O 0 3.8530213686271964e-08
- O 0 2.975959978357423e-05
D O 0 2.120228782587219e-05
segregared O 0 2.3071160981658068e-08
with O 0 6.781727089621992e-12
HLA O 0 6.577312028355209e-09
- O 0 6.330689217293184e-08
A O 0 2.3269588922403273e-08
and O 0 1.8123851308615713e-09
B O 0 6.50767120191631e-08
. O 0 1.3726464409558048e-10

These O 0 9.464493772037841e-11
studies O 0 2.011401462054252e-11
suggest O 0 2.2118917808455762e-11
that O 0 2.0976368428696213e-13
the O 0 3.9012914535181686e-14
genes O 0 1.361774148306294e-11
for O 0 6.679494457539903e-11
Factor O 0 5.07054949139274e-07
B O 0 0.08279047906398773
and O 0 0.14931218326091766
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
are O 0 6.029426957709916e-11
located O 0 3.531789444233269e-11
outside O 0 2.0048592994093006e-11
those O 0 7.738297849724241e-13
for O 0 3.027069697333906e-12
HLA O 0 1.1315234305087074e-09
, O 0 9.740903830074421e-13
that O 0 1.168234617116709e-13
the O 0 5.026712553146684e-13
order O 0 3.59071843439307e-12
of O 0 4.077018670584076e-13
genese O 0 1.7069526236923593e-08
is O 0 1.012712570053198e-11
HLA O 0 3.556166194851329e-10
- O 0 1.4222841571154277e-08
A O 0 8.955548302935767e-09
, O 0 1.7221073525530706e-11
- O 0 6.122107976125335e-08
B O 0 5.2398238636897077e-08
, O 0 8.61437570581769e-12
- O 0 9.393934874424303e-08
D O 0 5.362886099646857e-07
, O 0 1.1247781135301227e-12
Factor O 0 2.096036261223233e-10
B O 0 5.523810386875994e-07
allotype O 0 0.0003159142506774515
, O 0 5.16023465024773e-06
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999996423721313
, O 0 3.140432792286818e-13
that O 0 1.1747294963496656e-14
the O 0 1.6074491184740053e-13
genes O 0 1.2722156661482131e-09
coding O 0 2.0299665266065858e-05
for O 0 0.001158532570116222
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
and O 0 1.0289636920290945e-09
Factor O 0 1.3230766482408285e-09
B O 0 2.511688812489865e-08
allotypes O 0 7.497627407815344e-09
are O 0 4.3257162175153185e-13
approximately O 0 1.3301950686772646e-12
3 O 0 4.576232448538775e-11
- O 0 5.394966962057879e-08
- O 0 1.717862261330083e-07
5 O 0 1.584239683882771e-10
centimorgans O 0 3.9770844950659523e-10
from O 0 3.900525058107493e-14
the O 0 4.073984869617554e-14
HLA O 0 2.4165433543110737e-10
- O 0 1.1985693548766108e-09
A O 0 7.77363617920912e-10
and O 0 5.328293362083514e-11
HLA O 0 2.3187713082961636e-08
- O 0 1.052525931299897e-06
B O 0 1.7516262218464362e-08
loci O 0 1.2565877505199552e-10
, O 0 1.7432270904560454e-12
and O 0 3.946053824411405e-13
that O 0 3.3355978569515887e-13
the O 0 3.2155085885610113e-12
apparent O 0 3.87004783775069e-09
lack O 0 4.764068306517544e-11
of O 0 3.7819340758041275e-13
recombinants O 0 1.72594738501175e-08
between O 0 4.986283955177306e-12
the O 0 8.011796955031958e-12
Factor O 0 1.1047347037163036e-08
B O 0 3.5202251638111193e-06
gene O 0 9.796235644898843e-06
and O 0 0.002146443584933877
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999995231628418
gene O 0 2.261896803190666e-08
suggests O 0 4.6021617072788956e-10
that O 0 2.1165994304461755e-12
these O 0 9.591452794759786e-14
two O 0 1.2382385915221672e-11
genes O 0 9.654874233433475e-09
lie O 0 2.8118805062149477e-07
in O 0 1.3610964785804036e-11
close O 0 1.487501344321629e-09
proximity O 0 5.991472318278568e-10
to O 0 8.292495162764979e-11
one O 0 1.0360923924368493e-10
another O 0 3.0914444337781788e-09
. O 0 2.0971291370130984e-09

Distribution O 0 1.3683400190700468e-08
of O 0 2.728881010050088e-10
emerin O 0 1.5485675248783082e-05
and O 0 9.43254585550335e-10
lamins O 0 1.2013631476293085e-06
in O 0 1.6076162970279917e-11
the O 0 4.801268757570476e-11
heart O 0 1.6440200312217712e-08
and O 0 1.9721889052415342e-11
implications O 0 2.002605581363781e-10
for O 0 3.6137595693652713e-10
Emery B-Disease 0 0.031704679131507874
- I-Disease 1 0.9999253749847412
Dreifuss I-Disease 1 0.9999678134918213
muscular I-Disease 1 0.9999188184738159
dystrophy I-Disease 1 0.9992018342018127
. O 0 1.3104612150982575e-07

Emerin O 0 0.00020091832266189158
is O 0 1.0820621731966185e-08
a O 0 5.410563108654287e-10
nuclear O 0 3.2762466162239434e-06
membrane O 0 3.953912308674035e-09
protein O 0 1.9194554834456312e-09
which O 0 2.5436392575572953e-11
is O 0 8.249627543588378e-12
missing O 0 1.4596120145871083e-10
or O 0 2.803881016255616e-10
defective O 0 1.081990103557473e-05
in O 0 4.188192459508855e-09
Emery B-Disease 1 0.9848685264587402
- I-Disease 1 0.9999936819076538
Dreifuss I-Disease 1 0.9999979734420776
muscular I-Disease 1 0.9999949932098389
dystrophy I-Disease 1 0.9999611377716064
( O 0 1.6116810002131388e-06
EDMD B-Disease 1 0.9999933242797852
) O 0 2.6448780943155725e-09
. O 0 7.273989743872278e-10

It O 0 2.0458275074020094e-09
is O 0 1.7535466134699362e-10
one O 0 2.8155732953449863e-11
member O 0 2.8738667695593634e-11
of O 0 1.1063835394717336e-12
a O 0 6.287314557873458e-10
family O 0 2.5688682292468457e-09
of O 0 4.349481538823419e-11
lamina O 0 1.6629604715490132e-06
- O 0 0.00015076350246090442
associated O 0 2.738073989760892e-09
proteins O 0 3.1135372058344046e-11
which O 0 2.7730838458861484e-12
includes O 0 1.4334315852349011e-11
LAP1 O 0 4.739632004202576e-06
, O 0 7.973870869149025e-11
LAP2 O 0 4.252350208844291e-06
and O 0 3.023508332589131e-09
lamin O 0 0.0004944446263834834
B O 0 0.00016843450430314988
receptor O 0 7.075214512042294e-07
( O 0 8.90393703212311e-10
LBR O 0 0.00022071742569096386
) O 0 3.049673846788892e-10
. O 0 1.3594236847325192e-10

A O 0 9.891361685276934e-08
panel O 0 4.773407624725223e-08
of O 0 9.030858699743405e-11
16 O 0 2.7936333246714184e-09
monoclonal O 0 1.2182530539917025e-08
antibodies O 0 1.3695019340786985e-08
( O 0 2.696988032208081e-12
mAbs O 0 4.791583241292585e-10
) O 0 2.865479988706232e-12
has O 0 3.9930520695508065e-11
been O 0 2.379449241807219e-11
mapped O 0 9.979080317634725e-08
to O 0 9.503148962197727e-11
six O 0 1.1123093418552443e-10
specific O 0 8.075523756645442e-13
sites O 0 6.653186335192629e-11
throughout O 0 7.910784115446046e-13
the O 0 4.3984648280363803e-13
emerin O 0 1.429228735361221e-09
molecule O 0 4.148070342074872e-12
using O 0 1.285976446857573e-11
phage O 0 9.971689030052744e-10
- O 0 3.934024661589319e-08
displayed O 0 1.016823247823595e-08
peptide O 0 1.38144273797991e-10
libraries O 0 1.1320900814015822e-11
and O 0 3.6383170781695284e-11
has O 0 7.948452313000232e-11
been O 0 3.0553667235144744e-11
used O 0 2.480794736303693e-11
to O 0 5.263773791841508e-12
localize O 0 4.8886754200339055e-08
emerin O 0 1.1200745575479232e-06
in O 0 1.3996868768184623e-11
human O 0 9.37590116656395e-10
and O 0 1.5337832115491778e-09
rabbit O 0 0.0012779514072462916
heart O 0 2.00664817384677e-05
. O 0 2.643203655949833e-09

Several O 0 2.1596378019239637e-09
mAbs O 0 1.377369187594013e-07
against O 0 7.722282813205084e-10
different O 0 1.8514210997633285e-11
emerin O 0 3.8826786408208136e-07
epitopes O 0 2.2071124305966805e-07
did O 0 2.8782911609681605e-09
not O 0 1.3573062812577419e-11
recognize O 0 1.1396010003716928e-11
intercalated O 0 1.2918311975695929e-09
discs O 0 6.835992394371715e-07
in O 0 1.8495409370711258e-10
the O 0 1.1387114584593405e-09
heart O 0 1.6677584824265068e-07
, O 0 1.3063746265307152e-11
though O 0 1.9338145668124085e-11
they O 0 1.9276387777655835e-11
recognized O 0 4.3048474507312307e-11
cardiomyocyte O 0 6.543864117247722e-09
nuclei O 0 1.0433684471955473e-10
strongly O 0 5.39891464867992e-10
, O 0 9.05921171412416e-13
both O 0 4.465875586001644e-12
at O 0 3.5995972869073967e-09
the O 0 7.036597415854828e-10
rim O 0 3.714001422849833e-06
and O 0 2.9736708651029176e-09
in O 0 1.9065152234709615e-11
intranuclear O 0 4.669168731652462e-07
spots O 0 1.1992194792753708e-08
or O 0 1.8839210191856637e-09
channels O 0 1.2470033539102587e-07
. O 0 2.6241653294789558e-09

A O 0 8.30288797715184e-08
polyclonal O 0 2.621911107780761e-06
rabbit O 0 7.318310508708237e-06
antiserum O 0 5.26379699294921e-06
against O 0 1.138806879907861e-07
emerin O 0 2.7179964945389656e-06
did O 0 7.361586895626715e-10
recognize O 0 3.8105896910112236e-11
both O 0 4.733559898217887e-12
nuclear O 0 3.754496162855503e-07
membrane O 0 8.236146209483763e-10
and O 0 3.562260902922887e-11
intercalated O 0 1.2514602687474508e-09
discs O 0 2.959888831810531e-07
but O 0 1.902596552527669e-10
, O 0 2.612075323833035e-13
after O 0 7.178917291357501e-13
affinity O 0 9.036915096446996e-13
purification O 0 7.436091672974321e-12
against O 0 8.268625367735538e-12
a O 0 1.4561318730649253e-12
pure O 0 7.805396606830328e-11
- O 0 2.3358850285148947e-06
emerin O 0 1.2294598263906664e-06
band O 0 4.1533393391191e-10
on O 0 3.4274399290934454e-11
a O 0 5.2676932260631304e-11
western O 0 7.712386979052965e-11
blot O 0 5.364438038668595e-06
, O 0 4.0637312959113103e-11
it O 0 2.3881882582621472e-11
stained O 0 2.0243367544026114e-05
only O 0 2.6497328636798656e-11
the O 0 2.974496343677302e-11
nuclear O 0 4.517029083217494e-06
membrane O 0 1.6233517641239814e-08
. O 0 1.1172364144940161e-09

These O 0 4.141133824742127e-10
results O 0 1.4993223329540228e-09
would O 0 2.8785696049027365e-10
not O 0 2.2335586071647873e-12
be O 0 4.970730424491698e-12
expected O 0 1.2744244895501744e-11
if O 0 2.1119789944679113e-11
immunostaining O 0 1.8953977942715028e-08
at O 0 9.025882125035523e-11
intercalated O 0 1.452383990852013e-09
discs O 0 7.904881158538046e-07
were O 0 4.4705865676064604e-09
due O 0 1.4142747736811678e-11
to O 0 1.3354770035060165e-13
a O 0 1.058781859929192e-12
product O 0 1.823914769216728e-10
of O 0 4.1270445719741866e-13
the O 0 2.209479821324578e-11
emerin O 0 2.387001529768895e-07
gene O 0 3.328505693289685e-09
and O 0 2.7395458124246375e-10
, O 0 4.0523747552034806e-12
therefore O 0 2.740666634609701e-12
, O 0 6.038074771078095e-13
cast O 0 1.1707951275141681e-10
some O 0 7.565988986582908e-14
doubt O 0 9.17243971748638e-12
upon O 0 4.6221124258734314e-14
the O 0 3.5300552086482695e-13
hypothesis O 0 4.239014694817911e-10
that O 0 5.212926090791825e-09
cardiac B-Disease 0 0.00020081720140296966
defects I-Disease 1 0.9579043388366699
in O 0 2.7282123227223565e-08
EDMD B-Disease 1 0.9999998807907104
are O 0 7.970381687982808e-09
caused O 0 3.0820597185510223e-09
by O 0 2.1535478261780483e-11
absence O 0 2.5553950067092046e-09
of O 0 5.505059602617379e-11
emerin O 0 1.4754620679013897e-05
from O 0 3.1518751497650044e-10
intercalated O 0 2.585183835890348e-07
discs O 0 2.5749635824467987e-05
. O 0 4.347412208005608e-09

Although O 0 1.796996151881558e-08
emerin O 0 1.9181959487468703e-06
was O 0 8.654622796200329e-09
abundant O 0 3.47181866588997e-11
in O 0 7.923347850220808e-13
the O 0 3.594075991680823e-12
membranes O 0 8.218151492656034e-09
of O 0 4.285448038099382e-11
cardiomyocyte O 0 5.087269414616458e-07
nuclei O 0 1.0978193909494394e-09
, O 0 2.0173104506304718e-11
it O 0 1.2382669542509994e-11
was O 0 4.0164072068193946e-09
absent O 0 1.7945420149878544e-10
from O 0 1.3039941305567626e-12
many O 0 4.756219289941965e-13
non O 0 6.535158192377821e-09
- O 0 8.166463771885901e-07
myocyte O 0 3.0107228212727932e-06
cells O 0 3.218286748207788e-09
in O 0 2.608865380671066e-12
the O 0 1.480511963025677e-10
heart O 0 4.1025495534086076e-07
. O 0 1.3627811101812881e-09

This O 0 3.025662706490628e-11
distribution O 0 2.37698749572246e-10
of O 0 1.3511690898082573e-11
emerin O 0 1.6252405430350336e-06
was O 0 5.08815878319524e-09
similar O 0 5.500771821549677e-13
to O 0 5.539454528760701e-13
that O 0 9.2198633710322e-13
of O 0 9.537605080711664e-13
lamin O 0 5.686179633812571e-07
A O 0 8.094599657226809e-09
, O 0 2.5830438048907167e-12
a O 0 1.5408004733208358e-12
candidate O 0 1.1850970725590937e-11
gene O 0 3.9116634931168903e-10
for O 0 8.344917812319608e-11
an O 0 3.1438309733289316e-09
autosomal O 0 0.00018223465303890407
form O 0 1.4947552529065433e-07
of O 0 7.705243660893757e-07
EDMD B-Disease 1 0.9999994039535522
. O 0 1.9355266545062477e-07

In O 0 2.4627642147834194e-09
contrast O 0 5.271055592004359e-09
, O 0 4.130263631108022e-10
lamin O 0 0.0004374467534944415
B1 O 1 0.8816395401954651
was O 0 4.3672571337083355e-07
absent O 0 2.522624331646739e-09
from O 0 6.386806014613278e-12
cardiomyocyte O 0 5.745396602918618e-09
nuclei O 0 6.686785847254129e-11
, O 0 3.397795933501868e-12
showing O 0 1.7549670161542963e-08
that O 0 8.611854562801113e-10
lamin O 0 0.00024321151431649923
B1 O 0 0.15724152326583862
is O 0 2.2243736019778027e-10
not O 0 4.3433423632839585e-13
essential O 0 3.540243456463116e-13
for O 0 6.644666506469901e-14
localization O 0 5.1134006751052397e-11
of O 0 1.4885746715126436e-12
emerin O 0 9.237065512479603e-08
to O 0 8.57540947973856e-12
the O 0 7.134669938180238e-11
nuclear O 0 5.335467903933022e-06
lamina O 0 5.286559030537319e-07
. O 0 1.3737735393704043e-09

Lamin O 1 0.7752618789672852
B1 O 1 0.9977884292602539
is O 0 2.5424455429856607e-07
also O 0 9.567608927341098e-10
almost O 0 8.029133607978522e-11
completely O 0 1.7380049399662312e-08
absent O 0 1.5961329324909457e-07
from O 0 2.5051711816104216e-09
skeletal O 0 0.013488425873219967
muscle O 0 1.296326627198141e-05
nuclei O 0 1.1774871921943486e-07
. O 0 4.3413468375774755e-09

In O 0 9.840479009426417e-08
EDMD B-Disease 1 0.9999548196792603
, O 0 2.4826692784918336e-11
the O 0 2.5921582588739334e-13
additional O 0 1.1081561016035302e-11
absence O 0 2.645673680135019e-10
of O 0 2.3605450927277616e-11
lamin O 0 0.0036359173245728016
B1 O 1 0.9827909469604492
from O 0 7.999535256431045e-08
heart O 0 6.362662134051789e-06
and O 0 1.2877707433744945e-07
skeletal O 0 0.030279917642474174
muscle O 0 1.128952021645091e-06
nuclei O 0 1.3036179913328283e-09
which O 0 1.3608123516917203e-09
already O 0 2.125711375811079e-07
lack O 0 1.4308435547505383e-09
emerin O 0 1.209593506246165e-06
may O 0 1.8793273603989746e-09
offer O 0 6.43861374806376e-13
an O 0 8.94960104289022e-14
alternative O 0 5.711884415969537e-13
explanation O 0 4.937541803369527e-13
of O 0 9.645873509656067e-13
why O 0 1.5618820681240209e-09
these O 0 1.2733456650204644e-11
tissues O 0 1.3709628099434212e-08
are O 0 1.0096421962368929e-11
particularly O 0 2.5670729431048755e-11
affected O 0 6.792837820013276e-11
. O 0 3.5118641935477646e-12
. O 0 1.2786421921262558e-10

Genetic O 0 1.5070592951360595e-07
mapping O 0 4.7240270362181036e-08
of O 0 3.137019255472495e-10
the O 0 2.126078868514014e-09
copper B-Disease 0 0.00016039630281738937
toxicosis I-Disease 0 2.3124319341150112e-05
locus O 0 1.3601777482108446e-07
in O 0 2.08638772924985e-10
Bedlington O 0 1.0973092685162555e-05
terriers O 0 7.440217450493947e-05
to O 0 1.4320339358775414e-09
dog O 0 5.1673694542841986e-05
chromosome O 0 5.8442383306100965e-05
10 O 0 4.731428138171623e-09
, O 0 1.6080448604627318e-12
in O 0 4.08840333549626e-13
a O 0 1.5684670229276776e-10
region O 0 9.814509205341437e-10
syntenic O 0 6.992038947828405e-07
to O 0 4.797131095135576e-11
human O 0 1.921580228270159e-09
chromosome O 0 2.886009133362677e-05
region O 0 1.634960788976514e-08
2p13 O 0 2.2143588296330563e-07
- O 0 1.9898275240848307e-06
p16 O 0 3.362819995800237e-07
. O 0 9.121505217812853e-10

Abnormal O 1 0.9963855743408203
hepatic B-Disease 1 0.9994718432426453
copper I-Disease 0 0.18676549196243286
accumulation I-Disease 0 7.994446605152916e-06
is O 0 9.070710405012505e-09
recognized O 0 1.4972105777388833e-09
as O 0 6.579030653597329e-09
an O 0 2.8208376079419395e-06
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 2.519856536764564e-07
man O 0 0.0014556602109223604
, O 0 3.017164018626062e-10
mouse O 0 2.8504355213954113e-06
, O 0 5.223094734496669e-10
rat O 0 2.7860158297698945e-05
and O 0 6.725882073510547e-09
dog O 0 8.401077502639964e-05
. O 0 5.315031970098971e-09

The O 0 8.29807245139591e-09
major O 0 2.1615969103550015e-07
cause O 0 7.174293870093607e-08
of O 0 4.452138213650869e-09
hepatic B-Disease 1 0.9680172204971313
copper I-Disease 0 0.4722616672515869
accumulation I-Disease 0 7.379556336672977e-06
in O 0 1.3152415823114438e-09
man O 0 6.346614554786356e-06
is O 0 3.725408870280944e-10
a O 0 4.75279871015033e-10
dysfunctional O 0 8.943327884480823e-06
ATP7B O 0 6.359813414746895e-05
gene O 0 6.089592119451481e-08
, O 0 1.317648767873436e-10
causing O 0 4.7498582489424734e-07
Wilson B-Disease 0 0.0004105647385586053
disease I-Disease 0 0.018757494166493416
( O 0 6.019458709261016e-09
WD B-Disease 0 0.0008258313755504787
) O 0 9.469969253217414e-10
. O 0 4.213124016327896e-10

Mutations O 0 1.7860595107777044e-05
in O 0 1.3331478976308375e-10
the O 0 2.4272637719202628e-11
ATP7B O 0 9.846362445387058e-06
genes O 0 5.294353755402881e-08
have O 0 1.1226107821116216e-09
also O 0 1.0619459478444782e-10
been O 0 9.998613742512319e-11
demonstrated O 0 3.068378190418386e-11
in O 0 1.886518068497378e-12
mouse O 0 2.5929816729330923e-06
and O 0 2.7177213368645425e-08
rat O 0 0.00044567830627784133
. O 0 3.1092082242167862e-09

The O 0 3.3074127880894366e-09
ATP7B O 0 5.689690624421928e-06
gene O 0 8.682716270413948e-07
has O 0 1.1197607285851063e-08
been O 0 2.2547444467058142e-10
excluded O 0 2.927968978383433e-10
in O 0 1.3864056387299928e-13
the O 0 1.928751348087912e-13
much O 0 3.7343423492375294e-11
rarer O 0 1.6439798855572008e-07
human O 0 1.0798522964705626e-07
copper B-Disease 0 0.026192735880613327
overload I-Disease 0 0.02146659418940544
disease O 0 0.18322348594665527
non B-Disease 0 8.719012839719653e-06
- I-Disease 0 0.03804496303200722
Indian I-Disease 0 2.3744171357975574e-06
childhood I-Disease 0 1.5119872841751203e-05
cirrhosis I-Disease 0 4.2132549424422905e-05
, O 0 1.0204451866835385e-11
indicating O 0 7.387891409749159e-10
genetic O 0 4.9692992831751326e-08
heterogeneity O 0 1.1953370631090365e-06
. O 0 8.550384400507482e-09

By O 0 7.601037022020307e-10
investigating O 0 6.923509943135286e-08
the O 0 3.4133904591726605e-09
common O 0 1.0292782235410414e-06
autosomal O 1 0.9729214906692505
recessive O 1 0.9996819496154785
copper B-Disease 1 0.9997074007987976
toxicosis I-Disease 0 0.42094069719314575
( O 0 3.864500719430453e-09
CT B-Disease 0 0.0003000273718498647
) O 0 8.44254388621124e-11
in O 0 6.871018944781815e-12
Bedlington O 0 9.903790669341106e-06
terriers O 0 0.0005128097254782915
, O 0 5.04422892344536e-10
we O 0 8.477236967951995e-11
have O 0 2.2007640935323147e-12
identified O 0 3.646679746366344e-12
a O 0 6.500137342442536e-13
new O 0 2.706130285135e-11
locus O 0 1.521282122496359e-08
involved O 0 4.186341584500042e-08
in O 0 2.590924275125417e-08
progressive O 0 0.04157876595854759
liver B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999982118606567
. O 0 1.895096772841498e-07

We O 0 3.136643833556718e-09
examined O 0 2.3999260356788454e-09
whether O 0 7.184636219292884e-11
the O 0 2.6547713680158402e-11
WD B-Disease 0 0.000124176440294832
gene O 0 1.977024624011392e-07
ATP7B O 0 9.93332068901509e-05
was O 0 8.063015144443852e-08
also O 0 2.5301004347166867e-11
causative O 0 1.5493697436141929e-09
for O 0 1.6955336874097116e-12
CT B-Disease 0 1.2806738141080132e-06
by O 0 6.857573103119519e-12
investigating O 0 1.7923682094078686e-08
the O 0 1.6473392094873418e-10
chromosomal O 0 0.0010396522702649236
co O 0 1.379136574541917e-05
- O 0 2.8875561497443414e-07
localization O 0 1.1614007888738342e-07
of O 0 1.2808194782554239e-10
ATP7B O 0 1.5862595319049433e-05
and O 0 2.5436002262790858e-11
C04107 O 0 3.231051884378111e-11
, O 0 9.998555633341632e-15
using O 0 4.3198107715696973e-14
fluorescence O 0 1.1264381788445021e-11
in O 0 1.7157187671458518e-13
situ O 0 1.4584347618473714e-10
hybridization O 0 4.768152539469384e-10
( O 0 9.582580562383924e-11
FISH O 0 2.252645145972565e-07
) O 0 7.863195511381704e-11
. O 0 9.645183263184975e-11

C04107 O 0 1.0767241292342078e-05
is O 0 1.2350697131680022e-09
an O 0 2.655134575743623e-12
anonymous O 0 6.095009913442695e-11
microsatellite O 0 1.1813659739345894e-06
marker O 0 4.775726210937137e-06
closely O 0 1.6897782018077123e-07
linked O 0 5.461494765768293e-06
to O 0 5.497992727754308e-09
CT B-Disease 0 0.031137866899371147
. O 0 1.0119706850275634e-08

However O 0 8.246257898747444e-09
, O 0 4.263785158276079e-11
BAC O 0 8.795760564339616e-09
clones O 0 7.360597464867169e-08
containing O 0 1.4884983023932818e-08
ATP7B O 0 1.7488309822510928e-05
and O 0 4.297038072587078e-11
C04107 O 0 1.8252720168643322e-10
mapped O 0 5.140865511066295e-09
to O 0 1.9004811613321237e-11
the O 0 4.693412325451618e-11
canine O 0 4.780092785949819e-05
chromosome O 0 0.00047755989362485707
regions O 0 2.114678920861479e-08
CFA22q11 O 0 5.881450761080487e-06
and O 0 9.241444831609158e-10
CFA10q26 O 0 1.9840773290979996e-07
, O 0 5.996805482744172e-12
respectively O 0 8.793067662882237e-11
, O 0 6.134119904729896e-13
demonstrating O 0 9.460360966828674e-11
that O 0 2.185531616794023e-10
WD B-Disease 0 0.0002783816016744822
cannot O 0 1.7475808578026886e-09
be O 0 4.794896684562344e-12
homologous O 0 5.5744608928876e-10
to O 0 9.78128134043743e-10
CT B-Disease 0 0.001911983941681683
. O 0 7.879297214685721e-09

The O 0 9.707000536707255e-09
copper O 0 6.19844968241523e-06
transport O 0 4.644208129178651e-09
genes O 0 3.974554019237075e-09
CTR1 O 0 8.293585779028945e-06
and O 0 5.816678805281583e-10
CTR2 O 0 7.425145668094046e-06
were O 0 7.72718833363939e-10
also O 0 3.441799623082886e-11
excluded O 0 1.990715925437314e-10
as O 0 3.743611323714369e-12
candidate O 0 6.769601155684479e-13
genes O 0 2.055944997580994e-11
for O 0 1.4149788979400668e-11
CT B-Disease 0 0.0003682052483782172
since O 0 3.785925350996422e-09
they O 0 3.997492874913133e-12
both O 0 4.676340694884096e-13
mapped O 0 3.712574141445657e-07
to O 0 5.011453474423888e-09
canine O 0 0.010667657479643822
chromosome O 0 0.011352312751114368
region O 0 2.9457382311193214e-07
CFA11q22 O 0 6.664804823230952e-05
. O 0 6.716600609024681e-09

2 O 0 1.9772498944803374e-06
- O 0 0.00011270759569015354
22 O 0 2.7015607884095516e-07
. O 0 1.984681308186964e-09

5 O 0 2.3780430637998506e-06
. O 0 7.59814540174375e-08

A O 0 6.899935733883922e-09
transcribed O 0 3.569133433245497e-09
sequence O 0 4.5691525563107405e-10
identified O 0 4.873795589332985e-09
from O 0 2.77166679364671e-12
the O 0 2.70433350192667e-12
C04107 O 0 3.2783458170371205e-09
- O 0 3.348252519685957e-08
containing O 0 3.5496758865605216e-09
BAC O 0 6.525818463387623e-08
was O 0 1.652568215604333e-08
found O 0 5.938848024467092e-11
to O 0 4.887786681471995e-13
be O 0 2.587738400297579e-12
homologous O 0 1.441561106596545e-11
to O 0 4.873285802675653e-12
a O 0 3.0525415528614985e-11
gene O 0 1.655731773908542e-09
expressed O 0 3.9620290555320015e-12
from O 0 8.580198725995081e-13
human O 0 1.2133079263509927e-10
chromosome O 0 2.7925163976760814e-06
2p13 O 0 5.0749125790616745e-08
- O 0 1.720488853607094e-07
p16 O 0 7.1466894624450106e-09
, O 0 3.7089918809851685e-12
a O 0 7.060709655837272e-12
region O 0 7.43078862330826e-12
devoid O 0 1.608947697295804e-11
of O 0 1.5165993461074834e-13
any O 0 1.8905892476550612e-11
positional O 0 3.3279934541496914e-07
candidate O 0 1.940970717484447e-09
genes O 0 1.984598974047458e-08
. O 0 9.033792047752343e-10

Molecular O 0 1.23723955525179e-08
analysis O 0 2.736255666491161e-10
of O 0 9.450075270922564e-12
the O 0 1.1787848475108831e-11
APC B-Disease 0 2.4190086378439446e-08
gene O 0 1.3449789060260287e-09
in O 0 2.289785982351189e-12
205 O 0 2.196825166222993e-09
families O 0 2.5448766358127095e-11
: O 0 1.3078126906082566e-12
extended O 0 5.633480487654552e-11
genotype O 0 3.7283129472598375e-08
- O 0 2.0846732695645187e-06
phenotype O 0 6.354763115723472e-08
correlations O 0 6.570969901531498e-08
in O 0 3.290326344718153e-11
FAP B-Disease 0 1.2683391004131295e-09
and O 0 1.1240102815515685e-12
evidence O 0 7.033665750527662e-12
for O 0 7.993155833399546e-13
the O 0 1.9188413878656885e-12
role O 0 2.349613004160034e-10
of O 0 2.4382075134929404e-13
APC B-Disease 0 4.801493425077297e-09
amino O 0 8.74336436584855e-11
acid O 0 4.933463637613045e-10
changes O 0 1.544701699884854e-09
in O 0 4.769467523146886e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
predisposition O 0 0.26565927267074585
. O 0 1.1356097218140349e-07

BACKGROUND O 0 3.5542717569114757e-07
/ O 0 8.061075504883775e-07
AIMS O 0 5.295990135323336e-08
The O 0 3.030173334472863e-11
development O 0 2.0532577027498888e-10
of O 0 2.8392150852596387e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.131765792194983e-08
a O 0 1.2528877935125138e-10
variable O 0 8.627313974329809e-09
range O 0 1.874634847354173e-08
of O 0 1.2690166695250582e-09
extracolonic O 0 0.16767968237400055
manifestations O 0 0.003795342519879341
in O 0 7.674167136428878e-06
familial B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 0.999992847442627
polyposis I-Disease 1 0.9999992847442627
( O 0 1.2417287962307455e-06
FAP B-Disease 0 1.0534477041801438e-06
) O 0 4.237686937469398e-11
is O 0 2.8078062878217347e-12
the O 0 5.843892535682682e-13
result O 0 2.2489662909741526e-11
of O 0 5.75439218844509e-12
the O 0 2.6142437103970906e-09
dominant O 0 8.826074190437794e-05
inheritance O 0 0.0030301434453576803
of O 0 0.002259449567645788
adenomatous B-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.999987006187439
coli I-Disease 1 0.9999994039535522
( O 0 1.0022494478789667e-07
APC B-Disease 0 5.701791678802692e-07
) O 0 2.499922838183899e-11
gene O 0 7.73360664396705e-09
mutations O 0 1.128682924900204e-06
. O 0 7.73686714694577e-09

In O 0 5.462200691752628e-10
this O 0 1.1332192779642258e-12
study O 0 9.031813925225451e-13
, O 0 5.914377061017051e-14
direct O 0 5.991495006293229e-14
mutation O 0 2.3071829169385438e-11
analysis O 0 6.077269763815618e-12
of O 0 1.9665009638042408e-12
the O 0 2.5255296118298354e-11
APC B-Disease 0 9.769967945771896e-09
gene O 0 6.050696610415685e-10
was O 0 4.25940838155725e-09
performed O 0 3.52022196115076e-11
to O 0 4.3984144126353597e-13
determine O 0 5.2115586152146065e-11
genotype O 0 1.6567403449130325e-08
- O 0 9.966086054191692e-07
phenotype O 0 2.367388773905077e-08
correlations O 0 1.2054341524958545e-08
for O 0 3.0280658536163685e-10
nine O 0 1.8688549374701324e-08
extracolonic O 0 7.765685040794779e-06
manifestations O 0 6.525158369186101e-08
and O 0 1.163985487856456e-11
to O 0 2.740628633323555e-13
investigate O 0 2.1420824836138053e-10
the O 0 3.320772129500327e-11
incidence O 0 1.2490260132835829e-06
of O 0 3.3454197745363956e-11
APC B-Disease 0 7.205017595879326e-07
mutations O 0 1.0273761574808304e-07
in O 0 2.334286930416596e-10
non O 0 5.706822412321344e-05
- O 1 0.9996898174285889
FAP O 1 0.9990373849868774
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999920129776001
. O 0 2.682363344774785e-07

METHODS O 0 4.086043503548353e-08
The O 0 4.0083977803639925e-11
APC B-Disease 0 2.5512811419048376e-08
gene O 0 3.930677561214679e-09
was O 0 1.0541567618815861e-09
analysed O 0 2.2326973603270517e-09
in O 0 9.1346190594227e-13
190 O 0 2.5370204201347057e-11
unrelated O 0 4.473612591482379e-10
FAP B-Disease 0 9.94138460441718e-09
and O 0 1.6581928885539554e-10
15 O 0 2.4724078340199185e-09
non O 0 6.045054760761559e-06
- O 1 0.9983415603637695
FAP O 1 0.999116837978363
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999986886978149
patients O 0 2.2746212380297948e-07
using O 0 1.200553101377011e-09
denaturing O 0 5.604075704468414e-05
gradient O 0 1.0311900041415356e-05
gel O 0 4.505585093284026e-05
electrophoresis O 0 4.807030791198486e-07
, O 0 1.6692095622383718e-11
the O 0 6.104660505400206e-13
protein O 0 5.82255910153151e-11
truncation O 0 1.3702361023604226e-08
test O 0 1.8326805673041235e-07
, O 0 1.3309361208621584e-12
and O 0 7.778692512165619e-14
direct O 0 1.87739342301374e-12
sequencing O 0 2.198863668922968e-08
. O 0 2.0935482236694725e-09

RESULTS O 0 5.898830863770854e-07
Chain O 0 7.618794484187674e-07
terminating O 0 2.3517365832503856e-07
signals O 0 1.990655817962761e-07
were O 0 6.393930940262749e-10
only O 0 3.526200815714975e-12
identified O 0 1.436681995592437e-09
in O 0 6.928608294737293e-12
patients O 0 2.7824364340345298e-11
belonging O 0 7.91738827277122e-11
to O 0 1.3006861213082921e-11
the O 0 1.4944792625648518e-10
FAP B-Disease 0 1.4779325852032343e-07
group O 0 4.697964794964093e-10
( O 0 7.616703275037384e-12
105 O 0 5.204101594102895e-10
patients O 0 5.621439980174614e-10
) O 0 8.057833913999168e-12
. O 0 5.435986383250935e-11

Amino O 0 1.1832720758775395e-07
acid O 0 1.0506585823577552e-08
changes O 0 4.0448783211743944e-11
were O 0 6.067331966702616e-12
identified O 0 1.803841798153627e-10
in O 0 3.28595332367565e-12
four O 0 1.6181204154364082e-09
patients O 0 4.316623725131308e-10
, O 0 6.4692533014582e-13
three O 0 1.208793742185632e-11
of O 0 7.048200217907308e-11
whom O 0 7.93200101156799e-08
belonged O 0 2.281507605061961e-08
to O 0 3.3979419278296064e-10
the O 0 8.501302439789526e-10
non O 0 1.1185119319634396e-06
- O 0 1.0889766599575523e-05
FAP O 0 2.7034266736336576e-07
group O 0 4.5723282937615295e-09
of O 0 1.015763814393722e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
patients O 0 6.037944331183098e-06
. O 0 8.994179845345229e-10

Genotype O 0 0.0004397028824314475
- O 0 0.00036317226476967335
phenotype O 0 1.2916102605231572e-05
correlations O 0 3.2963164358079666e-06
identified O 0 2.1985717921779724e-06
significant O 0 6.938974284054211e-09
differences O 0 5.4059679399642846e-08
in O 0 6.431918886384835e-11
the O 0 2.7621422510337723e-11
nature O 0 3.2166588836979315e-10
of O 0 4.327154086436469e-12
certain O 0 1.2886215705609771e-10
extracolonic O 0 3.320452833577292e-06
manifestations O 0 2.9438306015094895e-08
in O 0 2.38193752916116e-11
FAP B-Disease 0 8.942988927174156e-08
patients O 0 5.798623248232104e-10
belonging O 0 7.110989574954374e-11
to O 0 1.542468583415335e-11
three O 0 7.726392858842246e-10
mutation O 0 3.674973640954704e-07
subgroups O 0 5.638148081743566e-07
. O 0 5.6147242410986564e-09

CONCLUSIONS O 0 1.6978923156329984e-07
Extended O 0 4.790627983197737e-08
genotype O 0 2.6710342808655696e-06
- O 0 2.38989287026925e-05
phenotype O 0 1.0510493666515686e-06
correlations O 0 1.0583466973912437e-06
made O 0 4.8848605160856096e-09
in O 0 5.124821574054028e-12
this O 0 5.486479326410887e-13
study O 0 2.3874230717368938e-11
may O 0 8.080836000345926e-10
have O 0 5.95186009852422e-13
the O 0 1.7426378807854082e-13
potential O 0 6.000321073340587e-11
to O 0 4.1856446151948556e-13
determine O 0 4.1173761448909385e-12
the O 0 6.101528787424981e-13
most O 0 3.513476944279337e-13
appropriate O 0 9.978560946283244e-13
surveillance O 0 5.46948335511388e-08
and O 0 4.660521968347098e-11
prophylactic O 0 9.905006592703103e-09
treatment O 0 4.387593413590629e-11
regimens O 0 6.536219482322636e-12
for O 0 2.7503528426085777e-13
those O 0 2.1735247282550496e-11
patients O 0 4.484365656587386e-11
with O 0 2.89248573009937e-12
mutations O 0 3.3738821514361916e-08
associated O 0 7.984970462615593e-10
with O 0 9.040169168805789e-10
life O 0 5.719256819247676e-07
threatening O 0 0.0009928988292813301
conditions O 0 1.0826281737763566e-07
. O 0 5.213042775231713e-10

This O 0 5.2868379812887056e-11
study O 0 5.826047283497005e-11
also O 0 1.3015298040708334e-11
provided O 0 4.132369359893806e-13
evidence O 0 9.618430184266114e-12
for O 0 6.786139792464008e-12
the O 0 3.0251551264015575e-11
pathological O 0 1.2084133516054862e-07
nature O 0 2.900693019114442e-10
of O 0 1.369580230475842e-12
amino O 0 1.3502990392488812e-10
acid O 0 1.5776027706415618e-10
changes O 0 6.483103984211702e-12
in O 0 9.3950411686472e-13
APC O 0 1.1897872020938394e-08
associated O 0 3.1340929851353394e-11
with O 0 1.872526222621018e-12
both O 0 4.6893496030708803e-11
FAP B-Disease 0 7.758652742495542e-08
and O 0 2.47835685307507e-09
non O 0 1.9069211703026667e-05
- O 1 0.9993724226951599
FAP O 1 0.9996376037597656
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
patients O 0 2.349231181142386e-06
. O 0 1.782064079636214e-11
. O 0 2.430368961636731e-10

Inherited B-Disease 1 0.9999306201934814
colorectal I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999551773071289
and O 0 8.049065218074247e-05
cancer B-Disease 0 0.02674228325486183
risk O 0 3.56013106284081e-06
of O 0 1.3590004122043808e-11
the O 0 2.6090071769679923e-10
APC O 0 2.489070311639807e-06
I1307K O 0 1.1519704656848262e-07
polymorphism O 0 1.5256007372954627e-06
. O 0 3.441520624036798e-09

Germ O 0 0.0023777210153639317
- O 0 0.0006149078835733235
line O 0 5.9821654758707155e-06
and O 0 5.149555434846853e-11
somatic O 0 4.910793993673224e-09
truncating O 0 7.872871066183507e-08
mutations O 0 4.010499310425075e-08
of O 0 2.4319849519643943e-12
the O 0 1.7310946079374112e-11
APC B-Disease 0 3.080368671248834e-08
gene O 0 6.950826025864387e-10
are O 0 9.1153343553807e-13
thought O 0 3.560032824090342e-11
to O 0 5.165117292205146e-11
initiate O 0 1.0142054634343367e-05
colorectal B-Disease 1 0.9999997615814209
tumor I-Disease 1 0.7707650065422058
formation O 0 4.968898792867549e-05
in O 0 3.138419197057374e-05
familial B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 0.9999977350234985
polyposis I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999995231628418
and O 0 1.002717681330978e-06
sporadic O 0 0.0006862960290163755
colorectal O 1 0.9999994039535522
carcinogenesis O 1 0.965080738067627
, O 0 9.31531971559707e-08
respectively O 0 1.3873052751023351e-07
. O 0 3.3555775935667498e-09

Recently O 0 3.665858912427211e-06
, O 0 5.4282980888054055e-11
an O 0 1.0838450796579746e-11
isoleucine O 0 4.1210158087778836e-05
- O 0 0.0001893994922284037
- O 0 1.8412507415632717e-05
> O 0 1.2367440405114394e-08
lysine O 0 3.1618062621419085e-06
polymorphism O 0 3.236346231005882e-07
at O 0 2.690488898338117e-08
codon O 0 4.618839355430282e-08
1307 O 0 2.740123505873271e-08
( O 0 7.486670138001639e-12
I1307K O 0 1.2823692108199225e-10
) O 0 5.001614357055817e-14
of O 0 1.0033362758243153e-14
the O 0 4.589584463345064e-13
APC B-Disease 0 5.284565229857208e-09
gene O 0 1.281616812676134e-09
has O 0 8.42440395221189e-10
been O 0 4.76856221176547e-10
identified O 0 2.1857076148990018e-09
in O 0 2.501196472159961e-11
6 O 0 1.3209894511589937e-08
% O 0 4.634520198165681e-12
- O 0 3.814122635503736e-07
7 O 0 1.498239754482711e-08
% O 0 2.750069865841559e-13
of O 0 2.930702284586334e-13
the O 0 2.2369502084007564e-10
Ashkenazi O 0 1.8920863453786296e-07
Jewish O 0 1.0822184259851042e-09
population O 0 9.358012281746042e-11
. O 0 8.481926966341646e-11

To O 0 1.6389376522596422e-09
assess O 0 2.160537171391752e-08
the O 0 4.5746701565763104e-11
risk O 0 6.073106906256953e-09
of O 0 1.193960295214902e-13
this O 0 5.080332855789127e-13
common O 0 4.2338087896665044e-11
APC B-Disease 0 1.0605120337459084e-08
allelic O 0 1.5483898607726587e-08
variant O 0 1.710804644972086e-05
in O 0 3.3988658998396204e-08
colorectal O 1 0.9999997615814209
carcinogenesis O 0 0.006391220726072788
, O 0 4.363595262901754e-09
we O 0 3.7538971930928255e-10
have O 0 2.093808633418792e-12
analyzed O 0 6.662723150974159e-11
a O 0 8.030201503750334e-12
large O 0 2.6611234049678245e-11
cohort O 0 2.2730235471613014e-09
of O 0 2.037713400793173e-11
unselected O 0 9.88598694675602e-05
Ashkenazi O 0 7.4395202318555675e-06
Jewish O 0 6.0188392048132755e-09
subjects O 0 1.7048636280492246e-08
with O 0 6.543464881048067e-09
adenomatous B-Disease 0 0.006275225430727005
polyps I-Disease 0 0.21739903092384338
and O 0 3.948563076505707e-08
. O 0 2.1394621629866606e-09
or O 0 0.025783197954297066
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 5.081590703781558e-10
for O 0 4.834624020566558e-12
the O 0 1.3610445236122981e-11
APC O 0 5.032284775552398e-07
I1307K O 0 6.211155323398998e-08
polymorphism O 0 8.342150863427378e-07
. O 0 4.505546602473487e-09

The O 0 1.5838960143454983e-09
APC O 0 1.5150193632962328e-07
I1307K O 0 2.6849729550804113e-08
allele O 0 1.5444873824321803e-08
was O 0 9.039760051621215e-09
identified O 0 1.875381405724852e-09
in O 0 1.1993593618253584e-11
48 O 0 4.740280168391564e-09
( O 0 4.862293293689257e-12
10 O 0 1.9443108581485014e-11
. O 0 1.5633154493155388e-13
1 O 0 2.3675613552986974e-11
% O 0 1.2008369830191629e-13
) O 0 4.6256492966479865e-14
of O 0 5.374679108889613e-13
476 O 0 1.2176309382994077e-07
patients O 0 5.888750376215057e-09
. O 0 1.241879377111843e-10

Compared O 0 9.253817978560619e-08
with O 0 5.2586789089925645e-11
the O 0 2.639134353762951e-12
frequency O 0 1.6046884654397076e-10
in O 0 2.4066916536925886e-13
two O 0 1.6229513121867462e-13
separate O 0 4.514426159285545e-12
population O 0 9.99643510329884e-12
control O 0 3.6529487768000024e-10
groups O 0 1.3855605031365403e-12
, O 0 7.109381985025143e-13
the O 0 2.5499771565129503e-12
APC O 0 1.305305730170403e-08
I1307K O 0 1.206482358462324e-09
allele O 0 6.52792875310837e-10
is O 0 1.5372120243384302e-10
associated O 0 6.609206237850884e-12
with O 0 2.7771702038742463e-12
an O 0 1.8170456458910245e-11
estimated O 0 1.3559576572674814e-08
relative O 0 7.900037246599823e-08
risk O 0 4.847847208111489e-07
of O 0 4.488558830173517e-11
1 O 0 1.7039079480696273e-08
. O 0 1.2169264484995779e-09

5 O 0 2.6403489528092905e-07
- O 0 1.9833329133689404e-05
1 O 0 3.873794085507143e-08
. O 0 8.734001299970373e-10

7 O 0 8.60019781612209e-07
for O 0 1.0888386725582677e-07
colorectal B-Disease 1 0.9999971389770508
neoplasia I-Disease 1 0.9951364398002625
( O 0 2.831219774179772e-07
both O 0 6.932428675554547e-08
P O 1 0.6974256038665771
= O 0 5.356136171030812e-06
. O 0 2.005089844159258e-10
01 O 0 2.267286618007347e-06
) O 0 5.96266092056652e-11
. O 0 3.0757277280635265e-10

Furthermore O 0 1.929547188694869e-08
, O 0 6.608100178162601e-11
compared O 0 1.2678964544932114e-09
with O 0 2.8045269231946612e-11
noncarriers O 0 9.73793248704169e-07
, O 0 5.969735990263292e-12
APC O 0 1.3051233427319175e-09
I1307K O 0 4.762599203900209e-10
carriers O 0 3.6460159891227306e-10
had O 0 2.539160201542323e-11
increased O 0 1.328602700946535e-12
numbers O 0 3.970456342178297e-12
of O 0 9.961413638404082e-12
adenomas B-Disease 0 0.00275687244720757
and O 0 4.1113448787655216e-06
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9911864399909973
per O 0 1.7340186104775057e-06
patient O 0 0.00020562198187690228
( O 0 1.54983759159677e-08
P O 0 0.07205785810947418
= O 0 2.298841764059034e-06
. O 0 4.595124974970943e-11
03 O 0 4.3135500504831725e-08
) O 0 3.1095592680635553e-12
, O 0 1.434576849673741e-12
as O 0 2.055678544055084e-11
well O 0 1.4491781039072116e-11
as O 0 3.275167637095677e-11
a O 0 7.58973300873933e-11
younger O 0 1.4256519520472466e-08
age O 0 2.273196963997748e-09
at O 0 7.032308513288399e-09
diagnosis O 0 8.753603424338507e-07
. O 0 1.4001207970792962e-09

We O 0 1.826798490256465e-09
conclude O 0 5.34520316897158e-10
that O 0 4.694565049201405e-12
the O 0 1.4484726352376187e-12
APC O 0 1.2036926122505065e-08
I1307K O 0 2.0915724707748495e-09
variant O 0 1.292240980887982e-08
leads O 0 3.3269760280063565e-09
to O 0 1.1102517794014943e-09
increased O 0 2.2045344394427957e-06
adenoma B-Disease 1 0.9999984502792358
formation O 0 1.0400180627812006e-07
and O 0 3.7451863832416166e-10
directly O 0 6.146986392119302e-11
contributes O 0 1.3221231887072804e-09
to O 0 2.946454885632832e-11
3 O 0 5.705327876803779e-10
% O 0 3.339508140506875e-12
- O 0 2.20262474925903e-08
4 O 0 6.239123662155066e-10
% O 0 4.5485615057447304e-14
of O 0 4.5530663657714077e-14
all O 0 8.644274740454705e-10
Ashkenazi O 0 5.4200027079787105e-05
Jewish O 0 0.0007963639800436795
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999964237213135
. O 0 1.365522308560685e-07

The O 0 1.493288270815185e-10
estimated O 0 9.184686344809734e-10
relative O 0 1.7564263377067846e-09
risk O 0 3.8078415087738904e-08
for O 0 2.6760930277314188e-11
carriers O 0 1.3821082056608702e-08
may O 0 6.529494306350969e-11
justify O 0 4.265369307754341e-12
specific O 0 1.1602561088546598e-13
clinical O 0 2.094647372219427e-12
screening O 0 7.508721075466518e-12
for O 0 2.444423786648886e-13
the O 0 1.9643856853657216e-13
360 O 0 2.2071884250851603e-11
, O 0 2.835889346703563e-13
000 O 0 1.757864795566555e-12
Americans O 0 4.179065513781888e-12
expected O 0 9.849304531683867e-12
to O 0 1.3678258829405432e-12
harbor O 0 5.146200132699619e-10
this O 0 2.2462674081902279e-13
allele O 0 3.2335922134363315e-11
, O 0 9.114291352890769e-13
and O 0 1.5988782292499643e-13
genetic O 0 1.651847061912015e-11
testing O 0 2.3132042947793252e-09
in O 0 7.042817392645395e-13
the O 0 6.610387692958242e-13
setting O 0 3.03616271013496e-10
of O 0 2.567464643665751e-11
long O 0 7.522210410115804e-08
- O 0 1.3269551345729269e-05
term O 0 5.930684565669253e-08
- O 0 2.0944758816199283e-08
outcome O 0 7.582064143196732e-11
studies O 0 3.4748447608895505e-12
may O 0 1.2016308954809762e-11
impact O 0 2.573427582142074e-10
significantly O 0 1.0421447171893305e-07
on O 0 0.025187844410538673
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
prevention O 0 1.8328064754769002e-07
in O 0 1.064995639420141e-12
this O 0 6.067930988402914e-13
population O 0 2.5665244235417717e-11
. O 0 2.4011975741089486e-10

Localization O 0 7.18196702109708e-07
of O 0 2.592434045212144e-10
human O 0 1.4040553608651862e-08
BRCA1 O 0 0.00010246894817100838
and O 0 8.406282336892446e-10
its O 0 1.6385859682999104e-11
loss O 0 1.2684993500045039e-08
in O 0 9.620080773653505e-12
high O 0 4.363339769497543e-07
- O 0 0.00022695810184814036
grade O 0 8.628906653029844e-05
, O 0 6.321138612541688e-10
non B-Disease 0 1.742817062222457e-06
- I-Disease 0 0.16860836744308472
inherited I-Disease 1 0.9882025122642517
breast I-Disease 1 0.999171257019043
carcinomas I-Disease 1 0.999995231628418
. O 0 6.041154847480357e-07

Although O 0 4.4498120743696745e-09
the O 0 9.924357342872003e-12
link O 0 7.494081799563901e-09
between O 0 9.805228851078596e-10
the O 0 1.3462422288057496e-08
BRCA1 O 1 0.7465978860855103
tumour B-Disease 1 0.9999992847442627
- O 0 1.6430487448815256e-05
suppressor O 0 8.5414394561667e-06
gene O 0 1.8969398297485895e-05
and O 0 1.0886597010539845e-06
hereditary B-Disease 1 0.9999834299087524
breast I-Disease 1 0.9999994039535522
and I-Disease 1 0.9999942779541016
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.3158553429093445e-06
established O 0 4.07219280518234e-09
, O 0 5.1076302909347504e-11
the O 0 2.8297055670867266e-11
role O 0 5.995536156433445e-08
, O 0 2.3264573861120352e-12
if O 0 6.737552681566894e-13
any O 0 7.793131374597695e-13
, O 0 7.518692157586215e-13
of O 0 1.6696035829918965e-12
BRCA1 O 0 2.926015258708503e-05
in O 0 2.984296365582395e-09
non B-Disease 0 0.0005199376028031111
- I-Disease 1 0.9479648470878601
familial I-Disease 1 0.9256011247634888
cancers I-Disease 1 0.8772751092910767
is O 0 5.8150178006144415e-09
unclear O 0 1.0779438452956924e-09
. O 0 4.859572189097605e-10

BRCA1 O 0 0.3344186544418335
mutations O 0 0.00015371592598967254
are O 0 4.880509330007499e-10
rare O 0 2.0365265029909096e-09
in O 0 1.1454243803443731e-10
sporadic B-Disease 0 6.023393780196784e-06
cancers I-Disease 1 0.9747517108917236
, O 0 2.8415856334618184e-09
but O 0 3.1514241216612504e-10
loss O 0 2.30719514604516e-08
of O 0 5.462219218599351e-11
BRCA1 O 0 0.00010198456584475935
resulting O 0 1.2630456680540192e-08
from O 0 2.608724791741679e-09
reduced O 0 6.145025821524541e-08
expression O 0 1.6948572545416596e-09
or O 0 1.0653949944483543e-10
incorrect O 0 5.298351535287793e-09
subcellular O 0 4.391183239249585e-08
localization O 0 1.567757408338366e-07
is O 0 4.244985751800101e-10
postulated O 0 7.343636809764575e-10
to O 0 4.9188882134121314e-11
be O 0 1.1683277956198168e-10
important O 0 1.725273396369076e-11
in O 0 4.532624622854975e-11
non B-Disease 0 6.654618573520565e-06
- I-Disease 1 0.9421191215515137
familial I-Disease 1 0.9997163414955139
breast I-Disease 1 0.9999915361404419
and I-Disease 1 0.9987892508506775
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999991655349731
. O 0 5.748840976593783e-07

Epigenetic O 0 3.536434451234527e-05
loss O 0 0.001671933219768107
, O 0 2.354261452452988e-09
however O 0 5.1094812408836177e-11
, O 0 3.029039042160009e-12
has O 0 3.251403660198271e-11
not O 0 4.216172224714987e-13
received O 0 9.702815807755005e-13
general O 0 2.2064761042578374e-12
acceptance O 0 6.267770330525835e-11
due O 0 1.7139217128869788e-11
to O 0 4.676572172047921e-13
controversy O 0 3.190864239499547e-11
regarding O 0 3.734924695908415e-12
the O 0 4.405996509478094e-13
subcellular O 0 6.494297877246424e-10
localization O 0 2.8649598249330666e-09
of O 0 1.5698518873730194e-11
BRCA1 O 0 5.796046593786741e-07
proteins O 0 1.2845675911865584e-10
, O 0 2.1843197552367383e-13
reports O 0 3.0111761608470067e-12
of O 0 7.404116382503378e-13
which O 0 1.4728369912564432e-10
have O 0 1.2856117559412183e-10
ranged O 0 1.4951700988419248e-09
from O 0 3.1536698166106936e-12
exclusively O 0 2.468561743906861e-10
nuclear O 0 3.5960860600425804e-07
, O 0 1.3825713577469978e-13
to O 0 9.080173543401723e-14
conditionally O 0 1.3291522327207872e-09
nuclear O 0 2.1375218040020627e-08
, O 0 1.3677991031468828e-13
to O 0 3.980205379693069e-13
the O 0 2.4679107715752657e-11
ER O 0 7.0383880483859684e-06
/ O 0 1.9391066530261014e-08
golgi O 0 1.4459091346452624e-07
, O 0 5.088918002271736e-12
to O 0 6.848458974396954e-13
cytoplasmic O 0 1.009901273718583e-09
invaginations O 0 1.653305758964052e-08
into O 0 4.294921623210213e-12
the O 0 1.9766023887091144e-11
nucleus O 0 5.776702227677788e-09
. O 0 7.850879946147415e-10

In O 0 3.159398576091377e-10
an O 0 1.2709969361701656e-11
attempt O 0 7.251825806520174e-10
to O 0 1.4736406539483937e-10
resolve O 0 1.902333579550941e-08
this O 0 1.7362288906933032e-12
issue O 0 2.478984517662042e-10
, O 0 1.3290234798096767e-12
we O 0 1.5502757064189687e-11
have O 0 8.407765803020162e-12
comprehensively O 0 5.808690843878139e-07
characterized O 0 1.4284602389835754e-09
19 O 0 2.2380353126294494e-09
anti O 0 4.732577053800924e-06
- O 0 0.0006687272107228637
BRCA1 O 0 0.001214755466207862
antibodies O 0 3.514002742122102e-07
. O 0 3.576962059881339e-10

These O 0 3.4104732926643067e-10
reagents O 0 4.460468439049237e-09
detect O 0 6.173761590844151e-08
a O 0 5.299154864912836e-11
220 O 0 2.5649010693129526e-10
- O 0 1.8681105018458766e-07
kD O 0 7.392817735762947e-08
protein O 0 5.074307085628504e-10
localized O 0 1.2962189654963652e-10
in O 0 9.037462076443015e-14
discrete O 0 2.6238722999893938e-11
nuclear O 0 1.5640449646525667e-06
foci O 0 1.792135861933275e-08
in O 0 7.971160190245463e-12
all O 0 1.1372732616754533e-11
epithelial O 0 6.404992536346299e-09
cell O 0 1.0873460496441112e-06
lines O 0 8.876456263351429e-07
, O 0 1.4292437025553717e-11
including O 0 3.791368694688879e-12
those O 0 5.80982050663037e-12
derived O 0 1.2217982181539355e-10
from O 0 2.3995323505943134e-09
breast B-Disease 0 0.002301751170307398
malignancies I-Disease 0 0.0001382565824314952
. O 0 1.9429272413162835e-08

Immunohistochemical O 0 6.688705616397783e-05
staining O 0 1.2760223398800008e-05
of O 0 3.1678599743401037e-09
human O 0 1.6946957259733608e-07
breast O 0 0.0009096598951146007
specimens O 0 7.233497399283806e-06
also O 0 5.0420506880755056e-08
revealed O 0 1.1959378980463953e-06
BRCA1 O 0 0.0018497415585443377
nuclear O 0 0.00013077666517347097
foci O 0 8.264483767561615e-06
in O 0 9.758961638794972e-09
benign O 0 0.04709011688828468
breast O 0 0.4300176203250885
, O 0 7.891317466146575e-08
invasive B-Disease 0 0.434659868478775
lobular I-Disease 1 0.9997410178184509
cancers I-Disease 1 0.999929666519165
and O 0 4.4247731239011046e-06
low B-Disease 0 0.09245265275239944
- I-Disease 1 0.9970132112503052
grade I-Disease 1 0.9835784435272217
ductal I-Disease 1 0.9987537860870361
carcinomas I-Disease 1 0.999983549118042
. O 0 1.0642453389664297e-06

Conversely O 0 6.564432624145411e-06
, O 0 6.963528864645241e-09
BRCA1 O 0 8.727949170861393e-05
expression O 0 3.202899634402456e-08
was O 0 1.246715584102276e-07
reduced O 0 8.45896153123249e-09
or O 0 1.7315585632005082e-09
undetectable O 0 5.750191121478565e-06
in O 0 4.248026843484132e-12
the O 0 8.218229157093415e-13
majority O 0 1.50733147751686e-12
of O 0 4.39274918523358e-12
high O 0 2.0818679331569e-06
- O 0 9.421532013220713e-05
grade O 0 7.912106229923666e-05
, O 0 5.660129032136751e-10
ductal B-Disease 0 2.7859041438205168e-05
carcinomas I-Disease 1 0.9999942779541016
, O 0 1.4815233762011104e-10
suggesting O 0 1.425324969162034e-09
that O 0 3.585218233403964e-11
absence O 0 6.228803028918151e-10
of O 0 3.574436927000768e-11
BRCA1 O 0 0.0031738621182739735
may O 0 6.602176227943346e-08
contribute O 0 2.5978977649665502e-11
to O 0 1.8824061233380096e-12
the O 0 1.3879251480747312e-12
pathogenesis O 0 3.798115988384865e-11
of O 0 4.621204745367154e-14
a O 0 1.2490830852279755e-12
significant O 0 4.13429490295214e-12
percentage O 0 2.261991838281574e-08
of O 0 2.5716809237685823e-10
sporadic B-Disease 0 0.00033271589200012386
breast I-Disease 1 0.9957907795906067
cancers I-Disease 0 0.44693195819854736
. O 0 9.289248814603468e-10
. O 0 1.6664882807049253e-09

